data_1z8r_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1z8r _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.812 0.339 . . . . 0.0 110.996 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.7 t -121.02 109.23 24.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.126 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.442 ' CD1' ' HG3' ' A' ' 16' ' ' LYS . 0.4 OUTLIER -93.88 115.83 28.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.423 179.864 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.412 ' CG2' HD13 ' A' ' 53' ' ' ILE . 19.2 t -121.29 108.89 23.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.786 0.327 . . . . 0.0 111.816 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 48.35 -124.59 11.63 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.94 -0.648 . . . . 0.0 113.242 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.436 ' O ' ' HA ' ' A' ' 44' ' ' THR . 33.0 p-10 -90.96 13.08 17.64 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.448 ' CE2' ' CE3' ' A' ' 142' ' ' TRP . 6.6 m-85 -130.34 127.8 40.17 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.442 ' HG3' ' CD1' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -116.4 114.89 24.89 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.561 0.219 . . . . 0.0 110.686 179.687 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.536 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 0.7 OUTLIER -100.63 122.08 52.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.119 0.485 . . . . 0.0 110.777 179.68 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.6 p -136.07 161.03 38.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.152 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -59.97 141.51 55.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.558 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 11.8 ttt180 -56.59 -47.12 80.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.855 0.36 . . . . 0.0 110.832 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 41.7 t-80 -69.1 -8.79 48.55 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.15 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 13.9 tp -110.78 -10.87 14.43 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.508 ' O ' ' CZ3' ' A' ' 28' ' ' TRP . . . -73.27 150.61 41.83 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 120.792 0.329 . . . . 0.0 110.814 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.7 p -103.65 169.32 8.59 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.442 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -54.64 -29.78 53.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.886 0.374 . . . . 0.0 110.543 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.5 t -73.93 -31.42 30.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.42 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.403 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 0.2 OUTLIER -67.29 -44.08 80.15 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.898 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.508 ' CZ3' ' O ' ' A' ' 23' ' ' ALA . 7.1 m-90 -74.29 -31.33 62.46 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.226 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 9.5 mm-40 -58.22 -43.8 87.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.452 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -113.46 33.39 5.16 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.404 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.449 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 27.2 t -80.05 134.11 36.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.279 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.416 ' CG2' HG11 ' A' ' 42' ' ' VAL . 15.3 m -97.28 -39.86 9.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.617 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.435 ' CE3' HG21 ' A' ' 42' ' ' VAL . 1.2 t90 -139.36 153.11 47.62 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.856 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -160.34 118.15 2.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.959 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -107.1 111.05 23.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.973 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.402 ' CE2' ' OD1' ' A' ' 37' ' ' ASN . 50.5 p90 -59.63 -47.23 86.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.242 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.415 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 2.1 m120 -60.02 -25.94 65.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.793 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.401 ' CZ ' ' HB3' ' A' ' 139' ' ' ASP . 20.7 ttm180 -100.07 -7.7 24.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.302 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 51.06 34.83 11.56 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 121.145 0.497 . . . . 0.0 110.258 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.5 tp -133.71 149.68 51.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.974 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.536 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -145.0 155.88 43.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.361 179.572 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.435 HG21 ' CE3' ' A' ' 33' ' ' TRP . 38.9 t -118.5 127.37 75.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.626 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.5 p -120.81 157.46 29.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.345 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 14' ' ' ASN . 10.5 p -97.57 146.59 25.13 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.165 0.507 . . . . 0.0 111.66 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.441 HG23 ' CZ ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -136.29 165.49 25.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.853 -179.25 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.1 t -93.29 -34.1 13.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.082 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.79 128.6 34.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.1 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -59.09 147.98 32.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.926 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -80.23 177.69 54.21 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.584 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -132.12 33.5 3.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.761 0.315 . . . . 0.0 110.905 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -138.45 144.49 40.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.911 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 63.0 m -120.83 115.91 24.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.793 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.499 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 0.4 OUTLIER -73.86 139.54 19.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.018 -179.872 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -93.38 133.53 36.54 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.54 27.11 2.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.991 0.424 . . . . 0.0 110.402 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 30.8 p -100.01 167.13 10.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.029 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -127.72 32.42 4.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.89 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 25.2 m -56.61 132.63 52.3 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.791 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.5 t -74.15 -8.61 56.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.969 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.1 p -118.46 130.77 56.14 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.891 0.377 . . . . 0.0 111.073 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -153.33 -167.94 16.45 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.84 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.407 HG22 ' HB2' ' A' ' 71' ' ' HIS . 7.5 p -133.75 126.24 50.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.007 0.432 . . . . 0.0 110.885 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.483 ' HB2' ' CZ ' ' A' ' 134' ' ' PHE . 3.1 p90 -111.14 153.91 25.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.102 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 4.0 t80 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.647 179.747 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.407 ' HB2' HG22 ' A' ' 62' ' ' VAL . 50.8 p-80 . . . . . 0 N--CA 1.456 -0.128 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -126.47 114.03 23.15 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.661 -178.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -74.54 120.54 6.24 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.356 2.037 . . . . 0.0 110.255 178.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 97.1 t -144.3 147.42 19.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.048 0.452 . . . . 0.0 112.167 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 53.6 p -92.02 137.19 32.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.295 178.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.46 ' CD1' ' N ' ' A' ' 76' ' ' PHE . 0.0 OUTLIER -146.48 168.43 21.22 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.22 0.534 . . . . 0.0 111.942 -178.882 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -113.0 158.39 20.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.05 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -106.03 68.17 0.24 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.917 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.528 ' HD2' ' HA ' ' A' ' 99' ' ' LEU . 38.0 Cg_endo -67.6 135.16 35.14 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.471 2.114 . . . . 0.0 112.227 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -59.27 -82.8 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.288 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.514 HD13 ' CD2' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -97.08 119.86 36.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.898 0.38 . . . . 0.0 111.749 -179.897 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.424 ' HB ' ' CG1' ' A' ' 98' ' ' VAL . 46.8 t -124.99 122.18 62.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.217 178.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.13 107.98 5.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.776 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 19.3 m -81.79 126.85 39.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.236 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.84 150.65 46.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.06 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.542 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 3.9 pt-20 -67.73 102.54 1.23 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.87 0.367 . . . . 0.0 110.431 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.428 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -143.89 164.1 31.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.425 -179.732 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.411 ' HG2' ' CE2' ' A' ' 89' ' ' TYR . 2.8 tt0 56.95 -81.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.543 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.428 ' N ' ' O ' ' A' ' 87' ' ' SER . 0.4 OUTLIER -155.64 22.93 0.4 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.926 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.542 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 9.7 t80 -123.79 136.8 27.78 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.883 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.446 ' O ' ' N ' ' A' ' 93' ' ' ARG . 86.4 Cg_endo -81.76 148.95 15.97 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.09 2.527 . . . . 0.0 112.451 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.562 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -49.2 89.52 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.804 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.446 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -124.13 169.64 11.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.259 0.552 . . . . 0.0 112.209 -179.126 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.514 ' CD2' HD13 ' A' ' 81' ' ' LEU . 2.9 m-85 -90.86 132.46 35.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.928 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.415 ' HA ' ' O ' ' A' ' 37' ' ' ASN . 10.1 mm-40 -124.5 131.87 53.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.054 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 12.0 p -101.31 147.52 26.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.998 0.428 . . . . 0.0 111.835 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.47 ' CD2' ' HB3' ' A' ' 136' ' ' ASP . 4.2 t60 63.85 55.98 1.55 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.946 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.424 ' CG1' ' HB ' ' A' ' 82' ' ' VAL . 11.6 p -123.44 135.86 61.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.872 0.368 . . . . 0.0 111.364 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.528 ' HA ' ' HD2' ' A' ' 79' ' ' PRO . 1.8 mp -104.3 133.42 49.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.161 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.804 ' HA ' ' O ' ' A' ' 132' ' ' VAL . 7.4 mt -116.53 138.54 51.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.18 0.514 . . . . 0.0 112.311 -179.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.416 ' O ' ' N ' ' A' ' 132' ' ' VAL . . . -128.47 119.28 24.6 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.565 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.7 t -87.37 111.83 21.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.886 0.374 . . . . 0.0 110.648 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 0.239 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.541 -179.854 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 112.671 -0.172 . . . . 0.0 112.671 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.6 pp -126.0 146.18 32.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.922 0.391 . . . . 0.0 111.415 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.447 HD22 ' CE2' ' A' ' 76' ' ' PHE . 56.2 tp -87.82 115.84 25.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.73 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 18.6 ptt-85 -118.74 143.95 46.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.076 0.465 . . . . 0.0 112.111 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.444 ' N ' ' CD1' ' A' ' 121' ' ' ILE . 35.4 t -108.14 166.15 10.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.264 178.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -55.51 -18.13 6.67 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.657 0.265 . . . . 0.0 110.867 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 53.7 m80 -91.33 -36.86 13.6 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.47 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 176.81 -140.82 5.14 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.201 -1.0 . . . . 0.0 113.57 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.499 ' HB ' ' HA ' ' A' ' 53' ' ' ILE . 3.6 t -100.72 135.87 34.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 122.536 0.335 . . . . 0.0 111.628 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.444 ' CD1' ' N ' ' A' ' 116' ' ' CYS . 3.4 mp -98.94 -64.6 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.517 178.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 135' ' ' ALA . . . -164.7 -167.02 24.61 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.196 -1.002 . . . . 0.0 113.239 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.0 164.15 15.15 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.92 0.39 . . . . 0.0 110.892 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.443 ' HA ' ' CD1' ' A' ' 134' ' ' PHE . 10.3 p -60.35 109.23 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.936 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.44 ' CG2' ' N ' ' A' ' 126' ' ' MET . 2.0 m -91.34 -88.6 0.18 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.453 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -128.56 162.1 28.04 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.941 0.4 . . . . 0.0 111.205 179.375 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -131.41 157.82 22.48 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.645 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -114.36 -153.89 10.86 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.411 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -71.96 -19.25 61.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.733 0.301 . . . . 0.0 110.998 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -168.71 28.4 0.15 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.547 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.4 t -130.03 157.05 42.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.716 0.294 . . . . 0.0 110.874 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.804 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 2.0 t -112.97 118.01 56.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.199 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.429 ' HA3' ' O ' ' A' ' 126' ' ' MET . . . -99.12 123.7 7.99 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.61 -0.805 . . . . 0.0 111.871 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.483 ' CZ ' ' HB2' ' A' ' 63' ' ' TYR . 52.6 m-85 -125.12 139.29 53.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.95 0.405 . . . . 0.0 111.727 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.495 ' O ' ' HA3' ' A' ' 122' ' ' GLY . . . -88.88 108.13 19.37 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.694 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.47 ' HB3' ' CD2' ' A' ' 97' ' ' HIS . 1.0 OUTLIER -67.55 143.36 56.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.472 0.653 . . . . 0.0 112.549 -178.095 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.438 ' O ' HD12 ' A' ' 140' ' ' LEU . 19.3 t -102.24 7.17 9.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.149 178.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.402 ' HB3' ' CZ ' ' A' ' 138' ' ' ARG . 2.1 mmm180 -72.48 -6.29 42.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.435 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.444 ' HB2' ' CD2' ' A' ' 97' ' ' HIS . 4.4 t70 -97.72 -1.99 42.26 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.721 0.296 . . . . 0.0 111.363 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.535 ' N ' ' CD1' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -156.1 64.71 0.57 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.464 0.65 . . . . 0.0 109.732 179.548 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.561 ' O ' ' N ' ' A' ' 143' ' ' LEU . 0.1 OUTLIER -77.64 -14.48 59.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.267 -0.879 . . . . 0.0 112.458 -178.906 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . 0.448 ' CE3' ' CE2' ' A' ' 15' ' ' TYR . 14.4 p-90 -53.7 80.19 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.006 0.431 . . . . 0.0 111.216 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.561 ' N ' ' O ' ' A' ' 141' ' ' LEU . 4.9 mp -153.36 -48.19 0.09 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.956 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -156.56 -171.14 3.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.462 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.85 144.24 45.01 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.913 0.387 . . . . 0.0 111.034 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -104.9 154.19 20.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.927 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.186 -179.933 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.745 0.307 . . . . 0.0 111.07 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.6 p -131.24 113.19 23.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.88 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 7.9 p90 -112.02 134.43 53.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.979 0.418 . . . . 0.0 111.157 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.514 ' CG1' ' HB2' ' A' ' 144' ' ' GLU . 93.1 t -119.19 128.25 75.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.439 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 49.54 -126.51 20.51 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 121.142 -0.551 . . . . 0.0 113.175 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.443 ' O ' ' HA ' ' A' ' 44' ' ' THR . 21.1 m-20 -89.56 14.72 10.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.624 0.249 . . . . 0.0 111.453 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.419 ' CE2' ' CE3' ' A' ' 142' ' ' TRP . 7.2 m-85 -128.91 141.44 51.27 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.518 ' HA ' ' HA ' ' A' ' 11' ' ' TYR . 9.3 tttt -127.21 114.82 18.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.651 -0.25 . . . . 0.0 110.748 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 0.6 OUTLIER -102.36 121.74 53.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-O 121.202 0.525 . . . . 0.0 110.749 179.709 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.406 HG21 ' HB3' ' A' ' 22' ' ' LEU . 13.6 p -136.35 160.52 37.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.995 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -60.56 141.62 56.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.334 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.43 -47.35 79.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.811 0.339 . . . . 0.0 110.718 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.91 -9.04 53.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.909 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.406 ' HB3' HG21 ' A' ' 18' ' ' VAL . 13.9 tp -109.61 -11.48 14.76 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.652 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.5 ' O ' ' CZ3' ' A' ' 28' ' ' TRP . . . -70.85 150.67 45.56 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 120.805 0.336 . . . . 0.0 110.826 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 58.6 p -104.67 169.2 8.59 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.329 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -54.72 -29.69 54.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.033 0.444 . . . . 0.0 110.576 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 23.9 t -74.66 -31.34 26.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.4 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.406 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 0.3 OUTLIER -67.16 -44.12 80.53 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.984 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.5 ' CZ3' ' O ' ' A' ' 23' ' ' ALA . 7.2 m-90 -74.54 -30.78 61.89 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.217 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.4 mm100 -58.42 -44.14 88.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.509 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -114.21 34.78 4.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.519 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.443 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 36.9 t -80.1 134.56 36.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.404 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.427 HG13 ' CG2' ' A' ' 44' ' ' THR . 12.5 m -98.96 -39.38 7.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.522 179.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.428 ' CZ3' ' HA ' ' A' ' 41' ' ' LEU . 1.9 t90 -139.39 152.91 47.49 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.989 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -160.86 120.39 2.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.975 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.418 ' HB2' ' CZ2' ' A' ' 33' ' ' TRP . 11.0 m-20 -107.04 111.99 24.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.007 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -61.27 -43.58 98.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.964 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.402 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 4.3 m-20 -65.73 -23.56 66.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.771 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.43 ' CZ ' ' HA ' ' A' ' 38' ' ' ARG . 3.4 tpm_? -105.55 -2.02 24.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.34 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 44.27 37.26 1.87 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.947 0.403 . . . . 0.0 110.818 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.0 tp -133.75 141.72 47.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.694 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.531 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -139.2 155.84 47.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.913 0.387 . . . . 0.0 111.759 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.423 HG13 ' CG2' ' A' ' 32' ' ' VAL . 25.3 t -118.72 129.89 74.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.568 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.8 p -121.84 157.16 31.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.306 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 14' ' ' ASN . 8.3 p -97.68 124.35 41.96 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.177 0.513 . . . . 0.0 111.628 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -113.65 162.99 15.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.78 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -108.69 37.45 2.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.885 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -126.73 169.42 13.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.044 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 10.4 m80 -83.74 141.12 31.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.861 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.422 ' HA2' ' CE2' ' A' ' 11' ' ' TYR . . . -91.04 152.0 21.44 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.558 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.43 -46.81 2.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.833 0.349 . . . . 0.0 110.909 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -59.82 135.89 57.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.918 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 33.2 m -117.27 116.0 26.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.824 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.525 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 0.2 OUTLIER -82.5 139.38 17.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.761 179.994 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -95.51 130.51 42.32 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.839 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -93.31 42.5 1.1 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 8.2 p -99.86 167.31 10.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.955 -1.02 . . . . 0.0 111.501 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -117.66 25.54 10.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.073 178.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 14.8 p -66.51 145.38 55.7 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.061 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.0 m -103.04 13.18 34.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.216 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 56.0 p -132.91 125.32 29.63 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.855 0.359 . . . . 0.0 110.996 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -150.99 165.71 30.29 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.388 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.431 HG23 ' CG ' ' A' ' 71' ' ' HIS . 10.6 p -104.51 134.83 44.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.933 0.397 . . . . 0.0 111.338 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.448 ' HB2' ' CZ ' ' A' ' 134' ' ' PHE . 4.9 p90 -110.97 160.44 16.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.843 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 5.4 t80 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.026 -179.916 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.431 ' CG ' HG23 ' A' ' 62' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.118 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -111.41 114.39 52.98 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.435 -178.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -74.77 120.66 6.23 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.235 1.956 . . . . 0.0 110.422 178.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 90.6 t -142.56 144.99 23.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.107 0.479 . . . . 0.0 112.226 -178.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.66 135.78 33.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.39 178.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.434 ' CE2' HD23 ' A' ' 114' ' ' LEU . 0.1 OUTLIER -141.46 169.66 17.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.226 0.536 . . . . 0.0 111.811 -178.879 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -111.85 158.3 19.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.068 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -105.79 68.34 0.25 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.542 -0.837 . . . . 0.0 113.095 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.478 ' HD2' ' HA ' ' A' ' 99' ' ' LEU . 37.6 Cg_endo -67.52 135.44 36.25 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.391 2.06 . . . . 0.0 112.231 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -59.66 -90.82 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.195 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.442 HD12 ' CD2' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -88.32 119.56 28.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.853 0.359 . . . . 0.0 111.497 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.466 ' HB ' ' CG1' ' A' ' 98' ' ' VAL . 40.1 t -126.99 122.46 60.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.075 178.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -72.54 107.55 5.12 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.934 0.397 . . . . 0.0 110.55 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.563 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 18.3 m -75.24 123.88 31.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.732 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -69.4 150.38 47.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.027 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.532 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 0.6 OUTLIER -67.69 102.67 1.24 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.006 0.432 . . . . 0.0 110.458 -179.474 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.453 ' O ' ' N ' ' A' ' 89' ' ' TYR . 3.5 m -143.87 161.64 38.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.519 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 57.41 -79.14 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.534 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.453 ' N ' ' O ' ' A' ' 87' ' ' SER . 1.3 p90 -159.59 25.38 0.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.699 0.285 . . . . 0.0 110.942 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.532 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 3.6 t80 -124.73 126.09 25.4 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.831 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -69.68 148.77 66.32 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.113 2.542 . . . . 0.0 112.446 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.563 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 1.7 ttpp -53.14 92.26 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.853 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.82 176.55 6.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.184 0.516 . . . . 0.0 112.085 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.442 ' CD2' HD12 ' A' ' 81' ' ' LEU . 4.9 m-85 -98.28 132.32 43.86 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.163 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.402 ' HA ' ' O ' ' A' ' 37' ' ' ASN . 4.4 mt-30 -131.23 132.95 45.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.678 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.65 142.91 33.03 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.014 0.435 . . . . 0.0 112.06 -179.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.436 ' CE1' ' HB3' ' A' ' 139' ' ' ASP . 0.1 OUTLIER 75.76 55.53 0.06 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.064 179.1 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.466 ' CG1' ' HB ' ' A' ' 82' ' ' VAL . 12.4 p -123.4 139.45 50.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.962 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.478 ' HA ' ' HD2' ' A' ' 79' ' ' PRO . 4.4 mp -105.09 134.0 48.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.168 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.775 ' HA ' ' O ' ' A' ' 132' ' ' VAL . 6.8 mt -117.61 138.64 51.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.131 0.491 . . . . 0.0 112.192 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 132' ' ' VAL . . . -130.02 119.46 23.17 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.597 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 1.7 t -86.02 111.69 20.53 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.849 0.356 . . . . 0.0 110.727 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.255 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.45 -179.834 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.56 -0.216 . . . . 0.0 112.56 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.423 ' HA ' ' HA ' ' A' ' 123' ' ' LEU . 31.2 pt -125.99 146.22 32.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.711 0.291 . . . . 0.0 111.074 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.434 HD23 ' CE2' ' A' ' 76' ' ' PHE . 41.6 tp -87.71 113.02 23.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.65 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 25.9 mtm180 -119.56 146.88 45.1 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.474 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.418 ' HB3' HD13 ' A' ' 121' ' ' ILE . 27.2 p -118.99 177.42 4.87 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -56.77 -18.75 13.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.681 0.276 . . . . 0.0 111.251 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -93.3 -32.58 14.26 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 165.64 -133.58 3.01 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.176 -1.011 . . . . 0.0 113.643 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.525 ' HB ' ' HA ' ' A' ' 53' ' ' ILE . 20.0 t -107.78 135.67 45.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.774 0.321 . . . . 0.0 111.609 -179.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.432 ' N ' ' CD1' ' A' ' 121' ' ' ILE . 2.5 mp -105.26 -52.83 7.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.155 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -161.06 -167.08 21.02 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 119.94 -1.124 . . . . 0.0 113.496 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 0.2 OUTLIER -124.39 164.18 20.21 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.841 0.353 . . . . 0.0 111.021 -179.867 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.5 m -57.06 114.12 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.802 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.426 HG22 ' NH2' ' A' ' 38' ' ' ARG . 2.3 m -105.27 -88.95 0.43 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.01 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.42 ' O ' ' HA3' ' A' ' 133' ' ' GLY . 1.5 tpt -132.28 162.1 31.84 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.247 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -133.23 161.43 24.17 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.513 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -119.26 -154.61 9.59 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.527 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -72.04 -19.08 61.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.691 0.282 . . . . 0.0 110.963 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -168.27 29.71 0.16 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.545 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 1.3 t -132.21 157.1 43.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.785 0.326 . . . . 0.0 111.001 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.775 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 1.8 t -113.72 117.98 56.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.903 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.42 ' HA3' ' O ' ' A' ' 126' ' ' MET . . . -102.07 122.33 7.51 Favored Glycine 0 CA--C 1.516 0.14 0 C-N-CA 120.525 -0.845 . . . . 0.0 111.84 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.489 ' CE2' ' CG1' ' A' ' 132' ' ' VAL . 48.9 m-85 -124.99 144.0 50.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.992 0.425 . . . . 0.0 111.742 -179.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.416 ' HB2' ' OG1' ' A' ' 125' ' ' THR . . . -88.9 114.22 25.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.739 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -67.53 137.6 55.88 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.542 ' O ' HD11 ' A' ' 140' ' ' LEU . 69.2 t -99.42 3.67 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.943 178.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.41 ' HA ' ' CD2' ' A' ' 141' ' ' LEU . 0.5 OUTLIER -72.57 -6.27 42.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.43 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.436 ' HB3' ' CE1' ' A' ' 97' ' ' HIS . 1.4 p30 -95.32 3.35 54.54 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.708 0.29 . . . . 0.0 111.345 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.552 ' N ' ' CD1' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -162.11 51.8 0.21 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.294 0.569 . . . . 0.0 110.119 179.669 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.531 ' O ' ' N ' ' A' ' 143' ' ' LEU . 0.1 OUTLIER -68.59 -14.63 63.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.149 -179.44 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . 0.419 ' CE3' ' CE2' ' A' ' 15' ' ' TYR . 13.2 p-90 -53.86 81.92 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.17 0.51 . . . . 0.0 111.379 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.531 ' N ' ' O ' ' A' ' 141' ' ' LEU . 5.0 mp -150.95 -44.84 0.12 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.834 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.514 ' HB2' ' CG1' ' A' ' 12' ' ' VAL . 1.1 tp10 -146.59 -159.23 0.99 Allowed 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.417 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -77.86 149.04 34.38 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.837 0.351 . . . . 0.0 110.988 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -84.84 154.2 22.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.936 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.066 -179.981 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.697 0.284 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.0 p -127.59 107.32 16.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.032 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 6.0 p90 -104.43 129.42 52.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.951 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.425 ' CG1' ' HB2' ' A' ' 144' ' ' GLU . 31.2 t -119.28 133.21 66.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.773 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 49.84 -128.39 25.24 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 121.068 -0.586 . . . . 0.0 112.966 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.417 ' O ' ' HA ' ' A' ' 44' ' ' THR . 36.5 m120 -91.35 17.13 8.82 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.673 0.273 . . . . 0.0 111.176 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.425 ' HB3' HG12 ' A' ' 42' ' ' VAL . 9.7 m-85 -129.94 148.45 51.81 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.241 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.566 ' HA ' ' HA ' ' A' ' 11' ' ' TYR . 37.3 tttt -132.26 114.68 14.72 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.696 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 0.9 OUTLIER -101.94 121.42 52.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-O 121.209 0.528 . . . . 0.0 110.74 179.72 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.0 p -136.94 161.42 35.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.428 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -60.55 141.79 56.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.152 178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.425 ' HG3' ' N ' ' A' ' 21' ' ' HIS . 7.8 ptm180 -56.34 -46.99 79.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.803 0.335 . . . . 0.0 111.378 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.425 ' N ' ' HG3' ' A' ' 20' ' ' ARG . 4.0 t60 -69.66 -6.45 31.59 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.331 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -115.14 -1.39 13.01 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.434 ' HB1' HD21 ' A' ' 41' ' ' LEU . . . -87.29 126.75 35.03 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.238 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.534 ' O ' ' HD1' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -74.79 164.37 26.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.682 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -53.78 -29.71 41.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.332 -179.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.406 HG13 ' CG2' ' A' ' 24' ' ' THR . 13.8 p -71.86 -31.37 40.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.971 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.95 -44.06 77.64 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.035 0.445 . . . . 0.0 109.828 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.534 ' HD1' ' O ' ' A' ' 24' ' ' THR . 39.7 m95 -73.99 -33.44 63.84 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.623 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 13.2 tp60 -56.66 -44.0 80.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.644 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -111.56 30.01 7.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.423 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.413 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 10.8 t -77.3 131.88 38.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.092 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.451 ' CG2' HG13 ' A' ' 42' ' ' VAL . 13.1 m -94.04 -39.76 10.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.979 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.436 ' CE3' HG22 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -139.7 153.41 47.23 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.976 0.417 . . . . 0.0 111.8 -179.216 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -158.52 120.52 3.58 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.576 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.433 ' HB2' ' CZ2' ' A' ' 33' ' ' TRP . 14.2 m-20 -106.99 116.92 32.77 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.484 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -66.39 -29.99 70.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.954 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.474 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 26.1 p30 -66.56 -25.89 66.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.057 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 18.0 mtm180 -117.44 -0.97 11.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.459 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 51.22 37.86 19.63 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.898 0.38 . . . . 0.0 110.572 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.4 tp -125.39 152.36 44.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.928 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.53 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -143.93 156.07 44.3 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.944 0.402 . . . . 0.0 111.667 179.627 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.451 HG13 ' CG2' ' A' ' 32' ' ' VAL . 22.6 t -120.21 129.95 74.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.636 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.9 p -120.49 157.3 29.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.119 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 14' ' ' ASN . 10.1 p -97.45 123.29 41.24 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.163 0.506 . . . . 0.0 111.596 -179.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -117.33 140.17 49.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.882 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.1 p -95.14 45.97 1.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.98 0.419 . . . . 0.0 110.907 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.94 177.17 5.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.022 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -87.94 121.6 30.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.928 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.429 ' HA2' ' CE2' ' A' ' 11' ' ' TYR . . . -64.44 175.75 11.42 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.441 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 m -154.1 -46.15 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.862 0.363 . . . . 0.0 110.94 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -73.34 143.78 46.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.058 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 55.1 m -120.45 119.64 33.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.193 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.479 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 2.9 mm -72.5 139.36 19.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.089 0.471 . . . . 0.0 111.063 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.474 ' HB1' ' HB2' ' A' ' 118' ' ' HIS . . . -75.36 -47.89 25.56 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.513 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.93 13.54 9.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.825 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 23.9 p -99.78 166.92 10.86 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.665 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -121.76 39.28 3.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.124 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 59.5 m -62.7 156.81 22.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.706 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.3 -19.87 20.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.964 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.3 p -116.34 123.91 48.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.946 0.403 . . . . 0.0 111.123 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -140.71 -164.02 9.74 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 121.028 -0.606 . . . . 0.0 111.89 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.411 HG23 ' HB3' ' A' ' 71' ' ' HIS . 3.6 p -140.41 130.74 28.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 121.167 0.508 . . . . 0.0 111.815 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.479 ' CD1' ' O ' ' A' ' 63' ' ' TYR . 24.4 p90 -109.28 126.27 53.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.772 178.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.416 ' CB ' ' CD2' ' A' ' 71' ' ' HIS . 55.6 p90 . . . . . 0 C--N 1.328 -0.352 0 CA-C-O 120.993 0.425 . . . . 0.0 111.578 -179.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.416 ' CD2' ' CB ' ' A' ' 64' ' ' PHE . 13.0 m170 . . . . . 0 C--O 1.23 0.075 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.426 ' HB2' ' CE1' ' A' ' 63' ' ' TYR . 3.9 m-85 -124.91 114.29 26.62 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.615 -178.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -74.21 120.78 6.45 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.354 2.036 . . . . 0.0 111.043 178.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.443 ' CG1' ' CE2' ' A' ' 76' ' ' PHE . 2.3 p -139.78 158.8 27.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.034 0.445 . . . . 0.0 111.923 -179.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.9 m -102.04 123.91 46.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.424 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.468 ' CD1' ' N ' ' A' ' 76' ' ' PHE . 0.0 OUTLIER -125.11 161.78 26.05 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.41 0.624 . . . . 0.0 111.771 -179.259 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.417 ' O ' ' CD ' ' A' ' 79' ' ' PRO . 4.6 mt-10 -111.79 158.77 18.98 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.349 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -104.76 67.22 0.28 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.412 -0.899 . . . . 0.0 113.187 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.45 ' HD2' ' O ' ' A' ' 98' ' ' VAL . 41.7 Cg_endo -67.72 135.47 35.81 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.375 2.05 . . . . 0.0 112.07 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -60.84 -86.77 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.682 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.424 HD12 ' O ' ' A' ' 95' ' ' GLN . 0.0 OUTLIER -94.62 119.85 33.93 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -179.365 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.422 ' HB ' ' CG1' ' A' ' 98' ' ' VAL . 80.0 t -124.63 123.28 65.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.344 178.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.418 ' HG3' ' CZ ' ' A' ' 94' ' ' TYR . 0.1 OUTLIER -72.14 107.86 5.03 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.019 0.438 . . . . 0.0 111.037 -178.826 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 2.2 p -73.31 114.41 12.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.486 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -76.27 150.23 37.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.56 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.676 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 28.0 tt0 -68.0 101.04 1.05 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.122 0.487 . . . . 0.0 110.505 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.43 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.5 OUTLIER -144.7 143.01 30.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.875 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 59.25 -80.21 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.423 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.43 ' N ' ' O ' ' A' ' 87' ' ' SER . 0.8 OUTLIER -152.11 22.18 0.66 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.658 0.266 . . . . 0.0 111.173 -179.945 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.676 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 0.8 OUTLIER -110.51 114.64 54.87 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.302 179.68 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -60.98 148.26 93.26 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.728 2.285 . . . . 0.0 112.888 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -67.77 71.51 0.14 Allowed 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.598 179.507 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.4 ttm180 -123.61 -174.55 3.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.914 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.418 ' CZ ' ' HG3' ' A' ' 83' ' ' GLU . 13.6 m-85 -96.51 132.43 42.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.822 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.474 ' HA ' ' O ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -131.1 126.56 36.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.039 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.1 p -101.58 161.45 13.63 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.162 0.506 . . . . 0.0 111.926 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 61.63 57.57 2.23 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.565 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.45 ' O ' ' HD2' ' A' ' 79' ' ' PRO . 4.8 p -123.55 143.45 36.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.758 0.313 . . . . 0.0 111.37 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.5 mp -107.29 143.31 35.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.804 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.534 ' HA ' ' O ' ' A' ' 132' ' ' VAL . 5.1 mt -133.01 139.42 47.22 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -179.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.417 ' HB1' ' CD2' ' A' ' 76' ' ' PHE . . . -143.71 146.64 33.33 Favored 'General case' 0 CA--C 1.522 -0.109 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.728 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.2 t -104.54 131.42 51.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.932 0.396 . . . . 0.0 111.192 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.272 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.424 -179.982 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.438 ' HA ' ' HA ' ' A' ' 123' ' ' LEU . 24.8 pt -126.08 146.49 31.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.822 0.344 . . . . 0.0 111.326 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.445 ' HB2' ' CD2' ' A' ' 134' ' ' PHE . 11.5 tp -87.44 122.2 30.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.109 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 27.5 mtp180 -118.26 138.74 52.15 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.254 0.549 . . . . 0.0 112.064 -178.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.436 ' HB2' ' CD1' ' A' ' 121' ' ' ILE . 15.1 t -106.03 166.51 10.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.614 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -55.77 -19.7 12.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.64 0.257 . . . . 0.0 111.031 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.474 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . 31.4 m80 -89.66 -35.92 15.54 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.514 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 169.32 -142.41 7.31 Favored Glycine 0 C--O 1.227 -0.316 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.561 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.479 ' HB ' ' HA ' ' A' ' 53' ' ' ILE . 3.4 t -89.73 135.22 26.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.562 0.22 . . . . 0.0 110.704 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.436 ' CD1' ' HB2' ' A' ' 116' ' ' CYS . 6.3 mt -106.32 -52.75 7.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 121.051 -0.259 . . . . 0.0 111.05 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 135' ' ' ALA . . . -161.74 -174.68 31.91 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.088 -1.053 . . . . 0.0 113.239 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.469 ' N ' ' CD1' ' A' ' 123' ' ' LEU . 0.0 OUTLIER -121.16 164.06 17.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.833 0.349 . . . . 0.0 110.824 179.884 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 13.7 p -55.47 127.14 13.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.767 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.405 ' CG2' ' N ' ' A' ' 126' ' ' MET . 3.2 m -120.56 -90.35 0.58 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.045 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.456 ' O ' ' HA3' ' A' ' 133' ' ' GLY . 0.0 OUTLIER -122.65 125.89 46.53 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.977 0.418 . . . . 0.0 111.301 179.618 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -110.26 128.48 8.86 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.606 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -83.95 -159.9 29.79 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.533 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -71.9 -19.38 61.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.75 0.31 . . . . 0.0 111.217 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -158.42 20.22 0.33 Allowed Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.678 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 101' ' ' ALA . 1.3 t -129.17 157.07 42.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.755 0.312 . . . . 0.0 110.769 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 18.8 m -115.19 118.35 58.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.212 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.456 ' HA3' ' O ' ' A' ' 126' ' ' MET . . . -100.64 109.54 3.7 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.074 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.445 ' CD2' ' HB2' ' A' ' 114' ' ' LEU . 61.1 m-85 -111.16 139.79 46.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.746 0.308 . . . . 0.0 110.912 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.407 ' O ' ' HA3' ' A' ' 122' ' ' GLY . . . -88.57 120.56 30.07 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -67.36 137.1 55.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.197 0.522 . . . . 0.0 112.355 -178.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.462 ' O ' HD12 ' A' ' 140' ' ' LEU . 95.1 t -90.53 7.85 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.474 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.438 ' HA ' HD21 ' A' ' 141' ' ' LEU . 8.8 mtm180 -70.49 -6.44 36.04 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.812 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.6 11.18 39.2 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.608 0.242 . . . . 0.0 111.581 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.559 ' N ' ' CD1' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -173.14 48.67 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.256 0.551 . . . . 0.0 110.374 179.811 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.464 ' O ' ' N ' ' A' ' 143' ' ' LEU . 0.2 OUTLIER -67.67 -14.93 63.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.015 -179.551 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . 0.416 ' CE3' ' CE2' ' A' ' 15' ' ' TYR . 12.3 p-90 -56.65 82.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.069 0.461 . . . . 0.0 111.693 -179.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' A' ' 141' ' ' LEU . 5.1 mp -149.06 -47.29 0.14 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.805 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.425 ' HB2' ' CG1' ' A' ' 12' ' ' VAL . 0.5 OUTLIER -158.32 -168.89 2.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.418 179.895 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 14.7 p30 -58.83 138.94 57.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.851 0.358 . . . . 0.0 111.044 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -105.01 154.11 20.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.999 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.098 179.904 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.727 0.298 . . . . 0.0 111.052 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.2 t -112.94 103.01 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.001 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.455 ' CE2' ' CG2' ' A' ' 45' ' ' THR . 6.1 t80 -97.85 115.93 29.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.856 0.36 . . . . 0.0 110.631 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.457 ' HB ' ' CD2' ' A' ' 143' ' ' LEU . 32.8 t -121.21 108.96 23.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.517 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.405 ' O ' ' CE1' ' A' ' 11' ' ' TYR . . . 54.24 -128.75 41.99 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.897 -0.668 . . . . 0.0 113.309 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.415 ' O ' ' HA ' ' A' ' 44' ' ' THR . 22.6 m120 -88.75 13.26 12.83 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 111.706 0.262 . . . . 0.0 111.706 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.404 ' CE2' ' CE3' ' A' ' 142' ' ' TRP . 5.7 m-30 -130.3 127.95 40.54 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -118.97 114.74 23.03 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 121.124 -0.23 . . . . 0.0 110.688 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 0.7 OUTLIER -101.07 121.66 52.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.231 0.538 . . . . 0.0 110.993 179.91 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.1 p -136.7 161.36 36.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.047 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -58.91 141.49 53.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.376 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.425 ' CD ' ' N ' ' A' ' 21' ' ' HIS . 0.0 OUTLIER -56.54 -47.09 80.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.874 0.369 . . . . 0.0 111.294 -179.339 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.425 ' N ' ' CD ' ' A' ' 20' ' ' ARG . 13.3 p80 -68.36 -9.83 50.81 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.162 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.3 2.32 13.97 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.461 ' HB2' HD22 ' A' ' 41' ' ' LEU . . . -87.34 130.27 34.69 Favored 'General case' 0 C--N 1.334 -0.081 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.189 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.498 ' O ' ' HD1' ' A' ' 28' ' ' TRP . 41.9 p -74.69 163.04 28.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.742 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 61.1 m-70 -53.74 -29.71 40.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.975 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.2 t -70.33 -31.91 48.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.83 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -68.09 -44.25 76.69 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.123 0.487 . . . . 0.0 109.707 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.498 ' HD1' ' O ' ' A' ' 24' ' ' THR . 40.6 m95 -74.13 -33.14 63.46 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.702 179.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -56.79 -44.12 81.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.726 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -114.46 30.99 6.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.372 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.466 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 13.8 t -72.61 126.63 30.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.128 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.423 HG21 ' N ' ' A' ' 33' ' ' TRP . 18.4 m -88.9 -40.77 13.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.626 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.469 ' CE3' HG21 ' A' ' 42' ' ' VAL . 0.5 OUTLIER -139.75 153.21 47.12 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.916 0.388 . . . . 0.0 111.227 -179.94 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -157.61 119.37 3.69 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.974 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -107.13 117.73 34.84 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.133 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 19.4 p90 -68.2 -36.79 80.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.106 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.418 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 74.0 m-20 -70.13 -12.9 61.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.871 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.0 mpt_? -117.2 -6.35 11.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.178 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 50.77 36.04 13.47 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-O 121.074 0.464 . . . . 0.0 110.295 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 36.7 tp -132.85 153.19 51.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.931 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.514 HD21 ' N ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -147.83 155.63 41.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.491 179.682 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.469 HG21 ' CE3' ' A' ' 33' ' ' TRP . 38.2 t -115.78 130.68 70.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.337 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.0 p -123.29 157.24 33.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.637 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 14' ' ' ASN . 30.1 p -97.65 145.13 26.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.189 0.518 . . . . 0.0 111.793 -178.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.455 ' CG2' ' CE2' ' A' ' 11' ' ' TYR . 0.2 OUTLIER -140.02 171.28 14.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.841 -179.253 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.8 t -124.48 62.32 1.12 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.93 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -135.51 -173.54 3.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.978 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -90.83 142.88 27.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.866 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.58 159.45 30.46 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.556 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -142.23 -46.7 0.34 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.743 0.306 . . . . 0.0 110.956 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -103.23 142.5 34.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.025 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 91.7 m -120.08 120.85 37.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.286 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.508 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 0.9 OUTLIER -75.09 139.61 18.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.909 0.385 . . . . 0.0 110.921 -179.811 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -94.91 127.19 40.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.107 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.488 ' HB2' ' HB2' ' A' ' 146' ' ' ASP . 0.1 OUTLIER -92.33 34.76 1.02 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.528 179.452 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 26.5 p -99.65 160.5 14.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.874 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.69 34.79 4.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.084 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 66.5 m -58.28 126.87 29.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.707 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.3 m -68.92 -17.7 64.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.881 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 75' ' ' SER . 1.4 t -129.74 151.01 50.79 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.023 0.439 . . . . 0.0 111.319 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.451 ' N ' ' CE1' ' A' ' 76' ' ' PHE . . . -154.92 -148.24 4.94 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.688 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.438 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 7.1 p -140.08 123.57 17.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.015 0.436 . . . . 0.0 111.385 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.42 ' CZ ' ' CB ' ' A' ' 72' ' ' TYR . 8.5 p90 -94.87 172.06 8.39 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.892 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.849 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.414 ' HB2' HG23 ' A' ' 62' ' ' VAL . 9.2 p80 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.81 0.338 . . . . 0.0 110.272 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.42 ' CB ' ' CZ ' ' A' ' 63' ' ' TYR . 1.2 m-85 -121.98 114.45 30.93 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.06 -179.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.438 ' HA ' ' HA ' ' A' ' 62' ' ' VAL . 4.9 Cg_exo -76.49 120.82 5.74 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.5 2.134 . . . . 0.0 111.529 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.448 ' CG1' ' CE2' ' A' ' 76' ' ' PHE . 2.9 p -136.6 156.75 35.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.973 0.416 . . . . 0.0 111.773 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.454 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 59.0 p -97.41 123.34 41.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.71 178.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.463 ' CB ' ' HB3' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -124.39 163.44 21.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.373 0.606 . . . . 0.0 111.78 -179.411 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.424 ' O ' ' HA ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -111.72 158.72 19.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.224 179.024 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -104.87 65.51 0.3 Allowed Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.364 -0.922 . . . . 0.0 113.716 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.444 ' HD2' ' O ' ' A' ' 98' ' ' VAL . 41.6 Cg_endo -67.84 134.63 32.88 Favored 'Trans proline' 0 C--O 1.238 0.501 0 C-N-CA 122.254 1.97 . . . . 0.0 112.011 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -59.89 -86.82 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.981 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.435 HD12 ' O ' ' A' ' 95' ' ' GLN . 0.0 OUTLIER -96.25 119.76 35.32 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -179.227 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.422 ' CG2' ' CG1' ' A' ' 98' ' ' VAL . 87.1 t -122.99 122.85 66.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.341 178.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.28 109.61 6.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.067 0.46 . . . . 0.0 111.206 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.52 ' CG2' ' HG3' ' A' ' 126' ' ' MET . 1.2 p -72.79 114.54 12.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.452 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -75.06 149.53 39.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.326 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.555 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 2.4 tm-20 -68.51 101.3 1.23 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.044 0.45 . . . . 0.0 110.458 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.477 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.4 OUTLIER -144.79 155.11 43.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.047 179.816 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.416 ' HB3' ' H ' ' A' ' 89' ' ' TYR . 4.3 tt0 51.41 -83.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.611 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.477 ' N ' ' O ' ' A' ' 87' ' ' SER . 0.6 OUTLIER -145.67 19.75 1.49 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.835 0.35 . . . . 0.0 110.905 179.771 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.555 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 1.4 m-85 -107.88 140.35 21.53 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.538 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -86.35 148.5 8.95 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.095 2.53 . . . . 0.0 112.9 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -65.36 70.44 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.896 179.724 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 14.1 mtp180 -123.52 -175.03 3.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.995 0.426 . . . . 0.0 111.741 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.429 ' HB3' HD11 ' A' ' 81' ' ' LEU . 8.3 m-85 -98.47 132.7 43.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.205 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.435 ' O ' HD12 ' A' ' 81' ' ' LEU . 4.7 mt-30 -128.44 126.83 41.35 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.704 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 24.6 p -99.58 161.04 13.85 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.174 0.511 . . . . 0.0 112.332 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 57.84 60.22 2.86 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.878 179.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.444 ' O ' ' HD2' ' A' ' 79' ' ' PRO . 6.1 p -123.66 142.39 40.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 C-N-CA 120.894 -0.323 . . . . 0.0 111.093 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.428 ' HA ' ' HD2' ' A' ' 79' ' ' PRO . 10.7 mp -107.67 141.37 39.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.269 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.609 ' HA ' ' O ' ' A' ' 132' ' ' VAL . 6.3 mt -128.08 136.56 51.37 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.463 ' HB3' ' CB ' ' A' ' 76' ' ' PHE . . . -142.3 142.17 32.51 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.077 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 1.7 t -97.37 121.64 39.5 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.066 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.252 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.524 -179.855 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.269 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 17.6 pt -126.31 146.41 32.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.705 0.288 . . . . 0.0 111.302 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.48 ' HG ' ' HB ' ' A' ' 121' ' ' ILE . 20.6 tp -87.36 119.88 28.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.32 -0.4 . . . . 0.0 109.997 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 28.1 mtp85 -118.12 151.9 36.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.247 0.546 . . . . 0.0 111.648 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.436 ' HB2' HD12 ' A' ' 121' ' ' ILE . 4.2 t -119.03 160.92 21.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.175 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.421 ' CG ' ' CE1' ' A' ' 118' ' ' HIS . 3.0 pt-20 -56.29 -18.88 11.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.756 0.312 . . . . 0.0 110.925 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.421 ' CE1' ' CG ' ' A' ' 117' ' ' GLU . 13.2 m80 -93.65 -33.66 13.58 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.656 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 176.39 -138.67 4.18 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.408 -0.901 . . . . 0.0 113.102 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.508 ' HB ' ' HA ' ' A' ' 53' ' ' ILE . 4.9 t -102.57 135.56 39.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.765 0.317 . . . . 0.0 111.286 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.48 ' HB ' ' HG ' ' A' ' 114' ' ' LEU . 1.0 OUTLIER -99.03 -66.9 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.956 179.524 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -161.33 -164.4 16.15 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.698 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.94 164.24 14.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.701 0.286 . . . . 0.0 110.718 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 61.3 t -66.31 126.35 25.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.758 0.313 . . . . 0.0 111.188 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.418 ' CG2' ' N ' ' A' ' 126' ' ' MET . 2.9 m -109.45 -90.01 0.47 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.445 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.52 ' HG3' ' CG2' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -127.91 125.87 40.42 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 121.022 0.439 . . . . 0.0 111.742 179.946 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -107.87 128.33 9.11 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.66 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -81.69 -162.42 29.71 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.511 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -71.82 -19.72 61.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.71 0.291 . . . . 0.0 111.132 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -146.93 -7.27 0.28 Allowed Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.795 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 1.6 t -115.94 157.12 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 117.289 0.544 . . . . 0.0 110.927 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.609 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 11.8 m -114.75 118.63 59.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.563 -179.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.472 ' HA3' ' O ' ' A' ' 126' ' ' MET . . . -97.68 118.7 6.17 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.47 -0.872 . . . . 0.0 112.041 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.471 ' CZ ' ' CG2' ' A' ' 132' ' ' VAL . 11.5 m-85 -120.28 143.96 48.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.01 0.433 . . . . 0.0 111.637 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -90.44 110.83 21.93 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.937 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -67.97 143.61 55.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.095 0.474 . . . . 0.0 111.889 -178.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.498 ' O ' HD13 ' A' ' 140' ' ' LEU . 92.8 t -90.05 9.86 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.624 179.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.23 -7.94 46.13 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.528 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -90.21 8.11 34.74 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.55 ' N ' ' CD1' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -172.34 42.02 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.067 0.461 . . . . 0.0 110.899 179.886 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.465 ' O ' ' N ' ' A' ' 143' ' ' LEU . 0.1 OUTLIER -58.72 -14.99 9.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.229 -179.858 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . 0.422 ' CD1' ' HA ' ' A' ' 140' ' ' LEU . 16.1 p-90 -59.09 79.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.862 0.363 . . . . 0.0 111.327 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.465 ' N ' ' O ' ' A' ' 141' ' ' LEU . 4.7 mp -137.54 -45.98 0.55 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.469 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.438 ' HG2' ' CG1' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -165.58 -162.46 0.58 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.74 179.707 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -58.82 131.0 49.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.94 0.4 . . . . 0.0 111.189 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.488 ' HB2' ' HB2' ' A' ' 55' ' ' ARG . 3.7 p30 -105.0 154.25 20.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.639 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.206 0 CA-C-O 120.843 0.354 . . . . 0.0 111.142 -179.827 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.781 0.324 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.3 p -126.82 106.26 15.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.939 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 2.5 p90 -103.13 127.46 50.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.916 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.411 ' CG1' ' HB2' ' A' ' 144' ' ' GLU . 39.2 t -119.06 133.21 66.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.67 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 50.89 -130.51 31.83 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.885 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -91.35 18.62 6.89 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.741 0.305 . . . . 0.0 111.073 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.417 ' HB3' HG13 ' A' ' 42' ' ' VAL . 9.7 m-85 -129.87 144.2 51.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.119 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -127.7 114.72 17.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.587 179.386 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.538 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 0.7 OUTLIER -103.08 121.77 54.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-O 121.237 0.541 . . . . 0.0 111.024 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.434 HG23 ' HB3' ' A' ' 22' ' ' LEU . 7.3 p -136.47 160.55 37.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.076 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -59.71 141.51 55.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.463 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.43 -47.11 79.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.895 0.379 . . . . 0.0 110.908 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -68.86 -9.06 49.34 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.242 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.434 ' HB3' HG23 ' A' ' 18' ' ' VAL . 1.7 tp -109.58 -11.65 14.76 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.503 ' O ' ' CZ3' ' A' ' 28' ' ' TRP . . . -70.39 150.48 46.22 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 120.81 0.338 . . . . 0.0 110.875 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.404 ' O ' ' CE3' ' A' ' 28' ' ' TRP . 67.1 p -104.97 168.89 8.76 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.447 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -54.69 -29.79 53.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.972 0.415 . . . . 0.0 110.704 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.408 HG12 ' N ' ' A' ' 27' ' ' ASP . 8.2 p -76.47 -31.03 19.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.324 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.415 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 7.7 m-20 -66.27 -44.05 84.7 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.503 ' CZ3' ' O ' ' A' ' 23' ' ' ALA . 6.7 m-90 -74.26 -30.12 61.99 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.872 179.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -57.3 -44.16 83.86 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.431 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -114.25 31.86 6.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.436 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.421 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 14.3 t -79.6 129.07 34.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.171 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.444 ' CG2' HG11 ' A' ' 42' ' ' VAL . 12.7 m -91.47 -39.89 12.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.719 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.455 ' CE3' HG23 ' A' ' 42' ' ' VAL . 0.6 OUTLIER -139.43 152.4 47.03 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.01 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -159.83 117.41 2.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.977 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -107.03 118.33 36.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.232 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -65.96 -42.23 90.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.925 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.443 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 8.8 m-20 -66.63 -14.53 62.55 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.99 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.4 mtm180 -114.89 0.64 13.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.234 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.2 p30 42.54 38.99 1.41 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.996 0.427 . . . . 0.0 110.809 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 23.5 tp -137.12 152.15 49.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.091 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.538 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -147.79 155.72 41.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.153 179.455 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.455 HG23 ' CE3' ' A' ' 33' ' ' TRP . 29.3 t -119.78 129.97 74.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.94 0.4 . . . . 0.0 110.818 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.7 p -120.33 156.95 30.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.181 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 13.5 p -97.79 123.85 41.91 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.174 0.512 . . . . 0.0 111.542 -179.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -115.1 164.98 13.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.859 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.64 46.86 0.9 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.797 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -151.93 144.82 24.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.101 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 9.2 m170 -67.7 148.07 51.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.803 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.449 ' HA2' ' CE2' ' A' ' 11' ' ' TYR . . . -82.92 135.82 14.45 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.597 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 8.2 t -95.67 19.14 11.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.703 0.287 . . . . 0.0 111.037 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -135.27 145.9 48.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.751 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.0 m -119.54 117.62 28.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.603 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.526 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 0.5 OUTLIER -77.05 139.52 18.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.748 -179.873 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.419 ' HB1' ' HB2' ' A' ' 118' ' ' HIS . . . -93.21 132.21 37.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.225 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.1 28.7 1.8 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.391 179.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 28.1 p -99.56 166.08 11.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.965 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.62 34.44 4.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.709 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 40.7 m -55.18 131.37 45.12 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.082 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.7 m -72.47 -11.46 60.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.619 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.1 p -120.26 153.51 36.25 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.765 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -171.29 -164.14 26.46 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.892 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.418 HG23 ' CD2' ' A' ' 71' ' ' HIS . 10.2 p -139.66 128.08 26.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.962 0.411 . . . . 0.0 111.18 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.457 ' CE1' ' HB2' ' A' ' 72' ' ' TYR . 17.7 p90 -99.02 133.61 43.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.752 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.445 ' HB2' ' CD2' ' A' ' 71' ' ' HIS . 77.5 t80 . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.471 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.445 ' CD2' ' HB2' ' A' ' 64' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.133 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.457 ' HB2' ' CE1' ' A' ' 63' ' ' TYR . 0.5 OUTLIER -122.1 114.28 30.84 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.754 -178.36 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -68.79 120.59 7.49 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 121.987 1.791 . . . . 0.0 110.284 178.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.459 ' CG1' ' CE2' ' A' ' 76' ' ' PHE . 2.2 p -142.51 153.43 17.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.973 0.416 . . . . 0.0 111.782 -178.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.5 m -97.05 125.52 41.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.886 178.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.525 ' CD2' ' HB3' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -130.74 161.23 32.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.442 0.639 . . . . 0.0 111.793 -179.506 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.646 ' C ' ' HD3' ' A' ' 79' ' ' PRO . 3.0 mm-40 -111.77 159.31 18.4 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.959 178.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -108.57 64.53 0.26 Allowed Glycine 0 CA--C 1.522 0.53 0 C-N-CA 120.251 -0.976 . . . . 0.0 114.004 -179.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.646 ' HD3' ' C ' ' A' ' 77' ' ' GLU . 14.0 Cg_exo -67.0 140.94 56.2 Favored 'Trans proline' 0 C--O 1.242 0.695 0 C-N-CA 122.326 2.017 . . . . 0.0 112.524 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 96' ' ' SER . . . -63.04 -60.16 8.02 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.276 -0.874 . . . . 0.0 112.514 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.425 HD12 ' HB3' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -120.06 122.29 40.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.997 0.427 . . . . 0.0 111.813 -179.877 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.45 ' HB ' ' CG1' ' A' ' 98' ' ' VAL . 17.8 t -128.66 122.7 57.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.406 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.64 107.83 5.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.635 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 32.7 m -77.46 122.34 31.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.026 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -69.69 150.28 47.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.172 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 3.3 tt0 -67.92 102.58 1.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.54 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 89' ' ' TYR . 2.8 p -143.74 160.81 40.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.581 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 56.39 -81.98 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.651 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.419 ' N ' ' O ' ' A' ' 87' ' ' SER . 0.3 OUTLIER -153.44 21.44 0.55 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.724 0.297 . . . . 0.0 111.161 -179.805 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.508 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 1.6 t80 -119.68 133.28 23.84 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.674 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.425 ' HD2' ' CD1' ' A' ' 90' ' ' TYR . 79.7 Cg_endo -77.3 148.58 27.05 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.856 2.371 . . . . 0.0 112.538 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.542 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.7 OUTLIER -55.36 89.24 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.631 179.819 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.91 -175.62 3.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.258 0.552 . . . . 0.0 112.119 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.425 ' HB3' HD12 ' A' ' 81' ' ' LEU . 15.8 m-85 -100.06 132.62 45.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.636 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.443 ' HA ' ' O ' ' A' ' 37' ' ' ASN . 0.8 OUTLIER -127.22 124.41 38.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.863 0.363 . . . . 0.0 111.24 -179.662 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 40.2 t -89.79 162.29 15.59 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.068 0.461 . . . . 0.0 111.905 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 44.39 56.93 4.66 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.741 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.616 ' O ' ' HD2' ' A' ' 79' ' ' PRO . 8.4 p -124.0 136.77 59.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.267 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.483 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 2.2 mp -101.92 149.19 24.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.332 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.712 ' HA ' ' O ' ' A' ' 132' ' ' VAL . 7.7 mt -127.69 132.51 49.64 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.343 -0.543 . . . . 0.0 112.213 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.525 ' HB3' ' CD2' ' A' ' 76' ' ' PHE . . . -128.14 132.28 48.93 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.535 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 1.8 t -93.34 115.31 27.88 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.945 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 0.215 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.589 -179.87 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.551 -0.219 . . . . 0.0 112.551 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 25.9 pt -126.12 146.35 32.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.881 0.372 . . . . 0.0 111.245 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.483 ' HG ' ' HB ' ' A' ' 121' ' ' ILE . 23.3 tp -87.52 121.22 29.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.253 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 17.1 mtt85 -118.24 152.28 36.02 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.181 0.515 . . . . 0.0 111.999 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.5 ' HB2' HD11 ' A' ' 121' ' ' ILE . 5.6 t -118.75 164.24 15.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.086 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -58.54 -17.94 25.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.055 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.419 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . 14.9 m80 -94.89 -30.87 13.95 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.54 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 174.52 -135.93 3.32 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.516 -0.85 . . . . 0.0 112.811 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.526 ' HB ' ' HA ' ' A' ' 53' ' ' ILE . 5.4 t -105.48 134.99 45.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.653 0.263 . . . . 0.0 111.053 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.5 HD11 ' HB2' ' A' ' 116' ' ' CYS . 1.1 mm -93.62 -67.73 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.864 0.364 . . . . 0.0 110.983 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.429 ' HA3' ' O ' ' A' ' 135' ' ' ALA . . . -159.08 -143.03 3.54 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.843 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.31 164.15 28.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.852 0.358 . . . . 0.0 111.128 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 36.4 t -68.58 109.22 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.348 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.416 ' CG2' ' N ' ' A' ' 126' ' ' MET . 3.6 m -92.04 -90.83 0.17 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.4 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.488 ' O ' ' HA3' ' A' ' 133' ' ' GLY . 97.5 mmm -138.67 125.94 21.58 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.049 0.452 . . . . 0.0 111.301 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -110.22 131.25 10.33 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.593 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -70.04 -146.5 0.29 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.248 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -86.59 -19.38 29.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.698 0.285 . . . . 0.0 111.089 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -140.42 -9.97 0.73 Allowed Glycine 0 CA--C 1.522 0.473 0 C-N-CA 120.551 -0.833 . . . . 0.0 113.459 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 0.9 OUTLIER -115.74 157.56 16.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-N 117.241 0.52 . . . . 0.0 111.123 -179.704 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.712 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 20.2 t -114.61 118.33 58.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.109 -178.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.488 ' HA3' ' O ' ' A' ' 126' ' ' MET . . . -89.28 126.31 8.17 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.781 178.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.464 ' CZ ' ' CG1' ' A' ' 132' ' ' VAL . 40.2 m-85 -125.18 133.54 52.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.871 0.367 . . . . 0.0 111.586 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.429 ' O ' ' HA3' ' A' ' 122' ' ' GLY . . . -88.85 105.28 17.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.771 178.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.42 ' HB3' ' CD1' ' A' ' 99' ' ' LEU . 1.3 p30 -67.69 146.62 53.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.23 0.538 . . . . 0.0 112.181 -178.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.434 HG12 ' CD1' ' A' ' 140' ' ' LEU . 60.7 t -89.53 9.92 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.304 178.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.477 ' HA ' HD23 ' A' ' 141' ' ' LEU . 3.5 mmm180 -71.36 -7.02 44.41 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.566 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -99.87 11.13 40.04 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.594 0.235 . . . . 0.0 111.421 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.54 ' N ' ' CD1' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -174.98 40.53 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.016 0.436 . . . . 0.0 110.701 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.479 ' O ' ' N ' ' A' ' 143' ' ' LEU . 0.1 OUTLIER -57.75 -25.46 60.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.943 -0.572 . . . . 0.0 112.037 -179.557 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . 0.425 ' CD1' ' HA ' ' A' ' 140' ' ' LEU . 11.6 p-90 -47.22 88.12 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.039 0.447 . . . . 0.0 111.762 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.479 ' N ' ' O ' ' A' ' 141' ' ' LEU . 5.0 mp -153.02 -47.12 0.1 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.073 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.411 ' HB2' ' CG1' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -158.54 -169.92 2.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.755 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -59.05 133.02 55.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.953 0.406 . . . . 0.0 111.28 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -105.15 154.36 20.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.569 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.193 0 CA-C-O 120.864 0.364 . . . . 0.0 111.059 -179.916 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.829 0.347 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.7 t -103.37 115.85 46.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.955 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.47 ' CE2' HG21 ' A' ' 45' ' ' THR . 5.7 t80 -104.18 115.91 31.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.808 0.337 . . . . 0.0 110.659 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.465 ' HB ' ' CD2' ' A' ' 143' ' ' LEU . 57.6 t -121.17 112.64 36.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.652 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 50.54 -126.22 24.01 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.98 -0.629 . . . . 0.0 113.379 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.449 ' O ' ' HA ' ' A' ' 44' ' ' THR . 4.5 m-20 -91.01 17.97 7.29 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.656 0.265 . . . . 0.0 111.589 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -130.49 127.74 39.8 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.04 114.74 22.46 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 121.024 -0.27 . . . . 0.0 110.888 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 0.7 OUTLIER -99.64 121.9 50.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-O 120.984 0.421 . . . . 0.0 110.453 179.585 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.445 HG22 ' HB3' ' A' ' 22' ' ' LEU . 9.6 p -136.29 159.99 38.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.306 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -59.96 141.74 55.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.289 179.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.403 ' HA ' HD13 ' A' ' 41' ' ' LEU . 48.7 ttt-85 -56.17 -47.35 78.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.814 0.34 . . . . 0.0 110.774 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -69.2 -8.42 45.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.968 179.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.445 ' HB3' HG22 ' A' ' 18' ' ' VAL . 16.7 tp -110.59 -12.59 14.33 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.497 ' O ' ' CZ3' ' A' ' 28' ' ' TRP . . . -66.97 150.73 48.82 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 120.896 0.379 . . . . 0.0 110.796 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.19 170.02 8.11 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.395 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 56.6 p-80 -54.76 -29.76 54.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.914 0.388 . . . . 0.0 110.954 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.4 p -76.25 -31.21 20.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.559 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.25 -44.24 79.91 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.497 ' CZ3' ' O ' ' A' ' 23' ' ' ALA . 5.0 m-90 -74.82 -30.45 61.4 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.33 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -58.62 -43.37 89.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.609 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -118.36 39.56 3.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.555 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.464 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 30.4 p -79.97 126.74 31.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.312 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.42 HG22 ' N ' ' A' ' 33' ' ' TRP . 16.3 m -88.29 -39.16 12.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.543 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.447 ' CE3' HG21 ' A' ' 42' ' ' VAL . 0.5 OUTLIER -139.61 150.16 44.65 Favored 'General case' 0 CA--C 1.53 0.212 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.067 179.905 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -149.93 110.89 4.34 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.722 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.44 ' HB2' ' CZ2' ' A' ' 33' ' ' TRP . 27.4 t0 -107.23 112.88 25.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.88 0.371 . . . . 0.0 111.06 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -67.4 -34.82 78.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.076 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.434 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 0.3 OUTLIER -64.3 -20.24 65.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.845 179.718 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -115.11 0.96 13.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.316 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 46.58 35.12 2.75 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 121.221 0.534 . . . . 0.0 110.175 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 28.4 tp -131.84 153.46 50.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.911 -179.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.493 ' CD2' ' O ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -146.43 155.73 42.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.177 179.648 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.447 HG21 ' CE3' ' A' ' 33' ' ' TRP . 33.9 t -119.11 127.97 75.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.288 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.9 p -122.3 157.17 32.32 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.787 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 14' ' ' ASN . 25.1 p -97.57 145.09 26.59 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.216 0.531 . . . . 0.0 111.614 -179.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.47 HG21 ' CE2' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -137.4 171.76 14.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.907 -179.139 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.0 t -121.18 34.75 5.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.848 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -113.81 175.14 5.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.164 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.2 m80 -82.84 148.09 27.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.9 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.417 ' HA2' ' CE1' ' A' ' 11' ' ' TYR . . . -100.69 -174.18 29.48 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.563 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.9 t -165.06 -43.41 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.842 0.353 . . . . 0.0 110.879 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -74.15 137.17 43.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.973 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 81.0 m -122.66 123.55 41.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.499 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.499 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 1.0 OUTLIER -74.09 139.51 19.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.804 0.335 . . . . 0.0 110.689 179.915 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -95.21 128.2 41.87 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.008 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -94.67 36.09 1.19 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.584 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 20.6 p -99.98 167.25 10.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.981 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -117.22 28.64 8.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.468 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 14.0 m -62.18 120.44 10.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.753 0.311 . . . . 0.0 110.704 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.4 t -69.35 -13.37 62.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.947 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -117.71 126.56 52.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.21 0.529 . . . . 0.0 111.464 -179.664 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.491 ' O ' ' HA ' ' A' ' 73' ' ' PRO . . . -135.83 -153.78 6.74 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.114 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 11.2 p -140.08 131.31 31.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 117.26 0.53 . . . . 0.0 111.649 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -109.69 150.74 27.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.741 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.098 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 35.0 m80 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.894 0.378 . . . . 0.0 109.993 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -111.22 114.38 53.47 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.296 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.491 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 6.3 Cg_exo -78.27 125.89 7.36 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.459 2.106 . . . . 0.0 111.834 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.462 ' CG1' ' CE2' ' A' ' 76' ' ' PHE . 2.3 p -136.77 153.03 29.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.945 0.403 . . . . 0.0 111.745 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.518 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 0.0 OUTLIER -95.35 133.52 39.18 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.493 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.503 ' CD1' ' N ' ' A' ' 76' ' ' PHE . 0.0 OUTLIER -135.28 166.5 22.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.507 0.67 . . . . 0.0 111.955 -178.886 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.668 ' C ' ' HD3' ' A' ' 79' ' ' PRO . 1.8 mp0 -111.71 159.54 18.14 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.121 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -108.42 62.23 0.3 Allowed Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.044 -1.074 . . . . 0.0 114.191 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.668 ' HD3' ' C ' ' A' ' 77' ' ' GLU . 15.1 Cg_exo -67.01 142.52 62.2 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.075 1.85 . . . . 0.0 111.948 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -64.83 -90.67 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.739 -0.664 . . . . 0.0 113.016 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.475 HD12 ' HB3' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -85.08 129.99 34.7 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.031 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.429 ' HB ' ' CG1' ' A' ' 98' ' ' VAL . 98.7 t -138.75 126.04 26.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.478 178.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -72.35 107.86 5.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.944 0.402 . . . . 0.0 111.598 -178.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 4.1 p -73.11 114.27 12.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.959 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -73.01 149.39 43.3 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.546 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.559 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 1.0 OUTLIER -69.34 101.89 1.62 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.644 179.923 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.457 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -144.45 152.81 41.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.129 179.761 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 53.56 -82.85 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.558 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.457 ' N ' ' O ' ' A' ' 87' ' ' SER . 0.4 OUTLIER -146.38 18.65 1.36 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.693 0.283 . . . . 0.0 111.047 179.905 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.559 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 1.2 m-85 -106.9 136.54 19.43 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.315 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.429 ' HA ' ' HG2' ' A' ' 86' ' ' GLU . 95.2 Cg_endo -84.37 148.33 11.5 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.917 2.411 . . . . 0.0 112.954 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -65.05 77.58 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.518 179.547 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.445 ' O ' HG13 ' A' ' 84' ' ' VAL . 46.8 mtt180 -123.69 -174.75 3.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.126 0.489 . . . . 0.0 111.912 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.475 ' HB3' HD12 ' A' ' 81' ' ' LEU . 19.5 m-85 -99.14 132.26 44.58 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.841 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.434 ' HA ' ' O ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -131.22 126.74 36.33 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.098 -179.867 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 44.4 t -101.55 158.54 16.0 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.087 0.47 . . . . 0.0 111.803 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.403 ' CE1' ' HB2' ' A' ' 138' ' ' ARG . 0.0 OUTLIER 64.71 56.53 1.15 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.645 179.338 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.522 ' O ' ' HD2' ' A' ' 79' ' ' PRO . 9.5 p -123.53 141.81 42.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.994 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.435 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 11.0 mp -104.95 147.96 27.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.315 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.582 ' HA ' ' O ' ' A' ' 132' ' ' VAL . 6.8 mt -133.08 131.5 40.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.069 0.461 . . . . 0.0 112.183 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.456 ' O ' ' HA ' ' A' ' 131' ' ' VAL . . . -135.65 147.64 48.67 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.749 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.5 t -105.33 134.35 48.59 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.982 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 0.204 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.494 179.992 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.719 -0.152 . . . . 0.0 112.719 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 18.0 pt -126.11 146.72 31.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.829 0.347 . . . . 0.0 111.156 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.513 ' HG ' ' HB ' ' A' ' 121' ' ' ILE . 15.6 tp -87.14 115.49 24.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.126 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.05 150.94 38.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.059 0.457 . . . . 0.0 111.501 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.441 ' HB2' HD11 ' A' ' 121' ' ' ILE . 5.7 t -114.57 162.34 16.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.279 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -56.22 -19.47 13.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.919 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -92.26 -34.34 14.29 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.457 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 178.03 -140.03 4.47 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.345 -0.931 . . . . 0.0 113.145 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.499 ' HB ' ' HA ' ' A' ' 53' ' ' ILE . 4.0 t -102.1 135.58 38.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.705 0.288 . . . . 0.0 111.287 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.513 ' HB ' ' HG ' ' A' ' 114' ' ' LEU . 1.1 mm -98.4 -67.15 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.896 0.379 . . . . 0.0 110.735 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.416 ' HA2' ' CG2' ' A' ' 137' ' ' VAL . . . -159.88 -166.43 18.75 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.667 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -116.93 164.08 15.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.789 0.328 . . . . 0.0 110.698 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 7.7 m -65.6 128.94 29.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.453 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.431 ' CG2' ' N ' ' A' ' 126' ' ' MET . 2.5 m -111.09 -89.08 0.5 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.344 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.478 ' O ' ' HA3' ' A' ' 133' ' ' GLY . 0.8 OUTLIER -130.44 125.77 35.3 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.934 0.397 . . . . 0.0 111.409 179.915 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -110.71 151.19 17.68 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.47 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -110.04 -153.23 14.1 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.578 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -93.98 17.28 12.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.595 0.236 . . . . 0.0 111.239 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -168.74 -28.25 0.02 OUTLIER Glycine 0 CA--C 1.52 0.357 0 C-N-CA 120.527 -0.844 . . . . 0.0 113.182 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 101' ' ' ALA . 1.6 t -115.48 157.27 16.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.802 0.301 . . . . 0.0 111.038 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.582 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 10.0 m -114.73 118.86 59.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.658 -179.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.478 ' HA3' ' O ' ' A' ' 126' ' ' MET . . . -95.59 117.93 5.78 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.39 -0.909 . . . . 0.0 112.177 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.469 ' CZ ' ' HB ' ' A' ' 132' ' ' VAL . 13.5 m-85 -122.2 144.2 49.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.95 0.405 . . . . 0.0 111.512 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -89.34 111.06 21.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.076 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -68.34 147.34 52.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.01 0.433 . . . . 0.0 111.836 -179.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.463 ' CG1' ' O ' ' A' ' 137' ' ' VAL . 97.9 t -91.26 11.03 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.438 179.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.483 ' HA ' HD23 ' A' ' 141' ' ' LEU . 12.8 mmm180 -70.14 -6.93 37.61 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.748 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -98.26 11.11 38.98 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 111.706 0.261 . . . . 0.0 111.706 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.526 ' N ' ' CD1' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -175.03 39.07 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.202 0.525 . . . . 0.0 110.471 179.81 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.492 HD11 ' HB ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -56.77 -20.86 24.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.32 -179.608 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . 0.417 ' CD1' ' HA ' ' A' ' 140' ' ' LEU . 12.7 p-90 -55.68 85.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.941 0.4 . . . . 0.0 111.45 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.465 ' CD2' ' HB ' ' A' ' 12' ' ' VAL . 4.2 mp -146.0 -48.16 0.21 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.309 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -151.12 -173.21 4.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.676 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -58.93 136.01 57.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.92 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -82.95 154.1 24.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.916 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.239 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.069 179.983 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.772 0.32 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.4 t -106.73 108.24 24.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.033 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.443 ' CE2' HG22 ' A' ' 45' ' ' THR . 6.5 t80 -98.11 116.53 30.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.688 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.436 ' HB ' ' CD2' ' A' ' 143' ' ' LEU . 41.7 t -120.58 108.83 23.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.587 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 51.59 -127.78 31.18 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.955 -0.64 . . . . 0.0 113.304 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.448 ' O ' ' HA ' ' A' ' 44' ' ' THR . 0.9 OUTLIER -88.88 14.27 10.78 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.572 0.225 . . . . 0.0 111.599 -179.637 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.454 ' CE2' ' CE3' ' A' ' 142' ' ' TRP . 6.1 m-30 -130.34 128.01 40.6 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.49 114.68 23.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.66 0.267 . . . . 0.0 111.018 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 0.8 OUTLIER -99.13 122.49 50.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 121.032 0.444 . . . . 0.0 110.401 179.48 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.434 ' O ' HD21 ' A' ' 41' ' ' LEU . 12.6 p -135.42 161.49 39.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.256 -179.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -60.94 141.74 57.0 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.2 -47.03 79.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.824 0.345 . . . . 0.0 110.838 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -71.05 -6.93 42.79 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.151 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 52.4 mt -112.66 -3.68 14.24 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.493 ' O ' ' CZ3' ' A' ' 28' ' ' TRP . . . -77.13 151.0 35.55 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.865 0.364 . . . . 0.0 110.829 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.445 ' O ' ' CE3' ' A' ' 28' ' ' TRP . 1.2 t -102.89 166.64 10.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.133 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 30.1 t60 -54.04 -29.57 44.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.042 0.448 . . . . 0.0 110.345 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.5 t -72.07 -31.18 39.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.019 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.46 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 0.4 OUTLIER -67.43 -44.14 79.47 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.941 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.493 ' CZ3' ' O ' ' A' ' 23' ' ' ALA . 11.7 m-90 -73.9 -35.46 64.65 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.078 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.62 -38.62 72.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.045 0.45 . . . . 0.0 110.503 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -119.37 27.73 8.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.755 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 8.7 t -73.58 122.8 22.82 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.964 0.412 . . . . 0.0 110.863 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.418 HG22 ' N ' ' A' ' 33' ' ' TRP . 13.1 m -86.57 -39.77 13.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.515 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.475 ' CE3' HG23 ' A' ' 42' ' ' VAL . 0.5 OUTLIER -139.71 153.12 47.14 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.172 -179.893 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -156.82 121.28 4.44 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.813 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.409 ' HB2' ' CZ2' ' A' ' 33' ' ' TRP . 17.6 m-20 -107.05 116.86 32.66 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.23 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -67.24 -36.88 82.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.963 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.515 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 3.8 m-20 -72.41 -14.15 61.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.863 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 mtt85 -115.54 -3.77 12.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.777 -0.192 . . . . 0.0 111.274 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 46.91 42.15 11.79 Favored 'General case' 0 CA--C 1.524 -0.046 0 CA-C-O 121.216 0.532 . . . . 0.0 110.038 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.4 HD11 ' N ' ' A' ' 18' ' ' VAL . 29.3 tp -136.17 152.42 50.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.906 -178.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.621 ' O ' HD23 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -147.33 150.79 35.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.042 0.449 . . . . 0.0 111.194 179.408 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.475 HG23 ' CE3' ' A' ' 33' ' ' TRP . 31.0 t -114.54 126.75 72.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.403 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.9 p -117.87 157.28 26.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.416 178.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.448 ' HA ' ' O ' ' A' ' 14' ' ' ASN . 18.9 p -97.71 140.79 31.58 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.119 0.485 . . . . 0.0 111.701 -179.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.443 HG22 ' CE2' ' A' ' 11' ' ' TYR . 0.2 OUTLIER -135.29 168.94 18.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.875 -179.335 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.2 p -121.69 61.9 0.93 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.832 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.24 169.7 17.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.125 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 4.9 m170 -86.56 128.57 34.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.876 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -87.43 -179.48 48.13 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.489 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 73.3 m -144.09 -46.94 0.27 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.77 0.319 . . . . 0.0 110.892 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -64.25 138.88 58.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.939 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 83.2 m -122.7 121.05 35.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.509 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.517 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 0.4 OUTLIER -74.24 139.36 19.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.928 0.394 . . . . 0.0 111.211 -179.677 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.419 ' HB1' ' HB2' ' A' ' 118' ' ' HIS . . . -95.7 123.65 39.36 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.942 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -91.2 37.29 0.94 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.621 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 24.5 p -99.85 167.1 10.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.952 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -119.1 33.53 5.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.32 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 35.5 m -62.76 141.85 58.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.627 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -85.28 3.1 41.12 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.024 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.1 p -125.9 168.05 14.42 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.103 0.478 . . . . 0.0 111.117 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -179.44 -173.14 44.34 Favored Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.583 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.2 p -140.22 125.83 20.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 117.044 0.422 . . . . 0.0 111.225 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 63' ' ' TYR . 6.2 p90 -109.12 137.99 46.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.743 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.049 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.131 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -108.59 113.86 59.52 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.512 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.34 120.78 5.77 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.589 2.192 . . . . 0.0 111.024 178.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.455 ' CG1' ' HB3' ' A' ' 101' ' ' ALA . 54.5 t -134.83 141.78 42.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.977 0.418 . . . . 0.0 111.765 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 16.7 m -91.84 121.64 33.64 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.468 ' HB3' ' HB2' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -127.96 165.19 20.73 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.526 0.679 . . . . 0.0 111.947 -178.629 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.552 ' C ' ' HD3' ' A' ' 79' ' ' PRO . 10.7 mt-10 -111.72 158.83 18.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.899 178.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.453 ' HA2' ' HG ' ' A' ' 99' ' ' LEU . . . -112.16 68.6 0.23 Allowed Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.124 -1.036 . . . . 0.0 113.961 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.579 ' HD2' ' O ' ' A' ' 98' ' ' VAL . 15.7 Cg_exo -67.36 142.08 58.68 Favored 'Trans proline' 0 C--O 1.238 0.503 0 C-N-CA 122.22 1.946 . . . . 0.0 111.797 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -57.98 -91.73 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.538 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.411 HD11 ' HB3' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -94.37 119.82 33.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.91 0.386 . . . . 0.0 111.876 -179.587 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.429 ' HB ' ' CG1' ' A' ' 98' ' ' VAL . 61.7 t -122.76 122.62 66.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.923 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -72.43 107.62 5.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.859 0.362 . . . . 0.0 110.741 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.557 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 30.4 t -75.77 114.3 15.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.624 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.433 ' HA ' ' HD3' ' A' ' 92' ' ' LYS . 1.5 tt0 -71.86 150.02 44.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.032 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 0.8 OUTLIER -67.88 101.34 1.07 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.158 0.504 . . . . 0.0 110.159 -179.475 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.508 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.3 OUTLIER -144.65 175.7 9.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.839 -179.913 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 42.96 -86.23 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.787 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.508 ' N ' ' O ' ' A' ' 87' ' ' SER . 0.3 OUTLIER -150.56 23.5 0.8 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.825 0.345 . . . . 0.0 110.485 179.686 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.458 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -117.92 138.15 25.11 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.867 -179.704 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.427 ' O ' ' N ' ' A' ' 93' ' ' ARG . 93.7 Cg_endo -78.77 148.61 22.69 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.821 2.347 . . . . 0.0 112.247 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.557 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -60.9 79.9 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.866 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.427 ' N ' ' O ' ' A' ' 91' ' ' PRO . 1.5 ttp85 -123.65 177.41 5.7 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.692 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.411 ' HB3' HD11 ' A' ' 81' ' ' LEU . 10.6 m-85 -91.29 132.6 36.04 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.777 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.515 ' HA ' ' O ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -125.46 116.84 22.46 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.654 -179.571 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.0 t -91.53 154.4 19.12 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 120.92 0.391 . . . . 0.0 111.45 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 53.72 62.46 2.61 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.336 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.579 ' O ' ' HD2' ' A' ' 79' ' ' PRO . 5.9 p -123.35 152.28 28.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.1 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.453 ' HG ' ' HA2' ' A' ' 78' ' ' GLY . 5.5 mp -116.43 140.27 49.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.205 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.528 ' HA ' ' O ' ' A' ' 132' ' ' VAL . 5.5 mt -133.23 142.06 48.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.268 0.556 . . . . 0.0 112.456 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.477 ' O ' ' HA ' ' A' ' 131' ' ' VAL . . . -151.97 161.06 43.23 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.412 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.1 t -118.92 129.45 55.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.947 0.403 . . . . 0.0 111.004 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.334 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.493 179.949 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 28.4 pt -126.15 144.21 37.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.782 0.325 . . . . 0.0 111.17 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.454 ' HG ' ' HB ' ' A' ' 121' ' ' ILE . 10.8 tp -87.9 113.99 24.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.208 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 3.1 mtm180 -114.1 143.24 45.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.098 0.475 . . . . 0.0 111.554 -179.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.507 ' HB2' HD11 ' A' ' 121' ' ' ILE . 6.9 t -107.79 164.28 12.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.191 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -56.14 -20.35 17.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.788 0.328 . . . . 0.0 110.723 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.419 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . 26.7 m80 -89.59 -35.86 15.64 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.325 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 177.46 -136.36 3.06 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.854 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.517 ' HB ' ' HA ' ' A' ' 53' ' ' ILE . 3.8 t -102.88 135.38 40.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.685 0.279 . . . . 0.0 110.926 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.507 HD11 ' HB2' ' A' ' 116' ' ' CYS . 1.0 OUTLIER -94.59 -69.9 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.698 0.285 . . . . 0.0 111.248 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.443 ' HA3' ' O ' ' A' ' 135' ' ' ALA . . . -150.95 -160.09 9.2 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.381 -0.914 . . . . 0.0 113.236 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.38 164.48 17.01 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.737 0.303 . . . . 0.0 110.85 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 9.9 p -62.31 121.52 11.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.838 0.351 . . . . 0.0 111.796 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.451 ' CG2' ' N ' ' A' ' 126' ' ' MET . 3.0 m -112.17 -91.31 0.49 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.075 179.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.451 ' N ' ' CG2' ' A' ' 125' ' ' THR . 0.0 OUTLIER -92.58 160.4 15.04 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 120.787 0.327 . . . . 0.0 110.743 179.517 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -150.03 88.66 0.14 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.442 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -77.32 -176.59 44.81 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.429 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.79 -19.32 62.02 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.667 0.27 . . . . 0.0 111.015 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -142.03 -6.3 0.8 Allowed Glycine 0 CA--C 1.522 0.482 0 C-N-CA 120.598 -0.81 . . . . 0.0 113.447 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -115.82 157.17 16.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 117.322 0.561 . . . . 0.0 111.306 -179.764 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.528 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 13.1 m -119.73 118.69 57.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.5 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -100.99 120.06 6.75 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.728 -0.749 . . . . 0.0 111.9 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.47 ' CZ ' ' HB ' ' A' ' 132' ' ' VAL . 18.3 m-85 -125.13 136.72 53.9 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.914 0.387 . . . . 0.0 112.02 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.443 ' O ' ' HA3' ' A' ' 122' ' ' GLY . . . -88.86 114.22 25.25 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.198 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -67.79 141.16 56.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.975 0.417 . . . . 0.0 111.858 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.454 ' CG1' ' O ' ' A' ' 137' ' ' VAL . 88.9 t -89.31 9.72 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.615 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.74 -6.68 39.21 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.599 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -95.93 11.05 35.27 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 120.685 0.279 . . . . 0.0 111.317 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.572 ' N ' ' CD1' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -177.98 57.28 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.083 0.468 . . . . 0.0 110.484 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.469 ' O ' ' N ' ' A' ' 143' ' ' LEU . 0.1 OUTLIER -74.83 -14.83 60.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.883 -179.572 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . 0.454 ' CE3' ' CE2' ' A' ' 15' ' ' TYR . 13.2 p-90 -55.99 82.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.896 0.379 . . . . 0.0 111.261 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.469 ' N ' ' O ' ' A' ' 141' ' ' LEU . 5.1 mp -149.67 -45.67 0.13 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.466 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.424 ' HB2' ' CG1' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -154.35 -167.44 2.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.747 179.832 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -58.88 141.03 54.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.0 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 15.4 p30 -94.97 154.07 17.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.832 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.268 0 CA-C-O 120.904 0.383 . . . . 0.0 111.156 -179.922 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.801 0.334 . . . . 0.0 111.047 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.0 t -107.4 116.23 50.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.013 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.453 ' CZ ' HG21 ' A' ' 45' ' ' THR . 0.3 OUTLIER -98.02 115.52 28.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.604 179.889 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.42 ' HB ' ' CD2' ' A' ' 143' ' ' LEU . 17.3 t -121.47 108.8 23.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.525 179.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 48.21 -124.64 11.41 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.928 -0.653 . . . . 0.0 113.098 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -92.43 17.94 9.2 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.734 0.302 . . . . 0.0 111.403 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.411 ' CE2' ' CE3' ' A' ' 142' ' ' TRP . 4.9 m-30 -130.31 144.4 51.36 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.422 ' HG3' ' CD1' ' A' ' 11' ' ' TYR . 18.6 ttpt -133.83 118.26 17.79 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.702 0.287 . . . . 0.0 110.994 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -104.39 122.07 56.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.117 0.485 . . . . 0.0 110.434 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.491 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 14.0 p -136.01 162.0 37.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.033 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -58.53 141.24 52.52 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.418 ' O ' ' HZ2' ' A' ' 28' ' ' TRP . 13.9 mtm105 -56.45 -47.82 78.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.916 0.389 . . . . 0.0 111.17 -179.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -69.52 -7.62 39.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.441 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.9 tp -115.33 5.73 14.72 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.441 ' HB3' ' NE1' ' A' ' 28' ' ' TRP . . . -89.27 131.89 35.16 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.353 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.553 ' O ' ' HD1' ' A' ' 28' ' ' TRP . 44.1 p -74.76 162.5 28.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.469 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -53.66 -29.64 39.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.886 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.8 t -69.57 -31.94 50.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.915 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.425 ' O ' ' HB3' ' A' ' 31' ' ' CYS . 13.5 m-20 -67.72 -44.07 78.51 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.553 ' HD1' ' O ' ' A' ' 24' ' ' THR . 33.8 m95 -73.57 -29.88 62.69 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.594 179.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -58.8 -43.92 90.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.575 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -118.15 30.13 7.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.832 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.487 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 29.5 p -69.17 122.93 19.81 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.949 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.418 HG21 ' N ' ' A' ' 33' ' ' TRP . 17.7 m -86.2 -39.74 13.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.434 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.476 ' CE3' HG22 ' A' ' 42' ' ' VAL . 1.0 OUTLIER -139.66 153.25 47.25 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.08 179.689 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -160.44 115.92 2.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.008 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -107.19 117.75 34.9 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.936 0.398 . . . . 0.0 111.136 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -62.26 -48.84 78.14 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.353 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -59.9 -19.09 49.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.134 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -108.38 -8.02 15.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.276 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.4 t70 49.49 43.22 23.63 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 121.088 0.47 . . . . 0.0 110.224 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.0 tp -137.1 154.15 50.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.126 -178.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.572 ' N ' ' CD2' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -151.86 137.18 17.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.115 0.484 . . . . 0.0 111.131 179.555 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.476 HG22 ' CE3' ' A' ' 33' ' ' TRP . 34.3 t -100.96 130.58 50.11 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.406 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.4 p -123.19 157.45 32.99 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.261 -0.882 . . . . 0.0 109.435 178.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 19.4 p -97.21 134.48 40.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.235 0.54 . . . . 0.0 111.395 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.453 HG21 ' CZ ' ' A' ' 11' ' ' TYR . 0.5 OUTLIER -102.49 -29.56 11.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.026 -179.126 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.0 m 66.61 31.43 7.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.738 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -142.96 -167.78 2.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.017 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.85 144.94 43.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.827 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -72.65 -140.51 0.37 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.42 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.1 m -172.09 -44.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.693 0.282 . . . . 0.0 111.05 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -117.23 163.3 16.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.2 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 73.9 m -125.28 122.5 37.09 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.664 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.51 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 0.4 OUTLIER -75.29 139.52 18.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.03 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.408 ' HA ' ' HB3' ' A' ' 147' ' ' ALA . . . -94.57 128.45 41.2 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.061 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.439 ' HB3' ' HB3' ' A' ' 146' ' ' ASP . 0.0 OUTLIER -92.31 33.69 1.08 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.683 179.576 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 26.7 p -99.49 166.96 10.91 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.905 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -121.85 33.41 5.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.241 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 34.4 m -60.44 127.37 31.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.776 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.85 -9.32 58.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.994 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.9 p -117.84 124.0 47.28 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.008 0.432 . . . . 0.0 111.109 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.07 178.88 20.44 Favored Glycine 0 N--CA 1.452 -0.299 0 N-CA-C 111.632 -0.587 . . . . 0.0 111.632 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.465 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 8.3 p -119.28 124.83 73.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.205 0.526 . . . . 0.0 111.362 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -105.52 -173.94 2.42 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.433 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.134 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.414 ' HB2' HG21 ' A' ' 62' ' ' VAL . 7.8 p80 . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.639 0.257 . . . . 0.0 110.504 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -105.68 112.4 64.57 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.039 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.465 ' HA ' ' HA ' ' A' ' 62' ' ' VAL . 2.8 Cg_endo -84.03 120.88 2.69 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.044 2.496 . . . . 0.0 111.658 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.517 ' CG1' ' CE2' ' A' ' 76' ' ' PHE . 2.5 p -137.52 153.79 28.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.504 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.0 m -94.78 127.68 40.95 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.517 ' CE2' ' CG1' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -131.53 162.71 29.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.379 0.609 . . . . 0.0 111.919 -179.416 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.441 ' O ' ' HA ' ' A' ' 99' ' ' LEU . 0.7 OUTLIER -111.83 158.86 18.9 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.142 178.987 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -104.82 65.48 0.3 Allowed Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.275 -0.964 . . . . 0.0 113.557 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 99' ' ' LEU . 41.9 Cg_endo -68.34 135.23 33.41 Favored 'Trans proline' 0 C--O 1.239 0.535 0 C-N-CA 122.263 1.975 . . . . 0.0 112.198 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -59.3 -85.26 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.245 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.455 HD13 ' CD2' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -97.38 119.5 36.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.993 0.425 . . . . 0.0 111.594 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.455 ' HB ' ' CG1' ' A' ' 98' ' ' VAL . 44.1 t -123.25 122.42 65.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.823 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.59 107.51 5.13 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.992 0.425 . . . . 0.0 110.67 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.438 HG22 ' HG3' ' A' ' 126' ' ' MET . 2.7 p -74.53 119.29 21.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.557 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.404 ' HA ' ' HG2' ' A' ' 92' ' ' LYS . 24.3 mt-30 -69.65 149.41 48.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.06 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.528 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 14.3 tt0 -68.63 102.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.625 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.425 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -143.66 158.64 43.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.382 -179.827 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.434 ' HG2' ' CD2' ' A' ' 89' ' ' TYR . 5.7 tt0 53.54 -84.78 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.709 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.434 ' CD2' ' HG2' ' A' ' 88' ' ' GLU . 0.2 OUTLIER -145.43 19.36 1.53 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.663 0.268 . . . . 0.0 111.146 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.528 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 1.4 t80 -113.85 137.5 22.34 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.737 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.468 ' O ' ' N ' ' A' ' 93' ' ' ARG . 90.3 Cg_endo -85.79 148.59 9.66 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.065 2.51 . . . . 0.0 112.569 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -55.94 82.28 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.873 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.468 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -123.84 174.29 7.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.168 0.509 . . . . 0.0 111.905 -179.477 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.455 ' CD2' HD13 ' A' ' 81' ' ' LEU . 3.8 m-85 -93.29 132.78 37.17 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.175 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -125.36 126.28 44.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.818 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 12.1 t -96.28 154.68 17.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.091 0.472 . . . . 0.0 111.983 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.456 ' CE1' ' HB3' ' A' ' 136' ' ' ASP . 1.6 t-80 57.82 57.52 4.14 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.922 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.455 ' CG1' ' HB ' ' A' ' 82' ' ' VAL . 11.1 p -123.72 141.07 45.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.528 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.463 ' O ' ' HA2' ' A' ' 133' ' ' GLY . 6.2 mp -104.03 141.47 36.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.947 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.62 ' HA ' ' O ' ' A' ' 132' ' ' VAL . 7.3 mt -125.92 136.39 52.99 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.453 ' O ' ' N ' ' A' ' 132' ' ' VAL . . . -143.65 142.84 31.19 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.684 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 1.6 t -98.26 133.41 42.72 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.864 0.364 . . . . 0.0 111.217 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.277 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.507 -179.817 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.559 -0.216 . . . . 0.0 112.559 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 22.7 pt -126.25 146.39 32.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.806 0.336 . . . . 0.0 111.218 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.521 ' HG ' ' HB ' ' A' ' 121' ' ' ILE . 12.4 tp -87.43 117.05 25.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.175 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.15 153.11 34.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.111 0.481 . . . . 0.0 111.715 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.463 ' HB2' HD11 ' A' ' 121' ' ' ILE . 6.2 t -117.66 162.62 17.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.306 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -56.02 -20.86 18.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.926 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 18.4 m80 -90.19 -34.77 15.7 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.422 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 177.3 -139.13 4.2 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.026 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.51 ' HB ' ' HA ' ' A' ' 53' ' ' ILE . 4.0 t -102.0 135.5 38.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.759 0.314 . . . . 0.0 111.227 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.521 ' HB ' ' HG ' ' A' ' 114' ' ' LEU . 1.2 mm -94.49 -66.35 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.909 0.385 . . . . 0.0 110.631 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.42 ' HA2' ' CG2' ' A' ' 137' ' ' VAL . . . -164.05 -161.83 13.88 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.558 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -116.87 164.14 15.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.725 0.298 . . . . 0.0 110.631 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.445 ' HA ' ' CD1' ' A' ' 134' ' ' PHE . 29.4 m -73.89 129.33 36.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.91 0.386 . . . . 0.0 111.653 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.428 ' CG2' ' N ' ' A' ' 126' ' ' MET . 3.6 m -110.16 -94.25 0.43 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.129 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.572 ' O ' ' HA3' ' A' ' 133' ' ' GLY . 12.4 mmm -144.56 142.03 29.9 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.855 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -113.21 178.6 18.72 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.588 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -108.41 -139.38 8.81 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.499 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -72.5 -19.43 61.54 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.787 0.327 . . . . 0.0 111.095 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -165.64 19.17 0.1 Allowed Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.816 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 1.5 t -121.85 157.34 25.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.703 0.287 . . . . 0.0 110.576 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.62 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 12.2 m -115.4 118.39 58.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.825 -179.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.572 ' HA3' ' O ' ' A' ' 126' ' ' MET . . . -96.9 116.17 5.42 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.323 -0.942 . . . . 0.0 111.686 178.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.498 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 12.9 m-85 -116.2 141.66 47.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.994 0.426 . . . . 0.0 111.726 -179.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -88.89 109.36 20.16 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.066 178.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.456 ' HB3' ' CE1' ' A' ' 97' ' ' HIS . 0.6 OUTLIER -67.87 152.03 46.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.152 0.501 . . . . 0.0 111.984 -178.735 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.45 ' O ' HD13 ' A' ' 140' ' ' LEU . 48.0 t -99.33 9.39 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.843 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 5.9 mtm180 -72.29 -6.9 46.41 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.401 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -94.93 10.77 34.24 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.719 0.295 . . . . 0.0 110.846 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.573 ' N ' ' CD1' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -176.77 58.32 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.08 0.467 . . . . 0.0 110.303 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' A' ' 143' ' ' LEU . 0.1 OUTLIER -73.09 -14.86 61.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.914 -179.386 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . 0.411 ' CE3' ' CE2' ' A' ' 15' ' ' TYR . 15.8 p-90 -56.88 83.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.934 0.397 . . . . 0.0 111.476 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.449 ' N ' ' O ' ' A' ' 141' ' ' LEU . 4.8 mp -150.91 -47.0 0.12 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.614 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.412 ' HB2' ' CG1' ' A' ' 12' ' ' VAL . 0.4 OUTLIER -151.46 -166.81 2.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.065 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.48 149.09 50.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.369 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.439 ' HB3' ' HB3' ' A' ' 55' ' ' ARG . 9.6 m-20 -95.29 154.53 17.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.753 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.408 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . . . . . . . . 0 C--N 1.332 -0.153 0 CA-C-O 120.897 0.379 . . . . 0.0 111.124 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.104 0 CA-C-O 120.813 0.34 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 41.5 t -108.82 110.7 33.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.107 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.41 ' CE2' HG22 ' A' ' 45' ' ' THR . 5.2 t80 -99.73 116.32 31.55 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.791 0.329 . . . . 0.0 110.529 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.403 ' CG2' HD11 ' A' ' 53' ' ' ILE . 47.6 t -120.85 111.64 32.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.657 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.404 ' O ' ' CE1' ' A' ' 11' ' ' TYR . . . 53.0 -125.32 30.35 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.959 -0.639 . . . . 0.0 113.18 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.406 ' O ' ' HA ' ' A' ' 44' ' ' THR . 44.6 m-80 -91.93 18.73 7.44 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.701 0.286 . . . . 0.0 111.569 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.414 ' CE2' ' CE3' ' A' ' 142' ' ' TRP . 6.2 m-30 -130.35 149.94 51.81 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.5 tttp -139.09 114.87 10.02 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.709 -0.223 . . . . 0.0 110.629 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 0.6 OUTLIER -100.3 121.64 51.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.041 0.448 . . . . 0.0 110.77 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.409 HG23 ' HB3' ' A' ' 22' ' ' LEU . 7.3 p -136.43 160.26 37.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.037 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -62.26 141.51 58.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.227 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 8.4 ttp180 -56.27 -45.59 80.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.942 0.401 . . . . 0.0 110.85 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -66.85 -11.62 56.29 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.153 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.409 ' HB3' HG23 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -108.71 -13.41 14.79 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.735 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.505 ' O ' ' CZ3' ' A' ' 28' ' ' TRP . . . -68.74 150.72 47.56 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 120.796 0.331 . . . . 0.0 110.834 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.403 ' O ' ' CE3' ' A' ' 28' ' ' TRP . 32.6 p -104.59 168.94 8.75 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.269 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 52.5 p-80 -54.76 -29.68 54.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.002 0.43 . . . . 0.0 110.564 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.4 t -74.66 -31.36 26.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.459 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.413 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 0.6 OUTLIER -67.18 -43.98 80.84 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.505 ' CZ3' ' O ' ' A' ' 23' ' ' ALA . 7.2 m-90 -74.33 -30.37 62.01 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.145 179.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.15 -41.99 89.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.32 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -116.66 32.58 6.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.486 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.414 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 13.2 t -77.24 132.42 38.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.179 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.432 HG23 ' N ' ' A' ' 33' ' ' TRP . 16.8 m -96.06 -38.83 8.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.695 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.482 ' CE3' HG23 ' A' ' 42' ' ' VAL . 1.1 t90 -139.67 153.27 47.24 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.908 0.385 . . . . 0.0 111.548 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -155.69 120.51 4.74 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.79 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.444 ' HB2' ' CZ2' ' A' ' 33' ' ' TRP . 8.3 m-20 -107.09 99.2 8.77 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.038 0.447 . . . . 0.0 111.14 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -58.91 -28.92 66.66 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.8 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.675 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 0.9 OUTLIER -59.68 -38.74 82.35 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.755 -0.202 . . . . 0.0 111.301 -179.052 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.441 ' NH1' ' HB2' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -117.31 0.75 12.31 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 60.24 54.83 3.84 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.85 0.357 . . . . 0.0 111.892 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.441 ' HB2' ' NH1' ' A' ' 38' ' ' ARG . 38.3 tp -137.11 133.65 35.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.449 179.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.533 ' H ' HD22 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -131.44 156.0 46.38 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.053 0.454 . . . . 0.0 112.068 -179.526 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.482 HG23 ' CE3' ' A' ' 33' ' ' TRP . 23.7 t -117.17 130.08 72.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.062 179.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.4 p -120.49 157.15 30.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.57 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 14' ' ' ASN . 19.6 p -97.54 123.59 41.48 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.183 0.516 . . . . 0.0 111.493 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.41 HG22 ' CE2' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -98.28 -165.01 1.19 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.872 -179.429 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.0 t -138.86 42.35 2.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.856 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -136.03 -177.98 4.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.085 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -93.0 148.14 22.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.959 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -66.88 157.35 51.1 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.646 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -134.65 -49.17 0.76 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.872 0.368 . . . . 0.0 110.903 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -87.96 150.53 23.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.825 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 39.9 m -122.99 116.98 24.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.763 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.514 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 0.4 OUTLIER -74.62 139.55 19.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.048 0.452 . . . . 0.0 110.968 -179.843 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -88.8 121.97 31.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.971 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.44 29.01 1.02 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.11 0.481 . . . . 0.0 110.12 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 30.8 p -100.0 163.27 12.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.091 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.426 ' O ' ' O ' ' A' ' 58' ' ' CYS . 44.4 mt-30 -93.56 -70.19 0.71 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 178.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.426 ' O ' ' O ' ' A' ' 57' ' ' GLN . 96.3 m 54.47 159.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.74 178.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.11 -7.53 11.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.951 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.478 ' HA ' ' HA ' ' A' ' 75' ' ' SER . 10.0 p -132.41 123.97 27.75 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.973 0.416 . . . . 0.0 111.344 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -136.99 161.64 25.16 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.64 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.41 HG21 ' HB2' ' A' ' 71' ' ' HIS . 7.3 p -102.52 132.91 47.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.951 0.405 . . . . 0.0 111.308 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.487 ' HB2' ' CZ ' ' A' ' 134' ' ' PHE . 3.5 p90 -118.66 133.99 55.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.949 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 64.7 t80 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.902 -179.948 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.41 ' HB2' HG21 ' A' ' 62' ' ' VAL . 9.2 p80 . . . . . 0 N--CA 1.456 -0.137 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -116.31 113.94 40.92 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.835 -178.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -77.34 120.67 5.37 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.473 2.115 . . . . 0.0 110.319 178.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.414 HG22 ' CE2' ' A' ' 63' ' ' TYR . 43.2 t -137.47 151.09 26.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.164 0.507 . . . . 0.0 112.365 -178.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.478 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 20.7 m -98.71 133.92 42.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.522 178.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.478 ' CD1' ' N ' ' A' ' 76' ' ' PHE . 0.0 OUTLIER -145.75 174.14 11.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.444 0.64 . . . . 0.0 112.122 -179.188 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.579 ' C ' ' HD3' ' A' ' 79' ' ' PRO . 0.3 OUTLIER -111.86 158.84 18.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.703 179.425 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.419 ' HA2' ' HG ' ' A' ' 99' ' ' LEU . . . -112.77 66.76 0.25 Allowed Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.235 -0.983 . . . . 0.0 113.642 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.579 ' HD3' ' C ' ' A' ' 77' ' ' GLU . 14.0 Cg_exo -67.46 139.95 50.91 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.376 2.05 . . . . 0.0 112.212 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -57.42 -90.22 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.432 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.451 HD11 ' HB3' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -95.69 119.92 35.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.912 0.387 . . . . 0.0 111.733 -179.756 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.476 ' HB ' ' CG1' ' A' ' 98' ' ' VAL . 18.8 t -124.2 122.45 64.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.149 178.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -72.57 107.89 5.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.482 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 4.8 m -72.77 123.73 28.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.855 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -69.29 150.28 47.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.669 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.568 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 22.8 tt0 -67.61 102.01 1.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.143 0.497 . . . . 0.0 110.373 -179.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 89' ' ' TYR . 4.1 m -144.3 164.08 31.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.188 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 55.93 -81.48 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.542 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.447 ' N ' ' O ' ' A' ' 87' ' ' SER . 0.7 OUTLIER -156.92 24.17 0.32 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.759 0.314 . . . . 0.0 110.877 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.568 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 1.6 t80 -122.69 131.62 24.35 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.695 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.473 ' O ' ' N ' ' A' ' 93' ' ' ARG . 87.0 Cg_endo -81.98 148.84 15.49 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.095 2.53 . . . . 0.0 112.524 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.505 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.4 OUTLIER -42.6 88.99 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.509 -179.931 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.473 ' N ' ' O ' ' A' ' 91' ' ' PRO . 2.0 ttt180 -123.93 171.08 9.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.219 0.533 . . . . 0.0 112.074 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.451 ' HB3' HD11 ' A' ' 81' ' ' LEU . 3.9 m-85 -98.88 132.84 43.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.131 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.675 ' HA ' ' O ' ' A' ' 37' ' ' ASN . 2.0 tp60 -126.43 114.89 18.78 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.893 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.408 ' CB ' ' HB3' ' A' ' 37' ' ' ASN . 60.7 p -80.07 144.0 33.52 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.114 0.483 . . . . 0.0 111.875 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 21.7 m80 61.96 60.83 1.47 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.998 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.532 ' O ' ' HD2' ' A' ' 79' ' ' PRO . 7.1 p -124.17 131.06 73.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.721 0.296 . . . . 0.0 111.266 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.419 ' HG ' ' HA2' ' A' ' 78' ' ' GLY . 2.2 mp -101.76 149.16 24.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.976 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.666 ' HA ' ' O ' ' A' ' 132' ' ' VAL . 9.0 mt -128.69 136.37 50.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.161 0.505 . . . . 0.0 111.96 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 131' ' ' VAL . . . -125.69 124.3 40.8 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.352 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.3 t -96.78 112.01 23.94 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.799 0.333 . . . . 0.0 110.621 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.327 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.821 -179.744 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.386 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.403 HG22 HD11 ' A' ' 113' ' ' ILE . 27.3 pt -122.54 145.32 29.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.861 0.362 . . . . 0.0 111.139 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.517 ' HG ' ' HB ' ' A' ' 121' ' ' ILE . 8.4 tp -87.82 121.18 29.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.319 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -118.36 149.5 41.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.207 0.527 . . . . 0.0 111.962 -179.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.479 ' HB2' HD12 ' A' ' 121' ' ' ILE . 6.2 t -111.68 163.67 13.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.982 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -58.51 -17.26 19.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.022 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 18.8 m80 -95.66 -30.68 13.63 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.653 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 176.82 -143.1 6.16 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.424 -0.893 . . . . 0.0 113.034 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.514 ' HB ' ' HA ' ' A' ' 53' ' ' ILE . 3.6 t -98.93 135.33 34.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.726 0.298 . . . . 0.0 111.024 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.517 ' HB ' ' HG ' ' A' ' 114' ' ' LEU . 1.7 mm -92.35 -66.14 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.839 0.352 . . . . 0.0 110.794 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.446 ' HA3' ' O ' ' A' ' 135' ' ' ALA . . . -166.98 -156.26 9.6 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.622 -0.799 . . . . 0.0 113.045 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -116.94 164.16 15.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.804 0.335 . . . . 0.0 110.983 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.466 ' HA ' ' CD1' ' A' ' 134' ' ' PHE . 11.6 p -66.51 129.53 31.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.625 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.46 HG23 ' N ' ' A' ' 126' ' ' MET . 7.3 m -110.07 -87.35 0.52 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.228 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.471 ' CG ' ' HB ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -104.75 144.37 31.83 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.852 0.358 . . . . 0.0 111.13 179.825 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -118.86 96.26 0.65 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.154 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -77.43 174.5 54.63 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.603 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -71.93 -19.36 61.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.713 0.292 . . . . 0.0 110.931 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -145.16 4.74 1.37 Allowed Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.631 -0.795 . . . . 0.0 113.062 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 101' ' ' ALA . 1.4 t -128.66 157.05 41.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 117.023 0.412 . . . . 0.0 111.008 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.666 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 3.4 t -114.89 117.83 56.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.989 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.442 ' CA ' HD22 ' A' ' 100' ' ' LEU . . . -96.19 118.44 5.98 Favored Glycine 0 CA--C 1.517 0.16 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.801 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.487 ' CZ ' ' HB2' ' A' ' 63' ' ' TYR . 21.4 m-85 -125.13 133.06 52.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.909 0.385 . . . . 0.0 111.787 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.446 ' O ' ' HA3' ' A' ' 122' ' ' GLY . . . -93.62 107.76 19.58 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -67.72 151.84 46.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.262 0.554 . . . . 0.0 112.42 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.406 ' CG2' ' HA2' ' A' ' 122' ' ' GLY . 39.7 t -93.58 13.72 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.643 179.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.3 mtm105 -70.61 -6.99 40.86 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.772 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -96.69 11.13 36.54 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.555 0.217 . . . . 0.0 111.3 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.581 ' N ' ' CD1' ' A' ' 140' ' ' LEU . 0.0 OUTLIER 179.8 58.6 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.027 0.441 . . . . 0.0 110.501 -179.876 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.499 ' O ' ' N ' ' A' ' 143' ' ' LEU . 0.1 OUTLIER -74.58 -14.78 60.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.07 -179.515 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . 0.414 ' CE3' ' CE2' ' A' ' 15' ' ' TYR . 16.3 p-90 -55.48 81.66 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.006 0.431 . . . . 0.0 111.267 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.499 ' N ' ' O ' ' A' ' 141' ' ' LEU . 5.0 mp -147.14 -45.82 0.17 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.302 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -152.91 -173.41 4.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.815 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.84 130.46 47.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.07 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -83.75 154.21 23.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.863 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.198 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.066 -179.95 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.848 0.356 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.7 p -125.38 111.45 27.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.728 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 9.8 p90 -113.71 136.06 53.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.978 0.418 . . . . 0.0 111.16 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.474 ' CG1' ' HB2' ' A' ' 144' ' ' GLU . 95.1 t -118.94 134.88 61.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.491 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 45.51 -124.24 6.62 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 115.933 -0.576 . . . . 0.0 113.206 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.45 ' O ' ' HA ' ' A' ' 44' ' ' THR . 3.7 m-20 -91.59 17.96 8.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.646 0.26 . . . . 0.0 111.228 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 6.9 m-30 -127.82 147.36 50.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.259 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 11' ' ' TYR . 1.0 OUTLIER -133.63 114.73 13.84 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.771 179.467 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 1.2 m -102.26 121.37 53.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 121.242 0.544 . . . . 0.0 110.834 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.0 p -137.17 161.44 35.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.32 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.6 141.64 54.53 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 178.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.427 ' HG2' ' CH2' ' A' ' 28' ' ' TRP . 5.1 mtp-105 -56.29 -47.54 78.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.905 0.383 . . . . 0.0 111.254 -179.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.406 ' CD2' ' CE1' ' A' ' 90' ' ' TYR . 5.3 m-70 -69.09 -8.4 44.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.344 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.7 tp -115.35 5.86 14.72 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.489 ' HB1' HD21 ' A' ' 41' ' ' LEU . . . -88.88 129.26 35.63 Favored 'General case' 0 C--N 1.334 -0.07 0 C-N-CA 120.291 -0.563 . . . . 0.0 111.444 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.499 ' O ' ' HD1' ' A' ' 28' ' ' TRP . 27.4 p -74.85 164.68 26.3 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.703 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -53.74 -29.81 41.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.221 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.422 ' HA ' ' HG2' ' A' ' 29' ' ' GLN . 21.7 t -68.76 -33.99 62.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.973 0.416 . . . . 0.0 110.97 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.432 ' O ' ' HB3' ' A' ' 31' ' ' CYS . 0.4 OUTLIER -68.45 -43.5 76.89 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.258 179.67 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.499 ' HD1' ' O ' ' A' ' 24' ' ' THR . 59.0 m95 -73.69 -45.84 49.96 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.91 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.422 ' HG2' ' HA ' ' A' ' 26' ' ' VAL . 3.2 pt20 -54.97 -37.39 66.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.896 0.379 . . . . 0.0 110.689 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.2 m-20 -115.36 34.42 4.9 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.782 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.48 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 20.4 p -80.17 127.38 32.26 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.027 0.441 . . . . 0.0 111.365 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.426 HG23 ' N ' ' A' ' 33' ' ' TRP . 16.0 m -88.26 -38.95 12.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.329 179.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.496 ' CE3' HG23 ' A' ' 42' ' ' VAL . 0.4 OUTLIER -139.81 153.13 47.01 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.977 179.753 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -166.11 107.06 0.71 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.019 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.425 ' OD1' ' CZ2' ' A' ' 33' ' ' TRP . 34.6 p-10 -107.36 125.15 50.83 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.089 0.471 . . . . 0.0 111.118 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -67.0 -34.5 77.89 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.567 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -59.79 -24.49 64.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.913 0.387 . . . . 0.0 110.562 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.505 ' HA ' ' NE ' ' A' ' 38' ' ' ARG . 4.6 tpm_? -113.14 -4.74 13.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.975 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 48.97 36.87 9.14 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-O 121.112 0.482 . . . . 0.0 109.982 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 30.8 tp -130.79 154.58 47.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.247 -178.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.509 ' CD2' ' O ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -146.58 156.02 42.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.59 179.795 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.496 HG23 ' CE3' ' A' ' 33' ' ' TRP . 19.8 t -120.27 129.82 75.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.234 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 24.1 p -121.15 157.34 30.38 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.208 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 14' ' ' ASN . 16.6 p -97.49 119.86 36.81 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.164 0.506 . . . . 0.0 111.324 -179.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -111.7 -33.78 6.24 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.038 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.7 m 64.05 45.08 4.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.881 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.65 160.29 37.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.095 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -58.73 130.28 46.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.826 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.442 ' HA2' ' CZ ' ' A' ' 11' ' ' TYR . . . -104.59 -32.48 4.18 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.624 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER 59.22 20.81 8.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.669 0.271 . . . . 0.0 111.018 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -130.04 137.25 50.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.873 0.368 . . . . 0.0 110.742 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 73.5 m -121.99 120.37 34.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.421 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.491 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 0.9 OUTLIER -72.82 139.22 19.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.82 0.343 . . . . 0.0 110.652 -179.815 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.436 ' HB1' ' HB2' ' A' ' 118' ' ' HIS . . . -91.06 121.65 33.04 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.225 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -94.44 38.66 1.1 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.382 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 12.5 p -99.86 167.06 10.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.069 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -114.69 30.26 7.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.07 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 63.6 m -59.4 163.51 3.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.881 0.372 . . . . 0.0 110.875 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.6 m -117.0 2.66 12.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.93 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 75' ' ' SER . 17.6 p -136.02 126.25 26.41 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 120.879 0.371 . . . . 0.0 111.159 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -134.69 -161.75 9.59 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.041 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.446 HG22 ' HB2' ' A' ' 71' ' ' HIS . 7.2 p -140.37 137.78 36.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.992 0.425 . . . . 0.0 111.205 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.422 ' CD1' ' O ' ' A' ' 63' ' ' TYR . 6.5 p90 -143.53 129.94 19.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.439 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 41.1 p90 . . . . . 0 C--N 1.328 -0.347 0 CA-C-O 120.804 0.335 . . . . 0.0 110.972 -179.813 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.446 ' HB2' HG22 ' A' ' 62' ' ' VAL . 26.5 p-80 . . . . . 0 C--O 1.232 0.133 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -123.85 114.11 28.32 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.619 -178.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -71.91 120.57 6.94 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.265 1.977 . . . . 0.0 110.423 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.468 ' CG1' ' CB ' ' A' ' 101' ' ' ALA . 56.0 t -132.69 142.02 43.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.08 0.467 . . . . 0.0 112.155 -178.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 75.6 p -93.88 121.0 34.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.331 178.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.448 ' HB3' ' HB1' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -125.34 164.78 19.64 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.439 0.638 . . . . 0.0 112.017 -178.657 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 99' ' ' LEU . 12.0 mt-10 -111.8 159.02 18.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.162 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -104.56 65.03 0.32 Allowed Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.334 -0.936 . . . . 0.0 113.724 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.456 ' HD2' ' HA ' ' A' ' 99' ' ' LEU . 40.2 Cg_endo -67.97 136.09 37.08 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.419 2.079 . . . . 0.0 112.105 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -61.62 -87.43 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.255 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.442 HD12 ' CD2' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -90.76 119.65 31.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.813 0.34 . . . . 0.0 111.444 -179.878 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.48 ' HB ' ' CG1' ' A' ' 98' ' ' VAL . 23.4 t -129.04 122.2 55.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.34 178.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -74.42 108.1 6.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.839 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.548 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 35.0 m -72.65 124.59 29.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.234 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -69.24 149.84 48.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.327 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.633 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 2.0 pt-20 -68.36 102.83 1.48 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.793 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.411 ' O ' ' N ' ' A' ' 89' ' ' TYR . 1.4 m -143.57 155.19 44.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.395 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 59.48 -79.4 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.43 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.411 ' N ' ' O ' ' A' ' 87' ' ' SER . 1.0 OUTLIER -156.22 24.24 0.36 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.791 0.329 . . . . 0.0 111.028 -179.982 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.633 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -119.51 130.18 24.98 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.306 179.858 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.4 ' O ' ' N ' ' A' ' 93' ' ' ARG . 85.4 Cg_endo -83.92 148.42 12.16 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.862 2.375 . . . . 0.0 112.662 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -47.28 92.65 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.083 179.954 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.4 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.6 OUTLIER -123.88 166.31 15.87 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.116 0.484 . . . . 0.0 112.168 -179.304 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.442 ' CD2' HD12 ' A' ' 81' ' ' LEU . 4.3 m-85 -97.38 129.99 44.57 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.173 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 22.7 mm-40 -131.45 137.92 48.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.701 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.449 ' O ' ' HB2' ' A' ' 97' ' ' HIS . 23.2 t -103.66 142.81 33.68 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -179.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.449 ' HB2' ' O ' ' A' ' 96' ' ' SER . 96.3 m-70 75.93 56.04 0.05 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.353 179.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.48 ' CG1' ' HB ' ' A' ' 82' ' ' VAL . 12.1 p -123.57 143.85 35.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.737 0.304 . . . . 0.0 110.87 178.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.463 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 11.0 mp -102.71 140.54 36.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.039 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.496 ' HA ' ' O ' ' A' ' 132' ' ' VAL . 5.5 mt -130.96 140.33 50.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.188 0.518 . . . . 0.0 112.16 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.468 ' CB ' ' CG1' ' A' ' 74' ' ' VAL . . . -152.07 159.37 43.7 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.526 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 130' ' ' GLY . 0.7 OUTLIER -112.19 127.13 55.86 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.02 0.438 . . . . 0.0 111.046 179.694 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.289 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.465 -179.758 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 N-CA-C 112.373 -0.291 . . . . 0.0 112.373 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.54 ' HA ' ' HA ' ' A' ' 123' ' ' LEU . 2.7 pp -126.25 146.4 32.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.931 0.396 . . . . 0.0 111.738 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.413 HD23 ' CZ ' ' A' ' 76' ' ' PHE . 9.8 tp -87.5 123.47 32.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.146 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 2.7 mtm180 -115.5 145.5 42.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.155 0.502 . . . . 0.0 111.627 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.462 ' HB2' HD13 ' A' ' 121' ' ' ILE . 4.5 t -109.4 165.46 11.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.145 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -60.86 -16.28 39.69 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.805 0.336 . . . . 0.0 110.616 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.436 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . 19.3 m80 -95.39 -29.24 14.54 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.528 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.409 ' N ' ' HB1' ' A' ' 54' ' ' ALA . . . 171.27 -140.47 5.92 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.537 -0.839 . . . . 0.0 113.015 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.491 ' HB ' ' HA ' ' A' ' 53' ' ' ILE . 2.7 t -99.24 135.23 35.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.637 0.256 . . . . 0.0 110.835 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.462 HD13 ' HB2' ' A' ' 116' ' ' CYS . 0.9 OUTLIER -99.96 -71.5 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.397 -179.95 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.417 ' HA2' ' CG2' ' A' ' 137' ' ' VAL . . . -153.65 -168.04 16.8 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.326 -0.94 . . . . 0.0 113.294 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.54 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 0.5 OUTLIER -116.88 164.2 15.04 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.635 0.255 . . . . 0.0 110.884 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 28.0 m -66.22 126.52 25.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.743 0.306 . . . . 0.0 111.189 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.448 ' CG2' ' N ' ' A' ' 126' ' ' MET . 3.7 m -108.38 -94.05 0.4 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.779 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.541 ' O ' ' HA3' ' A' ' 133' ' ' GLY . 73.7 mmm -144.02 162.3 36.56 Favored 'General case' 0 C--O 1.228 -0.076 0 CA-C-O 121.085 0.469 . . . . 0.0 111.538 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 175.85 -159.2 26.64 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.232 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -130.39 -153.32 7.68 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.404 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -89.75 11.83 18.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.722 0.296 . . . . 0.0 110.92 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 102' ' ' THR . . . -134.17 -36.32 0.25 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.728 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -115.67 157.28 16.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-O 120.949 0.404 . . . . 0.0 111.421 -179.859 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 4.5 m -122.42 118.83 56.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.423 -179.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.541 ' HA3' ' O ' ' A' ' 126' ' ' MET . . . -101.76 114.89 5.09 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.384 -0.912 . . . . 0.0 112.082 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.458 ' CZ ' ' CG2' ' A' ' 132' ' ' VAL . 10.7 m-85 -114.76 140.52 48.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.871 0.367 . . . . 0.0 111.261 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.429 ' HB3' ' OG1' ' A' ' 125' ' ' THR . . . -88.85 115.35 26.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.41 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.0 142.61 55.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.072 -178.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.465 ' O ' HD13 ' A' ' 140' ' ' LEU . 93.6 t -91.37 9.68 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.38 178.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 4.4 mtm-85 -71.53 -6.76 43.0 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.406 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -95.04 10.99 33.62 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 120.579 0.228 . . . . 0.0 111.23 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.585 ' N ' ' CD1' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -176.09 61.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.295 0.569 . . . . 0.0 110.332 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.477 ' O ' ' N ' ' A' ' 143' ' ' LEU . 0.1 OUTLIER -78.89 -14.66 59.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.024 -179.474 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 18.2 p-90 -59.78 76.46 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.006 0.432 . . . . 0.0 111.785 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.477 ' N ' ' O ' ' A' ' 141' ' ' LEU . 4.9 mp -140.77 -47.39 0.41 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.823 178.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.474 ' HB2' ' CG1' ' A' ' 12' ' ' VAL . 1.5 tp10 -150.05 -161.89 1.44 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.441 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -69.35 146.36 52.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.832 0.348 . . . . 0.0 110.851 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -93.17 154.12 18.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.906 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.166 179.971 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.831 0.348 . . . . 0.0 111.108 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.6 t -108.68 111.89 37.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.059 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.478 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 1.5 p90 -117.34 124.09 48.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.898 0.38 . . . . 0.0 110.874 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.447 ' CG1' ' HB2' ' A' ' 144' ' ' GLU . 75.1 t -119.26 140.96 41.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.703 -179.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 45.37 -129.83 8.83 Favored Glycine 0 C--N 1.333 0.379 0 CA-C-N 115.94 -0.573 . . . . 0.0 113.306 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.438 ' O ' ' HA ' ' A' ' 44' ' ' THR . 28.6 p30 -89.49 18.84 4.94 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.693 0.282 . . . . 0.0 111.23 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.444 ' HB3' HG12 ' A' ' 42' ' ' VAL . 7.8 m-30 -127.61 147.69 50.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.287 -0.415 . . . . 0.0 109.954 179.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 11' ' ' TYR . 10.6 tttt -132.79 114.7 14.42 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.685 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 1.6 m -101.44 121.29 52.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-O 121.148 0.499 . . . . 0.0 110.765 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.0 p -137.02 161.41 35.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.31 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -61.74 141.51 57.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.044 178.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.55 -44.64 81.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.763 0.316 . . . . 0.0 111.211 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -69.41 -7.51 38.37 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.166 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 79.9 mt -115.1 -2.88 12.66 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.424 ' HB1' HD22 ' A' ' 41' ' ' LEU . . . -86.08 126.57 34.29 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.229 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.528 ' O ' ' HD1' ' A' ' 28' ' ' TRP . 1.8 t -74.86 165.16 25.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.721 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -53.7 -29.98 41.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.845 -178.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.41 HG11 ' CG2' ' A' ' 24' ' ' THR . 11.4 p -72.65 -31.25 36.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.717 0.294 . . . . 0.0 110.967 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -67.66 -43.76 79.47 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.14 0.495 . . . . 0.0 109.697 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.528 ' HD1' ' O ' ' A' ' 24' ' ' THR . 48.9 m95 -73.85 -30.04 62.45 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.725 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -60.09 -44.23 94.96 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.556 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -110.2 27.75 9.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.336 179.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.441 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 7.0 t -73.13 123.64 24.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.043 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.424 ' CG2' HG13 ' A' ' 42' ' ' VAL . 13.3 m -86.32 -40.11 14.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.696 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.469 ' CE3' HG23 ' A' ' 42' ' ' VAL . 0.3 OUTLIER -139.59 153.13 47.31 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.885 0.374 . . . . 0.0 111.181 179.825 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -159.88 117.04 2.58 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.846 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.417 ' HB2' ' CZ2' ' A' ' 33' ' ' TRP . 0.7 OUTLIER -107.11 118.04 35.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.234 -179.759 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -62.93 -46.97 85.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.585 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -59.9 -18.86 47.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.242 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? -111.75 -6.05 14.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.191 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 48.55 38.93 12.08 Favored 'General case' 0 N--CA 1.461 0.079 0 CA-C-O 121.132 0.492 . . . . 0.0 110.401 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 27.1 tp -132.42 156.23 47.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.978 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.502 ' CD2' ' O ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -150.2 156.12 41.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.478 179.746 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.469 HG23 ' CE3' ' A' ' 33' ' ' TRP . 21.3 t -120.01 133.04 68.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.98 0.419 . . . . 0.0 110.301 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.5 t -125.98 157.42 37.87 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.202 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 14' ' ' ASN . 11.8 p -97.33 119.99 36.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.266 0.555 . . . . 0.0 111.529 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -108.14 160.72 15.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.887 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.0 t -105.99 42.48 1.25 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.875 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.33 169.94 16.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.139 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 10.1 p-80 -76.99 143.8 39.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.856 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -83.69 128.35 8.52 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.468 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -105.64 28.53 7.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.794 0.33 . . . . 0.0 110.87 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -153.02 133.57 13.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.82 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 48.7 m -117.64 116.43 27.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.813 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.504 ' HB ' HD11 ' A' ' 141' ' ' LEU . 3.8 mm -72.9 139.72 19.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.839 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.459 ' HB3' ' HB2' ' A' ' 118' ' ' HIS . . . -83.83 -53.57 5.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.785 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 29.0 ttt-85 63.75 35.54 11.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.997 0.427 . . . . 0.0 110.038 -178.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 6.0 p -99.71 146.65 26.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.991 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -88.03 54.22 3.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.051 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 77.1 m -85.98 164.8 17.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.828 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.65 -19.37 12.9 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.884 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 75' ' ' SER . 12.1 p -126.21 123.95 39.35 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.941 0.4 . . . . 0.0 111.336 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -138.3 166.02 25.33 Favored Glycine 0 N--CA 1.452 -0.265 0 N-CA-C 111.631 -0.588 . . . . 0.0 111.631 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.412 HG22 ' CG ' ' A' ' 71' ' ' HIS . 14.9 p -102.57 130.82 51.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.967 0.413 . . . . 0.0 111.351 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.456 ' HB2' ' CZ ' ' A' ' 134' ' ' PHE . 4.2 p90 -106.55 139.43 41.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.986 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 39.4 t80 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 179.992 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.412 ' CG ' HG22 ' A' ' 62' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.127 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -107.81 113.99 60.65 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.46 -179.121 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -77.03 120.81 5.55 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.389 2.059 . . . . 0.0 110.582 178.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.402 HG21 ' CE2' ' A' ' 63' ' ' TYR . 47.6 t -139.85 145.81 26.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.058 0.456 . . . . 0.0 112.186 -178.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.429 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 1.1 m -91.9 134.62 34.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.267 178.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.456 ' CE2' ' CD2' ' A' ' 114' ' ' LEU . 0.1 OUTLIER -143.5 169.2 18.15 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.479 0.657 . . . . 0.0 112.329 -178.966 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.514 ' C ' ' HD3' ' A' ' 79' ' ' PRO . 0.1 OUTLIER -111.92 159.29 18.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.747 179.384 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.43 ' HA2' ' HG ' ' A' ' 99' ' ' LEU . . . -111.61 72.31 0.21 Allowed Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.322 -0.942 . . . . 0.0 113.52 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.646 ' HD2' ' O ' ' A' ' 98' ' ' VAL . 15.9 Cg_exo -66.93 138.57 48.6 Favored 'Trans proline' 0 C--O 1.24 0.601 0 C-N-CA 122.401 2.067 . . . . 0.0 112.459 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -63.71 -59.98 7.97 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.621 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.43 HD11 ' O ' ' A' ' 95' ' ' GLN . 0.0 OUTLIER -120.15 119.96 34.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.993 0.425 . . . . 0.0 112.074 -179.786 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.431 ' HB ' HG12 ' A' ' 98' ' ' VAL . 37.4 t -125.15 127.62 72.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.823 178.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -72.17 107.86 5.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.922 0.392 . . . . 0.0 110.693 -179.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 1.6 p -72.83 114.49 12.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.405 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -69.89 150.17 47.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.602 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.557 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -68.04 101.58 1.16 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.151 0.501 . . . . 0.0 110.318 -179.517 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.443 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.4 OUTLIER -144.39 163.37 33.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.002 179.999 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.405 ' HG2' ' CD2' ' A' ' 89' ' ' TYR . 15.6 tt0 53.39 -84.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.482 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.443 ' N ' ' O ' ' A' ' 87' ' ' SER . 0.1 OUTLIER -152.41 21.41 0.63 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.757 0.313 . . . . 0.0 110.917 179.921 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.557 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 1.9 t80 -116.61 125.9 28.0 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.707 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.437 ' O ' ' N ' ' A' ' 93' ' ' ARG . 59.8 Cg_endo -73.5 148.58 42.87 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.754 2.303 . . . . 0.0 112.665 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.3 OUTLIER -53.2 85.01 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.455 -179.676 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.437 ' N ' ' O ' ' A' ' 91' ' ' PRO . 5.3 mtp-105 -124.04 -174.39 2.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.084 0.469 . . . . 0.0 111.737 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.415 ' HB3' HD13 ' A' ' 81' ' ' LEU . 26.2 m-85 -100.34 132.49 45.69 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.745 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.43 ' O ' HD11 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -125.56 122.53 36.78 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.119 -179.722 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 28.1 t -92.03 158.25 16.33 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 121.104 0.478 . . . . 0.0 112.114 -179.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 51.4 60.6 3.75 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.774 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.646 ' O ' ' HD2' ' A' ' 79' ' ' PRO . 9.9 p -123.99 136.56 59.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.187 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.43 ' HG ' ' HA2' ' A' ' 78' ' ' GLY . 6.3 mp -102.0 149.0 24.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.301 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.743 ' HA ' ' O ' ' A' ' 132' ' ' VAL . 6.4 mt -133.25 134.13 43.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.074 0.464 . . . . 0.0 111.801 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.42 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . . . -125.9 119.65 28.36 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.434 -179.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 1.5 t -86.15 111.7 20.61 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.907 0.384 . . . . 0.0 110.63 179.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.224 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.554 -179.711 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.544 -0.222 . . . . 0.0 112.544 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 31.3 pt -125.96 146.48 31.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.662 0.268 . . . . 0.0 111.156 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.488 ' HG ' ' HB ' ' A' ' 121' ' ' ILE . 8.1 tp -87.24 115.87 24.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.855 0.36 . . . . 0.0 110.171 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 7.5 mtt180 -118.14 145.95 44.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.35 0.595 . . . . 0.0 111.842 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.413 ' HB2' HD12 ' A' ' 121' ' ' ILE . 14.3 t -111.75 164.52 12.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.678 179.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -55.72 -18.71 8.82 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.72 0.295 . . . . 0.0 110.896 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.459 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 50.8 m80 -91.34 -36.13 14.02 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.532 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 174.91 -139.9 5.05 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.357 -0.925 . . . . 0.0 113.398 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.486 ' HB ' ' HA ' ' A' ' 53' ' ' ILE . 4.1 t -97.95 135.78 31.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.75 0.309 . . . . 0.0 111.63 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.488 ' HB ' ' HG ' ' A' ' 114' ' ' LEU . 0.9 OUTLIER -101.4 -66.91 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.928 179.195 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 135' ' ' ALA . . . -151.51 -165.88 13.39 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.556 -0.83 . . . . 0.0 113.068 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -120.11 164.19 16.55 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.785 0.326 . . . . 0.0 110.881 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.404 ' HA ' ' CD1' ' A' ' 134' ' ' PHE . 12.6 p -61.9 115.07 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.783 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.425 ' OG1' ' CB ' ' A' ' 135' ' ' ALA . 6.0 m -105.87 -93.21 0.37 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.984 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.42 ' CG ' ' CG2' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -105.1 158.78 16.34 Favored 'General case' 0 C--N 1.335 -0.043 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.851 179.329 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -135.77 106.96 0.59 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.448 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -79.23 -178.62 51.24 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.476 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -71.92 -19.3 61.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.703 0.287 . . . . 0.0 111.141 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -150.33 17.22 1.02 Allowed Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.754 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.447 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 1.0 OUTLIER -136.65 157.51 36.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.693 0.282 . . . . 0.0 110.831 179.888 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.743 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 2.5 t -112.59 117.94 56.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.008 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.405 ' CA ' HD23 ' A' ' 100' ' ' LEU . . . -96.89 119.01 6.21 Favored Glycine 0 CA--C 1.518 0.236 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.89 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.459 ' CE2' ' CG1' ' A' ' 132' ' ' VAL . 27.7 m-85 -125.18 144.09 50.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.02 0.438 . . . . 0.0 112.039 -179.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.445 ' O ' ' HA3' ' A' ' 122' ' ' GLY . . . -93.78 111.05 22.68 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.26 142.02 57.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.259 0.552 . . . . 0.0 112.174 -178.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.402 HG13 ' CD1' ' A' ' 140' ' ' LEU . 31.6 t -90.25 12.31 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.502 179.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.535 ' HA ' HD23 ' A' ' 141' ' ' LEU . 15.7 mmm-85 -71.52 -6.92 44.18 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.446 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -96.1 7.52 46.19 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.526 ' O ' ' CD2' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -171.83 34.35 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 121.208 0.528 . . . . 0.0 110.36 179.716 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.535 HD23 ' HA ' ' A' ' 138' ' ' ARG . 0.1 OUTLIER -57.6 -14.84 5.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.583 -179.506 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . 0.425 ' CD1' ' HA ' ' A' ' 140' ' ' LEU . 13.6 p-90 -61.45 77.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.903 0.382 . . . . 0.0 111.828 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 141' ' ' LEU . 5.1 mp -136.32 -52.66 0.72 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.057 178.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.447 ' HB2' ' CG1' ' A' ' 12' ' ' VAL . 2.2 tp10 -144.41 -163.3 1.65 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.657 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -67.94 145.16 54.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.858 0.361 . . . . 0.0 110.822 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -105.03 154.16 20.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.981 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.062 179.942 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.838 0.352 . . . . 0.0 111.285 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.8 t -101.14 127.12 54.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.877 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.485 ' CE2' HG21 ' A' ' 45' ' ' THR . 7.0 t80 -111.66 116.06 30.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.841 0.353 . . . . 0.0 110.624 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.403 ' CG2' HD12 ' A' ' 53' ' ' ILE . 48.3 t -120.77 111.25 31.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.667 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 50.41 -124.92 20.12 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 121.064 -0.588 . . . . 0.0 113.273 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.457 ' O ' ' HA ' ' A' ' 44' ' ' THR . 77.8 m-20 -91.45 17.18 8.91 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.573 0.225 . . . . 0.0 111.601 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -130.31 127.84 40.3 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 9.1 tttt -120.42 114.81 22.36 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 121.11 -0.236 . . . . 0.0 110.742 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 0.6 OUTLIER -98.97 121.52 49.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 121.02 0.438 . . . . 0.0 110.761 179.861 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.401 ' O ' HD23 ' A' ' 41' ' ' LEU . 15.0 p -136.67 161.35 36.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.288 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 25.4 t30 -61.05 141.48 57.36 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.8 ppt_? -56.46 -45.9 80.62 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.928 0.394 . . . . 0.0 111.311 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -66.38 -10.29 41.97 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.157 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.4 mt -115.21 0.85 13.67 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.436 ' HB1' HD21 ' A' ' 41' ' ' LEU . . . -88.98 127.37 35.67 Favored 'General case' 0 N--CA 1.457 -0.084 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.212 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.533 ' O ' ' HD1' ' A' ' 28' ' ' TRP . 1.1 t -74.6 163.2 27.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.706 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -53.59 -29.77 39.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.746 0.308 . . . . 0.0 111.008 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.411 ' HA ' ' HG2' ' A' ' 29' ' ' GLN . 22.3 t -69.79 -32.25 51.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.967 0.413 . . . . 0.0 110.767 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.433 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 0.5 OUTLIER -68.56 -43.62 76.21 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.417 179.587 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.533 ' HD1' ' O ' ' A' ' 24' ' ' THR . 46.6 m95 -73.27 -45.97 52.63 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.019 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.411 ' HG2' ' HA ' ' A' ' 26' ' ' VAL . 14.4 pt20 -54.99 -44.07 74.16 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.768 0.318 . . . . 0.0 110.685 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -102.82 29.9 5.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.178 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.445 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 35.4 t -80.07 145.56 32.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.483 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 42' ' ' VAL . 10.0 m -103.67 -41.96 7.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.335 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.436 ' CE3' HG22 ' A' ' 42' ' ' VAL . 0.9 OUTLIER -139.69 152.86 47.03 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.018 179.696 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -157.22 117.81 3.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.136 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.411 ' HB3' ' CG ' ' A' ' 38' ' ' ARG . 26.6 t0 -107.13 105.02 14.81 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.789 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -63.27 -29.2 70.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.173 -179.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.515 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 10.7 m-20 -62.2 -30.16 70.88 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 120.403 0.144 . . . . 0.0 110.93 -179.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.498 ' HA ' ' HA ' ' A' ' 95' ' ' GLN . 14.5 ptm180 -113.71 -3.43 13.54 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 60.48 46.24 9.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.918 0.39 . . . . 0.0 110.906 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 26.6 tp -135.04 153.32 52.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.748 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.496 ' CD2' ' O ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -152.04 155.88 38.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.064 0.459 . . . . 0.0 111.719 179.683 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.436 HG22 ' CE3' ' A' ' 33' ' ' TRP . 28.9 t -116.6 133.04 64.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.93 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.2 t -125.69 157.11 38.15 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.748 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 14' ' ' ASN . 22.7 p -97.75 144.33 27.48 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.083 0.468 . . . . 0.0 111.538 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.485 HG21 ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -135.02 171.41 14.46 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.957 -179.167 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.0 m -115.68 55.34 0.79 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.884 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.5 -175.11 3.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.147 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -99.4 148.06 24.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.021 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -67.52 170.47 35.3 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.644 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.3 m -149.21 -60.58 0.22 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.81 0.338 . . . . 0.0 110.812 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -83.66 150.41 25.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.884 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 86.6 m -122.38 119.29 30.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.959 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.502 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 0.4 OUTLIER -76.46 139.75 18.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.767 179.854 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.43 ' HB1' ' N ' ' A' ' 119' ' ' GLY . . . -90.89 135.56 33.65 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.396 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -94.18 27.22 2.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.035 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 24.7 p -99.96 167.3 10.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.198 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -122.86 31.6 5.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.035 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 15.6 m -58.58 132.12 52.85 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.814 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.5 t -74.94 -8.17 55.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.115 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.2 p -107.98 127.21 53.56 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.89 0.376 . . . . 0.0 111.059 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -149.63 146.61 16.06 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.198 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.426 HG22 ' HB2' ' A' ' 71' ' ' HIS . 9.6 p -103.86 125.39 58.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.933 0.396 . . . . 0.0 111.216 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -108.01 163.6 13.0 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.796 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.863 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.426 ' HB2' HG22 ' A' ' 62' ' ' VAL . 16.5 p80 . . . . . 0 N--CA 1.456 -0.134 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -126.04 114.25 24.14 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.631 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -72.75 120.79 6.88 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.467 2.111 . . . . 0.0 110.497 178.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.455 ' CG1' ' HB2' ' A' ' 101' ' ' ALA . 84.6 t -137.64 142.02 37.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.257 0.551 . . . . 0.0 112.466 -178.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.19 135.0 39.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.495 -0.775 . . . . 0.0 108.961 178.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.507 ' HB3' ' HB1' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -141.97 172.76 12.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.381 0.61 . . . . 0.0 112.214 -178.362 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.443 ' O ' ' HA ' ' A' ' 99' ' ' LEU . 9.8 mt-10 -111.78 158.86 18.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.264 179.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -103.73 68.56 0.29 Allowed Glycine 0 CA--C 1.522 0.486 0 C-N-CA 120.366 -0.921 . . . . 0.0 113.735 -179.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.62 ' HD2' ' HA ' ' A' ' 99' ' ' LEU . 36.9 Cg_endo -67.77 139.2 47.2 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.464 2.109 . . . . 0.0 112.188 179.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -56.73 -91.77 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.693 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -98.62 122.73 42.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.921 0.391 . . . . 0.0 111.85 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.441 ' HB ' ' CG1' ' A' ' 98' ' ' VAL . 96.0 t -119.25 126.19 75.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.149 179.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -72.33 107.85 5.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.674 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.446 ' CG2' ' HB2' ' A' ' 126' ' ' MET . 1.0 OUTLIER -74.55 114.83 14.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.099 -179.834 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -70.75 149.77 46.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.843 179.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 4.2 pt-20 -68.06 101.0 1.06 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.086 0.469 . . . . 0.0 109.892 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.05 145.18 31.36 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.972 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.582 ' O ' ' CD1' ' A' ' 89' ' ' TYR . 0.3 OUTLIER 43.33 93.72 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.31 -0.404 . . . . 0.0 112.072 178.702 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.582 ' CD1' ' O ' ' A' ' 88' ' ' GLU . 4.3 p90 37.91 28.87 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.485 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -131.38 125.11 20.62 Favored Pre-proline 0 C--N 1.329 -0.312 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.541 -179.64 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -86.68 148.84 8.57 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.335 2.69 . . . . 0.0 112.476 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.0 mttm -45.73 93.63 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.352 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.68 170.77 10.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.511 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -102.9 132.47 49.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.961 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.515 ' HA ' ' O ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -126.12 110.89 14.02 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.183 -179.823 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 97.5 p -82.84 153.93 24.92 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.981 0.419 . . . . 0.0 111.441 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 54.47 62.22 2.66 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.621 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.462 ' O ' ' HD2' ' A' ' 79' ' ' PRO . 9.4 p -123.66 146.01 29.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.942 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.62 ' HA ' ' HD2' ' A' ' 79' ' ' PRO . 0.9 OUTLIER -105.28 146.64 29.06 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.133 179.72 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.529 ' HA ' ' O ' ' A' ' 132' ' ' VAL . 6.0 mt -133.02 143.27 49.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.27 0.557 . . . . 0.0 112.492 -179.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.507 ' HB1' ' HB3' ' A' ' 76' ' ' PHE . . . -151.0 140.92 21.97 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.603 179.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 1.3 t -95.52 118.11 31.64 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.954 0.407 . . . . 0.0 111.017 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.266 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.424 -179.786 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.3 pp -126.0 146.74 31.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.798 0.332 . . . . 0.0 111.24 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.454 ' CD2' ' CZ ' ' A' ' 76' ' ' PHE . 19.3 tp -87.18 120.4 28.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.713 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.06 145.03 45.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.394 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.412 ' HB2' ' CD1' ' A' ' 121' ' ' ILE . 5.1 t -108.4 164.56 12.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.111 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.49 -19.23 23.08 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.928 0.394 . . . . 0.0 110.482 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.403 ' HB2' ' HB2' ' A' ' 54' ' ' ALA . 22.3 m80 -92.68 -33.6 14.29 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.348 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.43 ' N ' ' HB1' ' A' ' 54' ' ' ALA . . . 176.78 -128.44 1.34 Allowed Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.894 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.502 ' HB ' ' HA ' ' A' ' 53' ' ' ILE . 3.3 t -113.0 135.66 51.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.596 0.236 . . . . 0.0 110.856 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.412 ' CD1' ' HB2' ' A' ' 116' ' ' CYS . 0.2 OUTLIER -100.06 -49.0 11.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.872 179.636 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.418 ' HA3' ' HA ' ' A' ' 136' ' ' ASP . . . -170.39 -165.61 28.01 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.319 -0.943 . . . . 0.0 113.252 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -116.93 164.2 15.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.679 0.276 . . . . 0.0 110.626 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.0 p -69.45 129.96 34.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.357 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.401 ' CG2' ' N ' ' A' ' 126' ' ' MET . 12.1 m -112.01 -95.37 0.44 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.682 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.551 ' O ' ' HA3' ' A' ' 133' ' ' GLY . 95.0 mmm -144.07 140.19 29.35 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.717 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -115.25 154.47 16.94 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.52 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -86.89 -150.02 16.44 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.473 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -71.92 -19.45 61.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.759 0.314 . . . . 0.0 110.991 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -157.4 13.98 0.29 Allowed Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.784 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 1.2 t -121.39 157.05 25.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.725 0.298 . . . . 0.0 110.794 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 7.6 m -115.66 118.41 58.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.406 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.551 ' HA3' ' O ' ' A' ' 126' ' ' MET . . . -101.19 115.28 5.24 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.378 -0.915 . . . . 0.0 112.085 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.465 ' CZ ' ' HB ' ' A' ' 132' ' ' VAL . 15.4 m-85 -117.55 139.83 50.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.778 0.323 . . . . 0.0 111.116 -179.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -88.84 114.75 25.79 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.689 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.418 ' HA ' ' HA3' ' A' ' 122' ' ' GLY . 1.4 p30 -74.63 140.93 44.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.769 -179.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.436 ' O ' HD12 ' A' ' 140' ' ' LEU . 48.8 t -89.51 10.09 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.48 178.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -70.82 -6.9 41.39 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.632 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -94.75 11.1 32.6 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.685 0.279 . . . . 0.0 111.206 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.577 ' N ' ' CD1' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -178.17 62.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.245 0.545 . . . . 0.0 110.317 -179.918 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.512 ' O ' ' N ' ' A' ' 143' ' ' LEU . 0.1 OUTLIER -77.3 -14.75 59.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.026 -179.311 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 15.3 p-90 -56.23 78.65 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.004 0.43 . . . . 0.0 111.437 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' A' ' 141' ' ' LEU . 5.0 mp -143.02 -46.66 0.31 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.147 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -151.48 -163.56 1.79 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.719 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -65.95 142.31 57.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.845 0.355 . . . . 0.0 111.039 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -86.57 154.13 21.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.914 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.171 179.925 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.821 0.343 . . . . 0.0 111.108 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.403 ' CG2' ' CG2' ' A' ' 113' ' ' ILE . 45.4 t -130.29 110.0 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.127 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.464 ' CE2' ' CG2' ' A' ' 45' ' ' THR . 5.9 t80 -95.92 116.11 28.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.841 0.353 . . . . 0.0 110.514 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.419 ' CG1' ' HB2' ' A' ' 144' ' ' GLU . 21.9 t -120.92 108.96 23.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.637 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 51.06 -125.96 25.58 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.898 -0.668 . . . . 0.0 113.327 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.41 ' O ' ' HA ' ' A' ' 44' ' ' THR . 24.8 m120 -89.07 14.25 11.15 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.722 0.296 . . . . 0.0 111.672 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.436 ' CE2' ' CE3' ' A' ' 142' ' ' TRP . 6.5 m-30 -130.37 146.94 52.02 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.8 tttt -137.67 114.93 10.98 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 121.197 -0.201 . . . . 0.0 110.651 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 0.6 OUTLIER -99.29 121.53 50.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 121.144 0.497 . . . . 0.0 111.145 -179.927 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.1 p -136.74 161.1 36.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.805 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -59.84 141.24 55.74 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 179.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.45 ' HG2' ' CH2' ' A' ' 28' ' ' TRP . 25.3 mtp180 -56.61 -47.12 80.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.948 0.404 . . . . 0.0 110.842 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.22 -8.04 28.55 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.245 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.09 -2.42 12.78 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -88.62 129.01 35.59 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.102 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.584 ' O ' ' HD1' ' A' ' 28' ' ' TRP . 43.8 p -74.73 162.89 28.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.56 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 24.1 p80 -53.51 -29.49 36.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.888 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.0 t -69.95 -31.85 49.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.82 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.428 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 3.7 m-20 -68.22 -43.97 76.78 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.584 ' HD1' ' O ' ' A' ' 24' ' ' THR . 27.5 m95 -73.64 -37.23 65.4 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.015 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.31 -44.23 79.71 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.96 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -110.16 32.4 5.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.275 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.46 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 54.1 t -80.14 149.34 30.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.542 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.408 HG21 ' N ' ' A' ' 33' ' ' TRP . 15.9 m -107.92 -39.32 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.048 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.45 ' CE3' HG23 ' A' ' 42' ' ' VAL . 0.7 OUTLIER -139.49 150.89 45.69 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.952 0.406 . . . . 0.0 111.7 -179.615 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.41 ' HG3' ' SG ' ' A' ' 31' ' ' CYS . 5.6 mp0 -147.0 118.47 7.92 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.792 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.425 ' HB2' ' CZ2' ' A' ' 33' ' ' TRP . 24.6 t70 -107.09 105.55 15.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.917 0.389 . . . . 0.0 110.891 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -64.46 -29.85 70.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.401 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.552 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 25.5 m120 -68.73 -27.59 66.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.88 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.4 ttp-105 -114.42 5.64 15.71 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 121.152 -0.219 . . . . 0.0 111.479 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.406 ' HA ' ' CD ' ' A' ' 20' ' ' ARG . 0.8 OUTLIER 46.55 38.98 6.14 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.994 0.426 . . . . 0.0 110.618 -179.862 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 26.5 tp -129.29 150.03 50.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.938 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.498 ' CD2' ' O ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -144.88 155.57 43.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.321 179.489 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.45 HG23 ' CE3' ' A' ' 33' ' ' TRP . 24.9 t -115.94 130.05 71.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.29 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 12.2 p -120.69 157.35 29.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.532 179.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 14' ' ' ASN . 17.8 p -97.49 130.67 44.56 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.22 0.533 . . . . 0.0 111.659 -179.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.464 ' CG2' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -126.5 160.53 30.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.849 -179.296 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -118.19 58.02 0.83 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.796 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -135.05 -173.69 3.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.132 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -101.53 120.59 40.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.459 ' CA ' ' CE1' ' A' ' 11' ' ' TYR . . . -80.17 -170.36 41.2 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.52 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -155.48 -46.23 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.828 0.347 . . . . 0.0 110.859 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -64.3 141.95 58.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.892 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 87.0 m -125.14 118.12 25.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.924 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.526 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 0.1 OUTLIER -79.44 139.54 18.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.905 179.825 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -98.57 135.85 39.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.839 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.409 ' HB2' ' HB3' ' A' ' 146' ' ' ASP . 0.5 OUTLIER -92.45 42.93 1.11 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.457 0.646 . . . . 0.0 109.409 178.614 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 19.4 p -99.65 167.19 10.73 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.569 -178.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -120.15 24.89 10.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.2 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 16.1 p -64.17 139.52 58.77 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.048 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.7 m -91.36 12.99 18.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.381 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 39.0 p -125.94 160.87 28.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.815 0.34 . . . . 0.0 110.883 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 176.13 152.81 9.9 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.442 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.406 HG23 ' HB2' ' A' ' 71' ' ' HIS . 7.1 p -103.71 137.83 30.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.808 0.337 . . . . 0.0 111.032 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.469 ' CE2' ' CG2' ' A' ' 74' ' ' VAL . 8.8 p90 -130.13 -170.9 2.41 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.357 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.41 ' HB2' ' O ' ' A' ' 63' ' ' TYR . 0.7 OUTLIER . . . . . 0 N--CA 1.464 0.235 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.241 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.406 ' HB2' HG23 ' A' ' 62' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.731 0.3 . . . . 0.0 110.612 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -102.37 113.07 66.04 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.77 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -80.61 121.06 4.08 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.663 2.242 . . . . 0.0 111.217 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.503 ' CG1' ' HB2' ' A' ' 101' ' ' ALA . 44.4 t -134.21 147.48 30.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.073 0.463 . . . . 0.0 112.027 -178.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 74.2 m -100.58 128.62 46.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.458 178.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.497 ' HB3' ' HB1' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -132.52 169.25 16.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.381 0.61 . . . . 0.0 112.05 -178.588 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 99' ' ' LEU . 28.6 tt0 -111.91 158.44 19.47 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.156 178.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -105.44 65.97 0.28 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.474 -0.869 . . . . 0.0 113.172 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.407 ' HD2' ' O ' ' A' ' 98' ' ' VAL . 41.2 Cg_endo -67.99 134.45 32.02 Favored 'Trans proline' 0 C--O 1.239 0.557 0 C-N-CA 122.29 1.993 . . . . 0.0 112.23 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -58.86 -87.77 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.202 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -94.32 119.84 33.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.031 0.444 . . . . 0.0 111.826 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.433 ' CG2' ' CG1' ' A' ' 98' ' ' VAL . 48.8 t -122.91 122.9 66.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.686 178.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.414 ' HG3' ' CE1' ' A' ' 94' ' ' TYR . 3.9 tt0 -72.08 107.61 4.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.976 0.417 . . . . 0.0 110.808 -179.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.54 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 47.6 t -73.96 114.62 13.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.757 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -72.84 150.02 43.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.752 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.515 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 0.6 OUTLIER -67.71 100.9 0.96 Allowed 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.331 -0.548 . . . . 0.0 110.232 -179.388 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.522 ' O ' ' N ' ' A' ' 89' ' ' TYR . 3.7 m -144.78 169.58 17.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.591 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.42 ' HB3' ' H ' ' A' ' 89' ' ' TYR . 4.4 tt0 45.65 -84.82 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.658 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.522 ' N ' ' O ' ' A' ' 87' ' ' SER . 0.6 OUTLIER -153.99 24.75 0.49 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.818 0.342 . . . . 0.0 110.378 179.652 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.515 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -117.43 116.47 37.08 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.623 -179.934 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.457 ' O ' ' N ' ' A' ' 93' ' ' ARG . 30.9 Cg_exo -61.51 148.52 92.78 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.706 2.271 . . . . 0.0 112.181 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.54 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -59.05 79.24 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.858 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.457 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.2 OUTLIER -123.97 179.96 4.64 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.172 0.51 . . . . 0.0 111.816 -179.498 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.414 ' CE1' ' HG3' ' A' ' 83' ' ' GLU . 12.5 m-85 -93.93 132.56 38.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.784 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.552 ' HA ' ' O ' ' A' ' 37' ' ' ASN . 2.2 tt0 -130.57 123.14 28.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.209 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.403 ' CB ' ' HB3' ' A' ' 37' ' ' ASN . 5.1 t -97.71 161.49 13.73 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.114 0.483 . . . . 0.0 112.02 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 55.72 56.32 6.26 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.585 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.433 ' CG1' ' CG2' ' A' ' 82' ' ' VAL . 11.1 p -123.66 139.64 49.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.815 0.341 . . . . 0.0 111.559 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.404 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 11.2 mp -101.97 140.25 36.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.169 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.49 ' HA ' ' O ' ' A' ' 132' ' ' VAL . 5.6 mt -133.18 142.29 48.54 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -179.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.503 ' HB2' ' CG1' ' A' ' 74' ' ' VAL . . . -152.12 147.12 26.08 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.706 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 0.9 OUTLIER -100.42 118.24 36.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.058 0.456 . . . . 0.0 111.129 179.865 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.287 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.868 -179.928 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.29 0 N-CA-C 112.549 -0.22 . . . . 0.0 112.549 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.415 ' HA ' ' HA ' ' A' ' 123' ' ' LEU . 2.5 pp -97.61 146.39 7.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.738 0.304 . . . . 0.0 111.077 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.423 HD22 ' CZ ' ' A' ' 76' ' ' PHE . 47.0 tp -87.58 113.15 23.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.822 0.344 . . . . 0.0 110.843 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -119.36 138.11 53.28 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.298 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.401 ' SG ' ' CD1' ' A' ' 121' ' ' ILE . 28.0 p -111.5 177.01 4.79 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -56.61 -19.94 18.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.686 0.279 . . . . 0.0 111.218 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 22.1 m80 -90.77 -33.66 15.64 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 159.83 -150.65 21.07 Favored Glycine 0 C--N 1.334 0.445 0 C-N-CA 120.425 -0.893 . . . . 0.0 113.136 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.526 ' HB ' ' HA ' ' A' ' 53' ' ' ILE . 9.1 t -83.83 135.6 24.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.768 0.318 . . . . 0.0 111.63 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.429 ' N ' ' CD1' ' A' ' 121' ' ' ILE . 3.0 mp -109.31 -47.97 7.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.028 179.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -168.45 -171.94 34.82 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.078 -1.058 . . . . 0.0 113.215 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 0.3 OUTLIER -118.76 164.13 15.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.803 0.335 . . . . 0.0 110.826 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 11.2 p -60.72 121.33 8.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.486 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.422 ' CG2' ' N ' ' A' ' 126' ' ' MET . 19.3 m -116.02 -98.49 0.45 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.4 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.422 ' N ' ' CG2' ' A' ' 125' ' ' THR . 0.0 OUTLIER -87.06 161.85 17.92 Favored 'General case' 0 CA--C 1.527 0.059 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.644 179.664 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -146.64 93.61 0.16 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.467 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -74.98 -177.96 40.62 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.375 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -71.98 -19.36 61.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.702 0.287 . . . . 0.0 111.042 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -142.6 -7.34 0.65 Allowed Glycine 0 CA--C 1.523 0.545 0 C-N-CA 120.571 -0.823 . . . . 0.0 113.514 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.46 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 0.6 OUTLIER -115.86 157.08 16.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 117.242 0.521 . . . . 0.0 111.18 -179.842 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 15.6 m -113.4 118.45 58.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.602 -179.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -95.77 119.3 6.19 Favored Glycine 0 C--N 1.329 0.178 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.162 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.437 ' CZ ' ' HB ' ' A' ' 132' ' ' VAL . 18.5 m-85 -125.04 144.04 50.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.867 0.365 . . . . 0.0 111.557 -179.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.415 ' CB ' ' OG1' ' A' ' 125' ' ' THR . . . -93.11 113.64 25.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.11 179.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -67.99 133.76 49.59 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -178.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.525 ' O ' HD13 ' A' ' 140' ' ' LEU . 48.9 t -97.17 2.39 10.29 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.505 178.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 6.4 mtm105 -72.73 -6.22 43.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.304 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.78 3.71 54.69 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.661 0.267 . . . . 0.0 111.278 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.559 ' N ' ' CD1' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -163.78 57.25 0.17 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.228 0.537 . . . . 0.0 109.956 179.827 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.565 ' O ' ' N ' ' A' ' 143' ' ' LEU . 0.1 OUTLIER -72.67 -14.5 61.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.607 -179.048 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . 0.436 ' CE3' ' CE2' ' A' ' 15' ' ' TYR . 16.7 p-90 -52.87 81.15 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.991 0.424 . . . . 0.0 111.219 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.565 ' N ' ' O ' ' A' ' 141' ' ' LEU . 5.0 mp -151.1 -45.77 0.12 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.327 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.419 ' HB2' ' CG1' ' A' ' 12' ' ' VAL . 1.2 mm-40 -157.41 -170.19 3.15 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.645 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -59.4 144.99 45.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.063 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.409 ' HB3' ' HB2' ' A' ' 55' ' ' ARG . 0.1 OUTLIER -103.11 154.35 19.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.647 179.932 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.242 0 CA-C-O 120.926 0.393 . . . . 0.0 111.32 -179.677 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.068 0 CA-C-O 120.825 0.345 . . . . 0.0 111.051 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.5 t -114.49 107.1 22.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.019 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.451 ' CE2' HG23 ' A' ' 45' ' ' THR . 6.0 t80 -96.54 116.24 28.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.527 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.425 ' CG1' ' HB2' ' A' ' 144' ' ' GLU . 30.5 t -120.94 111.66 32.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.683 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.405 ' O ' ' CE1' ' A' ' 11' ' ' TYR . . . 50.88 -126.26 25.58 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.996 -0.621 . . . . 0.0 113.296 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.428 ' O ' ' HA ' ' A' ' 44' ' ' THR . 21.1 p30 -89.89 17.47 6.7 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.727 0.299 . . . . 0.0 111.561 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 7.0 m-30 -130.29 145.51 51.78 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.05 114.8 11.25 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.578 0.227 . . . . 0.0 110.677 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.529 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 0.6 OUTLIER -101.22 121.36 51.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 121.123 0.487 . . . . 0.0 111.036 -179.855 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.7 p -136.7 161.35 36.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.869 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -58.99 141.16 54.63 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.77 -47.38 80.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.864 0.364 . . . . 0.0 111.267 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -67.7 -9.51 44.31 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.213 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.26 2.09 13.95 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.436 ' HB2' HD21 ' A' ' 41' ' ' LEU . . . -87.65 131.82 34.31 Favored 'General case' 0 C--O 1.23 0.07 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.975 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.497 ' O ' ' HD1' ' A' ' 28' ' ' TRP . 42.2 p -74.67 163.29 27.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.712 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 46.3 p-80 -53.74 -29.71 40.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.855 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.7 t -68.61 -33.2 58.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.804 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -68.0 -43.93 77.73 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.497 ' HD1' ' O ' ' A' ' 24' ' ' THR . 45.5 m95 -73.96 -29.95 62.26 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.993 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -60.89 -44.1 97.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.46 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -115.71 33.9 5.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.593 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.488 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 30.5 p -72.64 122.92 22.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.187 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.411 ' CG2' HG13 ' A' ' 42' ' ' VAL . 11.6 m -86.19 -40.01 14.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.682 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.479 ' CE3' HG23 ' A' ' 42' ' ' VAL . 0.8 OUTLIER -139.87 151.18 45.45 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.202 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.414 ' HG2' ' HB2' ' A' ' 41' ' ' LEU . 5.3 mt-10 -154.79 116.3 4.09 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.188 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.435 ' HB2' ' CZ2' ' A' ' 33' ' ' TRP . 23.5 m-20 -107.26 110.27 22.26 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.804 0.335 . . . . 0.0 111.054 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -65.16 -29.91 70.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.427 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.508 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 0.4 OUTLIER -63.78 -27.83 69.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.128 -179.727 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -117.53 6.67 12.55 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 121.096 -0.242 . . . . 0.0 111.56 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 47.56 45.12 17.55 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.961 0.41 . . . . 0.0 110.673 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 23.0 tp -133.2 151.23 51.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.142 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.529 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -148.36 155.7 41.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.374 179.569 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.479 HG23 ' CE3' ' A' ' 33' ' ' TRP . 39.0 t -117.95 132.48 67.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.325 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.9 t -123.86 157.01 35.17 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.215 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' A' ' 14' ' ' ASN . 18.6 p -97.76 128.89 44.73 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.269 0.557 . . . . 0.0 111.638 -179.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.451 HG23 ' CE2' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -121.39 167.15 13.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.831 -179.368 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.6 m -114.85 38.62 3.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.846 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -113.29 -168.77 1.38 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.105 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 29.5 m80 -101.57 144.76 29.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.855 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -106.42 129.55 9.79 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.529 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 92.2 m -113.69 -32.05 6.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.803 0.335 . . . . 0.0 111.043 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -70.09 134.12 47.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.939 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 67.6 m -118.97 117.25 28.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.599 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.521 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 0.4 OUTLIER -76.36 139.46 18.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.04 0.448 . . . . 0.0 111.406 -179.591 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.469 ' HB2' ' CA ' ' A' ' 119' ' ' GLY . . . -96.59 101.53 13.16 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.397 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -80.18 59.19 3.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.089 0.471 . . . . 0.0 110.148 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -120.73 158.97 26.33 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.159 -179.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -96.74 18.72 13.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.384 179.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 29.5 p -57.31 129.07 40.16 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.97 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.1 m -92.03 12.35 22.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.272 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 25.9 p -129.99 130.81 45.48 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.818 0.342 . . . . 0.0 110.947 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -153.96 -161.8 10.67 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.31 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.9 p -140.05 135.52 37.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.096 0.474 . . . . 0.0 111.225 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.447 ' CD1' ' O ' ' A' ' 63' ' ' TYR . 27.4 p90 -109.97 125.94 53.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.678 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.438 ' HA ' ' HA ' ' A' ' 71' ' ' HIS . 15.4 t80 . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.916 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 64' ' ' PHE . 56.4 p-80 . . . . . 0 C--O 1.231 0.131 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.443 ' HB2' ' CE1' ' A' ' 63' ' ' TYR . 13.5 m-85 -129.84 114.9 17.84 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -178.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -69.98 120.65 7.37 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.259 1.973 . . . . 0.0 110.319 178.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.451 ' CG1' ' CE2' ' A' ' 76' ' ' PHE . 2.5 p -143.68 153.76 16.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.5 m -95.03 132.9 39.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.172 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.501 ' CD1' ' N ' ' A' ' 76' ' ' PHE . 0.0 OUTLIER -135.02 163.27 30.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.324 0.583 . . . . 0.0 111.921 -179.008 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.448 ' O ' ' HA ' ' A' ' 99' ' ' LEU . 5.9 pt-20 -111.8 158.32 19.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.142 -0.936 . . . . 0.0 109.293 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -106.04 65.8 0.27 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.385 -0.912 . . . . 0.0 113.591 -179.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.498 ' HD2' ' HA ' ' A' ' 99' ' ' LEU . 37.5 Cg_endo -67.74 134.15 31.69 Favored 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 122.263 1.975 . . . . 0.0 111.949 179.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -58.27 -84.48 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.586 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.486 HD13 ' HB3' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -97.18 120.32 37.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.866 0.365 . . . . 0.0 111.855 -179.618 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.422 ' CG2' ' CG1' ' A' ' 98' ' ' VAL . 48.1 t -123.91 122.58 64.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.371 178.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -72.44 107.99 5.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.91 0.386 . . . . 0.0 110.521 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.472 ' HB ' ' HG3' ' A' ' 126' ' ' MET . 17.2 m -76.11 123.46 32.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.666 -179.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -69.92 150.52 46.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.734 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.516 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 31.0 tt0 -67.7 102.43 1.2 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.939 0.399 . . . . 0.0 110.321 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.439 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.7 OUTLIER -143.94 165.95 26.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.331 -179.729 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 55.08 -82.42 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.564 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.439 ' N ' ' O ' ' A' ' 87' ' ' SER . 0.4 OUTLIER -154.92 22.84 0.44 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.703 0.287 . . . . 0.0 110.917 -179.878 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.516 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 2.3 t80 -122.88 133.18 24.33 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.918 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.432 ' O ' ' N ' ' A' ' 93' ' ' ARG . 89.1 Cg_endo -83.08 148.96 13.49 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.173 2.582 . . . . 0.0 112.417 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.2 OUTLIER -40.16 92.79 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.401 -179.908 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.432 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -123.71 -179.19 4.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.133 0.492 . . . . 0.0 111.683 -179.342 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.486 ' HB3' HD13 ' A' ' 81' ' ' LEU . 23.0 m-85 -106.38 132.29 52.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.024 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.508 ' HA ' ' O ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -128.79 124.03 34.39 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.934 -179.888 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -96.74 156.58 16.28 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 121.058 0.456 . . . . 0.0 111.779 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 56.91 57.18 4.82 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.491 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.422 ' CG1' ' CG2' ' A' ' 82' ' ' VAL . 8.0 p -123.37 135.55 62.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.964 0.411 . . . . 0.0 111.367 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.498 ' HA ' ' HD2' ' A' ' 79' ' ' PRO . 2.7 mp -101.91 146.94 27.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.907 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.543 ' HA ' ' O ' ' A' ' 132' ' ' VAL . 6.5 mt -133.03 139.87 47.43 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.461 ' O ' ' HA ' ' A' ' 131' ' ' VAL . . . -144.13 150.97 38.93 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.394 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.2 t -111.13 140.04 46.01 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.862 0.363 . . . . 0.0 111.231 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.19 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.468 179.995 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.405 0 N-CA-C 112.411 -0.276 . . . . 0.0 112.411 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 28.3 pt -126.07 146.11 32.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.773 0.321 . . . . 0.0 111.164 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.515 ' HG ' ' HB ' ' A' ' 121' ' ' ILE . 6.7 tp -87.81 113.5 23.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.388 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.83 139.38 51.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.257 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 21.8 p -105.66 166.87 10.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.194 179.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -55.93 -20.2 15.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.348 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 11.4 m80 -91.16 -22.21 20.78 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.79 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.469 ' CA ' ' HB2' ' A' ' 54' ' ' ALA . . . 163.56 -143.8 8.94 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.145 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.521 ' HB ' ' HA ' ' A' ' 53' ' ' ILE . 3.6 t -100.24 135.53 35.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.724 0.297 . . . . 0.0 111.107 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.515 ' HB ' ' HG ' ' A' ' 114' ' ' LEU . 1.3 mm -96.95 -67.15 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.835 0.35 . . . . 0.0 110.982 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.462 ' HA3' ' O ' ' A' ' 135' ' ' ALA . . . -155.4 -154.01 6.76 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.831 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.53 164.14 25.51 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.031 0.443 . . . . 0.0 111.069 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.424 ' HA ' ' HD1' ' A' ' 134' ' ' PHE . 14.5 p -57.86 115.08 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.319 -179.225 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.45 ' CG2' ' N ' ' A' ' 126' ' ' MET . 1.6 m -101.49 -87.22 0.4 Allowed 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.494 ' O ' ' HA3' ' A' ' 133' ' ' GLY . 0.0 OUTLIER -136.13 129.78 32.3 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-O 120.997 0.427 . . . . 0.0 111.583 179.57 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -109.14 149.13 17.08 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.654 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -104.47 -156.9 23.62 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.469 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -71.81 -19.44 61.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.725 0.298 . . . . 0.0 111.173 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -159.03 16.18 0.24 Allowed Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.983 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 101' ' ' ALA . 0.9 OUTLIER -126.51 157.23 37.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.755 0.312 . . . . 0.0 110.857 179.861 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.543 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 29.0 m -116.97 118.32 58.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.354 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.494 ' HA3' ' O ' ' A' ' 126' ' ' MET . . . -99.87 113.94 4.87 Favored Glycine 0 C--N 1.329 0.192 0 C-N-CA 120.499 -0.858 . . . . 0.0 111.997 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.455 ' CD2' ' HB2' ' A' ' 114' ' ' LEU . 53.4 m-85 -118.14 138.04 52.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.748 0.308 . . . . 0.0 111.357 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.462 ' O ' ' HA3' ' A' ' 122' ' ' GLY . . . -88.41 115.4 25.88 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 179.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -67.38 141.93 56.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.25 0.548 . . . . 0.0 112.438 -178.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.403 HG12 ' CD1' ' A' ' 140' ' ' LEU . 56.5 t -89.9 9.87 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.413 178.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.44 ' HA ' HD22 ' A' ' 141' ' ' LEU . 9.3 mmm180 -70.63 -6.74 39.07 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.641 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -98.28 11.04 39.21 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.481 0.181 . . . . 0.0 111.439 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.56 ' N ' ' CD1' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -177.19 47.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.018 0.437 . . . . 0.0 110.595 -179.811 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' A' ' 143' ' ' LEU . 0.1 OUTLIER -66.39 -14.6 62.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.15 -179.67 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 15.6 p-90 -54.52 81.61 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.068 0.461 . . . . 0.0 111.539 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.519 ' N ' ' O ' ' A' ' 141' ' ' LEU . 5.0 mp -149.37 -43.89 0.14 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.954 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.425 ' HB2' ' CG1' ' A' ' 12' ' ' VAL . 7.6 mt-10 -152.29 -170.42 3.64 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.445 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -58.83 132.27 53.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.79 0.328 . . . . 0.0 110.888 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -94.63 154.11 17.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.003 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.086 179.973 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.799 0.333 . . . . 0.0 110.988 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.2 t -116.49 108.21 24.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.069 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.466 ' CE2' ' CG2' ' A' ' 45' ' ' THR . 6.1 t80 -99.57 116.41 31.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.692 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.42 ' CG2' HD13 ' A' ' 53' ' ' ILE . 24.8 t -120.77 108.95 23.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.804 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 50.8 -126.49 25.8 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.986 -0.626 . . . . 0.0 113.259 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.501 ' O ' ' HA ' ' A' ' 44' ' ' THR . 2.7 p-10 -88.58 13.06 12.95 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.436 ' CE2' ' CE3' ' A' ' 142' ' ' TRP . 5.8 m-30 -130.49 127.93 40.17 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.6 tttt -120.56 114.88 22.38 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.994 -0.282 . . . . 0.0 110.792 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.516 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 0.6 OUTLIER -99.33 121.64 50.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-O 121.161 0.505 . . . . 0.0 110.916 179.894 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.6 p -136.92 161.32 36.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.02 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -59.89 141.22 55.86 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.418 ' HB2' ' CH2' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -56.77 -43.98 81.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.796 0.332 . . . . 0.0 111.235 -179.493 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -67.82 -10.93 57.03 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.11 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -115.26 0.61 13.56 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.463 ' HB2' HD21 ' A' ' 41' ' ' LEU . . . -86.69 127.06 34.93 Favored 'General case' 0 C--O 1.23 0.072 0 C-N-CA 120.331 -0.548 . . . . 0.0 111.028 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.504 ' O ' ' HD1' ' A' ' 28' ' ' TRP . 1.7 t -74.71 165.48 25.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.916 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -53.62 -29.86 40.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.878 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.436 HG11 ' N ' ' A' ' 27' ' ' ASP . 11.5 p -71.85 -31.67 41.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.716 0.293 . . . . 0.0 110.996 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.436 ' N ' HG11 ' A' ' 26' ' ' VAL . 0.4 OUTLIER -68.11 -43.97 77.2 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.099 0.475 . . . . 0.0 109.751 179.332 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.504 ' HD1' ' O ' ' A' ' 24' ' ' THR . 53.2 m95 -74.05 -35.27 64.28 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.064 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.56 -40.92 80.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.75 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -116.94 34.63 5.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.782 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.471 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 29.2 p -77.15 125.62 29.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.043 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.423 HG12 ' CG2' ' A' ' 44' ' ' THR . 16.1 m -87.43 -38.04 11.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.705 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.45 ' CE3' HG23 ' A' ' 42' ' ' VAL . 2.9 t90 -139.56 153.52 47.44 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.776 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 5.2 tm-20 -162.69 120.54 2.06 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.789 0.328 . . . . 0.0 111.581 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.412 ' HB2' ' CZ2' ' A' ' 33' ' ' TRP . 0.7 OUTLIER -107.05 98.68 8.3 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.45 179.338 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -56.95 -29.55 63.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.935 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.595 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 6.3 t-20 -64.4 -41.04 96.86 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 120.584 0.23 . . . . 0.0 110.822 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -99.55 -4.23 31.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.532 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 60.03 48.36 8.7 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.047 0.451 . . . . 0.0 110.706 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 21.2 tp -136.41 146.51 46.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.671 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.516 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -147.24 155.79 42.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.987 0.422 . . . . 0.0 111.899 179.802 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.45 HG23 ' CE3' ' A' ' 33' ' ' TRP . 35.8 t -117.36 125.0 73.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.272 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.0 p -118.19 157.41 27.02 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.567 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 14' ' ' ASN . 15.2 p -97.29 142.71 28.84 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.243 0.544 . . . . 0.0 111.638 -178.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.466 ' CG2' ' CE2' ' A' ' 11' ' ' TYR . 0.4 OUTLIER -137.52 172.49 12.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.89 -179.195 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -122.68 36.04 4.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.759 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -107.38 -167.89 1.32 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.183 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -102.83 148.03 26.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.985 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -57.09 -174.39 0.26 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.552 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -154.59 -45.97 0.09 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.9 0.381 . . . . 0.0 111.021 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -128.66 170.71 12.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.969 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 29.6 m -125.13 123.39 39.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.533 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.486 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 0.5 OUTLIER -72.65 139.55 19.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.871 0.367 . . . . 0.0 111.175 -179.643 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.402 ' HB1' ' CA ' ' A' ' 119' ' ' GLY . . . -88.08 122.93 32.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.383 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -94.11 28.98 2.28 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.172 0.51 . . . . 0.0 109.962 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 23.0 p -99.82 167.3 10.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.996 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -117.69 28.81 8.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.26 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 34.0 m -58.84 131.16 50.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.853 0.359 . . . . 0.0 110.539 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.48 -1.07 44.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.326 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 16.3 p -127.91 123.99 36.32 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.998 0.428 . . . . 0.0 111.265 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.25 -169.14 12.01 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.753 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.8 p -140.22 132.76 33.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 117.143 0.472 . . . . 0.0 111.327 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.475 ' CG ' ' CZ ' ' A' ' 134' ' ' PHE . 40.5 p90 -120.18 132.12 55.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.582 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.408 ' HA ' ' HA ' ' A' ' 71' ' ' HIS . 1.2 t80 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.579 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 64' ' ' PHE . 5.1 p80 . . . . . 0 N--CA 1.457 -0.098 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -126.03 114.58 24.14 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.57 -178.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -68.34 120.46 7.41 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 121.886 1.724 . . . . 0.0 109.964 178.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.45 ' CG1' ' CB ' ' A' ' 101' ' ' ALA . 43.8 t -140.41 141.83 32.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -178.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 87.9 p -93.02 133.15 36.45 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.51 ' HB3' ' HB3' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -136.25 166.2 23.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.372 0.606 . . . . 0.0 112.166 -178.347 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' A' ' 99' ' ' LEU . 0.1 OUTLIER -111.71 158.48 19.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.183 178.848 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -105.16 67.5 0.27 Allowed Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.378 -0.915 . . . . 0.0 113.464 -179.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.49 ' HD2' ' HA ' ' A' ' 99' ' ' LEU . 37.6 Cg_endo -67.63 134.28 32.33 Favored 'Trans proline' 0 C--O 1.237 0.47 0 C-N-CA 122.227 1.951 . . . . 0.0 111.952 179.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -54.84 -83.24 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.673 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.473 HD12 ' CD2' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -105.09 120.18 40.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.867 0.365 . . . . 0.0 111.959 -179.646 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.427 ' HB ' ' CG1' ' A' ' 98' ' ' VAL . 42.2 t -121.1 122.18 66.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.376 178.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -76.35 108.05 9.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.941 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 34.8 m -73.83 124.13 30.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.055 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -69.55 150.11 47.48 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.722 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.577 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 61.3 tt0 -68.02 102.16 1.25 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.999 0.428 . . . . 0.0 110.638 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.436 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.3 OUTLIER -144.07 160.11 41.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.364 -179.825 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.401 ' HB3' ' H ' ' A' ' 89' ' ' TYR . 8.1 tt0 56.06 -81.51 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.679 179.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.436 ' N ' ' O ' ' A' ' 87' ' ' SER . 3.2 p90 -155.73 26.18 0.39 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.861 0.363 . . . . 0.0 110.822 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.577 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 1.0 OUTLIER -122.48 124.35 26.8 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.557 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.46 ' O ' ' N ' ' A' ' 93' ' ' ARG . 72.0 Cg_endo -76.46 148.65 30.06 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.881 2.387 . . . . 0.0 112.512 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -46.25 89.4 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.17 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.46 ' N ' ' O ' ' A' ' 91' ' ' PRO . 1.7 mmm180 -124.02 174.34 7.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.299 0.571 . . . . 0.0 112.156 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.473 ' CD2' HD12 ' A' ' 81' ' ' LEU . 5.4 m-85 -100.18 132.62 45.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.214 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.595 ' HA ' ' O ' ' A' ' 37' ' ' ASN . 12.2 mm-40 -118.85 116.58 26.8 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.245 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.408 ' CB ' ' HB3' ' A' ' 37' ' ' ASN . 44.3 t -83.15 146.07 28.85 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.048 0.452 . . . . 0.0 111.716 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.417 ' CE1' ' HB3' ' A' ' 136' ' ' ASP . 1.5 t-80 52.22 65.55 1.47 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.037 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.427 ' CG1' ' HB ' ' A' ' 82' ' ' VAL . 10.6 p -123.6 141.8 42.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.17 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.49 ' HA ' ' HD2' ' A' ' 79' ' ' PRO . 9.4 mp -102.13 142.49 33.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.009 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.556 ' HA ' ' O ' ' A' ' 132' ' ' VAL . 5.6 mt -133.09 142.08 48.54 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -179.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.51 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . . . -152.17 146.08 25.19 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.806 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 1.1 t -99.93 129.28 45.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.913 0.387 . . . . 0.0 111.228 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.273 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.436 -179.855 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 26.9 pt -109.32 145.68 15.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.793 0.33 . . . . 0.0 111.065 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.428 HD13 ' CZ ' ' A' ' 76' ' ' PHE . 34.2 tp -87.77 117.02 26.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.444 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.407 ' HA ' HD12 ' A' ' 121' ' ' ILE . 8.1 mtt180 -118.49 145.86 44.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.148 0.499 . . . . 0.0 111.93 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.437 ' HB2' HD11 ' A' ' 121' ' ' ILE . 13.9 t -107.85 165.05 11.73 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.304 178.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.68 -17.46 5.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.777 0.322 . . . . 0.0 110.484 179.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 45.4 m80 -93.54 -36.25 12.51 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.581 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.402 ' CA ' ' HB1' ' A' ' 54' ' ' ALA . . . 179.02 -136.91 3.0 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 120.191 -1.004 . . . . 0.0 113.936 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.486 ' HB ' ' HA ' ' A' ' 53' ' ' ILE . 3.0 t -105.11 136.24 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -179.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.453 ' N ' HD12 ' A' ' 121' ' ' ILE . 1.9 mp -95.47 -40.07 10.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.43 ' HA2' ' CG2' ' A' ' 137' ' ' VAL . . . 162.01 -156.78 28.44 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.889 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.79 164.11 15.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.791 0.329 . . . . 0.0 110.851 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 11.4 p -68.36 131.62 33.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.427 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.453 ' CG2' ' N ' ' A' ' 126' ' ' MET . 1.9 m -103.08 -87.49 0.42 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.231 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.453 ' N ' ' CG2' ' A' ' 125' ' ' THR . 0.0 OUTLIER -131.42 162.05 31.05 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-O 120.807 0.337 . . . . 0.0 111.415 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -133.48 150.92 19.98 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.669 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -104.13 -153.06 22.86 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.449 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.94 -19.55 61.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.651 0.262 . . . . 0.0 111.103 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -164.04 16.78 0.11 Allowed Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.597 -0.811 . . . . 0.0 113.081 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 0.9 OUTLIER -120.29 157.26 23.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.776 0.322 . . . . 0.0 110.692 179.806 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.561 ' HB ' ' CZ ' ' A' ' 134' ' ' PHE . 14.3 m -115.85 118.4 58.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.408 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 99' ' ' LEU . . . -100.2 123.19 7.84 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.966 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.561 ' CZ ' ' HB ' ' A' ' 132' ' ' VAL . 10.0 m-85 -124.83 140.15 53.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.854 0.359 . . . . 0.0 111.413 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.422 ' O ' ' HA3' ' A' ' 122' ' ' GLY . . . -88.76 114.34 25.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.057 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.417 ' HB3' ' CE1' ' A' ' 97' ' ' HIS . 3.0 t0 -73.12 146.55 45.64 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -178.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.507 ' O ' HD13 ' A' ' 140' ' ' LEU . 62.0 t -104.95 5.86 10.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.139 178.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 12.2 mtm-85 -72.17 -6.51 43.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.26 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -94.64 7.34 46.07 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 120.726 0.298 . . . . 0.0 111.277 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.567 ' N ' ' CD1' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -169.6 59.79 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.289 0.566 . . . . 0.0 109.92 179.818 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' A' ' 143' ' ' LEU . 0.1 OUTLIER -74.06 -14.88 61.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.298 -179.092 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . 0.436 ' CE3' ' CE2' ' A' ' 15' ' ' TYR . 15.5 p-90 -54.72 81.51 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.972 0.415 . . . . 0.0 111.388 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.519 ' N ' ' O ' ' A' ' 141' ' ' LEU . 5.0 mp -150.17 -47.21 0.13 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.979 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.415 ' HB2' ' CG1' ' A' ' 12' ' ' VAL . 9.2 mm-40 -154.07 -170.01 3.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.527 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.95 139.8 56.27 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.832 0.349 . . . . 0.0 111.043 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.97 154.22 18.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.878 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.114 -179.889 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.839 0.352 . . . . 0.0 111.107 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.62 117.62 50.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.242 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.43 ' CE2' HG21 ' A' ' 45' ' ' THR . 5.6 t80 -106.55 116.59 32.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.483 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.433 HG11 ' CB ' ' A' ' 143' ' ' LEU . 21.2 t -120.8 114.62 44.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.802 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 46.94 -123.87 8.01 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 121.157 -0.544 . . . . 0.0 113.335 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.428 ' O ' ' HA ' ' A' ' 44' ' ' THR . 68.6 m-20 -90.07 15.79 9.54 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.638 0.256 . . . . 0.0 111.602 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.417 ' CE2' ' CE3' ' A' ' 142' ' ' TRP . 6.8 m-30 -130.41 148.62 52.24 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.01 114.71 9.93 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.56 0.219 . . . . 0.0 110.579 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.545 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 0.6 OUTLIER -100.38 122.0 51.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.054 0.454 . . . . 0.0 110.842 -179.969 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.433 HG21 ' HB3' ' A' ' 22' ' ' LEU . 12.5 p -136.06 160.98 38.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.216 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.4 m-20 -61.47 141.44 57.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.447 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.4 ttt-85 -56.63 -47.33 79.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.899 0.38 . . . . 0.0 110.736 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -68.75 -11.02 59.83 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.912 179.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.433 ' HB3' HG21 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -108.65 -12.1 15.0 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.686 -179.735 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.498 ' O ' ' CZ3' ' A' ' 28' ' ' TRP . . . -70.02 150.71 46.36 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 120.763 0.316 . . . . 0.0 110.753 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 16.9 p -105.03 169.04 8.66 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.326 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.443 ' CE1' ' CG2' ' A' ' 26' ' ' VAL . 13.8 p-80 -54.6 -29.63 52.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.044 0.449 . . . . 0.0 110.656 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.443 ' CG2' ' CE1' ' A' ' 25' ' ' HIS . 21.8 t -74.72 -31.32 26.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.385 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.402 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 4.0 m-20 -67.11 -44.14 80.69 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.498 ' CZ3' ' O ' ' A' ' 23' ' ' ALA . 7.4 m-90 -74.47 -31.63 62.29 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.125 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -58.02 -42.31 85.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.483 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -115.81 33.93 5.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.494 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.439 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 29.2 t -80.05 129.38 34.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.26 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.409 HG21 ' N ' ' A' ' 33' ' ' TRP . 13.0 m -92.57 -40.73 12.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.622 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.455 ' CE3' HG23 ' A' ' 42' ' ' VAL . 0.3 OUTLIER -139.72 153.49 47.23 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 121.047 0.451 . . . . 0.0 111.644 -179.361 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -154.41 120.25 5.23 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.472 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.434 ' HB2' ' CZ2' ' A' ' 33' ' ' TRP . 6.1 m-20 -100.42 116.7 32.99 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.414 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -65.83 -43.32 88.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.875 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.47 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 7.0 m120 -71.2 -10.96 60.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.011 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.413 ' NE ' ' CB ' ' A' ' 135' ' ' ALA . 3.5 tpm_? -117.1 -4.96 11.41 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 121.151 -0.22 . . . . 0.0 111.301 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 47.12 33.98 2.69 Favored 'General case' 0 N--CA 1.46 0.059 0 CA-C-O 121.122 0.486 . . . . 0.0 110.27 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 41.6 tp -126.8 153.37 45.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.747 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.545 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -146.79 155.69 42.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.871 0.367 . . . . 0.0 111.781 179.754 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.455 HG23 ' CE3' ' A' ' 33' ' ' TRP . 24.7 t -119.14 130.04 74.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.342 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.6 p -121.07 157.13 30.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.556 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' A' ' 14' ' ' ASN . 17.4 p -97.74 128.67 44.57 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.182 0.515 . . . . 0.0 111.471 -179.183 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.43 HG21 ' CE2' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -103.61 -34.19 8.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.889 -179.245 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.0 m 68.37 59.22 0.41 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.017 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.13 -167.86 2.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.201 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 46.8 p-80 -81.93 148.01 28.96 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.984 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -93.55 153.17 21.18 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.718 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.5 m -125.73 -62.72 1.17 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.869 0.366 . . . . 0.0 110.742 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -69.07 147.21 51.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.681 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 62.8 m -123.56 117.53 25.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.94 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.493 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 0.4 OUTLIER -73.07 139.34 19.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.644 179.864 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -95.96 124.84 40.14 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.926 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.94 33.9 0.93 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.504 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 26.6 p -99.69 167.13 10.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.892 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -123.03 39.71 3.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.177 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 19.3 m -68.94 131.77 45.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.779 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.1 t -76.86 -7.15 54.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.811 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.7 p -117.84 123.93 47.11 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.988 0.423 . . . . 0.0 111.091 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -148.98 162.56 28.96 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.571 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.506 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 13.2 p -99.86 134.42 39.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.193 0.521 . . . . 0.0 111.669 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -120.26 -170.7 2.02 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.059 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.531 0.221 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.197 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.447 ' HB2' HG23 ' A' ' 62' ' ' VAL . 12.5 p-80 . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.612 0.244 . . . . 0.0 110.569 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.407 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 1.8 m-85 -106.78 113.17 63.07 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.073 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.506 ' HA ' ' HA ' ' A' ' 62' ' ' VAL . 6.0 Cg_exo -80.27 139.11 12.97 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.846 2.364 . . . . 0.0 111.632 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.452 ' CG1' ' CE2' ' A' ' 76' ' ' PHE . 1.3 p -151.14 161.26 3.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.016 0.436 . . . . 0.0 111.892 -179.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.5 p -106.88 126.62 52.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.227 178.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.479 ' CD1' ' N ' ' A' ' 76' ' ' PHE . 0.0 OUTLIER -128.48 166.18 19.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.654 0.74 . . . . 0.0 112.294 -179.111 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.655 ' C ' ' HD3' ' A' ' 79' ' ' PRO . 1.3 mp0 -111.91 159.36 18.45 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.552 -1.204 . . . . 0.0 108.918 178.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.43 ' HA2' ' HG ' ' A' ' 99' ' ' LEU . . . -108.57 64.19 0.26 Allowed Glycine 0 CA--C 1.522 0.495 0 C-N-CA 120.135 -1.031 . . . . 0.0 114.155 -179.159 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.655 ' HD3' ' C ' ' A' ' 77' ' ' GLU . 14.9 Cg_exo -66.96 138.27 47.44 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.12 1.88 . . . . 0.0 111.965 179.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -62.77 -90.7 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.752 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.425 HD12 ' HB3' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -87.79 120.0 28.68 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.343 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.447 ' HB ' ' CG1' ' A' ' 98' ' ' VAL . 89.1 t -124.8 122.93 64.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.534 178.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.407 ' OE2' ' CE1' ' A' ' 94' ' ' TYR . 1.2 tp10 -72.11 107.9 5.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.986 0.422 . . . . 0.0 110.686 -179.163 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 2.9 p -83.06 114.39 23.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.739 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -74.35 150.37 40.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.471 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.512 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 5.8 pt-20 -67.72 100.78 0.95 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.274 0.559 . . . . 0.0 109.88 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.529 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.5 OUTLIER -145.16 172.92 12.42 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.62 -179.976 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 44.14 -85.17 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.614 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.529 ' N ' ' O ' ' A' ' 87' ' ' SER . 0.2 OUTLIER -150.15 23.21 0.84 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.818 0.342 . . . . 0.0 110.413 179.597 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.512 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 0.4 OUTLIER -116.34 145.68 35.66 Favored Pre-proline 0 C--O 1.232 0.17 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.999 -179.63 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -85.44 148.74 10.13 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.307 2.671 . . . . 0.0 112.697 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -65.42 72.81 0.05 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 179.894 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.92 -178.23 3.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.961 0.41 . . . . 0.0 111.621 -179.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.425 ' HB3' HD12 ' A' ' 81' ' ' LEU . 14.6 m-85 -94.99 132.17 40.15 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.586 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.47 ' HA ' ' O ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -131.15 125.56 33.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.667 0.27 . . . . 0.0 111.321 -179.681 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.415 ' HA ' ' HA ' ' A' ' 81' ' ' LEU . 1.4 t -102.09 154.21 19.2 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 120.917 0.389 . . . . 0.0 111.868 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 70.19 54.52 0.32 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.395 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.573 ' O ' ' HD2' ' A' ' 79' ' ' PRO . 5.0 p -123.46 141.73 42.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.223 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.43 ' HG ' ' HA2' ' A' ' 78' ' ' GLY . 5.6 mp -107.49 146.49 31.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.094 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.476 ' HA ' ' O ' ' A' ' 132' ' ' VAL . 6.1 mt -133.28 133.74 42.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.113 0.482 . . . . 0.0 112.189 -179.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' A' ' 131' ' ' VAL . . . -136.39 150.47 48.81 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.65 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.1 t -108.84 129.27 55.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.857 0.361 . . . . 0.0 110.98 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.637 -179.765 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.443 -0.263 . . . . 0.0 112.443 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 34.5 pt -125.99 146.12 32.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.809 0.337 . . . . 0.0 111.218 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.446 HD12 ' CE2' ' A' ' 76' ' ' PHE . 16.3 tp -87.82 119.46 28.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.24 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -118.13 149.32 41.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.067 0.46 . . . . 0.0 111.786 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.492 ' HB2' HD12 ' A' ' 121' ' ' ILE . 7.4 t -115.48 163.08 16.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.149 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -55.85 -20.07 14.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.814 0.34 . . . . 0.0 110.818 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 26.7 m80 -90.64 -35.47 14.95 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.422 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 177.45 -139.31 4.25 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.333 -0.937 . . . . 0.0 113.281 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.493 ' HB ' ' HA ' ' A' ' 53' ' ' ILE . 3.4 t -100.91 135.39 37.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.687 0.279 . . . . 0.0 111.341 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.492 HD12 ' HB2' ' A' ' 116' ' ' CYS . 1.1 mm -95.78 -61.99 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.871 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.533 ' HA3' ' O ' ' A' ' 135' ' ' ALA . . . -174.9 -163.57 28.26 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.302 -0.951 . . . . 0.0 113.387 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.89 141.75 47.82 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.864 0.364 . . . . 0.0 111.002 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 10.6 p -57.94 148.81 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.94 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.87 -87.17 0.55 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.225 179.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.6 138.87 43.03 Favored 'General case' 0 N--CA 1.461 0.087 0 CA-C-O 120.997 0.427 . . . . 0.0 110.8 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -122.93 129.13 7.33 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.158 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -81.06 -160.19 23.98 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.497 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -71.84 -19.24 62.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.807 0.336 . . . . 0.0 110.815 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -158.07 18.23 0.33 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.708 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 101' ' ' ALA . 0.9 OUTLIER -125.03 157.01 33.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-O 120.666 0.269 . . . . 0.0 110.783 -180.0 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 11.3 m -118.55 118.79 59.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.801 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.405 ' CA ' HD22 ' A' ' 100' ' ' LEU . . . -91.67 124.51 7.65 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.615 -0.802 . . . . 0.0 111.487 179.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.418 ' CD2' ' HB2' ' A' ' 114' ' ' LEU . 19.2 m-85 -124.25 135.43 53.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.999 0.428 . . . . 0.0 111.912 -178.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.533 ' O ' ' HA3' ' A' ' 122' ' ' GLY . . . -88.84 112.19 22.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.836 178.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -67.55 136.76 55.03 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -178.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.446 ' O ' HD12 ' A' ' 140' ' ' LEU . 67.6 t -89.5 7.57 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.382 178.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 30.6 mmm-85 -71.11 -6.66 40.93 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.588 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.43 10.99 38.25 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.62 0.248 . . . . 0.0 111.332 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.57 ' N ' ' CD1' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -175.19 53.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.128 0.489 . . . . 0.0 110.6 -179.868 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.488 ' O ' ' N ' ' A' ' 143' ' ' LEU . 0.1 OUTLIER -70.61 -14.69 62.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.012 -179.52 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . 0.417 ' CE3' ' CE2' ' A' ' 15' ' ' TYR . 15.6 p-90 -54.52 83.62 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.134 0.493 . . . . 0.0 111.358 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.488 ' N ' ' O ' ' A' ' 141' ' ' LEU . 5.0 mp -151.52 -44.87 0.11 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.972 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -155.95 -163.19 1.43 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.662 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.03 145.62 55.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.889 0.376 . . . . 0.0 111.041 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -105.1 154.14 20.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.896 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.207 0 CA-C-O 120.876 0.369 . . . . 0.0 111.043 179.976 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.759 0.314 . . . . 0.0 110.985 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.4 p -124.61 119.13 55.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.981 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.451 ' CE1' ' CG2' ' A' ' 45' ' ' THR . 7.3 t80 -98.69 117.09 32.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.69 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.407 ' HB ' ' CD2' ' A' ' 143' ' ' LEU . 22.3 t -120.1 130.05 74.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.584 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.445 ' O ' ' CE1' ' A' ' 11' ' ' TYR . . . 46.01 -123.91 7.0 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 121.085 -0.579 . . . . 0.0 113.141 179.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 59.3 m-80 -99.27 19.82 14.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.784 0.326 . . . . 0.0 111.002 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.442 ' HB3' HG12 ' A' ' 42' ' ' VAL . 9.2 m-30 -130.22 152.14 49.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.085 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.59 114.79 10.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.276 179.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.525 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 0.7 OUTLIER -102.59 122.05 54.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 121.229 0.538 . . . . 0.0 111.388 -179.588 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.402 ' CG1' HD22 ' A' ' 41' ' ' LEU . 7.4 p -136.4 161.03 37.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.626 179.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -63.53 140.02 58.83 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 179.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.1 -38.86 73.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.717 0.294 . . . . 0.0 110.977 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.72 -10.45 58.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.11 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.62 -6.89 13.89 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.724 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.499 ' O ' ' CZ3' ' A' ' 28' ' ' TRP . . . -80.36 150.68 29.78 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.832 0.348 . . . . 0.0 110.925 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.413 ' O ' ' CE3' ' A' ' 28' ' ' TRP . 43.5 p -103.77 169.17 8.67 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.254 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -54.49 -29.56 50.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.917 0.389 . . . . 0.0 110.645 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.5 t -74.28 -31.37 28.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.324 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.422 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 0.5 OUTLIER -67.19 -44.08 80.51 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 179.856 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.499 ' CZ3' ' O ' ' A' ' 23' ' ' ALA . 7.5 m-90 -73.97 -30.15 62.36 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.884 179.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -58.1 -44.15 87.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.439 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -111.69 28.89 8.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.538 179.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 13.0 t -80.09 136.14 36.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.162 -179.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.427 HG23 ' N ' ' A' ' 33' ' ' TRP . 15.7 m -94.58 -41.61 12.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.753 179.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.459 ' CH2' ' HG ' ' A' ' 140' ' ' LEU . 0.1 OUTLIER -139.73 153.2 47.15 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.952 0.406 . . . . 0.0 111.503 -179.465 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -164.6 111.87 1.05 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.897 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 35.7 p-10 -107.26 126.54 52.55 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.017 0.437 . . . . 0.0 111.375 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -67.7 -34.56 77.13 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.295 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.425 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 11.7 p30 -59.75 -22.76 62.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.877 0.37 . . . . 0.0 110.601 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.436 ' NE ' ' HA ' ' A' ' 38' ' ' ARG . 3.2 tpm_? -117.39 -3.91 11.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.06 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 48.66 34.68 5.29 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.07 0.462 . . . . 0.0 110.059 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 41.5 tp -124.85 152.6 43.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.953 -179.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.525 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -143.78 155.92 44.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.472 179.692 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.446 HG21 ' CE3' ' A' ' 33' ' ' TRP . 24.4 t -121.41 130.33 74.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.152 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.0 p -121.93 157.26 31.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.29 179.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.8 p -97.36 125.11 41.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.166 0.508 . . . . 0.0 111.576 -179.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.451 ' CG2' ' CE1' ' A' ' 11' ' ' TYR . 0.7 OUTLIER -93.39 -31.55 14.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.904 -179.503 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.82 38.07 6.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.893 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -136.78 -175.39 4.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.078 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -71.77 125.85 28.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.895 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.38 173.53 11.24 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.498 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.2 m -142.9 -71.92 0.31 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.847 0.356 . . . . 0.0 110.903 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -67.52 146.67 53.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.007 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 62.7 m -120.91 118.97 31.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.579 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.499 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 1.0 OUTLIER -76.56 139.55 18.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.996 -179.84 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -100.81 118.42 36.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.802 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.77 42.65 1.11 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.104 0.478 . . . . 0.0 110.519 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 15.6 p -99.7 167.16 10.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.835 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.64 39.32 3.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.43 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 28.9 m -72.85 128.06 34.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.759 0.314 . . . . 0.0 110.526 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.54 -13.03 62.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.961 179.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.5 p -108.38 159.26 16.8 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.952 0.406 . . . . 0.0 111.09 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -177.18 148.84 9.08 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.675 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.4 p -105.08 136.47 38.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.997 0.427 . . . . 0.0 111.572 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.407 ' C ' ' CD1' ' A' ' 63' ' ' TYR . 5.6 p90 -125.1 142.08 51.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.564 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 8.9 t80 . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.915 -179.871 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 5.5 m170 . . . . . 0 N--CA 1.455 -0.18 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -110.28 114.01 55.91 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.659 -178.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -79.14 120.6 4.61 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.534 2.156 . . . . 0.0 110.712 178.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.451 ' CG1' ' HB3' ' A' ' 101' ' ' ALA . 54.9 t -134.63 141.9 42.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.038 0.446 . . . . 0.0 112.162 -178.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.1 p -95.22 126.45 40.55 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.501 ' HB3' ' HB2' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -130.45 167.65 18.26 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.548 0.69 . . . . 0.0 112.358 -178.279 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.594 ' C ' ' HD3' ' A' ' 79' ' ' PRO . 0.9 OUTLIER -111.79 159.14 18.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.799 178.741 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -110.52 65.97 0.24 Allowed Glycine 0 CA--C 1.522 0.501 0 C-N-CA 120.081 -1.057 . . . . 0.0 114.196 -179.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.594 ' HD3' ' C ' ' A' ' 77' ' ' GLU . 16.2 Cg_exo -66.92 141.66 59.49 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.113 1.875 . . . . 0.0 111.914 179.301 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -61.59 -94.55 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.777 -0.647 . . . . 0.0 113.089 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.431 HD13 ' HB3' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -86.22 119.92 27.02 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.119 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.46 ' HB ' ' CG1' ' A' ' 98' ' ' VAL . 67.6 t -124.36 122.96 65.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.218 177.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.01 107.68 4.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.042 0.449 . . . . 0.0 110.679 -178.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 24.4 t -74.88 114.35 14.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.834 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.432 ' HA ' ' HG2' ' A' ' 92' ' ' LYS . 8.5 pt20 -77.02 150.18 35.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.574 179.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.579 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 23.0 tt0 -67.54 100.35 0.86 Allowed 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.945 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.523 ' O ' ' N ' ' A' ' 89' ' ' TYR . 43.0 t -145.12 159.8 42.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.674 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 50.96 -82.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.664 178.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.523 ' N ' ' O ' ' A' ' 87' ' ' SER . 2.0 p90 -155.91 25.83 0.38 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.846 0.355 . . . . 0.0 110.594 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.579 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 0.3 OUTLIER -116.67 116.45 38.67 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.574 -179.934 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.454 ' O ' ' N ' ' A' ' 93' ' ' ARG . 37.9 Cg_exo -60.4 148.68 89.65 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.88 2.387 . . . . 0.0 112.729 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.2 OUTLIER -61.95 73.07 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.832 179.55 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.454 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -124.14 179.76 4.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.189 0.518 . . . . 0.0 112.027 -179.314 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.431 ' HB3' HD13 ' A' ' 81' ' ' LEU . 11.1 m-85 -99.28 132.26 44.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.642 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.425 ' HA ' ' O ' ' A' ' 37' ' ' ASN . 1.5 mm100 -131.57 130.6 42.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.713 0.292 . . . . 0.0 111.242 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 11.0 p -102.4 147.88 26.17 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.886 0.374 . . . . 0.0 111.736 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 73.74 56.3 0.1 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.876 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.584 ' O ' ' HD2' ' A' ' 79' ' ' PRO . 10.0 p -123.57 143.18 37.59 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.036 179.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.431 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 10.7 mp -104.59 143.54 32.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.278 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.537 ' HA ' ' O ' ' A' ' 132' ' ' VAL . 6.5 mt -133.26 141.5 48.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.041 0.448 . . . . 0.0 112.158 -179.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.501 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . . . -150.99 144.86 25.17 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.971 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 1.2 t -100.28 125.32 46.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.914 0.387 . . . . 0.0 111.021 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.28 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.527 -179.749 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.376 0 N-CA-C 112.359 -0.297 . . . . 0.0 112.359 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.5 pp -126.04 146.19 32.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.881 0.372 . . . . 0.0 111.192 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.561 ' HG ' ' HB ' ' A' ' 121' ' ' ILE . 7.9 tp -87.61 115.57 25.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.083 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.99 148.3 42.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.222 0.534 . . . . 0.0 111.718 -179.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.461 ' HB2' HD13 ' A' ' 121' ' ' ILE . 8.2 t -109.4 164.79 12.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.08 179.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.81 -20.41 15.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.807 0.337 . . . . 0.0 110.618 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 28.9 m80 -88.9 -36.84 15.72 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.291 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 178.42 -135.3 2.6 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.398 -0.906 . . . . 0.0 113.063 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.499 ' HB ' ' HA ' ' A' ' 53' ' ' ILE . 3.9 t -104.38 135.67 41.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.793 0.33 . . . . 0.0 111.402 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.561 ' HB ' ' HG ' ' A' ' 114' ' ' LEU . 1.1 mm -97.86 -67.05 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.774 179.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.439 ' HA2' ' CG2' ' A' ' 137' ' ' VAL . . . -156.96 -168.34 19.42 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.023 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -116.75 164.45 14.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.637 0.256 . . . . 0.0 110.456 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 31.3 m -71.99 137.78 22.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.933 0.397 . . . . 0.0 111.841 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.01 -91.23 0.46 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.168 178.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.94 145.63 27.06 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.333 179.255 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -145.81 107.28 0.41 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.596 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -91.18 -167.2 40.99 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.439 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -92.92 17.2 11.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.661 0.267 . . . . 0.0 111.135 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 102' ' ' THR . . . -158.6 -31.09 0.02 OUTLIER Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.94 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 1.7 t -115.39 157.11 16.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.772 0.32 . . . . 0.0 111.108 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.537 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 15.2 m -115.73 118.26 58.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.383 -179.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.432 ' CA ' HD21 ' A' ' 100' ' ' LEU . . . -96.06 122.02 7.16 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.055 179.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.455 ' CZ ' ' HB ' ' A' ' 132' ' ' VAL . 15.6 m-85 -125.17 139.47 53.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.976 0.417 . . . . 0.0 111.608 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.401 ' O ' ' HA3' ' A' ' 122' ' ' GLY . . . -88.87 115.08 26.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.364 179.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -68.98 140.07 55.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.984 0.421 . . . . 0.0 112.004 -179.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.476 ' CG1' ' O ' ' A' ' 137' ' ' VAL . 81.2 t -90.46 9.02 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.511 178.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.413 ' HA ' HD22 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -70.1 -6.58 34.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.619 179.922 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -97.08 11.17 37.15 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.577 ' N ' ' CD1' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -175.77 49.17 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.231 0.538 . . . . 0.0 110.61 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.476 ' O ' ' N ' ' A' ' 143' ' ' LEU . 0.1 OUTLIER -67.41 -14.75 63.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.997 -179.629 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . 0.422 ' CE3' ' CE2' ' A' ' 15' ' ' TYR . 16.7 p-90 -57.71 80.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.039 0.447 . . . . 0.0 111.495 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.476 ' N ' ' O ' ' A' ' 141' ' ' LEU . 4.9 mp -142.29 -47.28 0.34 Allowed 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.162 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -154.71 -162.98 1.48 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.669 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.69 122.15 16.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.976 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -85.33 154.21 22.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.935 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.218 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.06 -179.955 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 112.582 -0.207 . . . . 0.0 112.582 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.15 172.41 14.02 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.581 2.187 . . . . 0.0 112.358 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -161.62 -46.71 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.784 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -67.55 134.67 30.66 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.49 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -109.52 149.52 29.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.816 0.341 . . . . 0.0 110.95 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -163.75 143.95 8.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.876 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.3 t -103.3 -44.91 5.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.919 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.68 23.19 66.88 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.588 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -165.9 179.15 6.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.812 0.339 . . . . 0.0 110.996 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.7 t -121.02 109.23 24.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.126 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.442 ' CD1' ' HG3' ' A' ' 16' ' ' LYS . 0.4 OUTLIER -93.88 115.83 28.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.423 179.864 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.412 ' CG2' HD13 ' A' ' 53' ' ' ILE . 19.2 t -121.29 108.89 23.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.786 0.327 . . . . 0.0 111.816 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 48.35 -124.59 11.63 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.94 -0.648 . . . . 0.0 113.242 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.436 ' O ' ' HA ' ' A' ' 44' ' ' THR . 33.0 p-10 -90.96 13.08 17.64 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.448 ' CE2' ' CE3' ' A' ' 142' ' ' TRP . 6.6 m-85 -130.34 127.8 40.17 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.442 ' HG3' ' CD1' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -116.4 114.89 24.89 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.561 0.219 . . . . 0.0 110.686 179.687 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.536 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 0.7 OUTLIER -100.63 122.08 52.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.119 0.485 . . . . 0.0 110.777 179.68 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.6 p -136.07 161.03 38.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.152 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -59.97 141.51 55.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.558 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 11.8 ttt180 -56.59 -47.12 80.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.855 0.36 . . . . 0.0 110.832 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 41.7 t-80 -69.1 -8.79 48.55 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.15 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 13.9 tp -110.78 -10.87 14.43 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.508 ' O ' ' CZ3' ' A' ' 28' ' ' TRP . . . -73.27 150.61 41.83 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 120.792 0.329 . . . . 0.0 110.814 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.7 p -103.65 169.32 8.59 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.442 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -54.64 -29.78 53.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.886 0.374 . . . . 0.0 110.543 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.5 t -73.93 -31.42 30.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.42 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.403 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 0.2 OUTLIER -67.29 -44.08 80.15 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.898 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.508 ' CZ3' ' O ' ' A' ' 23' ' ' ALA . 7.1 m-90 -74.29 -31.33 62.46 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.226 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 9.5 mm-40 -58.22 -43.8 87.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.452 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -113.46 33.39 5.16 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.404 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.449 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 27.2 t -80.05 134.11 36.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.279 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.416 ' CG2' HG11 ' A' ' 42' ' ' VAL . 15.3 m -97.28 -39.86 9.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.617 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.435 ' CE3' HG21 ' A' ' 42' ' ' VAL . 1.2 t90 -139.36 153.11 47.62 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.856 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -160.34 118.15 2.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.959 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -107.1 111.05 23.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.973 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.402 ' CE2' ' OD1' ' A' ' 37' ' ' ASN . 50.5 p90 -59.63 -47.23 86.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.242 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.415 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 2.1 m120 -60.02 -25.94 65.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.793 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.401 ' CZ ' ' HB3' ' A' ' 139' ' ' ASP . 20.7 ttm180 -100.07 -7.7 24.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.302 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 51.06 34.83 11.56 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 121.145 0.497 . . . . 0.0 110.258 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.5 tp -133.71 149.68 51.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.974 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.536 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -145.0 155.88 43.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.361 179.572 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.435 HG21 ' CE3' ' A' ' 33' ' ' TRP . 38.9 t -118.5 127.37 75.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.626 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.5 p -120.81 157.46 29.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.345 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 14' ' ' ASN . 10.5 p -97.57 146.59 25.13 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.165 0.507 . . . . 0.0 111.66 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.441 HG23 ' CZ ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -136.29 165.49 25.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.853 -179.25 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.1 t -93.29 -34.1 13.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.082 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.79 128.6 34.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.1 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -59.09 147.98 32.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.926 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -80.23 177.69 54.21 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.584 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -132.12 33.5 3.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.761 0.315 . . . . 0.0 110.905 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -138.45 144.49 40.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.911 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 63.0 m -120.83 115.91 24.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.793 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.499 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 0.4 OUTLIER -73.86 139.54 19.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.018 -179.872 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -93.38 133.53 36.54 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.54 27.11 2.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.991 0.424 . . . . 0.0 110.402 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 30.8 p -100.01 167.13 10.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.029 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -127.72 32.42 4.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.89 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 25.2 m -56.61 132.63 52.3 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.791 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.5 t -74.15 -8.61 56.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.969 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.1 p -118.46 130.77 56.14 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.891 0.377 . . . . 0.0 111.073 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -153.33 -167.94 16.45 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.84 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.407 HG22 ' HB2' ' A' ' 71' ' ' HIS . 7.5 p -133.75 126.24 50.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.007 0.432 . . . . 0.0 110.885 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.483 ' HB2' ' CZ ' ' A' ' 134' ' ' PHE . 3.1 p90 -111.14 153.91 25.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.102 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -93.14 143.87 25.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.647 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 7.6 t -120.99 137.69 54.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.049 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.82 -45.07 53.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.016 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.7 -50.11 68.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.822 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.1 mmpt? -74.6 -27.52 60.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.882 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 59.57 21.06 9.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.954 0.407 . . . . 0.0 110.859 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.92 170.04 16.2 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.622 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.407 ' HB2' HG22 ' A' ' 62' ' ' VAL . 50.8 p-80 -84.1 139.31 32.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.9 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -126.47 114.03 23.15 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.661 -178.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -74.54 120.54 6.24 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.356 2.037 . . . . 0.0 110.255 178.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 97.1 t -144.3 147.42 19.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.048 0.452 . . . . 0.0 112.167 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 53.6 p -92.02 137.19 32.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.295 178.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.46 ' CD1' ' N ' ' A' ' 76' ' ' PHE . 0.0 OUTLIER -146.48 168.43 21.22 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.22 0.534 . . . . 0.0 111.942 -178.882 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -113.0 158.39 20.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.05 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -106.03 68.17 0.24 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.917 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.528 ' HD2' ' HA ' ' A' ' 99' ' ' LEU . 38.0 Cg_endo -67.6 135.16 35.14 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.471 2.114 . . . . 0.0 112.227 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -59.27 -82.8 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.288 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.514 HD13 ' CD2' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -97.08 119.86 36.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.898 0.38 . . . . 0.0 111.749 -179.897 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.424 ' HB ' ' CG1' ' A' ' 98' ' ' VAL . 46.8 t -124.99 122.18 62.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.217 178.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.13 107.98 5.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.776 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 19.3 m -81.79 126.85 39.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.236 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.84 150.65 46.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.06 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.542 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 3.9 pt-20 -67.73 102.54 1.23 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.87 0.367 . . . . 0.0 110.431 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.428 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -143.89 164.1 31.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.425 -179.732 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.411 ' HG2' ' CE2' ' A' ' 89' ' ' TYR . 2.8 tt0 56.95 -81.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.543 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.428 ' N ' ' O ' ' A' ' 87' ' ' SER . 0.4 OUTLIER -155.64 22.93 0.4 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.926 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.542 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 9.7 t80 -123.79 136.8 27.78 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.883 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.446 ' O ' ' N ' ' A' ' 93' ' ' ARG . 86.4 Cg_endo -81.76 148.95 15.97 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.09 2.527 . . . . 0.0 112.451 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.562 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -49.2 89.52 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.804 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.446 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -124.13 169.64 11.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.259 0.552 . . . . 0.0 112.209 -179.126 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.514 ' CD2' HD13 ' A' ' 81' ' ' LEU . 2.9 m-85 -90.86 132.46 35.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.928 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.415 ' HA ' ' O ' ' A' ' 37' ' ' ASN . 10.1 mm-40 -124.5 131.87 53.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.054 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 12.0 p -101.31 147.52 26.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.998 0.428 . . . . 0.0 111.835 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.47 ' CD2' ' HB3' ' A' ' 136' ' ' ASP . 4.2 t60 63.85 55.98 1.55 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.946 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.424 ' CG1' ' HB ' ' A' ' 82' ' ' VAL . 11.6 p -123.44 135.86 61.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.872 0.368 . . . . 0.0 111.364 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.528 ' HA ' ' HD2' ' A' ' 79' ' ' PRO . 1.8 mp -104.3 133.42 49.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.161 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.804 ' HA ' ' O ' ' A' ' 132' ' ' VAL . 7.4 mt -116.53 138.54 51.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.18 0.514 . . . . 0.0 112.311 -179.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.416 ' O ' ' N ' ' A' ' 132' ' ' VAL . . . -128.47 119.28 24.6 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.565 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.7 t -87.37 111.83 21.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.886 0.374 . . . . 0.0 110.648 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -71.74 -165.24 7.13 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.541 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -123.89 29.89 6.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.889 0.376 . . . . 0.0 110.817 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.9 m -159.24 -177.24 6.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.799 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.491 ' HB2' ' HD3' ' A' ' 107' ' ' PRO . 2.0 mt-10 -83.17 -45.18 0.85 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.356 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.491 ' HD3' ' HB2' ' A' ' 106' ' ' GLU . 32.6 Cg_exo -59.4 174.42 1.08 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.326 2.017 . . . . 0.0 112.163 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.67 86.8 1.94 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.61 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -118.39 -63.69 1.38 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.797 0.332 . . . . 0.0 110.809 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -123.59 179.88 4.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.983 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -178.47 -103.94 0.18 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.57 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -143.53 -106.59 0.56 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.671 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.6 pp -126.0 146.18 32.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.922 0.391 . . . . 0.0 111.415 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.447 HD22 ' CE2' ' A' ' 76' ' ' PHE . 56.2 tp -87.82 115.84 25.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.73 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 18.6 ptt-85 -118.74 143.95 46.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.076 0.465 . . . . 0.0 112.111 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.444 ' N ' ' CD1' ' A' ' 121' ' ' ILE . 35.4 t -108.14 166.15 10.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.264 178.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -55.51 -18.13 6.67 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.657 0.265 . . . . 0.0 110.867 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 53.7 m80 -91.33 -36.86 13.6 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.47 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 176.81 -140.82 5.14 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.201 -1.0 . . . . 0.0 113.57 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.499 ' HB ' ' HA ' ' A' ' 53' ' ' ILE . 3.6 t -100.72 135.87 34.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 122.536 0.335 . . . . 0.0 111.628 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.444 ' CD1' ' N ' ' A' ' 116' ' ' CYS . 3.4 mp -98.94 -64.6 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.517 178.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 135' ' ' ALA . . . -164.7 -167.02 24.61 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.196 -1.002 . . . . 0.0 113.239 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.0 164.15 15.15 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.92 0.39 . . . . 0.0 110.892 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.443 ' HA ' ' CD1' ' A' ' 134' ' ' PHE . 10.3 p -60.35 109.23 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.936 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.44 ' CG2' ' N ' ' A' ' 126' ' ' MET . 2.0 m -91.34 -88.6 0.18 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.453 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -128.56 162.1 28.04 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.941 0.4 . . . . 0.0 111.205 179.375 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -131.41 157.82 22.48 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.645 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -114.36 -153.89 10.86 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.411 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -71.96 -19.25 61.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.733 0.301 . . . . 0.0 110.998 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -168.71 28.4 0.15 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.547 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.4 t -130.03 157.05 42.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.716 0.294 . . . . 0.0 110.874 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.804 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 2.0 t -112.97 118.01 56.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.199 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.429 ' HA3' ' O ' ' A' ' 126' ' ' MET . . . -99.12 123.7 7.99 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.61 -0.805 . . . . 0.0 111.871 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.483 ' CZ ' ' HB2' ' A' ' 63' ' ' TYR . 52.6 m-85 -125.12 139.29 53.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.95 0.405 . . . . 0.0 111.727 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.495 ' O ' ' HA3' ' A' ' 122' ' ' GLY . . . -88.88 108.13 19.37 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.694 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.47 ' HB3' ' CD2' ' A' ' 97' ' ' HIS . 1.0 OUTLIER -67.55 143.36 56.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.472 0.653 . . . . 0.0 112.549 -178.095 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.438 ' O ' HD12 ' A' ' 140' ' ' LEU . 19.3 t -102.24 7.17 9.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.149 178.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.402 ' HB3' ' CZ ' ' A' ' 138' ' ' ARG . 2.1 mmm180 -72.48 -6.29 42.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.435 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.444 ' HB2' ' CD2' ' A' ' 97' ' ' HIS . 4.4 t70 -97.72 -1.99 42.26 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.721 0.296 . . . . 0.0 111.363 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.535 ' N ' ' CD1' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -156.1 64.71 0.57 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.464 0.65 . . . . 0.0 109.732 179.548 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.561 ' O ' ' N ' ' A' ' 143' ' ' LEU . 0.1 OUTLIER -77.64 -14.48 59.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.267 -0.879 . . . . 0.0 112.458 -178.906 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . 0.448 ' CE3' ' CE2' ' A' ' 15' ' ' TYR . 14.4 p-90 -53.7 80.19 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.006 0.431 . . . . 0.0 111.216 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.561 ' N ' ' O ' ' A' ' 141' ' ' LEU . 4.9 mp -153.36 -48.19 0.09 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.956 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -156.56 -171.14 3.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.462 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.85 144.24 45.01 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.913 0.387 . . . . 0.0 111.034 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -104.9 154.19 20.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.927 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -89.13 136.65 32.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.186 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.31 177.57 4.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.948 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -106.37 -32.28 8.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.942 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.838 -179.995 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.213 0 N-CA-C 112.494 -0.243 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -51.97 169.16 0.29 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.582 2.188 . . . . 0.0 112.308 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -95.11 -43.78 7.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.918 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.57 -82.77 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.56 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 24.7 m-70 -100.12 -51.88 3.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.812 0.339 . . . . 0.0 110.944 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.07 111.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.805 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 63.87 131.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.887 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -157.26 37.78 0.55 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.562 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -103.66 -174.04 2.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.745 0.307 . . . . 0.0 111.07 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.6 p -131.24 113.19 23.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.88 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 7.9 p90 -112.02 134.43 53.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.979 0.418 . . . . 0.0 111.157 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.514 ' CG1' ' HB2' ' A' ' 144' ' ' GLU . 93.1 t -119.19 128.25 75.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.439 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 49.54 -126.51 20.51 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 121.142 -0.551 . . . . 0.0 113.175 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.443 ' O ' ' HA ' ' A' ' 44' ' ' THR . 21.1 m-20 -89.56 14.72 10.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.624 0.249 . . . . 0.0 111.453 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.419 ' CE2' ' CE3' ' A' ' 142' ' ' TRP . 7.2 m-85 -128.91 141.44 51.27 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.518 ' HA ' ' HA ' ' A' ' 11' ' ' TYR . 9.3 tttt -127.21 114.82 18.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.651 -0.25 . . . . 0.0 110.748 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 0.6 OUTLIER -102.36 121.74 53.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-O 121.202 0.525 . . . . 0.0 110.749 179.709 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.406 HG21 ' HB3' ' A' ' 22' ' ' LEU . 13.6 p -136.35 160.52 37.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.995 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -60.56 141.62 56.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.334 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.43 -47.35 79.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.811 0.339 . . . . 0.0 110.718 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.91 -9.04 53.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.909 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.406 ' HB3' HG21 ' A' ' 18' ' ' VAL . 13.9 tp -109.61 -11.48 14.76 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.652 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.5 ' O ' ' CZ3' ' A' ' 28' ' ' TRP . . . -70.85 150.67 45.56 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 120.805 0.336 . . . . 0.0 110.826 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 58.6 p -104.67 169.2 8.59 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.329 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -54.72 -29.69 54.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.033 0.444 . . . . 0.0 110.576 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 23.9 t -74.66 -31.34 26.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.4 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.406 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 0.3 OUTLIER -67.16 -44.12 80.53 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.984 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.5 ' CZ3' ' O ' ' A' ' 23' ' ' ALA . 7.2 m-90 -74.54 -30.78 61.89 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.217 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.4 mm100 -58.42 -44.14 88.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.509 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -114.21 34.78 4.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.519 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.443 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 36.9 t -80.1 134.56 36.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.404 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.427 HG13 ' CG2' ' A' ' 44' ' ' THR . 12.5 m -98.96 -39.38 7.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.522 179.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.428 ' CZ3' ' HA ' ' A' ' 41' ' ' LEU . 1.9 t90 -139.39 152.91 47.49 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.989 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -160.86 120.39 2.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.975 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.418 ' HB2' ' CZ2' ' A' ' 33' ' ' TRP . 11.0 m-20 -107.04 111.99 24.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.007 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -61.27 -43.58 98.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.964 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.402 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 4.3 m-20 -65.73 -23.56 66.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.771 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.43 ' CZ ' ' HA ' ' A' ' 38' ' ' ARG . 3.4 tpm_? -105.55 -2.02 24.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.34 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 44.27 37.26 1.87 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.947 0.403 . . . . 0.0 110.818 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.0 tp -133.75 141.72 47.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.694 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.531 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -139.2 155.84 47.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.913 0.387 . . . . 0.0 111.759 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.423 HG13 ' CG2' ' A' ' 32' ' ' VAL . 25.3 t -118.72 129.89 74.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.568 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.8 p -121.84 157.16 31.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.306 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 14' ' ' ASN . 8.3 p -97.68 124.35 41.96 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.177 0.513 . . . . 0.0 111.628 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -113.65 162.99 15.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.78 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -108.69 37.45 2.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.885 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -126.73 169.42 13.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.044 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 10.4 m80 -83.74 141.12 31.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.861 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.422 ' HA2' ' CE2' ' A' ' 11' ' ' TYR . . . -91.04 152.0 21.44 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.558 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.43 -46.81 2.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.833 0.349 . . . . 0.0 110.909 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -59.82 135.89 57.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.918 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 33.2 m -117.27 116.0 26.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.824 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.525 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 0.2 OUTLIER -82.5 139.38 17.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.761 179.994 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -95.51 130.51 42.32 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.839 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -93.31 42.5 1.1 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 8.2 p -99.86 167.31 10.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.955 -1.02 . . . . 0.0 111.501 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -117.66 25.54 10.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.073 178.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 14.8 p -66.51 145.38 55.7 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.061 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.0 m -103.04 13.18 34.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.216 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 56.0 p -132.91 125.32 29.63 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.855 0.359 . . . . 0.0 110.996 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -150.99 165.71 30.29 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.388 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.431 HG23 ' CG ' ' A' ' 71' ' ' HIS . 10.6 p -104.51 134.83 44.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.933 0.397 . . . . 0.0 111.338 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.448 ' HB2' ' CZ ' ' A' ' 134' ' ' PHE . 4.9 p90 -110.97 160.44 16.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.843 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -85.11 129.36 34.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.026 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -103.91 141.77 35.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.862 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -92.0 -45.05 8.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.087 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 58.7 m -70.71 -30.7 67.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.923 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.421 ' HG3' ' CE1' ' A' ' 72' ' ' TYR . 0.3 OUTLIER -94.22 -25.67 16.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.101 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.8 t 59.92 23.9 12.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.896 0.379 . . . . 0.0 110.748 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.4 mtpp -134.82 170.21 16.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.731 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.431 ' CG ' HG23 ' A' ' 62' ' ' VAL . 0.0 OUTLIER -84.26 125.21 32.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.925 179.528 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.421 ' CE1' ' HG3' ' A' ' 68' ' ' LYS . 0.6 OUTLIER -111.41 114.39 52.98 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.435 -178.921 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -74.77 120.66 6.23 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.235 1.956 . . . . 0.0 110.422 178.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 90.6 t -142.56 144.99 23.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.107 0.479 . . . . 0.0 112.226 -178.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.66 135.78 33.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.39 178.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.434 ' CE2' HD23 ' A' ' 114' ' ' LEU . 0.1 OUTLIER -141.46 169.66 17.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.226 0.536 . . . . 0.0 111.811 -178.879 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -111.85 158.3 19.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.068 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -105.79 68.34 0.25 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.542 -0.837 . . . . 0.0 113.095 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.478 ' HD2' ' HA ' ' A' ' 99' ' ' LEU . 37.6 Cg_endo -67.52 135.44 36.25 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.391 2.06 . . . . 0.0 112.231 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -59.66 -90.82 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.195 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.442 HD12 ' CD2' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -88.32 119.56 28.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.853 0.359 . . . . 0.0 111.497 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.466 ' HB ' ' CG1' ' A' ' 98' ' ' VAL . 40.1 t -126.99 122.46 60.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.075 178.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -72.54 107.55 5.12 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.934 0.397 . . . . 0.0 110.55 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.563 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 18.3 m -75.24 123.88 31.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.732 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -69.4 150.38 47.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.027 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.532 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 0.6 OUTLIER -67.69 102.67 1.24 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.006 0.432 . . . . 0.0 110.458 -179.474 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.453 ' O ' ' N ' ' A' ' 89' ' ' TYR . 3.5 m -143.87 161.64 38.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.519 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 57.41 -79.14 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.534 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.453 ' N ' ' O ' ' A' ' 87' ' ' SER . 1.3 p90 -159.59 25.38 0.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.699 0.285 . . . . 0.0 110.942 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.532 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 3.6 t80 -124.73 126.09 25.4 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.831 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -69.68 148.77 66.32 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.113 2.542 . . . . 0.0 112.446 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.563 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 1.7 ttpp -53.14 92.26 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.853 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.82 176.55 6.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.184 0.516 . . . . 0.0 112.085 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.442 ' CD2' HD12 ' A' ' 81' ' ' LEU . 4.9 m-85 -98.28 132.32 43.86 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.163 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.402 ' HA ' ' O ' ' A' ' 37' ' ' ASN . 4.4 mt-30 -131.23 132.95 45.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.678 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.65 142.91 33.03 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.014 0.435 . . . . 0.0 112.06 -179.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.436 ' CE1' ' HB3' ' A' ' 139' ' ' ASP . 0.1 OUTLIER 75.76 55.53 0.06 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.064 179.1 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.466 ' CG1' ' HB ' ' A' ' 82' ' ' VAL . 12.4 p -123.4 139.45 50.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.962 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.478 ' HA ' ' HD2' ' A' ' 79' ' ' PRO . 4.4 mp -105.09 134.0 48.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.168 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.775 ' HA ' ' O ' ' A' ' 132' ' ' VAL . 6.8 mt -117.61 138.64 51.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.131 0.491 . . . . 0.0 112.192 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 132' ' ' VAL . . . -130.02 119.46 23.17 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.597 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 1.7 t -86.02 111.69 20.53 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.849 0.356 . . . . 0.0 110.727 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -85.16 -94.12 0.76 Allowed Glycine 0 C--N 1.331 0.255 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.45 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -156.32 -46.02 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.883 0.373 . . . . 0.0 110.841 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 16.3 t -171.63 80.79 0.07 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.89 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -120.21 89.52 43.38 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.925 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -51.7 -59.79 1.0 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.55 2.167 . . . . 0.0 112.27 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -96.61 -173.0 35.0 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.488 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -156.92 90.75 1.16 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.822 0.344 . . . . 0.0 110.842 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -122.3 64.98 0.94 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.097 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -100.8 -102.61 2.55 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.554 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -178.58 -93.0 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.56 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.423 ' HA ' ' HA ' ' A' ' 123' ' ' LEU . 31.2 pt -125.99 146.22 32.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.711 0.291 . . . . 0.0 111.074 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.434 HD23 ' CE2' ' A' ' 76' ' ' PHE . 41.6 tp -87.71 113.02 23.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.65 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 25.9 mtm180 -119.56 146.88 45.1 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.474 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.418 ' HB3' HD13 ' A' ' 121' ' ' ILE . 27.2 p -118.99 177.42 4.87 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -56.77 -18.75 13.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.681 0.276 . . . . 0.0 111.251 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -93.3 -32.58 14.26 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 165.64 -133.58 3.01 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.176 -1.011 . . . . 0.0 113.643 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.525 ' HB ' ' HA ' ' A' ' 53' ' ' ILE . 20.0 t -107.78 135.67 45.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.774 0.321 . . . . 0.0 111.609 -179.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.432 ' N ' ' CD1' ' A' ' 121' ' ' ILE . 2.5 mp -105.26 -52.83 7.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.155 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -161.06 -167.08 21.02 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 119.94 -1.124 . . . . 0.0 113.496 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 0.2 OUTLIER -124.39 164.18 20.21 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.841 0.353 . . . . 0.0 111.021 -179.867 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.5 m -57.06 114.12 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.802 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.426 HG22 ' NH2' ' A' ' 38' ' ' ARG . 2.3 m -105.27 -88.95 0.43 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.01 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.42 ' O ' ' HA3' ' A' ' 133' ' ' GLY . 1.5 tpt -132.28 162.1 31.84 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.247 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -133.23 161.43 24.17 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.513 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -119.26 -154.61 9.59 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.527 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -72.04 -19.08 61.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.691 0.282 . . . . 0.0 110.963 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -168.27 29.71 0.16 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.545 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 1.3 t -132.21 157.1 43.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.785 0.326 . . . . 0.0 111.001 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.775 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 1.8 t -113.72 117.98 56.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.903 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.42 ' HA3' ' O ' ' A' ' 126' ' ' MET . . . -102.07 122.33 7.51 Favored Glycine 0 CA--C 1.516 0.14 0 C-N-CA 120.525 -0.845 . . . . 0.0 111.84 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.489 ' CE2' ' CG1' ' A' ' 132' ' ' VAL . 48.9 m-85 -124.99 144.0 50.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.992 0.425 . . . . 0.0 111.742 -179.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.416 ' HB2' ' OG1' ' A' ' 125' ' ' THR . . . -88.9 114.22 25.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.739 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -67.53 137.6 55.88 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.542 ' O ' HD11 ' A' ' 140' ' ' LEU . 69.2 t -99.42 3.67 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.943 178.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.41 ' HA ' ' CD2' ' A' ' 141' ' ' LEU . 0.5 OUTLIER -72.57 -6.27 42.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.43 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.436 ' HB3' ' CE1' ' A' ' 97' ' ' HIS . 1.4 p30 -95.32 3.35 54.54 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.708 0.29 . . . . 0.0 111.345 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.552 ' N ' ' CD1' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -162.11 51.8 0.21 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.294 0.569 . . . . 0.0 110.119 179.669 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.531 ' O ' ' N ' ' A' ' 143' ' ' LEU . 0.1 OUTLIER -68.59 -14.63 63.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.149 -179.44 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . 0.419 ' CE3' ' CE2' ' A' ' 15' ' ' TYR . 13.2 p-90 -53.86 81.92 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.17 0.51 . . . . 0.0 111.379 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.531 ' N ' ' O ' ' A' ' 141' ' ' LEU . 5.0 mp -150.95 -44.84 0.12 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.834 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.514 ' HB2' ' CG1' ' A' ' 12' ' ' VAL . 1.1 tp10 -146.59 -159.23 0.99 Allowed 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.417 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -77.86 149.04 34.38 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.837 0.351 . . . . 0.0 110.988 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -84.84 154.2 22.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.936 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -91.39 136.45 33.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.066 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.49 -175.81 0.2 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.895 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -112.9 147.03 37.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.913 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.182 -0.913 . . . . 0.0 110.909 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.207 0 N-CA-C 112.438 -0.265 . . . . 0.0 112.438 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.23 91.1 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.653 2.235 . . . . 0.0 112.408 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 60.82 174.82 0.1 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.948 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 72.55 -148.18 41.6 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.543 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -146.33 128.69 15.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.864 0.364 . . . . 0.0 110.871 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -74.82 70.57 1.93 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.741 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.3 m -114.55 113.22 24.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.927 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 166.76 -51.63 0.25 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.327 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -127.99 163.89 23.53 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.697 0.284 . . . . 0.0 110.937 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.0 p -127.59 107.32 16.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.032 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 6.0 p90 -104.43 129.42 52.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.951 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.425 ' CG1' ' HB2' ' A' ' 144' ' ' GLU . 31.2 t -119.28 133.21 66.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.773 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 49.84 -128.39 25.24 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 121.068 -0.586 . . . . 0.0 112.966 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.417 ' O ' ' HA ' ' A' ' 44' ' ' THR . 36.5 m120 -91.35 17.13 8.82 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.673 0.273 . . . . 0.0 111.176 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.425 ' HB3' HG12 ' A' ' 42' ' ' VAL . 9.7 m-85 -129.94 148.45 51.81 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.241 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.566 ' HA ' ' HA ' ' A' ' 11' ' ' TYR . 37.3 tttt -132.26 114.68 14.72 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.696 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 0.9 OUTLIER -101.94 121.42 52.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-O 121.209 0.528 . . . . 0.0 110.74 179.72 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.0 p -136.94 161.42 35.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.428 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -60.55 141.79 56.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.152 178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.425 ' HG3' ' N ' ' A' ' 21' ' ' HIS . 7.8 ptm180 -56.34 -46.99 79.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.803 0.335 . . . . 0.0 111.378 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.425 ' N ' ' HG3' ' A' ' 20' ' ' ARG . 4.0 t60 -69.66 -6.45 31.59 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.331 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -115.14 -1.39 13.01 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.434 ' HB1' HD21 ' A' ' 41' ' ' LEU . . . -87.29 126.75 35.03 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.238 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.534 ' O ' ' HD1' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -74.79 164.37 26.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.682 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -53.78 -29.71 41.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.332 -179.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.406 HG13 ' CG2' ' A' ' 24' ' ' THR . 13.8 p -71.86 -31.37 40.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.971 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.95 -44.06 77.64 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.035 0.445 . . . . 0.0 109.828 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.534 ' HD1' ' O ' ' A' ' 24' ' ' THR . 39.7 m95 -73.99 -33.44 63.84 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.623 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 13.2 tp60 -56.66 -44.0 80.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.644 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -111.56 30.01 7.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.423 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.413 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 10.8 t -77.3 131.88 38.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.092 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.451 ' CG2' HG13 ' A' ' 42' ' ' VAL . 13.1 m -94.04 -39.76 10.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.979 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.436 ' CE3' HG22 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -139.7 153.41 47.23 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.976 0.417 . . . . 0.0 111.8 -179.216 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -158.52 120.52 3.58 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.576 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.433 ' HB2' ' CZ2' ' A' ' 33' ' ' TRP . 14.2 m-20 -106.99 116.92 32.77 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.484 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -66.39 -29.99 70.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.954 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.474 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 26.1 p30 -66.56 -25.89 66.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.057 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 18.0 mtm180 -117.44 -0.97 11.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.459 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 51.22 37.86 19.63 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.898 0.38 . . . . 0.0 110.572 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.4 tp -125.39 152.36 44.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.928 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.53 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -143.93 156.07 44.3 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.944 0.402 . . . . 0.0 111.667 179.627 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.451 HG13 ' CG2' ' A' ' 32' ' ' VAL . 22.6 t -120.21 129.95 74.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.636 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.9 p -120.49 157.3 29.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.119 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 14' ' ' ASN . 10.1 p -97.45 123.29 41.24 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.163 0.506 . . . . 0.0 111.596 -179.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -117.33 140.17 49.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.882 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.1 p -95.14 45.97 1.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.98 0.419 . . . . 0.0 110.907 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.94 177.17 5.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.022 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -87.94 121.6 30.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.928 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.429 ' HA2' ' CE2' ' A' ' 11' ' ' TYR . . . -64.44 175.75 11.42 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.441 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 m -154.1 -46.15 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.862 0.363 . . . . 0.0 110.94 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -73.34 143.78 46.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.058 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 55.1 m -120.45 119.64 33.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.193 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.479 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 2.9 mm -72.5 139.36 19.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.089 0.471 . . . . 0.0 111.063 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.474 ' HB1' ' HB2' ' A' ' 118' ' ' HIS . . . -75.36 -47.89 25.56 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.513 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.93 13.54 9.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.825 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 23.9 p -99.78 166.92 10.86 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.665 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -121.76 39.28 3.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.124 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 59.5 m -62.7 156.81 22.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.706 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.3 -19.87 20.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.964 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.3 p -116.34 123.91 48.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.946 0.403 . . . . 0.0 111.123 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -140.71 -164.02 9.74 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 121.028 -0.606 . . . . 0.0 111.89 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.411 HG23 ' HB3' ' A' ' 71' ' ' HIS . 3.6 p -140.41 130.74 28.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 121.167 0.508 . . . . 0.0 111.815 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.479 ' CD1' ' O ' ' A' ' 63' ' ' TYR . 24.4 p90 -109.28 126.27 53.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.772 178.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.416 ' CB ' ' CD2' ' A' ' 71' ' ' HIS . 55.6 p90 -115.55 149.77 37.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.993 0.425 . . . . 0.0 111.578 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 40.6 m 61.07 22.76 13.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.642 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.408 ' HB2' ' CD1' ' A' ' 63' ' ' TYR . . . -92.07 -45.13 8.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.86 0.362 . . . . 0.0 110.971 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.41 -39.31 3.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.663 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.419 ' HB3' ' HD3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -125.08 -169.06 1.92 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.522 179.834 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.1 p -97.63 33.49 2.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.015 0.436 . . . . 0.0 110.458 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.419 ' HD3' ' HB3' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -144.2 170.93 15.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.668 -179.389 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.416 ' CD2' ' CB ' ' A' ' 64' ' ' PHE . 13.0 m170 -83.85 139.03 32.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.756 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.426 ' HB2' ' CE1' ' A' ' 63' ' ' TYR . 3.9 m-85 -124.91 114.29 26.62 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.615 -178.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -74.21 120.78 6.45 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.354 2.036 . . . . 0.0 111.043 178.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.443 ' CG1' ' CE2' ' A' ' 76' ' ' PHE . 2.3 p -139.78 158.8 27.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.034 0.445 . . . . 0.0 111.923 -179.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.9 m -102.04 123.91 46.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.424 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.468 ' CD1' ' N ' ' A' ' 76' ' ' PHE . 0.0 OUTLIER -125.11 161.78 26.05 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.41 0.624 . . . . 0.0 111.771 -179.259 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.417 ' O ' ' CD ' ' A' ' 79' ' ' PRO . 4.6 mt-10 -111.79 158.77 18.98 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.349 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -104.76 67.22 0.28 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.412 -0.899 . . . . 0.0 113.187 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.45 ' HD2' ' O ' ' A' ' 98' ' ' VAL . 41.7 Cg_endo -67.72 135.47 35.81 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.375 2.05 . . . . 0.0 112.07 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -60.84 -86.77 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.682 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.424 HD12 ' O ' ' A' ' 95' ' ' GLN . 0.0 OUTLIER -94.62 119.85 33.93 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -179.365 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.422 ' HB ' ' CG1' ' A' ' 98' ' ' VAL . 80.0 t -124.63 123.28 65.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.344 178.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.418 ' HG3' ' CZ ' ' A' ' 94' ' ' TYR . 0.1 OUTLIER -72.14 107.86 5.03 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.019 0.438 . . . . 0.0 111.037 -178.826 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 2.2 p -73.31 114.41 12.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.486 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -76.27 150.23 37.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.56 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.676 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 28.0 tt0 -68.0 101.04 1.05 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.122 0.487 . . . . 0.0 110.505 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.43 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.5 OUTLIER -144.7 143.01 30.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.875 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 59.25 -80.21 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.423 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.43 ' N ' ' O ' ' A' ' 87' ' ' SER . 0.8 OUTLIER -152.11 22.18 0.66 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.658 0.266 . . . . 0.0 111.173 -179.945 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.676 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 0.8 OUTLIER -110.51 114.64 54.87 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.302 179.68 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -60.98 148.26 93.26 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.728 2.285 . . . . 0.0 112.888 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -67.77 71.51 0.14 Allowed 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.598 179.507 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.4 ttm180 -123.61 -174.55 3.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.914 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.418 ' CZ ' ' HG3' ' A' ' 83' ' ' GLU . 13.6 m-85 -96.51 132.43 42.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.822 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.474 ' HA ' ' O ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -131.1 126.56 36.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.039 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.1 p -101.58 161.45 13.63 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.162 0.506 . . . . 0.0 111.926 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 61.63 57.57 2.23 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.565 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.45 ' O ' ' HD2' ' A' ' 79' ' ' PRO . 4.8 p -123.55 143.45 36.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.758 0.313 . . . . 0.0 111.37 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.5 mp -107.29 143.31 35.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.804 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.534 ' HA ' ' O ' ' A' ' 132' ' ' VAL . 5.1 mt -133.01 139.42 47.22 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -179.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.417 ' HB1' ' CD2' ' A' ' 76' ' ' PHE . . . -143.71 146.64 33.33 Favored 'General case' 0 CA--C 1.522 -0.109 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.728 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.2 t -104.54 131.42 51.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.932 0.396 . . . . 0.0 111.192 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -134.13 63.45 0.61 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.424 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -58.21 95.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.867 0.365 . . . . 0.0 111.083 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 69.7 m -154.45 -46.48 0.09 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.9 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.31 154.72 36.41 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.888 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_exo -51.85 140.9 46.99 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.596 2.197 . . . . 0.0 112.196 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -134.22 167.08 23.91 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.662 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -170.65 -57.63 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.832 0.348 . . . . 0.0 110.886 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -131.51 148.91 52.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.984 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -145.74 -153.55 5.91 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.535 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -112.1 -108.48 2.98 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.478 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.438 ' HA ' ' HA ' ' A' ' 123' ' ' LEU . 24.8 pt -126.08 146.49 31.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.822 0.344 . . . . 0.0 111.326 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.445 ' HB2' ' CD2' ' A' ' 134' ' ' PHE . 11.5 tp -87.44 122.2 30.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.109 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 27.5 mtp180 -118.26 138.74 52.15 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.254 0.549 . . . . 0.0 112.064 -178.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.436 ' HB2' ' CD1' ' A' ' 121' ' ' ILE . 15.1 t -106.03 166.51 10.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.614 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -55.77 -19.7 12.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.64 0.257 . . . . 0.0 111.031 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.474 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . 31.4 m80 -89.66 -35.92 15.54 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.514 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 169.32 -142.41 7.31 Favored Glycine 0 C--O 1.227 -0.316 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.561 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.479 ' HB ' ' HA ' ' A' ' 53' ' ' ILE . 3.4 t -89.73 135.22 26.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.562 0.22 . . . . 0.0 110.704 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.436 ' CD1' ' HB2' ' A' ' 116' ' ' CYS . 6.3 mt -106.32 -52.75 7.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 121.051 -0.259 . . . . 0.0 111.05 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 135' ' ' ALA . . . -161.74 -174.68 31.91 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.088 -1.053 . . . . 0.0 113.239 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.469 ' N ' ' CD1' ' A' ' 123' ' ' LEU . 0.0 OUTLIER -121.16 164.06 17.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.833 0.349 . . . . 0.0 110.824 179.884 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 13.7 p -55.47 127.14 13.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.767 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.405 ' CG2' ' N ' ' A' ' 126' ' ' MET . 3.2 m -120.56 -90.35 0.58 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.045 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.456 ' O ' ' HA3' ' A' ' 133' ' ' GLY . 0.0 OUTLIER -122.65 125.89 46.53 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.977 0.418 . . . . 0.0 111.301 179.618 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -110.26 128.48 8.86 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.606 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -83.95 -159.9 29.79 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.533 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -71.9 -19.38 61.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.75 0.31 . . . . 0.0 111.217 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -158.42 20.22 0.33 Allowed Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.678 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 101' ' ' ALA . 1.3 t -129.17 157.07 42.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.755 0.312 . . . . 0.0 110.769 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 18.8 m -115.19 118.35 58.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.212 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.456 ' HA3' ' O ' ' A' ' 126' ' ' MET . . . -100.64 109.54 3.7 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.074 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.445 ' CD2' ' HB2' ' A' ' 114' ' ' LEU . 61.1 m-85 -111.16 139.79 46.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.746 0.308 . . . . 0.0 110.912 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.407 ' O ' ' HA3' ' A' ' 122' ' ' GLY . . . -88.57 120.56 30.07 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -67.36 137.1 55.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.197 0.522 . . . . 0.0 112.355 -178.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.462 ' O ' HD12 ' A' ' 140' ' ' LEU . 95.1 t -90.53 7.85 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.474 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.438 ' HA ' HD21 ' A' ' 141' ' ' LEU . 8.8 mtm180 -70.49 -6.44 36.04 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.812 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.6 11.18 39.2 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.608 0.242 . . . . 0.0 111.581 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.559 ' N ' ' CD1' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -173.14 48.67 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.256 0.551 . . . . 0.0 110.374 179.811 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.464 ' O ' ' N ' ' A' ' 143' ' ' LEU . 0.2 OUTLIER -67.67 -14.93 63.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.015 -179.551 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . 0.416 ' CE3' ' CE2' ' A' ' 15' ' ' TYR . 12.3 p-90 -56.65 82.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.069 0.461 . . . . 0.0 111.693 -179.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' A' ' 141' ' ' LEU . 5.1 mp -149.06 -47.29 0.14 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.805 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.425 ' HB2' ' CG1' ' A' ' 12' ' ' VAL . 0.5 OUTLIER -158.32 -168.89 2.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.418 179.895 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 14.7 p30 -58.83 138.94 57.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.851 0.358 . . . . 0.0 111.044 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -105.01 154.11 20.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.999 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -100.18 151.66 21.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.098 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 1.8 ttp -155.88 -57.75 0.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.948 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -61.58 171.08 1.63 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.863 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.895 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.181 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.56 -28.02 26.71 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.595 2.196 . . . . 0.0 112.269 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -127.12 -63.95 1.03 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.934 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 76.55 88.98 0.28 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.567 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 41.6 t60 -107.13 85.08 2.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.918 0.39 . . . . 0.0 110.874 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -63.28 -31.03 72.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.969 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.2 m -59.66 151.51 24.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.882 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -156.58 140.77 7.43 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.614 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -125.46 -172.72 2.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.727 0.298 . . . . 0.0 111.052 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.2 t -112.94 103.01 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.001 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.455 ' CE2' ' CG2' ' A' ' 45' ' ' THR . 6.1 t80 -97.85 115.93 29.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.856 0.36 . . . . 0.0 110.631 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.457 ' HB ' ' CD2' ' A' ' 143' ' ' LEU . 32.8 t -121.21 108.96 23.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.517 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.405 ' O ' ' CE1' ' A' ' 11' ' ' TYR . . . 54.24 -128.75 41.99 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.897 -0.668 . . . . 0.0 113.309 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.415 ' O ' ' HA ' ' A' ' 44' ' ' THR . 22.6 m120 -88.75 13.26 12.83 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 111.706 0.262 . . . . 0.0 111.706 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.404 ' CE2' ' CE3' ' A' ' 142' ' ' TRP . 5.7 m-30 -130.3 127.95 40.54 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -118.97 114.74 23.03 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 121.124 -0.23 . . . . 0.0 110.688 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 0.7 OUTLIER -101.07 121.66 52.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.231 0.538 . . . . 0.0 110.993 179.91 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.1 p -136.7 161.36 36.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.047 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -58.91 141.49 53.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.376 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.425 ' CD ' ' N ' ' A' ' 21' ' ' HIS . 0.0 OUTLIER -56.54 -47.09 80.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.874 0.369 . . . . 0.0 111.294 -179.339 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.425 ' N ' ' CD ' ' A' ' 20' ' ' ARG . 13.3 p80 -68.36 -9.83 50.81 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.162 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.3 2.32 13.97 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.461 ' HB2' HD22 ' A' ' 41' ' ' LEU . . . -87.34 130.27 34.69 Favored 'General case' 0 C--N 1.334 -0.081 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.189 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.498 ' O ' ' HD1' ' A' ' 28' ' ' TRP . 41.9 p -74.69 163.04 28.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.742 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 61.1 m-70 -53.74 -29.71 40.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.975 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.2 t -70.33 -31.91 48.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.83 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -68.09 -44.25 76.69 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.123 0.487 . . . . 0.0 109.707 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.498 ' HD1' ' O ' ' A' ' 24' ' ' THR . 40.6 m95 -74.13 -33.14 63.46 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.702 179.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -56.79 -44.12 81.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.726 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -114.46 30.99 6.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.372 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.466 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 13.8 t -72.61 126.63 30.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.128 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.423 HG21 ' N ' ' A' ' 33' ' ' TRP . 18.4 m -88.9 -40.77 13.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.626 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.469 ' CE3' HG21 ' A' ' 42' ' ' VAL . 0.5 OUTLIER -139.75 153.21 47.12 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.916 0.388 . . . . 0.0 111.227 -179.94 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -157.61 119.37 3.69 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.974 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -107.13 117.73 34.84 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.133 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 19.4 p90 -68.2 -36.79 80.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.106 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.418 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 74.0 m-20 -70.13 -12.9 61.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.871 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.0 mpt_? -117.2 -6.35 11.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.178 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 50.77 36.04 13.47 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-O 121.074 0.464 . . . . 0.0 110.295 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 36.7 tp -132.85 153.19 51.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.931 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.514 HD21 ' N ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -147.83 155.63 41.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.491 179.682 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.469 HG21 ' CE3' ' A' ' 33' ' ' TRP . 38.2 t -115.78 130.68 70.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.337 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.0 p -123.29 157.24 33.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.637 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 14' ' ' ASN . 30.1 p -97.65 145.13 26.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.189 0.518 . . . . 0.0 111.793 -178.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.455 ' CG2' ' CE2' ' A' ' 11' ' ' TYR . 0.2 OUTLIER -140.02 171.28 14.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.841 -179.253 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.8 t -124.48 62.32 1.12 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.93 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -135.51 -173.54 3.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.978 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -90.83 142.88 27.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.866 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.58 159.45 30.46 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.556 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -142.23 -46.7 0.34 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.743 0.306 . . . . 0.0 110.956 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -103.23 142.5 34.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.025 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 91.7 m -120.08 120.85 37.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.286 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.508 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 0.9 OUTLIER -75.09 139.61 18.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.909 0.385 . . . . 0.0 110.921 -179.811 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -94.91 127.19 40.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.107 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.488 ' HB2' ' HB2' ' A' ' 146' ' ' ASP . 0.1 OUTLIER -92.33 34.76 1.02 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.528 179.452 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 26.5 p -99.65 160.5 14.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.874 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.69 34.79 4.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.084 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 66.5 m -58.28 126.87 29.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.707 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.3 m -68.92 -17.7 64.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.881 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 75' ' ' SER . 1.4 t -129.74 151.01 50.79 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.023 0.439 . . . . 0.0 111.319 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.451 ' N ' ' CE1' ' A' ' 76' ' ' PHE . . . -154.92 -148.24 4.94 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.688 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.438 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 7.1 p -140.08 123.57 17.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.015 0.436 . . . . 0.0 111.385 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.42 ' CZ ' ' CB ' ' A' ' 72' ' ' TYR . 8.5 p90 -94.87 172.06 8.39 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.892 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.85 122.53 44.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.849 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -86.57 144.27 27.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.01 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.88 -43.63 9.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.165 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.6 t -80.95 -50.71 9.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.888 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.3 mmtm -65.28 -23.89 67.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.079 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 55.72 26.05 8.97 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.055 0.455 . . . . 0.0 110.803 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.2 mtpt -134.05 170.11 16.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.876 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.414 ' HB2' HG23 ' A' ' 62' ' ' VAL . 9.2 p80 -84.24 131.96 34.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.272 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.42 ' CB ' ' CZ ' ' A' ' 63' ' ' TYR . 1.2 m-85 -121.98 114.45 30.93 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.06 -179.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.438 ' HA ' ' HA ' ' A' ' 62' ' ' VAL . 4.9 Cg_exo -76.49 120.82 5.74 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.5 2.134 . . . . 0.0 111.529 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.448 ' CG1' ' CE2' ' A' ' 76' ' ' PHE . 2.9 p -136.6 156.75 35.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.973 0.416 . . . . 0.0 111.773 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.454 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 59.0 p -97.41 123.34 41.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.71 178.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.463 ' CB ' ' HB3' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -124.39 163.44 21.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.373 0.606 . . . . 0.0 111.78 -179.411 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.424 ' O ' ' HA ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -111.72 158.72 19.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.224 179.024 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -104.87 65.51 0.3 Allowed Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.364 -0.922 . . . . 0.0 113.716 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.444 ' HD2' ' O ' ' A' ' 98' ' ' VAL . 41.6 Cg_endo -67.84 134.63 32.88 Favored 'Trans proline' 0 C--O 1.238 0.501 0 C-N-CA 122.254 1.97 . . . . 0.0 112.011 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -59.89 -86.82 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.981 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.435 HD12 ' O ' ' A' ' 95' ' ' GLN . 0.0 OUTLIER -96.25 119.76 35.32 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -179.227 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.422 ' CG2' ' CG1' ' A' ' 98' ' ' VAL . 87.1 t -122.99 122.85 66.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.341 178.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.28 109.61 6.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.067 0.46 . . . . 0.0 111.206 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.52 ' CG2' ' HG3' ' A' ' 126' ' ' MET . 1.2 p -72.79 114.54 12.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.452 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -75.06 149.53 39.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.326 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.555 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 2.4 tm-20 -68.51 101.3 1.23 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.044 0.45 . . . . 0.0 110.458 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.477 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.4 OUTLIER -144.79 155.11 43.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.047 179.816 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.416 ' HB3' ' H ' ' A' ' 89' ' ' TYR . 4.3 tt0 51.41 -83.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.611 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.477 ' N ' ' O ' ' A' ' 87' ' ' SER . 0.6 OUTLIER -145.67 19.75 1.49 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.835 0.35 . . . . 0.0 110.905 179.771 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.555 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 1.4 m-85 -107.88 140.35 21.53 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.538 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -86.35 148.5 8.95 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.095 2.53 . . . . 0.0 112.9 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -65.36 70.44 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.896 179.724 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 14.1 mtp180 -123.52 -175.03 3.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.995 0.426 . . . . 0.0 111.741 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.429 ' HB3' HD11 ' A' ' 81' ' ' LEU . 8.3 m-85 -98.47 132.7 43.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.205 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.435 ' O ' HD12 ' A' ' 81' ' ' LEU . 4.7 mt-30 -128.44 126.83 41.35 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.704 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 24.6 p -99.58 161.04 13.85 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.174 0.511 . . . . 0.0 112.332 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 57.84 60.22 2.86 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.878 179.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.444 ' O ' ' HD2' ' A' ' 79' ' ' PRO . 6.1 p -123.66 142.39 40.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 C-N-CA 120.894 -0.323 . . . . 0.0 111.093 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.428 ' HA ' ' HD2' ' A' ' 79' ' ' PRO . 10.7 mp -107.67 141.37 39.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.269 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.609 ' HA ' ' O ' ' A' ' 132' ' ' VAL . 6.3 mt -128.08 136.56 51.37 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.463 ' HB3' ' CB ' ' A' ' 76' ' ' PHE . . . -142.3 142.17 32.51 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.077 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 1.7 t -97.37 121.64 39.5 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.066 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -139.84 -110.83 0.9 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.524 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -126.06 89.93 3.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.792 0.33 . . . . 0.0 110.843 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 37.7 m -101.1 62.69 0.98 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.91 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.474 ' N ' ' HD2' ' A' ' 107' ' ' PRO . 0.6 OUTLIER -73.77 -49.0 6.36 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.28 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 106' ' ' GLU . 72.1 Cg_endo -76.64 -172.43 1.4 Allowed 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.197 1.931 . . . . 0.0 112.345 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -133.0 39.44 1.74 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.478 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -120.91 178.63 4.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.842 0.353 . . . . 0.0 110.942 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -147.82 175.53 10.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.154 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 128.4 135.65 4.05 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.476 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 126.56 175.25 14.07 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.468 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 17.6 pt -126.31 146.41 32.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.705 0.288 . . . . 0.0 111.302 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.48 ' HG ' ' HB ' ' A' ' 121' ' ' ILE . 20.6 tp -87.36 119.88 28.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.32 -0.4 . . . . 0.0 109.997 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 28.1 mtp85 -118.12 151.9 36.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.247 0.546 . . . . 0.0 111.648 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.436 ' HB2' HD12 ' A' ' 121' ' ' ILE . 4.2 t -119.03 160.92 21.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.175 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.421 ' CG ' ' CE1' ' A' ' 118' ' ' HIS . 3.0 pt-20 -56.29 -18.88 11.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.756 0.312 . . . . 0.0 110.925 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.421 ' CE1' ' CG ' ' A' ' 117' ' ' GLU . 13.2 m80 -93.65 -33.66 13.58 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.656 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 176.39 -138.67 4.18 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.408 -0.901 . . . . 0.0 113.102 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.508 ' HB ' ' HA ' ' A' ' 53' ' ' ILE . 4.9 t -102.57 135.56 39.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.765 0.317 . . . . 0.0 111.286 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.48 ' HB ' ' HG ' ' A' ' 114' ' ' LEU . 1.0 OUTLIER -99.03 -66.9 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.956 179.524 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -161.33 -164.4 16.15 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.698 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.94 164.24 14.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.701 0.286 . . . . 0.0 110.718 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 61.3 t -66.31 126.35 25.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.758 0.313 . . . . 0.0 111.188 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.418 ' CG2' ' N ' ' A' ' 126' ' ' MET . 2.9 m -109.45 -90.01 0.47 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.445 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.52 ' HG3' ' CG2' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -127.91 125.87 40.42 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 121.022 0.439 . . . . 0.0 111.742 179.946 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -107.87 128.33 9.11 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.66 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -81.69 -162.42 29.71 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.511 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -71.82 -19.72 61.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.71 0.291 . . . . 0.0 111.132 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -146.93 -7.27 0.28 Allowed Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.795 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 1.6 t -115.94 157.12 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 117.289 0.544 . . . . 0.0 110.927 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.609 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 11.8 m -114.75 118.63 59.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.563 -179.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.472 ' HA3' ' O ' ' A' ' 126' ' ' MET . . . -97.68 118.7 6.17 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.47 -0.872 . . . . 0.0 112.041 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.471 ' CZ ' ' CG2' ' A' ' 132' ' ' VAL . 11.5 m-85 -120.28 143.96 48.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.01 0.433 . . . . 0.0 111.637 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -90.44 110.83 21.93 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.937 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -67.97 143.61 55.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.095 0.474 . . . . 0.0 111.889 -178.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.498 ' O ' HD13 ' A' ' 140' ' ' LEU . 92.8 t -90.05 9.86 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.624 179.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.23 -7.94 46.13 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.528 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -90.21 8.11 34.74 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.55 ' N ' ' CD1' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -172.34 42.02 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.067 0.461 . . . . 0.0 110.899 179.886 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.465 ' O ' ' N ' ' A' ' 143' ' ' LEU . 0.1 OUTLIER -58.72 -14.99 9.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.229 -179.858 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . 0.422 ' CD1' ' HA ' ' A' ' 140' ' ' LEU . 16.1 p-90 -59.09 79.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.862 0.363 . . . . 0.0 111.327 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.465 ' N ' ' O ' ' A' ' 141' ' ' LEU . 4.7 mp -137.54 -45.98 0.55 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.469 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.438 ' HG2' ' CG1' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -165.58 -162.46 0.58 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.74 179.707 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -58.82 131.0 49.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.94 0.4 . . . . 0.0 111.189 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.488 ' HB2' ' HB2' ' A' ' 55' ' ' ARG . 3.7 p30 -105.0 154.25 20.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.639 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.87 153.21 42.59 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.843 0.354 . . . . 0.0 111.142 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 58.97 71.5 0.58 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.853 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.03 177.45 4.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.919 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.918 179.967 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.228 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -69.51 127.93 15.51 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.553 2.169 . . . . 0.0 112.304 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -103.75 115.24 30.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.943 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.97 -48.48 85.87 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.443 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 63.43 140.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.766 0.317 . . . . 0.0 110.961 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 61.05 87.24 0.09 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.895 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.1 m 61.14 179.81 0.11 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.021 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -161.29 -76.02 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.349 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 60.39 -167.47 0.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.781 0.324 . . . . 0.0 111.232 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.3 p -126.82 106.26 15.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.939 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 2.5 p90 -103.13 127.46 50.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.916 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.411 ' CG1' ' HB2' ' A' ' 144' ' ' GLU . 39.2 t -119.06 133.21 66.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.67 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 50.89 -130.51 31.83 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.885 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -91.35 18.62 6.89 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.741 0.305 . . . . 0.0 111.073 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.417 ' HB3' HG13 ' A' ' 42' ' ' VAL . 9.7 m-85 -129.87 144.2 51.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.119 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -127.7 114.72 17.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.587 179.386 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.538 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 0.7 OUTLIER -103.08 121.77 54.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-O 121.237 0.541 . . . . 0.0 111.024 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.434 HG23 ' HB3' ' A' ' 22' ' ' LEU . 7.3 p -136.47 160.55 37.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.076 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -59.71 141.51 55.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.463 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.43 -47.11 79.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.895 0.379 . . . . 0.0 110.908 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -68.86 -9.06 49.34 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.242 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.434 ' HB3' HG23 ' A' ' 18' ' ' VAL . 1.7 tp -109.58 -11.65 14.76 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.503 ' O ' ' CZ3' ' A' ' 28' ' ' TRP . . . -70.39 150.48 46.22 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 120.81 0.338 . . . . 0.0 110.875 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.404 ' O ' ' CE3' ' A' ' 28' ' ' TRP . 67.1 p -104.97 168.89 8.76 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.447 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -54.69 -29.79 53.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.972 0.415 . . . . 0.0 110.704 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.408 HG12 ' N ' ' A' ' 27' ' ' ASP . 8.2 p -76.47 -31.03 19.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.324 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.415 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 7.7 m-20 -66.27 -44.05 84.7 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.503 ' CZ3' ' O ' ' A' ' 23' ' ' ALA . 6.7 m-90 -74.26 -30.12 61.99 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.872 179.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -57.3 -44.16 83.86 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.431 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -114.25 31.86 6.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.436 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.421 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 14.3 t -79.6 129.07 34.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.171 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.444 ' CG2' HG11 ' A' ' 42' ' ' VAL . 12.7 m -91.47 -39.89 12.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.719 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.455 ' CE3' HG23 ' A' ' 42' ' ' VAL . 0.6 OUTLIER -139.43 152.4 47.03 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.01 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -159.83 117.41 2.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.977 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -107.03 118.33 36.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.232 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -65.96 -42.23 90.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.925 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.443 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 8.8 m-20 -66.63 -14.53 62.55 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.99 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.4 mtm180 -114.89 0.64 13.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.234 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.2 p30 42.54 38.99 1.41 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.996 0.427 . . . . 0.0 110.809 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 23.5 tp -137.12 152.15 49.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.091 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.538 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -147.79 155.72 41.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.153 179.455 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.455 HG23 ' CE3' ' A' ' 33' ' ' TRP . 29.3 t -119.78 129.97 74.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.94 0.4 . . . . 0.0 110.818 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.7 p -120.33 156.95 30.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.181 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 13.5 p -97.79 123.85 41.91 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.174 0.512 . . . . 0.0 111.542 -179.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -115.1 164.98 13.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.859 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.64 46.86 0.9 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.797 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -151.93 144.82 24.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.101 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 9.2 m170 -67.7 148.07 51.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.803 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.449 ' HA2' ' CE2' ' A' ' 11' ' ' TYR . . . -82.92 135.82 14.45 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.597 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 8.2 t -95.67 19.14 11.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.703 0.287 . . . . 0.0 111.037 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -135.27 145.9 48.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.751 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.0 m -119.54 117.62 28.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.603 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.526 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 0.5 OUTLIER -77.05 139.52 18.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.748 -179.873 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.419 ' HB1' ' HB2' ' A' ' 118' ' ' HIS . . . -93.21 132.21 37.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.225 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.1 28.7 1.8 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.391 179.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 28.1 p -99.56 166.08 11.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.965 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.62 34.44 4.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.709 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 40.7 m -55.18 131.37 45.12 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.082 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.7 m -72.47 -11.46 60.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.619 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.1 p -120.26 153.51 36.25 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.765 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -171.29 -164.14 26.46 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.892 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.418 HG23 ' CD2' ' A' ' 71' ' ' HIS . 10.2 p -139.66 128.08 26.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.962 0.411 . . . . 0.0 111.18 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.457 ' CE1' ' HB2' ' A' ' 72' ' ' TYR . 17.7 p90 -99.02 133.61 43.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.752 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.445 ' HB2' ' CD2' ' A' ' 71' ' ' HIS . 77.5 t80 -109.46 131.55 54.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.471 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 69' ' ' SER . 4.1 t 54.77 23.05 4.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.725 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.454 ' CB ' ' CD1' ' A' ' 63' ' ' TYR . . . -71.59 -45.02 63.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.023 0.439 . . . . 0.0 110.461 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.5 m -160.2 20.49 0.15 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.196 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -148.7 6.72 0.73 Allowed 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.44 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 0.4 OUTLIER 52.35 21.93 1.88 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.769 0.319 . . . . 0.0 111.087 -179.649 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.44 ' HG3' ' O ' ' A' ' 69' ' ' SER . 0.5 OUTLIER -146.71 170.66 16.5 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.57 -179.504 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.445 ' CD2' ' HB2' ' A' ' 64' ' ' PHE . 0.2 OUTLIER -83.46 119.26 24.45 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.244 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.457 ' HB2' ' CE1' ' A' ' 63' ' ' TYR . 0.5 OUTLIER -122.1 114.28 30.84 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.754 -178.36 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -68.79 120.59 7.49 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 121.987 1.791 . . . . 0.0 110.284 178.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.459 ' CG1' ' CE2' ' A' ' 76' ' ' PHE . 2.2 p -142.51 153.43 17.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.973 0.416 . . . . 0.0 111.782 -178.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.5 m -97.05 125.52 41.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.886 178.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.525 ' CD2' ' HB3' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -130.74 161.23 32.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.442 0.639 . . . . 0.0 111.793 -179.506 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.646 ' C ' ' HD3' ' A' ' 79' ' ' PRO . 3.0 mm-40 -111.77 159.31 18.4 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.959 178.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -108.57 64.53 0.26 Allowed Glycine 0 CA--C 1.522 0.53 0 C-N-CA 120.251 -0.976 . . . . 0.0 114.004 -179.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.646 ' HD3' ' C ' ' A' ' 77' ' ' GLU . 14.0 Cg_exo -67.0 140.94 56.2 Favored 'Trans proline' 0 C--O 1.242 0.695 0 C-N-CA 122.326 2.017 . . . . 0.0 112.524 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 96' ' ' SER . . . -63.04 -60.16 8.02 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.276 -0.874 . . . . 0.0 112.514 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.425 HD12 ' HB3' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -120.06 122.29 40.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.997 0.427 . . . . 0.0 111.813 -179.877 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.45 ' HB ' ' CG1' ' A' ' 98' ' ' VAL . 17.8 t -128.66 122.7 57.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.406 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.64 107.83 5.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.635 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 32.7 m -77.46 122.34 31.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.026 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -69.69 150.28 47.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.172 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 3.3 tt0 -67.92 102.58 1.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.54 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 89' ' ' TYR . 2.8 p -143.74 160.81 40.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.581 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 56.39 -81.98 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.651 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.419 ' N ' ' O ' ' A' ' 87' ' ' SER . 0.3 OUTLIER -153.44 21.44 0.55 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.724 0.297 . . . . 0.0 111.161 -179.805 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.508 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 1.6 t80 -119.68 133.28 23.84 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.674 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.425 ' HD2' ' CD1' ' A' ' 90' ' ' TYR . 79.7 Cg_endo -77.3 148.58 27.05 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.856 2.371 . . . . 0.0 112.538 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.542 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.7 OUTLIER -55.36 89.24 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.631 179.819 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.91 -175.62 3.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.258 0.552 . . . . 0.0 112.119 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.425 ' HB3' HD12 ' A' ' 81' ' ' LEU . 15.8 m-85 -100.06 132.62 45.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.636 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.443 ' HA ' ' O ' ' A' ' 37' ' ' ASN . 0.8 OUTLIER -127.22 124.41 38.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.863 0.363 . . . . 0.0 111.24 -179.662 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 40.2 t -89.79 162.29 15.59 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.068 0.461 . . . . 0.0 111.905 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 44.39 56.93 4.66 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.741 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.616 ' O ' ' HD2' ' A' ' 79' ' ' PRO . 8.4 p -124.0 136.77 59.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.267 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.483 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 2.2 mp -101.92 149.19 24.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.332 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.712 ' HA ' ' O ' ' A' ' 132' ' ' VAL . 7.7 mt -127.69 132.51 49.64 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.343 -0.543 . . . . 0.0 112.213 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.525 ' HB3' ' CD2' ' A' ' 76' ' ' PHE . . . -128.14 132.28 48.93 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.535 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 1.8 t -93.34 115.31 27.88 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.945 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -102.13 -110.46 3.38 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.589 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -128.6 -53.24 1.25 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.886 0.374 . . . . 0.0 110.915 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 24.8 m -168.0 178.59 5.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.952 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -128.52 112.43 19.35 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.854 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.13 -46.36 2.3 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.401 2.068 . . . . 0.0 112.238 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 158.38 -46.37 0.45 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.553 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -66.81 129.62 40.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.827 0.346 . . . . 0.0 110.866 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -144.09 116.15 8.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.205 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 176.16 109.69 0.25 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.489 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 172.99 -171.62 44.56 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.551 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 25.9 pt -126.12 146.35 32.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.881 0.372 . . . . 0.0 111.245 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.483 ' HG ' ' HB ' ' A' ' 121' ' ' ILE . 23.3 tp -87.52 121.22 29.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.253 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 17.1 mtt85 -118.24 152.28 36.02 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.181 0.515 . . . . 0.0 111.999 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.5 ' HB2' HD11 ' A' ' 121' ' ' ILE . 5.6 t -118.75 164.24 15.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.086 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -58.54 -17.94 25.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.055 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.419 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . 14.9 m80 -94.89 -30.87 13.95 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.54 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 174.52 -135.93 3.32 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.516 -0.85 . . . . 0.0 112.811 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.526 ' HB ' ' HA ' ' A' ' 53' ' ' ILE . 5.4 t -105.48 134.99 45.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.653 0.263 . . . . 0.0 111.053 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.5 HD11 ' HB2' ' A' ' 116' ' ' CYS . 1.1 mm -93.62 -67.73 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.864 0.364 . . . . 0.0 110.983 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.429 ' HA3' ' O ' ' A' ' 135' ' ' ALA . . . -159.08 -143.03 3.54 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.843 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.31 164.15 28.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.852 0.358 . . . . 0.0 111.128 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 36.4 t -68.58 109.22 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.348 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.416 ' CG2' ' N ' ' A' ' 126' ' ' MET . 3.6 m -92.04 -90.83 0.17 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.4 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.488 ' O ' ' HA3' ' A' ' 133' ' ' GLY . 97.5 mmm -138.67 125.94 21.58 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.049 0.452 . . . . 0.0 111.301 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -110.22 131.25 10.33 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.593 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -70.04 -146.5 0.29 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.248 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -86.59 -19.38 29.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.698 0.285 . . . . 0.0 111.089 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -140.42 -9.97 0.73 Allowed Glycine 0 CA--C 1.522 0.473 0 C-N-CA 120.551 -0.833 . . . . 0.0 113.459 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 0.9 OUTLIER -115.74 157.56 16.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-N 117.241 0.52 . . . . 0.0 111.123 -179.704 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.712 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 20.2 t -114.61 118.33 58.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.109 -178.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.488 ' HA3' ' O ' ' A' ' 126' ' ' MET . . . -89.28 126.31 8.17 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.781 178.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.464 ' CZ ' ' CG1' ' A' ' 132' ' ' VAL . 40.2 m-85 -125.18 133.54 52.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.871 0.367 . . . . 0.0 111.586 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.429 ' O ' ' HA3' ' A' ' 122' ' ' GLY . . . -88.85 105.28 17.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.771 178.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.42 ' HB3' ' CD1' ' A' ' 99' ' ' LEU . 1.3 p30 -67.69 146.62 53.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.23 0.538 . . . . 0.0 112.181 -178.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.434 HG12 ' CD1' ' A' ' 140' ' ' LEU . 60.7 t -89.53 9.92 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.304 178.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.477 ' HA ' HD23 ' A' ' 141' ' ' LEU . 3.5 mmm180 -71.36 -7.02 44.41 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.566 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -99.87 11.13 40.04 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.594 0.235 . . . . 0.0 111.421 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.54 ' N ' ' CD1' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -174.98 40.53 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.016 0.436 . . . . 0.0 110.701 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.479 ' O ' ' N ' ' A' ' 143' ' ' LEU . 0.1 OUTLIER -57.75 -25.46 60.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.943 -0.572 . . . . 0.0 112.037 -179.557 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . 0.425 ' CD1' ' HA ' ' A' ' 140' ' ' LEU . 11.6 p-90 -47.22 88.12 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.039 0.447 . . . . 0.0 111.762 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.479 ' N ' ' O ' ' A' ' 141' ' ' LEU . 5.0 mp -153.02 -47.12 0.1 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.073 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.411 ' HB2' ' CG1' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -158.54 -169.92 2.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.755 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -59.05 133.02 55.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.953 0.406 . . . . 0.0 111.28 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -105.15 154.36 20.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.569 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.98 143.07 58.15 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.864 0.364 . . . . 0.0 111.059 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 1.5 mtm -89.33 145.82 25.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.957 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -143.58 -47.55 0.29 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.818 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.894 179.961 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.228 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 -28.37 25.32 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.572 2.181 . . . . 0.0 112.328 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -101.7 119.14 38.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.874 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -140.85 162.67 26.68 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.445 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -175.94 -40.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.798 0.332 . . . . 0.0 110.922 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -73.49 64.81 0.88 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.895 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 54.0 p -115.74 -37.37 3.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.921 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 97.24 83.98 1.72 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.484 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -151.84 159.47 43.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.829 0.347 . . . . 0.0 111.165 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.7 t -103.37 115.85 46.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.955 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.47 ' CE2' HG21 ' A' ' 45' ' ' THR . 5.7 t80 -104.18 115.91 31.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.808 0.337 . . . . 0.0 110.659 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.465 ' HB ' ' CD2' ' A' ' 143' ' ' LEU . 57.6 t -121.17 112.64 36.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.652 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 50.54 -126.22 24.01 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.98 -0.629 . . . . 0.0 113.379 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.449 ' O ' ' HA ' ' A' ' 44' ' ' THR . 4.5 m-20 -91.01 17.97 7.29 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.656 0.265 . . . . 0.0 111.589 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -130.49 127.74 39.8 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.04 114.74 22.46 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 121.024 -0.27 . . . . 0.0 110.888 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 0.7 OUTLIER -99.64 121.9 50.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-O 120.984 0.421 . . . . 0.0 110.453 179.585 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.445 HG22 ' HB3' ' A' ' 22' ' ' LEU . 9.6 p -136.29 159.99 38.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.306 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -59.96 141.74 55.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.289 179.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.403 ' HA ' HD13 ' A' ' 41' ' ' LEU . 48.7 ttt-85 -56.17 -47.35 78.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.814 0.34 . . . . 0.0 110.774 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -69.2 -8.42 45.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.968 179.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.445 ' HB3' HG22 ' A' ' 18' ' ' VAL . 16.7 tp -110.59 -12.59 14.33 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.497 ' O ' ' CZ3' ' A' ' 28' ' ' TRP . . . -66.97 150.73 48.82 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 120.896 0.379 . . . . 0.0 110.796 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.19 170.02 8.11 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.395 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 56.6 p-80 -54.76 -29.76 54.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.914 0.388 . . . . 0.0 110.954 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.4 p -76.25 -31.21 20.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.559 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.25 -44.24 79.91 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.497 ' CZ3' ' O ' ' A' ' 23' ' ' ALA . 5.0 m-90 -74.82 -30.45 61.4 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.33 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -58.62 -43.37 89.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.609 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -118.36 39.56 3.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.555 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.464 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 30.4 p -79.97 126.74 31.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.312 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.42 HG22 ' N ' ' A' ' 33' ' ' TRP . 16.3 m -88.29 -39.16 12.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.543 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.447 ' CE3' HG21 ' A' ' 42' ' ' VAL . 0.5 OUTLIER -139.61 150.16 44.65 Favored 'General case' 0 CA--C 1.53 0.212 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.067 179.905 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -149.93 110.89 4.34 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.722 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.44 ' HB2' ' CZ2' ' A' ' 33' ' ' TRP . 27.4 t0 -107.23 112.88 25.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.88 0.371 . . . . 0.0 111.06 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -67.4 -34.82 78.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.076 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.434 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 0.3 OUTLIER -64.3 -20.24 65.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.845 179.718 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -115.11 0.96 13.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.316 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 46.58 35.12 2.75 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 121.221 0.534 . . . . 0.0 110.175 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 28.4 tp -131.84 153.46 50.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.911 -179.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.493 ' CD2' ' O ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -146.43 155.73 42.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.177 179.648 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.447 HG21 ' CE3' ' A' ' 33' ' ' TRP . 33.9 t -119.11 127.97 75.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.288 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.9 p -122.3 157.17 32.32 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.787 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 14' ' ' ASN . 25.1 p -97.57 145.09 26.59 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.216 0.531 . . . . 0.0 111.614 -179.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.47 HG21 ' CE2' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -137.4 171.76 14.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.907 -179.139 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.0 t -121.18 34.75 5.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.848 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -113.81 175.14 5.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.164 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.2 m80 -82.84 148.09 27.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.9 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.417 ' HA2' ' CE1' ' A' ' 11' ' ' TYR . . . -100.69 -174.18 29.48 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.563 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.9 t -165.06 -43.41 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.842 0.353 . . . . 0.0 110.879 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -74.15 137.17 43.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.973 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 81.0 m -122.66 123.55 41.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.499 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.499 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 1.0 OUTLIER -74.09 139.51 19.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.804 0.335 . . . . 0.0 110.689 179.915 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -95.21 128.2 41.87 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.008 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -94.67 36.09 1.19 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.584 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 20.6 p -99.98 167.25 10.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.981 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -117.22 28.64 8.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.468 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 14.0 m -62.18 120.44 10.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.753 0.311 . . . . 0.0 110.704 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.4 t -69.35 -13.37 62.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.947 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -117.71 126.56 52.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.21 0.529 . . . . 0.0 111.464 -179.664 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.491 ' O ' ' HA ' ' A' ' 73' ' ' PRO . . . -135.83 -153.78 6.74 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.114 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 11.2 p -140.08 131.31 31.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 117.26 0.53 . . . . 0.0 111.649 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -109.69 150.74 27.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.741 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -74.14 125.68 28.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.098 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -88.77 139.33 30.58 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.716 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -92.06 -40.27 11.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.188 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -85.81 -28.83 24.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.166 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.3 mmtt -92.17 -24.56 19.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.295 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 55.94 29.21 13.84 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.995 0.426 . . . . 0.0 110.482 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.2 mtpp -134.37 170.54 15.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.845 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 35.0 m80 -83.91 117.09 23.11 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.993 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -111.22 114.38 53.47 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.296 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.491 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 6.3 Cg_exo -78.27 125.89 7.36 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.459 2.106 . . . . 0.0 111.834 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.462 ' CG1' ' CE2' ' A' ' 76' ' ' PHE . 2.3 p -136.77 153.03 29.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.945 0.403 . . . . 0.0 111.745 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.518 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 0.0 OUTLIER -95.35 133.52 39.18 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.493 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.503 ' CD1' ' N ' ' A' ' 76' ' ' PHE . 0.0 OUTLIER -135.28 166.5 22.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.507 0.67 . . . . 0.0 111.955 -178.886 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.668 ' C ' ' HD3' ' A' ' 79' ' ' PRO . 1.8 mp0 -111.71 159.54 18.14 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.121 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -108.42 62.23 0.3 Allowed Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.044 -1.074 . . . . 0.0 114.191 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.668 ' HD3' ' C ' ' A' ' 77' ' ' GLU . 15.1 Cg_exo -67.01 142.52 62.2 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.075 1.85 . . . . 0.0 111.948 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -64.83 -90.67 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.739 -0.664 . . . . 0.0 113.016 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.475 HD12 ' HB3' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -85.08 129.99 34.7 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.031 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.429 ' HB ' ' CG1' ' A' ' 98' ' ' VAL . 98.7 t -138.75 126.04 26.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.478 178.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -72.35 107.86 5.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.944 0.402 . . . . 0.0 111.598 -178.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 4.1 p -73.11 114.27 12.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.959 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -73.01 149.39 43.3 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.546 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.559 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 1.0 OUTLIER -69.34 101.89 1.62 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.644 179.923 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.457 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -144.45 152.81 41.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.129 179.761 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 53.56 -82.85 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.558 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.457 ' N ' ' O ' ' A' ' 87' ' ' SER . 0.4 OUTLIER -146.38 18.65 1.36 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.693 0.283 . . . . 0.0 111.047 179.905 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.559 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 1.2 m-85 -106.9 136.54 19.43 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.315 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.429 ' HA ' ' HG2' ' A' ' 86' ' ' GLU . 95.2 Cg_endo -84.37 148.33 11.5 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.917 2.411 . . . . 0.0 112.954 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -65.05 77.58 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.518 179.547 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.445 ' O ' HG13 ' A' ' 84' ' ' VAL . 46.8 mtt180 -123.69 -174.75 3.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.126 0.489 . . . . 0.0 111.912 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.475 ' HB3' HD12 ' A' ' 81' ' ' LEU . 19.5 m-85 -99.14 132.26 44.58 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.841 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.434 ' HA ' ' O ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -131.22 126.74 36.33 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.098 -179.867 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 44.4 t -101.55 158.54 16.0 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.087 0.47 . . . . 0.0 111.803 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.403 ' CE1' ' HB2' ' A' ' 138' ' ' ARG . 0.0 OUTLIER 64.71 56.53 1.15 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.645 179.338 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.522 ' O ' ' HD2' ' A' ' 79' ' ' PRO . 9.5 p -123.53 141.81 42.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.994 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.435 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 11.0 mp -104.95 147.96 27.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.315 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.582 ' HA ' ' O ' ' A' ' 132' ' ' VAL . 6.8 mt -133.08 131.5 40.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.069 0.461 . . . . 0.0 112.183 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.456 ' O ' ' HA ' ' A' ' 131' ' ' VAL . . . -135.65 147.64 48.67 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.749 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.5 t -105.33 134.35 48.59 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.982 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -103.57 -75.33 1.05 Allowed Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.494 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -146.54 -60.97 0.3 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.853 0.359 . . . . 0.0 110.905 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -177.38 73.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.888 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 60.77 84.23 0.2 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.913 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -68.67 -27.69 31.86 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.483 2.122 . . . . 0.0 112.311 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -179.25 -158.35 21.4 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.528 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -144.41 32.32 1.2 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.809 0.337 . . . . 0.0 110.914 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -164.99 95.22 0.68 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.089 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -107.79 -169.23 21.67 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.498 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -123.71 -107.72 1.81 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.719 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 18.0 pt -126.11 146.72 31.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.829 0.347 . . . . 0.0 111.156 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.513 ' HG ' ' HB ' ' A' ' 121' ' ' ILE . 15.6 tp -87.14 115.49 24.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.126 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.05 150.94 38.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.059 0.457 . . . . 0.0 111.501 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.441 ' HB2' HD11 ' A' ' 121' ' ' ILE . 5.7 t -114.57 162.34 16.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.279 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -56.22 -19.47 13.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.919 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -92.26 -34.34 14.29 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.457 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 178.03 -140.03 4.47 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.345 -0.931 . . . . 0.0 113.145 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.499 ' HB ' ' HA ' ' A' ' 53' ' ' ILE . 4.0 t -102.1 135.58 38.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.705 0.288 . . . . 0.0 111.287 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.513 ' HB ' ' HG ' ' A' ' 114' ' ' LEU . 1.1 mm -98.4 -67.15 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.896 0.379 . . . . 0.0 110.735 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.416 ' HA2' ' CG2' ' A' ' 137' ' ' VAL . . . -159.88 -166.43 18.75 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.667 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -116.93 164.08 15.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.789 0.328 . . . . 0.0 110.698 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 7.7 m -65.6 128.94 29.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.453 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.431 ' CG2' ' N ' ' A' ' 126' ' ' MET . 2.5 m -111.09 -89.08 0.5 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.344 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.478 ' O ' ' HA3' ' A' ' 133' ' ' GLY . 0.8 OUTLIER -130.44 125.77 35.3 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.934 0.397 . . . . 0.0 111.409 179.915 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -110.71 151.19 17.68 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.47 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -110.04 -153.23 14.1 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.578 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -93.98 17.28 12.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.595 0.236 . . . . 0.0 111.239 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -168.74 -28.25 0.02 OUTLIER Glycine 0 CA--C 1.52 0.357 0 C-N-CA 120.527 -0.844 . . . . 0.0 113.182 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 101' ' ' ALA . 1.6 t -115.48 157.27 16.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.802 0.301 . . . . 0.0 111.038 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.582 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 10.0 m -114.73 118.86 59.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.658 -179.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.478 ' HA3' ' O ' ' A' ' 126' ' ' MET . . . -95.59 117.93 5.78 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.39 -0.909 . . . . 0.0 112.177 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.469 ' CZ ' ' HB ' ' A' ' 132' ' ' VAL . 13.5 m-85 -122.2 144.2 49.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.95 0.405 . . . . 0.0 111.512 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -89.34 111.06 21.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.076 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -68.34 147.34 52.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.01 0.433 . . . . 0.0 111.836 -179.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.463 ' CG1' ' O ' ' A' ' 137' ' ' VAL . 97.9 t -91.26 11.03 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.438 179.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.483 ' HA ' HD23 ' A' ' 141' ' ' LEU . 12.8 mmm180 -70.14 -6.93 37.61 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.748 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -98.26 11.11 38.98 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 111.706 0.261 . . . . 0.0 111.706 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.526 ' N ' ' CD1' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -175.03 39.07 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.202 0.525 . . . . 0.0 110.471 179.81 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.492 HD11 ' HB ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -56.77 -20.86 24.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.32 -179.608 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . 0.417 ' CD1' ' HA ' ' A' ' 140' ' ' LEU . 12.7 p-90 -55.68 85.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.941 0.4 . . . . 0.0 111.45 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.465 ' CD2' ' HB ' ' A' ' 12' ' ' VAL . 4.2 mp -146.0 -48.16 0.21 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.309 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -151.12 -173.21 4.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.676 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -58.93 136.01 57.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.92 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -82.95 154.1 24.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.916 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -81.94 145.2 30.43 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.069 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 2.0 ttm 60.97 67.64 0.8 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.933 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -73.53 -63.82 1.12 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.836 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.855 179.981 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.169 0 N-CA-C 112.577 -0.209 . . . . 0.0 112.577 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.31 -176.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.626 2.217 . . . . 0.0 112.259 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -154.26 141.76 19.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.776 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 76.71 67.12 1.72 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.422 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -148.12 126.36 12.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.854 0.359 . . . . 0.0 110.863 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -133.16 40.89 3.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.855 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.7 m 62.11 170.87 0.13 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.946 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 158.61 -28.51 0.43 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.499 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -170.18 -174.28 1.7 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.772 0.32 . . . . 0.0 111.157 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.4 t -106.73 108.24 24.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.033 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.443 ' CE2' HG22 ' A' ' 45' ' ' THR . 6.5 t80 -98.11 116.53 30.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.688 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.436 ' HB ' ' CD2' ' A' ' 143' ' ' LEU . 41.7 t -120.58 108.83 23.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.587 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 51.59 -127.78 31.18 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.955 -0.64 . . . . 0.0 113.304 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.448 ' O ' ' HA ' ' A' ' 44' ' ' THR . 0.9 OUTLIER -88.88 14.27 10.78 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.572 0.225 . . . . 0.0 111.599 -179.637 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.454 ' CE2' ' CE3' ' A' ' 142' ' ' TRP . 6.1 m-30 -130.34 128.01 40.6 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.49 114.68 23.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.66 0.267 . . . . 0.0 111.018 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 0.8 OUTLIER -99.13 122.49 50.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 121.032 0.444 . . . . 0.0 110.401 179.48 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.434 ' O ' HD21 ' A' ' 41' ' ' LEU . 12.6 p -135.42 161.49 39.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.256 -179.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -60.94 141.74 57.0 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.2 -47.03 79.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.824 0.345 . . . . 0.0 110.838 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -71.05 -6.93 42.79 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.151 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 52.4 mt -112.66 -3.68 14.24 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.493 ' O ' ' CZ3' ' A' ' 28' ' ' TRP . . . -77.13 151.0 35.55 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.865 0.364 . . . . 0.0 110.829 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.445 ' O ' ' CE3' ' A' ' 28' ' ' TRP . 1.2 t -102.89 166.64 10.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.133 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 30.1 t60 -54.04 -29.57 44.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.042 0.448 . . . . 0.0 110.345 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.5 t -72.07 -31.18 39.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.019 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.46 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 0.4 OUTLIER -67.43 -44.14 79.47 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.941 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.493 ' CZ3' ' O ' ' A' ' 23' ' ' ALA . 11.7 m-90 -73.9 -35.46 64.65 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.078 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.62 -38.62 72.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.045 0.45 . . . . 0.0 110.503 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -119.37 27.73 8.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.755 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 8.7 t -73.58 122.8 22.82 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.964 0.412 . . . . 0.0 110.863 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.418 HG22 ' N ' ' A' ' 33' ' ' TRP . 13.1 m -86.57 -39.77 13.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.515 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.475 ' CE3' HG23 ' A' ' 42' ' ' VAL . 0.5 OUTLIER -139.71 153.12 47.14 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.172 -179.893 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -156.82 121.28 4.44 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.813 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.409 ' HB2' ' CZ2' ' A' ' 33' ' ' TRP . 17.6 m-20 -107.05 116.86 32.66 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.23 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -67.24 -36.88 82.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.963 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.515 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 3.8 m-20 -72.41 -14.15 61.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.863 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 mtt85 -115.54 -3.77 12.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.777 -0.192 . . . . 0.0 111.274 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 46.91 42.15 11.79 Favored 'General case' 0 CA--C 1.524 -0.046 0 CA-C-O 121.216 0.532 . . . . 0.0 110.038 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.4 HD11 ' N ' ' A' ' 18' ' ' VAL . 29.3 tp -136.17 152.42 50.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.906 -178.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.621 ' O ' HD23 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -147.33 150.79 35.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.042 0.449 . . . . 0.0 111.194 179.408 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.475 HG23 ' CE3' ' A' ' 33' ' ' TRP . 31.0 t -114.54 126.75 72.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.403 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.9 p -117.87 157.28 26.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.416 178.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.448 ' HA ' ' O ' ' A' ' 14' ' ' ASN . 18.9 p -97.71 140.79 31.58 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.119 0.485 . . . . 0.0 111.701 -179.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.443 HG22 ' CE2' ' A' ' 11' ' ' TYR . 0.2 OUTLIER -135.29 168.94 18.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.875 -179.335 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.2 p -121.69 61.9 0.93 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.832 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.24 169.7 17.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.125 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 4.9 m170 -86.56 128.57 34.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.876 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -87.43 -179.48 48.13 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.489 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 73.3 m -144.09 -46.94 0.27 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.77 0.319 . . . . 0.0 110.892 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -64.25 138.88 58.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.939 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 83.2 m -122.7 121.05 35.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.509 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.517 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 0.4 OUTLIER -74.24 139.36 19.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.928 0.394 . . . . 0.0 111.211 -179.677 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.419 ' HB1' ' HB2' ' A' ' 118' ' ' HIS . . . -95.7 123.65 39.36 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.942 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -91.2 37.29 0.94 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.621 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 24.5 p -99.85 167.1 10.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.952 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -119.1 33.53 5.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.32 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 35.5 m -62.76 141.85 58.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.627 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -85.28 3.1 41.12 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.024 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.1 p -125.9 168.05 14.42 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.103 0.478 . . . . 0.0 111.117 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -179.44 -173.14 44.34 Favored Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.583 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.2 p -140.22 125.83 20.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 117.044 0.422 . . . . 0.0 111.225 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 63' ' ' TYR . 6.2 p90 -109.12 137.99 46.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.743 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.9 145.64 50.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.049 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 1.6 t -113.77 150.95 32.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.882 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.95 -45.14 8.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.237 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -70.76 -41.36 71.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.879 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.538 ' HG2' ' HD3' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -86.16 -28.57 23.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.979 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.0 p 58.75 37.15 25.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.181 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.538 ' HD3' ' HG2' ' A' ' 68' ' ' LYS . 1.3 ptmt -140.61 169.57 17.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.011 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -84.61 119.93 25.78 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.05 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.452 ' HE1' ' CG ' ' A' ' 70' ' ' LYS . 2.7 m-85 -108.59 113.86 59.52 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.512 -179.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.34 120.78 5.77 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.589 2.192 . . . . 0.0 111.024 178.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.455 ' CG1' ' HB3' ' A' ' 101' ' ' ALA . 54.5 t -134.83 141.78 42.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.977 0.418 . . . . 0.0 111.765 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 16.7 m -91.84 121.64 33.64 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.468 ' HB3' ' HB2' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -127.96 165.19 20.73 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.526 0.679 . . . . 0.0 111.947 -178.629 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.552 ' C ' ' HD3' ' A' ' 79' ' ' PRO . 10.7 mt-10 -111.72 158.83 18.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.899 178.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.453 ' HA2' ' HG ' ' A' ' 99' ' ' LEU . . . -112.16 68.6 0.23 Allowed Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.124 -1.036 . . . . 0.0 113.961 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.579 ' HD2' ' O ' ' A' ' 98' ' ' VAL . 15.7 Cg_exo -67.36 142.08 58.68 Favored 'Trans proline' 0 C--O 1.238 0.503 0 C-N-CA 122.22 1.946 . . . . 0.0 111.797 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -57.98 -91.73 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.538 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.411 HD11 ' HB3' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -94.37 119.82 33.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.91 0.386 . . . . 0.0 111.876 -179.587 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.429 ' HB ' ' CG1' ' A' ' 98' ' ' VAL . 61.7 t -122.76 122.62 66.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.923 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -72.43 107.62 5.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.859 0.362 . . . . 0.0 110.741 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.557 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 30.4 t -75.77 114.3 15.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.624 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.433 ' HA ' ' HD3' ' A' ' 92' ' ' LYS . 1.5 tt0 -71.86 150.02 44.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.032 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 0.8 OUTLIER -67.88 101.34 1.07 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.158 0.504 . . . . 0.0 110.159 -179.475 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.508 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.3 OUTLIER -144.65 175.7 9.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.839 -179.913 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 42.96 -86.23 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.787 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.508 ' N ' ' O ' ' A' ' 87' ' ' SER . 0.3 OUTLIER -150.56 23.5 0.8 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.825 0.345 . . . . 0.0 110.485 179.686 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.458 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -117.92 138.15 25.11 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.867 -179.704 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.427 ' O ' ' N ' ' A' ' 93' ' ' ARG . 93.7 Cg_endo -78.77 148.61 22.69 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.821 2.347 . . . . 0.0 112.247 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.557 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -60.9 79.9 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.866 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.427 ' N ' ' O ' ' A' ' 91' ' ' PRO . 1.5 ttp85 -123.65 177.41 5.7 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.692 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.411 ' HB3' HD11 ' A' ' 81' ' ' LEU . 10.6 m-85 -91.29 132.6 36.04 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.777 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.515 ' HA ' ' O ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -125.46 116.84 22.46 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.654 -179.571 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.0 t -91.53 154.4 19.12 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 120.92 0.391 . . . . 0.0 111.45 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 53.72 62.46 2.61 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.336 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.579 ' O ' ' HD2' ' A' ' 79' ' ' PRO . 5.9 p -123.35 152.28 28.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.1 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.453 ' HG ' ' HA2' ' A' ' 78' ' ' GLY . 5.5 mp -116.43 140.27 49.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.205 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.528 ' HA ' ' O ' ' A' ' 132' ' ' VAL . 5.5 mt -133.23 142.06 48.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.268 0.556 . . . . 0.0 112.456 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.477 ' O ' ' HA ' ' A' ' 131' ' ' VAL . . . -151.97 161.06 43.23 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.412 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.1 t -118.92 129.45 55.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.947 0.403 . . . . 0.0 111.004 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -70.64 -141.23 0.19 Allowed Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.493 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -155.5 -45.93 0.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.891 0.377 . . . . 0.0 110.937 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.42 107.12 9.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.788 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 61.92 114.21 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.916 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -68.94 -38.23 10.01 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.473 2.116 . . . . 0.0 112.27 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.11 161.02 24.52 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.504 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.69 -68.27 0.52 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.867 0.365 . . . . 0.0 110.914 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -101.94 -171.32 1.95 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.179 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -136.98 -45.71 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.494 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 84.67 -123.9 6.47 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.517 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 28.4 pt -126.15 144.21 37.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.782 0.325 . . . . 0.0 111.17 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.454 ' HG ' ' HB ' ' A' ' 121' ' ' ILE . 10.8 tp -87.9 113.99 24.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.208 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 3.1 mtm180 -114.1 143.24 45.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.098 0.475 . . . . 0.0 111.554 -179.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.507 ' HB2' HD11 ' A' ' 121' ' ' ILE . 6.9 t -107.79 164.28 12.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.191 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -56.14 -20.35 17.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.788 0.328 . . . . 0.0 110.723 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.419 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . 26.7 m80 -89.59 -35.86 15.64 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.325 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 177.46 -136.36 3.06 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.854 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.517 ' HB ' ' HA ' ' A' ' 53' ' ' ILE . 3.8 t -102.88 135.38 40.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.685 0.279 . . . . 0.0 110.926 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.507 HD11 ' HB2' ' A' ' 116' ' ' CYS . 1.0 OUTLIER -94.59 -69.9 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.698 0.285 . . . . 0.0 111.248 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.443 ' HA3' ' O ' ' A' ' 135' ' ' ALA . . . -150.95 -160.09 9.2 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.381 -0.914 . . . . 0.0 113.236 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.38 164.48 17.01 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.737 0.303 . . . . 0.0 110.85 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 9.9 p -62.31 121.52 11.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.838 0.351 . . . . 0.0 111.796 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.451 ' CG2' ' N ' ' A' ' 126' ' ' MET . 3.0 m -112.17 -91.31 0.49 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.075 179.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.451 ' N ' ' CG2' ' A' ' 125' ' ' THR . 0.0 OUTLIER -92.58 160.4 15.04 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 120.787 0.327 . . . . 0.0 110.743 179.517 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -150.03 88.66 0.14 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.442 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -77.32 -176.59 44.81 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.429 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.79 -19.32 62.02 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.667 0.27 . . . . 0.0 111.015 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -142.03 -6.3 0.8 Allowed Glycine 0 CA--C 1.522 0.482 0 C-N-CA 120.598 -0.81 . . . . 0.0 113.447 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -115.82 157.17 16.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 117.322 0.561 . . . . 0.0 111.306 -179.764 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.528 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 13.1 m -119.73 118.69 57.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.5 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -100.99 120.06 6.75 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.728 -0.749 . . . . 0.0 111.9 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.47 ' CZ ' ' HB ' ' A' ' 132' ' ' VAL . 18.3 m-85 -125.13 136.72 53.9 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.914 0.387 . . . . 0.0 112.02 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.443 ' O ' ' HA3' ' A' ' 122' ' ' GLY . . . -88.86 114.22 25.25 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.198 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -67.79 141.16 56.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.975 0.417 . . . . 0.0 111.858 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.454 ' CG1' ' O ' ' A' ' 137' ' ' VAL . 88.9 t -89.31 9.72 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.615 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.74 -6.68 39.21 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.599 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -95.93 11.05 35.27 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 120.685 0.279 . . . . 0.0 111.317 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.572 ' N ' ' CD1' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -177.98 57.28 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.083 0.468 . . . . 0.0 110.484 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.469 ' O ' ' N ' ' A' ' 143' ' ' LEU . 0.1 OUTLIER -74.83 -14.83 60.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.883 -179.572 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . 0.454 ' CE3' ' CE2' ' A' ' 15' ' ' TYR . 13.2 p-90 -55.99 82.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.896 0.379 . . . . 0.0 111.261 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.469 ' N ' ' O ' ' A' ' 141' ' ' LEU . 5.1 mp -149.67 -45.67 0.13 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.466 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.424 ' HB2' ' CG1' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -154.35 -167.44 2.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.747 179.832 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -58.88 141.03 54.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.0 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 15.4 p30 -94.97 154.07 17.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.832 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -98.39 126.18 43.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.904 0.383 . . . . 0.0 111.156 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 3.0 ptt? -132.39 -179.56 5.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.885 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -135.83 169.73 17.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.925 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 . . . . . 0 C--O 1.251 1.144 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.851 -179.954 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 112.539 -0.225 . . . . 0.0 112.539 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -52.99 -61.94 0.41 Allowed 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.535 2.156 . . . . 0.0 112.349 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 23.3 t80 68.4 -67.52 0.2 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.924 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -155.28 -44.17 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.573 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 10.6 p80 -108.38 144.62 35.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.803 0.335 . . . . 0.0 110.873 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 60.89 111.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.933 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.0 m -127.6 31.42 5.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.904 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.8 60.38 0.18 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.519 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -157.12 170.5 22.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.801 0.334 . . . . 0.0 111.047 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.0 t -107.4 116.23 50.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.013 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.453 ' CZ ' HG21 ' A' ' 45' ' ' THR . 0.3 OUTLIER -98.02 115.52 28.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.604 179.889 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.42 ' HB ' ' CD2' ' A' ' 143' ' ' LEU . 17.3 t -121.47 108.8 23.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.525 179.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 48.21 -124.64 11.41 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.928 -0.653 . . . . 0.0 113.098 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -92.43 17.94 9.2 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.734 0.302 . . . . 0.0 111.403 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.411 ' CE2' ' CE3' ' A' ' 142' ' ' TRP . 4.9 m-30 -130.31 144.4 51.36 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.422 ' HG3' ' CD1' ' A' ' 11' ' ' TYR . 18.6 ttpt -133.83 118.26 17.79 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.702 0.287 . . . . 0.0 110.994 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -104.39 122.07 56.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.117 0.485 . . . . 0.0 110.434 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.491 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 14.0 p -136.01 162.0 37.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.033 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -58.53 141.24 52.52 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.418 ' O ' ' HZ2' ' A' ' 28' ' ' TRP . 13.9 mtm105 -56.45 -47.82 78.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.916 0.389 . . . . 0.0 111.17 -179.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -69.52 -7.62 39.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.441 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.9 tp -115.33 5.73 14.72 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.441 ' HB3' ' NE1' ' A' ' 28' ' ' TRP . . . -89.27 131.89 35.16 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.353 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.553 ' O ' ' HD1' ' A' ' 28' ' ' TRP . 44.1 p -74.76 162.5 28.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.469 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -53.66 -29.64 39.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.886 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.8 t -69.57 -31.94 50.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.915 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.425 ' O ' ' HB3' ' A' ' 31' ' ' CYS . 13.5 m-20 -67.72 -44.07 78.51 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.553 ' HD1' ' O ' ' A' ' 24' ' ' THR . 33.8 m95 -73.57 -29.88 62.69 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.594 179.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -58.8 -43.92 90.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.575 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -118.15 30.13 7.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.832 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.487 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 29.5 p -69.17 122.93 19.81 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.949 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.418 HG21 ' N ' ' A' ' 33' ' ' TRP . 17.7 m -86.2 -39.74 13.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.434 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.476 ' CE3' HG22 ' A' ' 42' ' ' VAL . 1.0 OUTLIER -139.66 153.25 47.25 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.08 179.689 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -160.44 115.92 2.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.008 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -107.19 117.75 34.9 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.936 0.398 . . . . 0.0 111.136 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -62.26 -48.84 78.14 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.353 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -59.9 -19.09 49.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.134 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -108.38 -8.02 15.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.276 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.4 t70 49.49 43.22 23.63 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 121.088 0.47 . . . . 0.0 110.224 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.0 tp -137.1 154.15 50.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.126 -178.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.572 ' N ' ' CD2' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -151.86 137.18 17.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.115 0.484 . . . . 0.0 111.131 179.555 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.476 HG22 ' CE3' ' A' ' 33' ' ' TRP . 34.3 t -100.96 130.58 50.11 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.406 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.4 p -123.19 157.45 32.99 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.261 -0.882 . . . . 0.0 109.435 178.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 19.4 p -97.21 134.48 40.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.235 0.54 . . . . 0.0 111.395 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.453 HG21 ' CZ ' ' A' ' 11' ' ' TYR . 0.5 OUTLIER -102.49 -29.56 11.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.026 -179.126 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.0 m 66.61 31.43 7.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.738 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -142.96 -167.78 2.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.017 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.85 144.94 43.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.827 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -72.65 -140.51 0.37 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.42 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.1 m -172.09 -44.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.693 0.282 . . . . 0.0 111.05 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -117.23 163.3 16.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.2 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 73.9 m -125.28 122.5 37.09 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.664 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.51 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 0.4 OUTLIER -75.29 139.52 18.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.03 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.408 ' HA ' ' HB3' ' A' ' 147' ' ' ALA . . . -94.57 128.45 41.2 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.061 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.439 ' HB3' ' HB3' ' A' ' 146' ' ' ASP . 0.0 OUTLIER -92.31 33.69 1.08 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.683 179.576 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 26.7 p -99.49 166.96 10.91 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.905 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -121.85 33.41 5.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.241 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 34.4 m -60.44 127.37 31.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.776 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.85 -9.32 58.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.994 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.9 p -117.84 124.0 47.28 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.008 0.432 . . . . 0.0 111.109 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.07 178.88 20.44 Favored Glycine 0 N--CA 1.452 -0.299 0 N-CA-C 111.632 -0.587 . . . . 0.0 111.632 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.465 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 8.3 p -119.28 124.83 73.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.205 0.526 . . . . 0.0 111.362 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -105.52 -173.94 2.42 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.433 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.467 ' CG ' ' HB3' ' A' ' 67' ' ' SER . 0.6 OUTLIER 67.88 -90.03 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.134 179.739 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 69.37 -65.44 0.3 Allowed 'General case' 0 C--O 1.231 0.085 0 CA-C-O 120.785 0.326 . . . . 0.0 111.18 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -92.11 -39.55 11.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.695 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.467 ' HB3' ' CG ' ' A' ' 64' ' ' PHE . 20.9 t -46.37 -67.99 0.23 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.779 0.323 . . . . 0.0 111.37 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -86.51 8.72 20.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.141 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 65.62 12.85 8.55 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.731 0.301 . . . . 0.0 111.079 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.68 168.98 18.44 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.911 0.386 . . . . 0.0 110.677 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.414 ' HB2' HG21 ' A' ' 62' ' ' VAL . 7.8 p80 -92.14 116.68 29.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.504 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -105.68 112.4 64.57 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.039 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.465 ' HA ' ' HA ' ' A' ' 62' ' ' VAL . 2.8 Cg_endo -84.03 120.88 2.69 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.044 2.496 . . . . 0.0 111.658 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.517 ' CG1' ' CE2' ' A' ' 76' ' ' PHE . 2.5 p -137.52 153.79 28.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.504 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.0 m -94.78 127.68 40.95 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.517 ' CE2' ' CG1' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -131.53 162.71 29.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.379 0.609 . . . . 0.0 111.919 -179.416 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.441 ' O ' ' HA ' ' A' ' 99' ' ' LEU . 0.7 OUTLIER -111.83 158.86 18.9 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.142 178.987 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -104.82 65.48 0.3 Allowed Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.275 -0.964 . . . . 0.0 113.557 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 99' ' ' LEU . 41.9 Cg_endo -68.34 135.23 33.41 Favored 'Trans proline' 0 C--O 1.239 0.535 0 C-N-CA 122.263 1.975 . . . . 0.0 112.198 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -59.3 -85.26 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.245 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.455 HD13 ' CD2' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -97.38 119.5 36.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.993 0.425 . . . . 0.0 111.594 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.455 ' HB ' ' CG1' ' A' ' 98' ' ' VAL . 44.1 t -123.25 122.42 65.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.823 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.59 107.51 5.13 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.992 0.425 . . . . 0.0 110.67 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.438 HG22 ' HG3' ' A' ' 126' ' ' MET . 2.7 p -74.53 119.29 21.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.557 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.404 ' HA ' ' HG2' ' A' ' 92' ' ' LYS . 24.3 mt-30 -69.65 149.41 48.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.06 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.528 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 14.3 tt0 -68.63 102.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.625 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.425 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -143.66 158.64 43.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.382 -179.827 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.434 ' HG2' ' CD2' ' A' ' 89' ' ' TYR . 5.7 tt0 53.54 -84.78 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.709 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.434 ' CD2' ' HG2' ' A' ' 88' ' ' GLU . 0.2 OUTLIER -145.43 19.36 1.53 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.663 0.268 . . . . 0.0 111.146 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.528 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 1.4 t80 -113.85 137.5 22.34 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.737 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.468 ' O ' ' N ' ' A' ' 93' ' ' ARG . 90.3 Cg_endo -85.79 148.59 9.66 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.065 2.51 . . . . 0.0 112.569 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -55.94 82.28 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.873 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.468 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -123.84 174.29 7.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.168 0.509 . . . . 0.0 111.905 -179.477 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.455 ' CD2' HD13 ' A' ' 81' ' ' LEU . 3.8 m-85 -93.29 132.78 37.17 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.175 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -125.36 126.28 44.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.818 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 12.1 t -96.28 154.68 17.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.091 0.472 . . . . 0.0 111.983 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.456 ' CE1' ' HB3' ' A' ' 136' ' ' ASP . 1.6 t-80 57.82 57.52 4.14 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.922 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.455 ' CG1' ' HB ' ' A' ' 82' ' ' VAL . 11.1 p -123.72 141.07 45.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.528 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.463 ' O ' ' HA2' ' A' ' 133' ' ' GLY . 6.2 mp -104.03 141.47 36.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.947 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.62 ' HA ' ' O ' ' A' ' 132' ' ' VAL . 7.3 mt -125.92 136.39 52.99 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.453 ' O ' ' N ' ' A' ' 132' ' ' VAL . . . -143.65 142.84 31.19 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.684 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 1.6 t -98.26 133.41 42.72 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.864 0.364 . . . . 0.0 111.217 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.3 -134.2 5.55 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.507 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -115.71 -41.32 3.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.801 0.334 . . . . 0.0 110.842 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.88 152.26 38.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.87 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -88.28 147.91 41.34 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.891 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.47 -169.35 0.47 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.513 2.142 . . . . 0.0 112.355 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -112.0 -65.97 0.5 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.499 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -96.51 -29.42 13.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.799 0.333 . . . . 0.0 110.886 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 62.8 157.06 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.105 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 153.93 49.92 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.448 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -130.46 177.01 18.59 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.559 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 22.7 pt -126.25 146.39 32.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.806 0.336 . . . . 0.0 111.218 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.521 ' HG ' ' HB ' ' A' ' 121' ' ' ILE . 12.4 tp -87.43 117.05 25.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.175 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.15 153.11 34.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.111 0.481 . . . . 0.0 111.715 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.463 ' HB2' HD11 ' A' ' 121' ' ' ILE . 6.2 t -117.66 162.62 17.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.306 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -56.02 -20.86 18.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.926 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 18.4 m80 -90.19 -34.77 15.7 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.422 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 177.3 -139.13 4.2 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.026 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.51 ' HB ' ' HA ' ' A' ' 53' ' ' ILE . 4.0 t -102.0 135.5 38.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.759 0.314 . . . . 0.0 111.227 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.521 ' HB ' ' HG ' ' A' ' 114' ' ' LEU . 1.2 mm -94.49 -66.35 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.909 0.385 . . . . 0.0 110.631 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.42 ' HA2' ' CG2' ' A' ' 137' ' ' VAL . . . -164.05 -161.83 13.88 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.558 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -116.87 164.14 15.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.725 0.298 . . . . 0.0 110.631 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.445 ' HA ' ' CD1' ' A' ' 134' ' ' PHE . 29.4 m -73.89 129.33 36.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.91 0.386 . . . . 0.0 111.653 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.428 ' CG2' ' N ' ' A' ' 126' ' ' MET . 3.6 m -110.16 -94.25 0.43 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.129 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.572 ' O ' ' HA3' ' A' ' 133' ' ' GLY . 12.4 mmm -144.56 142.03 29.9 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.855 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -113.21 178.6 18.72 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.588 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -108.41 -139.38 8.81 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.499 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -72.5 -19.43 61.54 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.787 0.327 . . . . 0.0 111.095 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -165.64 19.17 0.1 Allowed Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.816 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 1.5 t -121.85 157.34 25.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.703 0.287 . . . . 0.0 110.576 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.62 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 12.2 m -115.4 118.39 58.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.825 -179.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.572 ' HA3' ' O ' ' A' ' 126' ' ' MET . . . -96.9 116.17 5.42 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.323 -0.942 . . . . 0.0 111.686 178.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.498 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 12.9 m-85 -116.2 141.66 47.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.994 0.426 . . . . 0.0 111.726 -179.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -88.89 109.36 20.16 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.066 178.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.456 ' HB3' ' CE1' ' A' ' 97' ' ' HIS . 0.6 OUTLIER -67.87 152.03 46.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.152 0.501 . . . . 0.0 111.984 -178.735 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.45 ' O ' HD13 ' A' ' 140' ' ' LEU . 48.0 t -99.33 9.39 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.843 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 5.9 mtm180 -72.29 -6.9 46.41 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.401 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -94.93 10.77 34.24 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.719 0.295 . . . . 0.0 110.846 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.573 ' N ' ' CD1' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -176.77 58.32 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.08 0.467 . . . . 0.0 110.303 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' A' ' 143' ' ' LEU . 0.1 OUTLIER -73.09 -14.86 61.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.914 -179.386 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . 0.411 ' CE3' ' CE2' ' A' ' 15' ' ' TYR . 15.8 p-90 -56.88 83.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.934 0.397 . . . . 0.0 111.476 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.449 ' N ' ' O ' ' A' ' 141' ' ' LEU . 4.8 mp -150.91 -47.0 0.12 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.614 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.412 ' HB2' ' CG1' ' A' ' 12' ' ' VAL . 0.4 OUTLIER -151.46 -166.81 2.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.065 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.48 149.09 50.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.369 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.439 ' HB3' ' HB3' ' A' ' 55' ' ' ARG . 9.6 m-20 -95.29 154.53 17.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.753 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.408 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . . . -63.81 144.85 56.72 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.897 0.379 . . . . 0.0 111.124 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 1.7 ptm 174.54 -33.28 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.758 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 67.75 85.56 0.14 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.852 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.146 -0.93 . . . . 0.0 110.909 -179.991 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.161 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.05 105.22 1.49 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.591 2.194 . . . . 0.0 112.318 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -79.42 121.34 25.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.951 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -137.53 113.08 0.97 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.552 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.2 m170 -110.72 -54.37 2.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.826 0.346 . . . . 0.0 110.878 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -139.78 -47.45 0.45 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.863 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -155.51 163.93 39.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.938 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -160.13 179.27 35.78 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.479 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.37 -174.35 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.813 0.34 . . . . 0.0 111.099 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 41.5 t -108.82 110.7 33.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.107 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.41 ' CE2' HG22 ' A' ' 45' ' ' THR . 5.2 t80 -99.73 116.32 31.55 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.791 0.329 . . . . 0.0 110.529 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.403 ' CG2' HD11 ' A' ' 53' ' ' ILE . 47.6 t -120.85 111.64 32.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.657 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.404 ' O ' ' CE1' ' A' ' 11' ' ' TYR . . . 53.0 -125.32 30.35 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.959 -0.639 . . . . 0.0 113.18 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.406 ' O ' ' HA ' ' A' ' 44' ' ' THR . 44.6 m-80 -91.93 18.73 7.44 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.701 0.286 . . . . 0.0 111.569 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.414 ' CE2' ' CE3' ' A' ' 142' ' ' TRP . 6.2 m-30 -130.35 149.94 51.81 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.5 tttp -139.09 114.87 10.02 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.709 -0.223 . . . . 0.0 110.629 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 0.6 OUTLIER -100.3 121.64 51.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.041 0.448 . . . . 0.0 110.77 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.409 HG23 ' HB3' ' A' ' 22' ' ' LEU . 7.3 p -136.43 160.26 37.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.037 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -62.26 141.51 58.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.227 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 8.4 ttp180 -56.27 -45.59 80.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.942 0.401 . . . . 0.0 110.85 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -66.85 -11.62 56.29 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.153 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.409 ' HB3' HG23 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -108.71 -13.41 14.79 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.735 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.505 ' O ' ' CZ3' ' A' ' 28' ' ' TRP . . . -68.74 150.72 47.56 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 120.796 0.331 . . . . 0.0 110.834 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.403 ' O ' ' CE3' ' A' ' 28' ' ' TRP . 32.6 p -104.59 168.94 8.75 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.269 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 52.5 p-80 -54.76 -29.68 54.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.002 0.43 . . . . 0.0 110.564 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.4 t -74.66 -31.36 26.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.459 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.413 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 0.6 OUTLIER -67.18 -43.98 80.84 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.505 ' CZ3' ' O ' ' A' ' 23' ' ' ALA . 7.2 m-90 -74.33 -30.37 62.01 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.145 179.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.15 -41.99 89.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.32 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -116.66 32.58 6.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.486 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.414 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 13.2 t -77.24 132.42 38.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.179 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.432 HG23 ' N ' ' A' ' 33' ' ' TRP . 16.8 m -96.06 -38.83 8.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.695 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.482 ' CE3' HG23 ' A' ' 42' ' ' VAL . 1.1 t90 -139.67 153.27 47.24 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.908 0.385 . . . . 0.0 111.548 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -155.69 120.51 4.74 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.79 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.444 ' HB2' ' CZ2' ' A' ' 33' ' ' TRP . 8.3 m-20 -107.09 99.2 8.77 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.038 0.447 . . . . 0.0 111.14 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -58.91 -28.92 66.66 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.8 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.675 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 0.9 OUTLIER -59.68 -38.74 82.35 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.755 -0.202 . . . . 0.0 111.301 -179.052 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.441 ' NH1' ' HB2' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -117.31 0.75 12.31 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 60.24 54.83 3.84 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.85 0.357 . . . . 0.0 111.892 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.441 ' HB2' ' NH1' ' A' ' 38' ' ' ARG . 38.3 tp -137.11 133.65 35.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.449 179.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.533 ' H ' HD22 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -131.44 156.0 46.38 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.053 0.454 . . . . 0.0 112.068 -179.526 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.482 HG23 ' CE3' ' A' ' 33' ' ' TRP . 23.7 t -117.17 130.08 72.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.062 179.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.4 p -120.49 157.15 30.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.57 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 14' ' ' ASN . 19.6 p -97.54 123.59 41.48 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.183 0.516 . . . . 0.0 111.493 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.41 HG22 ' CE2' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -98.28 -165.01 1.19 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.872 -179.429 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.0 t -138.86 42.35 2.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.856 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -136.03 -177.98 4.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.085 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -93.0 148.14 22.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.959 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -66.88 157.35 51.1 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.646 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -134.65 -49.17 0.76 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.872 0.368 . . . . 0.0 110.903 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -87.96 150.53 23.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.825 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 39.9 m -122.99 116.98 24.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.763 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.514 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 0.4 OUTLIER -74.62 139.55 19.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.048 0.452 . . . . 0.0 110.968 -179.843 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -88.8 121.97 31.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.971 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.44 29.01 1.02 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.11 0.481 . . . . 0.0 110.12 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 30.8 p -100.0 163.27 12.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.091 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.426 ' O ' ' O ' ' A' ' 58' ' ' CYS . 44.4 mt-30 -93.56 -70.19 0.71 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 178.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.426 ' O ' ' O ' ' A' ' 57' ' ' GLN . 96.3 m 54.47 159.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.74 178.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.11 -7.53 11.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.951 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.478 ' HA ' ' HA ' ' A' ' 75' ' ' SER . 10.0 p -132.41 123.97 27.75 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.973 0.416 . . . . 0.0 111.344 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -136.99 161.64 25.16 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.64 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.41 HG21 ' HB2' ' A' ' 71' ' ' HIS . 7.3 p -102.52 132.91 47.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.951 0.405 . . . . 0.0 111.308 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.487 ' HB2' ' CZ ' ' A' ' 134' ' ' PHE . 3.5 p90 -118.66 133.99 55.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.949 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -68.4 132.69 47.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.902 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.4 ' CB ' ' HB2' ' A' ' 68' ' ' LYS . 0.8 OUTLIER -91.58 155.49 18.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.909 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -92.03 -36.29 13.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.058 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.2 t -90.69 -48.36 7.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.875 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.4 ' HB2' ' CB ' ' A' ' 65' ' ' CYS . 14.3 mmtt -63.38 -27.03 69.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.096 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.2 m 57.03 24.26 9.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.921 0.391 . . . . 0.0 110.738 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp -133.62 170.05 16.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.691 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.41 ' HB2' HG21 ' A' ' 62' ' ' VAL . 9.2 p80 -83.99 126.78 33.37 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -116.31 113.94 40.92 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.835 -178.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -77.34 120.67 5.37 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.473 2.115 . . . . 0.0 110.319 178.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.414 HG22 ' CE2' ' A' ' 63' ' ' TYR . 43.2 t -137.47 151.09 26.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.164 0.507 . . . . 0.0 112.365 -178.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.478 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 20.7 m -98.71 133.92 42.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.522 178.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.478 ' CD1' ' N ' ' A' ' 76' ' ' PHE . 0.0 OUTLIER -145.75 174.14 11.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.444 0.64 . . . . 0.0 112.122 -179.188 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.579 ' C ' ' HD3' ' A' ' 79' ' ' PRO . 0.3 OUTLIER -111.86 158.84 18.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.703 179.425 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.419 ' HA2' ' HG ' ' A' ' 99' ' ' LEU . . . -112.77 66.76 0.25 Allowed Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.235 -0.983 . . . . 0.0 113.642 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.579 ' HD3' ' C ' ' A' ' 77' ' ' GLU . 14.0 Cg_exo -67.46 139.95 50.91 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.376 2.05 . . . . 0.0 112.212 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -57.42 -90.22 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.432 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.451 HD11 ' HB3' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -95.69 119.92 35.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.912 0.387 . . . . 0.0 111.733 -179.756 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.476 ' HB ' ' CG1' ' A' ' 98' ' ' VAL . 18.8 t -124.2 122.45 64.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.149 178.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -72.57 107.89 5.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.482 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 4.8 m -72.77 123.73 28.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.855 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -69.29 150.28 47.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.669 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.568 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 22.8 tt0 -67.61 102.01 1.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.143 0.497 . . . . 0.0 110.373 -179.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 89' ' ' TYR . 4.1 m -144.3 164.08 31.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.188 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 55.93 -81.48 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.542 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.447 ' N ' ' O ' ' A' ' 87' ' ' SER . 0.7 OUTLIER -156.92 24.17 0.32 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.759 0.314 . . . . 0.0 110.877 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.568 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 1.6 t80 -122.69 131.62 24.35 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.695 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.473 ' O ' ' N ' ' A' ' 93' ' ' ARG . 87.0 Cg_endo -81.98 148.84 15.49 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.095 2.53 . . . . 0.0 112.524 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.505 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.4 OUTLIER -42.6 88.99 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.509 -179.931 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.473 ' N ' ' O ' ' A' ' 91' ' ' PRO . 2.0 ttt180 -123.93 171.08 9.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.219 0.533 . . . . 0.0 112.074 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.451 ' HB3' HD11 ' A' ' 81' ' ' LEU . 3.9 m-85 -98.88 132.84 43.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.131 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.675 ' HA ' ' O ' ' A' ' 37' ' ' ASN . 2.0 tp60 -126.43 114.89 18.78 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.893 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.408 ' CB ' ' HB3' ' A' ' 37' ' ' ASN . 60.7 p -80.07 144.0 33.52 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.114 0.483 . . . . 0.0 111.875 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 21.7 m80 61.96 60.83 1.47 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.998 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.532 ' O ' ' HD2' ' A' ' 79' ' ' PRO . 7.1 p -124.17 131.06 73.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.721 0.296 . . . . 0.0 111.266 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.419 ' HG ' ' HA2' ' A' ' 78' ' ' GLY . 2.2 mp -101.76 149.16 24.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.976 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.666 ' HA ' ' O ' ' A' ' 132' ' ' VAL . 9.0 mt -128.69 136.37 50.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.161 0.505 . . . . 0.0 111.96 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 131' ' ' VAL . . . -125.69 124.3 40.8 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.352 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.3 t -96.78 112.01 23.94 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.799 0.333 . . . . 0.0 110.621 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -48.78 150.09 3.85 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.821 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.43 -70.88 0.27 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.808 0.337 . . . . 0.0 110.855 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 52.6 m -141.48 143.57 33.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.848 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 60.06 79.48 0.29 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.867 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.81 163.22 39.86 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.572 2.181 . . . . 0.0 112.321 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -150.92 -177.61 24.95 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.396 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -67.49 163.44 21.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.881 0.372 . . . . 0.0 110.855 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -156.93 136.01 11.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.165 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -166.94 111.28 0.44 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.496 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 159.81 -140.1 6.58 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.484 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.403 HG22 HD11 ' A' ' 113' ' ' ILE . 27.3 pt -122.54 145.32 29.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.861 0.362 . . . . 0.0 111.139 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.517 ' HG ' ' HB ' ' A' ' 121' ' ' ILE . 8.4 tp -87.82 121.18 29.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.319 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -118.36 149.5 41.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.207 0.527 . . . . 0.0 111.962 -179.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.479 ' HB2' HD12 ' A' ' 121' ' ' ILE . 6.2 t -111.68 163.67 13.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.982 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -58.51 -17.26 19.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.022 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 18.8 m80 -95.66 -30.68 13.63 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.653 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 176.82 -143.1 6.16 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.424 -0.893 . . . . 0.0 113.034 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.514 ' HB ' ' HA ' ' A' ' 53' ' ' ILE . 3.6 t -98.93 135.33 34.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.726 0.298 . . . . 0.0 111.024 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.517 ' HB ' ' HG ' ' A' ' 114' ' ' LEU . 1.7 mm -92.35 -66.14 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.839 0.352 . . . . 0.0 110.794 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.446 ' HA3' ' O ' ' A' ' 135' ' ' ALA . . . -166.98 -156.26 9.6 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.622 -0.799 . . . . 0.0 113.045 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -116.94 164.16 15.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.804 0.335 . . . . 0.0 110.983 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.466 ' HA ' ' CD1' ' A' ' 134' ' ' PHE . 11.6 p -66.51 129.53 31.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.625 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.46 HG23 ' N ' ' A' ' 126' ' ' MET . 7.3 m -110.07 -87.35 0.52 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.228 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.471 ' CG ' ' HB ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -104.75 144.37 31.83 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.852 0.358 . . . . 0.0 111.13 179.825 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -118.86 96.26 0.65 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.154 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -77.43 174.5 54.63 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.603 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -71.93 -19.36 61.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.713 0.292 . . . . 0.0 110.931 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -145.16 4.74 1.37 Allowed Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.631 -0.795 . . . . 0.0 113.062 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 101' ' ' ALA . 1.4 t -128.66 157.05 41.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 117.023 0.412 . . . . 0.0 111.008 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.666 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 3.4 t -114.89 117.83 56.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.989 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.442 ' CA ' HD22 ' A' ' 100' ' ' LEU . . . -96.19 118.44 5.98 Favored Glycine 0 CA--C 1.517 0.16 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.801 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.487 ' CZ ' ' HB2' ' A' ' 63' ' ' TYR . 21.4 m-85 -125.13 133.06 52.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.909 0.385 . . . . 0.0 111.787 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.446 ' O ' ' HA3' ' A' ' 122' ' ' GLY . . . -93.62 107.76 19.58 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -67.72 151.84 46.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.262 0.554 . . . . 0.0 112.42 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.406 ' CG2' ' HA2' ' A' ' 122' ' ' GLY . 39.7 t -93.58 13.72 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.643 179.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.3 mtm105 -70.61 -6.99 40.86 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.772 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -96.69 11.13 36.54 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.555 0.217 . . . . 0.0 111.3 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.581 ' N ' ' CD1' ' A' ' 140' ' ' LEU . 0.0 OUTLIER 179.8 58.6 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.027 0.441 . . . . 0.0 110.501 -179.876 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.499 ' O ' ' N ' ' A' ' 143' ' ' LEU . 0.1 OUTLIER -74.58 -14.78 60.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.07 -179.515 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . 0.414 ' CE3' ' CE2' ' A' ' 15' ' ' TYR . 16.3 p-90 -55.48 81.66 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.006 0.431 . . . . 0.0 111.267 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.499 ' N ' ' O ' ' A' ' 141' ' ' LEU . 5.0 mp -147.14 -45.82 0.17 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.302 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -152.91 -173.41 4.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.815 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.84 130.46 47.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.07 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -83.75 154.21 23.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.863 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -77.31 130.88 37.75 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.066 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 2.8 mtt -103.32 163.59 12.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.892 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.6 -61.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.86 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.173 -0.917 . . . . 0.0 110.918 -179.997 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.169 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.96 144.71 53.81 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.604 2.203 . . . . 0.0 112.359 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -164.62 145.82 8.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.96 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.76 -65.83 3.47 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.531 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -89.97 137.4 32.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.767 0.317 . . . . 0.0 110.939 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -119.17 119.14 33.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.878 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.1 p -79.39 123.78 27.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.963 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 152.45 -36.12 0.81 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.516 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -131.72 173.16 11.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.848 0.356 . . . . 0.0 111.039 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.7 p -125.38 111.45 27.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.728 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 9.8 p90 -113.71 136.06 53.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.978 0.418 . . . . 0.0 111.16 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.474 ' CG1' ' HB2' ' A' ' 144' ' ' GLU . 95.1 t -118.94 134.88 61.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.491 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 45.51 -124.24 6.62 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 115.933 -0.576 . . . . 0.0 113.206 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.45 ' O ' ' HA ' ' A' ' 44' ' ' THR . 3.7 m-20 -91.59 17.96 8.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.646 0.26 . . . . 0.0 111.228 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 6.9 m-30 -127.82 147.36 50.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.259 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 11' ' ' TYR . 1.0 OUTLIER -133.63 114.73 13.84 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.771 179.467 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 1.2 m -102.26 121.37 53.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 121.242 0.544 . . . . 0.0 110.834 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.0 p -137.17 161.44 35.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.32 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.6 141.64 54.53 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 178.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.427 ' HG2' ' CH2' ' A' ' 28' ' ' TRP . 5.1 mtp-105 -56.29 -47.54 78.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.905 0.383 . . . . 0.0 111.254 -179.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.406 ' CD2' ' CE1' ' A' ' 90' ' ' TYR . 5.3 m-70 -69.09 -8.4 44.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.344 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.7 tp -115.35 5.86 14.72 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.489 ' HB1' HD21 ' A' ' 41' ' ' LEU . . . -88.88 129.26 35.63 Favored 'General case' 0 C--N 1.334 -0.07 0 C-N-CA 120.291 -0.563 . . . . 0.0 111.444 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.499 ' O ' ' HD1' ' A' ' 28' ' ' TRP . 27.4 p -74.85 164.68 26.3 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.703 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -53.74 -29.81 41.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.221 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.422 ' HA ' ' HG2' ' A' ' 29' ' ' GLN . 21.7 t -68.76 -33.99 62.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.973 0.416 . . . . 0.0 110.97 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.432 ' O ' ' HB3' ' A' ' 31' ' ' CYS . 0.4 OUTLIER -68.45 -43.5 76.89 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.258 179.67 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.499 ' HD1' ' O ' ' A' ' 24' ' ' THR . 59.0 m95 -73.69 -45.84 49.96 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.91 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.422 ' HG2' ' HA ' ' A' ' 26' ' ' VAL . 3.2 pt20 -54.97 -37.39 66.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.896 0.379 . . . . 0.0 110.689 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.2 m-20 -115.36 34.42 4.9 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.782 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.48 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 20.4 p -80.17 127.38 32.26 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.027 0.441 . . . . 0.0 111.365 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.426 HG23 ' N ' ' A' ' 33' ' ' TRP . 16.0 m -88.26 -38.95 12.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.329 179.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.496 ' CE3' HG23 ' A' ' 42' ' ' VAL . 0.4 OUTLIER -139.81 153.13 47.01 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.977 179.753 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -166.11 107.06 0.71 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.019 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.425 ' OD1' ' CZ2' ' A' ' 33' ' ' TRP . 34.6 p-10 -107.36 125.15 50.83 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.089 0.471 . . . . 0.0 111.118 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -67.0 -34.5 77.89 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.567 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -59.79 -24.49 64.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.913 0.387 . . . . 0.0 110.562 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.505 ' HA ' ' NE ' ' A' ' 38' ' ' ARG . 4.6 tpm_? -113.14 -4.74 13.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.975 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 48.97 36.87 9.14 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-O 121.112 0.482 . . . . 0.0 109.982 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 30.8 tp -130.79 154.58 47.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.247 -178.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.509 ' CD2' ' O ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -146.58 156.02 42.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.59 179.795 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.496 HG23 ' CE3' ' A' ' 33' ' ' TRP . 19.8 t -120.27 129.82 75.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.234 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 24.1 p -121.15 157.34 30.38 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.208 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 14' ' ' ASN . 16.6 p -97.49 119.86 36.81 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.164 0.506 . . . . 0.0 111.324 -179.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -111.7 -33.78 6.24 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.038 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.7 m 64.05 45.08 4.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.881 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.65 160.29 37.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.095 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -58.73 130.28 46.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.826 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.442 ' HA2' ' CZ ' ' A' ' 11' ' ' TYR . . . -104.59 -32.48 4.18 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.624 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER 59.22 20.81 8.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.669 0.271 . . . . 0.0 111.018 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -130.04 137.25 50.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.873 0.368 . . . . 0.0 110.742 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 73.5 m -121.99 120.37 34.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.421 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.491 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 0.9 OUTLIER -72.82 139.22 19.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.82 0.343 . . . . 0.0 110.652 -179.815 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.436 ' HB1' ' HB2' ' A' ' 118' ' ' HIS . . . -91.06 121.65 33.04 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.225 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -94.44 38.66 1.1 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.382 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 12.5 p -99.86 167.06 10.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.069 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -114.69 30.26 7.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.07 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 63.6 m -59.4 163.51 3.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.881 0.372 . . . . 0.0 110.875 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.6 m -117.0 2.66 12.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.93 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 75' ' ' SER . 17.6 p -136.02 126.25 26.41 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 120.879 0.371 . . . . 0.0 111.159 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -134.69 -161.75 9.59 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.041 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.446 HG22 ' HB2' ' A' ' 71' ' ' HIS . 7.2 p -140.37 137.78 36.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.992 0.425 . . . . 0.0 111.205 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.422 ' CD1' ' O ' ' A' ' 63' ' ' TYR . 6.5 p90 -143.53 129.94 19.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.439 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -59.87 134.06 56.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.804 0.335 . . . . 0.0 110.972 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -70.2 159.19 34.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.092 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.76 -45.05 54.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.206 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.4 m -85.72 -42.92 13.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.714 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.5 mmtt -81.28 129.27 34.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.657 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.19 50.06 1.94 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.012 0.434 . . . . 0.0 110.69 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.43 170.03 17.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.652 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.446 ' HB2' HG22 ' A' ' 62' ' ' VAL . 26.5 p-80 -83.71 139.51 32.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.059 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -123.85 114.11 28.32 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.619 -178.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -71.91 120.57 6.94 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.265 1.977 . . . . 0.0 110.423 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.468 ' CG1' ' CB ' ' A' ' 101' ' ' ALA . 56.0 t -132.69 142.02 43.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.08 0.467 . . . . 0.0 112.155 -178.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 75.6 p -93.88 121.0 34.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.331 178.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.448 ' HB3' ' HB1' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -125.34 164.78 19.64 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.439 0.638 . . . . 0.0 112.017 -178.657 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 99' ' ' LEU . 12.0 mt-10 -111.8 159.02 18.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.162 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -104.56 65.03 0.32 Allowed Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.334 -0.936 . . . . 0.0 113.724 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.456 ' HD2' ' HA ' ' A' ' 99' ' ' LEU . 40.2 Cg_endo -67.97 136.09 37.08 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.419 2.079 . . . . 0.0 112.105 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -61.62 -87.43 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.255 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.442 HD12 ' CD2' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -90.76 119.65 31.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.813 0.34 . . . . 0.0 111.444 -179.878 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.48 ' HB ' ' CG1' ' A' ' 98' ' ' VAL . 23.4 t -129.04 122.2 55.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.34 178.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -74.42 108.1 6.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.839 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.548 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 35.0 m -72.65 124.59 29.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.234 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -69.24 149.84 48.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.327 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.633 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 2.0 pt-20 -68.36 102.83 1.48 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.793 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.411 ' O ' ' N ' ' A' ' 89' ' ' TYR . 1.4 m -143.57 155.19 44.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.395 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 59.48 -79.4 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.43 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.411 ' N ' ' O ' ' A' ' 87' ' ' SER . 1.0 OUTLIER -156.22 24.24 0.36 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.791 0.329 . . . . 0.0 111.028 -179.982 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.633 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -119.51 130.18 24.98 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.306 179.858 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.4 ' O ' ' N ' ' A' ' 93' ' ' ARG . 85.4 Cg_endo -83.92 148.42 12.16 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.862 2.375 . . . . 0.0 112.662 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -47.28 92.65 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.083 179.954 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.4 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.6 OUTLIER -123.88 166.31 15.87 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.116 0.484 . . . . 0.0 112.168 -179.304 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.442 ' CD2' HD12 ' A' ' 81' ' ' LEU . 4.3 m-85 -97.38 129.99 44.57 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.173 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 22.7 mm-40 -131.45 137.92 48.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.701 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.449 ' O ' ' HB2' ' A' ' 97' ' ' HIS . 23.2 t -103.66 142.81 33.68 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -179.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.449 ' HB2' ' O ' ' A' ' 96' ' ' SER . 96.3 m-70 75.93 56.04 0.05 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.353 179.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.48 ' CG1' ' HB ' ' A' ' 82' ' ' VAL . 12.1 p -123.57 143.85 35.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.737 0.304 . . . . 0.0 110.87 178.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.463 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 11.0 mp -102.71 140.54 36.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.039 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.496 ' HA ' ' O ' ' A' ' 132' ' ' VAL . 5.5 mt -130.96 140.33 50.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.188 0.518 . . . . 0.0 112.16 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.468 ' CB ' ' CG1' ' A' ' 74' ' ' VAL . . . -152.07 159.37 43.7 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.526 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 130' ' ' GLY . 0.7 OUTLIER -112.19 127.13 55.86 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.02 0.438 . . . . 0.0 111.046 179.694 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -125.19 -121.58 2.55 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.465 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -154.47 77.75 1.06 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.861 0.363 . . . . 0.0 110.684 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 34.7 p -134.75 -162.99 1.31 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.844 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.452 ' CB ' ' CD ' ' A' ' 107' ' ' PRO . 0.1 OUTLIER -161.96 -65.02 0.02 OUTLIER Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.931 179.911 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.452 ' CD ' ' CB ' ' A' ' 106' ' ' GLU . 28.2 Cg_endo -62.43 -45.08 15.72 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.432 2.088 . . . . 0.0 112.138 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 70.41 -66.21 0.76 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.509 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 61.14 178.83 0.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.801 0.334 . . . . 0.0 110.842 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -101.4 -175.09 2.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.097 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 67.87 135.32 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.562 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 129.23 140.47 4.88 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.373 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.54 ' HA ' ' HA ' ' A' ' 123' ' ' LEU . 2.7 pp -126.25 146.4 32.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.931 0.396 . . . . 0.0 111.738 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.413 HD23 ' CZ ' ' A' ' 76' ' ' PHE . 9.8 tp -87.5 123.47 32.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.146 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 2.7 mtm180 -115.5 145.5 42.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.155 0.502 . . . . 0.0 111.627 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.462 ' HB2' HD13 ' A' ' 121' ' ' ILE . 4.5 t -109.4 165.46 11.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.145 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -60.86 -16.28 39.69 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.805 0.336 . . . . 0.0 110.616 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.436 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . 19.3 m80 -95.39 -29.24 14.54 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.528 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.409 ' N ' ' HB1' ' A' ' 54' ' ' ALA . . . 171.27 -140.47 5.92 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.537 -0.839 . . . . 0.0 113.015 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.491 ' HB ' ' HA ' ' A' ' 53' ' ' ILE . 2.7 t -99.24 135.23 35.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.637 0.256 . . . . 0.0 110.835 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.462 HD13 ' HB2' ' A' ' 116' ' ' CYS . 0.9 OUTLIER -99.96 -71.5 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.397 -179.95 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.417 ' HA2' ' CG2' ' A' ' 137' ' ' VAL . . . -153.65 -168.04 16.8 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.326 -0.94 . . . . 0.0 113.294 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.54 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 0.5 OUTLIER -116.88 164.2 15.04 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.635 0.255 . . . . 0.0 110.884 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 28.0 m -66.22 126.52 25.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.743 0.306 . . . . 0.0 111.189 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.448 ' CG2' ' N ' ' A' ' 126' ' ' MET . 3.7 m -108.38 -94.05 0.4 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.779 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.541 ' O ' ' HA3' ' A' ' 133' ' ' GLY . 73.7 mmm -144.02 162.3 36.56 Favored 'General case' 0 C--O 1.228 -0.076 0 CA-C-O 121.085 0.469 . . . . 0.0 111.538 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 175.85 -159.2 26.64 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.232 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -130.39 -153.32 7.68 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.404 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -89.75 11.83 18.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.722 0.296 . . . . 0.0 110.92 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 102' ' ' THR . . . -134.17 -36.32 0.25 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.728 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -115.67 157.28 16.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-O 120.949 0.404 . . . . 0.0 111.421 -179.859 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 4.5 m -122.42 118.83 56.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.423 -179.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.541 ' HA3' ' O ' ' A' ' 126' ' ' MET . . . -101.76 114.89 5.09 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.384 -0.912 . . . . 0.0 112.082 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.458 ' CZ ' ' CG2' ' A' ' 132' ' ' VAL . 10.7 m-85 -114.76 140.52 48.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.871 0.367 . . . . 0.0 111.261 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.429 ' HB3' ' OG1' ' A' ' 125' ' ' THR . . . -88.85 115.35 26.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.41 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.0 142.61 55.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.072 -178.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.465 ' O ' HD13 ' A' ' 140' ' ' LEU . 93.6 t -91.37 9.68 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.38 178.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 4.4 mtm-85 -71.53 -6.76 43.0 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.406 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -95.04 10.99 33.62 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 120.579 0.228 . . . . 0.0 111.23 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.585 ' N ' ' CD1' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -176.09 61.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.295 0.569 . . . . 0.0 110.332 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.477 ' O ' ' N ' ' A' ' 143' ' ' LEU . 0.1 OUTLIER -78.89 -14.66 59.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.024 -179.474 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 18.2 p-90 -59.78 76.46 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.006 0.432 . . . . 0.0 111.785 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.477 ' N ' ' O ' ' A' ' 141' ' ' LEU . 4.9 mp -140.77 -47.39 0.41 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.823 178.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.474 ' HB2' ' CG1' ' A' ' 12' ' ' VAL . 1.5 tp10 -150.05 -161.89 1.44 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.441 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -69.35 146.36 52.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.832 0.348 . . . . 0.0 110.851 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -93.17 154.12 18.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.906 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -91.74 132.43 36.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.166 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 19.7 ttt -164.48 -55.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.996 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -109.09 164.02 12.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.877 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.956 179.992 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.87 173.88 10.42 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.63 2.22 . . . . 0.0 112.309 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 99.8 m-85 60.38 -177.81 0.1 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.93 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 165.4 80.9 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.545 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -112.64 -36.61 5.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.735 0.302 . . . . 0.0 110.892 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -160.17 106.61 1.57 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.898 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.2 m -140.84 79.55 1.7 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.91 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 178.73 37.45 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.546 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -124.99 140.31 53.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.831 0.348 . . . . 0.0 111.108 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.6 t -108.68 111.89 37.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.059 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.478 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 1.5 p90 -117.34 124.09 48.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.898 0.38 . . . . 0.0 110.874 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.447 ' CG1' ' HB2' ' A' ' 144' ' ' GLU . 75.1 t -119.26 140.96 41.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.703 -179.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 45.37 -129.83 8.83 Favored Glycine 0 C--N 1.333 0.379 0 CA-C-N 115.94 -0.573 . . . . 0.0 113.306 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.438 ' O ' ' HA ' ' A' ' 44' ' ' THR . 28.6 p30 -89.49 18.84 4.94 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.693 0.282 . . . . 0.0 111.23 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.444 ' HB3' HG12 ' A' ' 42' ' ' VAL . 7.8 m-30 -127.61 147.69 50.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.287 -0.415 . . . . 0.0 109.954 179.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 11' ' ' TYR . 10.6 tttt -132.79 114.7 14.42 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.685 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 1.6 m -101.44 121.29 52.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-O 121.148 0.499 . . . . 0.0 110.765 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.0 p -137.02 161.41 35.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.31 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -61.74 141.51 57.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.044 178.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.55 -44.64 81.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.763 0.316 . . . . 0.0 111.211 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -69.41 -7.51 38.37 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.166 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 79.9 mt -115.1 -2.88 12.66 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.424 ' HB1' HD22 ' A' ' 41' ' ' LEU . . . -86.08 126.57 34.29 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.229 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.528 ' O ' ' HD1' ' A' ' 28' ' ' TRP . 1.8 t -74.86 165.16 25.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.721 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -53.7 -29.98 41.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.845 -178.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.41 HG11 ' CG2' ' A' ' 24' ' ' THR . 11.4 p -72.65 -31.25 36.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.717 0.294 . . . . 0.0 110.967 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -67.66 -43.76 79.47 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.14 0.495 . . . . 0.0 109.697 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.528 ' HD1' ' O ' ' A' ' 24' ' ' THR . 48.9 m95 -73.85 -30.04 62.45 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.725 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -60.09 -44.23 94.96 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.556 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -110.2 27.75 9.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.336 179.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.441 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 7.0 t -73.13 123.64 24.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.043 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.424 ' CG2' HG13 ' A' ' 42' ' ' VAL . 13.3 m -86.32 -40.11 14.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.696 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.469 ' CE3' HG23 ' A' ' 42' ' ' VAL . 0.3 OUTLIER -139.59 153.13 47.31 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.885 0.374 . . . . 0.0 111.181 179.825 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -159.88 117.04 2.58 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.846 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.417 ' HB2' ' CZ2' ' A' ' 33' ' ' TRP . 0.7 OUTLIER -107.11 118.04 35.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.234 -179.759 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -62.93 -46.97 85.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.585 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -59.9 -18.86 47.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.242 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? -111.75 -6.05 14.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.191 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 48.55 38.93 12.08 Favored 'General case' 0 N--CA 1.461 0.079 0 CA-C-O 121.132 0.492 . . . . 0.0 110.401 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 27.1 tp -132.42 156.23 47.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.978 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.502 ' CD2' ' O ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -150.2 156.12 41.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.478 179.746 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.469 HG23 ' CE3' ' A' ' 33' ' ' TRP . 21.3 t -120.01 133.04 68.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.98 0.419 . . . . 0.0 110.301 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.5 t -125.98 157.42 37.87 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.202 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 14' ' ' ASN . 11.8 p -97.33 119.99 36.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.266 0.555 . . . . 0.0 111.529 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -108.14 160.72 15.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.887 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.0 t -105.99 42.48 1.25 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.875 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.33 169.94 16.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.139 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 10.1 p-80 -76.99 143.8 39.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.856 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -83.69 128.35 8.52 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.468 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -105.64 28.53 7.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.794 0.33 . . . . 0.0 110.87 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -153.02 133.57 13.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.82 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 48.7 m -117.64 116.43 27.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.813 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.504 ' HB ' HD11 ' A' ' 141' ' ' LEU . 3.8 mm -72.9 139.72 19.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.839 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.459 ' HB3' ' HB2' ' A' ' 118' ' ' HIS . . . -83.83 -53.57 5.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.785 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 29.0 ttt-85 63.75 35.54 11.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.997 0.427 . . . . 0.0 110.038 -178.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 6.0 p -99.71 146.65 26.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.991 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -88.03 54.22 3.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.051 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 77.1 m -85.98 164.8 17.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.828 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.65 -19.37 12.9 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.884 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 75' ' ' SER . 12.1 p -126.21 123.95 39.35 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.941 0.4 . . . . 0.0 111.336 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -138.3 166.02 25.33 Favored Glycine 0 N--CA 1.452 -0.265 0 N-CA-C 111.631 -0.588 . . . . 0.0 111.631 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.412 HG22 ' CG ' ' A' ' 71' ' ' HIS . 14.9 p -102.57 130.82 51.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.967 0.413 . . . . 0.0 111.351 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.456 ' HB2' ' CZ ' ' A' ' 134' ' ' PHE . 4.2 p90 -106.55 139.43 41.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.986 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -67.45 123.55 20.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 13.5 m -86.63 135.99 33.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.851 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -84.5 -34.39 23.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.011 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.3 m -93.55 -53.57 4.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.757 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.02 -25.59 65.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.985 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.1 m 58.97 22.67 10.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.872 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.4 mtpt -133.09 169.81 16.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.697 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.412 ' CG ' HG22 ' A' ' 62' ' ' VAL . 0.3 OUTLIER -84.34 119.74 25.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.107 179.637 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -107.81 113.99 60.65 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.46 -179.121 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -77.03 120.81 5.55 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.389 2.059 . . . . 0.0 110.582 178.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.402 HG21 ' CE2' ' A' ' 63' ' ' TYR . 47.6 t -139.85 145.81 26.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.058 0.456 . . . . 0.0 112.186 -178.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.429 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 1.1 m -91.9 134.62 34.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.267 178.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.456 ' CE2' ' CD2' ' A' ' 114' ' ' LEU . 0.1 OUTLIER -143.5 169.2 18.15 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.479 0.657 . . . . 0.0 112.329 -178.966 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.514 ' C ' ' HD3' ' A' ' 79' ' ' PRO . 0.1 OUTLIER -111.92 159.29 18.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.747 179.384 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.43 ' HA2' ' HG ' ' A' ' 99' ' ' LEU . . . -111.61 72.31 0.21 Allowed Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.322 -0.942 . . . . 0.0 113.52 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.646 ' HD2' ' O ' ' A' ' 98' ' ' VAL . 15.9 Cg_exo -66.93 138.57 48.6 Favored 'Trans proline' 0 C--O 1.24 0.601 0 C-N-CA 122.401 2.067 . . . . 0.0 112.459 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -63.71 -59.98 7.97 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.621 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.43 HD11 ' O ' ' A' ' 95' ' ' GLN . 0.0 OUTLIER -120.15 119.96 34.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.993 0.425 . . . . 0.0 112.074 -179.786 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.431 ' HB ' HG12 ' A' ' 98' ' ' VAL . 37.4 t -125.15 127.62 72.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.823 178.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -72.17 107.86 5.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.922 0.392 . . . . 0.0 110.693 -179.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 1.6 p -72.83 114.49 12.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.405 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -69.89 150.17 47.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.602 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.557 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -68.04 101.58 1.16 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.151 0.501 . . . . 0.0 110.318 -179.517 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.443 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.4 OUTLIER -144.39 163.37 33.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.002 179.999 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.405 ' HG2' ' CD2' ' A' ' 89' ' ' TYR . 15.6 tt0 53.39 -84.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.482 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.443 ' N ' ' O ' ' A' ' 87' ' ' SER . 0.1 OUTLIER -152.41 21.41 0.63 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.757 0.313 . . . . 0.0 110.917 179.921 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.557 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 1.9 t80 -116.61 125.9 28.0 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.707 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.437 ' O ' ' N ' ' A' ' 93' ' ' ARG . 59.8 Cg_endo -73.5 148.58 42.87 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.754 2.303 . . . . 0.0 112.665 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.3 OUTLIER -53.2 85.01 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.455 -179.676 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.437 ' N ' ' O ' ' A' ' 91' ' ' PRO . 5.3 mtp-105 -124.04 -174.39 2.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.084 0.469 . . . . 0.0 111.737 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.415 ' HB3' HD13 ' A' ' 81' ' ' LEU . 26.2 m-85 -100.34 132.49 45.69 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.745 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.43 ' O ' HD11 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -125.56 122.53 36.78 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.119 -179.722 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 28.1 t -92.03 158.25 16.33 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 121.104 0.478 . . . . 0.0 112.114 -179.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 51.4 60.6 3.75 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.774 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.646 ' O ' ' HD2' ' A' ' 79' ' ' PRO . 9.9 p -123.99 136.56 59.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.187 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.43 ' HG ' ' HA2' ' A' ' 78' ' ' GLY . 6.3 mp -102.0 149.0 24.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.301 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.743 ' HA ' ' O ' ' A' ' 132' ' ' VAL . 6.4 mt -133.25 134.13 43.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.074 0.464 . . . . 0.0 111.801 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.42 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . . . -125.9 119.65 28.36 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.434 -179.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 1.5 t -86.15 111.7 20.61 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.907 0.384 . . . . 0.0 110.63 179.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -78.78 -132.21 0.75 Allowed Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.554 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -152.89 136.39 15.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.814 0.34 . . . . 0.0 110.723 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.4 m 61.45 -177.04 0.12 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.797 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -58.87 109.66 2.04 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.975 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.1 -167.82 0.26 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.452 2.101 . . . . 0.0 112.325 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -170.74 39.09 0.18 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.504 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -99.86 153.63 19.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.81 0.338 . . . . 0.0 110.995 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -168.63 39.92 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.136 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 151.71 165.78 13.36 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.473 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 115.45 -177.11 17.03 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.544 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 31.3 pt -125.96 146.48 31.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.662 0.268 . . . . 0.0 111.156 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.488 ' HG ' ' HB ' ' A' ' 121' ' ' ILE . 8.1 tp -87.24 115.87 24.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.855 0.36 . . . . 0.0 110.171 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 7.5 mtt180 -118.14 145.95 44.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.35 0.595 . . . . 0.0 111.842 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.413 ' HB2' HD12 ' A' ' 121' ' ' ILE . 14.3 t -111.75 164.52 12.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.678 179.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -55.72 -18.71 8.82 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.72 0.295 . . . . 0.0 110.896 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.459 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 50.8 m80 -91.34 -36.13 14.02 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.532 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 174.91 -139.9 5.05 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.357 -0.925 . . . . 0.0 113.398 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.486 ' HB ' ' HA ' ' A' ' 53' ' ' ILE . 4.1 t -97.95 135.78 31.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.75 0.309 . . . . 0.0 111.63 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.488 ' HB ' ' HG ' ' A' ' 114' ' ' LEU . 0.9 OUTLIER -101.4 -66.91 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.928 179.195 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 135' ' ' ALA . . . -151.51 -165.88 13.39 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.556 -0.83 . . . . 0.0 113.068 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -120.11 164.19 16.55 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.785 0.326 . . . . 0.0 110.881 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.404 ' HA ' ' CD1' ' A' ' 134' ' ' PHE . 12.6 p -61.9 115.07 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.783 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.425 ' OG1' ' CB ' ' A' ' 135' ' ' ALA . 6.0 m -105.87 -93.21 0.37 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.984 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.42 ' CG ' ' CG2' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -105.1 158.78 16.34 Favored 'General case' 0 C--N 1.335 -0.043 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.851 179.329 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -135.77 106.96 0.59 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.448 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -79.23 -178.62 51.24 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.476 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -71.92 -19.3 61.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.703 0.287 . . . . 0.0 111.141 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -150.33 17.22 1.02 Allowed Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.754 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.447 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 1.0 OUTLIER -136.65 157.51 36.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.693 0.282 . . . . 0.0 110.831 179.888 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.743 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 2.5 t -112.59 117.94 56.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.008 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.405 ' CA ' HD23 ' A' ' 100' ' ' LEU . . . -96.89 119.01 6.21 Favored Glycine 0 CA--C 1.518 0.236 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.89 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.459 ' CE2' ' CG1' ' A' ' 132' ' ' VAL . 27.7 m-85 -125.18 144.09 50.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.02 0.438 . . . . 0.0 112.039 -179.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.445 ' O ' ' HA3' ' A' ' 122' ' ' GLY . . . -93.78 111.05 22.68 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.26 142.02 57.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.259 0.552 . . . . 0.0 112.174 -178.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.402 HG13 ' CD1' ' A' ' 140' ' ' LEU . 31.6 t -90.25 12.31 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.502 179.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.535 ' HA ' HD23 ' A' ' 141' ' ' LEU . 15.7 mmm-85 -71.52 -6.92 44.18 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.446 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -96.1 7.52 46.19 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.526 ' O ' ' CD2' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -171.83 34.35 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 121.208 0.528 . . . . 0.0 110.36 179.716 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.535 HD23 ' HA ' ' A' ' 138' ' ' ARG . 0.1 OUTLIER -57.6 -14.84 5.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.583 -179.506 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . 0.425 ' CD1' ' HA ' ' A' ' 140' ' ' LEU . 13.6 p-90 -61.45 77.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.903 0.382 . . . . 0.0 111.828 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 141' ' ' LEU . 5.1 mp -136.32 -52.66 0.72 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.057 178.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.447 ' HB2' ' CG1' ' A' ' 12' ' ' VAL . 2.2 tp10 -144.41 -163.3 1.65 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.657 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -67.94 145.16 54.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.858 0.361 . . . . 0.0 110.822 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -105.03 154.16 20.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.981 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -78.87 121.08 24.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.062 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 10.9 ttp -120.77 36.08 4.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.043 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.44 133.71 44.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.91 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.91 -179.992 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 112.577 -0.209 . . . . 0.0 112.577 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.3 147.79 27.45 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.553 2.169 . . . . 0.0 112.322 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -111.54 95.98 5.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.884 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 116.59 36.99 1.02 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.467 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.28 -31.59 72.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.838 0.352 . . . . 0.0 110.911 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -126.13 177.97 6.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.907 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.6 m -153.22 -46.34 0.1 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.92 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 140.08 -25.07 2.67 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.615 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.75 152.26 23.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.838 0.352 . . . . 0.0 111.285 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.8 t -101.14 127.12 54.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.877 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.485 ' CE2' HG21 ' A' ' 45' ' ' THR . 7.0 t80 -111.66 116.06 30.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.841 0.353 . . . . 0.0 110.624 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.403 ' CG2' HD12 ' A' ' 53' ' ' ILE . 48.3 t -120.77 111.25 31.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.667 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 50.41 -124.92 20.12 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 121.064 -0.588 . . . . 0.0 113.273 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.457 ' O ' ' HA ' ' A' ' 44' ' ' THR . 77.8 m-20 -91.45 17.18 8.91 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.573 0.225 . . . . 0.0 111.601 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -130.31 127.84 40.3 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 9.1 tttt -120.42 114.81 22.36 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 121.11 -0.236 . . . . 0.0 110.742 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 0.6 OUTLIER -98.97 121.52 49.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 121.02 0.438 . . . . 0.0 110.761 179.861 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.401 ' O ' HD23 ' A' ' 41' ' ' LEU . 15.0 p -136.67 161.35 36.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.288 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 25.4 t30 -61.05 141.48 57.36 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.8 ppt_? -56.46 -45.9 80.62 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.928 0.394 . . . . 0.0 111.311 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -66.38 -10.29 41.97 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.157 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.4 mt -115.21 0.85 13.67 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.436 ' HB1' HD21 ' A' ' 41' ' ' LEU . . . -88.98 127.37 35.67 Favored 'General case' 0 N--CA 1.457 -0.084 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.212 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.533 ' O ' ' HD1' ' A' ' 28' ' ' TRP . 1.1 t -74.6 163.2 27.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.706 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -53.59 -29.77 39.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.746 0.308 . . . . 0.0 111.008 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.411 ' HA ' ' HG2' ' A' ' 29' ' ' GLN . 22.3 t -69.79 -32.25 51.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.967 0.413 . . . . 0.0 110.767 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.433 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 0.5 OUTLIER -68.56 -43.62 76.21 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.417 179.587 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.533 ' HD1' ' O ' ' A' ' 24' ' ' THR . 46.6 m95 -73.27 -45.97 52.63 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.019 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.411 ' HG2' ' HA ' ' A' ' 26' ' ' VAL . 14.4 pt20 -54.99 -44.07 74.16 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.768 0.318 . . . . 0.0 110.685 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -102.82 29.9 5.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.178 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.445 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 35.4 t -80.07 145.56 32.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.483 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 42' ' ' VAL . 10.0 m -103.67 -41.96 7.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.335 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.436 ' CE3' HG22 ' A' ' 42' ' ' VAL . 0.9 OUTLIER -139.69 152.86 47.03 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.018 179.696 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -157.22 117.81 3.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.136 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.411 ' HB3' ' CG ' ' A' ' 38' ' ' ARG . 26.6 t0 -107.13 105.02 14.81 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.789 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -63.27 -29.2 70.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.173 -179.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.515 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 10.7 m-20 -62.2 -30.16 70.88 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 120.403 0.144 . . . . 0.0 110.93 -179.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.498 ' HA ' ' HA ' ' A' ' 95' ' ' GLN . 14.5 ptm180 -113.71 -3.43 13.54 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 60.48 46.24 9.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.918 0.39 . . . . 0.0 110.906 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 26.6 tp -135.04 153.32 52.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.748 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.496 ' CD2' ' O ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -152.04 155.88 38.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.064 0.459 . . . . 0.0 111.719 179.683 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.436 HG22 ' CE3' ' A' ' 33' ' ' TRP . 28.9 t -116.6 133.04 64.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.93 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.2 t -125.69 157.11 38.15 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.748 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 14' ' ' ASN . 22.7 p -97.75 144.33 27.48 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.083 0.468 . . . . 0.0 111.538 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.485 HG21 ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -135.02 171.41 14.46 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.957 -179.167 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.0 m -115.68 55.34 0.79 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.884 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.5 -175.11 3.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.147 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -99.4 148.06 24.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.021 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -67.52 170.47 35.3 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.644 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.3 m -149.21 -60.58 0.22 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.81 0.338 . . . . 0.0 110.812 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -83.66 150.41 25.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.884 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 86.6 m -122.38 119.29 30.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.959 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.502 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 0.4 OUTLIER -76.46 139.75 18.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.767 179.854 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.43 ' HB1' ' N ' ' A' ' 119' ' ' GLY . . . -90.89 135.56 33.65 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.396 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -94.18 27.22 2.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.035 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 24.7 p -99.96 167.3 10.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.198 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -122.86 31.6 5.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.035 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 15.6 m -58.58 132.12 52.85 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.814 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.5 t -74.94 -8.17 55.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.115 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.2 p -107.98 127.21 53.56 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.89 0.376 . . . . 0.0 111.059 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -149.63 146.61 16.06 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.198 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.426 HG22 ' HB2' ' A' ' 71' ' ' HIS . 9.6 p -103.86 125.39 58.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.933 0.396 . . . . 0.0 111.216 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -108.01 163.6 13.0 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.796 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -90.28 128.31 36.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.863 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -84.54 151.54 24.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.92 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.98 -42.27 10.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.984 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.8 p -89.7 -49.07 6.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.782 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.7 mmtm -59.84 -25.82 65.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.035 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 8.3 t 55.66 24.0 6.71 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.806 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.4 mtpt -135.23 170.03 16.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.73 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.426 ' HB2' HG22 ' A' ' 62' ' ' VAL . 16.5 p80 -84.4 135.15 34.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.103 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -126.04 114.25 24.14 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.631 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -72.75 120.79 6.88 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.467 2.111 . . . . 0.0 110.497 178.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.455 ' CG1' ' HB2' ' A' ' 101' ' ' ALA . 84.6 t -137.64 142.02 37.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.257 0.551 . . . . 0.0 112.466 -178.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.19 135.0 39.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.495 -0.775 . . . . 0.0 108.961 178.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.507 ' HB3' ' HB1' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -141.97 172.76 12.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.381 0.61 . . . . 0.0 112.214 -178.362 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.443 ' O ' ' HA ' ' A' ' 99' ' ' LEU . 9.8 mt-10 -111.78 158.86 18.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.264 179.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -103.73 68.56 0.29 Allowed Glycine 0 CA--C 1.522 0.486 0 C-N-CA 120.366 -0.921 . . . . 0.0 113.735 -179.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.62 ' HD2' ' HA ' ' A' ' 99' ' ' LEU . 36.9 Cg_endo -67.77 139.2 47.2 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.464 2.109 . . . . 0.0 112.188 179.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -56.73 -91.77 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.693 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -98.62 122.73 42.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.921 0.391 . . . . 0.0 111.85 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.441 ' HB ' ' CG1' ' A' ' 98' ' ' VAL . 96.0 t -119.25 126.19 75.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.149 179.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -72.33 107.85 5.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.674 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.446 ' CG2' ' HB2' ' A' ' 126' ' ' MET . 1.0 OUTLIER -74.55 114.83 14.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.099 -179.834 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -70.75 149.77 46.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.843 179.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 4.2 pt-20 -68.06 101.0 1.06 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.086 0.469 . . . . 0.0 109.892 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.05 145.18 31.36 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.972 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.582 ' O ' ' CD1' ' A' ' 89' ' ' TYR . 0.3 OUTLIER 43.33 93.72 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.31 -0.404 . . . . 0.0 112.072 178.702 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.582 ' CD1' ' O ' ' A' ' 88' ' ' GLU . 4.3 p90 37.91 28.87 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.485 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -131.38 125.11 20.62 Favored Pre-proline 0 C--N 1.329 -0.312 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.541 -179.64 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -86.68 148.84 8.57 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.335 2.69 . . . . 0.0 112.476 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.0 mttm -45.73 93.63 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.352 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.68 170.77 10.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.511 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -102.9 132.47 49.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.961 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.515 ' HA ' ' O ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -126.12 110.89 14.02 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.183 -179.823 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 97.5 p -82.84 153.93 24.92 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.981 0.419 . . . . 0.0 111.441 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 54.47 62.22 2.66 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.621 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.462 ' O ' ' HD2' ' A' ' 79' ' ' PRO . 9.4 p -123.66 146.01 29.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.942 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.62 ' HA ' ' HD2' ' A' ' 79' ' ' PRO . 0.9 OUTLIER -105.28 146.64 29.06 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.133 179.72 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.529 ' HA ' ' O ' ' A' ' 132' ' ' VAL . 6.0 mt -133.02 143.27 49.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.27 0.557 . . . . 0.0 112.492 -179.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.507 ' HB1' ' HB3' ' A' ' 76' ' ' PHE . . . -151.0 140.92 21.97 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.603 179.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 1.3 t -95.52 118.11 31.64 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.954 0.407 . . . . 0.0 111.017 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -71.66 -112.14 0.05 OUTLIER Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.424 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -166.61 74.69 0.17 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.911 0.386 . . . . 0.0 110.768 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.8 m 63.22 85.18 0.13 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.865 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -132.67 141.69 42.09 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.937 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.88 -62.9 0.23 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.382 2.055 . . . . 0.0 112.273 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -139.96 -55.31 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.495 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 61.81 -174.76 0.13 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.815 0.34 . . . . 0.0 110.845 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 67.85 113.27 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.098 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -173.68 34.67 0.12 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.442 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -165.63 -140.96 3.0 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.514 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.3 pp -126.0 146.74 31.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.798 0.332 . . . . 0.0 111.24 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.454 ' CD2' ' CZ ' ' A' ' 76' ' ' PHE . 19.3 tp -87.18 120.4 28.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.713 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.06 145.03 45.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.394 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.412 ' HB2' ' CD1' ' A' ' 121' ' ' ILE . 5.1 t -108.4 164.56 12.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.111 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.49 -19.23 23.08 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.928 0.394 . . . . 0.0 110.482 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.403 ' HB2' ' HB2' ' A' ' 54' ' ' ALA . 22.3 m80 -92.68 -33.6 14.29 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.348 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.43 ' N ' ' HB1' ' A' ' 54' ' ' ALA . . . 176.78 -128.44 1.34 Allowed Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.894 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.502 ' HB ' ' HA ' ' A' ' 53' ' ' ILE . 3.3 t -113.0 135.66 51.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.596 0.236 . . . . 0.0 110.856 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.412 ' CD1' ' HB2' ' A' ' 116' ' ' CYS . 0.2 OUTLIER -100.06 -49.0 11.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.872 179.636 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.418 ' HA3' ' HA ' ' A' ' 136' ' ' ASP . . . -170.39 -165.61 28.01 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.319 -0.943 . . . . 0.0 113.252 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -116.93 164.2 15.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.679 0.276 . . . . 0.0 110.626 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.0 p -69.45 129.96 34.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.357 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.401 ' CG2' ' N ' ' A' ' 126' ' ' MET . 12.1 m -112.01 -95.37 0.44 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.682 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.551 ' O ' ' HA3' ' A' ' 133' ' ' GLY . 95.0 mmm -144.07 140.19 29.35 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.717 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -115.25 154.47 16.94 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.52 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -86.89 -150.02 16.44 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.473 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -71.92 -19.45 61.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.759 0.314 . . . . 0.0 110.991 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -157.4 13.98 0.29 Allowed Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.784 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 1.2 t -121.39 157.05 25.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.725 0.298 . . . . 0.0 110.794 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 7.6 m -115.66 118.41 58.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.406 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.551 ' HA3' ' O ' ' A' ' 126' ' ' MET . . . -101.19 115.28 5.24 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.378 -0.915 . . . . 0.0 112.085 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.465 ' CZ ' ' HB ' ' A' ' 132' ' ' VAL . 15.4 m-85 -117.55 139.83 50.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.778 0.323 . . . . 0.0 111.116 -179.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -88.84 114.75 25.79 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.689 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.418 ' HA ' ' HA3' ' A' ' 122' ' ' GLY . 1.4 p30 -74.63 140.93 44.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.769 -179.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.436 ' O ' HD12 ' A' ' 140' ' ' LEU . 48.8 t -89.51 10.09 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.48 178.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -70.82 -6.9 41.39 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.632 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -94.75 11.1 32.6 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.685 0.279 . . . . 0.0 111.206 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.577 ' N ' ' CD1' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -178.17 62.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.245 0.545 . . . . 0.0 110.317 -179.918 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.512 ' O ' ' N ' ' A' ' 143' ' ' LEU . 0.1 OUTLIER -77.3 -14.75 59.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.026 -179.311 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 15.3 p-90 -56.23 78.65 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.004 0.43 . . . . 0.0 111.437 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' A' ' 141' ' ' LEU . 5.0 mp -143.02 -46.66 0.31 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.147 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -151.48 -163.56 1.79 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.719 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -65.95 142.31 57.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.845 0.355 . . . . 0.0 111.039 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -86.57 154.13 21.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.914 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -95.91 120.0 35.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.171 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 4.9 mtt -75.55 -177.54 3.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.902 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.68 176.06 12.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.868 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.907 179.953 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.144 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -52.16 164.15 1.31 Allowed 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.584 2.189 . . . . 0.0 112.332 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -87.86 119.48 28.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.832 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 154.83 -133.18 3.72 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.464 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 15.3 t60 -107.66 173.68 6.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.799 0.333 . . . . 0.0 110.94 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.52 111.66 0.91 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.855 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 89.8 p -156.13 168.99 25.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.935 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -160.57 27.39 0.31 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.531 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -110.71 -178.92 3.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.821 0.343 . . . . 0.0 111.108 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.403 ' CG2' ' CG2' ' A' ' 113' ' ' ILE . 45.4 t -130.29 110.0 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.127 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.464 ' CE2' ' CG2' ' A' ' 45' ' ' THR . 5.9 t80 -95.92 116.11 28.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.841 0.353 . . . . 0.0 110.514 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.419 ' CG1' ' HB2' ' A' ' 144' ' ' GLU . 21.9 t -120.92 108.96 23.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.637 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 51.06 -125.96 25.58 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.898 -0.668 . . . . 0.0 113.327 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.41 ' O ' ' HA ' ' A' ' 44' ' ' THR . 24.8 m120 -89.07 14.25 11.15 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.722 0.296 . . . . 0.0 111.672 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.436 ' CE2' ' CE3' ' A' ' 142' ' ' TRP . 6.5 m-30 -130.37 146.94 52.02 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.8 tttt -137.67 114.93 10.98 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 121.197 -0.201 . . . . 0.0 110.651 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 0.6 OUTLIER -99.29 121.53 50.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 121.144 0.497 . . . . 0.0 111.145 -179.927 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.1 p -136.74 161.1 36.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.805 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -59.84 141.24 55.74 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 179.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.45 ' HG2' ' CH2' ' A' ' 28' ' ' TRP . 25.3 mtp180 -56.61 -47.12 80.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.948 0.404 . . . . 0.0 110.842 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.22 -8.04 28.55 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.245 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.09 -2.42 12.78 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -88.62 129.01 35.59 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.102 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.584 ' O ' ' HD1' ' A' ' 28' ' ' TRP . 43.8 p -74.73 162.89 28.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.56 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 24.1 p80 -53.51 -29.49 36.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.888 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.0 t -69.95 -31.85 49.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.82 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.428 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 3.7 m-20 -68.22 -43.97 76.78 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.584 ' HD1' ' O ' ' A' ' 24' ' ' THR . 27.5 m95 -73.64 -37.23 65.4 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.015 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.31 -44.23 79.71 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.96 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -110.16 32.4 5.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.275 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.46 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 54.1 t -80.14 149.34 30.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.542 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.408 HG21 ' N ' ' A' ' 33' ' ' TRP . 15.9 m -107.92 -39.32 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.048 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.45 ' CE3' HG23 ' A' ' 42' ' ' VAL . 0.7 OUTLIER -139.49 150.89 45.69 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.952 0.406 . . . . 0.0 111.7 -179.615 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.41 ' HG3' ' SG ' ' A' ' 31' ' ' CYS . 5.6 mp0 -147.0 118.47 7.92 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.792 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.425 ' HB2' ' CZ2' ' A' ' 33' ' ' TRP . 24.6 t70 -107.09 105.55 15.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.917 0.389 . . . . 0.0 110.891 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -64.46 -29.85 70.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.401 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.552 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 25.5 m120 -68.73 -27.59 66.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.88 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.4 ttp-105 -114.42 5.64 15.71 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 121.152 -0.219 . . . . 0.0 111.479 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.406 ' HA ' ' CD ' ' A' ' 20' ' ' ARG . 0.8 OUTLIER 46.55 38.98 6.14 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.994 0.426 . . . . 0.0 110.618 -179.862 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 26.5 tp -129.29 150.03 50.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.938 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.498 ' CD2' ' O ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -144.88 155.57 43.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.321 179.489 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.45 HG23 ' CE3' ' A' ' 33' ' ' TRP . 24.9 t -115.94 130.05 71.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.29 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 12.2 p -120.69 157.35 29.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.532 179.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 14' ' ' ASN . 17.8 p -97.49 130.67 44.56 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.22 0.533 . . . . 0.0 111.659 -179.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.464 ' CG2' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -126.5 160.53 30.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.849 -179.296 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -118.19 58.02 0.83 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.796 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -135.05 -173.69 3.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.132 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -101.53 120.59 40.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.459 ' CA ' ' CE1' ' A' ' 11' ' ' TYR . . . -80.17 -170.36 41.2 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.52 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -155.48 -46.23 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.828 0.347 . . . . 0.0 110.859 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -64.3 141.95 58.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.892 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 87.0 m -125.14 118.12 25.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.924 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.526 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 0.1 OUTLIER -79.44 139.54 18.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.905 179.825 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -98.57 135.85 39.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.839 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.409 ' HB2' ' HB3' ' A' ' 146' ' ' ASP . 0.5 OUTLIER -92.45 42.93 1.11 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.457 0.646 . . . . 0.0 109.409 178.614 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 19.4 p -99.65 167.19 10.73 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.569 -178.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -120.15 24.89 10.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.2 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 16.1 p -64.17 139.52 58.77 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.048 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.7 m -91.36 12.99 18.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.381 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 39.0 p -125.94 160.87 28.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.815 0.34 . . . . 0.0 110.883 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 176.13 152.81 9.9 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.442 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.406 HG23 ' HB2' ' A' ' 71' ' ' HIS . 7.1 p -103.71 137.83 30.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.808 0.337 . . . . 0.0 111.032 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.469 ' CE2' ' CG2' ' A' ' 74' ' ' VAL . 8.8 p90 -130.13 -170.9 2.41 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.357 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.441 ' CD2' ' HB2' ' A' ' 67' ' ' SER . 0.7 OUTLIER 73.88 -90.71 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.241 179.844 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 70' ' ' LYS . 0.1 OUTLIER 69.2 -65.02 0.31 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.722 0.296 . . . . 0.0 111.101 -179.933 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -82.06 -44.8 16.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.625 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.441 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -48.78 -70.49 0.09 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.169 -179.689 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.4 mmtt -78.4 -1.57 34.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.277 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.7 t 76.18 1.58 3.45 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.121 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 65' ' ' CYS . 0.0 OUTLIER -141.81 169.05 18.33 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.922 0.391 . . . . 0.0 110.617 179.738 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.406 ' HB2' HG23 ' A' ' 62' ' ' VAL . 0.2 OUTLIER -85.22 116.66 23.71 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.612 179.707 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -102.37 113.07 66.04 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.77 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -80.61 121.06 4.08 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.663 2.242 . . . . 0.0 111.217 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.503 ' CG1' ' HB2' ' A' ' 101' ' ' ALA . 44.4 t -134.21 147.48 30.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.073 0.463 . . . . 0.0 112.027 -178.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 74.2 m -100.58 128.62 46.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.458 178.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.497 ' HB3' ' HB1' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -132.52 169.25 16.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.381 0.61 . . . . 0.0 112.05 -178.588 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 99' ' ' LEU . 28.6 tt0 -111.91 158.44 19.47 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.156 178.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -105.44 65.97 0.28 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.474 -0.869 . . . . 0.0 113.172 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.407 ' HD2' ' O ' ' A' ' 98' ' ' VAL . 41.2 Cg_endo -67.99 134.45 32.02 Favored 'Trans proline' 0 C--O 1.239 0.557 0 C-N-CA 122.29 1.993 . . . . 0.0 112.23 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -58.86 -87.77 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.202 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -94.32 119.84 33.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.031 0.444 . . . . 0.0 111.826 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.433 ' CG2' ' CG1' ' A' ' 98' ' ' VAL . 48.8 t -122.91 122.9 66.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.686 178.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.414 ' HG3' ' CE1' ' A' ' 94' ' ' TYR . 3.9 tt0 -72.08 107.61 4.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.976 0.417 . . . . 0.0 110.808 -179.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.54 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 47.6 t -73.96 114.62 13.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.757 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -72.84 150.02 43.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.752 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.515 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 0.6 OUTLIER -67.71 100.9 0.96 Allowed 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.331 -0.548 . . . . 0.0 110.232 -179.388 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.522 ' O ' ' N ' ' A' ' 89' ' ' TYR . 3.7 m -144.78 169.58 17.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.591 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.42 ' HB3' ' H ' ' A' ' 89' ' ' TYR . 4.4 tt0 45.65 -84.82 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.658 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.522 ' N ' ' O ' ' A' ' 87' ' ' SER . 0.6 OUTLIER -153.99 24.75 0.49 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.818 0.342 . . . . 0.0 110.378 179.652 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.515 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -117.43 116.47 37.08 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.623 -179.934 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.457 ' O ' ' N ' ' A' ' 93' ' ' ARG . 30.9 Cg_exo -61.51 148.52 92.78 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.706 2.271 . . . . 0.0 112.181 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.54 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -59.05 79.24 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.858 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.457 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.2 OUTLIER -123.97 179.96 4.64 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.172 0.51 . . . . 0.0 111.816 -179.498 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.414 ' CE1' ' HG3' ' A' ' 83' ' ' GLU . 12.5 m-85 -93.93 132.56 38.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.784 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.552 ' HA ' ' O ' ' A' ' 37' ' ' ASN . 2.2 tt0 -130.57 123.14 28.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.209 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.403 ' CB ' ' HB3' ' A' ' 37' ' ' ASN . 5.1 t -97.71 161.49 13.73 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.114 0.483 . . . . 0.0 112.02 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 55.72 56.32 6.26 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.585 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.433 ' CG1' ' CG2' ' A' ' 82' ' ' VAL . 11.1 p -123.66 139.64 49.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.815 0.341 . . . . 0.0 111.559 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.404 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 11.2 mp -101.97 140.25 36.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.169 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.49 ' HA ' ' O ' ' A' ' 132' ' ' VAL . 5.6 mt -133.18 142.29 48.54 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -179.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.503 ' HB2' ' CG1' ' A' ' 74' ' ' VAL . . . -152.12 147.12 26.08 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.706 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 0.9 OUTLIER -100.42 118.24 36.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.058 0.456 . . . . 0.0 111.129 179.865 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -86.39 -6.02 81.59 Favored Glycine 0 CA--C 1.519 0.287 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.868 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 67.83 -69.73 0.14 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.775 0.322 . . . . 0.0 110.887 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.19 88.78 2.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.887 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -118.37 143.86 33.97 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.975 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -56.72 -62.86 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.507 2.138 . . . . 0.0 112.197 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 146.75 -28.03 1.61 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.445 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -102.72 140.56 36.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.829 0.347 . . . . 0.0 110.883 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -140.78 163.09 33.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.079 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 169.38 66.1 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.485 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -160.07 176.6 36.75 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.549 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.415 ' HA ' ' HA ' ' A' ' 123' ' ' LEU . 2.5 pp -97.61 146.39 7.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.738 0.304 . . . . 0.0 111.077 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.423 HD22 ' CZ ' ' A' ' 76' ' ' PHE . 47.0 tp -87.58 113.15 23.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.822 0.344 . . . . 0.0 110.843 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -119.36 138.11 53.28 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.298 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.401 ' SG ' ' CD1' ' A' ' 121' ' ' ILE . 28.0 p -111.5 177.01 4.79 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -56.61 -19.94 18.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.686 0.279 . . . . 0.0 111.218 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 22.1 m80 -90.77 -33.66 15.64 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 159.83 -150.65 21.07 Favored Glycine 0 C--N 1.334 0.445 0 C-N-CA 120.425 -0.893 . . . . 0.0 113.136 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.526 ' HB ' ' HA ' ' A' ' 53' ' ' ILE . 9.1 t -83.83 135.6 24.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.768 0.318 . . . . 0.0 111.63 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.429 ' N ' ' CD1' ' A' ' 121' ' ' ILE . 3.0 mp -109.31 -47.97 7.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.028 179.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -168.45 -171.94 34.82 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.078 -1.058 . . . . 0.0 113.215 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 0.3 OUTLIER -118.76 164.13 15.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.803 0.335 . . . . 0.0 110.826 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 11.2 p -60.72 121.33 8.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.486 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.422 ' CG2' ' N ' ' A' ' 126' ' ' MET . 19.3 m -116.02 -98.49 0.45 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.4 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.422 ' N ' ' CG2' ' A' ' 125' ' ' THR . 0.0 OUTLIER -87.06 161.85 17.92 Favored 'General case' 0 CA--C 1.527 0.059 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.644 179.664 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -146.64 93.61 0.16 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.467 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -74.98 -177.96 40.62 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.375 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -71.98 -19.36 61.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.702 0.287 . . . . 0.0 111.042 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -142.6 -7.34 0.65 Allowed Glycine 0 CA--C 1.523 0.545 0 C-N-CA 120.571 -0.823 . . . . 0.0 113.514 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.46 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 0.6 OUTLIER -115.86 157.08 16.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 117.242 0.521 . . . . 0.0 111.18 -179.842 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 15.6 m -113.4 118.45 58.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.602 -179.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -95.77 119.3 6.19 Favored Glycine 0 C--N 1.329 0.178 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.162 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.437 ' CZ ' ' HB ' ' A' ' 132' ' ' VAL . 18.5 m-85 -125.04 144.04 50.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.867 0.365 . . . . 0.0 111.557 -179.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.415 ' CB ' ' OG1' ' A' ' 125' ' ' THR . . . -93.11 113.64 25.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.11 179.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -67.99 133.76 49.59 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -178.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.525 ' O ' HD13 ' A' ' 140' ' ' LEU . 48.9 t -97.17 2.39 10.29 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.505 178.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 6.4 mtm105 -72.73 -6.22 43.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.304 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.78 3.71 54.69 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.661 0.267 . . . . 0.0 111.278 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.559 ' N ' ' CD1' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -163.78 57.25 0.17 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.228 0.537 . . . . 0.0 109.956 179.827 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.565 ' O ' ' N ' ' A' ' 143' ' ' LEU . 0.1 OUTLIER -72.67 -14.5 61.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.607 -179.048 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . 0.436 ' CE3' ' CE2' ' A' ' 15' ' ' TYR . 16.7 p-90 -52.87 81.15 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.991 0.424 . . . . 0.0 111.219 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.565 ' N ' ' O ' ' A' ' 141' ' ' LEU . 5.0 mp -151.1 -45.77 0.12 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.327 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.419 ' HB2' ' CG1' ' A' ' 12' ' ' VAL . 1.2 mm-40 -157.41 -170.19 3.15 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.645 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -59.4 144.99 45.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.063 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.409 ' HB3' ' HB2' ' A' ' 55' ' ' ARG . 0.1 OUTLIER -103.11 154.35 19.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.647 179.932 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.4 130.04 39.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.926 0.393 . . . . 0.0 111.32 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 6.8 mtt -141.13 -175.96 4.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.763 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -152.22 -46.37 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.052 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.815 -179.928 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.145 0 N-CA-C 112.56 -0.216 . . . . 0.0 112.56 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.01 -35.89 62.92 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.555 2.17 . . . . 0.0 112.379 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -165.27 -67.63 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.891 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.36 81.43 1.75 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.384 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 15.1 p80 -119.11 165.8 13.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.861 0.362 . . . . 0.0 110.895 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -132.25 81.7 1.97 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.823 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.9 t -119.37 146.74 45.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.948 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 143.08 -40.92 1.2 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.446 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -116.27 178.07 4.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.825 0.345 . . . . 0.0 111.051 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.5 t -114.49 107.1 22.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.019 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.451 ' CE2' HG23 ' A' ' 45' ' ' THR . 6.0 t80 -96.54 116.24 28.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.527 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.425 ' CG1' ' HB2' ' A' ' 144' ' ' GLU . 30.5 t -120.94 111.66 32.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.683 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.405 ' O ' ' CE1' ' A' ' 11' ' ' TYR . . . 50.88 -126.26 25.58 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.996 -0.621 . . . . 0.0 113.296 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.428 ' O ' ' HA ' ' A' ' 44' ' ' THR . 21.1 p30 -89.89 17.47 6.7 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.727 0.299 . . . . 0.0 111.561 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 7.0 m-30 -130.29 145.51 51.78 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.05 114.8 11.25 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.578 0.227 . . . . 0.0 110.677 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.529 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 0.6 OUTLIER -101.22 121.36 51.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 121.123 0.487 . . . . 0.0 111.036 -179.855 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.7 p -136.7 161.35 36.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.869 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -58.99 141.16 54.63 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.77 -47.38 80.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.864 0.364 . . . . 0.0 111.267 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -67.7 -9.51 44.31 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.213 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.26 2.09 13.95 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.436 ' HB2' HD21 ' A' ' 41' ' ' LEU . . . -87.65 131.82 34.31 Favored 'General case' 0 C--O 1.23 0.07 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.975 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.497 ' O ' ' HD1' ' A' ' 28' ' ' TRP . 42.2 p -74.67 163.29 27.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.712 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 46.3 p-80 -53.74 -29.71 40.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.855 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.7 t -68.61 -33.2 58.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.804 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -68.0 -43.93 77.73 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.497 ' HD1' ' O ' ' A' ' 24' ' ' THR . 45.5 m95 -73.96 -29.95 62.26 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.993 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -60.89 -44.1 97.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.46 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -115.71 33.9 5.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.593 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.488 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 30.5 p -72.64 122.92 22.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.187 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.411 ' CG2' HG13 ' A' ' 42' ' ' VAL . 11.6 m -86.19 -40.01 14.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.682 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.479 ' CE3' HG23 ' A' ' 42' ' ' VAL . 0.8 OUTLIER -139.87 151.18 45.45 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.202 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.414 ' HG2' ' HB2' ' A' ' 41' ' ' LEU . 5.3 mt-10 -154.79 116.3 4.09 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.188 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.435 ' HB2' ' CZ2' ' A' ' 33' ' ' TRP . 23.5 m-20 -107.26 110.27 22.26 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.804 0.335 . . . . 0.0 111.054 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -65.16 -29.91 70.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.427 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.508 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 0.4 OUTLIER -63.78 -27.83 69.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.128 -179.727 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -117.53 6.67 12.55 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 121.096 -0.242 . . . . 0.0 111.56 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 47.56 45.12 17.55 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.961 0.41 . . . . 0.0 110.673 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 23.0 tp -133.2 151.23 51.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.142 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.529 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -148.36 155.7 41.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.374 179.569 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.479 HG23 ' CE3' ' A' ' 33' ' ' TRP . 39.0 t -117.95 132.48 67.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.325 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.9 t -123.86 157.01 35.17 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.215 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' A' ' 14' ' ' ASN . 18.6 p -97.76 128.89 44.73 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.269 0.557 . . . . 0.0 111.638 -179.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.451 HG23 ' CE2' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -121.39 167.15 13.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.831 -179.368 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.6 m -114.85 38.62 3.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.846 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -113.29 -168.77 1.38 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.105 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 29.5 m80 -101.57 144.76 29.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.855 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -106.42 129.55 9.79 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.529 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 92.2 m -113.69 -32.05 6.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.803 0.335 . . . . 0.0 111.043 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -70.09 134.12 47.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.939 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 67.6 m -118.97 117.25 28.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.599 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.521 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 0.4 OUTLIER -76.36 139.46 18.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.04 0.448 . . . . 0.0 111.406 -179.591 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.469 ' HB2' ' CA ' ' A' ' 119' ' ' GLY . . . -96.59 101.53 13.16 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.397 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -80.18 59.19 3.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.089 0.471 . . . . 0.0 110.148 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -120.73 158.97 26.33 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.159 -179.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -96.74 18.72 13.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.384 179.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 29.5 p -57.31 129.07 40.16 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.97 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.1 m -92.03 12.35 22.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.272 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 25.9 p -129.99 130.81 45.48 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.818 0.342 . . . . 0.0 110.947 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -153.96 -161.8 10.67 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.31 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.9 p -140.05 135.52 37.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.096 0.474 . . . . 0.0 111.225 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.447 ' CD1' ' O ' ' A' ' 63' ' ' TYR . 27.4 p90 -109.97 125.94 53.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.678 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.438 ' HA ' ' HA ' ' A' ' 71' ' ' HIS . 15.4 t80 -114.26 134.64 54.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.916 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 68' ' ' LYS . 0.8 OUTLIER 65.68 19.7 11.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.593 179.627 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.416 ' HB2' ' CD1' ' A' ' 63' ' ' TYR . . . -92.0 -45.32 8.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.858 0.361 . . . . 0.0 110.937 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.0 t -115.2 -37.97 3.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.314 179.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 65' ' ' CYS . 2.2 mmtt -127.9 -173.5 2.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.078 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.26 29.37 1.93 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.935 0.398 . . . . 0.0 110.866 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.429 ' HE3' ' HB3' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -143.36 171.42 14.15 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.814 -179.429 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 64' ' ' PHE . 56.4 p-80 -83.91 136.48 34.08 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.443 ' HB2' ' CE1' ' A' ' 63' ' ' TYR . 13.5 m-85 -129.84 114.9 17.84 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -178.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -69.98 120.65 7.37 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.259 1.973 . . . . 0.0 110.319 178.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.451 ' CG1' ' CE2' ' A' ' 76' ' ' PHE . 2.5 p -143.68 153.76 16.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.5 m -95.03 132.9 39.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.172 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.501 ' CD1' ' N ' ' A' ' 76' ' ' PHE . 0.0 OUTLIER -135.02 163.27 30.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.324 0.583 . . . . 0.0 111.921 -179.008 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.448 ' O ' ' HA ' ' A' ' 99' ' ' LEU . 5.9 pt-20 -111.8 158.32 19.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.142 -0.936 . . . . 0.0 109.293 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -106.04 65.8 0.27 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.385 -0.912 . . . . 0.0 113.591 -179.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.498 ' HD2' ' HA ' ' A' ' 99' ' ' LEU . 37.5 Cg_endo -67.74 134.15 31.69 Favored 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 122.263 1.975 . . . . 0.0 111.949 179.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -58.27 -84.48 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.586 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.486 HD13 ' HB3' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -97.18 120.32 37.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.866 0.365 . . . . 0.0 111.855 -179.618 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.422 ' CG2' ' CG1' ' A' ' 98' ' ' VAL . 48.1 t -123.91 122.58 64.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.371 178.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -72.44 107.99 5.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.91 0.386 . . . . 0.0 110.521 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.472 ' HB ' ' HG3' ' A' ' 126' ' ' MET . 17.2 m -76.11 123.46 32.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.666 -179.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -69.92 150.52 46.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.734 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.516 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 31.0 tt0 -67.7 102.43 1.2 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.939 0.399 . . . . 0.0 110.321 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.439 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.7 OUTLIER -143.94 165.95 26.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.331 -179.729 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 55.08 -82.42 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.564 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.439 ' N ' ' O ' ' A' ' 87' ' ' SER . 0.4 OUTLIER -154.92 22.84 0.44 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.703 0.287 . . . . 0.0 110.917 -179.878 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.516 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 2.3 t80 -122.88 133.18 24.33 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.918 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.432 ' O ' ' N ' ' A' ' 93' ' ' ARG . 89.1 Cg_endo -83.08 148.96 13.49 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.173 2.582 . . . . 0.0 112.417 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.2 OUTLIER -40.16 92.79 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.401 -179.908 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.432 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -123.71 -179.19 4.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.133 0.492 . . . . 0.0 111.683 -179.342 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.486 ' HB3' HD13 ' A' ' 81' ' ' LEU . 23.0 m-85 -106.38 132.29 52.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.024 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.508 ' HA ' ' O ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -128.79 124.03 34.39 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.934 -179.888 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -96.74 156.58 16.28 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 121.058 0.456 . . . . 0.0 111.779 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 56.91 57.18 4.82 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.491 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.422 ' CG1' ' CG2' ' A' ' 82' ' ' VAL . 8.0 p -123.37 135.55 62.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.964 0.411 . . . . 0.0 111.367 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.498 ' HA ' ' HD2' ' A' ' 79' ' ' PRO . 2.7 mp -101.91 146.94 27.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.907 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.543 ' HA ' ' O ' ' A' ' 132' ' ' VAL . 6.5 mt -133.03 139.87 47.43 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.461 ' O ' ' HA ' ' A' ' 131' ' ' VAL . . . -144.13 150.97 38.93 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.394 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.2 t -111.13 140.04 46.01 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.862 0.363 . . . . 0.0 111.231 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -131.89 -81.54 0.21 Allowed Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.468 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -123.91 157.43 34.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.844 0.354 . . . . 0.0 110.842 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.8 94.26 5.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.869 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -171.84 152.31 3.0 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.856 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.4 -59.81 0.95 Allowed 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.409 2.073 . . . . 0.0 112.284 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 117.49 -59.44 0.48 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.601 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.3 t70 61.18 170.29 0.1 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.783 0.325 . . . . 0.0 110.892 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 61.47 -172.23 0.15 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.011 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -156.31 133.34 3.63 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.441 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -138.44 -161.29 8.75 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.411 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 28.3 pt -126.07 146.11 32.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.773 0.321 . . . . 0.0 111.164 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.515 ' HG ' ' HB ' ' A' ' 121' ' ' ILE . 6.7 tp -87.81 113.5 23.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.388 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.83 139.38 51.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.257 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 21.8 p -105.66 166.87 10.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.194 179.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -55.93 -20.2 15.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.348 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 11.4 m80 -91.16 -22.21 20.78 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.79 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.469 ' CA ' ' HB2' ' A' ' 54' ' ' ALA . . . 163.56 -143.8 8.94 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.145 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.521 ' HB ' ' HA ' ' A' ' 53' ' ' ILE . 3.6 t -100.24 135.53 35.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.724 0.297 . . . . 0.0 111.107 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.515 ' HB ' ' HG ' ' A' ' 114' ' ' LEU . 1.3 mm -96.95 -67.15 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.835 0.35 . . . . 0.0 110.982 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.462 ' HA3' ' O ' ' A' ' 135' ' ' ALA . . . -155.4 -154.01 6.76 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.831 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.53 164.14 25.51 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.031 0.443 . . . . 0.0 111.069 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.424 ' HA ' ' HD1' ' A' ' 134' ' ' PHE . 14.5 p -57.86 115.08 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.319 -179.225 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.45 ' CG2' ' N ' ' A' ' 126' ' ' MET . 1.6 m -101.49 -87.22 0.4 Allowed 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.494 ' O ' ' HA3' ' A' ' 133' ' ' GLY . 0.0 OUTLIER -136.13 129.78 32.3 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-O 120.997 0.427 . . . . 0.0 111.583 179.57 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -109.14 149.13 17.08 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.654 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -104.47 -156.9 23.62 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.469 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -71.81 -19.44 61.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.725 0.298 . . . . 0.0 111.173 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -159.03 16.18 0.24 Allowed Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.983 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 101' ' ' ALA . 0.9 OUTLIER -126.51 157.23 37.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.755 0.312 . . . . 0.0 110.857 179.861 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.543 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 29.0 m -116.97 118.32 58.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.354 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.494 ' HA3' ' O ' ' A' ' 126' ' ' MET . . . -99.87 113.94 4.87 Favored Glycine 0 C--N 1.329 0.192 0 C-N-CA 120.499 -0.858 . . . . 0.0 111.997 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.455 ' CD2' ' HB2' ' A' ' 114' ' ' LEU . 53.4 m-85 -118.14 138.04 52.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.748 0.308 . . . . 0.0 111.357 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.462 ' O ' ' HA3' ' A' ' 122' ' ' GLY . . . -88.41 115.4 25.88 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 179.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -67.38 141.93 56.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.25 0.548 . . . . 0.0 112.438 -178.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.403 HG12 ' CD1' ' A' ' 140' ' ' LEU . 56.5 t -89.9 9.87 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.413 178.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.44 ' HA ' HD22 ' A' ' 141' ' ' LEU . 9.3 mmm180 -70.63 -6.74 39.07 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.641 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -98.28 11.04 39.21 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.481 0.181 . . . . 0.0 111.439 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.56 ' N ' ' CD1' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -177.19 47.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.018 0.437 . . . . 0.0 110.595 -179.811 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' A' ' 143' ' ' LEU . 0.1 OUTLIER -66.39 -14.6 62.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.15 -179.67 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 15.6 p-90 -54.52 81.61 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.068 0.461 . . . . 0.0 111.539 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.519 ' N ' ' O ' ' A' ' 141' ' ' LEU . 5.0 mp -149.37 -43.89 0.14 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.954 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.425 ' HB2' ' CG1' ' A' ' 12' ' ' VAL . 7.6 mt-10 -152.29 -170.42 3.64 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.445 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -58.83 132.27 53.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.79 0.328 . . . . 0.0 110.888 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -94.63 154.11 17.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.003 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.27 147.86 44.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.086 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.22 118.58 21.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.86 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -116.52 31.06 6.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.889 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.901 -179.999 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 112.534 -0.227 . . . . 0.0 112.534 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.9 -33.22 16.49 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.583 2.189 . . . . 0.0 112.319 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -114.83 175.31 5.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.928 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.13 36.46 8.95 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.485 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.76 -62.27 1.76 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.82 0.343 . . . . 0.0 110.982 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 60.59 179.5 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.883 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.3 m -152.95 157.12 40.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.909 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -135.2 27.15 3.17 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.51 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -175.64 -179.65 1.27 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.799 0.333 . . . . 0.0 110.988 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.2 t -116.49 108.21 24.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.069 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.466 ' CE2' ' CG2' ' A' ' 45' ' ' THR . 6.1 t80 -99.57 116.41 31.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.692 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.42 ' CG2' HD13 ' A' ' 53' ' ' ILE . 24.8 t -120.77 108.95 23.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.804 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 50.8 -126.49 25.8 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.986 -0.626 . . . . 0.0 113.259 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.501 ' O ' ' HA ' ' A' ' 44' ' ' THR . 2.7 p-10 -88.58 13.06 12.95 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.436 ' CE2' ' CE3' ' A' ' 142' ' ' TRP . 5.8 m-30 -130.49 127.93 40.17 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.6 tttt -120.56 114.88 22.38 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.994 -0.282 . . . . 0.0 110.792 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.516 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 0.6 OUTLIER -99.33 121.64 50.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-O 121.161 0.505 . . . . 0.0 110.916 179.894 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.6 p -136.92 161.32 36.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.02 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -59.89 141.22 55.86 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.418 ' HB2' ' CH2' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -56.77 -43.98 81.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.796 0.332 . . . . 0.0 111.235 -179.493 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -67.82 -10.93 57.03 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.11 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -115.26 0.61 13.56 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.463 ' HB2' HD21 ' A' ' 41' ' ' LEU . . . -86.69 127.06 34.93 Favored 'General case' 0 C--O 1.23 0.072 0 C-N-CA 120.331 -0.548 . . . . 0.0 111.028 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.504 ' O ' ' HD1' ' A' ' 28' ' ' TRP . 1.7 t -74.71 165.48 25.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.916 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -53.62 -29.86 40.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.878 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.436 HG11 ' N ' ' A' ' 27' ' ' ASP . 11.5 p -71.85 -31.67 41.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.716 0.293 . . . . 0.0 110.996 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.436 ' N ' HG11 ' A' ' 26' ' ' VAL . 0.4 OUTLIER -68.11 -43.97 77.2 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.099 0.475 . . . . 0.0 109.751 179.332 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.504 ' HD1' ' O ' ' A' ' 24' ' ' THR . 53.2 m95 -74.05 -35.27 64.28 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.064 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.56 -40.92 80.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.75 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -116.94 34.63 5.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.782 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.471 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 29.2 p -77.15 125.62 29.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.043 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.423 HG12 ' CG2' ' A' ' 44' ' ' THR . 16.1 m -87.43 -38.04 11.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.705 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.45 ' CE3' HG23 ' A' ' 42' ' ' VAL . 2.9 t90 -139.56 153.52 47.44 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.776 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 5.2 tm-20 -162.69 120.54 2.06 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.789 0.328 . . . . 0.0 111.581 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.412 ' HB2' ' CZ2' ' A' ' 33' ' ' TRP . 0.7 OUTLIER -107.05 98.68 8.3 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.45 179.338 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -56.95 -29.55 63.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.935 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.595 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 6.3 t-20 -64.4 -41.04 96.86 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 120.584 0.23 . . . . 0.0 110.822 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -99.55 -4.23 31.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.532 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 60.03 48.36 8.7 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.047 0.451 . . . . 0.0 110.706 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 21.2 tp -136.41 146.51 46.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.671 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.516 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -147.24 155.79 42.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.987 0.422 . . . . 0.0 111.899 179.802 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.45 HG23 ' CE3' ' A' ' 33' ' ' TRP . 35.8 t -117.36 125.0 73.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.272 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.0 p -118.19 157.41 27.02 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.567 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 14' ' ' ASN . 15.2 p -97.29 142.71 28.84 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.243 0.544 . . . . 0.0 111.638 -178.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.466 ' CG2' ' CE2' ' A' ' 11' ' ' TYR . 0.4 OUTLIER -137.52 172.49 12.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.89 -179.195 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -122.68 36.04 4.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.759 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -107.38 -167.89 1.32 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.183 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -102.83 148.03 26.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.985 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -57.09 -174.39 0.26 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.552 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -154.59 -45.97 0.09 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.9 0.381 . . . . 0.0 111.021 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -128.66 170.71 12.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.969 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 29.6 m -125.13 123.39 39.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.533 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.486 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 0.5 OUTLIER -72.65 139.55 19.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.871 0.367 . . . . 0.0 111.175 -179.643 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.402 ' HB1' ' CA ' ' A' ' 119' ' ' GLY . . . -88.08 122.93 32.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.383 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -94.11 28.98 2.28 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.172 0.51 . . . . 0.0 109.962 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 23.0 p -99.82 167.3 10.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.996 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -117.69 28.81 8.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.26 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 34.0 m -58.84 131.16 50.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.853 0.359 . . . . 0.0 110.539 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.48 -1.07 44.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.326 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 16.3 p -127.91 123.99 36.32 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.998 0.428 . . . . 0.0 111.265 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.25 -169.14 12.01 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.753 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.8 p -140.22 132.76 33.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 117.143 0.472 . . . . 0.0 111.327 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.475 ' CG ' ' CZ ' ' A' ' 134' ' ' PHE . 40.5 p90 -120.18 132.12 55.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.582 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.408 ' HA ' ' HA ' ' A' ' 71' ' ' HIS . 1.2 t80 -73.84 156.75 37.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.579 -179.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 1.3 m 66.01 60.57 0.66 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.204 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.405 ' HB3' ' CD1' ' A' ' 72' ' ' TYR . . . -92.22 -45.23 8.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.908 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 26.7 t 175.74 36.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.932 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.437 ' HG2' ' HD3' ' A' ' 70' ' ' LYS . 0.3 OUTLIER -176.29 31.91 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.595 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 45.86 31.24 1.01 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.09 0.471 . . . . 0.0 110.904 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.437 ' HD3' ' HG2' ' A' ' 68' ' ' LYS . 12.8 mtpt -134.87 171.55 14.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.768 -179.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 64' ' ' PHE . 5.1 p80 -83.19 139.04 33.38 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.405 ' CD1' ' HB3' ' A' ' 66' ' ' ALA . 2.6 m-85 -126.03 114.58 24.14 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.57 -178.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -68.34 120.46 7.41 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 121.886 1.724 . . . . 0.0 109.964 178.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.45 ' CG1' ' CB ' ' A' ' 101' ' ' ALA . 43.8 t -140.41 141.83 32.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -178.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 87.9 p -93.02 133.15 36.45 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.51 ' HB3' ' HB3' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -136.25 166.2 23.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.372 0.606 . . . . 0.0 112.166 -178.347 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' A' ' 99' ' ' LEU . 0.1 OUTLIER -111.71 158.48 19.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.183 178.848 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -105.16 67.5 0.27 Allowed Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.378 -0.915 . . . . 0.0 113.464 -179.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.49 ' HD2' ' HA ' ' A' ' 99' ' ' LEU . 37.6 Cg_endo -67.63 134.28 32.33 Favored 'Trans proline' 0 C--O 1.237 0.47 0 C-N-CA 122.227 1.951 . . . . 0.0 111.952 179.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -54.84 -83.24 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.673 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.473 HD12 ' CD2' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -105.09 120.18 40.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.867 0.365 . . . . 0.0 111.959 -179.646 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.427 ' HB ' ' CG1' ' A' ' 98' ' ' VAL . 42.2 t -121.1 122.18 66.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.376 178.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -76.35 108.05 9.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.941 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 34.8 m -73.83 124.13 30.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.055 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -69.55 150.11 47.48 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.722 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.577 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 61.3 tt0 -68.02 102.16 1.25 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.999 0.428 . . . . 0.0 110.638 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.436 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.3 OUTLIER -144.07 160.11 41.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.364 -179.825 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.401 ' HB3' ' H ' ' A' ' 89' ' ' TYR . 8.1 tt0 56.06 -81.51 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.679 179.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.436 ' N ' ' O ' ' A' ' 87' ' ' SER . 3.2 p90 -155.73 26.18 0.39 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.861 0.363 . . . . 0.0 110.822 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.577 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 1.0 OUTLIER -122.48 124.35 26.8 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.557 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.46 ' O ' ' N ' ' A' ' 93' ' ' ARG . 72.0 Cg_endo -76.46 148.65 30.06 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.881 2.387 . . . . 0.0 112.512 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -46.25 89.4 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.17 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.46 ' N ' ' O ' ' A' ' 91' ' ' PRO . 1.7 mmm180 -124.02 174.34 7.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.299 0.571 . . . . 0.0 112.156 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.473 ' CD2' HD12 ' A' ' 81' ' ' LEU . 5.4 m-85 -100.18 132.62 45.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.214 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.595 ' HA ' ' O ' ' A' ' 37' ' ' ASN . 12.2 mm-40 -118.85 116.58 26.8 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.245 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.408 ' CB ' ' HB3' ' A' ' 37' ' ' ASN . 44.3 t -83.15 146.07 28.85 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.048 0.452 . . . . 0.0 111.716 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.417 ' CE1' ' HB3' ' A' ' 136' ' ' ASP . 1.5 t-80 52.22 65.55 1.47 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.037 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.427 ' CG1' ' HB ' ' A' ' 82' ' ' VAL . 10.6 p -123.6 141.8 42.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.17 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.49 ' HA ' ' HD2' ' A' ' 79' ' ' PRO . 9.4 mp -102.13 142.49 33.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.009 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.556 ' HA ' ' O ' ' A' ' 132' ' ' VAL . 5.6 mt -133.09 142.08 48.54 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -179.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.51 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . . . -152.17 146.08 25.19 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.806 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 1.1 t -99.93 129.28 45.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.913 0.387 . . . . 0.0 111.228 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -109.91 -115.68 3.73 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.436 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -148.11 30.07 0.87 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.896 0.379 . . . . 0.0 110.851 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.3 m -98.94 -163.6 1.05 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.873 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.466 ' CB ' ' CD ' ' A' ' 107' ' ' PRO . 1.6 mt-10 -159.97 -65.79 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.029 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.466 ' CD ' ' CB ' ' A' ' 106' ' ' GLU . 55.9 Cg_endo -70.09 -40.9 4.31 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.304 2.003 . . . . 0.0 112.302 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 93.68 137.93 8.73 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.62 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -113.53 -36.77 4.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.86 0.362 . . . . 0.0 110.958 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 61.29 172.72 0.11 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.141 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 89.92 108.35 1.28 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.457 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 140.09 157.32 7.2 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.497 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 26.9 pt -109.32 145.68 15.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.793 0.33 . . . . 0.0 111.065 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.428 HD13 ' CZ ' ' A' ' 76' ' ' PHE . 34.2 tp -87.77 117.02 26.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.444 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.407 ' HA ' HD12 ' A' ' 121' ' ' ILE . 8.1 mtt180 -118.49 145.86 44.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.148 0.499 . . . . 0.0 111.93 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.437 ' HB2' HD11 ' A' ' 121' ' ' ILE . 13.9 t -107.85 165.05 11.73 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.304 178.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.68 -17.46 5.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.777 0.322 . . . . 0.0 110.484 179.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 45.4 m80 -93.54 -36.25 12.51 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.581 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.402 ' CA ' ' HB1' ' A' ' 54' ' ' ALA . . . 179.02 -136.91 3.0 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 120.191 -1.004 . . . . 0.0 113.936 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.486 ' HB ' ' HA ' ' A' ' 53' ' ' ILE . 3.0 t -105.11 136.24 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -179.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.453 ' N ' HD12 ' A' ' 121' ' ' ILE . 1.9 mp -95.47 -40.07 10.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.43 ' HA2' ' CG2' ' A' ' 137' ' ' VAL . . . 162.01 -156.78 28.44 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.889 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.79 164.11 15.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.791 0.329 . . . . 0.0 110.851 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 11.4 p -68.36 131.62 33.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.427 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.453 ' CG2' ' N ' ' A' ' 126' ' ' MET . 1.9 m -103.08 -87.49 0.42 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.231 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.453 ' N ' ' CG2' ' A' ' 125' ' ' THR . 0.0 OUTLIER -131.42 162.05 31.05 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-O 120.807 0.337 . . . . 0.0 111.415 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -133.48 150.92 19.98 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.669 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -104.13 -153.06 22.86 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.449 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.94 -19.55 61.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.651 0.262 . . . . 0.0 111.103 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -164.04 16.78 0.11 Allowed Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.597 -0.811 . . . . 0.0 113.081 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 0.9 OUTLIER -120.29 157.26 23.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.776 0.322 . . . . 0.0 110.692 179.806 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.561 ' HB ' ' CZ ' ' A' ' 134' ' ' PHE . 14.3 m -115.85 118.4 58.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.408 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 99' ' ' LEU . . . -100.2 123.19 7.84 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.966 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.561 ' CZ ' ' HB ' ' A' ' 132' ' ' VAL . 10.0 m-85 -124.83 140.15 53.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.854 0.359 . . . . 0.0 111.413 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.422 ' O ' ' HA3' ' A' ' 122' ' ' GLY . . . -88.76 114.34 25.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.057 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.417 ' HB3' ' CE1' ' A' ' 97' ' ' HIS . 3.0 t0 -73.12 146.55 45.64 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -178.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.507 ' O ' HD13 ' A' ' 140' ' ' LEU . 62.0 t -104.95 5.86 10.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.139 178.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 12.2 mtm-85 -72.17 -6.51 43.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.26 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -94.64 7.34 46.07 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 120.726 0.298 . . . . 0.0 111.277 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.567 ' N ' ' CD1' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -169.6 59.79 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.289 0.566 . . . . 0.0 109.92 179.818 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' A' ' 143' ' ' LEU . 0.1 OUTLIER -74.06 -14.88 61.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.298 -179.092 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . 0.436 ' CE3' ' CE2' ' A' ' 15' ' ' TYR . 15.5 p-90 -54.72 81.51 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.972 0.415 . . . . 0.0 111.388 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.519 ' N ' ' O ' ' A' ' 141' ' ' LEU . 5.0 mp -150.17 -47.21 0.13 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.979 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.415 ' HB2' ' CG1' ' A' ' 12' ' ' VAL . 9.2 mm-40 -154.07 -170.01 3.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.527 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.95 139.8 56.27 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.832 0.349 . . . . 0.0 111.043 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.97 154.22 18.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.878 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -79.04 149.02 32.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.114 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -179.2 -38.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.925 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -131.51 31.05 4.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.851 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.857 -179.981 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.24 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.07 146.52 58.51 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.625 2.216 . . . . 0.0 112.259 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -147.03 117.16 7.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.895 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -136.28 -143.43 4.66 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.5 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -108.45 -47.64 3.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.796 0.332 . . . . 0.0 110.8 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -113.77 149.87 34.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.932 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 91.1 p -169.55 -179.98 3.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.874 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 169.44 43.46 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.554 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -128.61 156.2 43.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.839 0.352 . . . . 0.0 111.107 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.62 117.62 50.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.242 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.43 ' CE2' HG21 ' A' ' 45' ' ' THR . 5.6 t80 -106.55 116.59 32.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.483 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.433 HG11 ' CB ' ' A' ' 143' ' ' LEU . 21.2 t -120.8 114.62 44.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.802 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 46.94 -123.87 8.01 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 121.157 -0.544 . . . . 0.0 113.335 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.428 ' O ' ' HA ' ' A' ' 44' ' ' THR . 68.6 m-20 -90.07 15.79 9.54 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.638 0.256 . . . . 0.0 111.602 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.417 ' CE2' ' CE3' ' A' ' 142' ' ' TRP . 6.8 m-30 -130.41 148.62 52.24 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.01 114.71 9.93 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.56 0.219 . . . . 0.0 110.579 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.545 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 0.6 OUTLIER -100.38 122.0 51.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.054 0.454 . . . . 0.0 110.842 -179.969 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.433 HG21 ' HB3' ' A' ' 22' ' ' LEU . 12.5 p -136.06 160.98 38.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.216 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.4 m-20 -61.47 141.44 57.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.447 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.4 ttt-85 -56.63 -47.33 79.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.899 0.38 . . . . 0.0 110.736 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -68.75 -11.02 59.83 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.912 179.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.433 ' HB3' HG21 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -108.65 -12.1 15.0 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.686 -179.735 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.498 ' O ' ' CZ3' ' A' ' 28' ' ' TRP . . . -70.02 150.71 46.36 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 120.763 0.316 . . . . 0.0 110.753 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 16.9 p -105.03 169.04 8.66 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.326 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.443 ' CE1' ' CG2' ' A' ' 26' ' ' VAL . 13.8 p-80 -54.6 -29.63 52.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.044 0.449 . . . . 0.0 110.656 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.443 ' CG2' ' CE1' ' A' ' 25' ' ' HIS . 21.8 t -74.72 -31.32 26.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.385 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.402 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 4.0 m-20 -67.11 -44.14 80.69 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.498 ' CZ3' ' O ' ' A' ' 23' ' ' ALA . 7.4 m-90 -74.47 -31.63 62.29 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.125 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -58.02 -42.31 85.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.483 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -115.81 33.93 5.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.494 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.439 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 29.2 t -80.05 129.38 34.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.26 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.409 HG21 ' N ' ' A' ' 33' ' ' TRP . 13.0 m -92.57 -40.73 12.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.622 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.455 ' CE3' HG23 ' A' ' 42' ' ' VAL . 0.3 OUTLIER -139.72 153.49 47.23 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 121.047 0.451 . . . . 0.0 111.644 -179.361 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -154.41 120.25 5.23 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.472 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.434 ' HB2' ' CZ2' ' A' ' 33' ' ' TRP . 6.1 m-20 -100.42 116.7 32.99 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.414 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -65.83 -43.32 88.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.875 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.47 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 7.0 m120 -71.2 -10.96 60.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.011 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.413 ' NE ' ' CB ' ' A' ' 135' ' ' ALA . 3.5 tpm_? -117.1 -4.96 11.41 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 121.151 -0.22 . . . . 0.0 111.301 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 47.12 33.98 2.69 Favored 'General case' 0 N--CA 1.46 0.059 0 CA-C-O 121.122 0.486 . . . . 0.0 110.27 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 41.6 tp -126.8 153.37 45.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.747 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.545 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -146.79 155.69 42.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.871 0.367 . . . . 0.0 111.781 179.754 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.455 HG23 ' CE3' ' A' ' 33' ' ' TRP . 24.7 t -119.14 130.04 74.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.342 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.6 p -121.07 157.13 30.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.556 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' A' ' 14' ' ' ASN . 17.4 p -97.74 128.67 44.57 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.182 0.515 . . . . 0.0 111.471 -179.183 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.43 HG21 ' CE2' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -103.61 -34.19 8.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.889 -179.245 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.0 m 68.37 59.22 0.41 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.017 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.13 -167.86 2.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.201 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 46.8 p-80 -81.93 148.01 28.96 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.984 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -93.55 153.17 21.18 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.718 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.5 m -125.73 -62.72 1.17 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.869 0.366 . . . . 0.0 110.742 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -69.07 147.21 51.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.681 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 62.8 m -123.56 117.53 25.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.94 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.493 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 0.4 OUTLIER -73.07 139.34 19.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.644 179.864 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -95.96 124.84 40.14 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.926 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.94 33.9 0.93 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.504 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 26.6 p -99.69 167.13 10.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.892 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -123.03 39.71 3.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.177 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 19.3 m -68.94 131.77 45.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.779 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.1 t -76.86 -7.15 54.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.811 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.7 p -117.84 123.93 47.11 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.988 0.423 . . . . 0.0 111.091 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -148.98 162.56 28.96 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.571 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.506 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 13.2 p -99.86 134.42 39.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.193 0.521 . . . . 0.0 111.669 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -120.26 -170.7 2.02 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.059 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.45 ' CG ' ' HB2' ' A' ' 67' ' ' SER . 0.6 OUTLIER 68.43 -91.09 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.197 179.913 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 70.63 -63.34 0.41 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.658 0.266 . . . . 0.0 111.255 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.65 -38.63 12.97 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.774 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.45 ' HB2' ' CG ' ' A' ' 64' ' ' PHE . 3.6 m -46.58 -68.18 0.22 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.295 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.22 9.87 21.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.097 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 66.13 12.53 8.57 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.144 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.84 168.35 20.15 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.066 0.46 . . . . 0.0 110.937 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.447 ' HB2' HG23 ' A' ' 62' ' ' VAL . 12.5 p-80 -87.9 116.8 26.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.569 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.407 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 1.8 m-85 -106.78 113.17 63.07 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.073 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.506 ' HA ' ' HA ' ' A' ' 62' ' ' VAL . 6.0 Cg_exo -80.27 139.11 12.97 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.846 2.364 . . . . 0.0 111.632 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.452 ' CG1' ' CE2' ' A' ' 76' ' ' PHE . 1.3 p -151.14 161.26 3.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.016 0.436 . . . . 0.0 111.892 -179.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.5 p -106.88 126.62 52.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.227 178.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.479 ' CD1' ' N ' ' A' ' 76' ' ' PHE . 0.0 OUTLIER -128.48 166.18 19.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.654 0.74 . . . . 0.0 112.294 -179.111 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.655 ' C ' ' HD3' ' A' ' 79' ' ' PRO . 1.3 mp0 -111.91 159.36 18.45 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.552 -1.204 . . . . 0.0 108.918 178.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.43 ' HA2' ' HG ' ' A' ' 99' ' ' LEU . . . -108.57 64.19 0.26 Allowed Glycine 0 CA--C 1.522 0.495 0 C-N-CA 120.135 -1.031 . . . . 0.0 114.155 -179.159 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.655 ' HD3' ' C ' ' A' ' 77' ' ' GLU . 14.9 Cg_exo -66.96 138.27 47.44 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.12 1.88 . . . . 0.0 111.965 179.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -62.77 -90.7 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.752 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.425 HD12 ' HB3' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -87.79 120.0 28.68 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.343 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.447 ' HB ' ' CG1' ' A' ' 98' ' ' VAL . 89.1 t -124.8 122.93 64.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.534 178.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.407 ' OE2' ' CE1' ' A' ' 94' ' ' TYR . 1.2 tp10 -72.11 107.9 5.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.986 0.422 . . . . 0.0 110.686 -179.163 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 2.9 p -83.06 114.39 23.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.739 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -74.35 150.37 40.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.471 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.512 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 5.8 pt-20 -67.72 100.78 0.95 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.274 0.559 . . . . 0.0 109.88 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.529 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.5 OUTLIER -145.16 172.92 12.42 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.62 -179.976 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 44.14 -85.17 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.614 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.529 ' N ' ' O ' ' A' ' 87' ' ' SER . 0.2 OUTLIER -150.15 23.21 0.84 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.818 0.342 . . . . 0.0 110.413 179.597 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.512 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 0.4 OUTLIER -116.34 145.68 35.66 Favored Pre-proline 0 C--O 1.232 0.17 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.999 -179.63 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -85.44 148.74 10.13 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.307 2.671 . . . . 0.0 112.697 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -65.42 72.81 0.05 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 179.894 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.92 -178.23 3.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.961 0.41 . . . . 0.0 111.621 -179.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.425 ' HB3' HD12 ' A' ' 81' ' ' LEU . 14.6 m-85 -94.99 132.17 40.15 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.586 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.47 ' HA ' ' O ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -131.15 125.56 33.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.667 0.27 . . . . 0.0 111.321 -179.681 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.415 ' HA ' ' HA ' ' A' ' 81' ' ' LEU . 1.4 t -102.09 154.21 19.2 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 120.917 0.389 . . . . 0.0 111.868 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 70.19 54.52 0.32 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.395 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.573 ' O ' ' HD2' ' A' ' 79' ' ' PRO . 5.0 p -123.46 141.73 42.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.223 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.43 ' HG ' ' HA2' ' A' ' 78' ' ' GLY . 5.6 mp -107.49 146.49 31.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.094 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.476 ' HA ' ' O ' ' A' ' 132' ' ' VAL . 6.1 mt -133.28 133.74 42.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.113 0.482 . . . . 0.0 112.189 -179.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' A' ' 131' ' ' VAL . . . -136.39 150.47 48.81 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.65 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.1 t -108.84 129.27 55.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.857 0.361 . . . . 0.0 110.98 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -89.96 -160.26 36.33 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.637 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -81.77 -66.18 0.92 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.78 0.324 . . . . 0.0 110.969 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 75.7 m -104.04 178.43 4.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.865 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -71.37 135.83 84.17 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.861 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -74.35 120.48 6.27 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.463 2.109 . . . . 0.0 112.379 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -91.19 -29.93 11.78 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.465 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -126.89 145.82 50.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.806 0.336 . . . . 0.0 110.885 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.67 172.26 0.73 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.051 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -114.51 -176.7 18.96 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.52 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -106.5 -96.06 2.44 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.443 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 34.5 pt -125.99 146.12 32.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.809 0.337 . . . . 0.0 111.218 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.446 HD12 ' CE2' ' A' ' 76' ' ' PHE . 16.3 tp -87.82 119.46 28.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.24 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -118.13 149.32 41.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.067 0.46 . . . . 0.0 111.786 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.492 ' HB2' HD12 ' A' ' 121' ' ' ILE . 7.4 t -115.48 163.08 16.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.149 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -55.85 -20.07 14.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.814 0.34 . . . . 0.0 110.818 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 26.7 m80 -90.64 -35.47 14.95 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.422 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 177.45 -139.31 4.25 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.333 -0.937 . . . . 0.0 113.281 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.493 ' HB ' ' HA ' ' A' ' 53' ' ' ILE . 3.4 t -100.91 135.39 37.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.687 0.279 . . . . 0.0 111.341 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.492 HD12 ' HB2' ' A' ' 116' ' ' CYS . 1.1 mm -95.78 -61.99 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.871 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.533 ' HA3' ' O ' ' A' ' 135' ' ' ALA . . . -174.9 -163.57 28.26 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.302 -0.951 . . . . 0.0 113.387 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.89 141.75 47.82 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.864 0.364 . . . . 0.0 111.002 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 10.6 p -57.94 148.81 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.94 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.87 -87.17 0.55 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.225 179.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.6 138.87 43.03 Favored 'General case' 0 N--CA 1.461 0.087 0 CA-C-O 120.997 0.427 . . . . 0.0 110.8 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -122.93 129.13 7.33 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.158 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -81.06 -160.19 23.98 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.497 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -71.84 -19.24 62.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.807 0.336 . . . . 0.0 110.815 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -158.07 18.23 0.33 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.708 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 101' ' ' ALA . 0.9 OUTLIER -125.03 157.01 33.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-O 120.666 0.269 . . . . 0.0 110.783 -180.0 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 11.3 m -118.55 118.79 59.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.801 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.405 ' CA ' HD22 ' A' ' 100' ' ' LEU . . . -91.67 124.51 7.65 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.615 -0.802 . . . . 0.0 111.487 179.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.418 ' CD2' ' HB2' ' A' ' 114' ' ' LEU . 19.2 m-85 -124.25 135.43 53.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.999 0.428 . . . . 0.0 111.912 -178.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.533 ' O ' ' HA3' ' A' ' 122' ' ' GLY . . . -88.84 112.19 22.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.836 178.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -67.55 136.76 55.03 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -178.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.446 ' O ' HD12 ' A' ' 140' ' ' LEU . 67.6 t -89.5 7.57 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.382 178.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 30.6 mmm-85 -71.11 -6.66 40.93 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.588 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.43 10.99 38.25 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.62 0.248 . . . . 0.0 111.332 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.57 ' N ' ' CD1' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -175.19 53.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.128 0.489 . . . . 0.0 110.6 -179.868 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.488 ' O ' ' N ' ' A' ' 143' ' ' LEU . 0.1 OUTLIER -70.61 -14.69 62.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.012 -179.52 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . 0.417 ' CE3' ' CE2' ' A' ' 15' ' ' TYR . 15.6 p-90 -54.52 83.62 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.134 0.493 . . . . 0.0 111.358 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.488 ' N ' ' O ' ' A' ' 141' ' ' LEU . 5.0 mp -151.52 -44.87 0.11 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.972 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -155.95 -163.19 1.43 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.662 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.03 145.62 55.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.889 0.376 . . . . 0.0 111.041 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -105.1 154.14 20.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.896 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -80.01 119.98 23.57 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.876 0.369 . . . . 0.0 111.043 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 2.2 ptp -127.69 137.18 52.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.955 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.18 82.85 2.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.849 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.251 -0.881 . . . . 0.0 110.867 179.969 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.157 0 N-CA-C 112.467 -0.253 . . . . 0.0 112.467 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.86 158.68 56.02 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.516 2.144 . . . . 0.0 112.251 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -85.53 145.28 27.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.96 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -114.99 152.83 17.98 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.45 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -149.76 160.08 43.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.735 0.303 . . . . 0.0 110.949 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -150.86 154.52 37.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.91 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 24.7 p -120.1 178.14 4.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.847 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 96.76 -29.64 10.17 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.458 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -107.31 -169.8 1.6 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.759 0.314 . . . . 0.0 110.985 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.4 p -124.61 119.13 55.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.981 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.451 ' CE1' ' CG2' ' A' ' 45' ' ' THR . 7.3 t80 -98.69 117.09 32.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.69 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.407 ' HB ' ' CD2' ' A' ' 143' ' ' LEU . 22.3 t -120.1 130.05 74.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.584 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.445 ' O ' ' CE1' ' A' ' 11' ' ' TYR . . . 46.01 -123.91 7.0 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 121.085 -0.579 . . . . 0.0 113.141 179.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 59.3 m-80 -99.27 19.82 14.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.784 0.326 . . . . 0.0 111.002 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.442 ' HB3' HG12 ' A' ' 42' ' ' VAL . 9.2 m-30 -130.22 152.14 49.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.085 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.59 114.79 10.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.276 179.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.525 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 0.7 OUTLIER -102.59 122.05 54.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 121.229 0.538 . . . . 0.0 111.388 -179.588 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.402 ' CG1' HD22 ' A' ' 41' ' ' LEU . 7.4 p -136.4 161.03 37.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.626 179.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -63.53 140.02 58.83 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 179.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.1 -38.86 73.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.717 0.294 . . . . 0.0 110.977 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.72 -10.45 58.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.11 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.62 -6.89 13.89 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.724 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.499 ' O ' ' CZ3' ' A' ' 28' ' ' TRP . . . -80.36 150.68 29.78 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.832 0.348 . . . . 0.0 110.925 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.413 ' O ' ' CE3' ' A' ' 28' ' ' TRP . 43.5 p -103.77 169.17 8.67 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.254 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -54.49 -29.56 50.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.917 0.389 . . . . 0.0 110.645 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.5 t -74.28 -31.37 28.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.324 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.422 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 0.5 OUTLIER -67.19 -44.08 80.51 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 179.856 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.499 ' CZ3' ' O ' ' A' ' 23' ' ' ALA . 7.5 m-90 -73.97 -30.15 62.36 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.884 179.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -58.1 -44.15 87.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.439 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -111.69 28.89 8.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.538 179.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 13.0 t -80.09 136.14 36.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.162 -179.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.427 HG23 ' N ' ' A' ' 33' ' ' TRP . 15.7 m -94.58 -41.61 12.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.753 179.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.459 ' CH2' ' HG ' ' A' ' 140' ' ' LEU . 0.1 OUTLIER -139.73 153.2 47.15 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.952 0.406 . . . . 0.0 111.503 -179.465 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -164.6 111.87 1.05 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.897 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 35.7 p-10 -107.26 126.54 52.55 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.017 0.437 . . . . 0.0 111.375 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -67.7 -34.56 77.13 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.295 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.425 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 11.7 p30 -59.75 -22.76 62.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.877 0.37 . . . . 0.0 110.601 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.436 ' NE ' ' HA ' ' A' ' 38' ' ' ARG . 3.2 tpm_? -117.39 -3.91 11.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.06 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 48.66 34.68 5.29 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.07 0.462 . . . . 0.0 110.059 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 41.5 tp -124.85 152.6 43.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.953 -179.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.525 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -143.78 155.92 44.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.472 179.692 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.446 HG21 ' CE3' ' A' ' 33' ' ' TRP . 24.4 t -121.41 130.33 74.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.152 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.0 p -121.93 157.26 31.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.29 179.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.8 p -97.36 125.11 41.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.166 0.508 . . . . 0.0 111.576 -179.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.451 ' CG2' ' CE1' ' A' ' 11' ' ' TYR . 0.7 OUTLIER -93.39 -31.55 14.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.904 -179.503 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.82 38.07 6.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.893 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -136.78 -175.39 4.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.078 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -71.77 125.85 28.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.895 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.38 173.53 11.24 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.498 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.2 m -142.9 -71.92 0.31 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.847 0.356 . . . . 0.0 110.903 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -67.52 146.67 53.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.007 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 62.7 m -120.91 118.97 31.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.579 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.499 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 1.0 OUTLIER -76.56 139.55 18.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.996 -179.84 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -100.81 118.42 36.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.802 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.77 42.65 1.11 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.104 0.478 . . . . 0.0 110.519 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 15.6 p -99.7 167.16 10.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.835 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.64 39.32 3.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.43 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 28.9 m -72.85 128.06 34.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.759 0.314 . . . . 0.0 110.526 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.54 -13.03 62.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.961 179.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.5 p -108.38 159.26 16.8 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.952 0.406 . . . . 0.0 111.09 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -177.18 148.84 9.08 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.675 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.4 p -105.08 136.47 38.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.997 0.427 . . . . 0.0 111.572 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.407 ' C ' ' CD1' ' A' ' 63' ' ' TYR . 5.6 p90 -125.1 142.08 51.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.564 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -56.27 120.06 6.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.915 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.443 ' HB2' ' CD1' ' A' ' 72' ' ' TYR . 0.8 OUTLIER -69.72 140.16 53.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.068 -179.804 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -85.14 -45.17 12.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.95 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.0 -30.64 62.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.535 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.9 tttp -115.15 152.89 31.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.67 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.2 m -96.02 36.25 1.33 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.951 0.405 . . . . 0.0 110.483 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.422 ' HD3' ' CE1' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -127.57 169.94 13.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.782 -179.472 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 5.5 m170 -84.24 127.05 33.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.75 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.443 ' CD1' ' HB2' ' A' ' 65' ' ' CYS . 3.1 m-85 -110.28 114.01 55.91 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.659 -178.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -79.14 120.6 4.61 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.534 2.156 . . . . 0.0 110.712 178.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.451 ' CG1' ' HB3' ' A' ' 101' ' ' ALA . 54.9 t -134.63 141.9 42.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.038 0.446 . . . . 0.0 112.162 -178.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.1 p -95.22 126.45 40.55 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.501 ' HB3' ' HB2' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -130.45 167.65 18.26 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.548 0.69 . . . . 0.0 112.358 -178.279 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.594 ' C ' ' HD3' ' A' ' 79' ' ' PRO . 0.9 OUTLIER -111.79 159.14 18.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.799 178.741 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -110.52 65.97 0.24 Allowed Glycine 0 CA--C 1.522 0.501 0 C-N-CA 120.081 -1.057 . . . . 0.0 114.196 -179.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.594 ' HD3' ' C ' ' A' ' 77' ' ' GLU . 16.2 Cg_exo -66.92 141.66 59.49 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.113 1.875 . . . . 0.0 111.914 179.301 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -61.59 -94.55 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.777 -0.647 . . . . 0.0 113.089 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.431 HD13 ' HB3' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -86.22 119.92 27.02 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.119 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.46 ' HB ' ' CG1' ' A' ' 98' ' ' VAL . 67.6 t -124.36 122.96 65.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.218 177.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.01 107.68 4.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.042 0.449 . . . . 0.0 110.679 -178.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 24.4 t -74.88 114.35 14.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.834 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.432 ' HA ' ' HG2' ' A' ' 92' ' ' LYS . 8.5 pt20 -77.02 150.18 35.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.574 179.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.579 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 23.0 tt0 -67.54 100.35 0.86 Allowed 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.945 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.523 ' O ' ' N ' ' A' ' 89' ' ' TYR . 43.0 t -145.12 159.8 42.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.674 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 50.96 -82.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.664 178.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.523 ' N ' ' O ' ' A' ' 87' ' ' SER . 2.0 p90 -155.91 25.83 0.38 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.846 0.355 . . . . 0.0 110.594 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.579 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 0.3 OUTLIER -116.67 116.45 38.67 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.574 -179.934 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.454 ' O ' ' N ' ' A' ' 93' ' ' ARG . 37.9 Cg_exo -60.4 148.68 89.65 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.88 2.387 . . . . 0.0 112.729 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.2 OUTLIER -61.95 73.07 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.832 179.55 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.454 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -124.14 179.76 4.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.189 0.518 . . . . 0.0 112.027 -179.314 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.431 ' HB3' HD13 ' A' ' 81' ' ' LEU . 11.1 m-85 -99.28 132.26 44.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.642 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.425 ' HA ' ' O ' ' A' ' 37' ' ' ASN . 1.5 mm100 -131.57 130.6 42.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.713 0.292 . . . . 0.0 111.242 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 11.0 p -102.4 147.88 26.17 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.886 0.374 . . . . 0.0 111.736 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 73.74 56.3 0.1 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.876 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.584 ' O ' ' HD2' ' A' ' 79' ' ' PRO . 10.0 p -123.57 143.18 37.59 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.036 179.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.431 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 10.7 mp -104.59 143.54 32.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.278 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.537 ' HA ' ' O ' ' A' ' 132' ' ' VAL . 6.5 mt -133.26 141.5 48.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.041 0.448 . . . . 0.0 112.158 -179.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.501 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . . . -150.99 144.86 25.17 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.971 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 1.2 t -100.28 125.32 46.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.914 0.387 . . . . 0.0 111.021 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -74.87 -45.98 19.08 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.527 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.6 t80 62.17 29.96 17.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.846 0.355 . . . . 0.0 110.917 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 43.9 m -138.94 -60.21 0.58 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.916 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -148.44 140.44 14.48 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.969 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -77.27 -175.51 2.7 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.611 2.207 . . . . 0.0 112.316 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.66 155.87 27.46 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.648 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -148.66 -49.76 0.16 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.777 0.322 . . . . 0.0 110.811 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 56.82 -168.3 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.222 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -90.36 104.55 3.15 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.561 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -152.01 175.12 30.87 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.359 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.5 pp -126.04 146.19 32.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.881 0.372 . . . . 0.0 111.192 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.561 ' HG ' ' HB ' ' A' ' 121' ' ' ILE . 7.9 tp -87.61 115.57 25.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.083 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.99 148.3 42.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.222 0.534 . . . . 0.0 111.718 -179.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.461 ' HB2' HD13 ' A' ' 121' ' ' ILE . 8.2 t -109.4 164.79 12.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.08 179.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.81 -20.41 15.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.807 0.337 . . . . 0.0 110.618 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 28.9 m80 -88.9 -36.84 15.72 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.291 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 178.42 -135.3 2.6 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.398 -0.906 . . . . 0.0 113.063 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.499 ' HB ' ' HA ' ' A' ' 53' ' ' ILE . 3.9 t -104.38 135.67 41.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.793 0.33 . . . . 0.0 111.402 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.561 ' HB ' ' HG ' ' A' ' 114' ' ' LEU . 1.1 mm -97.86 -67.05 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.774 179.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.439 ' HA2' ' CG2' ' A' ' 137' ' ' VAL . . . -156.96 -168.34 19.42 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.023 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -116.75 164.45 14.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.637 0.256 . . . . 0.0 110.456 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 31.3 m -71.99 137.78 22.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.933 0.397 . . . . 0.0 111.841 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.01 -91.23 0.46 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.168 178.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.94 145.63 27.06 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.333 179.255 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -145.81 107.28 0.41 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.596 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -91.18 -167.2 40.99 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.439 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -92.92 17.2 11.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.661 0.267 . . . . 0.0 111.135 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 102' ' ' THR . . . -158.6 -31.09 0.02 OUTLIER Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.94 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 1.7 t -115.39 157.11 16.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.772 0.32 . . . . 0.0 111.108 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.537 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 15.2 m -115.73 118.26 58.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.383 -179.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.432 ' CA ' HD21 ' A' ' 100' ' ' LEU . . . -96.06 122.02 7.16 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.055 179.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.455 ' CZ ' ' HB ' ' A' ' 132' ' ' VAL . 15.6 m-85 -125.17 139.47 53.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.976 0.417 . . . . 0.0 111.608 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.401 ' O ' ' HA3' ' A' ' 122' ' ' GLY . . . -88.87 115.08 26.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.364 179.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -68.98 140.07 55.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.984 0.421 . . . . 0.0 112.004 -179.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.476 ' CG1' ' O ' ' A' ' 137' ' ' VAL . 81.2 t -90.46 9.02 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.511 178.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.413 ' HA ' HD22 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -70.1 -6.58 34.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.619 179.922 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -97.08 11.17 37.15 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.577 ' N ' ' CD1' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -175.77 49.17 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.231 0.538 . . . . 0.0 110.61 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.476 ' O ' ' N ' ' A' ' 143' ' ' LEU . 0.1 OUTLIER -67.41 -14.75 63.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.997 -179.629 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . 0.422 ' CE3' ' CE2' ' A' ' 15' ' ' TYR . 16.7 p-90 -57.71 80.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.039 0.447 . . . . 0.0 111.495 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.476 ' N ' ' O ' ' A' ' 141' ' ' LEU . 4.9 mp -142.29 -47.28 0.34 Allowed 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.162 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -154.71 -162.98 1.48 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.669 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.69 122.15 16.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.976 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -85.33 154.21 22.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.935 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -80.91 120.03 24.21 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.06 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -105.23 169.82 8.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.93 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.02 125.67 24.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.893 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.859 179.941 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.812 0.339 . . . . 0.0 110.996 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.459 HG22 HG21 ' A' ' 113' ' ' ILE . 53.7 t -121.02 109.23 24.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.126 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.934 ' CE2' HG21 ' A' ' 45' ' ' THR . 0.4 OUTLIER -93.88 115.83 28.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.423 179.864 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.956 HG21 HD11 ' A' ' 53' ' ' ILE . 19.2 t -121.29 108.89 23.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.786 0.327 . . . . 0.0 111.816 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 48.35 -124.59 11.63 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.94 -0.648 . . . . 0.0 113.242 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.45 ' O ' ' HA ' ' A' ' 44' ' ' THR . 33.0 p-10 -90.96 13.08 17.64 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.655 ' CB ' HD23 ' A' ' 143' ' ' LEU . 6.6 m-85 -130.34 127.8 40.17 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.461 ' HG3' ' CD1' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -116.4 114.89 24.89 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.561 0.219 . . . . 0.0 110.686 179.687 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 1.067 HG12 HG22 ' A' ' 42' ' ' VAL . 0.7 OUTLIER -100.63 122.08 52.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.119 0.485 . . . . 0.0 110.777 179.68 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.526 HG22 ' N ' ' A' ' 19' ' ' ASN . 10.6 p -136.07 161.03 38.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.152 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.526 ' N ' HG22 ' A' ' 18' ' ' VAL . 4.7 t-20 -59.97 141.51 55.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.558 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 11.8 ttt180 -56.59 -47.12 80.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.855 0.36 . . . . 0.0 110.832 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 41.7 t-80 -69.1 -8.79 48.55 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.15 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 13.9 tp -110.78 -10.87 14.43 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.873 ' HB3' ' CZ2' ' A' ' 28' ' ' TRP . . . -73.27 150.61 41.83 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 120.792 0.329 . . . . 0.0 110.814 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.7 p -103.65 169.32 8.59 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.442 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -54.64 -29.78 53.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.886 0.374 . . . . 0.0 110.543 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.5 t -73.93 -31.42 30.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.42 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.421 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 0.2 OUTLIER -67.29 -44.08 80.15 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.898 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.873 ' CZ2' ' HB3' ' A' ' 23' ' ' ALA . 7.1 m-90 -74.29 -31.33 62.46 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.226 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 9.5 mm-40 -58.22 -43.8 87.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.452 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -113.46 33.39 5.16 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.404 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.476 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 27.2 t -80.05 134.11 36.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.279 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 42' ' ' VAL . 15.3 m -97.28 -39.86 9.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.617 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.612 ' HH2' HD23 ' A' ' 40' ' ' LEU . 1.2 t90 -139.36 153.11 47.62 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.856 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 2.0 tm-20 -160.34 118.15 2.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.959 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -107.1 111.05 23.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.973 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.402 ' CE2' ' OD1' ' A' ' 37' ' ' ASN . 50.5 p90 -59.63 -47.23 86.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.242 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.425 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 2.1 m120 -60.02 -25.94 65.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.793 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.411 ' CZ ' ' HB3' ' A' ' 139' ' ' ASP . 20.7 ttm180 -100.07 -7.7 24.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.302 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 51.06 34.83 11.56 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 121.145 0.497 . . . . 0.0 110.258 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.872 HD11 HG23 ' A' ' 17' ' ' VAL . 13.5 tp -133.71 149.68 51.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.974 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.667 ' O ' HD23 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -145.0 155.88 43.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.361 179.572 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 1.067 HG22 HG12 ' A' ' 17' ' ' VAL . 38.9 t -118.5 127.37 75.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.626 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.5 p -120.81 157.46 29.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.345 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.633 HG22 ' CE1' ' A' ' 15' ' ' TYR . 10.5 p -97.57 146.59 25.13 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.165 0.507 . . . . 0.0 111.66 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.934 HG21 ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -136.29 165.49 25.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.853 -179.25 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.1 t -93.29 -34.1 13.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.082 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.79 128.6 34.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.1 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -59.09 147.98 32.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.926 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -80.23 177.69 54.21 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.584 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -132.12 33.5 3.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.761 0.315 . . . . 0.0 110.905 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -138.45 144.49 40.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.911 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.85 ' O ' HG23 ' A' ' 120' ' ' VAL . 63.0 m -120.83 115.91 24.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.793 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.956 HD11 HG21 ' A' ' 12' ' ' VAL . 0.4 OUTLIER -73.86 139.54 19.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.018 -179.872 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.835 ' HB2' ' N ' ' A' ' 119' ' ' GLY . . . -93.38 133.53 36.54 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.402 ' HA ' ' HD2' ' A' ' 138' ' ' ARG . 0.0 OUTLIER -93.54 27.11 2.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.991 0.424 . . . . 0.0 110.402 179.275 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 30.8 p -100.01 167.13 10.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.029 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -127.72 32.42 4.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.89 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 25.2 m -56.61 132.63 52.3 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.791 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.5 t -74.15 -8.61 56.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.969 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.1 p -118.46 130.77 56.14 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.891 0.377 . . . . 0.0 111.073 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -153.33 -167.94 16.45 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.84 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.468 HG23 ' C ' ' A' ' 72' ' ' TYR . 7.5 p -133.75 126.24 50.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.007 0.432 . . . . 0.0 110.885 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.669 ' HE2' HG21 ' A' ' 74' ' ' VAL . 3.1 p90 -111.14 153.91 25.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.102 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 4.0 t80 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.647 179.747 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 11.7 p80 . . . . . 0 N--CA 1.456 -0.128 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.468 ' C ' HG23 ' A' ' 62' ' ' VAL . 0.7 OUTLIER -126.47 114.03 23.15 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.661 -178.834 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 72' ' ' TYR . 4.4 Cg_exo -74.54 120.54 6.24 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.356 2.037 . . . . 0.0 110.255 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.697 ' CG1' ' HB1' ' A' ' 101' ' ' ALA . 97.1 t -144.3 147.42 19.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.048 0.452 . . . . 0.0 112.167 -178.403 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 53.6 p -92.02 137.19 32.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.295 178.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.741 ' HD2' ' HB2' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -146.48 168.43 21.22 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.22 0.534 . . . . 0.0 111.942 -178.882 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -113.0 158.39 20.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.05 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -106.03 68.17 0.24 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.917 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.551 ' HD2' ' HA ' ' A' ' 99' ' ' LEU . 38.0 Cg_endo -67.6 135.16 35.14 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.471 2.114 . . . . 0.0 112.227 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -59.27 -82.8 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.288 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.794 HD11 ' HB3' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -97.08 119.86 36.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.898 0.38 . . . . 0.0 111.749 -179.897 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.627 ' HB ' HG11 ' A' ' 98' ' ' VAL . 46.8 t -124.99 122.18 62.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.217 178.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.13 107.98 5.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.776 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.579 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 19.3 m -81.79 126.85 39.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.236 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.84 150.65 46.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.06 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.555 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 3.9 pt-20 -67.73 102.54 1.23 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.87 0.367 . . . . 0.0 110.431 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.428 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -143.89 164.1 31.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.425 -179.732 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.422 ' HG2' ' CE2' ' A' ' 89' ' ' TYR . 2.8 tt0 56.95 -81.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.543 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.428 ' N ' ' O ' ' A' ' 87' ' ' SER . 0.4 OUTLIER -155.64 22.93 0.4 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.926 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.555 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 9.7 t80 -123.79 136.8 27.78 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.883 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.446 ' O ' ' N ' ' A' ' 93' ' ' ARG . 86.4 Cg_endo -81.76 148.95 15.97 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.09 2.527 . . . . 0.0 112.451 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.579 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -49.2 89.52 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.804 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.572 ' O ' HG22 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -124.13 169.64 11.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.259 0.552 . . . . 0.0 112.209 -179.126 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.794 ' HB3' HD11 ' A' ' 81' ' ' LEU . 2.9 m-85 -90.86 132.46 35.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.928 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.561 ' O ' HD13 ' A' ' 81' ' ' LEU . 0.5 OUTLIER -124.5 131.87 53.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.054 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 12.0 p -101.31 147.52 26.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.998 0.428 . . . . 0.0 111.835 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.492 ' CD2' ' HB3' ' A' ' 136' ' ' ASP . 4.2 t60 63.85 55.98 1.55 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.946 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.627 HG11 ' HB ' ' A' ' 82' ' ' VAL . 11.6 p -123.44 135.86 61.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.872 0.368 . . . . 0.0 111.364 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.771 HD11 ' HB2' ' A' ' 136' ' ' ASP . 1.8 mp -104.3 133.42 49.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.161 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.823 ' HA ' ' O ' ' A' ' 132' ' ' VAL . 7.4 mt -116.53 138.54 51.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.18 0.514 . . . . 0.0 112.311 -179.244 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.741 ' HB2' ' HD2' ' A' ' 76' ' ' PHE . . . -128.47 119.28 24.6 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.565 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 1.7 t -87.37 111.83 21.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.886 0.374 . . . . 0.0 110.648 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 0.239 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.541 -179.854 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 112.671 -0.172 . . . . 0.0 112.671 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.525 HD13 HG13 ' A' ' 120' ' ' VAL . 2.6 pp -126.0 146.18 32.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.922 0.391 . . . . 0.0 111.415 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.728 HD21 ' CZ ' ' A' ' 76' ' ' PHE . 56.2 tp -87.82 115.84 25.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.73 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 18.6 ptt-85 -118.74 143.95 46.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.076 0.465 . . . . 0.0 112.111 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.974 ' HB2' HD11 ' A' ' 121' ' ' ILE . 35.4 t -108.14 166.15 10.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.264 178.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -55.51 -18.13 6.67 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.657 0.265 . . . . 0.0 110.867 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 53.7 m80 -91.33 -36.86 13.6 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.47 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.835 ' N ' ' HB2' ' A' ' 54' ' ' ALA . . . 176.81 -140.82 5.14 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.201 -1.0 . . . . 0.0 113.57 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.85 HG23 ' O ' ' A' ' 52' ' ' THR . 3.6 t -100.72 135.87 34.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 122.536 0.335 . . . . 0.0 111.628 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.974 HD11 ' HB2' ' A' ' 116' ' ' CYS . 3.4 mp -98.94 -64.6 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.517 178.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.661 ' HA2' HG23 ' A' ' 137' ' ' VAL . . . -164.7 -167.02 24.61 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.196 -1.002 . . . . 0.0 113.239 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.685 HD21 HD13 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -117.0 164.15 15.15 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.92 0.39 . . . . 0.0 110.892 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.597 ' O ' HG13 ' A' ' 124' ' ' VAL . 10.3 p -60.35 109.23 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.936 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.81 ' OG1' ' HB2' ' A' ' 135' ' ' ALA . 2.0 m -91.34 -88.6 0.18 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.661 ' N ' HG22 ' A' ' 125' ' ' THR . 0.0 OUTLIER -128.56 162.1 28.04 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.941 0.4 . . . . 0.0 111.205 179.375 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -131.41 157.82 22.48 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.645 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -114.36 -153.89 10.86 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.411 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -71.96 -19.25 61.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.733 0.301 . . . . 0.0 110.998 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -168.71 28.4 0.15 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.547 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.565 ' HB ' HD22 ' A' ' 100' ' ' LEU . 1.4 t -130.03 157.05 42.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.716 0.294 . . . . 0.0 110.874 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.823 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 2.0 t -112.97 118.01 56.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.199 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' ' 126' ' ' MET . . . -99.12 123.7 7.99 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.61 -0.805 . . . . 0.0 111.871 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.515 ' CD2' HD22 ' A' ' 114' ' ' LEU . 52.6 m-85 -125.12 139.29 53.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.95 0.405 . . . . 0.0 111.727 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.81 ' HB2' ' OG1' ' A' ' 125' ' ' THR . . . -88.88 108.13 19.37 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.694 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.771 ' HB2' HD11 ' A' ' 99' ' ' LEU . 1.0 OUTLIER -67.55 143.36 56.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.472 0.653 . . . . 0.0 112.549 -178.095 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.661 HG23 ' HA2' ' A' ' 122' ' ' GLY . 19.3 t -102.24 7.17 9.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.149 178.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.403 ' HB3' ' CZ ' ' A' ' 138' ' ' ARG . 2.1 mmm180 -72.48 -6.29 42.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.435 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.462 ' HB2' ' CD2' ' A' ' 97' ' ' HIS . 4.4 t70 -97.72 -1.99 42.26 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.721 0.296 . . . . 0.0 111.363 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.831 ' O ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -156.1 64.71 0.57 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.464 0.65 . . . . 0.0 109.732 179.548 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.952 HD11 ' HB ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -77.64 -14.48 59.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.267 -0.879 . . . . 0.0 112.458 -178.906 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 142' ' ' TRP . . . . . 0.531 ' C ' HD12 ' A' ' 143' ' ' LEU . 14.4 p-90 -53.7 80.19 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.006 0.431 . . . . 0.0 111.216 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.681 HD12 ' C ' ' A' ' 141' ' ' LEU . 4.9 mp -153.36 -48.19 0.09 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.956 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.527 ' HG3' HG12 ' A' ' 12' ' ' VAL . 5.4 mt-10 -156.56 -171.14 3.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.462 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.85 144.24 45.01 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.913 0.387 . . . . 0.0 111.034 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -104.9 154.19 20.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.927 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.649 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . . . . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.186 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.882 ' HB2' HG23 ' A' ' 18' ' ' VAL . . . . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.745 0.307 . . . . 0.0 111.07 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.798 ' HB ' HG21 ' A' ' 113' ' ' ILE . 9.6 p -131.24 113.19 23.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.88 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.544 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 7.9 p90 -112.02 134.43 53.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.979 0.418 . . . . 0.0 111.157 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.581 ' HB ' HD22 ' A' ' 143' ' ' LEU . 93.1 t -119.19 128.25 75.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.439 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 49.54 -126.51 20.51 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 121.142 -0.551 . . . . 0.0 113.175 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.458 ' O ' ' HA ' ' A' ' 44' ' ' THR . 21.1 m-20 -89.56 14.72 10.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.624 0.249 . . . . 0.0 111.453 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.627 ' CE1' HG22 ' A' ' 44' ' ' THR . 7.2 m-85 -128.91 141.44 51.27 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.544 ' HA ' ' HA ' ' A' ' 11' ' ' TYR . 9.3 tttt -127.21 114.82 18.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.651 -0.25 . . . . 0.0 110.748 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 1.023 HG12 HG22 ' A' ' 42' ' ' VAL . 0.6 OUTLIER -102.36 121.74 53.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-O 121.202 0.525 . . . . 0.0 110.749 179.709 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.882 HG23 ' HB2' ' A' ' 9' ' ' ALA . 13.6 p -136.35 160.52 37.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.995 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.502 ' N ' HG22 ' A' ' 18' ' ' VAL . 7.0 t-20 -60.56 141.62 56.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.334 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.43 -47.35 79.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.811 0.339 . . . . 0.0 110.718 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.91 -9.04 53.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.909 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.419 ' HB3' HG22 ' A' ' 18' ' ' VAL . 13.9 tp -109.61 -11.48 14.76 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.652 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.945 ' HB3' ' CZ2' ' A' ' 28' ' ' TRP . . . -70.85 150.67 45.56 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 120.805 0.336 . . . . 0.0 110.826 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 58.6 p -104.67 169.2 8.59 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.329 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -54.72 -29.69 54.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.033 0.444 . . . . 0.0 110.576 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 23.9 t -74.66 -31.34 26.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.4 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.421 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 0.3 OUTLIER -67.16 -44.12 80.53 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.984 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.945 ' CZ2' ' HB3' ' A' ' 23' ' ' ALA . 7.2 m-90 -74.54 -30.78 61.89 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.217 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.4 mm100 -58.42 -44.14 88.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.509 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -114.21 34.78 4.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.519 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.47 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 36.9 t -80.1 134.56 36.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.404 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.472 HG22 ' O ' ' A' ' 42' ' ' VAL . 12.5 m -98.96 -39.38 7.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.522 179.252 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.682 ' CH2' HD23 ' A' ' 40' ' ' LEU . 1.9 t90 -139.39 152.91 47.49 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.989 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -160.86 120.39 2.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.975 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.407 ' HB2' ' CZ2' ' A' ' 33' ' ' TRP . 11.0 m-20 -107.04 111.99 24.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.007 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -61.27 -43.58 98.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.964 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.417 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 4.3 m-20 -65.73 -23.56 66.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.771 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.446 ' CZ ' ' HA ' ' A' ' 38' ' ' ARG . 3.4 tpm_? -105.55 -2.02 24.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.34 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 44.27 37.26 1.87 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.947 0.403 . . . . 0.0 110.818 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.846 HD11 HG23 ' A' ' 17' ' ' VAL . 7.0 tp -133.75 141.72 47.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.694 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.665 ' O ' HD23 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -139.2 155.84 47.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.913 0.387 . . . . 0.0 111.759 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 1.023 HG22 HG12 ' A' ' 17' ' ' VAL . 25.3 t -118.72 129.89 74.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.568 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.8 p -121.84 157.16 31.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.306 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.627 HG22 ' CE1' ' A' ' 15' ' ' TYR . 8.3 p -97.68 124.35 41.96 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.177 0.513 . . . . 0.0 111.628 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -113.65 162.99 15.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.78 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -108.69 37.45 2.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.885 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -126.73 169.42 13.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.044 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 10.4 m80 -83.74 141.12 31.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.861 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.431 ' HA2' ' CE2' ' A' ' 11' ' ' TYR . . . -91.04 152.0 21.44 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.558 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.43 -46.81 2.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.833 0.349 . . . . 0.0 110.909 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.579 ' OD2' HG23 ' A' ' 10' ' ' VAL . 2.8 m-20 -59.82 135.89 57.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.918 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.856 ' O ' HG23 ' A' ' 120' ' ' VAL . 33.2 m -117.27 116.0 26.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.824 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.974 ' HB ' HD11 ' A' ' 141' ' ' LEU . 0.2 OUTLIER -82.5 139.38 17.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.761 179.994 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -95.51 130.51 42.32 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.839 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.515 ' H ' ' HB3' ' A' ' 147' ' ' ALA . 2.7 ttt180 -93.31 42.5 1.1 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 178.337 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 8.2 p -99.86 167.31 10.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.955 -1.02 . . . . 0.0 111.501 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -117.66 25.54 10.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.073 178.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 14.8 p -66.51 145.38 55.7 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.061 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.0 m -103.04 13.18 34.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.216 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 56.0 p -132.91 125.32 29.63 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.855 0.359 . . . . 0.0 110.996 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -150.99 165.71 30.29 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.388 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.852 HG23 ' C ' ' A' ' 72' ' ' TYR . 10.6 p -104.51 134.83 44.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.933 0.397 . . . . 0.0 111.338 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.694 ' HE2' HG21 ' A' ' 74' ' ' VAL . 4.9 p90 -110.97 160.44 16.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.843 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 5.4 t80 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.026 -179.916 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.527 ' HB3' HG21 ' A' ' 62' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.118 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.852 ' C ' HG23 ' A' ' 62' ' ' VAL . 0.6 OUTLIER -111.41 114.39 52.98 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.435 -178.921 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 72' ' ' TYR . 3.4 Cg_exo -74.77 120.66 6.23 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.235 1.956 . . . . 0.0 110.422 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.694 HG21 ' HE2' ' A' ' 63' ' ' TYR . 90.6 t -142.56 144.99 23.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.107 0.479 . . . . 0.0 112.226 -178.539 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.66 135.78 33.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.39 178.55 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.802 ' CZ ' HD21 ' A' ' 114' ' ' LEU . 0.1 OUTLIER -141.46 169.66 17.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.226 0.536 . . . . 0.0 111.811 -178.879 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.403 ' O ' ' HD2' ' A' ' 79' ' ' PRO . 11.3 mm-40 -111.85 158.3 19.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.068 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -105.79 68.34 0.25 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.542 -0.837 . . . . 0.0 113.095 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.502 ' HD2' ' HA ' ' A' ' 99' ' ' LEU . 37.6 Cg_endo -67.52 135.44 36.25 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.391 2.06 . . . . 0.0 112.231 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -59.66 -90.82 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.195 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.722 HD11 ' HB3' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -88.32 119.56 28.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.853 0.359 . . . . 0.0 111.497 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.626 ' HB ' HG11 ' A' ' 98' ' ' VAL . 40.1 t -126.99 122.46 60.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.075 178.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -72.54 107.55 5.12 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.934 0.397 . . . . 0.0 110.55 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.579 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 18.3 m -75.24 123.88 31.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.732 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -69.4 150.38 47.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.027 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.547 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 0.6 OUTLIER -67.69 102.67 1.24 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.006 0.432 . . . . 0.0 110.458 -179.474 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.453 ' O ' ' N ' ' A' ' 89' ' ' TYR . 3.5 m -143.87 161.64 38.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.519 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 57.41 -79.14 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.534 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.453 ' N ' ' O ' ' A' ' 87' ' ' SER . 1.3 p90 -159.59 25.38 0.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.699 0.285 . . . . 0.0 110.942 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.547 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 3.6 t80 -124.73 126.09 25.4 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.831 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -69.68 148.77 66.32 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.113 2.542 . . . . 0.0 112.446 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.579 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 1.7 ttpp -53.14 92.26 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.853 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.443 ' O ' HG22 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -123.82 176.55 6.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.184 0.516 . . . . 0.0 112.085 -179.338 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.722 ' HB3' HD11 ' A' ' 81' ' ' LEU . 4.9 m-85 -98.28 132.32 43.86 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.163 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.495 ' O ' HD13 ' A' ' 81' ' ' LEU . 4.4 mt-30 -131.23 132.95 45.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.678 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.483 ' CB ' HD22 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -102.65 142.91 33.03 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.014 0.435 . . . . 0.0 112.06 -179.334 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.44 ' CE1' ' HB3' ' A' ' 139' ' ' ASP . 0.1 OUTLIER 75.76 55.53 0.06 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.064 179.1 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.626 HG11 ' HB ' ' A' ' 82' ' ' VAL . 12.4 p -123.4 139.45 50.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.962 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.502 ' HA ' ' HD2' ' A' ' 79' ' ' PRO . 4.4 mp -105.09 134.0 48.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.168 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.798 ' HA ' ' O ' ' A' ' 132' ' ' VAL . 6.8 mt -117.61 138.64 51.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.131 0.491 . . . . 0.0 112.192 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.722 ' O ' HG23 ' A' ' 132' ' ' VAL . . . -130.02 119.46 23.17 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.597 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 1.7 t -86.02 111.69 20.53 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.849 0.356 . . . . 0.0 110.727 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.255 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.45 -179.834 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.56 -0.216 . . . . 0.0 112.56 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.798 HG21 ' HB ' ' A' ' 10' ' ' VAL . 31.2 pt -125.99 146.22 32.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.711 0.291 . . . . 0.0 111.074 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.802 HD21 ' CZ ' ' A' ' 76' ' ' PHE . 41.6 tp -87.71 113.02 23.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.65 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.423 ' O ' HG12 ' A' ' 62' ' ' VAL . 25.9 mtm180 -119.56 146.88 45.1 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.474 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.9 ' SG ' HD11 ' A' ' 121' ' ' ILE . 27.2 p -118.99 177.42 4.87 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.502 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -56.77 -18.75 13.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.681 0.276 . . . . 0.0 111.251 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -93.3 -32.58 14.26 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 165.64 -133.58 3.01 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.176 -1.011 . . . . 0.0 113.643 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.856 HG23 ' O ' ' A' ' 52' ' ' THR . 20.0 t -107.78 135.67 45.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.774 0.321 . . . . 0.0 111.609 -179.283 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.9 HD11 ' SG ' ' A' ' 116' ' ' CYS . 2.5 mp -105.26 -52.83 7.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.155 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.679 ' HA2' HG23 ' A' ' 137' ' ' VAL . . . -161.06 -167.08 21.02 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 119.94 -1.124 . . . . 0.0 113.496 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.616 HD11 HD13 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -124.39 164.18 20.21 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.841 0.353 . . . . 0.0 111.021 -179.867 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.401 ' HA ' ' CD1' ' A' ' 134' ' ' PHE . 3.5 m -57.06 114.12 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.802 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.77 ' OG1' ' HB2' ' A' ' 135' ' ' ALA . 2.3 m -105.27 -88.95 0.43 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.01 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.625 ' N ' HG22 ' A' ' 125' ' ' THR . 1.5 tpt -132.28 162.1 31.84 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.247 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -133.23 161.43 24.17 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.513 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -119.26 -154.61 9.59 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.527 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -72.04 -19.08 61.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.691 0.282 . . . . 0.0 110.963 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -168.27 29.71 0.16 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.545 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.534 ' CG1' HD22 ' A' ' 100' ' ' LEU . 1.3 t -132.21 157.1 43.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.785 0.326 . . . . 0.0 111.001 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.798 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 1.8 t -113.72 117.98 56.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.903 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.41 ' HA3' ' O ' ' A' ' 126' ' ' MET . . . -102.07 122.33 7.51 Favored Glycine 0 CA--C 1.516 0.14 0 C-N-CA 120.525 -0.845 . . . . 0.0 111.84 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.489 ' CE2' ' CG1' ' A' ' 132' ' ' VAL . 48.9 m-85 -124.99 144.0 50.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.992 0.425 . . . . 0.0 111.742 -179.163 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.77 ' HB2' ' OG1' ' A' ' 125' ' ' THR . . . -88.9 114.22 25.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.739 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.435 ' HB2' HD11 ' A' ' 99' ' ' LEU . 7.9 t0 -67.53 137.6 55.88 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -178.23 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.679 HG23 ' HA2' ' A' ' 122' ' ' GLY . 69.2 t -99.42 3.67 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.943 178.457 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.497 ' HA ' HD23 ' A' ' 141' ' ' LEU . 0.5 OUTLIER -72.57 -6.27 42.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.43 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.44 ' HB3' ' CE1' ' A' ' 97' ' ' HIS . 1.4 p30 -95.32 3.35 54.54 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.708 0.29 . . . . 0.0 111.345 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.829 ' O ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -162.11 51.8 0.21 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.294 0.569 . . . . 0.0 110.119 179.669 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.974 HD11 ' HB ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -68.59 -14.63 63.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.149 -179.44 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 142' ' ' TRP . . . . . 0.459 ' C ' HD12 ' A' ' 143' ' ' LEU . 13.2 p-90 -53.86 81.92 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.17 0.51 . . . . 0.0 111.379 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.696 HD12 ' C ' ' A' ' 141' ' ' LEU . 5.0 mp -150.95 -44.84 0.12 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.834 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.534 ' HB2' ' CG1' ' A' ' 12' ' ' VAL . 1.1 tp10 -146.59 -159.23 0.99 Allowed 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.417 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -77.86 149.04 34.38 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.837 0.351 . . . . 0.0 110.988 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -84.84 154.2 22.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.936 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.515 ' HB3' ' H ' ' A' ' 55' ' ' ARG . . . . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.066 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.648 ' HB2' HG23 ' A' ' 18' ' ' VAL . . . . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.697 0.284 . . . . 0.0 110.937 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.683 ' HB ' HG21 ' A' ' 113' ' ' ILE . 9.0 p -127.59 107.32 16.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.032 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.6 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 6.0 p90 -104.43 129.42 52.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.951 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.896 HG21 HD11 ' A' ' 53' ' ' ILE . 31.2 t -119.28 133.21 66.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.773 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 49.84 -128.39 25.24 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 121.068 -0.586 . . . . 0.0 112.966 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.432 ' O ' ' HA ' ' A' ' 44' ' ' THR . 36.5 m120 -91.35 17.13 8.82 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.673 0.273 . . . . 0.0 111.176 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.683 ' HB2' HD23 ' A' ' 143' ' ' LEU . 9.7 m-85 -129.94 148.45 51.81 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.241 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.6 ' HA ' ' HA ' ' A' ' 11' ' ' TYR . 37.3 tttt -132.26 114.68 14.72 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.696 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.958 HG12 HG22 ' A' ' 42' ' ' VAL . 0.9 OUTLIER -101.94 121.42 52.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-O 121.209 0.528 . . . . 0.0 110.74 179.72 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.658 ' O ' HD12 ' A' ' 40' ' ' LEU . 13.0 p -136.94 161.42 35.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.428 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.51 ' N ' HG22 ' A' ' 18' ' ' VAL . 5.0 m-20 -60.55 141.79 56.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.152 178.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.439 ' HG3' ' N ' ' A' ' 21' ' ' HIS . 7.8 ptm180 -56.34 -46.99 79.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.803 0.335 . . . . 0.0 111.378 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.439 ' N ' ' HG3' ' A' ' 20' ' ' ARG . 7.8 t-80 -69.66 -6.45 31.59 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.331 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -115.14 -1.39 13.01 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.46 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.68 ' HB3' ' NE1' ' A' ' 28' ' ' TRP . . . -87.29 126.75 35.03 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.238 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.545 ' O ' ' HD1' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -74.79 164.37 26.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.682 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -53.78 -29.71 41.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.332 -179.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.544 HG12 HG23 ' A' ' 24' ' ' THR . 13.8 p -71.86 -31.37 40.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.971 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.95 -44.06 77.64 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.035 0.445 . . . . 0.0 109.828 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.68 ' NE1' ' HB3' ' A' ' 23' ' ' ALA . 39.7 m95 -73.99 -33.44 63.84 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.623 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 13.2 tp60 -56.66 -44.0 80.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.644 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -111.56 30.01 7.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.423 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.437 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 10.8 t -77.3 131.88 38.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.092 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.506 HG22 ' O ' ' A' ' 42' ' ' VAL . 13.1 m -94.04 -39.76 10.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.979 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.608 ' HH2' HD23 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -139.7 153.41 47.23 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.976 0.417 . . . . 0.0 111.8 -179.216 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -158.52 120.52 3.58 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.576 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.425 ' HB2' ' CZ2' ' A' ' 33' ' ' TRP . 14.2 m-20 -106.99 116.92 32.77 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.484 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -66.39 -29.99 70.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.954 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.484 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 26.1 p30 -66.56 -25.89 66.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.057 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 18.0 mtm180 -117.44 -0.97 11.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.459 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 51.22 37.86 19.63 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.898 0.38 . . . . 0.0 110.572 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.861 HD11 HG23 ' A' ' 17' ' ' VAL . 18.4 tp -125.39 152.36 44.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.928 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.64 ' O ' HD23 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -143.93 156.07 44.3 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.944 0.402 . . . . 0.0 111.667 179.627 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.958 HG22 HG12 ' A' ' 17' ' ' VAL . 22.6 t -120.21 129.95 74.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.636 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.9 p -120.49 157.3 29.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.119 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.644 HG22 ' CE1' ' A' ' 15' ' ' TYR . 10.1 p -97.45 123.29 41.24 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.163 0.506 . . . . 0.0 111.596 -179.001 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -117.33 140.17 49.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.882 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.1 p -95.14 45.97 1.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.98 0.419 . . . . 0.0 110.907 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.94 177.17 5.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.022 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -87.94 121.6 30.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.928 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.435 ' HA2' ' CE2' ' A' ' 11' ' ' TYR . . . -64.44 175.75 11.42 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.441 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 m -154.1 -46.15 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.862 0.363 . . . . 0.0 110.94 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -73.34 143.78 46.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.058 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.923 ' O ' HG23 ' A' ' 120' ' ' VAL . 55.1 m -120.45 119.64 33.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.193 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.896 HD11 HG21 ' A' ' 12' ' ' VAL . 2.9 mm -72.5 139.36 19.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.089 0.471 . . . . 0.0 111.063 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.744 ' O ' ' HB3' ' A' ' 147' ' ' ALA . . . -75.36 -47.89 25.56 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.513 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.417 ' CB ' ' HB2' ' A' ' 146' ' ' ASP . 0.0 OUTLIER 67.93 13.54 9.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.825 -179.34 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.519 ' SG ' ' HB1' ' A' ' 54' ' ' ALA . 23.9 p -99.78 166.92 10.86 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.665 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -121.76 39.28 3.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.124 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 59.5 m -62.7 156.81 22.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.706 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.3 -19.87 20.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.964 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.3 p -116.34 123.91 48.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.946 0.403 . . . . 0.0 111.123 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -140.71 -164.02 9.74 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 121.028 -0.606 . . . . 0.0 111.89 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.654 HG23 ' C ' ' A' ' 72' ' ' TYR . 3.6 p -140.41 130.74 28.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 121.167 0.508 . . . . 0.0 111.815 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.479 ' CD1' ' O ' ' A' ' 63' ' ' TYR . 24.4 p90 -109.28 126.27 53.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.772 178.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.408 ' HB3' ' CG ' ' A' ' 71' ' ' HIS . 55.6 p90 . . . . . 0 C--N 1.328 -0.352 0 CA-C-O 120.993 0.425 . . . . 0.0 111.578 -179.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.408 ' CG ' ' HB3' ' A' ' 64' ' ' PHE . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.075 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.654 ' C ' HG23 ' A' ' 62' ' ' VAL . 3.9 m-85 -124.91 114.29 26.62 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.615 -178.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 72' ' ' TYR . 4.7 Cg_exo -74.21 120.78 6.45 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.354 2.036 . . . . 0.0 111.043 178.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.443 ' CG1' ' CE2' ' A' ' 76' ' ' PHE . 2.3 p -139.78 158.8 27.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.034 0.445 . . . . 0.0 111.923 -179.101 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.9 m -102.04 123.91 46.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.424 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.696 ' CZ ' HD11 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -125.11 161.78 26.05 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.41 0.624 . . . . 0.0 111.771 -179.259 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.442 ' O ' ' HD2' ' A' ' 79' ' ' PRO . 4.6 mt-10 -111.79 158.77 18.98 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.349 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -104.76 67.22 0.28 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.412 -0.899 . . . . 0.0 113.187 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.442 ' HD2' ' O ' ' A' ' 77' ' ' GLU . 41.7 Cg_endo -67.72 135.47 35.81 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.375 2.05 . . . . 0.0 112.07 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -60.84 -86.77 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.682 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.664 HD22 ' HB3' ' A' ' 96' ' ' SER . 0.0 OUTLIER -94.62 119.85 33.93 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -179.365 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.607 ' HB ' HG11 ' A' ' 98' ' ' VAL . 80.0 t -124.63 123.28 65.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.344 178.376 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.436 ' HG3' ' CZ ' ' A' ' 94' ' ' TYR . 0.1 OUTLIER -72.14 107.86 5.03 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.019 0.438 . . . . 0.0 111.037 -178.826 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.91 HG23 ' HG2' ' A' ' 126' ' ' MET . 2.2 p -73.31 114.41 12.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.486 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -76.27 150.23 37.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.56 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.693 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 28.0 tt0 -68.0 101.04 1.05 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.122 0.487 . . . . 0.0 110.505 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.43 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.5 OUTLIER -144.7 143.01 30.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.875 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 59.25 -80.21 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.423 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.43 ' N ' ' O ' ' A' ' 87' ' ' SER . 0.8 OUTLIER -152.11 22.18 0.66 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.658 0.266 . . . . 0.0 111.173 -179.945 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.693 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 0.8 OUTLIER -110.51 114.64 54.87 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.302 179.68 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -60.98 148.26 93.26 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.728 2.285 . . . . 0.0 112.888 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -67.77 71.51 0.14 Allowed 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.598 179.507 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.443 ' O ' HG12 ' A' ' 84' ' ' VAL . 1.4 ttm180 -123.61 -174.55 3.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.914 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.436 ' CZ ' ' HG3' ' A' ' 83' ' ' GLU . 13.6 m-85 -96.51 132.43 42.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.822 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.484 ' HA ' ' O ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -131.1 126.56 36.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.039 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.664 ' HB3' HD22 ' A' ' 81' ' ' LEU . 15.1 p -101.58 161.45 13.63 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.162 0.506 . . . . 0.0 111.926 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 40.2 m80 61.63 57.57 2.23 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.565 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.607 HG11 ' HB ' ' A' ' 82' ' ' VAL . 4.8 p -123.55 143.45 36.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.758 0.313 . . . . 0.0 111.37 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.405 ' HA ' ' HD2' ' A' ' 79' ' ' PRO . 7.5 mp -107.29 143.31 35.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.804 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.73 HD23 ' O ' ' A' ' 132' ' ' VAL . 5.1 mt -133.01 139.42 47.22 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -179.402 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.556 ' HB2' ' CD2' ' A' ' 76' ' ' PHE . . . -143.71 146.64 33.33 Favored 'General case' 0 CA--C 1.522 -0.109 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.728 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 1.2 t -104.54 131.42 51.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.932 0.396 . . . . 0.0 111.192 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.272 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.424 -179.982 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.683 HG21 ' HB ' ' A' ' 10' ' ' VAL . 24.8 pt -126.08 146.49 31.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.822 0.344 . . . . 0.0 111.326 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.696 HD11 ' CZ ' ' A' ' 76' ' ' PHE . 11.5 tp -87.44 122.2 30.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.109 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.416 ' N ' HD12 ' A' ' 114' ' ' LEU . 27.5 mtp180 -118.26 138.74 52.15 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.254 0.549 . . . . 0.0 112.064 -178.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.446 ' HB2' ' CD1' ' A' ' 121' ' ' ILE . 15.1 t -106.03 166.51 10.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.614 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -55.77 -19.7 12.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.64 0.257 . . . . 0.0 111.031 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.424 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . 31.4 m80 -89.66 -35.92 15.54 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.514 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.501 ' C ' ' HB2' ' A' ' 54' ' ' ALA . . . 169.32 -142.41 7.31 Favored Glycine 0 C--O 1.227 -0.316 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.561 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.923 HG23 ' O ' ' A' ' 52' ' ' THR . 3.4 t -89.73 135.22 26.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.562 0.22 . . . . 0.0 110.704 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.446 ' CD1' ' HB2' ' A' ' 116' ' ' CYS . 6.3 mt -106.32 -52.75 7.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 121.051 -0.259 . . . . 0.0 111.05 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.702 ' HA2' HG23 ' A' ' 137' ' ' VAL . . . -161.74 -174.68 31.91 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.088 -1.053 . . . . 0.0 113.239 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.786 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 0.0 OUTLIER -121.16 164.06 17.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.833 0.349 . . . . 0.0 110.824 179.884 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.415 ' O ' HG13 ' A' ' 124' ' ' VAL . 13.7 p -55.47 127.14 13.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.767 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.665 ' OG1' ' HB2' ' A' ' 135' ' ' ALA . 3.2 m -120.56 -90.35 0.58 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.045 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.91 ' HG2' HG23 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -122.65 125.89 46.53 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.977 0.418 . . . . 0.0 111.301 179.618 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -110.26 128.48 8.86 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.606 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -83.95 -159.9 29.79 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.533 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -71.9 -19.38 61.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.75 0.31 . . . . 0.0 111.217 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -158.42 20.22 0.33 Allowed Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.678 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.672 ' CG1' HD22 ' A' ' 100' ' ' LEU . 1.3 t -129.17 157.07 42.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.755 0.312 . . . . 0.0 110.769 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.73 ' O ' HD23 ' A' ' 100' ' ' LEU . 18.8 m -115.19 118.35 58.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.212 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.452 ' HA3' ' O ' ' A' ' 126' ' ' MET . . . -100.64 109.54 3.7 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.074 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.456 ' CD2' ' HB2' ' A' ' 114' ' ' LEU . 61.1 m-85 -111.16 139.79 46.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.746 0.308 . . . . 0.0 110.912 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.786 ' HB3' ' CD2' ' A' ' 123' ' ' LEU . . . -88.57 120.56 30.07 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -67.36 137.1 55.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.197 0.522 . . . . 0.0 112.355 -178.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.702 HG23 ' HA2' ' A' ' 122' ' ' GLY . 95.1 t -90.53 7.85 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.474 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.613 ' HA ' HD23 ' A' ' 141' ' ' LEU . 8.8 mtm180 -70.49 -6.44 36.04 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.812 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.6 11.18 39.2 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.608 0.242 . . . . 0.0 111.581 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.834 ' O ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -173.14 48.67 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.256 0.551 . . . . 0.0 110.374 179.811 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.613 HD23 ' HA ' ' A' ' 138' ' ' ARG . 0.2 OUTLIER -67.67 -14.93 63.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.015 -179.551 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 142' ' ' TRP . . . . . 0.416 ' CE3' ' CE2' ' A' ' 15' ' ' TYR . 12.3 p-90 -56.65 82.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.069 0.461 . . . . 0.0 111.693 -179.365 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.683 HD23 ' HB2' ' A' ' 15' ' ' TYR . 5.1 mp -149.06 -47.29 0.14 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.805 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.455 ' HB2' HG12 ' A' ' 12' ' ' VAL . 0.5 OUTLIER -158.32 -168.89 2.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.418 179.895 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 14.7 p30 -58.83 138.94 57.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.851 0.358 . . . . 0.0 111.044 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.417 ' HB2' ' CB ' ' A' ' 55' ' ' ARG . 3.9 p-10 -105.01 154.11 20.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.999 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.744 ' HB3' ' O ' ' A' ' 54' ' ' ALA . . . . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.098 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.727 0.298 . . . . 0.0 111.052 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.607 HG22 HG21 ' A' ' 113' ' ' ILE . 39.2 t -112.94 103.01 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.001 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.912 ' CE2' HG21 ' A' ' 45' ' ' THR . 6.1 t80 -97.85 115.93 29.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.856 0.36 . . . . 0.0 110.631 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.877 HG21 HD11 ' A' ' 53' ' ' ILE . 32.8 t -121.21 108.96 23.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.517 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.405 ' O ' ' CE1' ' A' ' 11' ' ' TYR . . . 54.24 -128.75 41.99 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.897 -0.668 . . . . 0.0 113.309 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.432 ' O ' ' HA ' ' A' ' 44' ' ' THR . 22.6 m120 -88.75 13.26 12.83 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 111.706 0.262 . . . . 0.0 111.706 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.658 ' HE1' HG22 ' A' ' 44' ' ' THR . 5.7 m-30 -130.3 127.95 40.54 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -118.97 114.74 23.03 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 121.124 -0.23 . . . . 0.0 110.688 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.985 HG12 HG22 ' A' ' 42' ' ' VAL . 0.7 OUTLIER -101.07 121.66 52.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.231 0.538 . . . . 0.0 110.993 179.91 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.682 ' O ' HD12 ' A' ' 40' ' ' LEU . 14.1 p -136.7 161.36 36.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.047 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.506 ' N ' HG22 ' A' ' 18' ' ' VAL . 9.0 m120 -58.91 141.49 53.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.376 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.425 ' CD ' ' N ' ' A' ' 21' ' ' HIS . 0.0 OUTLIER -56.54 -47.09 80.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.874 0.369 . . . . 0.0 111.294 -179.339 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.425 ' N ' ' CD ' ' A' ' 20' ' ' ARG . 13.3 p80 -68.36 -9.83 50.81 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.162 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.3 2.32 13.97 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.703 ' HB3' ' NE1' ' A' ' 28' ' ' TRP . . . -87.34 130.27 34.69 Favored 'General case' 0 C--N 1.334 -0.081 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.189 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.51 ' O ' ' HD1' ' A' ' 28' ' ' TRP . 41.9 p -74.69 163.04 28.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.742 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 61.1 m-70 -53.74 -29.71 40.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.975 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.2 t -70.33 -31.91 48.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.83 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -68.09 -44.25 76.69 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.123 0.487 . . . . 0.0 109.707 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.703 ' NE1' ' HB3' ' A' ' 23' ' ' ALA . 40.6 m95 -74.13 -33.14 63.46 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.702 179.325 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -56.79 -44.12 81.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.726 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -114.46 30.99 6.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.372 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.498 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 13.8 t -72.61 126.63 30.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.128 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.562 ' CG2' HG12 ' A' ' 42' ' ' VAL . 18.4 m -88.9 -40.77 13.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.626 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.73 ' CE3' HG23 ' A' ' 42' ' ' VAL . 0.5 OUTLIER -139.75 153.21 47.12 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.916 0.388 . . . . 0.0 111.227 -179.94 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -157.61 119.37 3.69 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.974 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -107.13 117.73 34.84 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.133 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 19.4 p90 -68.2 -36.79 80.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.106 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.43 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 74.0 m-20 -70.13 -12.9 61.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.871 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.0 mpt_? -117.2 -6.35 11.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.178 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 50.77 36.04 13.47 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-O 121.074 0.464 . . . . 0.0 110.295 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.81 HD11 HG23 ' A' ' 17' ' ' VAL . 36.7 tp -132.85 153.19 51.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.931 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.707 ' O ' HD23 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -147.83 155.63 41.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.491 179.682 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.985 HG22 HG12 ' A' ' 17' ' ' VAL . 38.2 t -115.78 130.68 70.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.337 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.0 p -123.29 157.24 33.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.637 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.658 HG22 ' HE1' ' A' ' 15' ' ' TYR . 30.1 p -97.65 145.13 26.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.189 0.518 . . . . 0.0 111.793 -178.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.912 HG21 ' CE2' ' A' ' 11' ' ' TYR . 0.2 OUTLIER -140.02 171.28 14.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.841 -179.253 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.551 ' O ' HG23 ' A' ' 46' ' ' THR . 10.8 t -124.48 62.32 1.12 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.93 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.463 ' HB3' ' OH ' ' A' ' 11' ' ' TYR . . . -135.51 -173.54 3.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.978 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -90.83 142.88 27.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.866 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.58 159.45 30.46 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.556 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -142.23 -46.7 0.34 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.743 0.306 . . . . 0.0 110.956 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -103.23 142.5 34.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.025 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.925 ' O ' HG23 ' A' ' 120' ' ' VAL . 91.7 m -120.08 120.85 37.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.286 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.877 HD11 HG21 ' A' ' 12' ' ' VAL . 0.9 OUTLIER -75.09 139.61 18.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.909 0.385 . . . . 0.0 110.921 -179.811 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.81 ' HB2' ' N ' ' A' ' 119' ' ' GLY . . . -94.91 127.19 40.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.107 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.62 ' H ' ' HB3' ' A' ' 147' ' ' ALA . 0.1 OUTLIER -92.33 34.76 1.02 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.528 179.452 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 26.5 p -99.65 160.5 14.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.874 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.69 34.79 4.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.084 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 66.5 m -58.28 126.87 29.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.707 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.3 m -68.92 -17.7 64.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.881 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 75' ' ' SER . 1.4 t -129.74 151.01 50.79 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.023 0.439 . . . . 0.0 111.319 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.451 ' N ' ' CE1' ' A' ' 76' ' ' PHE . . . -154.92 -148.24 4.94 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.688 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.617 HG23 ' C ' ' A' ' 72' ' ' TYR . 7.1 p -140.08 123.57 17.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.015 0.436 . . . . 0.0 111.385 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.426 ' CZ ' ' HB3' ' A' ' 72' ' ' TYR . 8.5 p90 -94.87 172.06 8.39 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.892 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.849 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.581 ' HB2' HG21 ' A' ' 62' ' ' VAL . 9.2 p80 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.81 0.338 . . . . 0.0 110.272 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.617 ' C ' HG23 ' A' ' 62' ' ' VAL . 1.2 m-85 -121.98 114.45 30.93 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.06 -179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 62' ' ' VAL . 4.9 Cg_exo -76.49 120.82 5.74 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.5 2.134 . . . . 0.0 111.529 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.448 ' CG1' ' CE2' ' A' ' 76' ' ' PHE . 2.9 p -136.6 156.75 35.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.973 0.416 . . . . 0.0 111.773 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.468 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 59.0 p -97.41 123.34 41.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.71 178.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.617 ' CZ ' HD11 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -124.39 163.44 21.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.373 0.606 . . . . 0.0 111.78 -179.411 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.445 ' O ' ' HD2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -111.72 158.72 19.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.224 179.024 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -104.87 65.51 0.3 Allowed Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.364 -0.922 . . . . 0.0 113.716 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.451 ' HD2' ' HA ' ' A' ' 99' ' ' LEU . 41.6 Cg_endo -67.84 134.63 32.88 Favored 'Trans proline' 0 C--O 1.238 0.501 0 C-N-CA 122.254 1.97 . . . . 0.0 112.011 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -59.89 -86.82 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.981 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.608 HD22 ' HB3' ' A' ' 96' ' ' SER . 0.0 OUTLIER -96.25 119.76 35.32 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -179.227 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.619 ' HB ' HG11 ' A' ' 98' ' ' VAL . 87.1 t -122.99 122.85 66.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.341 178.159 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.28 109.61 6.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.067 0.46 . . . . 0.0 111.206 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.836 HG23 ' HG3' ' A' ' 126' ' ' MET . 1.2 p -72.79 114.54 12.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.452 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -75.06 149.53 39.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.326 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.573 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 2.4 tm-20 -68.51 101.3 1.23 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.044 0.45 . . . . 0.0 110.458 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.477 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.4 OUTLIER -144.79 155.11 43.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.047 179.816 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 51.41 -83.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.611 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.477 ' N ' ' O ' ' A' ' 87' ' ' SER . 0.6 OUTLIER -145.67 19.75 1.49 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.835 0.35 . . . . 0.0 110.905 179.771 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.573 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 1.4 m-85 -107.88 140.35 21.53 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.538 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.421 ' O ' ' N ' ' A' ' 93' ' ' ARG . 81.5 Cg_endo -86.35 148.5 8.95 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.095 2.53 . . . . 0.0 112.9 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -65.36 70.44 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.896 179.724 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.421 ' N ' ' O ' ' A' ' 91' ' ' PRO . 14.1 mtp180 -123.52 -175.03 3.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.995 0.426 . . . . 0.0 111.741 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.546 ' HB3' HD11 ' A' ' 81' ' ' LEU . 8.3 m-85 -98.47 132.7 43.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.205 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.657 HE22 HG23 ' A' ' 125' ' ' THR . 4.7 mt-30 -128.44 126.83 41.35 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.704 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.608 ' HB3' HD22 ' A' ' 81' ' ' LEU . 24.6 p -99.58 161.04 13.85 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.174 0.511 . . . . 0.0 112.332 -178.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 57.84 60.22 2.86 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.878 179.254 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.619 HG11 ' HB ' ' A' ' 82' ' ' VAL . 6.1 p -123.66 142.39 40.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 C-N-CA 120.894 -0.323 . . . . 0.0 111.093 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.569 HD13 ' CG ' ' A' ' 136' ' ' ASP . 10.7 mp -107.67 141.37 39.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.269 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.726 HD23 ' C ' ' A' ' 132' ' ' VAL . 6.3 mt -128.08 136.56 51.37 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.551 ' HB2' ' CB ' ' A' ' 76' ' ' PHE . . . -142.3 142.17 32.51 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.077 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 1.7 t -97.37 121.64 39.5 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.066 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.252 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.524 -179.855 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.874 ' O ' HG23 ' A' ' 124' ' ' VAL . . . . . . . . 0 N--CA 1.452 -0.269 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.607 HG21 HG22 ' A' ' 10' ' ' VAL . 17.6 pt -126.31 146.41 32.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.705 0.288 . . . . 0.0 111.302 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.738 HD22 ' HD2' ' A' ' 134' ' ' PHE . 20.6 tp -87.36 119.88 28.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.32 -0.4 . . . . 0.0 109.997 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 28.1 mtp85 -118.12 151.9 36.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.247 0.546 . . . . 0.0 111.648 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.486 ' HB2' HD11 ' A' ' 121' ' ' ILE . 4.2 t -119.03 160.92 21.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.175 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.421 ' CG ' ' CE1' ' A' ' 118' ' ' HIS . 3.0 pt-20 -56.29 -18.88 11.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.756 0.312 . . . . 0.0 110.925 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.428 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . 13.2 m80 -93.65 -33.66 13.58 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.656 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.81 ' N ' ' HB2' ' A' ' 54' ' ' ALA . . . 176.39 -138.67 4.18 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.408 -0.901 . . . . 0.0 113.102 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.925 HG23 ' O ' ' A' ' 52' ' ' THR . 4.9 t -102.57 135.56 39.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.765 0.317 . . . . 0.0 111.286 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.525 ' HB ' ' HG ' ' A' ' 114' ' ' LEU . 1.0 OUTLIER -99.03 -66.9 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.956 179.524 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.922 ' HA2' HG23 ' A' ' 137' ' ' VAL . . . -161.33 -164.4 16.15 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.698 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.585 HD21 HD22 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -116.94 164.24 14.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.701 0.286 . . . . 0.0 110.718 -179.97 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.874 HG23 ' O ' ' A' ' 112' ' ' GLY . 61.3 t -66.31 126.35 25.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.758 0.313 . . . . 0.0 111.188 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.732 ' OG1' ' HB2' ' A' ' 135' ' ' ALA . 2.9 m -109.45 -90.01 0.47 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.445 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.836 ' HG3' HG23 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -127.91 125.87 40.42 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 121.022 0.439 . . . . 0.0 111.742 179.946 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -107.87 128.33 9.11 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.66 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -81.69 -162.42 29.71 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.511 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -71.82 -19.72 61.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.71 0.291 . . . . 0.0 111.132 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -146.93 -7.27 0.28 Allowed Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.795 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.608 ' CG1' HD22 ' A' ' 100' ' ' LEU . 1.6 t -115.94 157.12 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 117.289 0.544 . . . . 0.0 110.927 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.726 ' C ' HD23 ' A' ' 100' ' ' LEU . 11.8 m -114.75 118.63 59.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.563 -179.132 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 126' ' ' MET . . . -97.68 118.7 6.17 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.47 -0.872 . . . . 0.0 112.041 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.738 ' HD2' HD22 ' A' ' 114' ' ' LEU . 11.5 m-85 -120.28 143.96 48.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.01 0.433 . . . . 0.0 111.637 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.732 ' HB2' ' OG1' ' A' ' 125' ' ' THR . . . -90.44 110.83 21.93 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.937 178.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.569 ' CG ' HD13 ' A' ' 99' ' ' LEU . 2.6 m-20 -67.97 143.61 55.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.095 0.474 . . . . 0.0 111.889 -178.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.922 HG23 ' HA2' ' A' ' 122' ' ' GLY . 92.8 t -90.05 9.86 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.624 179.221 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.661 ' HA ' HD23 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -70.23 -7.94 46.13 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.528 179.758 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -90.21 8.11 34.74 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.892 HD23 HG21 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -172.34 42.02 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.067 0.461 . . . . 0.0 110.899 179.886 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.719 HD11 ' HB ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -58.72 -14.99 9.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.229 -179.858 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 142' ' ' TRP . . . . . 0.437 ' CD1' ' HA ' ' A' ' 140' ' ' LEU . 16.1 p-90 -59.09 79.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.862 0.363 . . . . 0.0 111.327 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.676 HD22 ' HB ' ' A' ' 12' ' ' VAL . 4.7 mp -137.54 -45.98 0.55 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.469 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.462 ' HG2' ' CG1' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -165.58 -162.46 0.58 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.74 179.707 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -58.82 131.0 49.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.94 0.4 . . . . 0.0 111.189 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.483 ' HB2' ' HB2' ' A' ' 55' ' ' ARG . 3.7 p30 -105.0 154.25 20.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.639 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.62 ' HB3' ' H ' ' A' ' 55' ' ' ARG . . . . . . . . 0 C--N 1.331 -0.206 0 CA-C-O 120.843 0.354 . . . . 0.0 111.142 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.826 ' HB2' HG23 ' A' ' 18' ' ' VAL . . . . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.781 0.324 . . . . 0.0 111.232 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.632 HG13 HG22 ' A' ' 17' ' ' VAL . 8.3 p -126.82 106.26 15.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.939 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.512 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 2.5 p90 -103.13 127.46 50.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.916 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.69 HG21 HD11 ' A' ' 53' ' ' ILE . 39.2 t -119.06 133.21 66.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.67 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 50.89 -130.51 31.83 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.885 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.401 ' O ' ' HA ' ' A' ' 44' ' ' THR . 9.0 m-20 -91.35 18.62 6.89 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.741 0.305 . . . . 0.0 111.073 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.681 ' HB2' HD23 ' A' ' 143' ' ' LEU . 9.7 m-85 -129.87 144.2 51.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.119 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -127.7 114.72 17.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.587 179.386 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 1.008 HG12 HG22 ' A' ' 42' ' ' VAL . 0.7 OUTLIER -103.08 121.77 54.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-O 121.237 0.541 . . . . 0.0 111.024 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.826 HG23 ' HB2' ' A' ' 9' ' ' ALA . 7.3 p -136.47 160.55 37.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.076 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.507 ' N ' HG22 ' A' ' 18' ' ' VAL . 11.8 t-20 -59.71 141.51 55.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.463 179.177 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.43 -47.11 79.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.895 0.379 . . . . 0.0 110.908 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -68.86 -9.06 49.34 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.242 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.4 ' HB3' HG22 ' A' ' 18' ' ' VAL . 1.7 tp -109.58 -11.65 14.76 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.947 ' HB3' ' CZ2' ' A' ' 28' ' ' TRP . . . -70.39 150.48 46.22 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 120.81 0.338 . . . . 0.0 110.875 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.567 ' OG1' HG12 ' A' ' 26' ' ' VAL . 67.1 p -104.97 168.89 8.76 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.447 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -54.69 -29.79 53.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.972 0.415 . . . . 0.0 110.704 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.567 HG12 ' OG1' ' A' ' 24' ' ' THR . 8.2 p -76.47 -31.03 19.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.324 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.435 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 7.7 m-20 -66.27 -44.05 84.7 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.947 ' CZ2' ' HB3' ' A' ' 23' ' ' ALA . 6.7 m-90 -74.26 -30.12 61.99 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.872 179.096 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -57.3 -44.16 83.86 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.431 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -114.25 31.86 6.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.436 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.452 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 14.3 t -79.6 129.07 34.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.171 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.493 HG22 ' O ' ' A' ' 42' ' ' VAL . 12.7 m -91.47 -39.89 12.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.719 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.598 ' HH2' HD23 ' A' ' 40' ' ' LEU . 0.6 OUTLIER -139.43 152.4 47.03 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.01 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -159.83 117.41 2.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.977 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -107.03 118.33 36.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.232 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -65.96 -42.23 90.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.925 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.459 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 8.8 m-20 -66.63 -14.53 62.55 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.99 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.4 mtm180 -114.89 0.64 13.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.234 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.2 p30 42.54 38.99 1.41 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.996 0.427 . . . . 0.0 110.809 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.841 HD11 HG23 ' A' ' 17' ' ' VAL . 23.5 tp -137.12 152.15 49.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.091 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.683 HD11 ' CB ' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -147.79 155.72 41.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.153 179.455 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 1.008 HG22 HG12 ' A' ' 17' ' ' VAL . 29.3 t -119.78 129.97 74.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.94 0.4 . . . . 0.0 110.818 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.7 p -120.33 156.95 30.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.181 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.64 HG22 ' CE1' ' A' ' 15' ' ' TYR . 13.5 p -97.79 123.85 41.91 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.174 0.512 . . . . 0.0 111.542 -179.068 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -115.1 164.98 13.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.859 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.64 46.86 0.9 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.797 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -151.93 144.82 24.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.101 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 9.2 m170 -67.7 148.07 51.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.803 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.454 ' HA2' ' CE2' ' A' ' 11' ' ' TYR . . . -82.92 135.82 14.45 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.597 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 8.2 t -95.67 19.14 11.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.703 0.287 . . . . 0.0 111.037 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -135.27 145.9 48.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.751 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.903 ' O ' HG23 ' A' ' 120' ' ' VAL . 28.0 m -119.54 117.62 28.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.603 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.836 ' HB ' HD11 ' A' ' 141' ' ' LEU . 0.5 OUTLIER -77.05 139.52 18.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.748 -179.873 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.688 ' HB2' ' N ' ' A' ' 119' ' ' GLY . . . -93.21 132.21 37.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.225 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.652 ' H ' ' HB3' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -92.1 28.7 1.8 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.391 179.316 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 28.1 p -99.56 166.08 11.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.965 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.62 34.44 4.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.709 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 40.7 m -55.18 131.37 45.12 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.082 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.7 m -72.47 -11.46 60.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.619 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.1 p -120.26 153.51 36.25 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.765 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -171.29 -164.14 26.46 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.892 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.739 HG23 ' C ' ' A' ' 72' ' ' TYR . 10.2 p -139.66 128.08 26.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.962 0.411 . . . . 0.0 111.18 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.479 ' CE1' ' HB2' ' A' ' 72' ' ' TYR . 17.7 p90 -99.02 133.61 43.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.752 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.581 ' HB2' ' CE1' ' A' ' 71' ' ' HIS . 77.5 t80 . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.471 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.581 ' CE1' ' HB2' ' A' ' 64' ' ' PHE . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.133 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.739 ' C ' HG23 ' A' ' 62' ' ' VAL . 0.5 OUTLIER -122.1 114.28 30.84 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.754 -178.36 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.405 ' N ' HG23 ' A' ' 62' ' ' VAL . 13.9 Cg_exo -68.79 120.59 7.49 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 121.987 1.791 . . . . 0.0 110.284 178.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.459 ' CG1' ' CE2' ' A' ' 76' ' ' PHE . 2.2 p -142.51 153.43 17.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.973 0.416 . . . . 0.0 111.782 -178.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.5 m -97.05 125.52 41.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.886 178.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.731 ' CD2' ' HB2' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -130.74 161.23 32.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.442 0.639 . . . . 0.0 111.793 -179.506 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.681 ' C ' ' HD3' ' A' ' 79' ' ' PRO . 3.0 mm-40 -111.77 159.31 18.4 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.959 178.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -108.57 64.53 0.26 Allowed Glycine 0 CA--C 1.522 0.53 0 C-N-CA 120.251 -0.976 . . . . 0.0 114.004 -179.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.681 ' HD3' ' C ' ' A' ' 77' ' ' GLU . 14.0 Cg_exo -67.0 140.94 56.2 Favored 'Trans proline' 0 C--O 1.242 0.695 0 C-N-CA 122.326 2.017 . . . . 0.0 112.524 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 96' ' ' SER . . . -63.04 -60.16 8.02 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.276 -0.874 . . . . 0.0 112.514 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.484 HD11 ' HB3' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -120.06 122.29 40.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.997 0.427 . . . . 0.0 111.813 -179.877 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.539 ' HB ' HG11 ' A' ' 98' ' ' VAL . 17.8 t -128.66 122.7 57.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.406 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.64 107.83 5.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.635 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.557 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 32.7 m -77.46 122.34 31.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.026 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -69.69 150.28 47.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.172 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.522 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 3.3 tt0 -67.92 102.58 1.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.54 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 89' ' ' TYR . 2.8 p -143.74 160.81 40.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.581 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 56.39 -81.98 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.651 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.419 ' N ' ' O ' ' A' ' 87' ' ' SER . 0.3 OUTLIER -153.44 21.44 0.55 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.724 0.297 . . . . 0.0 111.161 -179.805 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.522 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 1.6 t80 -119.68 133.28 23.84 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.674 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.418 ' HD2' ' CD1' ' A' ' 90' ' ' TYR . 79.7 Cg_endo -77.3 148.58 27.05 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.856 2.371 . . . . 0.0 112.538 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.557 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.7 OUTLIER -55.36 89.24 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.631 179.819 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.91 -175.62 3.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.258 0.552 . . . . 0.0 112.119 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.484 ' HB3' HD11 ' A' ' 81' ' ' LEU . 15.8 m-85 -100.06 132.62 45.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.636 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.459 ' HA ' ' O ' ' A' ' 37' ' ' ASN . 0.8 OUTLIER -127.22 124.41 38.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.863 0.363 . . . . 0.0 111.24 -179.662 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 40.2 t -89.79 162.29 15.59 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.068 0.461 . . . . 0.0 111.905 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 44.39 56.93 4.66 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.741 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.619 ' O ' ' HD2' ' A' ' 79' ' ' PRO . 8.4 p -124.0 136.77 59.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.267 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.871 HD11 ' HB3' ' A' ' 136' ' ' ASP . 2.2 mp -101.92 149.19 24.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.332 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.775 HD23 ' C ' ' A' ' 132' ' ' VAL . 7.7 mt -127.69 132.51 49.64 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.343 -0.543 . . . . 0.0 112.213 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.731 ' HB2' ' CD2' ' A' ' 76' ' ' PHE . . . -128.14 132.28 48.93 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.535 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 1.8 t -93.34 115.31 27.88 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.945 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 0.215 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.589 -179.87 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.772 ' O ' HG23 ' A' ' 124' ' ' VAL . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.551 -0.219 . . . . 0.0 112.551 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.466 HG21 ' HB ' ' A' ' 10' ' ' VAL . 25.9 pt -126.12 146.35 32.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.881 0.372 . . . . 0.0 111.245 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.684 HD11 ' CZ ' ' A' ' 76' ' ' PHE . 23.3 tp -87.52 121.22 29.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.253 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 17.1 mtt85 -118.24 152.28 36.02 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.181 0.515 . . . . 0.0 111.999 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.591 ' HB2' HD11 ' A' ' 121' ' ' ILE . 5.6 t -118.75 164.24 15.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.086 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -58.54 -17.94 25.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.055 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 14.9 m80 -94.89 -30.87 13.95 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.54 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.688 ' N ' ' HB2' ' A' ' 54' ' ' ALA . . . 174.52 -135.93 3.32 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.516 -0.85 . . . . 0.0 112.811 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.903 HG23 ' O ' ' A' ' 52' ' ' THR . 5.4 t -105.48 134.99 45.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.653 0.263 . . . . 0.0 111.053 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.591 HD11 ' HB2' ' A' ' 116' ' ' CYS . 1.1 mm -93.62 -67.73 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.864 0.364 . . . . 0.0 110.983 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.901 ' HA2' HG23 ' A' ' 137' ' ' VAL . . . -159.08 -143.03 3.54 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.843 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.571 ' HG ' ' HB3' ' A' ' 135' ' ' ALA . 0.4 OUTLIER -136.31 164.15 28.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.852 0.358 . . . . 0.0 111.128 -179.84 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.772 HG23 ' O ' ' A' ' 112' ' ' GLY . 36.4 t -68.58 109.22 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.348 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.804 ' OG1' ' HB2' ' A' ' 135' ' ' ALA . 3.6 m -92.04 -90.83 0.17 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.4 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.635 ' N ' HG22 ' A' ' 125' ' ' THR . 97.5 mmm -138.67 125.94 21.58 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.049 0.452 . . . . 0.0 111.301 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -110.22 131.25 10.33 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.593 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -70.04 -146.5 0.29 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.248 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -86.59 -19.38 29.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.698 0.285 . . . . 0.0 111.089 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 102' ' ' THR . . . -140.42 -9.97 0.73 Allowed Glycine 0 CA--C 1.522 0.473 0 C-N-CA 120.551 -0.833 . . . . 0.0 113.459 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.639 ' HB ' HD22 ' A' ' 100' ' ' LEU . 0.9 OUTLIER -115.74 157.56 16.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-N 117.241 0.52 . . . . 0.0 111.123 -179.704 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.775 ' C ' HD23 ' A' ' 100' ' ' LEU . 20.2 t -114.61 118.33 58.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.109 -178.392 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.488 ' HA3' ' O ' ' A' ' 126' ' ' MET . . . -89.28 126.31 8.17 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.781 178.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.734 ' HE1' HG22 ' A' ' 124' ' ' VAL . 40.2 m-85 -125.18 133.54 52.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.871 0.367 . . . . 0.0 111.586 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.804 ' HB2' ' OG1' ' A' ' 125' ' ' THR . . . -88.85 105.28 17.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.771 178.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.871 ' HB3' HD11 ' A' ' 99' ' ' LEU . 1.3 p30 -67.69 146.62 53.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.23 0.538 . . . . 0.0 112.181 -178.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.901 HG23 ' HA2' ' A' ' 122' ' ' GLY . 60.7 t -89.53 9.92 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.304 178.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.54 ' HA ' HD23 ' A' ' 141' ' ' LEU . 3.5 mmm180 -71.36 -7.02 44.41 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.566 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -99.87 11.13 40.04 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.594 0.235 . . . . 0.0 111.421 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.858 ' O ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -174.98 40.53 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.016 0.436 . . . . 0.0 110.701 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.836 HD11 ' HB ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -57.75 -25.46 60.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.943 -0.572 . . . . 0.0 112.037 -179.557 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 142' ' ' TRP . . . . . 0.443 ' CD1' ' HA ' ' A' ' 140' ' ' LEU . 11.6 p-90 -47.22 88.12 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.039 0.447 . . . . 0.0 111.762 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.681 HD23 ' HB2' ' A' ' 15' ' ' TYR . 5.0 mp -153.02 -47.12 0.1 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.073 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.494 ' HB2' HG12 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -158.54 -169.92 2.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.755 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -59.05 133.02 55.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.953 0.406 . . . . 0.0 111.28 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -105.15 154.36 20.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.569 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.652 ' HB3' ' H ' ' A' ' 55' ' ' ARG . . . . . . . . 0 C--N 1.332 -0.193 0 CA-C-O 120.864 0.364 . . . . 0.0 111.059 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.549 ' HB2' HG23 ' A' ' 18' ' ' VAL . . . . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.829 0.347 . . . . 0.0 111.165 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.7 t -103.37 115.85 46.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.955 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.663 ' CE2' HG21 ' A' ' 45' ' ' THR . 5.7 t80 -104.18 115.91 31.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.808 0.337 . . . . 0.0 110.659 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.792 HG21 HD11 ' A' ' 53' ' ' ILE . 57.6 t -121.17 112.64 36.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.652 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 50.54 -126.22 24.01 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.98 -0.629 . . . . 0.0 113.379 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.466 ' O ' ' HA ' ' A' ' 44' ' ' THR . 4.5 m-20 -91.01 17.97 7.29 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.656 0.265 . . . . 0.0 111.589 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.641 ' CE1' HG22 ' A' ' 44' ' ' THR . 4.7 m-30 -130.49 127.74 39.8 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.04 114.74 22.46 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 121.024 -0.27 . . . . 0.0 110.888 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.926 HG12 HG22 ' A' ' 42' ' ' VAL . 0.7 OUTLIER -99.64 121.9 50.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-O 120.984 0.421 . . . . 0.0 110.453 179.585 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.666 ' O ' HD12 ' A' ' 40' ' ' LEU . 9.6 p -136.29 159.99 38.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.306 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.498 ' N ' HG22 ' A' ' 18' ' ' VAL . 32.5 m-80 -59.96 141.74 55.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.289 179.025 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 48.7 ttt-85 -56.17 -47.35 78.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.814 0.34 . . . . 0.0 110.774 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -69.2 -8.42 45.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.968 179.253 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.464 ' HB3' HG22 ' A' ' 18' ' ' VAL . 16.7 tp -110.59 -12.59 14.33 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.967 ' HB3' ' CZ2' ' A' ' 28' ' ' TRP . . . -66.97 150.73 48.82 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 120.896 0.379 . . . . 0.0 110.796 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.559 ' CG2' HG12 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -105.19 170.02 8.11 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.395 179.925 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 56.6 p-80 -54.76 -29.76 54.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.914 0.388 . . . . 0.0 110.954 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.559 HG12 ' CG2' ' A' ' 24' ' ' THR . 9.4 p -76.25 -31.21 20.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.559 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.25 -44.24 79.91 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.967 ' CZ2' ' HB3' ' A' ' 23' ' ' ALA . 5.0 m-90 -74.82 -30.45 61.4 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.33 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -58.62 -43.37 89.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.609 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -118.36 39.56 3.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.555 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.472 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 30.4 p -79.97 126.74 31.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.312 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.584 ' CG2' HG12 ' A' ' 42' ' ' VAL . 16.3 m -88.29 -39.16 12.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.543 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.637 ' CE3' HG23 ' A' ' 42' ' ' VAL . 0.5 OUTLIER -139.61 150.16 44.65 Favored 'General case' 0 CA--C 1.53 0.212 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.067 179.905 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -149.93 110.89 4.34 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.722 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.466 ' HB2' ' CZ2' ' A' ' 33' ' ' TRP . 27.4 t0 -107.23 112.88 25.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.88 0.371 . . . . 0.0 111.06 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -67.4 -34.82 78.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.076 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.448 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 0.3 OUTLIER -64.3 -20.24 65.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.845 179.718 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -115.11 0.96 13.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.316 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 46.58 35.12 2.75 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 121.221 0.534 . . . . 0.0 110.175 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.808 HD11 HG23 ' A' ' 17' ' ' VAL . 28.4 tp -131.84 153.46 50.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.911 -179.017 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.683 ' O ' HD23 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -146.43 155.73 42.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.177 179.648 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.926 HG22 HG12 ' A' ' 17' ' ' VAL . 33.9 t -119.11 127.97 75.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.288 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.9 p -122.3 157.17 32.32 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.787 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.641 HG22 ' CE1' ' A' ' 15' ' ' TYR . 25.1 p -97.57 145.09 26.59 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.216 0.531 . . . . 0.0 111.614 -179.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.663 HG21 ' CE2' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -137.4 171.76 14.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.907 -179.139 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.0 t -121.18 34.75 5.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.848 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -113.81 175.14 5.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.164 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.2 m80 -82.84 148.09 27.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.9 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.436 ' HA2' ' CE1' ' A' ' 11' ' ' TYR . . . -100.69 -174.18 29.48 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.563 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.9 t -165.06 -43.41 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.842 0.353 . . . . 0.0 110.879 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -74.15 137.17 43.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.973 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.92 ' O ' HG23 ' A' ' 120' ' ' VAL . 81.0 m -122.66 123.55 41.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.499 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.792 HD11 HG21 ' A' ' 12' ' ' VAL . 1.0 OUTLIER -74.09 139.51 19.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.804 0.335 . . . . 0.0 110.689 179.915 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.843 ' HB2' ' N ' ' A' ' 119' ' ' GLY . . . -95.21 128.2 41.87 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.008 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.585 ' H ' ' HB3' ' A' ' 147' ' ' ALA . 11.3 tpt180 -94.67 36.09 1.19 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.584 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 20.6 p -99.98 167.25 10.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.981 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -117.22 28.64 8.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.468 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 14.0 m -62.18 120.44 10.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.753 0.311 . . . . 0.0 110.704 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.4 t -69.35 -13.37 62.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.947 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -117.71 126.56 52.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.21 0.529 . . . . 0.0 111.464 -179.664 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 73' ' ' PRO . . . -135.83 -153.78 6.74 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.114 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.768 HG23 ' C ' ' A' ' 72' ' ' TYR . 11.2 p -140.08 131.31 31.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 117.26 0.53 . . . . 0.0 111.649 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -109.69 150.74 27.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.741 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.098 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.61 ' HB3' HG21 ' A' ' 62' ' ' VAL . 35.0 m80 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.894 0.378 . . . . 0.0 109.993 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.768 ' C ' HG23 ' A' ' 62' ' ' VAL . 0.6 OUTLIER -111.22 114.38 53.47 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.296 -179.096 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.506 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 6.3 Cg_exo -78.27 125.89 7.36 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.459 2.106 . . . . 0.0 111.834 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.462 ' CG1' ' CE2' ' A' ' 76' ' ' PHE . 2.3 p -136.77 153.03 29.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.945 0.403 . . . . 0.0 111.745 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.546 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 0.0 OUTLIER -95.35 133.52 39.18 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.493 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.609 ' CD2' ' HB2' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -135.28 166.5 22.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.507 0.67 . . . . 0.0 111.955 -178.886 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.696 ' C ' ' HD3' ' A' ' 79' ' ' PRO . 1.8 mp0 -111.71 159.54 18.14 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.121 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -108.42 62.23 0.3 Allowed Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.044 -1.074 . . . . 0.0 114.191 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.696 ' HD3' ' C ' ' A' ' 77' ' ' GLU . 15.1 Cg_exo -67.01 142.52 62.2 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.075 1.85 . . . . 0.0 111.948 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -64.83 -90.67 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.739 -0.664 . . . . 0.0 113.016 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.791 HD22 ' HB2' ' A' ' 96' ' ' SER . 0.0 OUTLIER -85.08 129.99 34.7 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.031 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.629 ' HB ' HG11 ' A' ' 98' ' ' VAL . 98.7 t -138.75 126.04 26.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.478 178.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -72.35 107.86 5.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.944 0.402 . . . . 0.0 111.598 -178.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.734 HG23 ' CG ' ' A' ' 126' ' ' MET . 4.1 p -73.11 114.27 12.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.959 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -73.01 149.39 43.3 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.546 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.575 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 1.0 OUTLIER -69.34 101.89 1.62 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.644 179.923 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.457 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -144.45 152.81 41.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.129 179.761 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 53.56 -82.85 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.558 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.457 ' N ' ' O ' ' A' ' 87' ' ' SER . 0.4 OUTLIER -146.38 18.65 1.36 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.693 0.283 . . . . 0.0 111.047 179.905 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.575 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 1.2 m-85 -106.9 136.54 19.43 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.315 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.495 ' HA ' ' HG2' ' A' ' 86' ' ' GLU . 95.2 Cg_endo -84.37 148.33 11.5 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.917 2.411 . . . . 0.0 112.954 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -65.05 77.58 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.518 179.547 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.55 ' O ' HG12 ' A' ' 84' ' ' VAL . 46.8 mtt180 -123.69 -174.75 3.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.126 0.489 . . . . 0.0 111.912 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.464 ' HB3' HD11 ' A' ' 81' ' ' LEU . 19.5 m-85 -99.14 132.26 44.58 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.841 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.606 ' OE1' HG11 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -131.22 126.74 36.33 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.098 -179.867 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.791 ' HB2' HD22 ' A' ' 81' ' ' LEU . 44.4 t -101.55 158.54 16.0 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.087 0.47 . . . . 0.0 111.803 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.42 ' CE1' ' HB2' ' A' ' 138' ' ' ARG . 0.0 OUTLIER 64.71 56.53 1.15 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.645 179.338 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.629 HG11 ' HB ' ' A' ' 82' ' ' VAL . 9.5 p -123.53 141.81 42.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.994 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.451 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 11.0 mp -104.95 147.96 27.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.315 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.721 HD23 ' C ' ' A' ' 132' ' ' VAL . 6.8 mt -133.08 131.5 40.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.069 0.461 . . . . 0.0 112.183 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.609 ' HB2' ' CD2' ' A' ' 76' ' ' PHE . . . -135.65 147.64 48.67 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.749 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.5 t -105.33 134.35 48.59 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.982 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 0.204 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.494 179.992 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.691 ' O ' HG13 ' A' ' 124' ' ' VAL . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.719 -0.152 . . . . 0.0 112.719 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 18.0 pt -126.11 146.72 31.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.829 0.347 . . . . 0.0 111.156 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.651 HD22 ' HD2' ' A' ' 134' ' ' PHE . 15.6 tp -87.14 115.49 24.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.126 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.643 ' HD3' HG22 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -118.05 150.94 38.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.059 0.457 . . . . 0.0 111.501 -179.416 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.523 ' HB2' HD11 ' A' ' 121' ' ' ILE . 5.7 t -114.57 162.34 16.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.279 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -56.22 -19.47 13.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.919 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.42 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . 18.9 m80 -92.26 -34.34 14.29 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.457 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.843 ' N ' ' HB2' ' A' ' 54' ' ' ALA . . . 178.03 -140.03 4.47 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.345 -0.931 . . . . 0.0 113.145 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.92 HG23 ' O ' ' A' ' 52' ' ' THR . 4.0 t -102.1 135.58 38.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.705 0.288 . . . . 0.0 111.287 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.554 ' HB ' ' HG ' ' A' ' 114' ' ' LEU . 1.1 mm -98.4 -67.15 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.896 0.379 . . . . 0.0 110.735 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.919 ' HA2' HG23 ' A' ' 137' ' ' VAL . . . -159.88 -166.43 18.75 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.667 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.464 HD11 HD13 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -116.93 164.08 15.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.789 0.328 . . . . 0.0 110.698 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.691 HG13 ' O ' ' A' ' 112' ' ' GLY . 7.7 m -65.6 128.94 29.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.453 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.748 ' OG1' ' HB2' ' A' ' 135' ' ' ALA . 2.5 m -111.09 -89.08 0.5 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.344 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.734 ' CG ' HG23 ' A' ' 84' ' ' VAL . 0.8 OUTLIER -130.44 125.77 35.3 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.934 0.397 . . . . 0.0 111.409 179.915 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -110.71 151.19 17.68 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.47 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -110.04 -153.23 14.1 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.578 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -93.98 17.28 12.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.595 0.236 . . . . 0.0 111.239 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -168.74 -28.25 0.02 OUTLIER Glycine 0 CA--C 1.52 0.357 0 C-N-CA 120.527 -0.844 . . . . 0.0 113.182 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.558 ' CG1' HD22 ' A' ' 100' ' ' LEU . 1.6 t -115.48 157.27 16.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.802 0.301 . . . . 0.0 111.038 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.721 ' C ' HD23 ' A' ' 100' ' ' LEU . 10.0 m -114.73 118.86 59.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.658 -179.128 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.472 ' HA3' ' O ' ' A' ' 126' ' ' MET . . . -95.59 117.93 5.78 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.39 -0.909 . . . . 0.0 112.177 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.651 ' HD2' HD22 ' A' ' 114' ' ' LEU . 13.5 m-85 -122.2 144.2 49.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.95 0.405 . . . . 0.0 111.512 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.748 ' HB2' ' OG1' ' A' ' 125' ' ' THR . . . -89.34 111.06 21.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.076 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -68.34 147.34 52.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.01 0.433 . . . . 0.0 111.836 -179.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.919 HG23 ' HA2' ' A' ' 122' ' ' GLY . 97.9 t -91.26 11.03 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.438 179.131 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.594 ' HA ' HD23 ' A' ' 141' ' ' LEU . 12.8 mmm180 -70.14 -6.93 37.61 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.748 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -98.26 11.11 38.98 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 111.706 0.261 . . . . 0.0 111.706 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.873 HD23 HG21 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -175.03 39.07 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.202 0.525 . . . . 0.0 110.471 179.81 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.662 HD11 ' HB ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -56.77 -20.86 24.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.32 -179.608 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 142' ' ' TRP . . . . . 0.432 ' CD1' ' HA ' ' A' ' 140' ' ' LEU . 12.7 p-90 -55.68 85.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.941 0.4 . . . . 0.0 111.45 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.575 HD23 ' CB ' ' A' ' 15' ' ' TYR . 4.2 mp -146.0 -48.16 0.21 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.309 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -151.12 -173.21 4.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.676 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -58.93 136.01 57.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.92 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -82.95 154.1 24.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.916 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.585 ' HB3' ' H ' ' A' ' 55' ' ' ARG . . . . . . . . 0 C--N 1.33 -0.239 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.069 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.601 ' HB2' HG23 ' A' ' 18' ' ' VAL . . . . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.772 0.32 . . . . 0.0 111.157 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.615 HG22 HG21 ' A' ' 113' ' ' ILE . 39.4 t -106.73 108.24 24.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.033 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.883 ' CE2' HG21 ' A' ' 45' ' ' THR . 6.5 t80 -98.11 116.53 30.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.688 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.895 HG21 HD11 ' A' ' 53' ' ' ILE . 41.7 t -120.58 108.83 23.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.587 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 51.59 -127.78 31.18 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.955 -0.64 . . . . 0.0 113.304 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.466 ' O ' ' HA ' ' A' ' 44' ' ' THR . 0.9 OUTLIER -88.88 14.27 10.78 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.572 0.225 . . . . 0.0 111.599 -179.637 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.647 ' HE1' HG22 ' A' ' 44' ' ' THR . 6.1 m-30 -130.34 128.01 40.6 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.49 114.68 23.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.66 0.267 . . . . 0.0 111.018 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.908 HG12 HG22 ' A' ' 42' ' ' VAL . 0.8 OUTLIER -99.13 122.49 50.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 121.032 0.444 . . . . 0.0 110.401 179.48 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.779 ' O ' HD12 ' A' ' 40' ' ' LEU . 12.6 p -135.42 161.49 39.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.256 -179.2 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.881 ' HB2' HD12 ' A' ' 22' ' ' LEU . 2.2 t30 -60.94 141.74 57.0 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 178.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.2 -47.03 79.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.824 0.345 . . . . 0.0 110.838 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -71.05 -6.93 42.79 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.151 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.881 HD12 ' HB2' ' A' ' 19' ' ' ASN . 52.4 mt -112.66 -3.68 14.24 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.825 ' HB3' ' CZ2' ' A' ' 28' ' ' TRP . . . -77.13 151.0 35.55 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.865 0.364 . . . . 0.0 110.829 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.445 ' O ' ' CE3' ' A' ' 28' ' ' TRP . 1.2 t -102.89 166.64 10.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.133 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 30.1 t60 -54.04 -29.57 44.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.042 0.448 . . . . 0.0 110.345 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.5 t -72.07 -31.18 39.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.019 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.482 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 0.4 OUTLIER -67.43 -44.14 79.47 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.941 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.825 ' CZ2' ' HB3' ' A' ' 23' ' ' ALA . 11.7 m-90 -73.9 -35.46 64.65 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.078 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.62 -38.62 72.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.045 0.45 . . . . 0.0 110.503 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -119.37 27.73 8.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.755 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 8.7 t -73.58 122.8 22.82 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.964 0.412 . . . . 0.0 110.863 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.549 HG22 ' O ' ' A' ' 42' ' ' VAL . 13.1 m -86.57 -39.77 13.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.515 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.604 ' HH2' HD23 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -139.71 153.12 47.14 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.172 -179.893 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -156.82 121.28 4.44 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.813 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.401 ' HB2' ' CZ2' ' A' ' 33' ' ' TRP . 17.6 m-20 -107.05 116.86 32.66 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.23 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -67.24 -36.88 82.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.963 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.53 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 3.8 m-20 -72.41 -14.15 61.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.863 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 mtt85 -115.54 -3.77 12.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.777 -0.192 . . . . 0.0 111.274 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 46.91 42.15 11.79 Favored 'General case' 0 CA--C 1.524 -0.046 0 CA-C-O 121.216 0.532 . . . . 0.0 110.038 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.85 HD11 HG23 ' A' ' 17' ' ' VAL . 29.3 tp -136.17 152.42 50.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.906 -178.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.662 HD12 ' NE1' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -147.33 150.79 35.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.042 0.449 . . . . 0.0 111.194 179.408 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.908 HG22 HG12 ' A' ' 17' ' ' VAL . 31.0 t -114.54 126.75 72.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.403 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.9 p -117.87 157.28 26.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.416 178.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.647 HG22 ' HE1' ' A' ' 15' ' ' TYR . 18.9 p -97.71 140.79 31.58 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.119 0.485 . . . . 0.0 111.701 -179.012 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.883 HG21 ' CE2' ' A' ' 11' ' ' TYR . 0.2 OUTLIER -135.29 168.94 18.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.875 -179.335 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.2 p -121.69 61.9 0.93 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.832 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.24 169.7 17.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.125 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 4.9 m170 -86.56 128.57 34.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.876 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -87.43 -179.48 48.13 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.489 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 73.3 m -144.09 -46.94 0.27 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.77 0.319 . . . . 0.0 110.892 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -64.25 138.88 58.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.939 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.873 ' O ' HG23 ' A' ' 120' ' ' VAL . 83.2 m -122.7 121.05 35.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.509 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.895 HD11 HG21 ' A' ' 12' ' ' VAL . 0.4 OUTLIER -74.24 139.36 19.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.928 0.394 . . . . 0.0 111.211 -179.677 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.83 ' HB2' ' N ' ' A' ' 119' ' ' GLY . . . -95.7 123.65 39.36 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.942 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.504 ' H ' ' HB3' ' A' ' 147' ' ' ALA . 0.3 OUTLIER -91.2 37.29 0.94 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.621 179.672 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 24.5 p -99.85 167.1 10.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.952 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -119.1 33.53 5.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.32 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 35.5 m -62.76 141.85 58.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.627 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -85.28 3.1 41.12 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.024 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.1 p -125.9 168.05 14.42 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.103 0.478 . . . . 0.0 111.117 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -179.44 -173.14 44.34 Favored Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.583 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.836 HG23 ' C ' ' A' ' 72' ' ' TYR . 9.2 p -140.22 125.83 20.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 117.044 0.422 . . . . 0.0 111.225 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.704 ' HE2' HG21 ' A' ' 74' ' ' VAL . 6.2 p90 -109.12 137.99 46.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.743 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.049 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.478 ' HB3' HG21 ' A' ' 62' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.131 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.836 ' C ' HG23 ' A' ' 62' ' ' VAL . 2.7 m-85 -108.59 113.86 59.52 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.512 -179.296 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 72' ' ' TYR . 2.7 Cg_exo -76.34 120.78 5.77 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.589 2.192 . . . . 0.0 111.024 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.704 HG21 ' HE2' ' A' ' 63' ' ' TYR . 54.5 t -134.83 141.78 42.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.977 0.418 . . . . 0.0 111.765 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 16.7 m -91.84 121.64 33.64 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.51 ' HB3' ' HB2' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -127.96 165.19 20.73 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.526 0.679 . . . . 0.0 111.947 -178.629 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.58 ' C ' ' HD3' ' A' ' 79' ' ' PRO . 10.7 mt-10 -111.72 158.83 18.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.899 178.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.484 ' HA2' ' HG ' ' A' ' 99' ' ' LEU . . . -112.16 68.6 0.23 Allowed Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.124 -1.036 . . . . 0.0 113.961 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.586 ' HD2' ' O ' ' A' ' 98' ' ' VAL . 15.7 Cg_exo -67.36 142.08 58.68 Favored 'Trans proline' 0 C--O 1.238 0.503 0 C-N-CA 122.22 1.946 . . . . 0.0 111.797 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -57.98 -91.73 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.538 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.585 HD22 ' CB ' ' A' ' 96' ' ' SER . 0.0 OUTLIER -94.37 119.82 33.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.91 0.386 . . . . 0.0 111.876 -179.587 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.643 ' HB ' HG11 ' A' ' 98' ' ' VAL . 61.7 t -122.76 122.62 66.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.923 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.401 ' HG3' ' CE1' ' A' ' 94' ' ' TYR . 1.8 tt0 -72.43 107.62 5.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.859 0.362 . . . . 0.0 110.741 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.709 HG13 ' HG2' ' A' ' 126' ' ' MET . 30.4 t -75.77 114.3 15.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.624 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.422 ' HA ' ' HD3' ' A' ' 92' ' ' LYS . 1.5 tt0 -71.86 150.02 44.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.032 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.472 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 0.8 OUTLIER -67.88 101.34 1.07 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.158 0.504 . . . . 0.0 110.159 -179.475 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.508 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.3 OUTLIER -144.65 175.7 9.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.839 -179.913 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 42.96 -86.23 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.787 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.508 ' N ' ' O ' ' A' ' 87' ' ' SER . 0.3 OUTLIER -150.56 23.5 0.8 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.825 0.345 . . . . 0.0 110.485 179.686 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.472 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -117.92 138.15 25.11 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.867 -179.704 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.427 ' O ' ' N ' ' A' ' 93' ' ' ARG . 93.7 Cg_endo -78.77 148.61 22.69 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.821 2.347 . . . . 0.0 112.247 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.578 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -60.9 79.9 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.866 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.427 ' N ' ' O ' ' A' ' 91' ' ' PRO . 1.5 ttp85 -123.65 177.41 5.7 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.692 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.457 ' HB3' HD11 ' A' ' 81' ' ' LEU . 10.6 m-85 -91.29 132.6 36.04 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.777 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.777 ' OE1' HG23 ' A' ' 125' ' ' THR . 0.1 OUTLIER -125.46 116.84 22.46 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.654 -179.571 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.585 ' CB ' HD22 ' A' ' 81' ' ' LEU . 3.0 t -91.53 154.4 19.12 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 120.92 0.391 . . . . 0.0 111.45 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 53.72 62.46 2.61 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.336 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.643 HG11 ' HB ' ' A' ' 82' ' ' VAL . 5.9 p -123.35 152.28 28.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.1 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.484 ' HG ' ' HA2' ' A' ' 78' ' ' GLY . 5.5 mp -116.43 140.27 49.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.205 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.8 HD23 ' O ' ' A' ' 132' ' ' VAL . 5.5 mt -133.23 142.06 48.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.268 0.556 . . . . 0.0 112.456 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.575 ' O ' HG12 ' A' ' 131' ' ' VAL . . . -151.97 161.06 43.23 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.412 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.1 t -118.92 129.45 55.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.947 0.403 . . . . 0.0 111.004 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.334 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.493 179.949 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.615 HG21 HG22 ' A' ' 10' ' ' VAL . 28.4 pt -126.15 144.21 37.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.782 0.325 . . . . 0.0 111.17 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.63 HD22 ' HD2' ' A' ' 134' ' ' PHE . 10.8 tp -87.9 113.99 24.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.208 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.63 ' HD3' HG22 ' A' ' 120' ' ' VAL . 3.1 mtm180 -114.1 143.24 45.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.098 0.475 . . . . 0.0 111.554 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.56 ' HB2' HD11 ' A' ' 121' ' ' ILE . 6.9 t -107.79 164.28 12.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.191 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -56.14 -20.35 17.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.788 0.328 . . . . 0.0 110.723 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.493 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . 26.7 m80 -89.59 -35.86 15.64 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.325 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.83 ' N ' ' HB2' ' A' ' 54' ' ' ALA . . . 177.46 -136.36 3.06 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.854 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.873 HG23 ' O ' ' A' ' 52' ' ' THR . 3.8 t -102.88 135.38 40.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.685 0.279 . . . . 0.0 110.926 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.56 HD11 ' HB2' ' A' ' 116' ' ' CYS . 1.0 OUTLIER -94.59 -69.9 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.698 0.285 . . . . 0.0 111.248 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.941 ' HA2' HG23 ' A' ' 137' ' ' VAL . . . -150.95 -160.09 9.2 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.381 -0.914 . . . . 0.0 113.236 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.634 ' CD1' HD13 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -121.38 164.48 17.01 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.737 0.303 . . . . 0.0 110.85 -179.789 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.481 ' O ' HG13 ' A' ' 124' ' ' VAL . 9.9 p -62.31 121.52 11.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.838 0.351 . . . . 0.0 111.796 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.777 HG23 ' OE1' ' A' ' 95' ' ' GLN . 3.0 m -112.17 -91.31 0.49 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.075 179.103 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.709 ' HG2' HG13 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -92.58 160.4 15.04 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 120.787 0.327 . . . . 0.0 110.743 179.517 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -150.03 88.66 0.14 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.442 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -77.32 -176.59 44.81 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.429 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.79 -19.32 62.02 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.667 0.27 . . . . 0.0 111.015 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -142.03 -6.3 0.8 Allowed Glycine 0 CA--C 1.522 0.482 0 C-N-CA 120.598 -0.81 . . . . 0.0 113.447 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.575 HG12 ' O ' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -115.82 157.17 16.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 117.322 0.561 . . . . 0.0 111.306 -179.764 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.8 ' O ' HD23 ' A' ' 100' ' ' LEU . 13.1 m -119.73 118.69 57.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.5 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -100.99 120.06 6.75 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.728 -0.749 . . . . 0.0 111.9 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.63 ' HD2' HD22 ' A' ' 114' ' ' LEU . 18.3 m-85 -125.13 136.72 53.9 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.914 0.387 . . . . 0.0 112.02 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.754 ' HB2' ' OG1' ' A' ' 125' ' ' THR . . . -88.86 114.22 25.25 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.198 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -67.79 141.16 56.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.975 0.417 . . . . 0.0 111.858 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.941 HG23 ' HA2' ' A' ' 122' ' ' GLY . 88.9 t -89.31 9.72 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.615 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.48 ' HA ' HD23 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -70.74 -6.68 39.21 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.599 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -95.93 11.05 35.27 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 120.685 0.279 . . . . 0.0 111.317 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.853 ' O ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -177.98 57.28 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.083 0.468 . . . . 0.0 110.484 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.871 HD11 ' HB ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -74.83 -14.83 60.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.883 -179.572 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 142' ' ' TRP . . . . . 0.465 ' C ' HD12 ' A' ' 143' ' ' LEU . 13.2 p-90 -55.99 82.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.896 0.379 . . . . 0.0 111.261 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.672 HD12 ' C ' ' A' ' 141' ' ' LEU . 5.1 mp -149.67 -45.67 0.13 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.466 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.433 ' HB2' ' CG1' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -154.35 -167.44 2.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.747 179.832 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -58.88 141.03 54.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.0 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.409 ' HB2' ' HB2' ' A' ' 55' ' ' ARG . 15.4 p30 -94.97 154.07 17.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.832 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.617 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . . . . . . . . 0 C--N 1.33 -0.268 0 CA-C-O 120.904 0.383 . . . . 0.0 111.156 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.801 0.334 . . . . 0.0 111.047 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.0 t -107.4 116.23 50.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.013 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.611 ' CZ ' HG21 ' A' ' 45' ' ' THR . 0.3 OUTLIER -98.02 115.52 28.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.604 179.889 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.988 HG21 HD11 ' A' ' 53' ' ' ILE . 17.3 t -121.47 108.8 23.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.525 179.325 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 48.21 -124.64 11.41 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.928 -0.653 . . . . 0.0 113.098 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.405 ' O ' ' HA ' ' A' ' 44' ' ' THR . 2.7 m120 -92.43 17.94 9.2 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.734 0.302 . . . . 0.0 111.403 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.662 ' HE1' HG22 ' A' ' 44' ' ' THR . 4.9 m-30 -130.31 144.4 51.36 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.411 ' HG3' ' CD1' ' A' ' 11' ' ' TYR . 18.6 ttpt -133.83 118.26 17.79 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.702 0.287 . . . . 0.0 110.994 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 1.098 HG12 HG22 ' A' ' 42' ' ' VAL . 0.6 OUTLIER -104.39 122.07 56.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.117 0.485 . . . . 0.0 110.434 179.572 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.737 ' O ' HD12 ' A' ' 40' ' ' LEU . 14.0 p -136.01 162.0 37.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.033 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.508 ' N ' HG22 ' A' ' 18' ' ' VAL . 0.4 OUTLIER -58.53 141.24 52.52 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.091 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.587 ' HG2' HD13 ' A' ' 41' ' ' LEU . 13.9 mtm105 -56.45 -47.82 78.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.916 0.389 . . . . 0.0 111.17 -179.03 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -69.52 -7.62 39.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.441 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.9 tp -115.33 5.73 14.72 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.8 ' HB2' HD21 ' A' ' 41' ' ' LEU . . . -89.27 131.89 35.16 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.353 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.563 ' O ' ' HD1' ' A' ' 28' ' ' TRP . 44.1 p -74.76 162.5 28.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.469 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.406 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 2.9 t-160 -53.66 -29.64 39.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.886 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.8 t -69.57 -31.94 50.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.915 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.437 ' O ' ' HB3' ' A' ' 31' ' ' CYS . 13.5 m-20 -67.72 -44.07 78.51 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.62 ' NE1' ' HB3' ' A' ' 23' ' ' ALA . 33.8 m95 -73.57 -29.88 62.69 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.594 179.058 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.406 ' HB2' ' O ' ' A' ' 25' ' ' HIS . 2.2 tp60 -58.8 -43.92 90.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.575 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -118.15 30.13 7.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.832 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.483 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 29.5 p -69.17 122.93 19.81 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.949 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.546 ' CG2' HG12 ' A' ' 42' ' ' VAL . 17.7 m -86.2 -39.74 13.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.434 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.755 ' HH2' HD23 ' A' ' 40' ' ' LEU . 1.0 OUTLIER -139.66 153.25 47.25 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.08 179.689 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -160.44 115.92 2.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.008 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -107.19 117.75 34.9 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.936 0.398 . . . . 0.0 111.136 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -62.26 -48.84 78.14 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.353 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -59.9 -19.09 49.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.134 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -108.38 -8.02 15.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.276 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.4 t70 49.49 43.22 23.63 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 121.088 0.47 . . . . 0.0 110.224 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.755 HD23 ' HH2' ' A' ' 33' ' ' TRP . 20.0 tp -137.1 154.15 50.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.126 -178.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.8 HD21 ' HB2' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -151.86 137.18 17.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.115 0.484 . . . . 0.0 111.131 179.555 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 1.098 HG22 HG12 ' A' ' 17' ' ' VAL . 34.3 t -100.96 130.58 50.11 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.406 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.4 p -123.19 157.45 32.99 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.261 -0.882 . . . . 0.0 109.435 178.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.662 HG22 ' HE1' ' A' ' 15' ' ' TYR . 19.4 p -97.21 134.48 40.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.235 0.54 . . . . 0.0 111.395 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.611 HG21 ' CZ ' ' A' ' 11' ' ' TYR . 0.5 OUTLIER -102.49 -29.56 11.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.026 -179.126 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.0 m 66.61 31.43 7.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.738 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -142.96 -167.78 2.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.017 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.85 144.94 43.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.827 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -72.65 -140.51 0.37 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.42 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.1 m -172.09 -44.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.693 0.282 . . . . 0.0 111.05 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -117.23 163.3 16.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.2 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.903 ' O ' HG23 ' A' ' 120' ' ' VAL . 73.9 m -125.28 122.5 37.09 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.664 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.988 HD11 HG21 ' A' ' 12' ' ' VAL . 0.4 OUTLIER -75.29 139.52 18.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.03 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.82 ' HB2' ' N ' ' A' ' 119' ' ' GLY . . . -94.57 128.45 41.2 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.061 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.443 ' HB3' ' HB3' ' A' ' 146' ' ' ASP . 0.0 OUTLIER -92.31 33.69 1.08 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.683 179.576 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 26.7 p -99.49 166.96 10.91 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.905 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -121.85 33.41 5.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.241 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 34.4 m -60.44 127.37 31.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.776 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.85 -9.32 58.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.994 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.9 p -117.84 124.0 47.28 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.008 0.432 . . . . 0.0 111.109 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.07 178.88 20.44 Favored Glycine 0 N--CA 1.452 -0.299 0 N-CA-C 111.632 -0.587 . . . . 0.0 111.632 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.844 HG21 ' HB2' ' A' ' 71' ' ' HIS . 8.3 p -119.28 124.83 73.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.205 0.526 . . . . 0.0 111.362 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -105.52 -173.94 2.42 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.433 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.134 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.844 ' HB2' HG21 ' A' ' 62' ' ' VAL . 7.8 p80 . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.639 0.257 . . . . 0.0 110.504 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.785 ' C ' HG23 ' A' ' 62' ' ' VAL . 4.5 m-85 -105.68 112.4 64.57 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.039 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.502 ' HA ' ' HA ' ' A' ' 62' ' ' VAL . 2.8 Cg_endo -84.03 120.88 2.69 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.044 2.496 . . . . 0.0 111.658 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.517 ' CG1' ' CE2' ' A' ' 76' ' ' PHE . 2.5 p -137.52 153.79 28.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.504 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.0 m -94.78 127.68 40.95 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.563 ' CD2' ' HB2' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -131.53 162.71 29.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.379 0.609 . . . . 0.0 111.919 -179.416 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' A' ' 99' ' ' LEU . 0.7 OUTLIER -111.83 158.86 18.9 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.142 178.987 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -104.82 65.48 0.3 Allowed Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.275 -0.964 . . . . 0.0 113.557 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.472 ' HD2' ' HA ' ' A' ' 99' ' ' LEU . 41.9 Cg_endo -68.34 135.23 33.41 Favored 'Trans proline' 0 C--O 1.239 0.535 0 C-N-CA 122.263 1.975 . . . . 0.0 112.198 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -59.3 -85.26 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.245 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.724 HD11 ' HB3' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -97.38 119.5 36.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.993 0.425 . . . . 0.0 111.594 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.626 ' HB ' HG11 ' A' ' 98' ' ' VAL . 44.1 t -123.25 122.42 65.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.823 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.59 107.51 5.13 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.992 0.425 . . . . 0.0 110.67 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.581 HG12 ' O ' ' A' ' 93' ' ' ARG . 2.7 p -74.53 119.29 21.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.557 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.427 ' HA ' ' HG2' ' A' ' 92' ' ' LYS . 24.3 mt-30 -69.65 149.41 48.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.06 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.544 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 14.3 tt0 -68.63 102.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.625 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.552 ' HB3' ' HE1' ' A' ' 126' ' ' MET . 0.1 OUTLIER -143.66 158.64 43.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.382 -179.827 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.451 ' HG2' ' CD2' ' A' ' 89' ' ' TYR . 5.7 tt0 53.54 -84.78 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.709 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.451 ' CD2' ' HG2' ' A' ' 88' ' ' GLU . 0.2 OUTLIER -145.43 19.36 1.53 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.663 0.268 . . . . 0.0 111.146 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.544 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 1.4 t80 -113.85 137.5 22.34 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.737 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.468 ' O ' ' N ' ' A' ' 93' ' ' ARG . 90.3 Cg_endo -85.79 148.59 9.66 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.065 2.51 . . . . 0.0 112.569 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -55.94 82.28 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.873 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.581 ' O ' HG12 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -123.84 174.29 7.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.168 0.509 . . . . 0.0 111.905 -179.477 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.724 ' HB3' HD11 ' A' ' 81' ' ' LEU . 3.8 m-85 -93.29 132.78 37.17 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.175 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.475 ' O ' HD13 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -125.36 126.28 44.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.818 179.896 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.498 ' HB2' HD22 ' A' ' 81' ' ' LEU . 12.1 t -96.28 154.68 17.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.091 0.472 . . . . 0.0 111.983 -179.362 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.6 ' CD2' ' HB2' ' A' ' 139' ' ' ASP . 5.4 t60 57.82 57.52 4.14 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.922 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.626 HG11 ' HB ' ' A' ' 82' ' ' VAL . 11.1 p -123.72 141.07 45.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.528 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.744 HD11 ' OD2' ' A' ' 136' ' ' ASP . 6.2 mp -104.03 141.47 36.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.947 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.731 HD23 ' C ' ' A' ' 132' ' ' VAL . 7.3 mt -125.92 136.39 52.99 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.17 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.563 ' HB2' ' CD2' ' A' ' 76' ' ' PHE . . . -143.65 142.84 31.19 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.684 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 1.6 t -98.26 133.41 42.72 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.864 0.364 . . . . 0.0 111.217 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.277 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.507 -179.817 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.74 ' O ' HG13 ' A' ' 124' ' ' VAL . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.559 -0.216 . . . . 0.0 112.559 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 22.7 pt -126.25 146.39 32.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.806 0.336 . . . . 0.0 111.218 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.564 ' HG ' ' HB ' ' A' ' 121' ' ' ILE . 12.4 tp -87.43 117.05 25.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.175 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.15 153.11 34.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.111 0.481 . . . . 0.0 111.715 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.515 ' HB2' HD11 ' A' ' 121' ' ' ILE . 6.2 t -117.66 162.62 17.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.306 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -56.02 -20.86 18.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.926 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.434 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . 18.4 m80 -90.19 -34.77 15.7 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.422 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.82 ' N ' ' HB2' ' A' ' 54' ' ' ALA . . . 177.3 -139.13 4.2 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.026 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.903 HG23 ' O ' ' A' ' 52' ' ' THR . 4.0 t -102.0 135.5 38.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.759 0.314 . . . . 0.0 111.227 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.572 HG22 ' OD1' ' A' ' 136' ' ' ASP . 1.2 mm -94.49 -66.35 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.909 0.385 . . . . 0.0 110.631 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.913 ' HA2' HG23 ' A' ' 137' ' ' VAL . . . -164.05 -161.83 13.88 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.558 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.685 HD11 HD13 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -116.87 164.14 15.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.725 0.298 . . . . 0.0 110.631 179.93 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.74 HG13 ' O ' ' A' ' 112' ' ' GLY . 29.4 m -73.89 129.33 36.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.91 0.386 . . . . 0.0 111.653 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.674 HG22 ' N ' ' A' ' 126' ' ' MET . 3.6 m -110.16 -94.25 0.43 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.129 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.674 ' N ' HG22 ' A' ' 125' ' ' THR . 12.4 mmm -144.56 142.03 29.9 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.855 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -113.21 178.6 18.72 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.588 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -108.41 -139.38 8.81 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.499 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -72.5 -19.43 61.54 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.787 0.327 . . . . 0.0 111.095 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -165.64 19.17 0.1 Allowed Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.816 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.561 ' CG1' HD22 ' A' ' 100' ' ' LEU . 1.5 t -121.85 157.34 25.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.703 0.287 . . . . 0.0 110.576 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.731 ' C ' HD23 ' A' ' 100' ' ' LEU . 12.2 m -115.4 118.39 58.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.825 -179.006 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.572 ' HA3' ' O ' ' A' ' 126' ' ' MET . . . -96.9 116.17 5.42 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.323 -0.942 . . . . 0.0 111.686 178.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.517 ' HD2' HD22 ' A' ' 114' ' ' LEU . 12.9 m-85 -116.2 141.66 47.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.994 0.426 . . . . 0.0 111.726 -179.187 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.509 ' HB2' ' OG1' ' A' ' 125' ' ' THR . . . -88.89 109.36 20.16 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.066 178.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.744 ' OD2' HD11 ' A' ' 99' ' ' LEU . 0.6 OUTLIER -67.87 152.03 46.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.152 0.501 . . . . 0.0 111.984 -178.735 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.913 HG23 ' HA2' ' A' ' 122' ' ' GLY . 48.0 t -99.33 9.39 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.843 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.486 ' HA ' HD23 ' A' ' 141' ' ' LEU . 5.9 mtm180 -72.29 -6.9 46.41 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.401 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.6 ' HB2' ' CD2' ' A' ' 97' ' ' HIS . 1.1 t70 -94.93 10.77 34.24 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.719 0.295 . . . . 0.0 110.846 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.846 ' O ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -176.77 58.32 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.08 0.467 . . . . 0.0 110.303 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.902 HD11 ' HB ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -73.09 -14.86 61.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.914 -179.386 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 142' ' ' TRP . . . . . 0.423 ' C ' HD12 ' A' ' 143' ' ' LEU . 15.8 p-90 -56.88 83.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.934 0.397 . . . . 0.0 111.476 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.69 HD12 ' C ' ' A' ' 141' ' ' LEU . 4.8 mp -150.91 -47.0 0.12 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.614 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.436 ' HB2' HG12 ' A' ' 12' ' ' VAL . 0.4 OUTLIER -151.46 -166.81 2.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.065 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.48 149.09 50.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.369 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.443 ' HB3' ' HB3' ' A' ' 55' ' ' ARG . 9.6 m-20 -95.29 154.53 17.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.753 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.153 0 CA-C-O 120.897 0.379 . . . . 0.0 111.124 -179.787 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.104 0 CA-C-O 120.813 0.34 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.449 HG22 HG21 ' A' ' 113' ' ' ILE . 41.5 t -108.82 110.7 33.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.107 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.802 ' CE2' HG21 ' A' ' 45' ' ' THR . 5.2 t80 -99.73 116.32 31.55 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.791 0.329 . . . . 0.0 110.529 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.844 HG21 HD11 ' A' ' 53' ' ' ILE . 47.6 t -120.85 111.64 32.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.657 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.404 ' O ' ' CE1' ' A' ' 11' ' ' TYR . . . 53.0 -125.32 30.35 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.959 -0.639 . . . . 0.0 113.18 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.423 ' O ' ' HA ' ' A' ' 44' ' ' THR . 44.6 m-80 -91.93 18.73 7.44 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.701 0.286 . . . . 0.0 111.569 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.648 ' HE1' HG22 ' A' ' 44' ' ' THR . 6.2 m-30 -130.35 149.94 51.81 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.5 tttp -139.09 114.87 10.02 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.709 -0.223 . . . . 0.0 110.629 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 1.018 HG12 HG22 ' A' ' 42' ' ' VAL . 0.6 OUTLIER -100.3 121.64 51.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.041 0.448 . . . . 0.0 110.77 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.664 ' O ' HD12 ' A' ' 40' ' ' LEU . 7.3 p -136.43 160.26 37.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.037 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.513 ' N ' HG22 ' A' ' 18' ' ' VAL . 0.6 OUTLIER -62.26 141.51 58.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.227 179.054 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 8.4 ttp180 -56.27 -45.59 80.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.942 0.401 . . . . 0.0 110.85 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -66.85 -11.62 56.29 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.153 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.71 -13.41 14.79 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.961 ' HB3' ' CZ2' ' A' ' 28' ' ' TRP . . . -68.74 150.72 47.56 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 120.796 0.331 . . . . 0.0 110.834 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.403 ' O ' ' CE3' ' A' ' 28' ' ' TRP . 32.6 p -104.59 168.94 8.75 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.269 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 52.5 p-80 -54.76 -29.68 54.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.002 0.43 . . . . 0.0 110.564 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.4 t -74.66 -31.36 26.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.459 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.431 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 0.6 OUTLIER -67.18 -43.98 80.84 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.961 ' CZ2' ' HB3' ' A' ' 23' ' ' ALA . 7.2 m-90 -74.33 -30.37 62.01 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.145 179.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.15 -41.99 89.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.32 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -116.66 32.58 6.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.486 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.444 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 13.2 t -77.24 132.42 38.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.179 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.566 HG22 ' O ' ' A' ' 42' ' ' VAL . 16.8 m -96.06 -38.83 8.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.695 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.663 ' CE3' HG23 ' A' ' 42' ' ' VAL . 1.1 t90 -139.67 153.27 47.24 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.908 0.385 . . . . 0.0 111.548 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -155.69 120.51 4.74 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.79 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.439 ' HB2' ' CZ2' ' A' ' 33' ' ' TRP . 8.3 m-20 -107.09 99.2 8.77 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.038 0.447 . . . . 0.0 111.14 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -58.91 -28.92 66.66 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.8 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.69 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 0.9 OUTLIER -59.68 -38.74 82.35 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.755 -0.202 . . . . 0.0 111.301 -179.052 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.605 ' CZ ' HD22 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -117.31 0.75 12.31 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 60.24 54.83 3.84 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.85 0.357 . . . . 0.0 111.892 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.716 HD11 HG23 ' A' ' 17' ' ' VAL . 38.3 tp -137.11 133.65 35.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.449 179.017 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.67 ' O ' HD23 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -131.44 156.0 46.38 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.053 0.454 . . . . 0.0 112.068 -179.526 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 1.018 HG22 HG12 ' A' ' 17' ' ' VAL . 23.7 t -117.17 130.08 72.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.062 179.383 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.4 p -120.49 157.15 30.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.57 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.648 HG22 ' HE1' ' A' ' 15' ' ' TYR . 19.6 p -97.54 123.59 41.48 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.183 0.516 . . . . 0.0 111.493 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.802 HG21 ' CE2' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -98.28 -165.01 1.19 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.872 -179.429 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.0 t -138.86 42.35 2.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.856 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -136.03 -177.98 4.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.085 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -93.0 148.14 22.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.959 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -66.88 157.35 51.1 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.646 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -134.65 -49.17 0.76 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.872 0.368 . . . . 0.0 110.903 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -87.96 150.53 23.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.825 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.872 ' O ' HG23 ' A' ' 120' ' ' VAL . 39.9 m -122.99 116.98 24.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.763 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.9 ' HB ' HD11 ' A' ' 141' ' ' LEU . 0.4 OUTLIER -74.62 139.55 19.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.048 0.452 . . . . 0.0 110.968 -179.843 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.77 ' HB2' ' CA ' ' A' ' 119' ' ' GLY . . . -88.8 121.97 31.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.971 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.594 ' H ' ' HB3' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -88.44 29.01 1.02 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.11 0.481 . . . . 0.0 110.12 179.054 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 30.8 p -100.0 163.27 12.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.091 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.426 ' O ' ' O ' ' A' ' 58' ' ' CYS . 44.4 mt-30 -93.56 -70.19 0.71 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 178.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.426 ' O ' ' O ' ' A' ' 57' ' ' GLN . 96.3 m 54.47 159.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.74 178.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.11 -7.53 11.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.951 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.499 ' HA ' ' HA ' ' A' ' 75' ' ' SER . 10.0 p -132.41 123.97 27.75 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.973 0.416 . . . . 0.0 111.344 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -136.99 161.64 25.16 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.64 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.773 HG23 ' C ' ' A' ' 72' ' ' TYR . 7.3 p -102.52 132.91 47.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.951 0.405 . . . . 0.0 111.308 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.737 ' HE2' HG21 ' A' ' 74' ' ' VAL . 3.5 p90 -118.66 133.99 55.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.949 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 64.7 t80 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.902 -179.948 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 9.2 p80 . . . . . 0 N--CA 1.456 -0.137 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.773 ' C ' HG23 ' A' ' 62' ' ' VAL . 0.5 OUTLIER -116.31 113.94 40.92 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.835 -178.666 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 72' ' ' TYR . 5.5 Cg_exo -77.34 120.67 5.37 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.473 2.115 . . . . 0.0 110.319 178.364 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.737 HG21 ' HE2' ' A' ' 63' ' ' TYR . 43.2 t -137.47 151.09 26.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.164 0.507 . . . . 0.0 112.365 -178.345 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.499 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 20.7 m -98.71 133.92 42.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.522 178.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.723 ' CD2' ' HB2' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -145.75 174.14 11.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.444 0.64 . . . . 0.0 112.122 -179.188 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.607 ' C ' ' HD3' ' A' ' 79' ' ' PRO . 0.3 OUTLIER -111.86 158.84 18.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.703 179.425 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.445 ' HA2' ' HG ' ' A' ' 99' ' ' LEU . . . -112.77 66.76 0.25 Allowed Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.235 -0.983 . . . . 0.0 113.642 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.607 ' HD3' ' C ' ' A' ' 77' ' ' GLU . 14.0 Cg_exo -67.46 139.95 50.91 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.376 2.05 . . . . 0.0 112.212 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -57.42 -90.22 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.432 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.701 HD11 ' HB3' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -95.69 119.92 35.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.912 0.387 . . . . 0.0 111.733 -179.756 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.597 ' HB ' HG11 ' A' ' 98' ' ' VAL . 18.8 t -124.2 122.45 64.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.149 178.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -72.57 107.89 5.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.482 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.61 HG22 ' O ' ' A' ' 93' ' ' ARG . 4.8 m -72.77 123.73 28.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.855 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -69.29 150.28 47.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.669 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.584 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 22.8 tt0 -67.61 102.01 1.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.143 0.497 . . . . 0.0 110.373 -179.363 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 89' ' ' TYR . 4.1 m -144.3 164.08 31.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.188 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 55.93 -81.48 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.542 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.447 ' N ' ' O ' ' A' ' 87' ' ' SER . 0.7 OUTLIER -156.92 24.17 0.32 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.759 0.314 . . . . 0.0 110.877 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.584 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 1.6 t80 -122.69 131.62 24.35 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.695 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.473 ' O ' ' N ' ' A' ' 93' ' ' ARG . 87.0 Cg_endo -81.98 148.84 15.49 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.095 2.53 . . . . 0.0 112.524 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.4 OUTLIER -42.6 88.99 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.509 -179.931 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.61 ' O ' HG22 ' A' ' 84' ' ' VAL . 2.0 ttt180 -123.93 171.08 9.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.219 0.533 . . . . 0.0 112.074 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.701 ' HB3' HD11 ' A' ' 81' ' ' LEU . 3.9 m-85 -98.88 132.84 43.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.131 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.69 ' HA ' ' O ' ' A' ' 37' ' ' ASN . 2.0 tp60 -126.43 114.89 18.78 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.893 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.59 ' HA ' HD22 ' A' ' 81' ' ' LEU . 60.7 p -80.07 144.0 33.52 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.114 0.483 . . . . 0.0 111.875 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 21.7 m80 61.96 60.83 1.47 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.998 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.597 HG11 ' HB ' ' A' ' 82' ' ' VAL . 7.1 p -124.17 131.06 73.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.721 0.296 . . . . 0.0 111.266 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.766 HD11 ' HB3' ' A' ' 136' ' ' ASP . 2.2 mp -101.76 149.16 24.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.976 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.693 HD23 ' C ' ' A' ' 132' ' ' VAL . 9.0 mt -128.69 136.37 50.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.161 0.505 . . . . 0.0 111.96 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.723 ' HB2' ' CD2' ' A' ' 76' ' ' PHE . . . -125.69 124.3 40.8 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.352 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.3 t -96.78 112.01 23.94 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.799 0.333 . . . . 0.0 110.621 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.327 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.821 -179.744 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.386 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.449 HG21 HG22 ' A' ' 10' ' ' VAL . 27.3 pt -122.54 145.32 29.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.861 0.362 . . . . 0.0 111.139 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.596 HD21 ' CZ ' ' A' ' 76' ' ' PHE . 8.4 tp -87.82 121.18 29.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.319 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.441 ' N ' HD12 ' A' ' 114' ' ' LEU . 0.8 OUTLIER -118.36 149.5 41.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.207 0.527 . . . . 0.0 111.962 -179.271 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.654 ' HB2' HD11 ' A' ' 121' ' ' ILE . 6.2 t -111.68 163.67 13.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.982 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -58.51 -17.26 19.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.022 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 18.8 m80 -95.66 -30.68 13.63 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.653 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.77 ' CA ' ' HB2' ' A' ' 54' ' ' ALA . . . 176.82 -143.1 6.16 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.424 -0.893 . . . . 0.0 113.034 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.872 HG23 ' O ' ' A' ' 52' ' ' THR . 3.6 t -98.93 135.33 34.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.726 0.298 . . . . 0.0 111.024 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.654 HD11 ' HB2' ' A' ' 116' ' ' CYS . 1.7 mm -92.35 -66.14 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.839 0.352 . . . . 0.0 110.794 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.847 ' HA2' HG23 ' A' ' 137' ' ' VAL . . . -166.98 -156.26 9.6 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.622 -0.799 . . . . 0.0 113.045 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.668 HD11 HD13 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -116.94 164.16 15.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.804 0.335 . . . . 0.0 110.983 -179.824 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.486 ' HA ' ' CD1' ' A' ' 134' ' ' PHE . 11.6 p -66.51 129.53 31.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.625 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.74 ' OG1' ' HB2' ' A' ' 135' ' ' ALA . 7.3 m -110.07 -87.35 0.52 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.228 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.537 ' N ' HG22 ' A' ' 125' ' ' THR . 0.0 OUTLIER -104.75 144.37 31.83 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.852 0.358 . . . . 0.0 111.13 179.825 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -118.86 96.26 0.65 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.154 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -77.43 174.5 54.63 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.603 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -71.93 -19.36 61.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.713 0.292 . . . . 0.0 110.931 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -145.16 4.74 1.37 Allowed Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.631 -0.795 . . . . 0.0 113.062 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.537 ' CG1' HD22 ' A' ' 100' ' ' LEU . 1.4 t -128.66 157.05 41.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 117.023 0.412 . . . . 0.0 111.008 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.693 ' C ' HD23 ' A' ' 100' ' ' LEU . 3.4 t -114.89 117.83 56.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.989 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -96.19 118.44 5.98 Favored Glycine 0 CA--C 1.517 0.16 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.801 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.501 ' CZ ' ' HB2' ' A' ' 63' ' ' TYR . 21.4 m-85 -125.13 133.06 52.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.909 0.385 . . . . 0.0 111.787 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.74 ' HB2' ' OG1' ' A' ' 125' ' ' THR . . . -93.62 107.76 19.58 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.766 ' HB3' HD11 ' A' ' 99' ' ' LEU . 2.5 p30 -67.72 151.84 46.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.262 0.554 . . . . 0.0 112.42 -178.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.847 HG23 ' HA2' ' A' ' 122' ' ' GLY . 39.7 t -93.58 13.72 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.643 179.103 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.472 ' HA ' HD23 ' A' ' 141' ' ' LEU . 1.3 mtm105 -70.61 -6.99 40.86 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.772 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -96.69 11.13 36.54 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.555 0.217 . . . . 0.0 111.3 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.847 ' O ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER 179.8 58.6 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.027 0.441 . . . . 0.0 110.501 -179.876 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.9 HD11 ' HB ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -74.58 -14.78 60.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.07 -179.515 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 142' ' ' TRP . . . . . 0.414 ' CE3' ' CE2' ' A' ' 15' ' ' TYR . 16.3 p-90 -55.48 81.66 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.006 0.431 . . . . 0.0 111.267 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.704 HD12 ' C ' ' A' ' 141' ' ' LEU . 5.0 mp -147.14 -45.82 0.17 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.302 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -152.91 -173.41 4.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.815 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.84 130.46 47.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.07 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -83.75 154.21 23.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.863 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.594 ' HB3' ' H ' ' A' ' 55' ' ' ARG . . . . . . . . 0 C--N 1.331 -0.198 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.066 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.81 ' HB2' HG23 ' A' ' 18' ' ' VAL . . . . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.848 0.356 . . . . 0.0 111.039 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.896 ' HB ' HG21 ' A' ' 113' ' ' ILE . 10.7 p -125.38 111.45 27.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.728 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 9.8 p90 -113.71 136.06 53.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.978 0.418 . . . . 0.0 111.16 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.606 HG21 HD11 ' A' ' 53' ' ' ILE . 95.1 t -118.94 134.88 61.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.491 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 45.51 -124.24 6.62 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 115.933 -0.576 . . . . 0.0 113.206 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.469 ' O ' ' HA ' ' A' ' 44' ' ' THR . 3.7 m-20 -91.59 17.96 8.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.646 0.26 . . . . 0.0 111.228 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.652 ' HB2' HD23 ' A' ' 143' ' ' LEU . 6.9 m-30 -127.82 147.36 50.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.259 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 11' ' ' TYR . 1.0 OUTLIER -133.63 114.73 13.84 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.771 179.467 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.861 HG12 HG22 ' A' ' 42' ' ' VAL . 1.2 m -102.26 121.37 53.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 121.242 0.544 . . . . 0.0 110.834 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.81 HG23 ' HB2' ' A' ' 9' ' ' ALA . 12.0 p -137.17 161.44 35.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.32 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.502 ' N ' HG22 ' A' ' 18' ' ' VAL . 0.7 OUTLIER -59.6 141.64 54.53 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 178.713 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.426 ' O ' ' HZ2' ' A' ' 28' ' ' TRP . 5.1 mtp-105 -56.29 -47.54 78.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.905 0.383 . . . . 0.0 111.254 -179.148 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -69.09 -8.4 44.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.344 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.7 tp -115.35 5.86 14.72 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.729 ' HB3' ' NE1' ' A' ' 28' ' ' TRP . . . -88.88 129.26 35.63 Favored 'General case' 0 C--N 1.334 -0.07 0 C-N-CA 120.291 -0.563 . . . . 0.0 111.444 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.512 ' O ' ' HD1' ' A' ' 28' ' ' TRP . 27.4 p -74.85 164.68 26.3 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.703 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -53.74 -29.81 41.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.221 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.421 ' HA ' ' HG2' ' A' ' 29' ' ' GLN . 21.7 t -68.76 -33.99 62.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.973 0.416 . . . . 0.0 110.97 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.445 ' O ' ' HB3' ' A' ' 31' ' ' CYS . 0.4 OUTLIER -68.45 -43.5 76.89 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.258 179.67 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.729 ' NE1' ' HB3' ' A' ' 23' ' ' ALA . 59.0 m95 -73.69 -45.84 49.96 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.91 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.421 ' HG2' ' HA ' ' A' ' 26' ' ' VAL . 3.2 pt20 -54.97 -37.39 66.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.896 0.379 . . . . 0.0 110.689 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.2 m-20 -115.36 34.42 4.9 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.782 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.5 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 20.4 p -80.17 127.38 32.26 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.027 0.441 . . . . 0.0 111.365 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.586 HG22 ' O ' ' A' ' 42' ' ' VAL . 16.0 m -88.26 -38.95 12.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.329 179.106 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.638 ' CZ3' HG23 ' A' ' 42' ' ' VAL . 0.4 OUTLIER -139.81 153.13 47.01 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.977 179.753 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.414 ' HG3' ' HB3' ' A' ' 41' ' ' LEU . 5.2 tt0 -166.11 107.06 0.71 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.019 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.425 ' OD1' ' CZ2' ' A' ' 33' ' ' TRP . 34.6 p-10 -107.36 125.15 50.83 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.089 0.471 . . . . 0.0 111.118 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -67.0 -34.5 77.89 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.567 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -59.79 -24.49 64.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.913 0.387 . . . . 0.0 110.562 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.513 ' NE ' ' HA ' ' A' ' 38' ' ' ARG . 4.6 tpm_? -113.14 -4.74 13.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.975 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.419 ' HA ' ' HD3' ' A' ' 20' ' ' ARG . 1.9 m-20 48.97 36.87 9.14 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-O 121.112 0.482 . . . . 0.0 109.982 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.804 HD12 ' O ' ' A' ' 18' ' ' VAL . 30.8 tp -130.79 154.58 47.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.247 -178.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.632 ' O ' HD23 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -146.58 156.02 42.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.59 179.795 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.861 HG22 HG12 ' A' ' 17' ' ' VAL . 19.8 t -120.27 129.82 75.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.234 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 24.1 p -121.15 157.34 30.38 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.208 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.631 HG22 ' CE1' ' A' ' 15' ' ' TYR . 16.6 p -97.49 119.86 36.81 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.164 0.506 . . . . 0.0 111.324 -179.195 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -111.7 -33.78 6.24 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.038 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.7 m 64.05 45.08 4.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.881 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.65 160.29 37.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.095 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -58.73 130.28 46.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.826 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.457 ' HA2' ' CE2' ' A' ' 11' ' ' TYR . . . -104.59 -32.48 4.18 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.624 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER 59.22 20.81 8.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.669 0.271 . . . . 0.0 111.018 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -130.04 137.25 50.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.873 0.368 . . . . 0.0 110.742 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.875 ' O ' HG23 ' A' ' 120' ' ' VAL . 73.5 m -121.99 120.37 34.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.421 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.765 ' HB ' HD11 ' A' ' 141' ' ' LEU . 0.9 OUTLIER -72.82 139.22 19.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.82 0.343 . . . . 0.0 110.652 -179.815 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.759 ' HB2' ' N ' ' A' ' 119' ' ' GLY . . . -91.06 121.65 33.04 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.225 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.508 ' H ' ' HB3' ' A' ' 147' ' ' ALA . 0.5 OUTLIER -94.44 38.66 1.1 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.382 179.395 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 12.5 p -99.86 167.06 10.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.069 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -114.69 30.26 7.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.07 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 63.6 m -59.4 163.51 3.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.881 0.372 . . . . 0.0 110.875 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.6 m -117.0 2.66 12.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.93 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 75' ' ' SER . 17.6 p -136.02 126.25 26.41 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 120.879 0.371 . . . . 0.0 111.159 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -134.69 -161.75 9.59 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.041 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.546 HG23 ' C ' ' A' ' 72' ' ' TYR . 7.2 p -140.37 137.78 36.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.992 0.425 . . . . 0.0 111.205 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.712 ' CE2' HG21 ' A' ' 74' ' ' VAL . 6.5 p90 -143.53 129.94 19.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.439 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 41.1 p90 . . . . . 0 C--N 1.328 -0.347 0 CA-C-O 120.804 0.335 . . . . 0.0 110.972 -179.813 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 26.5 p-80 . . . . . 0 C--O 1.232 0.133 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.546 ' C ' HG23 ' A' ' 62' ' ' VAL . 2.1 m-85 -123.85 114.11 28.32 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.619 -178.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 72' ' ' TYR . 7.9 Cg_exo -71.91 120.57 6.94 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.265 1.977 . . . . 0.0 110.423 178.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.712 HG21 ' CE2' ' A' ' 63' ' ' TYR . 56.0 t -132.69 142.02 43.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.08 0.467 . . . . 0.0 112.155 -178.445 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.443 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 75.6 p -93.88 121.0 34.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.331 178.606 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.436 ' CE1' HD21 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -125.34 164.78 19.64 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.439 0.638 . . . . 0.0 112.017 -178.657 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' A' ' 99' ' ' LEU . 12.0 mt-10 -111.8 159.02 18.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.162 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -104.56 65.03 0.32 Allowed Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.334 -0.936 . . . . 0.0 113.724 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.482 ' HD2' ' HA ' ' A' ' 99' ' ' LEU . 40.2 Cg_endo -67.97 136.09 37.08 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.419 2.079 . . . . 0.0 112.105 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -61.62 -87.43 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.255 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.686 HD11 ' HB3' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -90.76 119.65 31.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.813 0.34 . . . . 0.0 111.444 -179.878 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.638 ' HB ' HG11 ' A' ' 98' ' ' VAL . 23.4 t -129.04 122.2 55.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.34 178.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -74.42 108.1 6.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.839 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.565 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 35.0 m -72.65 124.59 29.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.234 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -69.24 149.84 48.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.327 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.649 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 2.0 pt-20 -68.36 102.83 1.48 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.793 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.411 ' O ' ' N ' ' A' ' 89' ' ' TYR . 1.4 m -143.57 155.19 44.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.395 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 59.48 -79.4 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.43 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.411 ' N ' ' O ' ' A' ' 87' ' ' SER . 1.0 OUTLIER -156.22 24.24 0.36 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.791 0.329 . . . . 0.0 111.028 -179.982 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.649 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -119.51 130.18 24.98 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.306 179.858 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.4 ' O ' ' N ' ' A' ' 93' ' ' ARG . 85.4 Cg_endo -83.92 148.42 12.16 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.862 2.375 . . . . 0.0 112.662 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.565 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -47.28 92.65 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.083 179.954 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.4 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.6 OUTLIER -123.88 166.31 15.87 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.116 0.484 . . . . 0.0 112.168 -179.304 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.686 ' HB3' HD11 ' A' ' 81' ' ' LEU . 4.3 m-85 -97.38 129.99 44.57 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.173 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.523 ' O ' HD13 ' A' ' 81' ' ' LEU . 22.7 mm-40 -131.45 137.92 48.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.701 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.539 ' HB2' HD22 ' A' ' 81' ' ' LEU . 23.2 t -103.66 142.81 33.68 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -179.54 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.454 ' HB2' ' O ' ' A' ' 96' ' ' SER . 96.3 m-70 75.93 56.04 0.05 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.353 179.074 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.638 HG11 ' HB ' ' A' ' 82' ' ' VAL . 12.1 p -123.57 143.85 35.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.737 0.304 . . . . 0.0 110.87 178.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.482 ' HA ' ' HD2' ' A' ' 79' ' ' PRO . 11.0 mp -102.71 140.54 36.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.039 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.712 HD23 ' O ' ' A' ' 132' ' ' VAL . 5.5 mt -130.96 140.33 50.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.188 0.518 . . . . 0.0 112.16 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.48 ' O ' HG12 ' A' ' 131' ' ' VAL . . . -152.07 159.37 43.7 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.526 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 130' ' ' GLY . 0.7 OUTLIER -112.19 127.13 55.86 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.02 0.438 . . . . 0.0 111.046 179.694 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.289 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.465 -179.758 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.697 ' O ' HG13 ' A' ' 124' ' ' VAL . . . . . . . . 0 N--CA 1.452 -0.297 0 N-CA-C 112.373 -0.291 . . . . 0.0 112.373 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.896 HG21 ' HB ' ' A' ' 10' ' ' VAL . 2.7 pp -126.25 146.4 32.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.931 0.396 . . . . 0.0 111.738 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.472 HD22 ' HD2' ' A' ' 134' ' ' PHE . 9.8 tp -87.5 123.47 32.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.146 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 2.7 mtm180 -115.5 145.5 42.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.155 0.502 . . . . 0.0 111.627 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.488 ' HB2' HD11 ' A' ' 121' ' ' ILE . 4.5 t -109.4 165.46 11.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.145 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -60.86 -16.28 39.69 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.805 0.336 . . . . 0.0 110.616 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.431 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . 19.3 m80 -95.39 -29.24 14.54 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.528 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.759 ' N ' ' HB2' ' A' ' 54' ' ' ALA . . . 171.27 -140.47 5.92 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.537 -0.839 . . . . 0.0 113.015 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' ' 52' ' ' THR . 2.7 t -99.24 135.23 35.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.637 0.256 . . . . 0.0 110.835 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.488 HD11 ' HB2' ' A' ' 116' ' ' CYS . 0.9 OUTLIER -99.96 -71.5 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.397 -179.95 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.921 ' HA2' HG23 ' A' ' 137' ' ' VAL . . . -153.65 -168.04 16.8 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.326 -0.94 . . . . 0.0 113.294 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.604 HD11 HD13 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -116.88 164.2 15.04 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.635 0.255 . . . . 0.0 110.884 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.697 HG13 ' O ' ' A' ' 112' ' ' GLY . 28.0 m -66.22 126.52 25.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.743 0.306 . . . . 0.0 111.189 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.743 ' OG1' ' HB2' ' A' ' 135' ' ' ALA . 3.7 m -108.38 -94.05 0.4 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.779 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.69 ' N ' HG22 ' A' ' 125' ' ' THR . 73.7 mmm -144.02 162.3 36.56 Favored 'General case' 0 C--O 1.228 -0.076 0 CA-C-O 121.085 0.469 . . . . 0.0 111.538 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 175.85 -159.2 26.64 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.232 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -130.39 -153.32 7.68 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.404 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -89.75 11.83 18.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.722 0.296 . . . . 0.0 110.92 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 102' ' ' THR . . . -134.17 -36.32 0.25 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.728 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -115.67 157.28 16.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-O 120.949 0.404 . . . . 0.0 111.421 -179.859 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.712 ' O ' HD23 ' A' ' 100' ' ' LEU . 4.5 m -122.42 118.83 56.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.423 -179.316 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.538 ' HA3' ' O ' ' A' ' 126' ' ' MET . . . -101.76 114.89 5.09 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.384 -0.912 . . . . 0.0 112.082 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.472 ' HD2' HD22 ' A' ' 114' ' ' LEU . 10.7 m-85 -114.76 140.52 48.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.871 0.367 . . . . 0.0 111.261 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.743 ' HB2' ' OG1' ' A' ' 125' ' ' THR . . . -88.85 115.35 26.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.41 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.413 ' OD1' HD13 ' A' ' 99' ' ' LEU . 1.0 OUTLIER -68.0 142.61 55.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.072 -178.862 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.921 HG23 ' HA2' ' A' ' 122' ' ' GLY . 93.6 t -91.37 9.68 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.38 178.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.537 ' HA ' HD23 ' A' ' 141' ' ' LEU . 4.4 mtm-85 -71.53 -6.76 43.0 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.406 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -95.04 10.99 33.62 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 120.579 0.228 . . . . 0.0 111.23 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.878 ' O ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -176.09 61.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.295 0.569 . . . . 0.0 110.332 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.765 HD11 ' HB ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -78.89 -14.66 59.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.024 -179.474 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 18.2 p-90 -59.78 76.46 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.006 0.432 . . . . 0.0 111.785 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.652 HD23 ' HB2' ' A' ' 15' ' ' TYR . 4.9 mp -140.77 -47.39 0.41 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.823 178.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.491 ' HB2' ' CG1' ' A' ' 12' ' ' VAL . 1.5 tp10 -150.05 -161.89 1.44 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.441 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -69.35 146.36 52.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.832 0.348 . . . . 0.0 110.851 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -93.17 154.12 18.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.906 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.508 ' HB3' ' H ' ' A' ' 55' ' ' ARG . . . . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.166 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.778 ' HB2' HG23 ' A' ' 18' ' ' VAL . . . . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.831 0.348 . . . . 0.0 111.108 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.852 HG22 HG21 ' A' ' 113' ' ' ILE . 25.6 t -108.68 111.89 37.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.059 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 1.5 p90 -117.34 124.09 48.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.898 0.38 . . . . 0.0 110.874 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.681 ' HB ' HD22 ' A' ' 143' ' ' LEU . 75.1 t -119.26 140.96 41.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.703 -179.169 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 45.37 -129.83 8.83 Favored Glycine 0 C--N 1.333 0.379 0 CA-C-N 115.94 -0.573 . . . . 0.0 113.306 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.457 ' O ' ' HA ' ' A' ' 44' ' ' THR . 28.6 p30 -89.49 18.84 4.94 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.693 0.282 . . . . 0.0 111.23 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.727 ' HB2' HD23 ' A' ' 143' ' ' LEU . 7.8 m-30 -127.61 147.69 50.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.287 -0.415 . . . . 0.0 109.954 179.497 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 11' ' ' TYR . 10.6 tttt -132.79 114.7 14.42 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.685 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.804 HG23 HD11 ' A' ' 40' ' ' LEU . 1.6 m -101.44 121.29 52.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-O 121.148 0.499 . . . . 0.0 110.765 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.778 HG23 ' HB2' ' A' ' 9' ' ' ALA . 12.0 p -137.02 161.41 35.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.31 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.501 ' N ' HG22 ' A' ' 18' ' ' VAL . 0.8 OUTLIER -61.74 141.51 57.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.044 178.823 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.55 -44.64 81.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.763 0.316 . . . . 0.0 111.211 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -69.41 -7.51 38.37 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.166 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.42 HD12 ' HB2' ' A' ' 19' ' ' ASN . 79.9 mt -115.1 -2.88 12.66 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.694 ' HB3' ' NE1' ' A' ' 28' ' ' TRP . . . -86.08 126.57 34.29 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.229 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.693 HG23 HG12 ' A' ' 26' ' ' VAL . 1.8 t -74.86 165.16 25.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.721 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -53.7 -29.98 41.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.845 -178.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.693 HG12 HG23 ' A' ' 24' ' ' THR . 11.4 p -72.65 -31.25 36.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.717 0.294 . . . . 0.0 110.967 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -67.66 -43.76 79.47 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.14 0.495 . . . . 0.0 109.697 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.694 ' NE1' ' HB3' ' A' ' 23' ' ' ALA . 48.9 m95 -73.85 -30.04 62.45 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.725 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -60.09 -44.23 94.96 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.556 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -110.2 27.75 9.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.336 179.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.465 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 7.0 t -73.13 123.64 24.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.043 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.56 ' CG2' HG12 ' A' ' 42' ' ' VAL . 13.3 m -86.32 -40.11 14.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.696 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.599 ' HH2' HD23 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -139.59 153.13 47.31 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.885 0.374 . . . . 0.0 111.181 179.825 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.408 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 1.0 OUTLIER -159.88 117.04 2.58 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.846 179.65 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.434 ' HB2' ' CZ2' ' A' ' 33' ' ' TRP . 0.7 OUTLIER -107.11 118.04 35.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.234 -179.759 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -62.93 -46.97 85.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.585 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -59.9 -18.86 47.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.242 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? -111.75 -6.05 14.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.191 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 48.55 38.93 12.08 Favored 'General case' 0 N--CA 1.461 0.079 0 CA-C-O 121.132 0.492 . . . . 0.0 110.401 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.804 HD11 HG23 ' A' ' 17' ' ' VAL . 27.1 tp -132.42 156.23 47.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.978 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.643 ' O ' HD23 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -150.2 156.12 41.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.478 179.746 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.91 HG21 HD23 ' A' ' 140' ' ' LEU . 21.3 t -120.01 133.04 68.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.98 0.419 . . . . 0.0 110.301 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.5 t -125.98 157.42 37.87 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.202 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.646 HG22 ' HE1' ' A' ' 15' ' ' TYR . 11.8 p -97.33 119.99 36.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.266 0.555 . . . . 0.0 111.529 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -108.14 160.72 15.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.887 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.0 t -105.99 42.48 1.25 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.875 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.33 169.94 16.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.139 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 10.1 p-80 -76.99 143.8 39.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.856 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -83.69 128.35 8.52 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.468 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -105.64 28.53 7.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.794 0.33 . . . . 0.0 110.87 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.516 ' O ' HG22 ' A' ' 12' ' ' VAL . 31.8 m-20 -153.02 133.57 13.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.82 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.905 ' O ' HG23 ' A' ' 120' ' ' VAL . 48.7 m -117.64 116.43 27.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.813 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.661 HG12 HG21 ' A' ' 12' ' ' VAL . 3.8 mm -72.9 139.72 19.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.839 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.849 ' HB2' ' N ' ' A' ' 119' ' ' GLY . . . -83.83 -53.57 5.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.785 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.405 ' CG ' ' HG ' ' A' ' 141' ' ' LEU . 29.0 ttt-85 63.75 35.54 11.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.997 0.427 . . . . 0.0 110.038 -178.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 6.0 p -99.71 146.65 26.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.991 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -88.03 54.22 3.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.051 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 77.1 m -85.98 164.8 17.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.828 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.65 -19.37 12.9 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.884 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 75' ' ' SER . 12.1 p -126.21 123.95 39.35 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.941 0.4 . . . . 0.0 111.336 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -138.3 166.02 25.33 Favored Glycine 0 N--CA 1.452 -0.265 0 N-CA-C 111.631 -0.588 . . . . 0.0 111.631 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.831 HG23 ' C ' ' A' ' 72' ' ' TYR . 14.9 p -102.57 130.82 51.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.967 0.413 . . . . 0.0 111.351 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.679 ' HE2' HG21 ' A' ' 74' ' ' VAL . 4.2 p90 -106.55 139.43 41.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.986 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 39.4 t80 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 179.992 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.587 ' HB3' HG21 ' A' ' 62' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.127 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.831 ' C ' HG23 ' A' ' 62' ' ' VAL . 0.5 OUTLIER -107.81 113.99 60.65 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.46 -179.121 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 72' ' ' TYR . 4.6 Cg_exo -77.03 120.81 5.55 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.389 2.059 . . . . 0.0 110.582 178.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.692 ' CG1' ' HB1' ' A' ' 101' ' ' ALA . 47.6 t -139.85 145.81 26.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.058 0.456 . . . . 0.0 112.186 -178.475 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.445 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 1.1 m -91.9 134.62 34.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.267 178.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.73 ' HD2' ' HB2' ' A' ' 101' ' ' ALA . 0.1 OUTLIER -143.5 169.2 18.15 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.479 0.657 . . . . 0.0 112.329 -178.966 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.537 ' C ' ' HD3' ' A' ' 79' ' ' PRO . 0.1 OUTLIER -111.92 159.29 18.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.747 179.384 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.465 ' HA2' ' HG ' ' A' ' 99' ' ' LEU . . . -111.61 72.31 0.21 Allowed Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.322 -0.942 . . . . 0.0 113.52 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.651 ' HD2' ' O ' ' A' ' 98' ' ' VAL . 15.9 Cg_exo -66.93 138.57 48.6 Favored 'Trans proline' 0 C--O 1.24 0.601 0 C-N-CA 122.401 2.067 . . . . 0.0 112.459 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -63.71 -59.98 7.97 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.621 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.448 HD13 ' O ' ' A' ' 95' ' ' GLN . 0.0 OUTLIER -120.15 119.96 34.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.993 0.425 . . . . 0.0 112.074 -179.786 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.63 ' HB ' HG11 ' A' ' 98' ' ' VAL . 37.4 t -125.15 127.62 72.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.823 178.56 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -72.17 107.86 5.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.922 0.392 . . . . 0.0 110.693 -179.185 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.959 HG23 ' CG ' ' A' ' 126' ' ' MET . 1.6 p -72.83 114.49 12.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.405 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -69.89 150.17 47.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.602 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.573 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -68.04 101.58 1.16 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.151 0.501 . . . . 0.0 110.318 -179.517 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.443 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.4 OUTLIER -144.39 163.37 33.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.002 179.999 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.42 ' HG2' ' CD2' ' A' ' 89' ' ' TYR . 15.6 tt0 53.39 -84.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.482 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.443 ' N ' ' O ' ' A' ' 87' ' ' SER . 0.1 OUTLIER -152.41 21.41 0.63 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.757 0.313 . . . . 0.0 110.917 179.921 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.573 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 1.9 t80 -116.61 125.9 28.0 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.707 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.437 ' O ' ' N ' ' A' ' 93' ' ' ARG . 59.8 Cg_endo -73.5 148.58 42.87 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.754 2.303 . . . . 0.0 112.665 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.3 OUTLIER -53.2 85.01 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.455 -179.676 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.437 ' N ' ' O ' ' A' ' 91' ' ' PRO . 5.3 mtp-105 -124.04 -174.39 2.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.084 0.469 . . . . 0.0 111.737 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.437 ' HB3' HD11 ' A' ' 81' ' ' LEU . 26.2 m-85 -100.34 132.49 45.69 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.745 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.448 ' O ' HD13 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -125.56 122.53 36.78 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.119 -179.722 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 28.1 t -92.03 158.25 16.33 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 121.104 0.478 . . . . 0.0 112.114 -179.417 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 51.4 60.6 3.75 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.774 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.651 ' O ' ' HD2' ' A' ' 79' ' ' PRO . 9.9 p -123.99 136.56 59.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.187 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.724 HD11 ' OD2' ' A' ' 136' ' ' ASP . 6.3 mp -102.0 149.0 24.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.301 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.765 ' HA ' ' O ' ' A' ' 132' ' ' VAL . 6.4 mt -133.25 134.13 43.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.074 0.464 . . . . 0.0 111.801 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.73 ' HB2' ' HD2' ' A' ' 76' ' ' PHE . . . -125.9 119.65 28.36 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.434 -179.497 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 1.5 t -86.15 111.7 20.61 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.907 0.384 . . . . 0.0 110.63 179.17 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.224 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.554 -179.711 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.544 -0.222 . . . . 0.0 112.544 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.852 HG21 HG22 ' A' ' 10' ' ' VAL . 31.3 pt -125.96 146.48 31.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.662 0.268 . . . . 0.0 111.156 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.6 HD21 ' CZ ' ' A' ' 76' ' ' PHE . 8.1 tp -87.24 115.87 24.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.855 0.36 . . . . 0.0 110.171 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.438 ' HE ' HD11 ' A' ' 113' ' ' ILE . 7.5 mtt180 -118.14 145.95 44.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.35 0.595 . . . . 0.0 111.842 -179.128 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.539 ' HB2' HD11 ' A' ' 121' ' ' ILE . 14.3 t -111.75 164.52 12.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.678 179.05 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -55.72 -18.71 8.82 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.72 0.295 . . . . 0.0 110.896 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.472 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . 50.8 m80 -91.34 -36.13 14.02 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.532 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.849 ' N ' ' HB2' ' A' ' 54' ' ' ALA . . . 174.91 -139.9 5.05 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.357 -0.925 . . . . 0.0 113.398 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.905 HG23 ' O ' ' A' ' 52' ' ' THR . 4.1 t -97.95 135.78 31.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.75 0.309 . . . . 0.0 111.63 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.539 HD11 ' HB2' ' A' ' 116' ' ' CYS . 0.9 OUTLIER -101.4 -66.91 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.928 179.195 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.846 ' HA2' HG23 ' A' ' 137' ' ' VAL . . . -151.51 -165.88 13.39 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.556 -0.83 . . . . 0.0 113.068 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.507 ' HG ' ' HB3' ' A' ' 135' ' ' ALA . 0.5 OUTLIER -120.11 164.19 16.55 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.785 0.326 . . . . 0.0 110.881 -179.92 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.556 ' O ' HG13 ' A' ' 124' ' ' VAL . 12.6 p -61.9 115.07 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.783 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.79 ' OG1' ' HB2' ' A' ' 135' ' ' ALA . 6.0 m -105.87 -93.21 0.37 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.984 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.959 ' CG ' HG23 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -105.1 158.78 16.34 Favored 'General case' 0 C--N 1.335 -0.043 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.851 179.329 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -135.77 106.96 0.59 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.448 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -79.23 -178.62 51.24 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.476 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -71.92 -19.3 61.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.703 0.287 . . . . 0.0 111.141 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -150.33 17.22 1.02 Allowed Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.754 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.56 ' CG1' HD22 ' A' ' 100' ' ' LEU . 1.0 OUTLIER -136.65 157.51 36.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.693 0.282 . . . . 0.0 110.831 179.888 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.765 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 2.5 t -112.59 117.94 56.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.008 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -96.89 119.01 6.21 Favored Glycine 0 CA--C 1.518 0.236 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.89 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.474 ' CZ ' ' HB2' ' A' ' 63' ' ' TYR . 27.7 m-85 -125.18 144.09 50.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.02 0.438 . . . . 0.0 112.039 -179.172 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.79 ' HB2' ' OG1' ' A' ' 125' ' ' THR . . . -93.78 111.05 22.68 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.428 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.724 ' OD2' HD11 ' A' ' 99' ' ' LEU . 0.8 OUTLIER -67.26 142.02 57.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.259 0.552 . . . . 0.0 112.174 -178.227 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.846 HG23 ' HA2' ' A' ' 122' ' ' GLY . 31.6 t -90.25 12.31 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.502 179.031 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.515 ' HA ' HD23 ' A' ' 141' ' ' LEU . 15.7 mmm-85 -71.52 -6.92 44.18 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.446 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -96.1 7.52 46.19 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.91 HD23 HG21 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -171.83 34.35 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 121.208 0.528 . . . . 0.0 110.36 179.716 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.625 HD11 ' CG2' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -57.6 -14.84 5.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.583 -179.506 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 142' ' ' TRP . . . . . 0.436 ' CD1' ' HA ' ' A' ' 140' ' ' LEU . 13.6 p-90 -61.45 77.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.903 0.382 . . . . 0.0 111.828 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.727 HD23 ' HB2' ' A' ' 15' ' ' TYR . 5.1 mp -136.32 -52.66 0.72 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.057 178.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.463 ' HB2' ' CG1' ' A' ' 12' ' ' VAL . 2.2 tp10 -144.41 -163.3 1.65 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.657 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -67.94 145.16 54.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.858 0.361 . . . . 0.0 110.822 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.405 ' CB ' ' HD3' ' A' ' 55' ' ' ARG . 1.4 p30 -105.03 154.16 20.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.981 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.062 179.942 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.665 ' HB2' HG23 ' A' ' 18' ' ' VAL . . . . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.838 0.352 . . . . 0.0 111.285 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.8 t -101.14 127.12 54.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.877 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.736 ' OH ' ' HB3' ' A' ' 47' ' ' ALA . 7.0 t80 -111.66 116.06 30.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.841 0.353 . . . . 0.0 110.624 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.815 HG21 HD11 ' A' ' 53' ' ' ILE . 48.3 t -120.77 111.25 31.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.667 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 50.41 -124.92 20.12 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 121.064 -0.588 . . . . 0.0 113.273 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.476 ' O ' ' HA ' ' A' ' 44' ' ' THR . 77.8 m-20 -91.45 17.18 8.91 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.573 0.225 . . . . 0.0 111.601 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.646 ' HE1' HG22 ' A' ' 44' ' ' THR . 5.2 m-30 -130.31 127.84 40.3 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 9.1 tttt -120.42 114.81 22.36 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 121.11 -0.236 . . . . 0.0 110.742 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 1.001 HG12 HG22 ' A' ' 42' ' ' VAL . 0.6 OUTLIER -98.97 121.52 49.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 121.02 0.438 . . . . 0.0 110.761 179.861 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.665 HG23 ' HB2' ' A' ' 9' ' ' ALA . 15.0 p -136.67 161.35 36.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.288 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.517 ' N ' HG22 ' A' ' 18' ' ' VAL . 10.4 t-20 -61.05 141.48 57.36 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 179.034 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.418 ' HG2' ' CB ' ' A' ' 39' ' ' ASP . 1.8 ppt_? -56.46 -45.9 80.62 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.928 0.394 . . . . 0.0 111.311 -179.495 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -66.38 -10.29 41.97 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.157 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.4 mt -115.21 0.85 13.67 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.669 ' HB3' ' NE1' ' A' ' 28' ' ' TRP . . . -88.98 127.37 35.67 Favored 'General case' 0 N--CA 1.457 -0.084 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.212 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.544 ' O ' ' HD1' ' A' ' 28' ' ' TRP . 1.1 t -74.6 163.2 27.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.706 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -53.59 -29.77 39.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.746 0.308 . . . . 0.0 111.008 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.403 ' O ' ' HG2' ' A' ' 29' ' ' GLN . 22.3 t -69.79 -32.25 51.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.967 0.413 . . . . 0.0 110.767 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.447 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 0.5 OUTLIER -68.56 -43.62 76.21 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.417 179.587 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.669 ' NE1' ' HB3' ' A' ' 23' ' ' ALA . 46.6 m95 -73.27 -45.97 52.63 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.019 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.403 ' HG2' ' O ' ' A' ' 26' ' ' VAL . 14.4 pt20 -54.99 -44.07 74.16 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.768 0.318 . . . . 0.0 110.685 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -102.82 29.9 5.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.178 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.484 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 35.4 t -80.07 145.56 32.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.483 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.664 ' CG2' HG12 ' A' ' 42' ' ' VAL . 10.0 m -103.67 -41.96 7.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.335 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.578 ' HH2' HD23 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -139.69 152.86 47.03 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.018 179.696 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -157.22 117.81 3.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.136 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.412 ' HB3' ' CG ' ' A' ' 38' ' ' ARG . 26.6 t0 -107.13 105.02 14.81 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.789 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -63.27 -29.2 70.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.173 -179.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.531 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 10.7 m-20 -62.2 -30.16 70.88 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 120.403 0.144 . . . . 0.0 110.93 -179.236 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.582 ' NH2' HD22 ' A' ' 40' ' ' LEU . 14.5 ptm180 -113.71 -3.43 13.54 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.418 ' CB ' ' HG2' ' A' ' 20' ' ' ARG . 8.2 m-20 60.48 46.24 9.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.918 0.39 . . . . 0.0 110.906 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.588 HD11 HG23 ' A' ' 17' ' ' VAL . 26.6 tp -135.04 153.32 52.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.748 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.682 ' O ' HD23 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -152.04 155.88 38.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.064 0.459 . . . . 0.0 111.719 179.683 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 1.001 HG22 HG12 ' A' ' 17' ' ' VAL . 28.9 t -116.6 133.04 64.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.93 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.2 t -125.69 157.11 38.15 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.748 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.646 HG22 ' HE1' ' A' ' 15' ' ' TYR . 22.7 p -97.75 144.33 27.48 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.083 0.468 . . . . 0.0 111.538 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.685 HG21 ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -135.02 171.41 14.46 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.957 -179.167 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.0 m -115.68 55.34 0.79 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.884 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.736 ' HB3' ' OH ' ' A' ' 11' ' ' TYR . . . -133.5 -175.11 3.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.147 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -99.4 148.06 24.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.021 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -67.52 170.47 35.3 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.644 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.3 m -149.21 -60.58 0.22 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.81 0.338 . . . . 0.0 110.812 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -83.66 150.41 25.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.884 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.896 ' O ' HG23 ' A' ' 120' ' ' VAL . 86.6 m -122.38 119.29 30.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.959 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.927 ' HB ' HD11 ' A' ' 141' ' ' LEU . 0.4 OUTLIER -76.46 139.75 18.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.767 179.854 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.651 ' HA ' ' HB3' ' A' ' 147' ' ' ALA . . . -90.89 135.56 33.65 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.396 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -94.18 27.22 2.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.035 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.405 ' SG ' ' HB1' ' A' ' 54' ' ' ALA . 24.7 p -99.96 167.3 10.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.198 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -122.86 31.6 5.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.035 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 15.6 m -58.58 132.12 52.85 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.814 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.5 t -74.94 -8.17 55.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.115 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.2 p -107.98 127.21 53.56 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.89 0.376 . . . . 0.0 111.059 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -149.63 146.61 16.06 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.198 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.671 HG23 ' C ' ' A' ' 72' ' ' TYR . 9.6 p -103.86 125.39 58.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.933 0.396 . . . . 0.0 111.216 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.696 ' HE2' HG21 ' A' ' 74' ' ' VAL . 9.5 p90 -108.01 163.6 13.0 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.796 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.863 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 16.5 p80 . . . . . 0 N--CA 1.456 -0.134 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.671 ' C ' HG23 ' A' ' 62' ' ' VAL . 1.3 m-85 -126.04 114.25 24.14 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.631 -179.063 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 72' ' ' TYR . 7.0 Cg_exo -72.75 120.79 6.88 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.467 2.111 . . . . 0.0 110.497 178.534 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.696 HG21 ' HE2' ' A' ' 63' ' ' TYR . 84.6 t -137.64 142.02 37.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.257 0.551 . . . . 0.0 112.466 -178.428 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.19 135.0 39.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.495 -0.775 . . . . 0.0 108.961 178.222 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.593 ' HB3' ' HB2' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -141.97 172.76 12.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.381 0.61 . . . . 0.0 112.214 -178.362 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.464 ' O ' ' HA ' ' A' ' 99' ' ' LEU . 9.8 mt-10 -111.78 158.86 18.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.264 179.062 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -103.73 68.56 0.29 Allowed Glycine 0 CA--C 1.522 0.486 0 C-N-CA 120.366 -0.921 . . . . 0.0 113.735 -179.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.651 ' HD2' ' HA ' ' A' ' 99' ' ' LEU . 36.9 Cg_endo -67.77 139.2 47.2 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.464 2.109 . . . . 0.0 112.188 179.237 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -56.73 -91.77 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.693 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.496 HD22 ' HB3' ' A' ' 96' ' ' SER . 0.0 OUTLIER -98.62 122.73 42.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.921 0.391 . . . . 0.0 111.85 -179.772 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.668 ' HB ' HG11 ' A' ' 98' ' ' VAL . 96.0 t -119.25 126.19 75.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.149 179.032 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -72.33 107.85 5.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.674 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.822 HG22 ' HB2' ' A' ' 126' ' ' MET . 1.0 OUTLIER -74.55 114.83 14.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.099 -179.834 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -70.75 149.77 46.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.843 179.114 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.501 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 4.2 pt-20 -68.06 101.0 1.06 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.086 0.469 . . . . 0.0 109.892 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.05 145.18 31.36 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.972 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.582 ' O ' ' CD1' ' A' ' 89' ' ' TYR . 0.3 OUTLIER 43.33 93.72 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.31 -0.404 . . . . 0.0 112.072 178.702 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.582 ' CD1' ' O ' ' A' ' 88' ' ' GLU . 4.3 p90 37.91 28.87 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.501 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -131.38 125.11 20.62 Favored Pre-proline 0 C--N 1.329 -0.312 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.541 -179.64 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -86.68 148.84 8.57 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.335 2.69 . . . . 0.0 112.476 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 5.0 mttm -45.73 93.63 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.352 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.68 170.77 10.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.511 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -102.9 132.47 49.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.961 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.908 ' NE2' HG23 ' A' ' 125' ' ' THR . 0.0 OUTLIER -126.12 110.89 14.02 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.183 -179.823 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.496 ' HB3' HD22 ' A' ' 81' ' ' LEU . 97.5 p -82.84 153.93 24.92 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.981 0.419 . . . . 0.0 111.441 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 54.47 62.22 2.66 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.621 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.668 HG11 ' HB ' ' A' ' 82' ' ' VAL . 9.4 p -123.66 146.01 29.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.942 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.963 HD11 ' HB3' ' A' ' 136' ' ' ASP . 0.9 OUTLIER -105.28 146.64 29.06 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.133 179.72 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.71 HD23 ' C ' ' A' ' 132' ' ' VAL . 6.0 mt -133.02 143.27 49.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.27 0.557 . . . . 0.0 112.492 -179.281 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.593 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . . . -151.0 140.92 21.97 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.603 179.43 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 1.3 t -95.52 118.11 31.64 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.954 0.407 . . . . 0.0 111.017 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.266 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.424 -179.786 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.463 ' O ' HG12 ' A' ' 124' ' ' VAL . . . . . . . . 0 N--CA 1.451 -0.344 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.524 HD13 HG13 ' A' ' 120' ' ' VAL . 2.3 pp -126.0 146.74 31.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.798 0.332 . . . . 0.0 111.24 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.589 HD21 ' CE1' ' A' ' 76' ' ' PHE . 19.3 tp -87.18 120.4 28.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.713 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.06 145.03 45.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.394 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.814 ' HB2' HD12 ' A' ' 121' ' ' ILE . 5.1 t -108.4 164.56 12.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.111 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.49 -19.23 23.08 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.928 0.394 . . . . 0.0 110.482 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -92.68 -33.6 14.29 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.348 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.52 ' N ' ' HB2' ' A' ' 54' ' ' ALA . . . 176.78 -128.44 1.34 Allowed Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.894 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.896 HG23 ' O ' ' A' ' 52' ' ' THR . 3.3 t -113.0 135.66 51.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.596 0.236 . . . . 0.0 110.856 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.814 HD12 ' HB2' ' A' ' 116' ' ' CYS . 0.2 OUTLIER -100.06 -49.0 11.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.872 179.636 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.935 ' HA2' HG23 ' A' ' 137' ' ' VAL . . . -170.39 -165.61 28.01 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.319 -0.943 . . . . 0.0 113.252 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 0.3 OUTLIER -116.93 164.2 15.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.679 0.276 . . . . 0.0 110.626 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.463 HG12 ' O ' ' A' ' 112' ' ' GLY . 12.0 p -69.45 129.96 34.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.357 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.908 HG23 ' NE2' ' A' ' 95' ' ' GLN . 12.1 m -112.01 -95.37 0.44 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.682 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.822 ' HB2' HG22 ' A' ' 84' ' ' VAL . 95.0 mmm -144.07 140.19 29.35 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.717 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -115.25 154.47 16.94 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.52 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -86.89 -150.02 16.44 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.473 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -71.92 -19.45 61.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.759 0.314 . . . . 0.0 110.991 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -157.4 13.98 0.29 Allowed Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.784 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.653 ' CG1' HD22 ' A' ' 100' ' ' LEU . 1.2 t -121.39 157.05 25.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.725 0.298 . . . . 0.0 110.794 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.71 ' C ' HD23 ' A' ' 100' ' ' LEU . 7.6 m -115.66 118.41 58.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.406 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.547 ' HA3' ' O ' ' A' ' 126' ' ' MET . . . -101.19 115.28 5.24 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.378 -0.915 . . . . 0.0 112.085 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.634 ' O ' HD12 ' A' ' 99' ' ' LEU . 15.4 m-85 -117.55 139.83 50.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.778 0.323 . . . . 0.0 111.116 -179.585 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.69 ' HB2' ' OG1' ' A' ' 125' ' ' THR . . . -88.84 114.75 25.79 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.689 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.963 ' HB3' HD11 ' A' ' 99' ' ' LEU . 1.4 p30 -74.63 140.93 44.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.769 -179.199 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.935 HG23 ' HA2' ' A' ' 122' ' ' GLY . 48.8 t -89.51 10.09 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.48 178.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.42 ' HA ' HD23 ' A' ' 141' ' ' LEU . 10.8 mmm180 -70.82 -6.9 41.39 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.632 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -94.75 11.1 32.6 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.685 0.279 . . . . 0.0 111.206 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.826 ' O ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -178.17 62.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.245 0.545 . . . . 0.0 110.317 -179.918 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.927 HD11 ' HB ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -77.3 -14.75 59.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.026 -179.311 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 15.3 p-90 -56.23 78.65 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.004 0.43 . . . . 0.0 111.437 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.717 HD12 ' C ' ' A' ' 141' ' ' LEU . 5.0 mp -143.02 -46.66 0.31 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.147 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -151.48 -163.56 1.79 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.719 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -65.95 142.31 57.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.845 0.355 . . . . 0.0 111.039 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -86.57 154.13 21.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.914 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.651 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . . . . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.171 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.821 0.343 . . . . 0.0 111.108 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.906 HG22 HG21 ' A' ' 113' ' ' ILE . 45.4 t -130.29 110.0 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.127 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.712 ' CE2' HG21 ' A' ' 45' ' ' THR . 5.9 t80 -95.92 116.11 28.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.841 0.353 . . . . 0.0 110.514 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.918 HG21 HD11 ' A' ' 53' ' ' ILE . 21.9 t -120.92 108.96 23.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.637 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 51.06 -125.96 25.58 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.898 -0.668 . . . . 0.0 113.327 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.424 ' O ' ' HA ' ' A' ' 44' ' ' THR . 24.8 m120 -89.07 14.25 11.15 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.722 0.296 . . . . 0.0 111.672 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.658 ' HE1' HG22 ' A' ' 44' ' ' THR . 6.5 m-30 -130.37 146.94 52.02 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.8 tttt -137.67 114.93 10.98 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 121.197 -0.201 . . . . 0.0 110.651 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 1.037 HG12 HG22 ' A' ' 42' ' ' VAL . 0.6 OUTLIER -99.29 121.53 50.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 121.144 0.497 . . . . 0.0 111.145 -179.927 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.645 ' O ' HD12 ' A' ' 40' ' ' LEU . 14.1 p -136.74 161.1 36.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.805 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.506 ' N ' HG22 ' A' ' 18' ' ' VAL . 4.5 t-20 -59.84 141.24 55.74 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 179.176 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.44 ' HG2' ' CH2' ' A' ' 28' ' ' TRP . 25.3 mtp180 -56.61 -47.12 80.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.948 0.404 . . . . 0.0 110.842 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.22 -8.04 28.55 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.245 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.09 -2.42 12.78 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.621 ' HB3' ' NE1' ' A' ' 28' ' ' TRP . . . -88.62 129.01 35.59 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.102 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.595 ' O ' ' HD1' ' A' ' 28' ' ' TRP . 43.8 p -74.73 162.89 28.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.56 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 24.1 p80 -53.51 -29.49 36.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.888 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.0 t -69.95 -31.85 49.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.82 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.437 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 3.7 m-20 -68.22 -43.97 76.78 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.437 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.621 ' NE1' ' HB3' ' A' ' 23' ' ' ALA . 27.5 m95 -73.64 -37.23 65.4 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.015 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.31 -44.23 79.71 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.96 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -110.16 32.4 5.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.275 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.485 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 54.1 t -80.14 149.34 30.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.542 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.516 HG22 ' O ' ' A' ' 42' ' ' VAL . 15.9 m -107.92 -39.32 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.048 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.705 ' CZ3' HG23 ' A' ' 42' ' ' VAL . 0.7 OUTLIER -139.49 150.89 45.69 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.952 0.406 . . . . 0.0 111.7 -179.615 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.424 ' HG3' ' SG ' ' A' ' 31' ' ' CYS . 5.6 mp0 -147.0 118.47 7.92 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.792 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.453 ' HB2' ' CZ2' ' A' ' 33' ' ' TRP . 24.6 t70 -107.09 105.55 15.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.917 0.389 . . . . 0.0 110.891 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -64.46 -29.85 70.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.401 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.569 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 25.5 m120 -68.73 -27.59 66.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.88 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.566 ' HD2' ' HB1' ' A' ' 135' ' ' ALA . 9.4 ttp-105 -114.42 5.64 15.71 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 121.152 -0.219 . . . . 0.0 111.479 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.42 ' HA ' ' CD ' ' A' ' 20' ' ' ARG . 0.8 OUTLIER 46.55 38.98 6.14 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.994 0.426 . . . . 0.0 110.618 -179.862 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.821 HD11 HG23 ' A' ' 17' ' ' VAL . 26.5 tp -129.29 150.03 50.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.938 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.682 ' O ' HD23 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -144.88 155.57 43.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.321 179.489 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 1.037 HG22 HG12 ' A' ' 17' ' ' VAL . 24.9 t -115.94 130.05 71.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.29 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 12.2 p -120.69 157.35 29.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.532 179.262 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.658 HG22 ' HE1' ' A' ' 15' ' ' TYR . 17.8 p -97.49 130.67 44.56 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.22 0.533 . . . . 0.0 111.659 -179.047 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.712 HG21 ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -126.5 160.53 30.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.849 -179.296 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -118.19 58.02 0.83 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.796 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -135.05 -173.69 3.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.132 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -101.53 120.59 40.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.459 ' CA ' ' CE1' ' A' ' 11' ' ' TYR . . . -80.17 -170.36 41.2 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.52 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -155.48 -46.23 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.828 0.347 . . . . 0.0 110.859 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -64.3 141.95 58.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.892 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.789 ' O ' HG23 ' A' ' 120' ' ' VAL . 87.0 m -125.14 118.12 25.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.924 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 1.022 ' HB ' HD11 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -79.44 139.54 18.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.905 179.825 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -98.57 135.85 39.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.839 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.423 ' HB2' ' HB3' ' A' ' 146' ' ' ASP . 0.5 OUTLIER -92.45 42.93 1.11 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.457 0.646 . . . . 0.0 109.409 178.614 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 19.4 p -99.65 167.19 10.73 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.569 -178.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -120.15 24.89 10.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.2 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 16.1 p -64.17 139.52 58.77 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.048 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.544 HG22 ' O ' ' A' ' 76' ' ' PHE . 1.7 m -91.36 12.99 18.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.381 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 39.0 p -125.94 160.87 28.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.815 0.34 . . . . 0.0 110.883 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 176.13 152.81 9.9 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.442 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.864 HG23 ' C ' ' A' ' 72' ' ' TYR . 7.1 p -103.71 137.83 30.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.808 0.337 . . . . 0.0 111.032 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.69 ' CZ ' HG11 ' A' ' 132' ' ' VAL . 8.8 p90 -130.13 -170.9 2.41 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.357 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.435 ' HB2' ' O ' ' A' ' 63' ' ' TYR . 0.7 OUTLIER . . . . . 0 N--CA 1.464 0.235 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.241 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.807 ' HB2' HG21 ' A' ' 62' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.731 0.3 . . . . 0.0 110.612 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.864 ' C ' HG23 ' A' ' 62' ' ' VAL . 1.3 m-85 -102.37 113.07 66.04 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.77 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 72' ' ' TYR . 4.6 Cg_exo -80.61 121.06 4.08 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.663 2.242 . . . . 0.0 111.217 179.455 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.69 HG21 ' CE2' ' A' ' 63' ' ' TYR . 44.4 t -134.21 147.48 30.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.073 0.463 . . . . 0.0 112.027 -178.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 74.2 m -100.58 128.62 46.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.458 178.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.743 ' HZ ' HD11 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -132.52 169.25 16.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.381 0.61 . . . . 0.0 112.05 -178.588 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.435 ' O ' ' HD2' ' A' ' 79' ' ' PRO . 28.6 tt0 -111.91 158.44 19.47 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.156 178.582 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -105.44 65.97 0.28 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.474 -0.869 . . . . 0.0 113.172 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.435 ' HD2' ' O ' ' A' ' 77' ' ' GLU . 41.2 Cg_endo -67.99 134.45 32.02 Favored 'Trans proline' 0 C--O 1.239 0.557 0 C-N-CA 122.29 1.993 . . . . 0.0 112.23 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -58.86 -87.77 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.202 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.606 HD22 ' HB2' ' A' ' 96' ' ' SER . 0.0 OUTLIER -94.32 119.84 33.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.031 0.444 . . . . 0.0 111.826 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.626 ' HB ' HG11 ' A' ' 98' ' ' VAL . 48.8 t -122.91 122.9 66.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.686 178.577 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.425 ' HG3' ' CE1' ' A' ' 94' ' ' TYR . 3.9 tt0 -72.08 107.61 4.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.976 0.417 . . . . 0.0 110.808 -179.123 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.781 HG13 ' CG ' ' A' ' 126' ' ' MET . 47.6 t -73.96 114.62 13.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.757 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -72.84 150.02 43.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.752 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.526 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 0.6 OUTLIER -67.71 100.9 0.96 Allowed 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.331 -0.548 . . . . 0.0 110.232 -179.388 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.522 ' O ' ' N ' ' A' ' 89' ' ' TYR . 3.7 m -144.78 169.58 17.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.591 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 45.65 -84.82 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.658 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.522 ' N ' ' O ' ' A' ' 87' ' ' SER . 0.6 OUTLIER -153.99 24.75 0.49 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.818 0.342 . . . . 0.0 110.378 179.652 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.526 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -117.43 116.47 37.08 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.623 -179.934 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.457 ' O ' ' N ' ' A' ' 93' ' ' ARG . 30.9 Cg_exo -61.51 148.52 92.78 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.706 2.271 . . . . 0.0 112.181 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.557 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -59.05 79.24 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.858 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.457 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.2 OUTLIER -123.97 179.96 4.64 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.172 0.51 . . . . 0.0 111.816 -179.498 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.455 ' HB3' HD11 ' A' ' 81' ' ' LEU . 12.5 m-85 -93.93 132.56 38.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.784 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.578 ' CD ' HG21 ' A' ' 125' ' ' THR . 2.2 tt0 -130.57 123.14 28.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.209 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.606 ' HB2' HD22 ' A' ' 81' ' ' LEU . 5.1 t -97.71 161.49 13.73 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.114 0.483 . . . . 0.0 112.02 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 55.72 56.32 6.26 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.585 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.626 HG11 ' HB ' ' A' ' 82' ' ' VAL . 11.1 p -123.66 139.64 49.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.815 0.341 . . . . 0.0 111.559 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.466 HD11 ' OD2' ' A' ' 136' ' ' ASP . 11.2 mp -101.97 140.25 36.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.169 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.815 HD23 ' O ' ' A' ' 132' ' ' VAL . 5.6 mt -133.18 142.29 48.54 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -179.246 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.57 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . . . -152.12 147.12 26.08 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.706 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 0.9 OUTLIER -100.42 118.24 36.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.058 0.456 . . . . 0.0 111.129 179.865 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.287 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.868 -179.928 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.29 0 N-CA-C 112.549 -0.22 . . . . 0.0 112.549 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.906 HG21 HG22 ' A' ' 10' ' ' VAL . 2.5 pp -97.61 146.39 7.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.738 0.304 . . . . 0.0 111.077 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.743 HD11 ' HZ ' ' A' ' 76' ' ' PHE . 47.0 tp -87.58 113.15 23.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.822 0.344 . . . . 0.0 110.843 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -119.36 138.11 53.28 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.298 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.945 ' SG ' HD11 ' A' ' 121' ' ' ILE . 28.0 p -111.5 177.01 4.79 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -56.61 -19.94 18.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.686 0.279 . . . . 0.0 111.218 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 22.1 m80 -90.77 -33.66 15.64 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 159.83 -150.65 21.07 Favored Glycine 0 C--N 1.334 0.445 0 C-N-CA 120.425 -0.893 . . . . 0.0 113.136 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.789 HG23 ' O ' ' A' ' 52' ' ' THR . 9.1 t -83.83 135.6 24.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.768 0.318 . . . . 0.0 111.63 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.945 HD11 ' SG ' ' A' ' 116' ' ' CYS . 3.0 mp -109.31 -47.97 7.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.028 179.439 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.85 ' HA2' HG23 ' A' ' 137' ' ' VAL . . . -168.45 -171.94 34.82 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.078 -1.058 . . . . 0.0 113.215 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.576 HD11 HD13 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -118.76 164.13 15.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.803 0.335 . . . . 0.0 110.826 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.476 ' O ' HG13 ' A' ' 124' ' ' VAL . 11.2 p -60.72 121.33 8.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.486 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.753 ' OG1' ' HB2' ' A' ' 135' ' ' ALA . 19.3 m -116.02 -98.49 0.45 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.4 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.781 ' CG ' HG13 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -87.06 161.85 17.92 Favored 'General case' 0 CA--C 1.527 0.059 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.644 179.664 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -146.64 93.61 0.16 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.467 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -74.98 -177.96 40.62 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.375 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -71.98 -19.36 61.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.702 0.287 . . . . 0.0 111.042 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -142.6 -7.34 0.65 Allowed Glycine 0 CA--C 1.523 0.545 0 C-N-CA 120.571 -0.823 . . . . 0.0 113.514 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.636 ' CG1' HD22 ' A' ' 100' ' ' LEU . 0.6 OUTLIER -115.86 157.08 16.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 117.242 0.521 . . . . 0.0 111.18 -179.842 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.815 ' O ' HD23 ' A' ' 100' ' ' LEU . 15.6 m -113.4 118.45 58.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.602 -179.36 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -95.77 119.3 6.19 Favored Glycine 0 C--N 1.329 0.178 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.162 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.539 ' HD2' HD22 ' A' ' 114' ' ' LEU . 18.5 m-85 -125.04 144.04 50.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.867 0.365 . . . . 0.0 111.557 -179.609 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.753 ' HB2' ' OG1' ' A' ' 125' ' ' THR . . . -93.11 113.64 25.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.11 179.135 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.466 ' OD2' HD11 ' A' ' 99' ' ' LEU . 2.7 t0 -67.99 133.76 49.59 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -178.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.85 HG23 ' HA2' ' A' ' 122' ' ' GLY . 48.9 t -97.17 2.39 10.29 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.505 178.603 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.44 ' HA ' HD23 ' A' ' 141' ' ' LEU . 6.4 mtm105 -72.73 -6.22 43.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.304 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.78 3.71 54.69 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.661 0.267 . . . . 0.0 111.278 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.836 ' O ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -163.78 57.25 0.17 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.228 0.537 . . . . 0.0 109.956 179.827 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 1.022 HD11 ' HB ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -72.67 -14.5 61.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.607 -179.048 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 142' ' ' TRP . . . . . 0.46 ' C ' HD12 ' A' ' 143' ' ' LEU . 16.7 p-90 -52.87 81.15 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.991 0.424 . . . . 0.0 111.219 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.717 HD12 ' C ' ' A' ' 141' ' ' LEU . 5.0 mp -151.1 -45.77 0.12 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.327 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.476 ' HB2' HG12 ' A' ' 12' ' ' VAL . 1.2 mm-40 -157.41 -170.19 3.15 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.645 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -59.4 144.99 45.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.063 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.423 ' HB3' ' HB2' ' A' ' 55' ' ' ARG . 0.1 OUTLIER -103.11 154.35 19.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.647 179.932 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.242 0 CA-C-O 120.926 0.393 . . . . 0.0 111.32 -179.677 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.406 ' HB2' HG23 ' A' ' 18' ' ' VAL . . . . . . . . 0 N--CA 1.458 -0.068 0 CA-C-O 120.825 0.345 . . . . 0.0 111.051 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.5 t -114.49 107.1 22.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.019 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.73 ' CE2' HG21 ' A' ' 45' ' ' THR . 6.0 t80 -96.54 116.24 28.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.527 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.841 HG21 HD11 ' A' ' 53' ' ' ILE . 30.5 t -120.94 111.66 32.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.683 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.405 ' O ' ' CE1' ' A' ' 11' ' ' TYR . . . 50.88 -126.26 25.58 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.996 -0.621 . . . . 0.0 113.296 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.448 ' O ' ' HA ' ' A' ' 44' ' ' THR . 21.1 p30 -89.89 17.47 6.7 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.727 0.299 . . . . 0.0 111.561 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.668 ' HE1' HG22 ' A' ' 44' ' ' THR . 7.0 m-30 -130.29 145.51 51.78 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.05 114.8 11.25 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.578 0.227 . . . . 0.0 110.677 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 1.061 HG12 HG22 ' A' ' 42' ' ' VAL . 0.6 OUTLIER -101.22 121.36 51.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 121.123 0.487 . . . . 0.0 111.036 -179.855 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.555 ' O ' HD12 ' A' ' 40' ' ' LEU . 13.7 p -136.7 161.35 36.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.869 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.509 ' N ' HG22 ' A' ' 18' ' ' VAL . 2.5 t30 -58.99 141.16 54.63 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.77 -47.38 80.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.864 0.364 . . . . 0.0 111.267 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -67.7 -9.51 44.31 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.213 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.26 2.09 13.95 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.669 ' HB3' ' NE1' ' A' ' 28' ' ' TRP . . . -87.65 131.82 34.31 Favored 'General case' 0 C--O 1.23 0.07 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.975 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.509 ' O ' ' HD1' ' A' ' 28' ' ' TRP . 42.2 p -74.67 163.29 27.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.712 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 46.3 p-80 -53.74 -29.71 40.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.855 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.7 t -68.61 -33.2 58.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.804 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -68.0 -43.93 77.73 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.669 ' NE1' ' HB3' ' A' ' 23' ' ' ALA . 45.5 m95 -73.96 -29.95 62.26 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.993 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -60.89 -44.1 97.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.46 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -115.71 33.9 5.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.593 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.494 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 30.5 p -72.64 122.92 22.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.187 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.548 HG22 ' O ' ' A' ' 42' ' ' VAL . 11.6 m -86.19 -40.01 14.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.682 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.648 ' HH2' HD23 ' A' ' 40' ' ' LEU . 0.8 OUTLIER -139.87 151.18 45.45 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.202 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.441 ' HG2' ' HB2' ' A' ' 41' ' ' LEU . 5.3 mt-10 -154.79 116.3 4.09 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.188 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.428 ' HB2' ' CZ2' ' A' ' 33' ' ' TRP . 23.5 m-20 -107.26 110.27 22.26 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.804 0.335 . . . . 0.0 111.054 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -65.16 -29.91 70.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.427 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.525 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 2.8 m-20 -63.78 -27.83 69.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.128 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.409 ' HG2' ' HB3' ' A' ' 35' ' ' ASP . 0.9 OUTLIER -117.53 6.67 12.55 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 121.096 -0.242 . . . . 0.0 111.56 179.794 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 47.56 45.12 17.55 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.961 0.41 . . . . 0.0 110.673 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.852 HD11 HG23 ' A' ' 17' ' ' VAL . 23.0 tp -133.2 151.23 51.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.142 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.667 ' O ' HD23 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -148.36 155.7 41.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.374 179.569 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 1.061 HG22 HG12 ' A' ' 17' ' ' VAL . 39.0 t -117.95 132.48 67.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.325 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.9 t -123.86 157.01 35.17 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.215 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.668 HG22 ' HE1' ' A' ' 15' ' ' TYR . 18.6 p -97.76 128.89 44.73 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.269 0.557 . . . . 0.0 111.638 -179.119 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.73 HG21 ' CE2' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -121.39 167.15 13.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.831 -179.368 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.6 m -114.85 38.62 3.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.846 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.423 ' HB3' ' OH ' ' A' ' 11' ' ' TYR . . . -113.29 -168.77 1.38 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.105 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 29.5 m80 -101.57 144.76 29.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.855 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -106.42 129.55 9.79 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.529 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 92.2 m -113.69 -32.05 6.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.803 0.335 . . . . 0.0 111.043 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -70.09 134.12 47.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.939 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.868 ' O ' HG23 ' A' ' 120' ' ' VAL . 67.6 m -118.97 117.25 28.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.599 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.903 ' HB ' HD11 ' A' ' 141' ' ' LEU . 0.4 OUTLIER -76.36 139.46 18.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.04 0.448 . . . . 0.0 111.406 -179.591 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.823 ' HB1' ' SG ' ' A' ' 56' ' ' CYS . . . -96.59 101.53 13.16 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.397 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.4 ' CB ' ' HB2' ' A' ' 146' ' ' ASP . 11.0 tpt180 -80.18 59.19 3.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.089 0.471 . . . . 0.0 110.148 179.181 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.823 ' SG ' ' HB1' ' A' ' 54' ' ' ALA . 0.5 OUTLIER -120.73 158.97 26.33 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.159 -179.293 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -96.74 18.72 13.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.384 179.188 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 29.5 p -57.31 129.07 40.16 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.97 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.1 m -92.03 12.35 22.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.272 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 25.9 p -129.99 130.81 45.48 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.818 0.342 . . . . 0.0 110.947 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -153.96 -161.8 10.67 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.31 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.811 HG23 ' C ' ' A' ' 72' ' ' TYR . 7.9 p -140.05 135.52 37.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.096 0.474 . . . . 0.0 111.225 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.454 ' CE1' ' HB2' ' A' ' 72' ' ' TYR . 27.4 p90 -109.97 125.94 53.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.678 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.44 ' HA ' ' HA ' ' A' ' 71' ' ' HIS . 15.4 t80 . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.916 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 64' ' ' PHE . 56.4 p-80 . . . . . 0 C--O 1.231 0.131 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.811 ' C ' HG23 ' A' ' 62' ' ' VAL . 13.5 m-85 -129.84 114.9 17.84 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -178.248 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.542 ' N ' HG23 ' A' ' 62' ' ' VAL . 10.0 Cg_exo -69.98 120.65 7.37 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.259 1.973 . . . . 0.0 110.319 178.174 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.451 ' CG1' ' CE2' ' A' ' 76' ' ' PHE . 2.5 p -143.68 153.76 16.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.641 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.5 m -95.03 132.9 39.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.172 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.691 ' CZ ' HD11 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -135.02 163.27 30.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.324 0.583 . . . . 0.0 111.921 -179.008 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.47 ' O ' ' HA ' ' A' ' 99' ' ' LEU . 5.9 pt-20 -111.8 158.32 19.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.142 -0.936 . . . . 0.0 109.293 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -106.04 65.8 0.27 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.385 -0.912 . . . . 0.0 113.591 -179.206 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.525 ' HD2' ' HA ' ' A' ' 99' ' ' LEU . 37.5 Cg_endo -67.74 134.15 31.69 Favored 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 122.263 1.975 . . . . 0.0 111.949 179.405 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -58.27 -84.48 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.586 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.55 HD11 ' HB3' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -97.18 120.32 37.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.866 0.365 . . . . 0.0 111.855 -179.618 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.608 ' HB ' HG11 ' A' ' 98' ' ' VAL . 48.1 t -123.91 122.58 64.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.371 178.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -72.44 107.99 5.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.91 0.386 . . . . 0.0 110.521 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.5 HG13 ' HB2' ' A' ' 95' ' ' GLN . 17.2 m -76.11 123.46 32.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.666 -179.526 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -69.92 150.52 46.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.734 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.532 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 31.0 tt0 -67.7 102.43 1.2 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.939 0.399 . . . . 0.0 110.321 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.439 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.7 OUTLIER -143.94 165.95 26.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.331 -179.729 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 55.08 -82.42 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.564 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.439 ' N ' ' O ' ' A' ' 87' ' ' SER . 0.4 OUTLIER -154.92 22.84 0.44 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.703 0.287 . . . . 0.0 110.917 -179.878 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.532 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 2.3 t80 -122.88 133.18 24.33 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.918 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.432 ' O ' ' N ' ' A' ' 93' ' ' ARG . 89.1 Cg_endo -83.08 148.96 13.49 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.173 2.582 . . . . 0.0 112.417 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.2 OUTLIER -40.16 92.79 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.401 -179.908 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.447 ' O ' HG22 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -123.71 -179.19 4.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.133 0.492 . . . . 0.0 111.683 -179.342 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.55 ' HB3' HD11 ' A' ' 81' ' ' LEU . 23.0 m-85 -106.38 132.29 52.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.024 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.525 ' HA ' ' O ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -128.79 124.03 34.39 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.934 -179.888 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -96.74 156.58 16.28 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 121.058 0.456 . . . . 0.0 111.779 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 56.91 57.18 4.82 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.491 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.608 HG11 ' HB ' ' A' ' 82' ' ' VAL . 8.0 p -123.37 135.55 62.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.964 0.411 . . . . 0.0 111.367 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.787 HD11 ' HB2' ' A' ' 136' ' ' ASP . 2.7 mp -101.91 146.94 27.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.907 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.706 HD23 ' O ' ' A' ' 132' ' ' VAL . 6.5 mt -133.03 139.87 47.43 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.533 ' HB2' ' CD2' ' A' ' 76' ' ' PHE . . . -144.13 150.97 38.93 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.394 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.2 t -111.13 140.04 46.01 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.862 0.363 . . . . 0.0 111.231 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.19 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.468 179.995 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.405 0 N-CA-C 112.411 -0.276 . . . . 0.0 112.411 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 28.3 pt -126.07 146.11 32.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.773 0.321 . . . . 0.0 111.164 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.691 HD11 ' CZ ' ' A' ' 76' ' ' PHE . 6.7 tp -87.81 113.5 23.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.388 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.517 ' O ' HG12 ' A' ' 62' ' ' VAL . 0.0 OUTLIER -118.83 139.38 51.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.257 -179.858 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.576 ' HB3' HD11 ' A' ' 121' ' ' ILE . 21.8 p -105.66 166.87 10.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.194 179.079 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -55.93 -20.2 15.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.348 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 11.4 m80 -91.16 -22.21 20.78 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.79 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.612 ' CA ' ' HB2' ' A' ' 54' ' ' ALA . . . 163.56 -143.8 8.94 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.145 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 52' ' ' THR . 3.6 t -100.24 135.53 35.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.724 0.297 . . . . 0.0 111.107 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.576 HD11 ' HB3' ' A' ' 116' ' ' CYS . 1.3 mm -96.95 -67.15 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.835 0.35 . . . . 0.0 110.982 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.864 ' HA2' HG23 ' A' ' 137' ' ' VAL . . . -155.4 -154.01 6.76 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.831 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.811 ' CD1' ' HB3' ' A' ' 135' ' ' ALA . 0.0 OUTLIER -130.53 164.14 25.51 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.031 0.443 . . . . 0.0 111.069 179.958 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.576 ' O ' HG13 ' A' ' 124' ' ' VAL . 14.5 p -57.86 115.08 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.319 -179.225 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.737 ' OG1' ' HB2' ' A' ' 135' ' ' ALA . 1.6 m -101.49 -87.22 0.4 Allowed 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.62 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.692 ' N ' HG22 ' A' ' 125' ' ' THR . 0.0 OUTLIER -136.13 129.78 32.3 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-O 120.997 0.427 . . . . 0.0 111.583 179.57 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -109.14 149.13 17.08 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.654 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -104.47 -156.9 23.62 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.469 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -71.81 -19.44 61.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.725 0.298 . . . . 0.0 111.173 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -159.03 16.18 0.24 Allowed Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.983 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.628 ' CG1' HD22 ' A' ' 100' ' ' LEU . 0.9 OUTLIER -126.51 157.23 37.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.755 0.312 . . . . 0.0 110.857 179.861 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.706 ' O ' HD23 ' A' ' 100' ' ' LEU . 29.0 m -116.97 118.32 58.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.354 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.496 ' HA3' ' O ' ' A' ' 126' ' ' MET . . . -99.87 113.94 4.87 Favored Glycine 0 C--N 1.329 0.192 0 C-N-CA 120.499 -0.858 . . . . 0.0 111.997 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.467 ' CD2' ' HB2' ' A' ' 114' ' ' LEU . 53.4 m-85 -118.14 138.04 52.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.748 0.308 . . . . 0.0 111.357 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.811 ' HB3' ' CD1' ' A' ' 123' ' ' LEU . . . -88.41 115.4 25.88 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 179.049 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.787 ' HB2' HD11 ' A' ' 99' ' ' LEU . 2.7 t0 -67.38 141.93 56.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.25 0.548 . . . . 0.0 112.438 -178.148 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.864 HG23 ' HA2' ' A' ' 122' ' ' GLY . 56.5 t -89.9 9.87 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.413 178.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.492 ' HA ' HD23 ' A' ' 141' ' ' LEU . 9.3 mmm180 -70.63 -6.74 39.07 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.641 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -98.28 11.04 39.21 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.481 0.181 . . . . 0.0 111.439 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.853 ' O ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -177.19 47.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.018 0.437 . . . . 0.0 110.595 -179.811 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.903 HD11 ' HB ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -66.39 -14.6 62.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.15 -179.67 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 142' ' ' TRP . . . . . 0.459 ' C ' HD12 ' A' ' 143' ' ' LEU . 15.6 p-90 -54.52 81.61 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.068 0.461 . . . . 0.0 111.539 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.695 HD12 ' C ' ' A' ' 141' ' ' LEU . 5.0 mp -149.37 -43.89 0.14 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.954 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.425 ' HB2' ' CG1' ' A' ' 12' ' ' VAL . 7.6 mt-10 -152.29 -170.42 3.64 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.445 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -58.83 132.27 53.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.79 0.328 . . . . 0.0 110.888 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.4 ' HB2' ' CB ' ' A' ' 55' ' ' ARG . 1.5 p30 -94.63 154.11 17.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.003 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.086 179.973 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.799 0.333 . . . . 0.0 110.988 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.2 t -116.49 108.21 24.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.069 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.89 ' CE2' HG21 ' A' ' 45' ' ' THR . 6.1 t80 -99.57 116.41 31.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.692 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.891 HG21 HD11 ' A' ' 53' ' ' ILE . 24.8 t -120.77 108.95 23.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.804 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 50.8 -126.49 25.8 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.986 -0.626 . . . . 0.0 113.259 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.518 ' O ' ' HA ' ' A' ' 44' ' ' THR . 2.7 p-10 -88.58 13.06 12.95 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.657 ' HE1' HG22 ' A' ' 44' ' ' THR . 5.8 m-30 -130.49 127.93 40.17 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.6 tttt -120.56 114.88 22.38 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.994 -0.282 . . . . 0.0 110.792 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 1.067 HG12 HG22 ' A' ' 42' ' ' VAL . 0.6 OUTLIER -99.33 121.64 50.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-O 121.161 0.505 . . . . 0.0 110.916 179.894 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.546 ' O ' HD22 ' A' ' 41' ' ' LEU . 12.6 p -136.92 161.32 36.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.02 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.52 ' N ' HG22 ' A' ' 18' ' ' VAL . 56.7 m-80 -59.89 141.22 55.86 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.056 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.441 ' HB2' ' CH2' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -56.77 -43.98 81.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.796 0.332 . . . . 0.0 111.235 -179.493 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -67.82 -10.93 57.03 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.11 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -115.26 0.61 13.56 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.712 ' HB3' ' NE1' ' A' ' 28' ' ' TRP . . . -86.69 127.06 34.93 Favored 'General case' 0 C--O 1.23 0.072 0 C-N-CA 120.331 -0.548 . . . . 0.0 111.028 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.711 HG23 HG12 ' A' ' 26' ' ' VAL . 1.7 t -74.71 165.48 25.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.916 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -53.62 -29.86 40.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.878 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.711 HG12 HG23 ' A' ' 24' ' ' THR . 11.5 p -71.85 -31.67 41.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.716 0.293 . . . . 0.0 110.996 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.484 ' HB3' ' HB1' ' A' ' 23' ' ' ALA . 0.4 OUTLIER -68.11 -43.97 77.2 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.099 0.475 . . . . 0.0 109.751 179.332 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.712 ' NE1' ' HB3' ' A' ' 23' ' ' ALA . 53.2 m95 -74.05 -35.27 64.28 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.064 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.56 -40.92 80.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.75 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -116.94 34.63 5.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.782 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.476 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 29.2 p -77.15 125.62 29.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.043 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.574 HG22 ' O ' ' A' ' 42' ' ' VAL . 16.1 m -87.43 -38.04 11.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.705 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.641 ' HH2' HD23 ' A' ' 40' ' ' LEU . 2.9 t90 -139.56 153.52 47.44 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.776 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 5.2 tm-20 -162.69 120.54 2.06 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.789 0.328 . . . . 0.0 111.581 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.408 ' HB2' ' CZ2' ' A' ' 33' ' ' TRP . 0.7 OUTLIER -107.05 98.68 8.3 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.45 179.338 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -56.95 -29.55 63.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.935 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.614 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 6.3 t-20 -64.4 -41.04 96.86 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 120.584 0.23 . . . . 0.0 110.822 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -99.55 -4.23 31.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.532 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.411 ' CB ' ' HG2' ' A' ' 20' ' ' ARG . 1.0 OUTLIER 60.03 48.36 8.7 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.047 0.451 . . . . 0.0 110.706 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.641 HD23 ' HH2' ' A' ' 33' ' ' TRP . 21.2 tp -136.41 146.51 46.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.671 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.669 ' O ' HD23 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -147.24 155.79 42.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.987 0.422 . . . . 0.0 111.899 179.802 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 1.067 HG22 HG12 ' A' ' 17' ' ' VAL . 35.8 t -117.36 125.0 73.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.272 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.0 p -118.19 157.41 27.02 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.567 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.657 HG22 ' HE1' ' A' ' 15' ' ' TYR . 15.2 p -97.29 142.71 28.84 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.243 0.544 . . . . 0.0 111.638 -178.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.89 HG21 ' CE2' ' A' ' 11' ' ' TYR . 0.4 OUTLIER -137.52 172.49 12.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.89 -179.195 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -122.68 36.04 4.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.759 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.435 ' HB3' ' OH ' ' A' ' 11' ' ' TYR . . . -107.38 -167.89 1.32 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.183 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -102.83 148.03 26.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.985 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -57.09 -174.39 0.26 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.552 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -154.59 -45.97 0.09 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.9 0.381 . . . . 0.0 111.021 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -128.66 170.71 12.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.969 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.871 ' O ' HG23 ' A' ' 120' ' ' VAL . 29.6 m -125.13 123.39 39.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.533 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.954 ' HB ' HD11 ' A' ' 141' ' ' LEU . 0.5 OUTLIER -72.65 139.55 19.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.871 0.367 . . . . 0.0 111.175 -179.643 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.607 ' HB2' ' N ' ' A' ' 119' ' ' GLY . . . -88.08 122.93 32.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.383 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.58 ' H ' ' HB3' ' A' ' 147' ' ' ALA . 25.0 tpt180 -94.11 28.98 2.28 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.172 0.51 . . . . 0.0 109.962 178.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.484 ' SG ' ' HB1' ' A' ' 54' ' ' ALA . 23.0 p -99.82 167.3 10.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.996 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -117.69 28.81 8.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.26 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 34.0 m -58.84 131.16 50.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.853 0.359 . . . . 0.0 110.539 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.48 -1.07 44.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.326 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 16.3 p -127.91 123.99 36.32 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.998 0.428 . . . . 0.0 111.265 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.25 -169.14 12.01 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.753 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.739 HG23 ' C ' ' A' ' 72' ' ' TYR . 6.8 p -140.22 132.76 33.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 117.143 0.472 . . . . 0.0 111.327 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.806 ' CZ ' HG11 ' A' ' 132' ' ' VAL . 40.5 p90 -120.18 132.12 55.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.582 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.425 ' HA ' ' HA ' ' A' ' 71' ' ' HIS . 1.2 t80 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.579 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 64' ' ' PHE . 5.1 p80 . . . . . 0 N--CA 1.457 -0.098 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.739 ' C ' HG23 ' A' ' 62' ' ' VAL . 2.6 m-85 -126.03 114.58 24.14 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.57 -178.346 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -68.34 120.46 7.41 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 121.886 1.724 . . . . 0.0 109.964 178.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.514 HG21 ' HE1' ' A' ' 63' ' ' TYR . 43.8 t -140.41 141.83 32.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -178.104 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 87.9 p -93.02 133.15 36.45 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.608 ' CZ ' HD11 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -136.25 166.2 23.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.372 0.606 . . . . 0.0 112.166 -178.347 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.437 ' O ' ' HA ' ' A' ' 99' ' ' LEU . 0.1 OUTLIER -111.71 158.48 19.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.183 178.848 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -105.16 67.5 0.27 Allowed Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.378 -0.915 . . . . 0.0 113.464 -179.112 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.516 ' HD2' ' HA ' ' A' ' 99' ' ' LEU . 37.6 Cg_endo -67.63 134.28 32.33 Favored 'Trans proline' 0 C--O 1.237 0.47 0 C-N-CA 122.227 1.951 . . . . 0.0 111.952 179.435 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -54.84 -83.24 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.673 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.703 HD11 ' HB3' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -105.09 120.18 40.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.867 0.365 . . . . 0.0 111.959 -179.646 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.619 ' HB ' HG11 ' A' ' 98' ' ' VAL . 42.2 t -121.1 122.18 66.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.376 178.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -76.35 108.05 9.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.941 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 34.8 m -73.83 124.13 30.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.055 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -69.55 150.11 47.48 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.722 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.594 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 61.3 tt0 -68.02 102.16 1.25 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.999 0.428 . . . . 0.0 110.638 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.436 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.3 OUTLIER -144.07 160.11 41.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.364 -179.825 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 56.06 -81.51 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.679 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.436 ' N ' ' O ' ' A' ' 87' ' ' SER . 3.2 p90 -155.73 26.18 0.39 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.861 0.363 . . . . 0.0 110.822 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.594 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 1.0 OUTLIER -122.48 124.35 26.8 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.557 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.46 ' O ' ' N ' ' A' ' 93' ' ' ARG . 72.0 Cg_endo -76.46 148.65 30.06 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.881 2.387 . . . . 0.0 112.512 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -46.25 89.4 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.17 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.46 ' N ' ' O ' ' A' ' 91' ' ' PRO . 1.7 mmm180 -124.02 174.34 7.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.299 0.571 . . . . 0.0 112.156 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.703 ' HB3' HD11 ' A' ' 81' ' ' LEU . 5.4 m-85 -100.18 132.62 45.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.214 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.614 ' HA ' ' O ' ' A' ' 37' ' ' ASN . 12.2 mm-40 -118.85 116.58 26.8 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.245 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.532 ' HA ' HD22 ' A' ' 81' ' ' LEU . 44.3 t -83.15 146.07 28.85 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.048 0.452 . . . . 0.0 111.716 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.427 ' CE1' ' HB3' ' A' ' 136' ' ' ASP . 1.5 t-80 52.22 65.55 1.47 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.037 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.619 HG11 ' HB ' ' A' ' 82' ' ' VAL . 10.6 p -123.6 141.8 42.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.17 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.516 ' HA ' ' HD2' ' A' ' 79' ' ' PRO . 9.4 mp -102.13 142.49 33.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.009 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.719 HD23 ' O ' ' A' ' 132' ' ' VAL . 5.6 mt -133.09 142.08 48.54 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -179.279 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.485 ' HB1' ' CG1' ' A' ' 74' ' ' VAL . . . -152.17 146.08 25.19 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.806 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 1.1 t -99.93 129.28 45.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.913 0.387 . . . . 0.0 111.228 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.273 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.436 -179.855 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 26.9 pt -109.32 145.68 15.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.793 0.33 . . . . 0.0 111.065 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.733 HD22 ' HD2' ' A' ' 134' ' ' PHE . 34.2 tp -87.77 117.02 26.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.444 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 8.1 mtt180 -118.49 145.86 44.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.148 0.499 . . . . 0.0 111.93 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.989 ' HB2' HD11 ' A' ' 121' ' ' ILE . 13.9 t -107.85 165.05 11.73 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.304 178.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.68 -17.46 5.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.777 0.322 . . . . 0.0 110.484 179.204 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 45.4 m80 -93.54 -36.25 12.51 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.581 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.607 ' N ' ' HB2' ' A' ' 54' ' ' ALA . . . 179.02 -136.91 3.0 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 120.191 -1.004 . . . . 0.0 113.936 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' ' 52' ' ' THR . 3.0 t -105.11 136.24 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -179.031 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.989 HD11 ' HB2' ' A' ' 116' ' ' CYS . 1.9 mp -95.47 -40.07 10.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.189 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.707 ' HA2' HG23 ' A' ' 137' ' ' VAL . . . 162.01 -156.78 28.44 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.889 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.539 ' N ' HD23 ' A' ' 123' ' ' LEU . 0.2 OUTLIER -116.79 164.11 15.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.791 0.329 . . . . 0.0 110.851 -179.714 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 11.4 p -68.36 131.62 33.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.427 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.805 ' OG1' ' HB2' ' A' ' 135' ' ' ALA . 1.9 m -103.08 -87.49 0.42 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.231 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.677 ' N ' HG22 ' A' ' 125' ' ' THR . 0.0 OUTLIER -131.42 162.05 31.05 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-O 120.807 0.337 . . . . 0.0 111.415 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -133.48 150.92 19.98 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.669 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -104.13 -153.06 22.86 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.449 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.94 -19.55 61.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.651 0.262 . . . . 0.0 111.103 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -164.04 16.78 0.11 Allowed Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.597 -0.811 . . . . 0.0 113.081 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.634 ' CG1' HD22 ' A' ' 100' ' ' LEU . 0.9 OUTLIER -120.29 157.26 23.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.776 0.322 . . . . 0.0 110.692 179.806 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.806 HG11 ' CZ ' ' A' ' 63' ' ' TYR . 14.3 m -115.85 118.4 58.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.408 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.419 ' HA2' ' O ' ' A' ' 99' ' ' LEU . . . -100.2 123.19 7.84 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.966 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.733 ' HD2' HD22 ' A' ' 114' ' ' LEU . 10.0 m-85 -124.83 140.15 53.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.854 0.359 . . . . 0.0 111.413 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.805 ' HB2' ' OG1' ' A' ' 125' ' ' THR . . . -88.76 114.34 25.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.057 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.427 ' HB3' ' CE1' ' A' ' 97' ' ' HIS . 3.0 t0 -73.12 146.55 45.64 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -178.463 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.707 HG23 ' HA2' ' A' ' 122' ' ' GLY . 62.0 t -104.95 5.86 10.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.139 178.51 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.45 ' HA ' HD23 ' A' ' 141' ' ' LEU . 12.2 mtm-85 -72.17 -6.51 43.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.26 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -94.64 7.34 46.07 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 120.726 0.298 . . . . 0.0 111.277 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.812 ' O ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -169.6 59.79 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.289 0.566 . . . . 0.0 109.92 179.818 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.954 HD11 ' HB ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -74.06 -14.88 61.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.298 -179.092 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 142' ' ' TRP . . . . . 0.45 ' C ' HD12 ' A' ' 143' ' ' LEU . 15.5 p-90 -54.72 81.51 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.972 0.415 . . . . 0.0 111.388 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.68 HD12 ' C ' ' A' ' 141' ' ' LEU . 5.0 mp -150.17 -47.21 0.13 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.979 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.421 ' HB2' ' CG1' ' A' ' 12' ' ' VAL . 9.2 mm-40 -154.07 -170.01 3.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.527 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.95 139.8 56.27 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.832 0.349 . . . . 0.0 111.043 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.97 154.22 18.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.878 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.58 ' HB3' ' H ' ' A' ' 55' ' ' ARG . . . . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.114 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.839 0.352 . . . . 0.0 111.107 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.62 117.62 50.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.242 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.807 ' CE2' HG21 ' A' ' 45' ' ' THR . 5.6 t80 -106.55 116.59 32.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.483 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.868 HG21 HD11 ' A' ' 53' ' ' ILE . 21.2 t -120.8 114.62 44.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.802 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 46.94 -123.87 8.01 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 121.157 -0.544 . . . . 0.0 113.335 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.445 ' O ' ' HA ' ' A' ' 44' ' ' THR . 68.6 m-20 -90.07 15.79 9.54 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.638 0.256 . . . . 0.0 111.602 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.647 ' HE1' HG22 ' A' ' 44' ' ' THR . 6.8 m-30 -130.41 148.62 52.24 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.399 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.01 114.71 9.93 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.56 0.219 . . . . 0.0 110.579 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 1.08 HG12 HG22 ' A' ' 42' ' ' VAL . 0.6 OUTLIER -100.38 122.0 51.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.054 0.454 . . . . 0.0 110.842 -179.969 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.727 ' O ' HD12 ' A' ' 40' ' ' LEU . 12.5 p -136.06 160.98 38.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.216 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.524 ' N ' HG22 ' A' ' 18' ' ' VAL . 10.4 m-20 -61.47 141.44 57.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.447 179.308 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.4 ttt-85 -56.63 -47.33 79.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.899 0.38 . . . . 0.0 110.736 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -68.75 -11.02 59.83 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.912 179.336 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.414 ' HB3' HG22 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -108.65 -12.1 15.0 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.686 -179.735 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.962 ' HB3' ' CZ2' ' A' ' 28' ' ' TRP . . . -70.02 150.71 46.36 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 120.763 0.316 . . . . 0.0 110.753 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 16.9 p -105.03 169.04 8.66 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.326 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.51 ' CD2' HG23 ' A' ' 26' ' ' VAL . 2.8 p80 -54.6 -29.63 52.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.044 0.449 . . . . 0.0 110.656 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.51 HG23 ' CD2' ' A' ' 25' ' ' HIS . 21.8 t -74.72 -31.32 26.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.385 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.42 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 4.0 m-20 -67.11 -44.14 80.69 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.962 ' CZ2' ' HB3' ' A' ' 23' ' ' ALA . 7.4 m-90 -74.47 -31.63 62.29 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.125 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -58.02 -42.31 85.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.483 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -115.81 33.93 5.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.494 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.462 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 29.2 t -80.05 129.38 34.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.26 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.507 HG13 HG23 ' A' ' 44' ' ' THR . 13.0 m -92.57 -40.73 12.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.622 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.601 ' CZ3' HG23 ' A' ' 42' ' ' VAL . 0.3 OUTLIER -139.72 153.49 47.23 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 121.047 0.451 . . . . 0.0 111.644 -179.361 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -154.41 120.25 5.23 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.472 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.424 ' HB2' ' CZ2' ' A' ' 33' ' ' TRP . 6.1 m-20 -100.42 116.7 32.99 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.414 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -65.83 -43.32 88.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.875 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.484 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 7.0 m120 -71.2 -10.96 60.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.011 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.454 ' NE ' ' HB1' ' A' ' 135' ' ' ALA . 3.5 tpm_? -117.1 -4.96 11.41 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 121.151 -0.22 . . . . 0.0 111.301 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 47.12 33.98 2.69 Favored 'General case' 0 N--CA 1.46 0.059 0 CA-C-O 121.122 0.486 . . . . 0.0 110.27 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.906 HD13 HD11 ' A' ' 123' ' ' LEU . 41.6 tp -126.8 153.37 45.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.747 -179.346 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.666 ' O ' HD23 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -146.79 155.69 42.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.871 0.367 . . . . 0.0 111.781 179.754 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 1.08 HG22 HG12 ' A' ' 17' ' ' VAL . 24.7 t -119.14 130.04 74.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.342 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.6 p -121.07 157.13 30.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.556 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.647 HG22 ' HE1' ' A' ' 15' ' ' TYR . 17.4 p -97.74 128.67 44.57 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.182 0.515 . . . . 0.0 111.471 -179.183 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.807 HG21 ' CE2' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -103.61 -34.19 8.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.889 -179.245 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.0 m 68.37 59.22 0.41 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.017 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.607 ' HB3' ' OH ' ' A' ' 11' ' ' TYR . . . -152.13 -167.86 2.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.201 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 46.8 p-80 -81.93 148.01 28.96 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.984 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -93.55 153.17 21.18 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.718 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.5 m -125.73 -62.72 1.17 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.869 0.366 . . . . 0.0 110.742 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -69.07 147.21 51.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.681 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.825 ' O ' HG23 ' A' ' 120' ' ' VAL . 62.8 m -123.56 117.53 25.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.94 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.889 ' HB ' HD11 ' A' ' 141' ' ' LEU . 0.4 OUTLIER -73.07 139.34 19.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.644 179.864 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.82 ' HB2' ' N ' ' A' ' 119' ' ' GLY . . . -95.96 124.84 40.14 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.926 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.608 ' H ' ' HB3' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -90.94 33.9 0.93 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.504 179.61 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 26.6 p -99.69 167.13 10.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.892 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -123.03 39.71 3.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.177 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 19.3 m -68.94 131.77 45.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.779 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.1 t -76.86 -7.15 54.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.811 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.7 p -117.84 123.93 47.11 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.988 0.423 . . . . 0.0 111.091 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -148.98 162.56 28.96 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.571 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.829 HG23 ' C ' ' A' ' 72' ' ' TYR . 13.2 p -99.86 134.42 39.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.193 0.521 . . . . 0.0 111.669 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -120.26 -170.7 2.02 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.059 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.531 0.221 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.197 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.769 ' HB2' HG21 ' A' ' 62' ' ' VAL . 12.5 p-80 . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.612 0.244 . . . . 0.0 110.569 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.829 ' C ' HG23 ' A' ' 62' ' ' VAL . 1.8 m-85 -106.78 113.17 63.07 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.073 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.54 ' HA ' ' HA ' ' A' ' 62' ' ' VAL . 6.0 Cg_exo -80.27 139.11 12.97 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.846 2.364 . . . . 0.0 111.632 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.452 ' CG1' ' CE2' ' A' ' 76' ' ' PHE . 1.3 p -151.14 161.26 3.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.016 0.436 . . . . 0.0 111.892 -179.23 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.5 p -106.88 126.62 52.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.227 178.297 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.646 ' CZ ' HD11 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -128.48 166.18 19.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.654 0.74 . . . . 0.0 112.294 -179.111 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.69 ' C ' ' HD3' ' A' ' 79' ' ' PRO . 1.3 mp0 -111.91 159.36 18.45 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.552 -1.204 . . . . 0.0 108.918 178.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.461 ' HA2' ' HG ' ' A' ' 99' ' ' LEU . . . -108.57 64.19 0.26 Allowed Glycine 0 CA--C 1.522 0.495 0 C-N-CA 120.135 -1.031 . . . . 0.0 114.155 -179.159 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.69 ' HD3' ' C ' ' A' ' 77' ' ' GLU . 14.9 Cg_exo -66.96 138.27 47.44 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.12 1.88 . . . . 0.0 111.965 179.384 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -62.77 -90.7 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.752 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.615 HD22 ' HB2' ' A' ' 96' ' ' SER . 0.0 OUTLIER -87.79 120.0 28.68 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.343 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.599 ' HB ' HG11 ' A' ' 98' ' ' VAL . 89.1 t -124.8 122.93 64.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.534 178.402 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.407 ' OE2' ' CE1' ' A' ' 94' ' ' TYR . 1.2 tp10 -72.11 107.9 5.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.986 0.422 . . . . 0.0 110.686 -179.163 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.847 HG23 ' HB2' ' A' ' 126' ' ' MET . 2.9 p -83.06 114.39 23.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.739 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -74.35 150.37 40.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.471 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 5.8 pt-20 -67.72 100.78 0.95 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.274 0.559 . . . . 0.0 109.88 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.529 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.5 OUTLIER -145.16 172.92 12.42 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.62 -179.976 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 44.14 -85.17 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.614 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.529 ' N ' ' O ' ' A' ' 87' ' ' SER . 0.2 OUTLIER -150.15 23.21 0.84 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.818 0.342 . . . . 0.0 110.413 179.597 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.749 ' HD2' HG21 ' A' ' 84' ' ' VAL . 0.4 OUTLIER -116.34 145.68 35.66 Favored Pre-proline 0 C--O 1.232 0.17 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.999 -179.63 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.404 ' O ' ' N ' ' A' ' 93' ' ' ARG . 92.2 Cg_endo -85.44 148.74 10.13 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.307 2.671 . . . . 0.0 112.697 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.515 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -65.42 72.81 0.05 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 179.894 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.486 ' O ' HG12 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -123.92 -178.23 3.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.961 0.41 . . . . 0.0 111.621 -179.653 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.432 ' HB3' HD11 ' A' ' 81' ' ' LEU . 14.6 m-85 -94.99 132.17 40.15 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.586 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.484 ' HA ' ' O ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -131.15 125.56 33.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.667 0.27 . . . . 0.0 111.321 -179.681 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.615 ' HB2' HD22 ' A' ' 81' ' ' LEU . 1.4 t -102.09 154.21 19.2 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 120.917 0.389 . . . . 0.0 111.868 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 70.19 54.52 0.32 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.395 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.599 HG11 ' HB ' ' A' ' 82' ' ' VAL . 5.0 p -123.46 141.73 42.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.223 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.535 ' N ' HD12 ' A' ' 99' ' ' LEU . 5.6 mp -107.49 146.49 31.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.094 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.675 HD23 ' C ' ' A' ' 132' ' ' VAL . 6.1 mt -133.28 133.74 42.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.113 0.482 . . . . 0.0 112.189 -179.403 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.608 ' HB2' ' CD2' ' A' ' 76' ' ' PHE . . . -136.39 150.47 48.81 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.65 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.1 t -108.84 129.27 55.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.857 0.361 . . . . 0.0 110.98 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.637 -179.765 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.443 -0.263 . . . . 0.0 112.443 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 34.5 pt -125.99 146.12 32.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.809 0.337 . . . . 0.0 111.218 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.646 HD11 ' CZ ' ' A' ' 76' ' ' PHE . 16.3 tp -87.82 119.46 28.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.24 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -118.13 149.32 41.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.067 0.46 . . . . 0.0 111.786 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.575 ' HB2' HD11 ' A' ' 121' ' ' ILE . 7.4 t -115.48 163.08 16.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.149 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -55.85 -20.07 14.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.814 0.34 . . . . 0.0 110.818 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.435 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . 26.7 m80 -90.64 -35.47 14.95 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.422 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.82 ' N ' ' HB2' ' A' ' 54' ' ' ALA . . . 177.45 -139.31 4.25 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.333 -0.937 . . . . 0.0 113.281 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' ' 52' ' ' THR . 3.4 t -100.91 135.39 37.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.687 0.279 . . . . 0.0 111.341 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.575 HD11 ' HB2' ' A' ' 116' ' ' CYS . 1.1 mm -95.78 -61.99 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.871 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.797 ' HA2' HG23 ' A' ' 137' ' ' VAL . . . -174.9 -163.57 28.26 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.302 -0.951 . . . . 0.0 113.387 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.906 HD11 HD13 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -116.89 141.75 47.82 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.864 0.364 . . . . 0.0 111.002 -179.792 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.407 ' HB ' ' CE1' ' A' ' 134' ' ' PHE . 10.6 p -57.94 148.81 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.94 -179.394 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.509 HG23 ' H ' ' A' ' 126' ' ' MET . 0.0 OUTLIER -128.87 -87.17 0.55 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.225 179.333 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.847 ' HB2' HG23 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -107.6 138.87 43.03 Favored 'General case' 0 N--CA 1.461 0.087 0 CA-C-O 120.997 0.427 . . . . 0.0 110.8 179.393 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -122.93 129.13 7.33 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.158 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -81.06 -160.19 23.98 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.497 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -71.84 -19.24 62.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.807 0.336 . . . . 0.0 110.815 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -158.07 18.23 0.33 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.708 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.57 ' CG1' HD22 ' A' ' 100' ' ' LEU . 0.9 OUTLIER -125.03 157.01 33.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-O 120.666 0.269 . . . . 0.0 110.783 -180.0 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.675 ' C ' HD23 ' A' ' 100' ' ' LEU . 11.3 m -118.55 118.79 59.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.801 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -91.67 124.51 7.65 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.615 -0.802 . . . . 0.0 111.487 179.114 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.434 ' CG ' ' HB2' ' A' ' 114' ' ' LEU . 19.2 m-85 -124.25 135.43 53.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.999 0.428 . . . . 0.0 111.912 -178.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.552 ' O ' ' HA3' ' A' ' 122' ' ' GLY . . . -88.84 112.19 22.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.836 178.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -67.55 136.76 55.03 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -178.206 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.797 HG23 ' HA2' ' A' ' 122' ' ' GLY . 67.6 t -89.5 7.57 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.382 178.674 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.432 ' HA ' HD23 ' A' ' 141' ' ' LEU . 30.6 mmm-85 -71.11 -6.66 40.93 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.588 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.43 10.99 38.25 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.62 0.248 . . . . 0.0 111.332 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.807 ' O ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -175.19 53.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.128 0.489 . . . . 0.0 110.6 -179.868 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.889 HD11 ' HB ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -70.61 -14.69 62.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.012 -179.52 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 142' ' ' TRP . . . . . 0.455 ' C ' HD12 ' A' ' 143' ' ' LEU . 15.6 p-90 -54.52 83.62 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.134 0.493 . . . . 0.0 111.358 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.701 HD12 ' C ' ' A' ' 141' ' ' LEU . 5.0 mp -151.52 -44.87 0.11 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.972 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.842 ' OE2' HG13 ' A' ' 12' ' ' VAL . 14.4 pt-20 -155.95 -163.19 1.43 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.662 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.03 145.62 55.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.889 0.376 . . . . 0.0 111.041 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -105.1 154.14 20.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.896 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.608 ' HB3' ' H ' ' A' ' 55' ' ' ARG . . . . . . . . 0 C--N 1.331 -0.207 0 CA-C-O 120.876 0.369 . . . . 0.0 111.043 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.742 ' HB2' HG23 ' A' ' 18' ' ' VAL . . . . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.759 0.314 . . . . 0.0 110.985 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.478 HG13 ' O ' ' A' ' 10' ' ' VAL . 8.4 p -124.61 119.13 55.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.981 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.683 ' CE1' HG21 ' A' ' 45' ' ' THR . 7.3 t80 -98.69 117.09 32.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.69 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.853 HG21 HD11 ' A' ' 53' ' ' ILE . 22.3 t -120.1 130.05 74.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.584 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.445 ' O ' ' CE1' ' A' ' 11' ' ' TYR . . . 46.01 -123.91 7.0 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 121.085 -0.579 . . . . 0.0 113.141 179.554 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.404 ' O ' ' HA ' ' A' ' 44' ' ' THR . 59.3 m-80 -99.27 19.82 14.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.784 0.326 . . . . 0.0 111.002 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.69 ' HB2' HD23 ' A' ' 143' ' ' LEU . 9.2 m-30 -130.22 152.14 49.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.085 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.403 ' HZ3' ' HB3' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -138.59 114.79 10.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.276 179.24 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 1.023 HG12 HG22 ' A' ' 42' ' ' VAL . 0.7 OUTLIER -102.59 122.05 54.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 121.229 0.538 . . . . 0.0 111.388 -179.588 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.742 HG23 ' HB2' ' A' ' 9' ' ' ALA . 7.4 p -136.4 161.03 37.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.626 179.692 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.523 ' N ' HG22 ' A' ' 18' ' ' VAL . 11.4 m-80 -63.53 140.02 58.83 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 179.392 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.1 -38.86 73.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.717 0.294 . . . . 0.0 110.977 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.72 -10.45 58.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.11 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.62 -6.89 13.89 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.724 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.798 ' HB3' ' CZ2' ' A' ' 28' ' ' TRP . . . -80.36 150.68 29.78 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.832 0.348 . . . . 0.0 110.925 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.413 ' O ' ' CE3' ' A' ' 28' ' ' TRP . 43.5 p -103.77 169.17 8.67 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.254 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.537 ' CE1' HG23 ' A' ' 26' ' ' VAL . 0.9 OUTLIER -54.49 -29.56 50.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.917 0.389 . . . . 0.0 110.645 179.87 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.537 HG23 ' CE1' ' A' ' 25' ' ' HIS . 21.5 t -74.28 -31.37 28.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.324 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.445 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 0.5 OUTLIER -67.19 -44.08 80.51 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 179.856 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.798 ' CZ2' ' HB3' ' A' ' 23' ' ' ALA . 7.5 m-90 -73.97 -30.15 62.36 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.884 179.172 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -58.1 -44.15 87.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.439 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -111.69 28.89 8.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.538 179.47 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 13.0 t -80.09 136.14 36.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.162 -179.673 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.504 HG22 ' O ' ' A' ' 42' ' ' VAL . 15.7 m -94.58 -41.61 12.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.753 179.277 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.612 ' CZ3' HG23 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -139.73 153.2 47.15 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.952 0.406 . . . . 0.0 111.503 -179.465 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -164.6 111.87 1.05 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.897 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 35.7 p-10 -107.26 126.54 52.55 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.017 0.437 . . . . 0.0 111.375 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -67.7 -34.56 77.13 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.295 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.436 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 11.7 p30 -59.75 -22.76 62.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.877 0.37 . . . . 0.0 110.601 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.446 ' NE ' ' HA ' ' A' ' 38' ' ' ARG . 3.2 tpm_? -117.39 -3.91 11.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.06 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 48.66 34.68 5.29 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.07 0.462 . . . . 0.0 110.059 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.776 HD13 HD11 ' A' ' 123' ' ' LEU . 41.5 tp -124.85 152.6 43.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.953 -179.181 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.765 HD12 ' NE1' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -143.78 155.92 44.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.472 179.692 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 1.023 HG22 HG12 ' A' ' 17' ' ' VAL . 24.4 t -121.41 130.33 74.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.152 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.0 p -121.93 157.26 31.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.29 179.098 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.645 HG22 ' HE1' ' A' ' 15' ' ' TYR . 17.8 p -97.36 125.11 41.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.166 0.508 . . . . 0.0 111.576 -179.105 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.683 HG21 ' CE1' ' A' ' 11' ' ' TYR . 0.7 OUTLIER -93.39 -31.55 14.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.904 -179.503 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.82 38.07 6.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.893 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -136.78 -175.39 4.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.078 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -71.77 125.85 28.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.895 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.38 173.53 11.24 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.498 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.2 m -142.9 -71.92 0.31 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.847 0.356 . . . . 0.0 110.903 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -67.52 146.67 53.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.007 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.926 ' O ' HG23 ' A' ' 120' ' ' VAL . 62.7 m -120.91 118.97 31.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.579 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.853 HD11 HG21 ' A' ' 12' ' ' VAL . 1.0 OUTLIER -76.56 139.55 18.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.996 -179.84 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.827 ' HB2' ' N ' ' A' ' 119' ' ' GLY . . . -100.81 118.42 36.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.802 179.487 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.554 ' H ' ' HB3' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -90.77 42.65 1.11 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.104 0.478 . . . . 0.0 110.519 179.701 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 15.6 p -99.7 167.16 10.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.835 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.64 39.32 3.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.43 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 28.9 m -72.85 128.06 34.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.759 0.314 . . . . 0.0 110.526 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.54 -13.03 62.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.961 179.601 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.5 p -108.38 159.26 16.8 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.952 0.406 . . . . 0.0 111.09 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -177.18 148.84 9.08 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.675 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.784 HG23 ' C ' ' A' ' 72' ' ' TYR . 7.4 p -105.08 136.47 38.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.997 0.427 . . . . 0.0 111.572 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.632 ' HE2' HG21 ' A' ' 74' ' ' VAL . 5.6 p90 -125.1 142.08 51.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.564 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 8.9 t80 . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.915 -179.871 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.689 ' HB3' HG21 ' A' ' 62' ' ' VAL . 5.5 m170 . . . . . 0 N--CA 1.455 -0.18 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.784 ' C ' HG23 ' A' ' 62' ' ' VAL . 3.1 m-85 -110.28 114.01 55.91 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.659 -178.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 72' ' ' TYR . 4.4 Cg_exo -79.14 120.6 4.61 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.534 2.156 . . . . 0.0 110.712 178.77 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.632 HG21 ' HE2' ' A' ' 63' ' ' TYR . 54.9 t -134.63 141.9 42.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.038 0.446 . . . . 0.0 112.162 -178.718 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.1 p -95.22 126.45 40.55 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.517 ' HB3' ' HB2' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -130.45 167.65 18.26 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.548 0.69 . . . . 0.0 112.358 -178.279 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.621 ' C ' ' HD3' ' A' ' 79' ' ' PRO . 0.9 OUTLIER -111.79 159.14 18.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.799 178.741 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -110.52 65.97 0.24 Allowed Glycine 0 CA--C 1.522 0.501 0 C-N-CA 120.081 -1.057 . . . . 0.0 114.196 -179.005 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.621 ' HD3' ' C ' ' A' ' 77' ' ' GLU . 16.2 Cg_exo -66.92 141.66 59.49 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.113 1.875 . . . . 0.0 111.914 179.301 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -61.59 -94.55 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.777 -0.647 . . . . 0.0 113.089 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.556 HD22 ' HB3' ' A' ' 96' ' ' SER . 0.0 OUTLIER -86.22 119.92 27.02 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.119 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.625 ' HB ' HG11 ' A' ' 98' ' ' VAL . 67.6 t -124.36 122.96 65.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.218 177.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.01 107.68 4.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.042 0.449 . . . . 0.0 110.679 -178.794 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.81 HG13 ' HG2' ' A' ' 126' ' ' MET . 24.4 t -74.88 114.35 14.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.834 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.448 ' HA ' ' HG2' ' A' ' 92' ' ' LYS . 8.5 pt20 -77.02 150.18 35.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.574 179.013 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.592 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 23.0 tt0 -67.54 100.35 0.86 Allowed 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.945 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.523 ' O ' ' N ' ' A' ' 89' ' ' TYR . 43.0 t -145.12 159.8 42.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.674 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.401 ' HB3' ' H ' ' A' ' 89' ' ' TYR . 6.0 tt0 50.96 -82.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.664 178.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.523 ' N ' ' O ' ' A' ' 87' ' ' SER . 2.0 p90 -155.91 25.83 0.38 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.846 0.355 . . . . 0.0 110.594 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.592 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 0.3 OUTLIER -116.67 116.45 38.67 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.574 -179.934 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.461 ' O ' ' N ' ' A' ' 93' ' ' ARG . 37.9 Cg_exo -60.4 148.68 89.65 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.88 2.387 . . . . 0.0 112.729 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.2 OUTLIER -61.95 73.07 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.832 179.55 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.461 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -124.14 179.76 4.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.189 0.518 . . . . 0.0 112.027 -179.314 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.441 ' HB3' HD11 ' A' ' 81' ' ' LEU . 11.1 m-85 -99.28 132.26 44.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.642 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.436 ' HA ' ' O ' ' A' ' 37' ' ' ASN . 1.5 mm100 -131.57 130.6 42.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.713 0.292 . . . . 0.0 111.242 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.556 ' HB3' HD22 ' A' ' 81' ' ' LEU . 11.0 p -102.4 147.88 26.17 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.886 0.374 . . . . 0.0 111.736 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 73.74 56.3 0.1 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.876 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.625 HG11 ' HB ' ' A' ' 82' ' ' VAL . 10.0 p -123.57 143.18 37.59 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.036 179.258 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.446 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 10.7 mp -104.59 143.54 32.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.278 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.711 HD23 ' O ' ' A' ' 132' ' ' VAL . 6.5 mt -133.26 141.5 48.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.041 0.448 . . . . 0.0 112.158 -179.46 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.517 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . . . -150.99 144.86 25.17 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.971 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 1.2 t -100.28 125.32 46.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.914 0.387 . . . . 0.0 111.021 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.28 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.527 -179.749 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.798 ' O ' HG13 ' A' ' 124' ' ' VAL . . . . . . . . 0 N--CA 1.45 -0.376 0 N-CA-C 112.359 -0.297 . . . . 0.0 112.359 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.56 HD13 HG13 ' A' ' 120' ' ' VAL . 2.5 pp -126.04 146.19 32.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.881 0.372 . . . . 0.0 111.192 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.604 ' HG ' ' HB ' ' A' ' 121' ' ' ILE . 7.9 tp -87.61 115.57 25.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.083 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.99 148.3 42.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.222 0.534 . . . . 0.0 111.718 -179.389 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.519 ' HB2' HD11 ' A' ' 121' ' ' ILE . 8.2 t -109.4 164.79 12.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.08 179.438 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.81 -20.41 15.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.807 0.337 . . . . 0.0 110.618 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.506 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . 28.9 m80 -88.9 -36.84 15.72 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.291 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.827 ' N ' ' HB2' ' A' ' 54' ' ' ALA . . . 178.42 -135.3 2.6 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.398 -0.906 . . . . 0.0 113.063 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.926 HG23 ' O ' ' A' ' 52' ' ' THR . 3.9 t -104.38 135.67 41.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.793 0.33 . . . . 0.0 111.402 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.604 ' HB ' ' HG ' ' A' ' 114' ' ' LEU . 1.1 mm -97.86 -67.05 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.774 179.315 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.952 ' HA2' HG23 ' A' ' 137' ' ' VAL . . . -156.96 -168.34 19.42 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.023 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.776 HD11 HD13 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -116.75 164.45 14.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.637 0.256 . . . . 0.0 110.456 179.913 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.798 HG13 ' O ' ' A' ' 112' ' ' GLY . 31.3 m -71.99 137.78 22.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.933 0.397 . . . . 0.0 111.841 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.518 HG23 ' H ' ' A' ' 126' ' ' MET . 0.0 OUTLIER -130.01 -91.23 0.46 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.168 178.98 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.81 ' HG2' HG13 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -85.94 145.63 27.06 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.333 179.255 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -145.81 107.28 0.41 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.596 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -91.18 -167.2 40.99 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.439 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -92.92 17.2 11.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.661 0.267 . . . . 0.0 111.135 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 102' ' ' THR . . . -158.6 -31.09 0.02 OUTLIER Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.94 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.675 ' CG1' HD22 ' A' ' 100' ' ' LEU . 1.7 t -115.39 157.11 16.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.772 0.32 . . . . 0.0 111.108 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.711 ' O ' HD23 ' A' ' 100' ' ' LEU . 15.2 m -115.73 118.26 58.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.383 -179.442 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -96.06 122.02 7.16 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.055 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.585 ' HD2' HD22 ' A' ' 114' ' ' LEU . 15.6 m-85 -125.17 139.47 53.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.976 0.417 . . . . 0.0 111.608 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.441 ' N ' HG22 ' A' ' 125' ' ' THR . . . -88.87 115.08 26.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.364 179.274 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -68.98 140.07 55.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.984 0.421 . . . . 0.0 112.004 -179.174 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.952 HG23 ' HA2' ' A' ' 122' ' ' GLY . 81.2 t -90.46 9.02 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.511 178.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.559 ' HA ' HD23 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -70.1 -6.58 34.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.619 179.922 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -97.08 11.17 37.15 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.859 ' O ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -175.77 49.17 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.231 0.538 . . . . 0.0 110.61 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.738 HD11 ' HB ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -67.41 -14.75 63.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.997 -179.629 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 142' ' ' TRP . . . . . 0.422 ' CE3' ' CE2' ' A' ' 15' ' ' TYR . 16.7 p-90 -57.71 80.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.039 0.447 . . . . 0.0 111.495 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.69 HD23 ' HB2' ' A' ' 15' ' ' TYR . 4.9 mp -142.29 -47.28 0.34 Allowed 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.162 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.682 ' OE2' HG23 ' A' ' 52' ' ' THR . 17.4 pt-20 -154.71 -162.98 1.48 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.669 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.69 122.15 16.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.976 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.661 ' OD1' HD12 ' A' ' 141' ' ' LEU . 86.4 m-20 -85.33 154.21 22.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.935 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.554 ' HB3' ' H ' ' A' ' 55' ' ' ARG . . . . . . . . 0 C--N 1.331 -0.218 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.06 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 112.582 -0.207 . . . . 0.0 112.582 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.15 172.41 14.02 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.581 2.187 . . . . 0.0 112.358 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -161.62 -46.71 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.784 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -67.55 134.67 30.66 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.49 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 19.9 t-80 -109.52 149.52 29.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.816 0.341 . . . . 0.0 110.95 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.75 143.95 8.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.876 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.3 t -103.3 -44.91 5.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.919 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.68 23.19 66.88 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.588 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -165.9 179.15 6.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.812 0.339 . . . . 0.0 110.996 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.459 HG22 HG21 ' A' ' 113' ' ' ILE . 53.7 t -121.02 109.23 24.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.126 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.934 ' CE2' HG21 ' A' ' 45' ' ' THR . 0.4 OUTLIER -93.88 115.83 28.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.423 179.864 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.956 HG21 HD11 ' A' ' 53' ' ' ILE . 19.2 t -121.29 108.89 23.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.786 0.327 . . . . 0.0 111.816 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 48.35 -124.59 11.63 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.94 -0.648 . . . . 0.0 113.242 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.45 ' O ' ' HA ' ' A' ' 44' ' ' THR . 33.0 p-10 -90.96 13.08 17.64 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.655 ' CB ' HD23 ' A' ' 143' ' ' LEU . 6.6 m-85 -130.34 127.8 40.17 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.461 ' HG3' ' CD1' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -116.4 114.89 24.89 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.561 0.219 . . . . 0.0 110.686 179.687 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 1.067 HG12 HG22 ' A' ' 42' ' ' VAL . 0.7 OUTLIER -100.63 122.08 52.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.119 0.485 . . . . 0.0 110.777 179.68 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.526 HG22 ' N ' ' A' ' 19' ' ' ASN . 10.6 p -136.07 161.03 38.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.152 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.526 ' N ' HG22 ' A' ' 18' ' ' VAL . 4.7 t-20 -59.97 141.51 55.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.558 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 11.8 ttt180 -56.59 -47.12 80.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.855 0.36 . . . . 0.0 110.832 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 41.7 t-80 -69.1 -8.79 48.55 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.15 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 13.9 tp -110.78 -10.87 14.43 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.873 ' HB3' ' CZ2' ' A' ' 28' ' ' TRP . . . -73.27 150.61 41.83 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 120.792 0.329 . . . . 0.0 110.814 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.7 p -103.65 169.32 8.59 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.442 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -54.64 -29.78 53.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.886 0.374 . . . . 0.0 110.543 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.5 t -73.93 -31.42 30.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.42 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.421 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 0.2 OUTLIER -67.29 -44.08 80.15 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.898 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.873 ' CZ2' ' HB3' ' A' ' 23' ' ' ALA . 7.1 m-90 -74.29 -31.33 62.46 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.226 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 9.5 mm-40 -58.22 -43.8 87.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.452 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -113.46 33.39 5.16 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.404 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.476 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 27.2 t -80.05 134.11 36.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.279 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 42' ' ' VAL . 15.3 m -97.28 -39.86 9.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.617 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.612 ' HH2' HD23 ' A' ' 40' ' ' LEU . 1.2 t90 -139.36 153.11 47.62 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.856 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 2.0 tm-20 -160.34 118.15 2.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.959 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -107.1 111.05 23.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.973 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.402 ' CE2' ' OD1' ' A' ' 37' ' ' ASN . 50.5 p90 -59.63 -47.23 86.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.242 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.425 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 2.1 m120 -60.02 -25.94 65.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.793 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.411 ' CZ ' ' HB3' ' A' ' 139' ' ' ASP . 20.7 ttm180 -100.07 -7.7 24.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.302 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 51.06 34.83 11.56 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 121.145 0.497 . . . . 0.0 110.258 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.872 HD11 HG23 ' A' ' 17' ' ' VAL . 13.5 tp -133.71 149.68 51.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.974 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.667 ' O ' HD23 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -145.0 155.88 43.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.361 179.572 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 1.067 HG22 HG12 ' A' ' 17' ' ' VAL . 38.9 t -118.5 127.37 75.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.626 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.5 p -120.81 157.46 29.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.345 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.633 HG22 ' CE1' ' A' ' 15' ' ' TYR . 10.5 p -97.57 146.59 25.13 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.165 0.507 . . . . 0.0 111.66 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.934 HG21 ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -136.29 165.49 25.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.853 -179.25 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.1 t -93.29 -34.1 13.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.082 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.79 128.6 34.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.1 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -59.09 147.98 32.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.926 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -80.23 177.69 54.21 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.584 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -132.12 33.5 3.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.761 0.315 . . . . 0.0 110.905 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -138.45 144.49 40.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.911 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.85 ' O ' HG23 ' A' ' 120' ' ' VAL . 63.0 m -120.83 115.91 24.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.793 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.956 HD11 HG21 ' A' ' 12' ' ' VAL . 0.4 OUTLIER -73.86 139.54 19.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.018 -179.872 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.835 ' HB2' ' N ' ' A' ' 119' ' ' GLY . . . -93.38 133.53 36.54 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.402 ' HA ' ' HD2' ' A' ' 138' ' ' ARG . 0.0 OUTLIER -93.54 27.11 2.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.991 0.424 . . . . 0.0 110.402 179.275 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 30.8 p -100.01 167.13 10.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.029 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -127.72 32.42 4.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.89 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 25.2 m -56.61 132.63 52.3 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.791 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.5 t -74.15 -8.61 56.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.969 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.1 p -118.46 130.77 56.14 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.891 0.377 . . . . 0.0 111.073 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -153.33 -167.94 16.45 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.84 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.468 HG23 ' C ' ' A' ' 72' ' ' TYR . 7.5 p -133.75 126.24 50.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.007 0.432 . . . . 0.0 110.885 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.669 ' HE2' HG21 ' A' ' 74' ' ' VAL . 3.1 p90 -111.14 153.91 25.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.102 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -93.14 143.87 25.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.647 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 7.6 t -120.99 137.69 54.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.049 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.82 -45.07 53.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.016 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.7 -50.11 68.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.822 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.1 mmpt? -74.6 -27.52 60.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.882 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 59.57 21.06 9.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.954 0.407 . . . . 0.0 110.859 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.92 170.04 16.2 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.622 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -84.1 139.31 32.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.9 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.468 ' C ' HG23 ' A' ' 62' ' ' VAL . 0.7 OUTLIER -126.47 114.03 23.15 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.661 -178.834 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 72' ' ' TYR . 4.4 Cg_exo -74.54 120.54 6.24 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.356 2.037 . . . . 0.0 110.255 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.697 ' CG1' ' HB1' ' A' ' 101' ' ' ALA . 97.1 t -144.3 147.42 19.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.048 0.452 . . . . 0.0 112.167 -178.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 53.6 p -92.02 137.19 32.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.295 178.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.741 ' HD2' ' HB2' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -146.48 168.43 21.22 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.22 0.534 . . . . 0.0 111.942 -178.882 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -113.0 158.39 20.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.05 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -106.03 68.17 0.24 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.917 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.551 ' HD2' ' HA ' ' A' ' 99' ' ' LEU . 38.0 Cg_endo -67.6 135.16 35.14 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.471 2.114 . . . . 0.0 112.227 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -59.27 -82.8 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.288 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.794 HD11 ' HB3' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -97.08 119.86 36.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.898 0.38 . . . . 0.0 111.749 -179.897 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.627 ' HB ' HG11 ' A' ' 98' ' ' VAL . 46.8 t -124.99 122.18 62.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.217 178.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.13 107.98 5.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.776 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.579 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 19.3 m -81.79 126.85 39.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.236 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.84 150.65 46.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.06 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.555 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 3.9 pt-20 -67.73 102.54 1.23 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.87 0.367 . . . . 0.0 110.431 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.428 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -143.89 164.1 31.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.425 -179.732 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.422 ' HG2' ' CE2' ' A' ' 89' ' ' TYR . 2.8 tt0 56.95 -81.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.543 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.428 ' N ' ' O ' ' A' ' 87' ' ' SER . 0.4 OUTLIER -155.64 22.93 0.4 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.926 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.555 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 9.7 t80 -123.79 136.8 27.78 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.883 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.446 ' O ' ' N ' ' A' ' 93' ' ' ARG . 86.4 Cg_endo -81.76 148.95 15.97 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.09 2.527 . . . . 0.0 112.451 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.579 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -49.2 89.52 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.804 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.572 ' O ' HG22 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -124.13 169.64 11.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.259 0.552 . . . . 0.0 112.209 -179.126 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.794 ' HB3' HD11 ' A' ' 81' ' ' LEU . 2.9 m-85 -90.86 132.46 35.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.928 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.561 ' O ' HD13 ' A' ' 81' ' ' LEU . 0.5 OUTLIER -124.5 131.87 53.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.054 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 12.0 p -101.31 147.52 26.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.998 0.428 . . . . 0.0 111.835 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.492 ' CD2' ' HB3' ' A' ' 136' ' ' ASP . 4.2 t60 63.85 55.98 1.55 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.946 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.627 HG11 ' HB ' ' A' ' 82' ' ' VAL . 11.6 p -123.44 135.86 61.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.872 0.368 . . . . 0.0 111.364 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.771 HD11 ' HB2' ' A' ' 136' ' ' ASP . 1.8 mp -104.3 133.42 49.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.161 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.823 ' HA ' ' O ' ' A' ' 132' ' ' VAL . 7.4 mt -116.53 138.54 51.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.18 0.514 . . . . 0.0 112.311 -179.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.741 ' HB2' ' HD2' ' A' ' 76' ' ' PHE . . . -128.47 119.28 24.6 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.565 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 1.7 t -87.37 111.83 21.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.886 0.374 . . . . 0.0 110.648 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -71.74 -165.24 7.13 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.541 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -123.89 29.89 6.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.889 0.376 . . . . 0.0 110.817 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.9 m -159.24 -177.24 6.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.799 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.506 ' HB2' ' HD3' ' A' ' 107' ' ' PRO . 2.0 mt-10 -83.17 -45.18 0.85 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.356 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.506 ' HD3' ' HB2' ' A' ' 106' ' ' GLU . 32.6 Cg_exo -59.4 174.42 1.08 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.326 2.017 . . . . 0.0 112.163 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.67 86.8 1.94 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.61 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -118.39 -63.69 1.38 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.797 0.332 . . . . 0.0 110.809 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -123.59 179.88 4.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.983 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -178.47 -103.94 0.18 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.57 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -143.53 -106.59 0.56 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.671 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.525 HD13 HG13 ' A' ' 120' ' ' VAL . 2.6 pp -126.0 146.18 32.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.922 0.391 . . . . 0.0 111.415 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.728 HD21 ' CZ ' ' A' ' 76' ' ' PHE . 56.2 tp -87.82 115.84 25.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.73 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 18.6 ptt-85 -118.74 143.95 46.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.076 0.465 . . . . 0.0 112.111 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.974 ' HB2' HD11 ' A' ' 121' ' ' ILE . 35.4 t -108.14 166.15 10.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.264 178.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -55.51 -18.13 6.67 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.657 0.265 . . . . 0.0 110.867 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 53.7 m80 -91.33 -36.86 13.6 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.47 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.835 ' N ' ' HB2' ' A' ' 54' ' ' ALA . . . 176.81 -140.82 5.14 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.201 -1.0 . . . . 0.0 113.57 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.85 HG23 ' O ' ' A' ' 52' ' ' THR . 3.6 t -100.72 135.87 34.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 122.536 0.335 . . . . 0.0 111.628 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.974 HD11 ' HB2' ' A' ' 116' ' ' CYS . 3.4 mp -98.94 -64.6 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.517 178.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.661 ' HA2' HG23 ' A' ' 137' ' ' VAL . . . -164.7 -167.02 24.61 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.196 -1.002 . . . . 0.0 113.239 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.685 HD21 HD13 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -117.0 164.15 15.15 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.92 0.39 . . . . 0.0 110.892 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.597 ' O ' HG13 ' A' ' 124' ' ' VAL . 10.3 p -60.35 109.23 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.936 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.81 ' OG1' ' HB2' ' A' ' 135' ' ' ALA . 2.0 m -91.34 -88.6 0.18 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.661 ' N ' HG22 ' A' ' 125' ' ' THR . 0.0 OUTLIER -128.56 162.1 28.04 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.941 0.4 . . . . 0.0 111.205 179.375 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -131.41 157.82 22.48 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.645 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -114.36 -153.89 10.86 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.411 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -71.96 -19.25 61.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.733 0.301 . . . . 0.0 110.998 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -168.71 28.4 0.15 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.547 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.565 ' HB ' HD22 ' A' ' 100' ' ' LEU . 1.4 t -130.03 157.05 42.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.716 0.294 . . . . 0.0 110.874 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.823 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 2.0 t -112.97 118.01 56.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.199 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' ' 126' ' ' MET . . . -99.12 123.7 7.99 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.61 -0.805 . . . . 0.0 111.871 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.515 ' CD2' HD22 ' A' ' 114' ' ' LEU . 52.6 m-85 -125.12 139.29 53.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.95 0.405 . . . . 0.0 111.727 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.81 ' HB2' ' OG1' ' A' ' 125' ' ' THR . . . -88.88 108.13 19.37 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.694 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.771 ' HB2' HD11 ' A' ' 99' ' ' LEU . 1.0 OUTLIER -67.55 143.36 56.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.472 0.653 . . . . 0.0 112.549 -178.095 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.661 HG23 ' HA2' ' A' ' 122' ' ' GLY . 19.3 t -102.24 7.17 9.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.149 178.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.403 ' HB3' ' CZ ' ' A' ' 138' ' ' ARG . 2.1 mmm180 -72.48 -6.29 42.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.435 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.462 ' HB2' ' CD2' ' A' ' 97' ' ' HIS . 4.4 t70 -97.72 -1.99 42.26 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.721 0.296 . . . . 0.0 111.363 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.831 ' O ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -156.1 64.71 0.57 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.464 0.65 . . . . 0.0 109.732 179.548 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.952 HD11 ' HB ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -77.64 -14.48 59.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.267 -0.879 . . . . 0.0 112.458 -178.906 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 142' ' ' TRP . . . . . 0.531 ' C ' HD12 ' A' ' 143' ' ' LEU . 14.4 p-90 -53.7 80.19 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.006 0.431 . . . . 0.0 111.216 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.681 HD12 ' C ' ' A' ' 141' ' ' LEU . 4.9 mp -153.36 -48.19 0.09 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.956 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.527 ' HG3' HG12 ' A' ' 12' ' ' VAL . 5.4 mt-10 -156.56 -171.14 3.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.462 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.85 144.24 45.01 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.913 0.387 . . . . 0.0 111.034 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -104.9 154.19 20.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.927 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.649 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . . . -89.13 136.65 32.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.186 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.31 177.57 4.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.948 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -106.37 -32.28 8.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.942 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.838 -179.995 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.213 0 N-CA-C 112.494 -0.243 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -51.97 169.16 0.29 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.582 2.188 . . . . 0.0 112.308 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -95.11 -43.78 7.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.918 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.57 -82.77 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.56 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 24.7 m-70 -100.12 -51.88 3.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.812 0.339 . . . . 0.0 110.944 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.07 111.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.805 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 63.87 131.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.887 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -157.26 37.78 0.55 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.562 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.882 ' HB2' HG23 ' A' ' 18' ' ' VAL . . . -103.66 -174.04 2.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.745 0.307 . . . . 0.0 111.07 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.798 ' HB ' HG21 ' A' ' 113' ' ' ILE . 9.6 p -131.24 113.19 23.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.88 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.544 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 7.9 p90 -112.02 134.43 53.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.979 0.418 . . . . 0.0 111.157 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.581 ' HB ' HD22 ' A' ' 143' ' ' LEU . 93.1 t -119.19 128.25 75.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.439 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 49.54 -126.51 20.51 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 121.142 -0.551 . . . . 0.0 113.175 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.458 ' O ' ' HA ' ' A' ' 44' ' ' THR . 21.1 m-20 -89.56 14.72 10.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.624 0.249 . . . . 0.0 111.453 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.627 ' CE1' HG22 ' A' ' 44' ' ' THR . 7.2 m-85 -128.91 141.44 51.27 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.544 ' HA ' ' HA ' ' A' ' 11' ' ' TYR . 9.3 tttt -127.21 114.82 18.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.651 -0.25 . . . . 0.0 110.748 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 1.023 HG12 HG22 ' A' ' 42' ' ' VAL . 0.6 OUTLIER -102.36 121.74 53.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-O 121.202 0.525 . . . . 0.0 110.749 179.709 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.882 HG23 ' HB2' ' A' ' 9' ' ' ALA . 13.6 p -136.35 160.52 37.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.995 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.502 ' N ' HG22 ' A' ' 18' ' ' VAL . 7.0 t-20 -60.56 141.62 56.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.334 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.43 -47.35 79.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.811 0.339 . . . . 0.0 110.718 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.91 -9.04 53.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.909 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.419 ' HB3' HG22 ' A' ' 18' ' ' VAL . 13.9 tp -109.61 -11.48 14.76 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.652 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.945 ' HB3' ' CZ2' ' A' ' 28' ' ' TRP . . . -70.85 150.67 45.56 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 120.805 0.336 . . . . 0.0 110.826 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 58.6 p -104.67 169.2 8.59 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.329 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -54.72 -29.69 54.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.033 0.444 . . . . 0.0 110.576 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 23.9 t -74.66 -31.34 26.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.4 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.421 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 0.3 OUTLIER -67.16 -44.12 80.53 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.984 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.945 ' CZ2' ' HB3' ' A' ' 23' ' ' ALA . 7.2 m-90 -74.54 -30.78 61.89 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.217 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.4 mm100 -58.42 -44.14 88.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.509 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -114.21 34.78 4.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.519 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.47 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 36.9 t -80.1 134.56 36.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.404 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.472 HG22 ' O ' ' A' ' 42' ' ' VAL . 12.5 m -98.96 -39.38 7.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.522 179.252 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.682 ' CH2' HD23 ' A' ' 40' ' ' LEU . 1.9 t90 -139.39 152.91 47.49 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.989 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -160.86 120.39 2.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.975 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.407 ' HB2' ' CZ2' ' A' ' 33' ' ' TRP . 11.0 m-20 -107.04 111.99 24.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.007 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -61.27 -43.58 98.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.964 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.417 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 4.3 m-20 -65.73 -23.56 66.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.771 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.446 ' CZ ' ' HA ' ' A' ' 38' ' ' ARG . 3.4 tpm_? -105.55 -2.02 24.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.34 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 44.27 37.26 1.87 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.947 0.403 . . . . 0.0 110.818 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.846 HD11 HG23 ' A' ' 17' ' ' VAL . 7.0 tp -133.75 141.72 47.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.694 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.665 ' O ' HD23 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -139.2 155.84 47.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.913 0.387 . . . . 0.0 111.759 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 1.023 HG22 HG12 ' A' ' 17' ' ' VAL . 25.3 t -118.72 129.89 74.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.568 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.8 p -121.84 157.16 31.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.306 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.627 HG22 ' CE1' ' A' ' 15' ' ' TYR . 8.3 p -97.68 124.35 41.96 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.177 0.513 . . . . 0.0 111.628 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -113.65 162.99 15.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.78 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -108.69 37.45 2.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.885 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -126.73 169.42 13.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.044 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 10.4 m80 -83.74 141.12 31.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.861 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.431 ' HA2' ' CE2' ' A' ' 11' ' ' TYR . . . -91.04 152.0 21.44 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.558 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.43 -46.81 2.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.833 0.349 . . . . 0.0 110.909 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.579 ' OD2' HG23 ' A' ' 10' ' ' VAL . 2.8 m-20 -59.82 135.89 57.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.918 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.856 ' O ' HG23 ' A' ' 120' ' ' VAL . 33.2 m -117.27 116.0 26.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.824 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.974 ' HB ' HD11 ' A' ' 141' ' ' LEU . 0.2 OUTLIER -82.5 139.38 17.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.761 179.994 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -95.51 130.51 42.32 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.839 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.515 ' H ' ' HB3' ' A' ' 147' ' ' ALA . 2.7 ttt180 -93.31 42.5 1.1 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 178.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 8.2 p -99.86 167.31 10.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.955 -1.02 . . . . 0.0 111.501 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -117.66 25.54 10.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.073 178.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 14.8 p -66.51 145.38 55.7 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.061 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.0 m -103.04 13.18 34.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.216 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 56.0 p -132.91 125.32 29.63 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.855 0.359 . . . . 0.0 110.996 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -150.99 165.71 30.29 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.388 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.852 HG23 ' C ' ' A' ' 72' ' ' TYR . 10.6 p -104.51 134.83 44.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.933 0.397 . . . . 0.0 111.338 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.694 ' HE2' HG21 ' A' ' 74' ' ' VAL . 4.9 p90 -110.97 160.44 16.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.843 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -85.11 129.36 34.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.026 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -103.91 141.77 35.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.862 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.634 ' HB2' ' O ' ' A' ' 110' ' ' ALA . . . -92.0 -45.05 8.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.087 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 58.7 m -70.71 -30.7 67.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.923 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.419 ' HG3' ' CE1' ' A' ' 72' ' ' TYR . 0.3 OUTLIER -94.22 -25.67 16.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.101 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.8 t 59.92 23.9 12.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.896 0.379 . . . . 0.0 110.748 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.4 mtpp -134.82 170.21 16.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.731 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.527 ' HB3' HG21 ' A' ' 62' ' ' VAL . 0.0 OUTLIER -84.26 125.21 32.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.925 179.528 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.852 ' C ' HG23 ' A' ' 62' ' ' VAL . 0.6 OUTLIER -111.41 114.39 52.98 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.435 -178.921 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 72' ' ' TYR . 3.4 Cg_exo -74.77 120.66 6.23 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.235 1.956 . . . . 0.0 110.422 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.694 HG21 ' HE2' ' A' ' 63' ' ' TYR . 90.6 t -142.56 144.99 23.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.107 0.479 . . . . 0.0 112.226 -178.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.66 135.78 33.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.39 178.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.802 ' CZ ' HD21 ' A' ' 114' ' ' LEU . 0.1 OUTLIER -141.46 169.66 17.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.226 0.536 . . . . 0.0 111.811 -178.879 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.403 ' O ' ' HD2' ' A' ' 79' ' ' PRO . 11.3 mm-40 -111.85 158.3 19.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.068 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -105.79 68.34 0.25 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.542 -0.837 . . . . 0.0 113.095 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.502 ' HD2' ' HA ' ' A' ' 99' ' ' LEU . 37.6 Cg_endo -67.52 135.44 36.25 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.391 2.06 . . . . 0.0 112.231 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -59.66 -90.82 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.195 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.722 HD11 ' HB3' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -88.32 119.56 28.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.853 0.359 . . . . 0.0 111.497 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.626 ' HB ' HG11 ' A' ' 98' ' ' VAL . 40.1 t -126.99 122.46 60.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.075 178.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -72.54 107.55 5.12 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.934 0.397 . . . . 0.0 110.55 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.579 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 18.3 m -75.24 123.88 31.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.732 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -69.4 150.38 47.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.027 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.547 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 0.6 OUTLIER -67.69 102.67 1.24 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.006 0.432 . . . . 0.0 110.458 -179.474 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.453 ' O ' ' N ' ' A' ' 89' ' ' TYR . 3.5 m -143.87 161.64 38.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.519 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 57.41 -79.14 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.534 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.453 ' N ' ' O ' ' A' ' 87' ' ' SER . 1.3 p90 -159.59 25.38 0.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.699 0.285 . . . . 0.0 110.942 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.547 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 3.6 t80 -124.73 126.09 25.4 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.831 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -69.68 148.77 66.32 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.113 2.542 . . . . 0.0 112.446 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.579 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 1.7 ttpp -53.14 92.26 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.853 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.443 ' O ' HG22 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -123.82 176.55 6.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.184 0.516 . . . . 0.0 112.085 -179.338 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.722 ' HB3' HD11 ' A' ' 81' ' ' LEU . 4.9 m-85 -98.28 132.32 43.86 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.163 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.495 ' O ' HD13 ' A' ' 81' ' ' LEU . 4.4 mt-30 -131.23 132.95 45.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.678 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.483 ' CB ' HD22 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -102.65 142.91 33.03 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.014 0.435 . . . . 0.0 112.06 -179.334 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.44 ' CE1' ' HB3' ' A' ' 139' ' ' ASP . 0.1 OUTLIER 75.76 55.53 0.06 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.064 179.1 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.626 HG11 ' HB ' ' A' ' 82' ' ' VAL . 12.4 p -123.4 139.45 50.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.962 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.502 ' HA ' ' HD2' ' A' ' 79' ' ' PRO . 4.4 mp -105.09 134.0 48.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.168 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.798 ' HA ' ' O ' ' A' ' 132' ' ' VAL . 6.8 mt -117.61 138.64 51.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.131 0.491 . . . . 0.0 112.192 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.722 ' O ' HG23 ' A' ' 132' ' ' VAL . . . -130.02 119.46 23.17 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.597 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 1.7 t -86.02 111.69 20.53 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.849 0.356 . . . . 0.0 110.727 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -85.16 -94.12 0.76 Allowed Glycine 0 C--N 1.331 0.255 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.45 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -156.32 -46.02 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.883 0.373 . . . . 0.0 110.841 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 16.3 t -171.63 80.79 0.07 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.89 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -120.21 89.52 43.38 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.925 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -51.7 -59.79 1.0 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.55 2.167 . . . . 0.0 112.27 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -96.61 -173.0 35.0 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.488 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -156.92 90.75 1.16 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.822 0.344 . . . . 0.0 110.842 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.634 ' O ' ' HB2' ' A' ' 66' ' ' ALA . . . -122.3 64.98 0.94 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.097 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -100.8 -102.61 2.55 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.554 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -178.58 -93.0 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.56 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.798 HG21 ' HB ' ' A' ' 10' ' ' VAL . 31.2 pt -125.99 146.22 32.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.711 0.291 . . . . 0.0 111.074 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.802 HD21 ' CZ ' ' A' ' 76' ' ' PHE . 41.6 tp -87.71 113.02 23.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.65 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.423 ' O ' HG12 ' A' ' 62' ' ' VAL . 25.9 mtm180 -119.56 146.88 45.1 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.474 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.9 ' SG ' HD11 ' A' ' 121' ' ' ILE . 27.2 p -118.99 177.42 4.87 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -56.77 -18.75 13.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.681 0.276 . . . . 0.0 111.251 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -93.3 -32.58 14.26 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 165.64 -133.58 3.01 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.176 -1.011 . . . . 0.0 113.643 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.856 HG23 ' O ' ' A' ' 52' ' ' THR . 20.0 t -107.78 135.67 45.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.774 0.321 . . . . 0.0 111.609 -179.283 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.9 HD11 ' SG ' ' A' ' 116' ' ' CYS . 2.5 mp -105.26 -52.83 7.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.155 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.679 ' HA2' HG23 ' A' ' 137' ' ' VAL . . . -161.06 -167.08 21.02 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 119.94 -1.124 . . . . 0.0 113.496 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.616 HD11 HD13 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -124.39 164.18 20.21 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.841 0.353 . . . . 0.0 111.021 -179.867 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.401 ' HA ' ' CD1' ' A' ' 134' ' ' PHE . 3.5 m -57.06 114.12 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.802 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.77 ' OG1' ' HB2' ' A' ' 135' ' ' ALA . 2.3 m -105.27 -88.95 0.43 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.01 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.625 ' N ' HG22 ' A' ' 125' ' ' THR . 1.5 tpt -132.28 162.1 31.84 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.247 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -133.23 161.43 24.17 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.513 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -119.26 -154.61 9.59 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.527 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -72.04 -19.08 61.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.691 0.282 . . . . 0.0 110.963 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -168.27 29.71 0.16 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.545 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.534 ' CG1' HD22 ' A' ' 100' ' ' LEU . 1.3 t -132.21 157.1 43.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.785 0.326 . . . . 0.0 111.001 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.798 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 1.8 t -113.72 117.98 56.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.903 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.41 ' HA3' ' O ' ' A' ' 126' ' ' MET . . . -102.07 122.33 7.51 Favored Glycine 0 CA--C 1.516 0.14 0 C-N-CA 120.525 -0.845 . . . . 0.0 111.84 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.489 ' CE2' ' CG1' ' A' ' 132' ' ' VAL . 48.9 m-85 -124.99 144.0 50.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.992 0.425 . . . . 0.0 111.742 -179.163 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.77 ' HB2' ' OG1' ' A' ' 125' ' ' THR . . . -88.9 114.22 25.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.739 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.435 ' HB2' HD11 ' A' ' 99' ' ' LEU . 7.9 t0 -67.53 137.6 55.88 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -178.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.679 HG23 ' HA2' ' A' ' 122' ' ' GLY . 69.2 t -99.42 3.67 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.943 178.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.497 ' HA ' HD23 ' A' ' 141' ' ' LEU . 0.5 OUTLIER -72.57 -6.27 42.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.43 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.44 ' HB3' ' CE1' ' A' ' 97' ' ' HIS . 1.4 p30 -95.32 3.35 54.54 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.708 0.29 . . . . 0.0 111.345 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.829 ' O ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -162.11 51.8 0.21 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.294 0.569 . . . . 0.0 110.119 179.669 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.974 HD11 ' HB ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -68.59 -14.63 63.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.149 -179.44 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 142' ' ' TRP . . . . . 0.459 ' C ' HD12 ' A' ' 143' ' ' LEU . 13.2 p-90 -53.86 81.92 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.17 0.51 . . . . 0.0 111.379 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.696 HD12 ' C ' ' A' ' 141' ' ' LEU . 5.0 mp -150.95 -44.84 0.12 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.834 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.534 ' HB2' ' CG1' ' A' ' 12' ' ' VAL . 1.1 tp10 -146.59 -159.23 0.99 Allowed 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.417 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -77.86 149.04 34.38 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.837 0.351 . . . . 0.0 110.988 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -84.84 154.2 22.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.936 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.515 ' HB3' ' H ' ' A' ' 55' ' ' ARG . . . -91.39 136.45 33.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.066 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.49 -175.81 0.2 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.895 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -112.9 147.03 37.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.913 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.182 -0.913 . . . . 0.0 110.909 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.207 0 N-CA-C 112.438 -0.265 . . . . 0.0 112.438 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.23 91.1 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.653 2.235 . . . . 0.0 112.408 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 60.82 174.82 0.1 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.948 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 72.55 -148.18 41.6 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.543 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -146.33 128.69 15.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.864 0.364 . . . . 0.0 110.871 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -74.82 70.57 1.93 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.741 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.3 m -114.55 113.22 24.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.927 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 166.76 -51.63 0.25 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.327 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.648 ' HB2' HG23 ' A' ' 18' ' ' VAL . . . -127.99 163.89 23.53 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.697 0.284 . . . . 0.0 110.937 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.683 ' HB ' HG21 ' A' ' 113' ' ' ILE . 9.0 p -127.59 107.32 16.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.032 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.6 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 6.0 p90 -104.43 129.42 52.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.951 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.896 HG21 HD11 ' A' ' 53' ' ' ILE . 31.2 t -119.28 133.21 66.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.773 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 49.84 -128.39 25.24 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 121.068 -0.586 . . . . 0.0 112.966 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.432 ' O ' ' HA ' ' A' ' 44' ' ' THR . 36.5 m120 -91.35 17.13 8.82 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.673 0.273 . . . . 0.0 111.176 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.683 ' HB2' HD23 ' A' ' 143' ' ' LEU . 9.7 m-85 -129.94 148.45 51.81 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.241 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.6 ' HA ' ' HA ' ' A' ' 11' ' ' TYR . 37.3 tttt -132.26 114.68 14.72 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.696 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.958 HG12 HG22 ' A' ' 42' ' ' VAL . 0.9 OUTLIER -101.94 121.42 52.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-O 121.209 0.528 . . . . 0.0 110.74 179.72 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.658 ' O ' HD12 ' A' ' 40' ' ' LEU . 13.0 p -136.94 161.42 35.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.428 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.51 ' N ' HG22 ' A' ' 18' ' ' VAL . 5.0 m-20 -60.55 141.79 56.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.152 178.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.439 ' HG3' ' N ' ' A' ' 21' ' ' HIS . 7.8 ptm180 -56.34 -46.99 79.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.803 0.335 . . . . 0.0 111.378 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.439 ' N ' ' HG3' ' A' ' 20' ' ' ARG . 7.8 t-80 -69.66 -6.45 31.59 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.331 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -115.14 -1.39 13.01 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.68 ' HB3' ' NE1' ' A' ' 28' ' ' TRP . . . -87.29 126.75 35.03 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.238 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.545 ' O ' ' HD1' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -74.79 164.37 26.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.682 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -53.78 -29.71 41.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.332 -179.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.544 HG12 HG23 ' A' ' 24' ' ' THR . 13.8 p -71.86 -31.37 40.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.971 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.95 -44.06 77.64 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.035 0.445 . . . . 0.0 109.828 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.68 ' NE1' ' HB3' ' A' ' 23' ' ' ALA . 39.7 m95 -73.99 -33.44 63.84 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.623 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 13.2 tp60 -56.66 -44.0 80.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.644 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -111.56 30.01 7.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.423 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.437 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 10.8 t -77.3 131.88 38.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.092 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.506 HG22 ' O ' ' A' ' 42' ' ' VAL . 13.1 m -94.04 -39.76 10.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.979 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.608 ' HH2' HD23 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -139.7 153.41 47.23 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.976 0.417 . . . . 0.0 111.8 -179.216 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -158.52 120.52 3.58 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.576 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.425 ' HB2' ' CZ2' ' A' ' 33' ' ' TRP . 14.2 m-20 -106.99 116.92 32.77 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.484 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -66.39 -29.99 70.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.954 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.484 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 26.1 p30 -66.56 -25.89 66.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.057 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 18.0 mtm180 -117.44 -0.97 11.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.459 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 51.22 37.86 19.63 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.898 0.38 . . . . 0.0 110.572 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.861 HD11 HG23 ' A' ' 17' ' ' VAL . 18.4 tp -125.39 152.36 44.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.928 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.64 ' O ' HD23 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -143.93 156.07 44.3 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.944 0.402 . . . . 0.0 111.667 179.627 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.958 HG22 HG12 ' A' ' 17' ' ' VAL . 22.6 t -120.21 129.95 74.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.636 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.9 p -120.49 157.3 29.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.119 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.644 HG22 ' CE1' ' A' ' 15' ' ' TYR . 10.1 p -97.45 123.29 41.24 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.163 0.506 . . . . 0.0 111.596 -179.001 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -117.33 140.17 49.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.882 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.1 p -95.14 45.97 1.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.98 0.419 . . . . 0.0 110.907 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.94 177.17 5.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.022 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -87.94 121.6 30.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.928 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.435 ' HA2' ' CE2' ' A' ' 11' ' ' TYR . . . -64.44 175.75 11.42 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.441 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 m -154.1 -46.15 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.862 0.363 . . . . 0.0 110.94 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -73.34 143.78 46.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.058 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.923 ' O ' HG23 ' A' ' 120' ' ' VAL . 55.1 m -120.45 119.64 33.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.193 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.896 HD11 HG21 ' A' ' 12' ' ' VAL . 2.9 mm -72.5 139.36 19.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.089 0.471 . . . . 0.0 111.063 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.744 ' O ' ' HB3' ' A' ' 147' ' ' ALA . . . -75.36 -47.89 25.56 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.513 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.417 ' CB ' ' HB2' ' A' ' 146' ' ' ASP . 0.0 OUTLIER 67.93 13.54 9.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.825 -179.34 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.519 ' SG ' ' HB1' ' A' ' 54' ' ' ALA . 23.9 p -99.78 166.92 10.86 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.665 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -121.76 39.28 3.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.124 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 59.5 m -62.7 156.81 22.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.706 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.3 -19.87 20.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.964 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.3 p -116.34 123.91 48.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.946 0.403 . . . . 0.0 111.123 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -140.71 -164.02 9.74 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 121.028 -0.606 . . . . 0.0 111.89 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.654 HG23 ' C ' ' A' ' 72' ' ' TYR . 3.6 p -140.41 130.74 28.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 121.167 0.508 . . . . 0.0 111.815 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.664 ' CD1' ' HB3' ' A' ' 66' ' ' ALA . 24.4 p90 -109.28 126.27 53.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.772 178.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.408 ' HB3' ' CG ' ' A' ' 71' ' ' HIS . 55.6 p90 -115.55 149.77 37.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.993 0.425 . . . . 0.0 111.578 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 40.6 m 61.07 22.76 13.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.642 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.664 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . . . -92.07 -45.13 8.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.86 0.362 . . . . 0.0 110.971 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.41 -39.31 3.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.663 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.447 ' HB3' ' HD3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -125.08 -169.06 1.92 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.522 179.834 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.1 p -97.63 33.49 2.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.015 0.436 . . . . 0.0 110.458 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.447 ' HD3' ' HB3' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -144.2 170.93 15.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.668 -179.389 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.408 ' CG ' ' HB3' ' A' ' 64' ' ' PHE . 0.3 OUTLIER -83.85 139.03 32.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.756 179.516 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.654 ' C ' HG23 ' A' ' 62' ' ' VAL . 3.9 m-85 -124.91 114.29 26.62 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.615 -178.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 72' ' ' TYR . 4.7 Cg_exo -74.21 120.78 6.45 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.354 2.036 . . . . 0.0 111.043 178.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.443 ' CG1' ' CE2' ' A' ' 76' ' ' PHE . 2.3 p -139.78 158.8 27.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.034 0.445 . . . . 0.0 111.923 -179.101 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.9 m -102.04 123.91 46.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.424 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.696 ' CZ ' HD11 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -125.11 161.78 26.05 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.41 0.624 . . . . 0.0 111.771 -179.259 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.442 ' O ' ' HD2' ' A' ' 79' ' ' PRO . 4.6 mt-10 -111.79 158.77 18.98 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.349 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -104.76 67.22 0.28 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.412 -0.899 . . . . 0.0 113.187 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.442 ' HD2' ' O ' ' A' ' 77' ' ' GLU . 41.7 Cg_endo -67.72 135.47 35.81 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.375 2.05 . . . . 0.0 112.07 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -60.84 -86.77 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.682 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.664 HD22 ' HB3' ' A' ' 96' ' ' SER . 0.0 OUTLIER -94.62 119.85 33.93 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -179.365 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.607 ' HB ' HG11 ' A' ' 98' ' ' VAL . 80.0 t -124.63 123.28 65.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.344 178.376 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.436 ' HG3' ' CZ ' ' A' ' 94' ' ' TYR . 0.1 OUTLIER -72.14 107.86 5.03 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.019 0.438 . . . . 0.0 111.037 -178.826 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.91 HG23 ' HG2' ' A' ' 126' ' ' MET . 2.2 p -73.31 114.41 12.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.486 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -76.27 150.23 37.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.56 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.693 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 28.0 tt0 -68.0 101.04 1.05 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.122 0.487 . . . . 0.0 110.505 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.43 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.5 OUTLIER -144.7 143.01 30.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.875 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 59.25 -80.21 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.423 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.43 ' N ' ' O ' ' A' ' 87' ' ' SER . 0.8 OUTLIER -152.11 22.18 0.66 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.658 0.266 . . . . 0.0 111.173 -179.945 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.693 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 0.8 OUTLIER -110.51 114.64 54.87 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.302 179.68 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -60.98 148.26 93.26 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.728 2.285 . . . . 0.0 112.888 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -67.77 71.51 0.14 Allowed 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.598 179.507 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.443 ' O ' HG12 ' A' ' 84' ' ' VAL . 1.4 ttm180 -123.61 -174.55 3.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.914 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.436 ' CZ ' ' HG3' ' A' ' 83' ' ' GLU . 13.6 m-85 -96.51 132.43 42.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.822 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.484 ' HA ' ' O ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -131.1 126.56 36.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.039 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.664 ' HB3' HD22 ' A' ' 81' ' ' LEU . 15.1 p -101.58 161.45 13.63 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.162 0.506 . . . . 0.0 111.926 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 40.2 m80 61.63 57.57 2.23 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.565 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.607 HG11 ' HB ' ' A' ' 82' ' ' VAL . 4.8 p -123.55 143.45 36.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.758 0.313 . . . . 0.0 111.37 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.405 ' HA ' ' HD2' ' A' ' 79' ' ' PRO . 7.5 mp -107.29 143.31 35.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.804 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.73 HD23 ' O ' ' A' ' 132' ' ' VAL . 5.1 mt -133.01 139.42 47.22 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -179.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.556 ' HB2' ' CD2' ' A' ' 76' ' ' PHE . . . -143.71 146.64 33.33 Favored 'General case' 0 CA--C 1.522 -0.109 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.728 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 1.2 t -104.54 131.42 51.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.932 0.396 . . . . 0.0 111.192 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -134.13 63.45 0.61 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.424 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -58.21 95.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.867 0.365 . . . . 0.0 111.083 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 69.7 m -154.45 -46.48 0.09 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.9 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.31 154.72 36.41 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.888 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_exo -51.85 140.9 46.99 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.596 2.197 . . . . 0.0 112.196 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -134.22 167.08 23.91 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.662 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -170.65 -57.63 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.832 0.348 . . . . 0.0 110.886 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -131.51 148.91 52.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.984 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.438 ' H ' HG21 ' A' ' 124' ' ' VAL . . . -145.74 -153.55 5.91 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.535 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -112.1 -108.48 2.98 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.478 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.683 HG21 ' HB ' ' A' ' 10' ' ' VAL . 24.8 pt -126.08 146.49 31.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.822 0.344 . . . . 0.0 111.326 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.696 HD11 ' CZ ' ' A' ' 76' ' ' PHE . 11.5 tp -87.44 122.2 30.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.109 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.416 ' N ' HD12 ' A' ' 114' ' ' LEU . 27.5 mtp180 -118.26 138.74 52.15 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.254 0.549 . . . . 0.0 112.064 -178.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.446 ' HB2' ' CD1' ' A' ' 121' ' ' ILE . 15.1 t -106.03 166.51 10.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.614 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -55.77 -19.7 12.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.64 0.257 . . . . 0.0 111.031 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.424 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . 31.4 m80 -89.66 -35.92 15.54 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.514 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.501 ' C ' ' HB2' ' A' ' 54' ' ' ALA . . . 169.32 -142.41 7.31 Favored Glycine 0 C--O 1.227 -0.316 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.561 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.923 HG23 ' O ' ' A' ' 52' ' ' THR . 3.4 t -89.73 135.22 26.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.562 0.22 . . . . 0.0 110.704 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.446 ' CD1' ' HB2' ' A' ' 116' ' ' CYS . 6.3 mt -106.32 -52.75 7.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 121.051 -0.259 . . . . 0.0 111.05 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.702 ' HA2' HG23 ' A' ' 137' ' ' VAL . . . -161.74 -174.68 31.91 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.088 -1.053 . . . . 0.0 113.239 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.786 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 0.0 OUTLIER -121.16 164.06 17.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.833 0.349 . . . . 0.0 110.824 179.884 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.438 HG21 ' H ' ' A' ' 111' ' ' GLY . 13.7 p -55.47 127.14 13.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.767 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.665 ' OG1' ' HB2' ' A' ' 135' ' ' ALA . 3.2 m -120.56 -90.35 0.58 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.045 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.91 ' HG2' HG23 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -122.65 125.89 46.53 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.977 0.418 . . . . 0.0 111.301 179.618 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -110.26 128.48 8.86 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.606 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -83.95 -159.9 29.79 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.533 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -71.9 -19.38 61.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.75 0.31 . . . . 0.0 111.217 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -158.42 20.22 0.33 Allowed Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.678 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.672 ' CG1' HD22 ' A' ' 100' ' ' LEU . 1.3 t -129.17 157.07 42.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.755 0.312 . . . . 0.0 110.769 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.73 ' O ' HD23 ' A' ' 100' ' ' LEU . 18.8 m -115.19 118.35 58.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.212 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.452 ' HA3' ' O ' ' A' ' 126' ' ' MET . . . -100.64 109.54 3.7 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.074 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.456 ' CD2' ' HB2' ' A' ' 114' ' ' LEU . 61.1 m-85 -111.16 139.79 46.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.746 0.308 . . . . 0.0 110.912 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.786 ' HB3' ' CD2' ' A' ' 123' ' ' LEU . . . -88.57 120.56 30.07 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -67.36 137.1 55.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.197 0.522 . . . . 0.0 112.355 -178.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.702 HG23 ' HA2' ' A' ' 122' ' ' GLY . 95.1 t -90.53 7.85 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.474 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.613 ' HA ' HD23 ' A' ' 141' ' ' LEU . 8.8 mtm180 -70.49 -6.44 36.04 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.812 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.6 11.18 39.2 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.608 0.242 . . . . 0.0 111.581 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.834 ' O ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -173.14 48.67 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.256 0.551 . . . . 0.0 110.374 179.811 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.613 HD23 ' HA ' ' A' ' 138' ' ' ARG . 0.2 OUTLIER -67.67 -14.93 63.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.015 -179.551 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 142' ' ' TRP . . . . . 0.416 ' CE3' ' CE2' ' A' ' 15' ' ' TYR . 12.3 p-90 -56.65 82.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.069 0.461 . . . . 0.0 111.693 -179.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.683 HD23 ' HB2' ' A' ' 15' ' ' TYR . 5.1 mp -149.06 -47.29 0.14 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.805 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.455 ' HB2' HG12 ' A' ' 12' ' ' VAL . 0.5 OUTLIER -158.32 -168.89 2.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.418 179.895 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 14.7 p30 -58.83 138.94 57.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.851 0.358 . . . . 0.0 111.044 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.417 ' HB2' ' CB ' ' A' ' 55' ' ' ARG . 3.9 p-10 -105.01 154.11 20.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.999 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.744 ' HB3' ' O ' ' A' ' 54' ' ' ALA . . . -100.18 151.66 21.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.098 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 1.8 ttp -155.88 -57.75 0.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.948 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -61.58 171.08 1.63 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.863 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.895 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.181 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.56 -28.02 26.71 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.595 2.196 . . . . 0.0 112.269 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -127.12 -63.95 1.03 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.934 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 76.55 88.98 0.28 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.567 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 41.6 t60 -107.13 85.08 2.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.918 0.39 . . . . 0.0 110.874 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -63.28 -31.03 72.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.969 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.2 m -59.66 151.51 24.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.882 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -156.58 140.77 7.43 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.614 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -125.46 -172.72 2.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.727 0.298 . . . . 0.0 111.052 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.607 HG22 HG21 ' A' ' 113' ' ' ILE . 39.2 t -112.94 103.01 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.001 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.912 ' CE2' HG21 ' A' ' 45' ' ' THR . 6.1 t80 -97.85 115.93 29.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.856 0.36 . . . . 0.0 110.631 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.877 HG21 HD11 ' A' ' 53' ' ' ILE . 32.8 t -121.21 108.96 23.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.517 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.405 ' O ' ' CE1' ' A' ' 11' ' ' TYR . . . 54.24 -128.75 41.99 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.897 -0.668 . . . . 0.0 113.309 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.432 ' O ' ' HA ' ' A' ' 44' ' ' THR . 22.6 m120 -88.75 13.26 12.83 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 111.706 0.262 . . . . 0.0 111.706 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.658 ' HE1' HG22 ' A' ' 44' ' ' THR . 5.7 m-30 -130.3 127.95 40.54 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -118.97 114.74 23.03 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 121.124 -0.23 . . . . 0.0 110.688 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.985 HG12 HG22 ' A' ' 42' ' ' VAL . 0.7 OUTLIER -101.07 121.66 52.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.231 0.538 . . . . 0.0 110.993 179.91 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.682 ' O ' HD12 ' A' ' 40' ' ' LEU . 14.1 p -136.7 161.36 36.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.047 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.506 ' N ' HG22 ' A' ' 18' ' ' VAL . 9.0 m120 -58.91 141.49 53.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.376 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.425 ' CD ' ' N ' ' A' ' 21' ' ' HIS . 0.0 OUTLIER -56.54 -47.09 80.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.874 0.369 . . . . 0.0 111.294 -179.339 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.425 ' N ' ' CD ' ' A' ' 20' ' ' ARG . 13.3 p80 -68.36 -9.83 50.81 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.162 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.3 2.32 13.97 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.703 ' HB3' ' NE1' ' A' ' 28' ' ' TRP . . . -87.34 130.27 34.69 Favored 'General case' 0 C--N 1.334 -0.081 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.189 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.51 ' O ' ' HD1' ' A' ' 28' ' ' TRP . 41.9 p -74.69 163.04 28.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.742 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 61.1 m-70 -53.74 -29.71 40.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.975 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.2 t -70.33 -31.91 48.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.83 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -68.09 -44.25 76.69 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.123 0.487 . . . . 0.0 109.707 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.703 ' NE1' ' HB3' ' A' ' 23' ' ' ALA . 40.6 m95 -74.13 -33.14 63.46 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.702 179.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -56.79 -44.12 81.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.726 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -114.46 30.99 6.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.372 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.498 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 13.8 t -72.61 126.63 30.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.128 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.562 ' CG2' HG12 ' A' ' 42' ' ' VAL . 18.4 m -88.9 -40.77 13.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.626 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.73 ' CE3' HG23 ' A' ' 42' ' ' VAL . 0.5 OUTLIER -139.75 153.21 47.12 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.916 0.388 . . . . 0.0 111.227 -179.94 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -157.61 119.37 3.69 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.974 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -107.13 117.73 34.84 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.133 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 19.4 p90 -68.2 -36.79 80.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.106 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.43 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 74.0 m-20 -70.13 -12.9 61.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.871 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.0 mpt_? -117.2 -6.35 11.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.178 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 50.77 36.04 13.47 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-O 121.074 0.464 . . . . 0.0 110.295 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.81 HD11 HG23 ' A' ' 17' ' ' VAL . 36.7 tp -132.85 153.19 51.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.931 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.707 ' O ' HD23 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -147.83 155.63 41.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.491 179.682 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.985 HG22 HG12 ' A' ' 17' ' ' VAL . 38.2 t -115.78 130.68 70.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.337 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.0 p -123.29 157.24 33.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.637 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.658 HG22 ' HE1' ' A' ' 15' ' ' TYR . 30.1 p -97.65 145.13 26.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.189 0.518 . . . . 0.0 111.793 -178.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.912 HG21 ' CE2' ' A' ' 11' ' ' TYR . 0.2 OUTLIER -140.02 171.28 14.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.841 -179.253 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.551 ' O ' HG23 ' A' ' 46' ' ' THR . 10.8 t -124.48 62.32 1.12 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.93 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.463 ' HB3' ' OH ' ' A' ' 11' ' ' TYR . . . -135.51 -173.54 3.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.978 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -90.83 142.88 27.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.866 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.58 159.45 30.46 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.556 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -142.23 -46.7 0.34 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.743 0.306 . . . . 0.0 110.956 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -103.23 142.5 34.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.025 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.925 ' O ' HG23 ' A' ' 120' ' ' VAL . 91.7 m -120.08 120.85 37.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.286 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.877 HD11 HG21 ' A' ' 12' ' ' VAL . 0.9 OUTLIER -75.09 139.61 18.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.909 0.385 . . . . 0.0 110.921 -179.811 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.81 ' HB2' ' N ' ' A' ' 119' ' ' GLY . . . -94.91 127.19 40.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.107 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.62 ' H ' ' HB3' ' A' ' 147' ' ' ALA . 0.1 OUTLIER -92.33 34.76 1.02 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.528 179.452 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 26.5 p -99.65 160.5 14.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.874 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.69 34.79 4.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.084 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 66.5 m -58.28 126.87 29.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.707 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.3 m -68.92 -17.7 64.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.881 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 75' ' ' SER . 1.4 t -129.74 151.01 50.79 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.023 0.439 . . . . 0.0 111.319 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.451 ' N ' ' CE1' ' A' ' 76' ' ' PHE . . . -154.92 -148.24 4.94 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.688 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.617 HG23 ' C ' ' A' ' 72' ' ' TYR . 7.1 p -140.08 123.57 17.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.015 0.436 . . . . 0.0 111.385 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.426 ' CZ ' ' HB3' ' A' ' 72' ' ' TYR . 8.5 p90 -94.87 172.06 8.39 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.892 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.85 122.53 44.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.849 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -86.57 144.27 27.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.01 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.88 -43.63 9.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.165 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.6 t -80.95 -50.71 9.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.888 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.3 mmtm -65.28 -23.89 67.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.079 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 55.72 26.05 8.97 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.055 0.455 . . . . 0.0 110.803 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.2 mtpt -134.05 170.11 16.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.876 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.581 ' HB2' HG21 ' A' ' 62' ' ' VAL . 9.2 p80 -84.24 131.96 34.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.272 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.617 ' C ' HG23 ' A' ' 62' ' ' VAL . 1.2 m-85 -121.98 114.45 30.93 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.06 -179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 62' ' ' VAL . 4.9 Cg_exo -76.49 120.82 5.74 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.5 2.134 . . . . 0.0 111.529 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.448 ' CG1' ' CE2' ' A' ' 76' ' ' PHE . 2.9 p -136.6 156.75 35.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.973 0.416 . . . . 0.0 111.773 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.468 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 59.0 p -97.41 123.34 41.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.71 178.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.617 ' CZ ' HD11 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -124.39 163.44 21.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.373 0.606 . . . . 0.0 111.78 -179.411 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.445 ' O ' ' HD2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -111.72 158.72 19.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.224 179.024 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -104.87 65.51 0.3 Allowed Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.364 -0.922 . . . . 0.0 113.716 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.451 ' HD2' ' HA ' ' A' ' 99' ' ' LEU . 41.6 Cg_endo -67.84 134.63 32.88 Favored 'Trans proline' 0 C--O 1.238 0.501 0 C-N-CA 122.254 1.97 . . . . 0.0 112.011 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -59.89 -86.82 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.981 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.608 HD22 ' HB3' ' A' ' 96' ' ' SER . 0.0 OUTLIER -96.25 119.76 35.32 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -179.227 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.619 ' HB ' HG11 ' A' ' 98' ' ' VAL . 87.1 t -122.99 122.85 66.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.341 178.159 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.28 109.61 6.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.067 0.46 . . . . 0.0 111.206 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.836 HG23 ' HG3' ' A' ' 126' ' ' MET . 1.2 p -72.79 114.54 12.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.452 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -75.06 149.53 39.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.326 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.573 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 2.4 tm-20 -68.51 101.3 1.23 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.044 0.45 . . . . 0.0 110.458 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.477 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.4 OUTLIER -144.79 155.11 43.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.047 179.816 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 51.41 -83.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.611 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.477 ' N ' ' O ' ' A' ' 87' ' ' SER . 0.6 OUTLIER -145.67 19.75 1.49 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.835 0.35 . . . . 0.0 110.905 179.771 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.573 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 1.4 m-85 -107.88 140.35 21.53 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.538 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.421 ' O ' ' N ' ' A' ' 93' ' ' ARG . 81.5 Cg_endo -86.35 148.5 8.95 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.095 2.53 . . . . 0.0 112.9 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -65.36 70.44 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.896 179.724 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.421 ' N ' ' O ' ' A' ' 91' ' ' PRO . 14.1 mtp180 -123.52 -175.03 3.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.995 0.426 . . . . 0.0 111.741 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.546 ' HB3' HD11 ' A' ' 81' ' ' LEU . 8.3 m-85 -98.47 132.7 43.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.205 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.657 HE22 HG23 ' A' ' 125' ' ' THR . 4.7 mt-30 -128.44 126.83 41.35 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.704 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.608 ' HB3' HD22 ' A' ' 81' ' ' LEU . 24.6 p -99.58 161.04 13.85 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.174 0.511 . . . . 0.0 112.332 -178.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 57.84 60.22 2.86 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.878 179.254 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.619 HG11 ' HB ' ' A' ' 82' ' ' VAL . 6.1 p -123.66 142.39 40.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 C-N-CA 120.894 -0.323 . . . . 0.0 111.093 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.569 HD13 ' CG ' ' A' ' 136' ' ' ASP . 10.7 mp -107.67 141.37 39.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.269 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.726 HD23 ' C ' ' A' ' 132' ' ' VAL . 6.3 mt -128.08 136.56 51.37 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.551 ' HB2' ' CB ' ' A' ' 76' ' ' PHE . . . -142.3 142.17 32.51 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.077 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 1.7 t -97.37 121.64 39.5 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.066 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -139.84 -110.83 0.9 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.524 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -126.06 89.93 3.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.792 0.33 . . . . 0.0 110.843 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 37.7 m -101.1 62.69 0.98 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.91 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.498 ' N ' ' HD2' ' A' ' 107' ' ' PRO . 0.6 OUTLIER -73.77 -49.0 6.36 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.28 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 106' ' ' GLU . 72.1 Cg_endo -76.64 -172.43 1.4 Allowed 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.197 1.931 . . . . 0.0 112.345 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -133.0 39.44 1.74 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.478 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -120.91 178.63 4.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.842 0.353 . . . . 0.0 110.942 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -147.82 175.53 10.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.154 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 128.4 135.65 4.05 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.476 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.874 ' O ' HG23 ' A' ' 124' ' ' VAL . . . 126.56 175.25 14.07 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.468 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.607 HG21 HG22 ' A' ' 10' ' ' VAL . 17.6 pt -126.31 146.41 32.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.705 0.288 . . . . 0.0 111.302 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.738 HD22 ' HD2' ' A' ' 134' ' ' PHE . 20.6 tp -87.36 119.88 28.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.32 -0.4 . . . . 0.0 109.997 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 28.1 mtp85 -118.12 151.9 36.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.247 0.546 . . . . 0.0 111.648 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.486 ' HB2' HD11 ' A' ' 121' ' ' ILE . 4.2 t -119.03 160.92 21.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.175 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.421 ' CG ' ' CE1' ' A' ' 118' ' ' HIS . 3.0 pt-20 -56.29 -18.88 11.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.756 0.312 . . . . 0.0 110.925 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.428 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . 13.2 m80 -93.65 -33.66 13.58 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.656 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.81 ' N ' ' HB2' ' A' ' 54' ' ' ALA . . . 176.39 -138.67 4.18 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.408 -0.901 . . . . 0.0 113.102 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.925 HG23 ' O ' ' A' ' 52' ' ' THR . 4.9 t -102.57 135.56 39.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.765 0.317 . . . . 0.0 111.286 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.525 ' HB ' ' HG ' ' A' ' 114' ' ' LEU . 1.0 OUTLIER -99.03 -66.9 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.956 179.524 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.922 ' HA2' HG23 ' A' ' 137' ' ' VAL . . . -161.33 -164.4 16.15 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.698 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.585 HD21 HD22 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -116.94 164.24 14.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.701 0.286 . . . . 0.0 110.718 -179.97 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.874 HG23 ' O ' ' A' ' 112' ' ' GLY . 61.3 t -66.31 126.35 25.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.758 0.313 . . . . 0.0 111.188 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.732 ' OG1' ' HB2' ' A' ' 135' ' ' ALA . 2.9 m -109.45 -90.01 0.47 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.445 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.836 ' HG3' HG23 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -127.91 125.87 40.42 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 121.022 0.439 . . . . 0.0 111.742 179.946 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -107.87 128.33 9.11 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.66 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -81.69 -162.42 29.71 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.511 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -71.82 -19.72 61.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.71 0.291 . . . . 0.0 111.132 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -146.93 -7.27 0.28 Allowed Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.795 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.608 ' CG1' HD22 ' A' ' 100' ' ' LEU . 1.6 t -115.94 157.12 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 117.289 0.544 . . . . 0.0 110.927 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.726 ' C ' HD23 ' A' ' 100' ' ' LEU . 11.8 m -114.75 118.63 59.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.563 -179.132 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 126' ' ' MET . . . -97.68 118.7 6.17 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.47 -0.872 . . . . 0.0 112.041 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.738 ' HD2' HD22 ' A' ' 114' ' ' LEU . 11.5 m-85 -120.28 143.96 48.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.01 0.433 . . . . 0.0 111.637 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.732 ' HB2' ' OG1' ' A' ' 125' ' ' THR . . . -90.44 110.83 21.93 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.937 178.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.569 ' CG ' HD13 ' A' ' 99' ' ' LEU . 2.6 m-20 -67.97 143.61 55.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.095 0.474 . . . . 0.0 111.889 -178.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.922 HG23 ' HA2' ' A' ' 122' ' ' GLY . 92.8 t -90.05 9.86 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.624 179.221 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.661 ' HA ' HD23 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -70.23 -7.94 46.13 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.528 179.758 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -90.21 8.11 34.74 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.892 HD23 HG21 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -172.34 42.02 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.067 0.461 . . . . 0.0 110.899 179.886 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.719 HD11 ' HB ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -58.72 -14.99 9.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.229 -179.858 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 142' ' ' TRP . . . . . 0.437 ' CD1' ' HA ' ' A' ' 140' ' ' LEU . 16.1 p-90 -59.09 79.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.862 0.363 . . . . 0.0 111.327 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.676 HD22 ' HB ' ' A' ' 12' ' ' VAL . 4.7 mp -137.54 -45.98 0.55 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.469 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.462 ' HG2' ' CG1' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -165.58 -162.46 0.58 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.74 179.707 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -58.82 131.0 49.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.94 0.4 . . . . 0.0 111.189 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.483 ' HB2' ' HB2' ' A' ' 55' ' ' ARG . 3.7 p30 -105.0 154.25 20.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.639 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.62 ' HB3' ' H ' ' A' ' 55' ' ' ARG . . . -65.87 153.21 42.59 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.843 0.354 . . . . 0.0 111.142 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 58.97 71.5 0.58 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.853 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.03 177.45 4.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.919 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.918 179.967 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.228 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -69.51 127.93 15.51 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.553 2.169 . . . . 0.0 112.304 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -103.75 115.24 30.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.943 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.97 -48.48 85.87 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.443 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 63.43 140.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.766 0.317 . . . . 0.0 110.961 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 61.05 87.24 0.09 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.895 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.1 m 61.14 179.81 0.11 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.021 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -161.29 -76.02 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.349 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.826 ' HB2' HG23 ' A' ' 18' ' ' VAL . . . 60.39 -167.47 0.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.781 0.324 . . . . 0.0 111.232 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.632 HG13 HG22 ' A' ' 17' ' ' VAL . 8.3 p -126.82 106.26 15.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.939 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.512 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 2.5 p90 -103.13 127.46 50.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.916 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.69 HG21 HD11 ' A' ' 53' ' ' ILE . 39.2 t -119.06 133.21 66.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.67 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 50.89 -130.51 31.83 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.885 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.401 ' O ' ' HA ' ' A' ' 44' ' ' THR . 9.0 m-20 -91.35 18.62 6.89 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.741 0.305 . . . . 0.0 111.073 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.681 ' HB2' HD23 ' A' ' 143' ' ' LEU . 9.7 m-85 -129.87 144.2 51.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.119 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -127.7 114.72 17.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.587 179.386 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 1.008 HG12 HG22 ' A' ' 42' ' ' VAL . 0.7 OUTLIER -103.08 121.77 54.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-O 121.237 0.541 . . . . 0.0 111.024 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.826 HG23 ' HB2' ' A' ' 9' ' ' ALA . 7.3 p -136.47 160.55 37.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.076 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.507 ' N ' HG22 ' A' ' 18' ' ' VAL . 11.8 t-20 -59.71 141.51 55.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.463 179.177 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.43 -47.11 79.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.895 0.379 . . . . 0.0 110.908 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -68.86 -9.06 49.34 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.242 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.4 ' HB3' HG22 ' A' ' 18' ' ' VAL . 1.7 tp -109.58 -11.65 14.76 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.947 ' HB3' ' CZ2' ' A' ' 28' ' ' TRP . . . -70.39 150.48 46.22 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 120.81 0.338 . . . . 0.0 110.875 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.567 ' OG1' HG12 ' A' ' 26' ' ' VAL . 67.1 p -104.97 168.89 8.76 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.447 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -54.69 -29.79 53.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.972 0.415 . . . . 0.0 110.704 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.567 HG12 ' OG1' ' A' ' 24' ' ' THR . 8.2 p -76.47 -31.03 19.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.324 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.435 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 7.7 m-20 -66.27 -44.05 84.7 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.947 ' CZ2' ' HB3' ' A' ' 23' ' ' ALA . 6.7 m-90 -74.26 -30.12 61.99 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.872 179.096 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -57.3 -44.16 83.86 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.431 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -114.25 31.86 6.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.436 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.452 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 14.3 t -79.6 129.07 34.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.171 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.493 HG22 ' O ' ' A' ' 42' ' ' VAL . 12.7 m -91.47 -39.89 12.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.719 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.598 ' HH2' HD23 ' A' ' 40' ' ' LEU . 0.6 OUTLIER -139.43 152.4 47.03 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.01 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -159.83 117.41 2.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.977 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -107.03 118.33 36.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.232 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -65.96 -42.23 90.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.925 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.459 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 8.8 m-20 -66.63 -14.53 62.55 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.99 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.4 mtm180 -114.89 0.64 13.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.234 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.2 p30 42.54 38.99 1.41 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.996 0.427 . . . . 0.0 110.809 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.841 HD11 HG23 ' A' ' 17' ' ' VAL . 23.5 tp -137.12 152.15 49.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.091 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.683 HD11 ' CB ' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -147.79 155.72 41.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.153 179.455 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 1.008 HG22 HG12 ' A' ' 17' ' ' VAL . 29.3 t -119.78 129.97 74.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.94 0.4 . . . . 0.0 110.818 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.7 p -120.33 156.95 30.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.181 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.64 HG22 ' CE1' ' A' ' 15' ' ' TYR . 13.5 p -97.79 123.85 41.91 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.174 0.512 . . . . 0.0 111.542 -179.068 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -115.1 164.98 13.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.859 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.64 46.86 0.9 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.797 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -151.93 144.82 24.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.101 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 9.2 m170 -67.7 148.07 51.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.803 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.454 ' HA2' ' CE2' ' A' ' 11' ' ' TYR . . . -82.92 135.82 14.45 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.597 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 8.2 t -95.67 19.14 11.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.703 0.287 . . . . 0.0 111.037 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -135.27 145.9 48.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.751 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.903 ' O ' HG23 ' A' ' 120' ' ' VAL . 28.0 m -119.54 117.62 28.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.603 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.836 ' HB ' HD11 ' A' ' 141' ' ' LEU . 0.5 OUTLIER -77.05 139.52 18.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.748 -179.873 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.688 ' HB2' ' N ' ' A' ' 119' ' ' GLY . . . -93.21 132.21 37.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.225 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.652 ' H ' ' HB3' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -92.1 28.7 1.8 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.391 179.316 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 28.1 p -99.56 166.08 11.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.965 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.62 34.44 4.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.709 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 40.7 m -55.18 131.37 45.12 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.082 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.7 m -72.47 -11.46 60.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.619 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.1 p -120.26 153.51 36.25 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.765 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -171.29 -164.14 26.46 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.892 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.739 HG23 ' C ' ' A' ' 72' ' ' TYR . 10.2 p -139.66 128.08 26.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.962 0.411 . . . . 0.0 111.18 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.813 ' CD1' ' HB3' ' A' ' 66' ' ' ALA . 17.7 p90 -99.02 133.61 43.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.752 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.581 ' HB2' ' CE1' ' A' ' 71' ' ' HIS . 77.5 t80 -109.46 131.55 54.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.471 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 69' ' ' SER . 4.1 t 54.77 23.05 4.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.725 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.813 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . . . -71.59 -45.02 63.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.023 0.439 . . . . 0.0 110.461 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.5 m -160.2 20.49 0.15 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.196 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -148.7 6.72 0.73 Allowed 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.444 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 0.4 OUTLIER 52.35 21.93 1.88 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.769 0.319 . . . . 0.0 111.087 -179.649 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 69' ' ' SER . 0.5 OUTLIER -146.71 170.66 16.5 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.57 -179.504 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.581 ' CE1' ' HB2' ' A' ' 64' ' ' PHE . 0.9 OUTLIER -83.46 119.26 24.45 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.244 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.739 ' C ' HG23 ' A' ' 62' ' ' VAL . 0.5 OUTLIER -122.1 114.28 30.84 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.754 -178.36 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.405 ' N ' HG23 ' A' ' 62' ' ' VAL . 13.9 Cg_exo -68.79 120.59 7.49 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 121.987 1.791 . . . . 0.0 110.284 178.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.459 ' CG1' ' CE2' ' A' ' 76' ' ' PHE . 2.2 p -142.51 153.43 17.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.973 0.416 . . . . 0.0 111.782 -178.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.5 m -97.05 125.52 41.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.886 178.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.731 ' CD2' ' HB2' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -130.74 161.23 32.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.442 0.639 . . . . 0.0 111.793 -179.506 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.681 ' C ' ' HD3' ' A' ' 79' ' ' PRO . 3.0 mm-40 -111.77 159.31 18.4 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.959 178.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -108.57 64.53 0.26 Allowed Glycine 0 CA--C 1.522 0.53 0 C-N-CA 120.251 -0.976 . . . . 0.0 114.004 -179.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.681 ' HD3' ' C ' ' A' ' 77' ' ' GLU . 14.0 Cg_exo -67.0 140.94 56.2 Favored 'Trans proline' 0 C--O 1.242 0.695 0 C-N-CA 122.326 2.017 . . . . 0.0 112.524 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 96' ' ' SER . . . -63.04 -60.16 8.02 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.276 -0.874 . . . . 0.0 112.514 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.484 HD11 ' HB3' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -120.06 122.29 40.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.997 0.427 . . . . 0.0 111.813 -179.877 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.539 ' HB ' HG11 ' A' ' 98' ' ' VAL . 17.8 t -128.66 122.7 57.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.406 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.64 107.83 5.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.635 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.557 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 32.7 m -77.46 122.34 31.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.026 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -69.69 150.28 47.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.172 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.522 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 3.3 tt0 -67.92 102.58 1.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.54 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 89' ' ' TYR . 2.8 p -143.74 160.81 40.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.581 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 56.39 -81.98 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.651 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.419 ' N ' ' O ' ' A' ' 87' ' ' SER . 0.3 OUTLIER -153.44 21.44 0.55 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.724 0.297 . . . . 0.0 111.161 -179.805 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.522 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 1.6 t80 -119.68 133.28 23.84 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.674 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.418 ' HD2' ' CD1' ' A' ' 90' ' ' TYR . 79.7 Cg_endo -77.3 148.58 27.05 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.856 2.371 . . . . 0.0 112.538 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.557 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.7 OUTLIER -55.36 89.24 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.631 179.819 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.91 -175.62 3.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.258 0.552 . . . . 0.0 112.119 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.484 ' HB3' HD11 ' A' ' 81' ' ' LEU . 15.8 m-85 -100.06 132.62 45.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.636 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.459 ' HA ' ' O ' ' A' ' 37' ' ' ASN . 0.8 OUTLIER -127.22 124.41 38.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.863 0.363 . . . . 0.0 111.24 -179.662 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 40.2 t -89.79 162.29 15.59 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.068 0.461 . . . . 0.0 111.905 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 44.39 56.93 4.66 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.741 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.619 ' O ' ' HD2' ' A' ' 79' ' ' PRO . 8.4 p -124.0 136.77 59.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.267 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.871 HD11 ' HB3' ' A' ' 136' ' ' ASP . 2.2 mp -101.92 149.19 24.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.332 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.775 HD23 ' C ' ' A' ' 132' ' ' VAL . 7.7 mt -127.69 132.51 49.64 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.343 -0.543 . . . . 0.0 112.213 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.731 ' HB2' ' CD2' ' A' ' 76' ' ' PHE . . . -128.14 132.28 48.93 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.535 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 1.8 t -93.34 115.31 27.88 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.945 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -102.13 -110.46 3.38 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.589 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -128.6 -53.24 1.25 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.886 0.374 . . . . 0.0 110.915 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 24.8 m -168.0 178.59 5.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.952 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -128.52 112.43 19.35 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.854 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.13 -46.36 2.3 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.401 2.068 . . . . 0.0 112.238 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 158.38 -46.37 0.45 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.553 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -66.81 129.62 40.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.827 0.346 . . . . 0.0 110.866 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -144.09 116.15 8.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.205 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 176.16 109.69 0.25 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.489 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.772 ' O ' HG23 ' A' ' 124' ' ' VAL . . . 172.99 -171.62 44.56 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.551 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.466 HG21 ' HB ' ' A' ' 10' ' ' VAL . 25.9 pt -126.12 146.35 32.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.881 0.372 . . . . 0.0 111.245 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.684 HD11 ' CZ ' ' A' ' 76' ' ' PHE . 23.3 tp -87.52 121.22 29.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.253 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 17.1 mtt85 -118.24 152.28 36.02 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.181 0.515 . . . . 0.0 111.999 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.591 ' HB2' HD11 ' A' ' 121' ' ' ILE . 5.6 t -118.75 164.24 15.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.086 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -58.54 -17.94 25.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.055 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 14.9 m80 -94.89 -30.87 13.95 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.54 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.688 ' N ' ' HB2' ' A' ' 54' ' ' ALA . . . 174.52 -135.93 3.32 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.516 -0.85 . . . . 0.0 112.811 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.903 HG23 ' O ' ' A' ' 52' ' ' THR . 5.4 t -105.48 134.99 45.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.653 0.263 . . . . 0.0 111.053 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.591 HD11 ' HB2' ' A' ' 116' ' ' CYS . 1.1 mm -93.62 -67.73 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.864 0.364 . . . . 0.0 110.983 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.901 ' HA2' HG23 ' A' ' 137' ' ' VAL . . . -159.08 -143.03 3.54 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.843 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.571 ' HG ' ' HB3' ' A' ' 135' ' ' ALA . 0.4 OUTLIER -136.31 164.15 28.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.852 0.358 . . . . 0.0 111.128 -179.84 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.772 HG23 ' O ' ' A' ' 112' ' ' GLY . 36.4 t -68.58 109.22 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.348 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.804 ' OG1' ' HB2' ' A' ' 135' ' ' ALA . 3.6 m -92.04 -90.83 0.17 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.4 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.635 ' N ' HG22 ' A' ' 125' ' ' THR . 97.5 mmm -138.67 125.94 21.58 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.049 0.452 . . . . 0.0 111.301 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -110.22 131.25 10.33 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.593 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -70.04 -146.5 0.29 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.248 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -86.59 -19.38 29.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.698 0.285 . . . . 0.0 111.089 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 102' ' ' THR . . . -140.42 -9.97 0.73 Allowed Glycine 0 CA--C 1.522 0.473 0 C-N-CA 120.551 -0.833 . . . . 0.0 113.459 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.639 ' HB ' HD22 ' A' ' 100' ' ' LEU . 0.9 OUTLIER -115.74 157.56 16.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-N 117.241 0.52 . . . . 0.0 111.123 -179.704 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.775 ' C ' HD23 ' A' ' 100' ' ' LEU . 20.2 t -114.61 118.33 58.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.109 -178.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.488 ' HA3' ' O ' ' A' ' 126' ' ' MET . . . -89.28 126.31 8.17 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.781 178.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.734 ' HE1' HG22 ' A' ' 124' ' ' VAL . 40.2 m-85 -125.18 133.54 52.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.871 0.367 . . . . 0.0 111.586 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.804 ' HB2' ' OG1' ' A' ' 125' ' ' THR . . . -88.85 105.28 17.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.771 178.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.871 ' HB3' HD11 ' A' ' 99' ' ' LEU . 1.3 p30 -67.69 146.62 53.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.23 0.538 . . . . 0.0 112.181 -178.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.901 HG23 ' HA2' ' A' ' 122' ' ' GLY . 60.7 t -89.53 9.92 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.304 178.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.54 ' HA ' HD23 ' A' ' 141' ' ' LEU . 3.5 mmm180 -71.36 -7.02 44.41 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.566 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -99.87 11.13 40.04 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.594 0.235 . . . . 0.0 111.421 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.858 ' O ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -174.98 40.53 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.016 0.436 . . . . 0.0 110.701 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.836 HD11 ' HB ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -57.75 -25.46 60.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.943 -0.572 . . . . 0.0 112.037 -179.557 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 142' ' ' TRP . . . . . 0.443 ' CD1' ' HA ' ' A' ' 140' ' ' LEU . 11.6 p-90 -47.22 88.12 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.039 0.447 . . . . 0.0 111.762 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.681 HD23 ' HB2' ' A' ' 15' ' ' TYR . 5.0 mp -153.02 -47.12 0.1 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.073 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.494 ' HB2' HG12 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -158.54 -169.92 2.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.755 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -59.05 133.02 55.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.953 0.406 . . . . 0.0 111.28 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -105.15 154.36 20.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.569 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.652 ' HB3' ' H ' ' A' ' 55' ' ' ARG . . . -63.98 143.07 58.15 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.864 0.364 . . . . 0.0 111.059 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 1.5 mtm -89.33 145.82 25.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.957 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -143.58 -47.55 0.29 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.818 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.894 179.961 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.228 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 -28.37 25.32 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.572 2.181 . . . . 0.0 112.328 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -101.7 119.14 38.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.874 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -140.85 162.67 26.68 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.445 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -175.94 -40.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.798 0.332 . . . . 0.0 110.922 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -73.49 64.81 0.88 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.895 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.454 ' HB2' HD21 ' A' ' 22' ' ' LEU . 54.0 p -115.74 -37.37 3.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.921 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 97.24 83.98 1.72 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.484 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.549 ' HB2' HG23 ' A' ' 18' ' ' VAL . . . -151.84 159.47 43.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.829 0.347 . . . . 0.0 111.165 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.7 t -103.37 115.85 46.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.955 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.663 ' CE2' HG21 ' A' ' 45' ' ' THR . 5.7 t80 -104.18 115.91 31.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.808 0.337 . . . . 0.0 110.659 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.792 HG21 HD11 ' A' ' 53' ' ' ILE . 57.6 t -121.17 112.64 36.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.652 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 50.54 -126.22 24.01 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.98 -0.629 . . . . 0.0 113.379 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.466 ' O ' ' HA ' ' A' ' 44' ' ' THR . 4.5 m-20 -91.01 17.97 7.29 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.656 0.265 . . . . 0.0 111.589 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.641 ' CE1' HG22 ' A' ' 44' ' ' THR . 4.7 m-30 -130.49 127.74 39.8 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.04 114.74 22.46 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 121.024 -0.27 . . . . 0.0 110.888 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.926 HG12 HG22 ' A' ' 42' ' ' VAL . 0.7 OUTLIER -99.64 121.9 50.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-O 120.984 0.421 . . . . 0.0 110.453 179.585 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.666 ' O ' HD12 ' A' ' 40' ' ' LEU . 9.6 p -136.29 159.99 38.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.306 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.498 ' N ' HG22 ' A' ' 18' ' ' VAL . 32.5 m-80 -59.96 141.74 55.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.289 179.025 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 48.7 ttt-85 -56.17 -47.35 78.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.814 0.34 . . . . 0.0 110.774 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -69.2 -8.42 45.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.968 179.253 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.464 ' HB3' HG22 ' A' ' 18' ' ' VAL . 16.7 tp -110.59 -12.59 14.33 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.967 ' HB3' ' CZ2' ' A' ' 28' ' ' TRP . . . -66.97 150.73 48.82 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 120.896 0.379 . . . . 0.0 110.796 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.559 ' CG2' HG12 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -105.19 170.02 8.11 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.395 179.925 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 56.6 p-80 -54.76 -29.76 54.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.914 0.388 . . . . 0.0 110.954 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.559 HG12 ' CG2' ' A' ' 24' ' ' THR . 9.4 p -76.25 -31.21 20.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.559 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.25 -44.24 79.91 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.967 ' CZ2' ' HB3' ' A' ' 23' ' ' ALA . 5.0 m-90 -74.82 -30.45 61.4 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.33 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -58.62 -43.37 89.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.609 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -118.36 39.56 3.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.555 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.472 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 30.4 p -79.97 126.74 31.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.312 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.584 ' CG2' HG12 ' A' ' 42' ' ' VAL . 16.3 m -88.29 -39.16 12.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.543 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.637 ' CE3' HG23 ' A' ' 42' ' ' VAL . 0.5 OUTLIER -139.61 150.16 44.65 Favored 'General case' 0 CA--C 1.53 0.212 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.067 179.905 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -149.93 110.89 4.34 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.722 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.466 ' HB2' ' CZ2' ' A' ' 33' ' ' TRP . 27.4 t0 -107.23 112.88 25.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.88 0.371 . . . . 0.0 111.06 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -67.4 -34.82 78.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.076 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.448 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 0.3 OUTLIER -64.3 -20.24 65.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.845 179.718 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -115.11 0.96 13.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.316 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 46.58 35.12 2.75 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 121.221 0.534 . . . . 0.0 110.175 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.808 HD11 HG23 ' A' ' 17' ' ' VAL . 28.4 tp -131.84 153.46 50.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.911 -179.017 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.683 ' O ' HD23 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -146.43 155.73 42.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.177 179.648 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.926 HG22 HG12 ' A' ' 17' ' ' VAL . 33.9 t -119.11 127.97 75.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.288 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.9 p -122.3 157.17 32.32 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.787 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.641 HG22 ' CE1' ' A' ' 15' ' ' TYR . 25.1 p -97.57 145.09 26.59 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.216 0.531 . . . . 0.0 111.614 -179.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.663 HG21 ' CE2' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -137.4 171.76 14.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.907 -179.139 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.0 t -121.18 34.75 5.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.848 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -113.81 175.14 5.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.164 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.2 m80 -82.84 148.09 27.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.9 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.436 ' HA2' ' CE1' ' A' ' 11' ' ' TYR . . . -100.69 -174.18 29.48 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.563 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.9 t -165.06 -43.41 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.842 0.353 . . . . 0.0 110.879 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -74.15 137.17 43.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.973 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.92 ' O ' HG23 ' A' ' 120' ' ' VAL . 81.0 m -122.66 123.55 41.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.499 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.792 HD11 HG21 ' A' ' 12' ' ' VAL . 1.0 OUTLIER -74.09 139.51 19.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.804 0.335 . . . . 0.0 110.689 179.915 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.843 ' HB2' ' N ' ' A' ' 119' ' ' GLY . . . -95.21 128.2 41.87 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.008 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.585 ' H ' ' HB3' ' A' ' 147' ' ' ALA . 11.3 tpt180 -94.67 36.09 1.19 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.584 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 20.6 p -99.98 167.25 10.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.981 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -117.22 28.64 8.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.468 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 14.0 m -62.18 120.44 10.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.753 0.311 . . . . 0.0 110.704 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.4 t -69.35 -13.37 62.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.947 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -117.71 126.56 52.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.21 0.529 . . . . 0.0 111.464 -179.664 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 73' ' ' PRO . . . -135.83 -153.78 6.74 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.114 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.768 HG23 ' C ' ' A' ' 72' ' ' TYR . 11.2 p -140.08 131.31 31.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 117.26 0.53 . . . . 0.0 111.649 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -109.69 150.74 27.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.741 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -74.14 125.68 28.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.098 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -88.77 139.33 30.58 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.716 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.512 ' HB2' ' O ' ' A' ' 110' ' ' ALA . . . -92.06 -40.27 11.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.188 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -85.81 -28.83 24.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.166 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.3 mmtt -92.17 -24.56 19.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.295 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 55.94 29.21 13.84 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.995 0.426 . . . . 0.0 110.482 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.2 mtpp -134.37 170.54 15.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.845 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.61 ' HB3' HG21 ' A' ' 62' ' ' VAL . 35.0 m80 -83.91 117.09 23.11 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.993 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.768 ' C ' HG23 ' A' ' 62' ' ' VAL . 0.6 OUTLIER -111.22 114.38 53.47 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.296 -179.096 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.506 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 6.3 Cg_exo -78.27 125.89 7.36 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.459 2.106 . . . . 0.0 111.834 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.462 ' CG1' ' CE2' ' A' ' 76' ' ' PHE . 2.3 p -136.77 153.03 29.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.945 0.403 . . . . 0.0 111.745 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.546 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 0.0 OUTLIER -95.35 133.52 39.18 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.493 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.609 ' CD2' ' HB2' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -135.28 166.5 22.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.507 0.67 . . . . 0.0 111.955 -178.886 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.696 ' C ' ' HD3' ' A' ' 79' ' ' PRO . 1.8 mp0 -111.71 159.54 18.14 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.121 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -108.42 62.23 0.3 Allowed Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.044 -1.074 . . . . 0.0 114.191 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.696 ' HD3' ' C ' ' A' ' 77' ' ' GLU . 15.1 Cg_exo -67.01 142.52 62.2 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.075 1.85 . . . . 0.0 111.948 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -64.83 -90.67 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.739 -0.664 . . . . 0.0 113.016 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.791 HD22 ' HB2' ' A' ' 96' ' ' SER . 0.0 OUTLIER -85.08 129.99 34.7 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.031 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.629 ' HB ' HG11 ' A' ' 98' ' ' VAL . 98.7 t -138.75 126.04 26.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.478 178.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -72.35 107.86 5.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.944 0.402 . . . . 0.0 111.598 -178.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.734 HG23 ' CG ' ' A' ' 126' ' ' MET . 4.1 p -73.11 114.27 12.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.959 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -73.01 149.39 43.3 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.546 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.575 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 1.0 OUTLIER -69.34 101.89 1.62 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.644 179.923 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.457 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -144.45 152.81 41.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.129 179.761 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 53.56 -82.85 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.558 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.457 ' N ' ' O ' ' A' ' 87' ' ' SER . 0.4 OUTLIER -146.38 18.65 1.36 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.693 0.283 . . . . 0.0 111.047 179.905 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.575 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 1.2 m-85 -106.9 136.54 19.43 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.315 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.495 ' HA ' ' HG2' ' A' ' 86' ' ' GLU . 95.2 Cg_endo -84.37 148.33 11.5 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.917 2.411 . . . . 0.0 112.954 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -65.05 77.58 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.518 179.547 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.55 ' O ' HG12 ' A' ' 84' ' ' VAL . 46.8 mtt180 -123.69 -174.75 3.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.126 0.489 . . . . 0.0 111.912 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.464 ' HB3' HD11 ' A' ' 81' ' ' LEU . 19.5 m-85 -99.14 132.26 44.58 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.841 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.606 ' OE1' HG11 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -131.22 126.74 36.33 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.098 -179.867 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.791 ' HB2' HD22 ' A' ' 81' ' ' LEU . 44.4 t -101.55 158.54 16.0 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.087 0.47 . . . . 0.0 111.803 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.42 ' CE1' ' HB2' ' A' ' 138' ' ' ARG . 0.0 OUTLIER 64.71 56.53 1.15 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.645 179.338 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.629 HG11 ' HB ' ' A' ' 82' ' ' VAL . 9.5 p -123.53 141.81 42.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.994 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.451 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 11.0 mp -104.95 147.96 27.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.315 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.721 HD23 ' C ' ' A' ' 132' ' ' VAL . 6.8 mt -133.08 131.5 40.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.069 0.461 . . . . 0.0 112.183 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.609 ' HB2' ' CD2' ' A' ' 76' ' ' PHE . . . -135.65 147.64 48.67 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.749 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.5 t -105.33 134.35 48.59 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.982 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -103.57 -75.33 1.05 Allowed Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.494 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -146.54 -60.97 0.3 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.853 0.359 . . . . 0.0 110.905 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -177.38 73.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.888 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 60.77 84.23 0.2 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.913 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -68.67 -27.69 31.86 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.483 2.122 . . . . 0.0 112.311 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -179.25 -158.35 21.4 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.528 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -144.41 32.32 1.2 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.809 0.337 . . . . 0.0 110.914 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.512 ' O ' ' HB2' ' A' ' 66' ' ' ALA . . . -164.99 95.22 0.68 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.089 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -107.79 -169.23 21.67 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.498 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.691 ' O ' HG13 ' A' ' 124' ' ' VAL . . . -123.71 -107.72 1.81 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.719 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 18.0 pt -126.11 146.72 31.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.829 0.347 . . . . 0.0 111.156 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.651 HD22 ' HD2' ' A' ' 134' ' ' PHE . 15.6 tp -87.14 115.49 24.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.126 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.643 ' HD3' HG22 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -118.05 150.94 38.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.059 0.457 . . . . 0.0 111.501 -179.416 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.523 ' HB2' HD11 ' A' ' 121' ' ' ILE . 5.7 t -114.57 162.34 16.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.279 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -56.22 -19.47 13.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.919 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.42 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . 18.9 m80 -92.26 -34.34 14.29 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.457 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.843 ' N ' ' HB2' ' A' ' 54' ' ' ALA . . . 178.03 -140.03 4.47 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.345 -0.931 . . . . 0.0 113.145 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.92 HG23 ' O ' ' A' ' 52' ' ' THR . 4.0 t -102.1 135.58 38.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.705 0.288 . . . . 0.0 111.287 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.554 ' HB ' ' HG ' ' A' ' 114' ' ' LEU . 1.1 mm -98.4 -67.15 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.896 0.379 . . . . 0.0 110.735 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.919 ' HA2' HG23 ' A' ' 137' ' ' VAL . . . -159.88 -166.43 18.75 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.667 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.464 HD11 HD13 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -116.93 164.08 15.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.789 0.328 . . . . 0.0 110.698 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.691 HG13 ' O ' ' A' ' 112' ' ' GLY . 7.7 m -65.6 128.94 29.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.453 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.748 ' OG1' ' HB2' ' A' ' 135' ' ' ALA . 2.5 m -111.09 -89.08 0.5 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.344 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.734 ' CG ' HG23 ' A' ' 84' ' ' VAL . 0.8 OUTLIER -130.44 125.77 35.3 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.934 0.397 . . . . 0.0 111.409 179.915 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -110.71 151.19 17.68 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.47 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -110.04 -153.23 14.1 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.578 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -93.98 17.28 12.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.595 0.236 . . . . 0.0 111.239 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -168.74 -28.25 0.02 OUTLIER Glycine 0 CA--C 1.52 0.357 0 C-N-CA 120.527 -0.844 . . . . 0.0 113.182 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.558 ' CG1' HD22 ' A' ' 100' ' ' LEU . 1.6 t -115.48 157.27 16.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.802 0.301 . . . . 0.0 111.038 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.721 ' C ' HD23 ' A' ' 100' ' ' LEU . 10.0 m -114.73 118.86 59.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.658 -179.128 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.472 ' HA3' ' O ' ' A' ' 126' ' ' MET . . . -95.59 117.93 5.78 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.39 -0.909 . . . . 0.0 112.177 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.651 ' HD2' HD22 ' A' ' 114' ' ' LEU . 13.5 m-85 -122.2 144.2 49.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.95 0.405 . . . . 0.0 111.512 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.748 ' HB2' ' OG1' ' A' ' 125' ' ' THR . . . -89.34 111.06 21.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.076 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -68.34 147.34 52.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.01 0.433 . . . . 0.0 111.836 -179.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.919 HG23 ' HA2' ' A' ' 122' ' ' GLY . 97.9 t -91.26 11.03 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.438 179.131 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.594 ' HA ' HD23 ' A' ' 141' ' ' LEU . 12.8 mmm180 -70.14 -6.93 37.61 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.748 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -98.26 11.11 38.98 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 111.706 0.261 . . . . 0.0 111.706 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.873 HD23 HG21 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -175.03 39.07 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.202 0.525 . . . . 0.0 110.471 179.81 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.662 HD11 ' HB ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -56.77 -20.86 24.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.32 -179.608 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 142' ' ' TRP . . . . . 0.432 ' CD1' ' HA ' ' A' ' 140' ' ' LEU . 12.7 p-90 -55.68 85.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.941 0.4 . . . . 0.0 111.45 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.575 HD23 ' CB ' ' A' ' 15' ' ' TYR . 4.2 mp -146.0 -48.16 0.21 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.309 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -151.12 -173.21 4.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.676 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -58.93 136.01 57.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.92 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -82.95 154.1 24.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.916 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.585 ' HB3' ' H ' ' A' ' 55' ' ' ARG . . . -81.94 145.2 30.43 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.069 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 2.0 ttm 60.97 67.64 0.8 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.933 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -73.53 -63.82 1.12 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.836 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.855 179.981 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.169 0 N-CA-C 112.577 -0.209 . . . . 0.0 112.577 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.31 -176.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.626 2.217 . . . . 0.0 112.259 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -154.26 141.76 19.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.776 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 76.71 67.12 1.72 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.422 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 6.0 p-80 -148.12 126.36 12.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.854 0.359 . . . . 0.0 110.863 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -133.16 40.89 3.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.855 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.7 m 62.11 170.87 0.13 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.946 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 158.61 -28.51 0.43 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.499 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.601 ' HB2' HG23 ' A' ' 18' ' ' VAL . . . -170.18 -174.28 1.7 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.772 0.32 . . . . 0.0 111.157 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.615 HG22 HG21 ' A' ' 113' ' ' ILE . 39.4 t -106.73 108.24 24.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.033 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.883 ' CE2' HG21 ' A' ' 45' ' ' THR . 6.5 t80 -98.11 116.53 30.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.688 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.895 HG21 HD11 ' A' ' 53' ' ' ILE . 41.7 t -120.58 108.83 23.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.587 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 51.59 -127.78 31.18 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.955 -0.64 . . . . 0.0 113.304 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.466 ' O ' ' HA ' ' A' ' 44' ' ' THR . 0.9 OUTLIER -88.88 14.27 10.78 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.572 0.225 . . . . 0.0 111.599 -179.637 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.647 ' HE1' HG22 ' A' ' 44' ' ' THR . 6.1 m-30 -130.34 128.01 40.6 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.49 114.68 23.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.66 0.267 . . . . 0.0 111.018 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.908 HG12 HG22 ' A' ' 42' ' ' VAL . 0.8 OUTLIER -99.13 122.49 50.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 121.032 0.444 . . . . 0.0 110.401 179.48 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.779 ' O ' HD12 ' A' ' 40' ' ' LEU . 12.6 p -135.42 161.49 39.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.256 -179.2 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.881 ' HB2' HD12 ' A' ' 22' ' ' LEU . 2.2 t30 -60.94 141.74 57.0 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 178.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.2 -47.03 79.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.824 0.345 . . . . 0.0 110.838 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -71.05 -6.93 42.79 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.151 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.881 HD12 ' HB2' ' A' ' 19' ' ' ASN . 52.4 mt -112.66 -3.68 14.24 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.825 ' HB3' ' CZ2' ' A' ' 28' ' ' TRP . . . -77.13 151.0 35.55 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.865 0.364 . . . . 0.0 110.829 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.445 ' O ' ' CE3' ' A' ' 28' ' ' TRP . 1.2 t -102.89 166.64 10.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.133 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 30.1 t60 -54.04 -29.57 44.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.042 0.448 . . . . 0.0 110.345 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.5 t -72.07 -31.18 39.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.019 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.482 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 0.4 OUTLIER -67.43 -44.14 79.47 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.941 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.825 ' CZ2' ' HB3' ' A' ' 23' ' ' ALA . 11.7 m-90 -73.9 -35.46 64.65 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.078 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.62 -38.62 72.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.045 0.45 . . . . 0.0 110.503 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -119.37 27.73 8.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.755 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 8.7 t -73.58 122.8 22.82 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.964 0.412 . . . . 0.0 110.863 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.549 HG22 ' O ' ' A' ' 42' ' ' VAL . 13.1 m -86.57 -39.77 13.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.515 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.604 ' HH2' HD23 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -139.71 153.12 47.14 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.172 -179.893 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -156.82 121.28 4.44 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.813 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.401 ' HB2' ' CZ2' ' A' ' 33' ' ' TRP . 17.6 m-20 -107.05 116.86 32.66 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.23 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -67.24 -36.88 82.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.963 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.53 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 3.8 m-20 -72.41 -14.15 61.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.863 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 mtt85 -115.54 -3.77 12.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.777 -0.192 . . . . 0.0 111.274 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 46.91 42.15 11.79 Favored 'General case' 0 CA--C 1.524 -0.046 0 CA-C-O 121.216 0.532 . . . . 0.0 110.038 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.85 HD11 HG23 ' A' ' 17' ' ' VAL . 29.3 tp -136.17 152.42 50.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.906 -178.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.662 HD12 ' NE1' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -147.33 150.79 35.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.042 0.449 . . . . 0.0 111.194 179.408 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.908 HG22 HG12 ' A' ' 17' ' ' VAL . 31.0 t -114.54 126.75 72.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.403 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.9 p -117.87 157.28 26.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.416 178.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.647 HG22 ' HE1' ' A' ' 15' ' ' TYR . 18.9 p -97.71 140.79 31.58 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.119 0.485 . . . . 0.0 111.701 -179.012 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.883 HG21 ' CE2' ' A' ' 11' ' ' TYR . 0.2 OUTLIER -135.29 168.94 18.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.875 -179.335 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.2 p -121.69 61.9 0.93 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.832 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.24 169.7 17.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.125 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 4.9 m170 -86.56 128.57 34.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.876 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -87.43 -179.48 48.13 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.489 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 73.3 m -144.09 -46.94 0.27 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.77 0.319 . . . . 0.0 110.892 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -64.25 138.88 58.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.939 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.873 ' O ' HG23 ' A' ' 120' ' ' VAL . 83.2 m -122.7 121.05 35.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.509 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.895 HD11 HG21 ' A' ' 12' ' ' VAL . 0.4 OUTLIER -74.24 139.36 19.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.928 0.394 . . . . 0.0 111.211 -179.677 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.83 ' HB2' ' N ' ' A' ' 119' ' ' GLY . . . -95.7 123.65 39.36 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.942 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.504 ' H ' ' HB3' ' A' ' 147' ' ' ALA . 0.3 OUTLIER -91.2 37.29 0.94 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.621 179.672 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 24.5 p -99.85 167.1 10.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.952 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -119.1 33.53 5.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.32 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 35.5 m -62.76 141.85 58.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.627 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -85.28 3.1 41.12 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.024 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.1 p -125.9 168.05 14.42 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.103 0.478 . . . . 0.0 111.117 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -179.44 -173.14 44.34 Favored Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.583 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.836 HG23 ' C ' ' A' ' 72' ' ' TYR . 9.2 p -140.22 125.83 20.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 117.044 0.422 . . . . 0.0 111.225 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.704 ' HE2' HG21 ' A' ' 74' ' ' VAL . 6.2 p90 -109.12 137.99 46.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.743 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.9 145.64 50.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.049 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 1.6 t -113.77 150.95 32.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.882 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.434 ' HB2' ' HB3' ' A' ' 110' ' ' ALA . . . -91.95 -45.14 8.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.237 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -70.76 -41.36 71.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.879 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.57 ' HG2' ' HD3' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -86.16 -28.57 23.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.979 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.0 p 58.75 37.15 25.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.181 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.57 ' HD3' ' HG2' ' A' ' 68' ' ' LYS . 1.3 ptmt -140.61 169.57 17.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.011 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.478 ' HB3' HG21 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -84.61 119.93 25.78 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.05 179.695 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.836 ' C ' HG23 ' A' ' 62' ' ' VAL . 2.7 m-85 -108.59 113.86 59.52 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.512 -179.296 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 72' ' ' TYR . 2.7 Cg_exo -76.34 120.78 5.77 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.589 2.192 . . . . 0.0 111.024 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.704 HG21 ' HE2' ' A' ' 63' ' ' TYR . 54.5 t -134.83 141.78 42.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.977 0.418 . . . . 0.0 111.765 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 16.7 m -91.84 121.64 33.64 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.51 ' HB3' ' HB2' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -127.96 165.19 20.73 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.526 0.679 . . . . 0.0 111.947 -178.629 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.58 ' C ' ' HD3' ' A' ' 79' ' ' PRO . 10.7 mt-10 -111.72 158.83 18.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.899 178.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.484 ' HA2' ' HG ' ' A' ' 99' ' ' LEU . . . -112.16 68.6 0.23 Allowed Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.124 -1.036 . . . . 0.0 113.961 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.586 ' HD2' ' O ' ' A' ' 98' ' ' VAL . 15.7 Cg_exo -67.36 142.08 58.68 Favored 'Trans proline' 0 C--O 1.238 0.503 0 C-N-CA 122.22 1.946 . . . . 0.0 111.797 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -57.98 -91.73 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.538 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.585 HD22 ' CB ' ' A' ' 96' ' ' SER . 0.0 OUTLIER -94.37 119.82 33.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.91 0.386 . . . . 0.0 111.876 -179.587 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.643 ' HB ' HG11 ' A' ' 98' ' ' VAL . 61.7 t -122.76 122.62 66.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.923 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.401 ' HG3' ' CE1' ' A' ' 94' ' ' TYR . 1.8 tt0 -72.43 107.62 5.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.859 0.362 . . . . 0.0 110.741 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.709 HG13 ' HG2' ' A' ' 126' ' ' MET . 30.4 t -75.77 114.3 15.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.624 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.422 ' HA ' ' HD3' ' A' ' 92' ' ' LYS . 1.5 tt0 -71.86 150.02 44.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.032 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.472 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 0.8 OUTLIER -67.88 101.34 1.07 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.158 0.504 . . . . 0.0 110.159 -179.475 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.508 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.3 OUTLIER -144.65 175.7 9.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.839 -179.913 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 42.96 -86.23 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.787 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.508 ' N ' ' O ' ' A' ' 87' ' ' SER . 0.3 OUTLIER -150.56 23.5 0.8 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.825 0.345 . . . . 0.0 110.485 179.686 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.472 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -117.92 138.15 25.11 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.867 -179.704 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.427 ' O ' ' N ' ' A' ' 93' ' ' ARG . 93.7 Cg_endo -78.77 148.61 22.69 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.821 2.347 . . . . 0.0 112.247 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.578 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -60.9 79.9 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.866 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.427 ' N ' ' O ' ' A' ' 91' ' ' PRO . 1.5 ttp85 -123.65 177.41 5.7 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.692 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.457 ' HB3' HD11 ' A' ' 81' ' ' LEU . 10.6 m-85 -91.29 132.6 36.04 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.777 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.777 ' OE1' HG23 ' A' ' 125' ' ' THR . 0.1 OUTLIER -125.46 116.84 22.46 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.654 -179.571 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.585 ' CB ' HD22 ' A' ' 81' ' ' LEU . 3.0 t -91.53 154.4 19.12 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 120.92 0.391 . . . . 0.0 111.45 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 53.72 62.46 2.61 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.336 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.643 HG11 ' HB ' ' A' ' 82' ' ' VAL . 5.9 p -123.35 152.28 28.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.1 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.484 ' HG ' ' HA2' ' A' ' 78' ' ' GLY . 5.5 mp -116.43 140.27 49.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.205 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.8 HD23 ' O ' ' A' ' 132' ' ' VAL . 5.5 mt -133.23 142.06 48.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.268 0.556 . . . . 0.0 112.456 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.575 ' O ' HG12 ' A' ' 131' ' ' VAL . . . -151.97 161.06 43.23 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.412 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.1 t -118.92 129.45 55.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.947 0.403 . . . . 0.0 111.004 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -70.64 -141.23 0.19 Allowed Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.493 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -155.5 -45.93 0.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.891 0.377 . . . . 0.0 110.937 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.42 107.12 9.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.788 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 61.92 114.21 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.916 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -68.94 -38.23 10.01 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.473 2.116 . . . . 0.0 112.27 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.11 161.02 24.52 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.504 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.69 -68.27 0.52 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.867 0.365 . . . . 0.0 110.914 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.434 ' HB3' ' HB2' ' A' ' 66' ' ' ALA . . . -101.94 -171.32 1.95 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.179 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -136.98 -45.71 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.494 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 84.67 -123.9 6.47 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.517 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.615 HG21 HG22 ' A' ' 10' ' ' VAL . 28.4 pt -126.15 144.21 37.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.782 0.325 . . . . 0.0 111.17 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.63 HD22 ' HD2' ' A' ' 134' ' ' PHE . 10.8 tp -87.9 113.99 24.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.208 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.63 ' HD3' HG22 ' A' ' 120' ' ' VAL . 3.1 mtm180 -114.1 143.24 45.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.098 0.475 . . . . 0.0 111.554 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.56 ' HB2' HD11 ' A' ' 121' ' ' ILE . 6.9 t -107.79 164.28 12.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.191 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -56.14 -20.35 17.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.788 0.328 . . . . 0.0 110.723 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.493 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . 26.7 m80 -89.59 -35.86 15.64 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.325 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.83 ' N ' ' HB2' ' A' ' 54' ' ' ALA . . . 177.46 -136.36 3.06 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.854 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.873 HG23 ' O ' ' A' ' 52' ' ' THR . 3.8 t -102.88 135.38 40.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.685 0.279 . . . . 0.0 110.926 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.56 HD11 ' HB2' ' A' ' 116' ' ' CYS . 1.0 OUTLIER -94.59 -69.9 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.698 0.285 . . . . 0.0 111.248 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.941 ' HA2' HG23 ' A' ' 137' ' ' VAL . . . -150.95 -160.09 9.2 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.381 -0.914 . . . . 0.0 113.236 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.634 ' CD1' HD13 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -121.38 164.48 17.01 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.737 0.303 . . . . 0.0 110.85 -179.789 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.481 ' O ' HG13 ' A' ' 124' ' ' VAL . 9.9 p -62.31 121.52 11.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.838 0.351 . . . . 0.0 111.796 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.777 HG23 ' OE1' ' A' ' 95' ' ' GLN . 3.0 m -112.17 -91.31 0.49 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.075 179.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.709 ' HG2' HG13 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -92.58 160.4 15.04 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 120.787 0.327 . . . . 0.0 110.743 179.517 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -150.03 88.66 0.14 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.442 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -77.32 -176.59 44.81 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.429 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.79 -19.32 62.02 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.667 0.27 . . . . 0.0 111.015 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -142.03 -6.3 0.8 Allowed Glycine 0 CA--C 1.522 0.482 0 C-N-CA 120.598 -0.81 . . . . 0.0 113.447 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.575 HG12 ' O ' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -115.82 157.17 16.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 117.322 0.561 . . . . 0.0 111.306 -179.764 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.8 ' O ' HD23 ' A' ' 100' ' ' LEU . 13.1 m -119.73 118.69 57.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.5 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -100.99 120.06 6.75 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.728 -0.749 . . . . 0.0 111.9 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.63 ' HD2' HD22 ' A' ' 114' ' ' LEU . 18.3 m-85 -125.13 136.72 53.9 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.914 0.387 . . . . 0.0 112.02 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.754 ' HB2' ' OG1' ' A' ' 125' ' ' THR . . . -88.86 114.22 25.25 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.198 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -67.79 141.16 56.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.975 0.417 . . . . 0.0 111.858 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.941 HG23 ' HA2' ' A' ' 122' ' ' GLY . 88.9 t -89.31 9.72 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.615 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.48 ' HA ' HD23 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -70.74 -6.68 39.21 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.599 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -95.93 11.05 35.27 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 120.685 0.279 . . . . 0.0 111.317 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.853 ' O ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -177.98 57.28 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.083 0.468 . . . . 0.0 110.484 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.871 HD11 ' HB ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -74.83 -14.83 60.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.883 -179.572 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 142' ' ' TRP . . . . . 0.465 ' C ' HD12 ' A' ' 143' ' ' LEU . 13.2 p-90 -55.99 82.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.896 0.379 . . . . 0.0 111.261 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.672 HD12 ' C ' ' A' ' 141' ' ' LEU . 5.1 mp -149.67 -45.67 0.13 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.466 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.433 ' HB2' ' CG1' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -154.35 -167.44 2.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.747 179.832 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -58.88 141.03 54.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.0 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.409 ' HB2' ' HB2' ' A' ' 55' ' ' ARG . 15.4 p30 -94.97 154.07 17.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.832 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.617 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . . . -98.39 126.18 43.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.904 0.383 . . . . 0.0 111.156 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 3.0 ptt? -132.39 -179.56 5.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.885 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -135.83 169.73 17.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.925 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 . . . . . 0 C--O 1.251 1.144 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.851 -179.954 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 112.539 -0.225 . . . . 0.0 112.539 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -52.99 -61.94 0.41 Allowed 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.535 2.156 . . . . 0.0 112.349 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 23.3 t80 68.4 -67.52 0.2 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.924 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -155.28 -44.17 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.573 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 10.6 p80 -108.38 144.62 35.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.803 0.335 . . . . 0.0 110.873 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 60.89 111.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.933 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.0 m -127.6 31.42 5.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.904 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.8 60.38 0.18 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.519 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -157.12 170.5 22.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.801 0.334 . . . . 0.0 111.047 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.0 t -107.4 116.23 50.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.013 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.611 ' CZ ' HG21 ' A' ' 45' ' ' THR . 0.3 OUTLIER -98.02 115.52 28.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.604 179.889 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.988 HG21 HD11 ' A' ' 53' ' ' ILE . 17.3 t -121.47 108.8 23.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.525 179.325 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 48.21 -124.64 11.41 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.928 -0.653 . . . . 0.0 113.098 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.405 ' O ' ' HA ' ' A' ' 44' ' ' THR . 2.7 m120 -92.43 17.94 9.2 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.734 0.302 . . . . 0.0 111.403 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.662 ' HE1' HG22 ' A' ' 44' ' ' THR . 4.9 m-30 -130.31 144.4 51.36 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.411 ' HG3' ' CD1' ' A' ' 11' ' ' TYR . 18.6 ttpt -133.83 118.26 17.79 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.702 0.287 . . . . 0.0 110.994 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 1.098 HG12 HG22 ' A' ' 42' ' ' VAL . 0.6 OUTLIER -104.39 122.07 56.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.117 0.485 . . . . 0.0 110.434 179.572 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.737 ' O ' HD12 ' A' ' 40' ' ' LEU . 14.0 p -136.01 162.0 37.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.033 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.508 ' N ' HG22 ' A' ' 18' ' ' VAL . 0.4 OUTLIER -58.53 141.24 52.52 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.091 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.587 ' HG2' HD13 ' A' ' 41' ' ' LEU . 13.9 mtm105 -56.45 -47.82 78.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.916 0.389 . . . . 0.0 111.17 -179.03 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -69.52 -7.62 39.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.441 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.9 tp -115.33 5.73 14.72 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.8 ' HB2' HD21 ' A' ' 41' ' ' LEU . . . -89.27 131.89 35.16 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.353 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.563 ' O ' ' HD1' ' A' ' 28' ' ' TRP . 44.1 p -74.76 162.5 28.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.469 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.406 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 2.9 t-160 -53.66 -29.64 39.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.886 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.8 t -69.57 -31.94 50.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.915 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.437 ' O ' ' HB3' ' A' ' 31' ' ' CYS . 13.5 m-20 -67.72 -44.07 78.51 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.62 ' NE1' ' HB3' ' A' ' 23' ' ' ALA . 33.8 m95 -73.57 -29.88 62.69 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.594 179.058 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.406 ' HB2' ' O ' ' A' ' 25' ' ' HIS . 2.2 tp60 -58.8 -43.92 90.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.575 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -118.15 30.13 7.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.832 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.483 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 29.5 p -69.17 122.93 19.81 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.949 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.546 ' CG2' HG12 ' A' ' 42' ' ' VAL . 17.7 m -86.2 -39.74 13.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.434 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.755 ' HH2' HD23 ' A' ' 40' ' ' LEU . 1.0 OUTLIER -139.66 153.25 47.25 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.08 179.689 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -160.44 115.92 2.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.008 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -107.19 117.75 34.9 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.936 0.398 . . . . 0.0 111.136 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -62.26 -48.84 78.14 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.353 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -59.9 -19.09 49.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.134 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -108.38 -8.02 15.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.276 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.4 t70 49.49 43.22 23.63 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 121.088 0.47 . . . . 0.0 110.224 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.755 HD23 ' HH2' ' A' ' 33' ' ' TRP . 20.0 tp -137.1 154.15 50.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.126 -178.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.8 HD21 ' HB2' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -151.86 137.18 17.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.115 0.484 . . . . 0.0 111.131 179.555 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 1.098 HG22 HG12 ' A' ' 17' ' ' VAL . 34.3 t -100.96 130.58 50.11 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.406 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.4 p -123.19 157.45 32.99 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.261 -0.882 . . . . 0.0 109.435 178.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.662 HG22 ' HE1' ' A' ' 15' ' ' TYR . 19.4 p -97.21 134.48 40.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.235 0.54 . . . . 0.0 111.395 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.611 HG21 ' CZ ' ' A' ' 11' ' ' TYR . 0.5 OUTLIER -102.49 -29.56 11.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.026 -179.126 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.0 m 66.61 31.43 7.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.738 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -142.96 -167.78 2.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.017 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.85 144.94 43.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.827 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -72.65 -140.51 0.37 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.42 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.1 m -172.09 -44.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.693 0.282 . . . . 0.0 111.05 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -117.23 163.3 16.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.2 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.903 ' O ' HG23 ' A' ' 120' ' ' VAL . 73.9 m -125.28 122.5 37.09 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.664 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.988 HD11 HG21 ' A' ' 12' ' ' VAL . 0.4 OUTLIER -75.29 139.52 18.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.03 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.82 ' HB2' ' N ' ' A' ' 119' ' ' GLY . . . -94.57 128.45 41.2 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.061 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.443 ' HB3' ' HB3' ' A' ' 146' ' ' ASP . 0.0 OUTLIER -92.31 33.69 1.08 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.683 179.576 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 26.7 p -99.49 166.96 10.91 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.905 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -121.85 33.41 5.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.241 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 34.4 m -60.44 127.37 31.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.776 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.85 -9.32 58.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.994 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.9 p -117.84 124.0 47.28 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.008 0.432 . . . . 0.0 111.109 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.07 178.88 20.44 Favored Glycine 0 N--CA 1.452 -0.299 0 N-CA-C 111.632 -0.587 . . . . 0.0 111.632 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.844 HG21 ' HB2' ' A' ' 71' ' ' HIS . 8.3 p -119.28 124.83 73.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.205 0.526 . . . . 0.0 111.362 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -105.52 -173.94 2.42 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.433 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.486 ' CG ' ' HB3' ' A' ' 67' ' ' SER . 0.6 OUTLIER 67.88 -90.03 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.134 179.739 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 69.37 -65.44 0.3 Allowed 'General case' 0 C--O 1.231 0.085 0 CA-C-O 120.785 0.326 . . . . 0.0 111.18 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -92.11 -39.55 11.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.695 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.486 ' HB3' ' CG ' ' A' ' 64' ' ' PHE . 20.9 t -46.37 -67.99 0.23 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.779 0.323 . . . . 0.0 111.37 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.437 ' HG3' ' HD3' ' A' ' 70' ' ' LYS . 2.6 tppt? -86.51 8.72 20.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.141 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 65.62 12.85 8.55 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.731 0.301 . . . . 0.0 111.079 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.437 ' HD3' ' HG3' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -142.68 168.98 18.44 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.911 0.386 . . . . 0.0 110.677 179.896 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.844 ' HB2' HG21 ' A' ' 62' ' ' VAL . 7.8 p80 -92.14 116.68 29.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.504 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.785 ' C ' HG23 ' A' ' 62' ' ' VAL . 4.5 m-85 -105.68 112.4 64.57 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.039 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.502 ' HA ' ' HA ' ' A' ' 62' ' ' VAL . 2.8 Cg_endo -84.03 120.88 2.69 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.044 2.496 . . . . 0.0 111.658 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.517 ' CG1' ' CE2' ' A' ' 76' ' ' PHE . 2.5 p -137.52 153.79 28.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.504 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.0 m -94.78 127.68 40.95 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.563 ' CD2' ' HB2' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -131.53 162.71 29.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.379 0.609 . . . . 0.0 111.919 -179.416 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' A' ' 99' ' ' LEU . 0.7 OUTLIER -111.83 158.86 18.9 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.142 178.987 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -104.82 65.48 0.3 Allowed Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.275 -0.964 . . . . 0.0 113.557 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.472 ' HD2' ' HA ' ' A' ' 99' ' ' LEU . 41.9 Cg_endo -68.34 135.23 33.41 Favored 'Trans proline' 0 C--O 1.239 0.535 0 C-N-CA 122.263 1.975 . . . . 0.0 112.198 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -59.3 -85.26 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.245 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.724 HD11 ' HB3' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -97.38 119.5 36.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.993 0.425 . . . . 0.0 111.594 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.626 ' HB ' HG11 ' A' ' 98' ' ' VAL . 44.1 t -123.25 122.42 65.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.823 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.59 107.51 5.13 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.992 0.425 . . . . 0.0 110.67 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.581 HG12 ' O ' ' A' ' 93' ' ' ARG . 2.7 p -74.53 119.29 21.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.557 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.427 ' HA ' ' HG2' ' A' ' 92' ' ' LYS . 24.3 mt-30 -69.65 149.41 48.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.06 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.544 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 14.3 tt0 -68.63 102.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.625 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.552 ' HB3' ' HE1' ' A' ' 126' ' ' MET . 0.1 OUTLIER -143.66 158.64 43.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.382 -179.827 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.451 ' HG2' ' CD2' ' A' ' 89' ' ' TYR . 5.7 tt0 53.54 -84.78 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.709 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.451 ' CD2' ' HG2' ' A' ' 88' ' ' GLU . 0.2 OUTLIER -145.43 19.36 1.53 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.663 0.268 . . . . 0.0 111.146 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.544 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 1.4 t80 -113.85 137.5 22.34 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.737 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.468 ' O ' ' N ' ' A' ' 93' ' ' ARG . 90.3 Cg_endo -85.79 148.59 9.66 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.065 2.51 . . . . 0.0 112.569 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -55.94 82.28 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.873 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.581 ' O ' HG12 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -123.84 174.29 7.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.168 0.509 . . . . 0.0 111.905 -179.477 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.724 ' HB3' HD11 ' A' ' 81' ' ' LEU . 3.8 m-85 -93.29 132.78 37.17 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.175 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.475 ' O ' HD13 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -125.36 126.28 44.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.818 179.896 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.498 ' HB2' HD22 ' A' ' 81' ' ' LEU . 12.1 t -96.28 154.68 17.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.091 0.472 . . . . 0.0 111.983 -179.362 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.6 ' CD2' ' HB2' ' A' ' 139' ' ' ASP . 5.4 t60 57.82 57.52 4.14 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.922 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.626 HG11 ' HB ' ' A' ' 82' ' ' VAL . 11.1 p -123.72 141.07 45.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.528 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.744 HD11 ' OD2' ' A' ' 136' ' ' ASP . 6.2 mp -104.03 141.47 36.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.947 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.731 HD23 ' C ' ' A' ' 132' ' ' VAL . 7.3 mt -125.92 136.39 52.99 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.17 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.563 ' HB2' ' CD2' ' A' ' 76' ' ' PHE . . . -143.65 142.84 31.19 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.684 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 1.6 t -98.26 133.41 42.72 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.864 0.364 . . . . 0.0 111.217 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.3 -134.2 5.55 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.507 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -115.71 -41.32 3.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.801 0.334 . . . . 0.0 110.842 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.88 152.26 38.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.87 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -88.28 147.91 41.34 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.891 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.47 -169.35 0.47 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.513 2.142 . . . . 0.0 112.355 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -112.0 -65.97 0.5 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.499 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -96.51 -29.42 13.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.799 0.333 . . . . 0.0 110.886 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 62.8 157.06 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.105 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 153.93 49.92 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.448 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.74 ' O ' HG13 ' A' ' 124' ' ' VAL . . . -130.46 177.01 18.59 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.559 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 22.7 pt -126.25 146.39 32.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.806 0.336 . . . . 0.0 111.218 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.564 ' HG ' ' HB ' ' A' ' 121' ' ' ILE . 12.4 tp -87.43 117.05 25.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.175 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.15 153.11 34.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.111 0.481 . . . . 0.0 111.715 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.515 ' HB2' HD11 ' A' ' 121' ' ' ILE . 6.2 t -117.66 162.62 17.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.306 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -56.02 -20.86 18.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.926 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.434 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . 18.4 m80 -90.19 -34.77 15.7 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.422 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.82 ' N ' ' HB2' ' A' ' 54' ' ' ALA . . . 177.3 -139.13 4.2 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.026 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.903 HG23 ' O ' ' A' ' 52' ' ' THR . 4.0 t -102.0 135.5 38.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.759 0.314 . . . . 0.0 111.227 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.572 HG22 ' OD1' ' A' ' 136' ' ' ASP . 1.2 mm -94.49 -66.35 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.909 0.385 . . . . 0.0 110.631 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.913 ' HA2' HG23 ' A' ' 137' ' ' VAL . . . -164.05 -161.83 13.88 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.558 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.685 HD11 HD13 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -116.87 164.14 15.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.725 0.298 . . . . 0.0 110.631 179.93 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.74 HG13 ' O ' ' A' ' 112' ' ' GLY . 29.4 m -73.89 129.33 36.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.91 0.386 . . . . 0.0 111.653 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.674 HG22 ' N ' ' A' ' 126' ' ' MET . 3.6 m -110.16 -94.25 0.43 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.129 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.674 ' N ' HG22 ' A' ' 125' ' ' THR . 12.4 mmm -144.56 142.03 29.9 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.855 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -113.21 178.6 18.72 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.588 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -108.41 -139.38 8.81 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.499 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -72.5 -19.43 61.54 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.787 0.327 . . . . 0.0 111.095 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -165.64 19.17 0.1 Allowed Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.816 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.561 ' CG1' HD22 ' A' ' 100' ' ' LEU . 1.5 t -121.85 157.34 25.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.703 0.287 . . . . 0.0 110.576 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.731 ' C ' HD23 ' A' ' 100' ' ' LEU . 12.2 m -115.4 118.39 58.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.825 -179.006 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.572 ' HA3' ' O ' ' A' ' 126' ' ' MET . . . -96.9 116.17 5.42 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.323 -0.942 . . . . 0.0 111.686 178.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.517 ' HD2' HD22 ' A' ' 114' ' ' LEU . 12.9 m-85 -116.2 141.66 47.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.994 0.426 . . . . 0.0 111.726 -179.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.509 ' HB2' ' OG1' ' A' ' 125' ' ' THR . . . -88.89 109.36 20.16 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.066 178.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.744 ' OD2' HD11 ' A' ' 99' ' ' LEU . 0.6 OUTLIER -67.87 152.03 46.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.152 0.501 . . . . 0.0 111.984 -178.735 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.913 HG23 ' HA2' ' A' ' 122' ' ' GLY . 48.0 t -99.33 9.39 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.843 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.486 ' HA ' HD23 ' A' ' 141' ' ' LEU . 5.9 mtm180 -72.29 -6.9 46.41 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.401 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.6 ' HB2' ' CD2' ' A' ' 97' ' ' HIS . 1.1 t70 -94.93 10.77 34.24 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.719 0.295 . . . . 0.0 110.846 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.846 ' O ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -176.77 58.32 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.08 0.467 . . . . 0.0 110.303 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.902 HD11 ' HB ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -73.09 -14.86 61.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.914 -179.386 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 142' ' ' TRP . . . . . 0.423 ' C ' HD12 ' A' ' 143' ' ' LEU . 15.8 p-90 -56.88 83.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.934 0.397 . . . . 0.0 111.476 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.69 HD12 ' C ' ' A' ' 141' ' ' LEU . 4.8 mp -150.91 -47.0 0.12 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.614 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.436 ' HB2' HG12 ' A' ' 12' ' ' VAL . 0.4 OUTLIER -151.46 -166.81 2.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.065 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.48 149.09 50.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.369 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.443 ' HB3' ' HB3' ' A' ' 55' ' ' ARG . 9.6 m-20 -95.29 154.53 17.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.753 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.81 144.85 56.72 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.897 0.379 . . . . 0.0 111.124 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 1.7 ptm 174.54 -33.28 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.758 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 67.75 85.56 0.14 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.852 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.146 -0.93 . . . . 0.0 110.909 -179.991 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.161 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.05 105.22 1.49 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.591 2.194 . . . . 0.0 112.318 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -79.42 121.34 25.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.951 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -137.53 113.08 0.97 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.552 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.2 m170 -110.72 -54.37 2.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.826 0.346 . . . . 0.0 110.878 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -139.78 -47.45 0.45 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.863 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -155.51 163.93 39.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.938 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -160.13 179.27 35.78 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.479 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.37 -174.35 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.813 0.34 . . . . 0.0 111.099 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.449 HG22 HG21 ' A' ' 113' ' ' ILE . 41.5 t -108.82 110.7 33.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.107 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.802 ' CE2' HG21 ' A' ' 45' ' ' THR . 5.2 t80 -99.73 116.32 31.55 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.791 0.329 . . . . 0.0 110.529 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.844 HG21 HD11 ' A' ' 53' ' ' ILE . 47.6 t -120.85 111.64 32.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.657 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.404 ' O ' ' CE1' ' A' ' 11' ' ' TYR . . . 53.0 -125.32 30.35 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.959 -0.639 . . . . 0.0 113.18 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.423 ' O ' ' HA ' ' A' ' 44' ' ' THR . 44.6 m-80 -91.93 18.73 7.44 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.701 0.286 . . . . 0.0 111.569 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.648 ' HE1' HG22 ' A' ' 44' ' ' THR . 6.2 m-30 -130.35 149.94 51.81 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.5 tttp -139.09 114.87 10.02 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.709 -0.223 . . . . 0.0 110.629 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 1.018 HG12 HG22 ' A' ' 42' ' ' VAL . 0.6 OUTLIER -100.3 121.64 51.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.041 0.448 . . . . 0.0 110.77 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.664 ' O ' HD12 ' A' ' 40' ' ' LEU . 7.3 p -136.43 160.26 37.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.037 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.513 ' N ' HG22 ' A' ' 18' ' ' VAL . 0.6 OUTLIER -62.26 141.51 58.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.227 179.054 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 8.4 ttp180 -56.27 -45.59 80.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.942 0.401 . . . . 0.0 110.85 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -66.85 -11.62 56.29 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.153 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.71 -13.41 14.79 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.961 ' HB3' ' CZ2' ' A' ' 28' ' ' TRP . . . -68.74 150.72 47.56 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 120.796 0.331 . . . . 0.0 110.834 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.403 ' O ' ' CE3' ' A' ' 28' ' ' TRP . 32.6 p -104.59 168.94 8.75 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.269 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 52.5 p-80 -54.76 -29.68 54.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.002 0.43 . . . . 0.0 110.564 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.4 t -74.66 -31.36 26.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.459 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.431 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 0.6 OUTLIER -67.18 -43.98 80.84 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.961 ' CZ2' ' HB3' ' A' ' 23' ' ' ALA . 7.2 m-90 -74.33 -30.37 62.01 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.145 179.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.15 -41.99 89.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.32 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -116.66 32.58 6.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.486 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.444 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 13.2 t -77.24 132.42 38.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.179 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.566 HG22 ' O ' ' A' ' 42' ' ' VAL . 16.8 m -96.06 -38.83 8.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.695 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.663 ' CE3' HG23 ' A' ' 42' ' ' VAL . 1.1 t90 -139.67 153.27 47.24 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.908 0.385 . . . . 0.0 111.548 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -155.69 120.51 4.74 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.79 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.439 ' HB2' ' CZ2' ' A' ' 33' ' ' TRP . 8.3 m-20 -107.09 99.2 8.77 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.038 0.447 . . . . 0.0 111.14 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -58.91 -28.92 66.66 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.8 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.69 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 0.9 OUTLIER -59.68 -38.74 82.35 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.755 -0.202 . . . . 0.0 111.301 -179.052 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.605 ' CZ ' HD22 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -117.31 0.75 12.31 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 60.24 54.83 3.84 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.85 0.357 . . . . 0.0 111.892 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.716 HD11 HG23 ' A' ' 17' ' ' VAL . 38.3 tp -137.11 133.65 35.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.449 179.017 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.67 ' O ' HD23 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -131.44 156.0 46.38 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.053 0.454 . . . . 0.0 112.068 -179.526 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 1.018 HG22 HG12 ' A' ' 17' ' ' VAL . 23.7 t -117.17 130.08 72.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.062 179.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.4 p -120.49 157.15 30.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.57 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.648 HG22 ' HE1' ' A' ' 15' ' ' TYR . 19.6 p -97.54 123.59 41.48 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.183 0.516 . . . . 0.0 111.493 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.802 HG21 ' CE2' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -98.28 -165.01 1.19 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.872 -179.429 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.0 t -138.86 42.35 2.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.856 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -136.03 -177.98 4.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.085 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -93.0 148.14 22.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.959 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -66.88 157.35 51.1 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.646 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -134.65 -49.17 0.76 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.872 0.368 . . . . 0.0 110.903 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -87.96 150.53 23.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.825 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.872 ' O ' HG23 ' A' ' 120' ' ' VAL . 39.9 m -122.99 116.98 24.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.763 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.9 ' HB ' HD11 ' A' ' 141' ' ' LEU . 0.4 OUTLIER -74.62 139.55 19.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.048 0.452 . . . . 0.0 110.968 -179.843 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.77 ' HB2' ' CA ' ' A' ' 119' ' ' GLY . . . -88.8 121.97 31.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.971 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.594 ' H ' ' HB3' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -88.44 29.01 1.02 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.11 0.481 . . . . 0.0 110.12 179.054 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 30.8 p -100.0 163.27 12.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.091 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.426 ' O ' ' O ' ' A' ' 58' ' ' CYS . 44.4 mt-30 -93.56 -70.19 0.71 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 178.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.426 ' O ' ' O ' ' A' ' 57' ' ' GLN . 96.3 m 54.47 159.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.74 178.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.11 -7.53 11.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.951 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.499 ' HA ' ' HA ' ' A' ' 75' ' ' SER . 10.0 p -132.41 123.97 27.75 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.973 0.416 . . . . 0.0 111.344 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -136.99 161.64 25.16 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.64 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.773 HG23 ' C ' ' A' ' 72' ' ' TYR . 7.3 p -102.52 132.91 47.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.951 0.405 . . . . 0.0 111.308 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.737 ' HE2' HG21 ' A' ' 74' ' ' VAL . 3.5 p90 -118.66 133.99 55.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.949 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -68.4 132.69 47.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.902 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.403 ' CB ' ' HB2' ' A' ' 68' ' ' LYS . 0.8 OUTLIER -91.58 155.49 18.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.909 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -92.03 -36.29 13.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.058 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.2 t -90.69 -48.36 7.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.875 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.403 ' HB2' ' CB ' ' A' ' 65' ' ' CYS . 14.3 mmtt -63.38 -27.03 69.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.096 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.2 m 57.03 24.26 9.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.921 0.391 . . . . 0.0 110.738 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp -133.62 170.05 16.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.691 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 45.1 p-80 -83.99 126.78 33.37 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.773 ' C ' HG23 ' A' ' 62' ' ' VAL . 0.5 OUTLIER -116.31 113.94 40.92 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.835 -178.666 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 72' ' ' TYR . 5.5 Cg_exo -77.34 120.67 5.37 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.473 2.115 . . . . 0.0 110.319 178.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.737 HG21 ' HE2' ' A' ' 63' ' ' TYR . 43.2 t -137.47 151.09 26.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.164 0.507 . . . . 0.0 112.365 -178.345 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.499 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 20.7 m -98.71 133.92 42.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.522 178.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.723 ' CD2' ' HB2' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -145.75 174.14 11.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.444 0.64 . . . . 0.0 112.122 -179.188 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.607 ' C ' ' HD3' ' A' ' 79' ' ' PRO . 0.3 OUTLIER -111.86 158.84 18.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.703 179.425 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.445 ' HA2' ' HG ' ' A' ' 99' ' ' LEU . . . -112.77 66.76 0.25 Allowed Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.235 -0.983 . . . . 0.0 113.642 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.607 ' HD3' ' C ' ' A' ' 77' ' ' GLU . 14.0 Cg_exo -67.46 139.95 50.91 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.376 2.05 . . . . 0.0 112.212 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -57.42 -90.22 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.432 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.701 HD11 ' HB3' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -95.69 119.92 35.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.912 0.387 . . . . 0.0 111.733 -179.756 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.597 ' HB ' HG11 ' A' ' 98' ' ' VAL . 18.8 t -124.2 122.45 64.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.149 178.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -72.57 107.89 5.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.482 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.61 HG22 ' O ' ' A' ' 93' ' ' ARG . 4.8 m -72.77 123.73 28.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.855 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -69.29 150.28 47.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.669 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.584 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 22.8 tt0 -67.61 102.01 1.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.143 0.497 . . . . 0.0 110.373 -179.363 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 89' ' ' TYR . 4.1 m -144.3 164.08 31.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.188 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 55.93 -81.48 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.542 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.447 ' N ' ' O ' ' A' ' 87' ' ' SER . 0.7 OUTLIER -156.92 24.17 0.32 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.759 0.314 . . . . 0.0 110.877 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.584 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 1.6 t80 -122.69 131.62 24.35 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.695 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.473 ' O ' ' N ' ' A' ' 93' ' ' ARG . 87.0 Cg_endo -81.98 148.84 15.49 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.095 2.53 . . . . 0.0 112.524 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.4 OUTLIER -42.6 88.99 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.509 -179.931 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.61 ' O ' HG22 ' A' ' 84' ' ' VAL . 2.0 ttt180 -123.93 171.08 9.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.219 0.533 . . . . 0.0 112.074 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.701 ' HB3' HD11 ' A' ' 81' ' ' LEU . 3.9 m-85 -98.88 132.84 43.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.131 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.69 ' HA ' ' O ' ' A' ' 37' ' ' ASN . 2.0 tp60 -126.43 114.89 18.78 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.893 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.59 ' HA ' HD22 ' A' ' 81' ' ' LEU . 60.7 p -80.07 144.0 33.52 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.114 0.483 . . . . 0.0 111.875 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 21.7 m80 61.96 60.83 1.47 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.998 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.597 HG11 ' HB ' ' A' ' 82' ' ' VAL . 7.1 p -124.17 131.06 73.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.721 0.296 . . . . 0.0 111.266 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.766 HD11 ' HB3' ' A' ' 136' ' ' ASP . 2.2 mp -101.76 149.16 24.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.976 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.693 HD23 ' C ' ' A' ' 132' ' ' VAL . 9.0 mt -128.69 136.37 50.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.161 0.505 . . . . 0.0 111.96 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.723 ' HB2' ' CD2' ' A' ' 76' ' ' PHE . . . -125.69 124.3 40.8 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.352 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.3 t -96.78 112.01 23.94 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.799 0.333 . . . . 0.0 110.621 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -48.78 150.09 3.85 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.821 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.43 -70.88 0.27 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.808 0.337 . . . . 0.0 110.855 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 52.6 m -141.48 143.57 33.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.848 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 60.06 79.48 0.29 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.867 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.81 163.22 39.86 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.572 2.181 . . . . 0.0 112.321 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -150.92 -177.61 24.95 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.396 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -67.49 163.44 21.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.881 0.372 . . . . 0.0 110.855 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -156.93 136.01 11.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.165 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -166.94 111.28 0.44 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.496 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 159.81 -140.1 6.58 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.484 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.449 HG21 HG22 ' A' ' 10' ' ' VAL . 27.3 pt -122.54 145.32 29.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.861 0.362 . . . . 0.0 111.139 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.596 HD21 ' CZ ' ' A' ' 76' ' ' PHE . 8.4 tp -87.82 121.18 29.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.319 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.441 ' N ' HD12 ' A' ' 114' ' ' LEU . 0.8 OUTLIER -118.36 149.5 41.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.207 0.527 . . . . 0.0 111.962 -179.271 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.654 ' HB2' HD11 ' A' ' 121' ' ' ILE . 6.2 t -111.68 163.67 13.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.982 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -58.51 -17.26 19.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.022 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 18.8 m80 -95.66 -30.68 13.63 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.653 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.77 ' CA ' ' HB2' ' A' ' 54' ' ' ALA . . . 176.82 -143.1 6.16 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.424 -0.893 . . . . 0.0 113.034 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.872 HG23 ' O ' ' A' ' 52' ' ' THR . 3.6 t -98.93 135.33 34.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.726 0.298 . . . . 0.0 111.024 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.654 HD11 ' HB2' ' A' ' 116' ' ' CYS . 1.7 mm -92.35 -66.14 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.839 0.352 . . . . 0.0 110.794 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.847 ' HA2' HG23 ' A' ' 137' ' ' VAL . . . -166.98 -156.26 9.6 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.622 -0.799 . . . . 0.0 113.045 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.668 HD11 HD13 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -116.94 164.16 15.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.804 0.335 . . . . 0.0 110.983 -179.824 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.486 ' HA ' ' CD1' ' A' ' 134' ' ' PHE . 11.6 p -66.51 129.53 31.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.625 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.74 ' OG1' ' HB2' ' A' ' 135' ' ' ALA . 7.3 m -110.07 -87.35 0.52 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.228 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.537 ' N ' HG22 ' A' ' 125' ' ' THR . 0.0 OUTLIER -104.75 144.37 31.83 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.852 0.358 . . . . 0.0 111.13 179.825 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -118.86 96.26 0.65 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.154 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -77.43 174.5 54.63 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.603 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -71.93 -19.36 61.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.713 0.292 . . . . 0.0 110.931 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -145.16 4.74 1.37 Allowed Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.631 -0.795 . . . . 0.0 113.062 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.537 ' CG1' HD22 ' A' ' 100' ' ' LEU . 1.4 t -128.66 157.05 41.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 117.023 0.412 . . . . 0.0 111.008 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.693 ' C ' HD23 ' A' ' 100' ' ' LEU . 3.4 t -114.89 117.83 56.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.989 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -96.19 118.44 5.98 Favored Glycine 0 CA--C 1.517 0.16 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.801 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.501 ' CZ ' ' HB2' ' A' ' 63' ' ' TYR . 21.4 m-85 -125.13 133.06 52.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.909 0.385 . . . . 0.0 111.787 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.74 ' HB2' ' OG1' ' A' ' 125' ' ' THR . . . -93.62 107.76 19.58 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.766 ' HB3' HD11 ' A' ' 99' ' ' LEU . 2.5 p30 -67.72 151.84 46.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.262 0.554 . . . . 0.0 112.42 -178.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.847 HG23 ' HA2' ' A' ' 122' ' ' GLY . 39.7 t -93.58 13.72 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.643 179.103 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.472 ' HA ' HD23 ' A' ' 141' ' ' LEU . 1.3 mtm105 -70.61 -6.99 40.86 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.772 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -96.69 11.13 36.54 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.555 0.217 . . . . 0.0 111.3 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.847 ' O ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER 179.8 58.6 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.027 0.441 . . . . 0.0 110.501 -179.876 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.9 HD11 ' HB ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -74.58 -14.78 60.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.07 -179.515 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 142' ' ' TRP . . . . . 0.414 ' CE3' ' CE2' ' A' ' 15' ' ' TYR . 16.3 p-90 -55.48 81.66 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.006 0.431 . . . . 0.0 111.267 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.704 HD12 ' C ' ' A' ' 141' ' ' LEU . 5.0 mp -147.14 -45.82 0.17 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.302 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -152.91 -173.41 4.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.815 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.84 130.46 47.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.07 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -83.75 154.21 23.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.863 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.594 ' HB3' ' H ' ' A' ' 55' ' ' ARG . . . -77.31 130.88 37.75 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.066 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 2.8 mtt -103.32 163.59 12.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.892 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.6 -61.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.86 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.173 -0.917 . . . . 0.0 110.918 -179.997 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.169 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.96 144.71 53.81 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.604 2.203 . . . . 0.0 112.359 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -164.62 145.82 8.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.96 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.76 -65.83 3.47 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.531 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -89.97 137.4 32.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.767 0.317 . . . . 0.0 110.939 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -119.17 119.14 33.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.878 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.1 p -79.39 123.78 27.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.963 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 152.45 -36.12 0.81 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.516 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.81 ' HB2' HG23 ' A' ' 18' ' ' VAL . . . -131.72 173.16 11.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.848 0.356 . . . . 0.0 111.039 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.896 ' HB ' HG21 ' A' ' 113' ' ' ILE . 10.7 p -125.38 111.45 27.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.728 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 9.8 p90 -113.71 136.06 53.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.978 0.418 . . . . 0.0 111.16 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.606 HG21 HD11 ' A' ' 53' ' ' ILE . 95.1 t -118.94 134.88 61.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.491 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 45.51 -124.24 6.62 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 115.933 -0.576 . . . . 0.0 113.206 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.469 ' O ' ' HA ' ' A' ' 44' ' ' THR . 3.7 m-20 -91.59 17.96 8.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.646 0.26 . . . . 0.0 111.228 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.652 ' HB2' HD23 ' A' ' 143' ' ' LEU . 6.9 m-30 -127.82 147.36 50.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.259 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 11' ' ' TYR . 1.0 OUTLIER -133.63 114.73 13.84 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.771 179.467 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.861 HG12 HG22 ' A' ' 42' ' ' VAL . 1.2 m -102.26 121.37 53.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 121.242 0.544 . . . . 0.0 110.834 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.81 HG23 ' HB2' ' A' ' 9' ' ' ALA . 12.0 p -137.17 161.44 35.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.32 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.502 ' N ' HG22 ' A' ' 18' ' ' VAL . 0.7 OUTLIER -59.6 141.64 54.53 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 178.713 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.426 ' O ' ' HZ2' ' A' ' 28' ' ' TRP . 5.1 mtp-105 -56.29 -47.54 78.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.905 0.383 . . . . 0.0 111.254 -179.148 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -69.09 -8.4 44.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.344 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.7 tp -115.35 5.86 14.72 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.729 ' HB3' ' NE1' ' A' ' 28' ' ' TRP . . . -88.88 129.26 35.63 Favored 'General case' 0 C--N 1.334 -0.07 0 C-N-CA 120.291 -0.563 . . . . 0.0 111.444 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.512 ' O ' ' HD1' ' A' ' 28' ' ' TRP . 27.4 p -74.85 164.68 26.3 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.703 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -53.74 -29.81 41.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.221 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.421 ' HA ' ' HG2' ' A' ' 29' ' ' GLN . 21.7 t -68.76 -33.99 62.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.973 0.416 . . . . 0.0 110.97 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.445 ' O ' ' HB3' ' A' ' 31' ' ' CYS . 0.4 OUTLIER -68.45 -43.5 76.89 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.258 179.67 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.729 ' NE1' ' HB3' ' A' ' 23' ' ' ALA . 59.0 m95 -73.69 -45.84 49.96 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.91 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.421 ' HG2' ' HA ' ' A' ' 26' ' ' VAL . 3.2 pt20 -54.97 -37.39 66.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.896 0.379 . . . . 0.0 110.689 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.2 m-20 -115.36 34.42 4.9 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.782 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.5 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 20.4 p -80.17 127.38 32.26 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.027 0.441 . . . . 0.0 111.365 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.586 HG22 ' O ' ' A' ' 42' ' ' VAL . 16.0 m -88.26 -38.95 12.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.329 179.106 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.638 ' CZ3' HG23 ' A' ' 42' ' ' VAL . 0.4 OUTLIER -139.81 153.13 47.01 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.977 179.753 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.414 ' HG3' ' HB3' ' A' ' 41' ' ' LEU . 5.2 tt0 -166.11 107.06 0.71 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.019 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.425 ' OD1' ' CZ2' ' A' ' 33' ' ' TRP . 34.6 p-10 -107.36 125.15 50.83 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.089 0.471 . . . . 0.0 111.118 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -67.0 -34.5 77.89 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.567 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -59.79 -24.49 64.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.913 0.387 . . . . 0.0 110.562 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.513 ' NE ' ' HA ' ' A' ' 38' ' ' ARG . 4.6 tpm_? -113.14 -4.74 13.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.975 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.419 ' HA ' ' HD3' ' A' ' 20' ' ' ARG . 1.9 m-20 48.97 36.87 9.14 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-O 121.112 0.482 . . . . 0.0 109.982 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.804 HD12 ' O ' ' A' ' 18' ' ' VAL . 30.8 tp -130.79 154.58 47.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.247 -178.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.632 ' O ' HD23 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -146.58 156.02 42.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.59 179.795 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.861 HG22 HG12 ' A' ' 17' ' ' VAL . 19.8 t -120.27 129.82 75.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.234 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 24.1 p -121.15 157.34 30.38 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.208 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.631 HG22 ' CE1' ' A' ' 15' ' ' TYR . 16.6 p -97.49 119.86 36.81 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.164 0.506 . . . . 0.0 111.324 -179.195 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -111.7 -33.78 6.24 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.038 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.7 m 64.05 45.08 4.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.881 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.65 160.29 37.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.095 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -58.73 130.28 46.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.826 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.457 ' HA2' ' CE2' ' A' ' 11' ' ' TYR . . . -104.59 -32.48 4.18 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.624 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER 59.22 20.81 8.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.669 0.271 . . . . 0.0 111.018 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -130.04 137.25 50.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.873 0.368 . . . . 0.0 110.742 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.875 ' O ' HG23 ' A' ' 120' ' ' VAL . 73.5 m -121.99 120.37 34.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.421 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.765 ' HB ' HD11 ' A' ' 141' ' ' LEU . 0.9 OUTLIER -72.82 139.22 19.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.82 0.343 . . . . 0.0 110.652 -179.815 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.759 ' HB2' ' N ' ' A' ' 119' ' ' GLY . . . -91.06 121.65 33.04 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.225 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.508 ' H ' ' HB3' ' A' ' 147' ' ' ALA . 0.5 OUTLIER -94.44 38.66 1.1 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.382 179.395 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 12.5 p -99.86 167.06 10.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.069 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -114.69 30.26 7.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.07 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 63.6 m -59.4 163.51 3.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.881 0.372 . . . . 0.0 110.875 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.6 m -117.0 2.66 12.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.93 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 75' ' ' SER . 17.6 p -136.02 126.25 26.41 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 120.879 0.371 . . . . 0.0 111.159 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -134.69 -161.75 9.59 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.041 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.546 HG23 ' C ' ' A' ' 72' ' ' TYR . 7.2 p -140.37 137.78 36.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.992 0.425 . . . . 0.0 111.205 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.712 ' CE2' HG21 ' A' ' 74' ' ' VAL . 6.5 p90 -143.53 129.94 19.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.439 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -59.87 134.06 56.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.804 0.335 . . . . 0.0 110.972 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -70.2 159.19 34.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.092 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.76 -45.05 54.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.206 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.4 m -85.72 -42.92 13.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.714 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.5 mmtt -81.28 129.27 34.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.657 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.19 50.06 1.94 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.012 0.434 . . . . 0.0 110.69 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.43 170.03 17.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.652 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 26.5 p-80 -83.71 139.51 32.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.059 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.546 ' C ' HG23 ' A' ' 62' ' ' VAL . 2.1 m-85 -123.85 114.11 28.32 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.619 -178.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 72' ' ' TYR . 7.9 Cg_exo -71.91 120.57 6.94 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.265 1.977 . . . . 0.0 110.423 178.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.712 HG21 ' CE2' ' A' ' 63' ' ' TYR . 56.0 t -132.69 142.02 43.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.08 0.467 . . . . 0.0 112.155 -178.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.443 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 75.6 p -93.88 121.0 34.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.331 178.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.436 ' CE1' HD21 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -125.34 164.78 19.64 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.439 0.638 . . . . 0.0 112.017 -178.657 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' A' ' 99' ' ' LEU . 12.0 mt-10 -111.8 159.02 18.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.162 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -104.56 65.03 0.32 Allowed Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.334 -0.936 . . . . 0.0 113.724 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.482 ' HD2' ' HA ' ' A' ' 99' ' ' LEU . 40.2 Cg_endo -67.97 136.09 37.08 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.419 2.079 . . . . 0.0 112.105 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -61.62 -87.43 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.255 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.686 HD11 ' HB3' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -90.76 119.65 31.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.813 0.34 . . . . 0.0 111.444 -179.878 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.638 ' HB ' HG11 ' A' ' 98' ' ' VAL . 23.4 t -129.04 122.2 55.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.34 178.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -74.42 108.1 6.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.839 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.565 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 35.0 m -72.65 124.59 29.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.234 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -69.24 149.84 48.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.327 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.649 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 2.0 pt-20 -68.36 102.83 1.48 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.793 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.411 ' O ' ' N ' ' A' ' 89' ' ' TYR . 1.4 m -143.57 155.19 44.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.395 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 59.48 -79.4 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.43 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.411 ' N ' ' O ' ' A' ' 87' ' ' SER . 1.0 OUTLIER -156.22 24.24 0.36 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.791 0.329 . . . . 0.0 111.028 -179.982 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.649 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -119.51 130.18 24.98 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.306 179.858 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.4 ' O ' ' N ' ' A' ' 93' ' ' ARG . 85.4 Cg_endo -83.92 148.42 12.16 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.862 2.375 . . . . 0.0 112.662 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.565 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -47.28 92.65 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.083 179.954 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.4 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.6 OUTLIER -123.88 166.31 15.87 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.116 0.484 . . . . 0.0 112.168 -179.304 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.686 ' HB3' HD11 ' A' ' 81' ' ' LEU . 4.3 m-85 -97.38 129.99 44.57 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.173 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.523 ' O ' HD13 ' A' ' 81' ' ' LEU . 22.7 mm-40 -131.45 137.92 48.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.701 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.539 ' HB2' HD22 ' A' ' 81' ' ' LEU . 23.2 t -103.66 142.81 33.68 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -179.54 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.454 ' HB2' ' O ' ' A' ' 96' ' ' SER . 96.3 m-70 75.93 56.04 0.05 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.353 179.074 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.638 HG11 ' HB ' ' A' ' 82' ' ' VAL . 12.1 p -123.57 143.85 35.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.737 0.304 . . . . 0.0 110.87 178.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.482 ' HA ' ' HD2' ' A' ' 79' ' ' PRO . 11.0 mp -102.71 140.54 36.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.039 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.712 HD23 ' O ' ' A' ' 132' ' ' VAL . 5.5 mt -130.96 140.33 50.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.188 0.518 . . . . 0.0 112.16 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.48 ' O ' HG12 ' A' ' 131' ' ' VAL . . . -152.07 159.37 43.7 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.526 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 130' ' ' GLY . 0.7 OUTLIER -112.19 127.13 55.86 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.02 0.438 . . . . 0.0 111.046 179.694 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -125.19 -121.58 2.55 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.465 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -154.47 77.75 1.06 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.861 0.363 . . . . 0.0 110.684 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 34.7 p -134.75 -162.99 1.31 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.844 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.452 ' CB ' ' CD ' ' A' ' 107' ' ' PRO . 0.1 OUTLIER -161.96 -65.02 0.02 OUTLIER Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.931 179.911 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.452 ' CD ' ' CB ' ' A' ' 106' ' ' GLU . 28.2 Cg_endo -62.43 -45.08 15.72 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.432 2.088 . . . . 0.0 112.138 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 70.41 -66.21 0.76 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.509 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 61.14 178.83 0.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.801 0.334 . . . . 0.0 110.842 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -101.4 -175.09 2.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.097 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 67.87 135.32 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.562 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.697 ' O ' HG13 ' A' ' 124' ' ' VAL . . . 129.23 140.47 4.88 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.373 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.896 HG21 ' HB ' ' A' ' 10' ' ' VAL . 2.7 pp -126.25 146.4 32.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.931 0.396 . . . . 0.0 111.738 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.472 HD22 ' HD2' ' A' ' 134' ' ' PHE . 9.8 tp -87.5 123.47 32.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.146 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 2.7 mtm180 -115.5 145.5 42.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.155 0.502 . . . . 0.0 111.627 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.488 ' HB2' HD11 ' A' ' 121' ' ' ILE . 4.5 t -109.4 165.46 11.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.145 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -60.86 -16.28 39.69 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.805 0.336 . . . . 0.0 110.616 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.431 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . 19.3 m80 -95.39 -29.24 14.54 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.528 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.759 ' N ' ' HB2' ' A' ' 54' ' ' ALA . . . 171.27 -140.47 5.92 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.537 -0.839 . . . . 0.0 113.015 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' ' 52' ' ' THR . 2.7 t -99.24 135.23 35.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.637 0.256 . . . . 0.0 110.835 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.488 HD11 ' HB2' ' A' ' 116' ' ' CYS . 0.9 OUTLIER -99.96 -71.5 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.397 -179.95 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.921 ' HA2' HG23 ' A' ' 137' ' ' VAL . . . -153.65 -168.04 16.8 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.326 -0.94 . . . . 0.0 113.294 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.604 HD11 HD13 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -116.88 164.2 15.04 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.635 0.255 . . . . 0.0 110.884 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.697 HG13 ' O ' ' A' ' 112' ' ' GLY . 28.0 m -66.22 126.52 25.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.743 0.306 . . . . 0.0 111.189 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.743 ' OG1' ' HB2' ' A' ' 135' ' ' ALA . 3.7 m -108.38 -94.05 0.4 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.779 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.69 ' N ' HG22 ' A' ' 125' ' ' THR . 73.7 mmm -144.02 162.3 36.56 Favored 'General case' 0 C--O 1.228 -0.076 0 CA-C-O 121.085 0.469 . . . . 0.0 111.538 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 175.85 -159.2 26.64 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.232 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -130.39 -153.32 7.68 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.404 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -89.75 11.83 18.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.722 0.296 . . . . 0.0 110.92 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 102' ' ' THR . . . -134.17 -36.32 0.25 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.728 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -115.67 157.28 16.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-O 120.949 0.404 . . . . 0.0 111.421 -179.859 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.712 ' O ' HD23 ' A' ' 100' ' ' LEU . 4.5 m -122.42 118.83 56.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.423 -179.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.538 ' HA3' ' O ' ' A' ' 126' ' ' MET . . . -101.76 114.89 5.09 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.384 -0.912 . . . . 0.0 112.082 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.472 ' HD2' HD22 ' A' ' 114' ' ' LEU . 10.7 m-85 -114.76 140.52 48.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.871 0.367 . . . . 0.0 111.261 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.743 ' HB2' ' OG1' ' A' ' 125' ' ' THR . . . -88.85 115.35 26.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.41 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.413 ' OD1' HD13 ' A' ' 99' ' ' LEU . 1.0 OUTLIER -68.0 142.61 55.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.072 -178.862 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.921 HG23 ' HA2' ' A' ' 122' ' ' GLY . 93.6 t -91.37 9.68 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.38 178.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.537 ' HA ' HD23 ' A' ' 141' ' ' LEU . 4.4 mtm-85 -71.53 -6.76 43.0 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.406 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -95.04 10.99 33.62 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 120.579 0.228 . . . . 0.0 111.23 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.878 ' O ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -176.09 61.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.295 0.569 . . . . 0.0 110.332 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.765 HD11 ' HB ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -78.89 -14.66 59.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.024 -179.474 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 18.2 p-90 -59.78 76.46 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.006 0.432 . . . . 0.0 111.785 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.652 HD23 ' HB2' ' A' ' 15' ' ' TYR . 4.9 mp -140.77 -47.39 0.41 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.823 178.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.491 ' HB2' ' CG1' ' A' ' 12' ' ' VAL . 1.5 tp10 -150.05 -161.89 1.44 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.441 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -69.35 146.36 52.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.832 0.348 . . . . 0.0 110.851 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -93.17 154.12 18.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.906 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.508 ' HB3' ' H ' ' A' ' 55' ' ' ARG . . . -91.74 132.43 36.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.166 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 19.7 ttt -164.48 -55.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.996 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -109.09 164.02 12.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.877 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.956 179.992 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.87 173.88 10.42 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.63 2.22 . . . . 0.0 112.309 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 99.8 m-85 60.38 -177.81 0.1 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.93 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 165.4 80.9 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.545 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -112.64 -36.61 5.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.735 0.302 . . . . 0.0 110.892 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -160.17 106.61 1.57 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.898 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.2 m -140.84 79.55 1.7 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.91 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 178.73 37.45 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.546 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.778 ' HB2' HG23 ' A' ' 18' ' ' VAL . . . -124.99 140.31 53.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.831 0.348 . . . . 0.0 111.108 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.852 HG22 HG21 ' A' ' 113' ' ' ILE . 25.6 t -108.68 111.89 37.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.059 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 1.5 p90 -117.34 124.09 48.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.898 0.38 . . . . 0.0 110.874 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.681 ' HB ' HD22 ' A' ' 143' ' ' LEU . 75.1 t -119.26 140.96 41.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.703 -179.169 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 45.37 -129.83 8.83 Favored Glycine 0 C--N 1.333 0.379 0 CA-C-N 115.94 -0.573 . . . . 0.0 113.306 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.457 ' O ' ' HA ' ' A' ' 44' ' ' THR . 28.6 p30 -89.49 18.84 4.94 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.693 0.282 . . . . 0.0 111.23 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.727 ' HB2' HD23 ' A' ' 143' ' ' LEU . 7.8 m-30 -127.61 147.69 50.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.287 -0.415 . . . . 0.0 109.954 179.497 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 11' ' ' TYR . 10.6 tttt -132.79 114.7 14.42 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.685 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.804 HG23 HD11 ' A' ' 40' ' ' LEU . 1.6 m -101.44 121.29 52.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-O 121.148 0.499 . . . . 0.0 110.765 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.778 HG23 ' HB2' ' A' ' 9' ' ' ALA . 12.0 p -137.02 161.41 35.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.31 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.501 ' N ' HG22 ' A' ' 18' ' ' VAL . 0.8 OUTLIER -61.74 141.51 57.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.044 178.823 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.55 -44.64 81.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.763 0.316 . . . . 0.0 111.211 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -69.41 -7.51 38.37 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.166 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.42 HD12 ' HB2' ' A' ' 19' ' ' ASN . 79.9 mt -115.1 -2.88 12.66 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.694 ' HB3' ' NE1' ' A' ' 28' ' ' TRP . . . -86.08 126.57 34.29 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.229 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.693 HG23 HG12 ' A' ' 26' ' ' VAL . 1.8 t -74.86 165.16 25.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.721 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -53.7 -29.98 41.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.845 -178.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.693 HG12 HG23 ' A' ' 24' ' ' THR . 11.4 p -72.65 -31.25 36.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.717 0.294 . . . . 0.0 110.967 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -67.66 -43.76 79.47 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.14 0.495 . . . . 0.0 109.697 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.694 ' NE1' ' HB3' ' A' ' 23' ' ' ALA . 48.9 m95 -73.85 -30.04 62.45 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.725 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -60.09 -44.23 94.96 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.556 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -110.2 27.75 9.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.336 179.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.465 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 7.0 t -73.13 123.64 24.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.043 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.56 ' CG2' HG12 ' A' ' 42' ' ' VAL . 13.3 m -86.32 -40.11 14.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.696 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.599 ' HH2' HD23 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -139.59 153.13 47.31 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.885 0.374 . . . . 0.0 111.181 179.825 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.408 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 1.0 OUTLIER -159.88 117.04 2.58 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.846 179.65 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.434 ' HB2' ' CZ2' ' A' ' 33' ' ' TRP . 0.7 OUTLIER -107.11 118.04 35.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.234 -179.759 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -62.93 -46.97 85.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.585 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -59.9 -18.86 47.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.242 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? -111.75 -6.05 14.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.191 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 48.55 38.93 12.08 Favored 'General case' 0 N--CA 1.461 0.079 0 CA-C-O 121.132 0.492 . . . . 0.0 110.401 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.804 HD11 HG23 ' A' ' 17' ' ' VAL . 27.1 tp -132.42 156.23 47.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.978 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.643 ' O ' HD23 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -150.2 156.12 41.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.478 179.746 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.91 HG21 HD23 ' A' ' 140' ' ' LEU . 21.3 t -120.01 133.04 68.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.98 0.419 . . . . 0.0 110.301 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.5 t -125.98 157.42 37.87 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.202 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.646 HG22 ' HE1' ' A' ' 15' ' ' TYR . 11.8 p -97.33 119.99 36.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.266 0.555 . . . . 0.0 111.529 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -108.14 160.72 15.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.887 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.0 t -105.99 42.48 1.25 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.875 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.33 169.94 16.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.139 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 10.1 p-80 -76.99 143.8 39.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.856 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -83.69 128.35 8.52 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.468 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -105.64 28.53 7.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.794 0.33 . . . . 0.0 110.87 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.516 ' O ' HG22 ' A' ' 12' ' ' VAL . 31.8 m-20 -153.02 133.57 13.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.82 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.905 ' O ' HG23 ' A' ' 120' ' ' VAL . 48.7 m -117.64 116.43 27.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.813 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.661 HG12 HG21 ' A' ' 12' ' ' VAL . 3.8 mm -72.9 139.72 19.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.839 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.849 ' HB2' ' N ' ' A' ' 119' ' ' GLY . . . -83.83 -53.57 5.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.785 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.405 ' CG ' ' HG ' ' A' ' 141' ' ' LEU . 29.0 ttt-85 63.75 35.54 11.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.997 0.427 . . . . 0.0 110.038 -178.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 6.0 p -99.71 146.65 26.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.991 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -88.03 54.22 3.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.051 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 77.1 m -85.98 164.8 17.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.828 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.65 -19.37 12.9 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.884 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 75' ' ' SER . 12.1 p -126.21 123.95 39.35 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.941 0.4 . . . . 0.0 111.336 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -138.3 166.02 25.33 Favored Glycine 0 N--CA 1.452 -0.265 0 N-CA-C 111.631 -0.588 . . . . 0.0 111.631 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.831 HG23 ' C ' ' A' ' 72' ' ' TYR . 14.9 p -102.57 130.82 51.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.967 0.413 . . . . 0.0 111.351 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.679 ' HE2' HG21 ' A' ' 74' ' ' VAL . 4.2 p90 -106.55 139.43 41.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.986 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -67.45 123.55 20.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 13.5 m -86.63 135.99 33.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.851 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -84.5 -34.39 23.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.011 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.3 m -93.55 -53.57 4.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.757 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.02 -25.59 65.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.985 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.1 m 58.97 22.67 10.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.872 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.4 mtpt -133.09 169.81 16.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.697 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.587 ' HB3' HG21 ' A' ' 62' ' ' VAL . 0.3 OUTLIER -84.34 119.74 25.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.107 179.637 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.831 ' C ' HG23 ' A' ' 62' ' ' VAL . 0.5 OUTLIER -107.81 113.99 60.65 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.46 -179.121 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 72' ' ' TYR . 4.6 Cg_exo -77.03 120.81 5.55 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.389 2.059 . . . . 0.0 110.582 178.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.692 ' CG1' ' HB1' ' A' ' 101' ' ' ALA . 47.6 t -139.85 145.81 26.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.058 0.456 . . . . 0.0 112.186 -178.475 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.445 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 1.1 m -91.9 134.62 34.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.267 178.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.73 ' HD2' ' HB2' ' A' ' 101' ' ' ALA . 0.1 OUTLIER -143.5 169.2 18.15 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.479 0.657 . . . . 0.0 112.329 -178.966 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.537 ' C ' ' HD3' ' A' ' 79' ' ' PRO . 0.1 OUTLIER -111.92 159.29 18.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.747 179.384 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.465 ' HA2' ' HG ' ' A' ' 99' ' ' LEU . . . -111.61 72.31 0.21 Allowed Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.322 -0.942 . . . . 0.0 113.52 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.651 ' HD2' ' O ' ' A' ' 98' ' ' VAL . 15.9 Cg_exo -66.93 138.57 48.6 Favored 'Trans proline' 0 C--O 1.24 0.601 0 C-N-CA 122.401 2.067 . . . . 0.0 112.459 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -63.71 -59.98 7.97 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.621 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.448 HD13 ' O ' ' A' ' 95' ' ' GLN . 0.0 OUTLIER -120.15 119.96 34.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.993 0.425 . . . . 0.0 112.074 -179.786 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.63 ' HB ' HG11 ' A' ' 98' ' ' VAL . 37.4 t -125.15 127.62 72.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.823 178.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -72.17 107.86 5.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.922 0.392 . . . . 0.0 110.693 -179.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.959 HG23 ' CG ' ' A' ' 126' ' ' MET . 1.6 p -72.83 114.49 12.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.405 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -69.89 150.17 47.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.602 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.573 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -68.04 101.58 1.16 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.151 0.501 . . . . 0.0 110.318 -179.517 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.443 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.4 OUTLIER -144.39 163.37 33.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.002 179.999 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.42 ' HG2' ' CD2' ' A' ' 89' ' ' TYR . 15.6 tt0 53.39 -84.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.482 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.443 ' N ' ' O ' ' A' ' 87' ' ' SER . 0.1 OUTLIER -152.41 21.41 0.63 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.757 0.313 . . . . 0.0 110.917 179.921 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.573 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 1.9 t80 -116.61 125.9 28.0 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.707 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.437 ' O ' ' N ' ' A' ' 93' ' ' ARG . 59.8 Cg_endo -73.5 148.58 42.87 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.754 2.303 . . . . 0.0 112.665 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.3 OUTLIER -53.2 85.01 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.455 -179.676 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.437 ' N ' ' O ' ' A' ' 91' ' ' PRO . 5.3 mtp-105 -124.04 -174.39 2.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.084 0.469 . . . . 0.0 111.737 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.437 ' HB3' HD11 ' A' ' 81' ' ' LEU . 26.2 m-85 -100.34 132.49 45.69 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.745 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.448 ' O ' HD13 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -125.56 122.53 36.78 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.119 -179.722 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 28.1 t -92.03 158.25 16.33 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 121.104 0.478 . . . . 0.0 112.114 -179.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 51.4 60.6 3.75 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.774 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.651 ' O ' ' HD2' ' A' ' 79' ' ' PRO . 9.9 p -123.99 136.56 59.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.187 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.724 HD11 ' OD2' ' A' ' 136' ' ' ASP . 6.3 mp -102.0 149.0 24.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.301 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.765 ' HA ' ' O ' ' A' ' 132' ' ' VAL . 6.4 mt -133.25 134.13 43.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.074 0.464 . . . . 0.0 111.801 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.73 ' HB2' ' HD2' ' A' ' 76' ' ' PHE . . . -125.9 119.65 28.36 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.434 -179.497 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 1.5 t -86.15 111.7 20.61 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.907 0.384 . . . . 0.0 110.63 179.17 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -78.78 -132.21 0.75 Allowed Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.554 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -152.89 136.39 15.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.814 0.34 . . . . 0.0 110.723 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.4 m 61.45 -177.04 0.12 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.797 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -58.87 109.66 2.04 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.975 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.1 -167.82 0.26 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.452 2.101 . . . . 0.0 112.325 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -170.74 39.09 0.18 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.504 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -99.86 153.63 19.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.81 0.338 . . . . 0.0 110.995 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -168.63 39.92 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.136 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.664 ' HA2' HG11 ' A' ' 124' ' ' VAL . . . 151.71 165.78 13.36 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.473 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 115.45 -177.11 17.03 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.544 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.852 HG21 HG22 ' A' ' 10' ' ' VAL . 31.3 pt -125.96 146.48 31.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.662 0.268 . . . . 0.0 111.156 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.6 HD21 ' CZ ' ' A' ' 76' ' ' PHE . 8.1 tp -87.24 115.87 24.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.855 0.36 . . . . 0.0 110.171 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.438 ' HE ' HD11 ' A' ' 113' ' ' ILE . 7.5 mtt180 -118.14 145.95 44.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.35 0.595 . . . . 0.0 111.842 -179.128 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.539 ' HB2' HD11 ' A' ' 121' ' ' ILE . 14.3 t -111.75 164.52 12.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.678 179.05 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -55.72 -18.71 8.82 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.72 0.295 . . . . 0.0 110.896 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.472 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . 50.8 m80 -91.34 -36.13 14.02 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.532 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.849 ' N ' ' HB2' ' A' ' 54' ' ' ALA . . . 174.91 -139.9 5.05 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.357 -0.925 . . . . 0.0 113.398 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.905 HG23 ' O ' ' A' ' 52' ' ' THR . 4.1 t -97.95 135.78 31.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.75 0.309 . . . . 0.0 111.63 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.539 HD11 ' HB2' ' A' ' 116' ' ' CYS . 0.9 OUTLIER -101.4 -66.91 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.928 179.195 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.846 ' HA2' HG23 ' A' ' 137' ' ' VAL . . . -151.51 -165.88 13.39 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.556 -0.83 . . . . 0.0 113.068 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.507 ' HG ' ' HB3' ' A' ' 135' ' ' ALA . 0.5 OUTLIER -120.11 164.19 16.55 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.785 0.326 . . . . 0.0 110.881 -179.92 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.664 HG11 ' HA2' ' A' ' 111' ' ' GLY . 12.6 p -61.9 115.07 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.783 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.79 ' OG1' ' HB2' ' A' ' 135' ' ' ALA . 6.0 m -105.87 -93.21 0.37 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.984 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.959 ' CG ' HG23 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -105.1 158.78 16.34 Favored 'General case' 0 C--N 1.335 -0.043 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.851 179.329 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -135.77 106.96 0.59 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.448 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -79.23 -178.62 51.24 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.476 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -71.92 -19.3 61.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.703 0.287 . . . . 0.0 111.141 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -150.33 17.22 1.02 Allowed Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.754 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.56 ' CG1' HD22 ' A' ' 100' ' ' LEU . 1.0 OUTLIER -136.65 157.51 36.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.693 0.282 . . . . 0.0 110.831 179.888 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.765 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 2.5 t -112.59 117.94 56.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.008 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -96.89 119.01 6.21 Favored Glycine 0 CA--C 1.518 0.236 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.89 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.474 ' CZ ' ' HB2' ' A' ' 63' ' ' TYR . 27.7 m-85 -125.18 144.09 50.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.02 0.438 . . . . 0.0 112.039 -179.172 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.79 ' HB2' ' OG1' ' A' ' 125' ' ' THR . . . -93.78 111.05 22.68 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.428 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.724 ' OD2' HD11 ' A' ' 99' ' ' LEU . 0.8 OUTLIER -67.26 142.02 57.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.259 0.552 . . . . 0.0 112.174 -178.227 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.846 HG23 ' HA2' ' A' ' 122' ' ' GLY . 31.6 t -90.25 12.31 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.502 179.031 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.515 ' HA ' HD23 ' A' ' 141' ' ' LEU . 15.7 mmm-85 -71.52 -6.92 44.18 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.446 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -96.1 7.52 46.19 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.91 HD23 HG21 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -171.83 34.35 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 121.208 0.528 . . . . 0.0 110.36 179.716 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.625 HD11 ' CG2' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -57.6 -14.84 5.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.583 -179.506 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 142' ' ' TRP . . . . . 0.436 ' CD1' ' HA ' ' A' ' 140' ' ' LEU . 13.6 p-90 -61.45 77.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.903 0.382 . . . . 0.0 111.828 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.727 HD23 ' HB2' ' A' ' 15' ' ' TYR . 5.1 mp -136.32 -52.66 0.72 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.057 178.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.463 ' HB2' ' CG1' ' A' ' 12' ' ' VAL . 2.2 tp10 -144.41 -163.3 1.65 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.657 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -67.94 145.16 54.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.858 0.361 . . . . 0.0 110.822 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.405 ' CB ' ' HD3' ' A' ' 55' ' ' ARG . 1.4 p30 -105.03 154.16 20.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.981 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -78.87 121.08 24.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.062 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 10.9 ttp -120.77 36.08 4.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.043 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.44 133.71 44.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.91 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.91 -179.992 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 112.577 -0.209 . . . . 0.0 112.577 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.3 147.79 27.45 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.553 2.169 . . . . 0.0 112.322 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -111.54 95.98 5.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.884 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 116.59 36.99 1.02 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.467 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.28 -31.59 72.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.838 0.352 . . . . 0.0 110.911 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -126.13 177.97 6.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.907 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.6 m -153.22 -46.34 0.1 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.92 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 140.08 -25.07 2.67 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.615 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.665 ' HB2' HG23 ' A' ' 18' ' ' VAL . . . -84.75 152.26 23.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.838 0.352 . . . . 0.0 111.285 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.8 t -101.14 127.12 54.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.877 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.736 ' OH ' ' HB3' ' A' ' 47' ' ' ALA . 7.0 t80 -111.66 116.06 30.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.841 0.353 . . . . 0.0 110.624 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.815 HG21 HD11 ' A' ' 53' ' ' ILE . 48.3 t -120.77 111.25 31.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.667 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 50.41 -124.92 20.12 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 121.064 -0.588 . . . . 0.0 113.273 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.476 ' O ' ' HA ' ' A' ' 44' ' ' THR . 77.8 m-20 -91.45 17.18 8.91 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.573 0.225 . . . . 0.0 111.601 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.646 ' HE1' HG22 ' A' ' 44' ' ' THR . 5.2 m-30 -130.31 127.84 40.3 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 9.1 tttt -120.42 114.81 22.36 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 121.11 -0.236 . . . . 0.0 110.742 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 1.001 HG12 HG22 ' A' ' 42' ' ' VAL . 0.6 OUTLIER -98.97 121.52 49.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 121.02 0.438 . . . . 0.0 110.761 179.861 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.665 HG23 ' HB2' ' A' ' 9' ' ' ALA . 15.0 p -136.67 161.35 36.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.288 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.517 ' N ' HG22 ' A' ' 18' ' ' VAL . 10.4 t-20 -61.05 141.48 57.36 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 179.034 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.418 ' HG2' ' CB ' ' A' ' 39' ' ' ASP . 1.8 ppt_? -56.46 -45.9 80.62 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.928 0.394 . . . . 0.0 111.311 -179.495 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -66.38 -10.29 41.97 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.157 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.4 mt -115.21 0.85 13.67 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.669 ' HB3' ' NE1' ' A' ' 28' ' ' TRP . . . -88.98 127.37 35.67 Favored 'General case' 0 N--CA 1.457 -0.084 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.212 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.544 ' O ' ' HD1' ' A' ' 28' ' ' TRP . 1.1 t -74.6 163.2 27.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.706 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -53.59 -29.77 39.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.746 0.308 . . . . 0.0 111.008 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.403 ' O ' ' HG2' ' A' ' 29' ' ' GLN . 22.3 t -69.79 -32.25 51.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.967 0.413 . . . . 0.0 110.767 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.447 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 0.5 OUTLIER -68.56 -43.62 76.21 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.417 179.587 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.669 ' NE1' ' HB3' ' A' ' 23' ' ' ALA . 46.6 m95 -73.27 -45.97 52.63 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.019 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.403 ' HG2' ' O ' ' A' ' 26' ' ' VAL . 14.4 pt20 -54.99 -44.07 74.16 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.768 0.318 . . . . 0.0 110.685 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -102.82 29.9 5.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.178 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.484 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 35.4 t -80.07 145.56 32.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.483 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.664 ' CG2' HG12 ' A' ' 42' ' ' VAL . 10.0 m -103.67 -41.96 7.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.335 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.578 ' HH2' HD23 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -139.69 152.86 47.03 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.018 179.696 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -157.22 117.81 3.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.136 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.412 ' HB3' ' CG ' ' A' ' 38' ' ' ARG . 26.6 t0 -107.13 105.02 14.81 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.789 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -63.27 -29.2 70.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.173 -179.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.531 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 10.7 m-20 -62.2 -30.16 70.88 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 120.403 0.144 . . . . 0.0 110.93 -179.236 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.582 ' NH2' HD22 ' A' ' 40' ' ' LEU . 14.5 ptm180 -113.71 -3.43 13.54 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.418 ' CB ' ' HG2' ' A' ' 20' ' ' ARG . 8.2 m-20 60.48 46.24 9.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.918 0.39 . . . . 0.0 110.906 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.588 HD11 HG23 ' A' ' 17' ' ' VAL . 26.6 tp -135.04 153.32 52.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.748 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.682 ' O ' HD23 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -152.04 155.88 38.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.064 0.459 . . . . 0.0 111.719 179.683 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 1.001 HG22 HG12 ' A' ' 17' ' ' VAL . 28.9 t -116.6 133.04 64.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.93 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.2 t -125.69 157.11 38.15 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.748 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.646 HG22 ' HE1' ' A' ' 15' ' ' TYR . 22.7 p -97.75 144.33 27.48 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.083 0.468 . . . . 0.0 111.538 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.685 HG21 ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -135.02 171.41 14.46 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.957 -179.167 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.0 m -115.68 55.34 0.79 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.884 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.736 ' HB3' ' OH ' ' A' ' 11' ' ' TYR . . . -133.5 -175.11 3.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.147 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -99.4 148.06 24.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.021 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -67.52 170.47 35.3 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.644 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.3 m -149.21 -60.58 0.22 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.81 0.338 . . . . 0.0 110.812 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -83.66 150.41 25.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.884 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.896 ' O ' HG23 ' A' ' 120' ' ' VAL . 86.6 m -122.38 119.29 30.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.959 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.927 ' HB ' HD11 ' A' ' 141' ' ' LEU . 0.4 OUTLIER -76.46 139.75 18.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.767 179.854 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.651 ' HA ' ' HB3' ' A' ' 147' ' ' ALA . . . -90.89 135.56 33.65 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.396 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -94.18 27.22 2.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.035 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.405 ' SG ' ' HB1' ' A' ' 54' ' ' ALA . 24.7 p -99.96 167.3 10.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.198 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -122.86 31.6 5.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.035 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 15.6 m -58.58 132.12 52.85 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.814 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.5 t -74.94 -8.17 55.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.115 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.2 p -107.98 127.21 53.56 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.89 0.376 . . . . 0.0 111.059 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -149.63 146.61 16.06 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.198 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.671 HG23 ' C ' ' A' ' 72' ' ' TYR . 9.6 p -103.86 125.39 58.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.933 0.396 . . . . 0.0 111.216 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.696 ' HE2' HG21 ' A' ' 74' ' ' VAL . 9.5 p90 -108.01 163.6 13.0 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.796 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -90.28 128.31 36.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.863 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -84.54 151.54 24.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.92 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.98 -42.27 10.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.984 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.8 p -89.7 -49.07 6.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.782 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.7 mmtm -59.84 -25.82 65.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.035 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 8.3 t 55.66 24.0 6.71 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.806 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.4 mtpt -135.23 170.03 16.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.73 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 49.1 p-80 -84.4 135.15 34.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.103 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.671 ' C ' HG23 ' A' ' 62' ' ' VAL . 1.3 m-85 -126.04 114.25 24.14 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.631 -179.063 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 72' ' ' TYR . 7.0 Cg_exo -72.75 120.79 6.88 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.467 2.111 . . . . 0.0 110.497 178.534 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.696 HG21 ' HE2' ' A' ' 63' ' ' TYR . 84.6 t -137.64 142.02 37.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.257 0.551 . . . . 0.0 112.466 -178.428 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.19 135.0 39.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.495 -0.775 . . . . 0.0 108.961 178.222 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.593 ' HB3' ' HB2' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -141.97 172.76 12.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.381 0.61 . . . . 0.0 112.214 -178.362 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.464 ' O ' ' HA ' ' A' ' 99' ' ' LEU . 9.8 mt-10 -111.78 158.86 18.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.264 179.062 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -103.73 68.56 0.29 Allowed Glycine 0 CA--C 1.522 0.486 0 C-N-CA 120.366 -0.921 . . . . 0.0 113.735 -179.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.651 ' HD2' ' HA ' ' A' ' 99' ' ' LEU . 36.9 Cg_endo -67.77 139.2 47.2 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.464 2.109 . . . . 0.0 112.188 179.237 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -56.73 -91.77 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.693 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.496 HD22 ' HB3' ' A' ' 96' ' ' SER . 0.0 OUTLIER -98.62 122.73 42.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.921 0.391 . . . . 0.0 111.85 -179.772 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.668 ' HB ' HG11 ' A' ' 98' ' ' VAL . 96.0 t -119.25 126.19 75.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.149 179.032 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -72.33 107.85 5.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.674 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.822 HG22 ' HB2' ' A' ' 126' ' ' MET . 1.0 OUTLIER -74.55 114.83 14.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.099 -179.834 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -70.75 149.77 46.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.843 179.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.501 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 4.2 pt-20 -68.06 101.0 1.06 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.086 0.469 . . . . 0.0 109.892 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.05 145.18 31.36 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.972 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.582 ' O ' ' CD1' ' A' ' 89' ' ' TYR . 0.3 OUTLIER 43.33 93.72 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.31 -0.404 . . . . 0.0 112.072 178.702 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.582 ' CD1' ' O ' ' A' ' 88' ' ' GLU . 4.3 p90 37.91 28.87 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.501 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -131.38 125.11 20.62 Favored Pre-proline 0 C--N 1.329 -0.312 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.541 -179.64 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -86.68 148.84 8.57 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.335 2.69 . . . . 0.0 112.476 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 5.0 mttm -45.73 93.63 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.352 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.68 170.77 10.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.511 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -102.9 132.47 49.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.961 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.908 ' NE2' HG23 ' A' ' 125' ' ' THR . 0.0 OUTLIER -126.12 110.89 14.02 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.183 -179.823 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.496 ' HB3' HD22 ' A' ' 81' ' ' LEU . 97.5 p -82.84 153.93 24.92 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.981 0.419 . . . . 0.0 111.441 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 54.47 62.22 2.66 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.621 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.668 HG11 ' HB ' ' A' ' 82' ' ' VAL . 9.4 p -123.66 146.01 29.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.942 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.963 HD11 ' HB3' ' A' ' 136' ' ' ASP . 0.9 OUTLIER -105.28 146.64 29.06 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.133 179.72 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.71 HD23 ' C ' ' A' ' 132' ' ' VAL . 6.0 mt -133.02 143.27 49.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.27 0.557 . . . . 0.0 112.492 -179.281 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.593 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . . . -151.0 140.92 21.97 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.603 179.43 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 1.3 t -95.52 118.11 31.64 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.954 0.407 . . . . 0.0 111.017 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -71.66 -112.14 0.05 OUTLIER Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.424 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -166.61 74.69 0.17 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.911 0.386 . . . . 0.0 110.768 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.8 m 63.22 85.18 0.13 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.865 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -132.67 141.69 42.09 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.937 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.88 -62.9 0.23 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.382 2.055 . . . . 0.0 112.273 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -139.96 -55.31 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.495 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.409 ' O ' ' HB3' ' A' ' 110' ' ' ALA . 16.2 m-20 61.81 -174.76 0.13 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.815 0.34 . . . . 0.0 110.845 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.741 ' HB1' ' CG2' ' A' ' 124' ' ' VAL . . . 67.85 113.27 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.098 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -173.68 34.67 0.12 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.442 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.463 ' O ' HG12 ' A' ' 124' ' ' VAL . . . -165.63 -140.96 3.0 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.514 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.524 HD13 HG13 ' A' ' 120' ' ' VAL . 2.3 pp -126.0 146.74 31.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.798 0.332 . . . . 0.0 111.24 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.589 HD21 ' CE1' ' A' ' 76' ' ' PHE . 19.3 tp -87.18 120.4 28.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.713 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.06 145.03 45.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.394 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.814 ' HB2' HD12 ' A' ' 121' ' ' ILE . 5.1 t -108.4 164.56 12.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.111 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.49 -19.23 23.08 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.928 0.394 . . . . 0.0 110.482 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -92.68 -33.6 14.29 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.348 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.52 ' N ' ' HB2' ' A' ' 54' ' ' ALA . . . 176.78 -128.44 1.34 Allowed Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.894 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.896 HG23 ' O ' ' A' ' 52' ' ' THR . 3.3 t -113.0 135.66 51.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.596 0.236 . . . . 0.0 110.856 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.814 HD12 ' HB2' ' A' ' 116' ' ' CYS . 0.2 OUTLIER -100.06 -49.0 11.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.872 179.636 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.935 ' HA2' HG23 ' A' ' 137' ' ' VAL . . . -170.39 -165.61 28.01 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.319 -0.943 . . . . 0.0 113.252 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 0.3 OUTLIER -116.93 164.2 15.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.679 0.276 . . . . 0.0 110.626 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.741 ' CG2' ' HB1' ' A' ' 110' ' ' ALA . 12.0 p -69.45 129.96 34.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.357 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.908 HG23 ' NE2' ' A' ' 95' ' ' GLN . 12.1 m -112.01 -95.37 0.44 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.682 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.822 ' HB2' HG22 ' A' ' 84' ' ' VAL . 95.0 mmm -144.07 140.19 29.35 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.717 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -115.25 154.47 16.94 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.52 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -86.89 -150.02 16.44 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.473 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -71.92 -19.45 61.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.759 0.314 . . . . 0.0 110.991 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -157.4 13.98 0.29 Allowed Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.784 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.653 ' CG1' HD22 ' A' ' 100' ' ' LEU . 1.2 t -121.39 157.05 25.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.725 0.298 . . . . 0.0 110.794 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.71 ' C ' HD23 ' A' ' 100' ' ' LEU . 7.6 m -115.66 118.41 58.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.406 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.547 ' HA3' ' O ' ' A' ' 126' ' ' MET . . . -101.19 115.28 5.24 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.378 -0.915 . . . . 0.0 112.085 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.634 ' O ' HD12 ' A' ' 99' ' ' LEU . 15.4 m-85 -117.55 139.83 50.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.778 0.323 . . . . 0.0 111.116 -179.585 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.69 ' HB2' ' OG1' ' A' ' 125' ' ' THR . . . -88.84 114.75 25.79 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.689 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.963 ' HB3' HD11 ' A' ' 99' ' ' LEU . 1.4 p30 -74.63 140.93 44.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.769 -179.199 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.935 HG23 ' HA2' ' A' ' 122' ' ' GLY . 48.8 t -89.51 10.09 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.48 178.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.42 ' HA ' HD23 ' A' ' 141' ' ' LEU . 10.8 mmm180 -70.82 -6.9 41.39 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.632 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -94.75 11.1 32.6 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.685 0.279 . . . . 0.0 111.206 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.826 ' O ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -178.17 62.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.245 0.545 . . . . 0.0 110.317 -179.918 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.927 HD11 ' HB ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -77.3 -14.75 59.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.026 -179.311 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 15.3 p-90 -56.23 78.65 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.004 0.43 . . . . 0.0 111.437 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.717 HD12 ' C ' ' A' ' 141' ' ' LEU . 5.0 mp -143.02 -46.66 0.31 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.147 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -151.48 -163.56 1.79 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.719 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -65.95 142.31 57.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.845 0.355 . . . . 0.0 111.039 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -86.57 154.13 21.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.914 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.651 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . . . -95.91 120.0 35.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.171 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 4.9 mtt -75.55 -177.54 3.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.902 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.68 176.06 12.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.868 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.907 179.953 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.144 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -52.16 164.15 1.31 Allowed 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.584 2.189 . . . . 0.0 112.332 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -87.86 119.48 28.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.832 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 154.83 -133.18 3.72 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.464 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 15.3 t60 -107.66 173.68 6.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.799 0.333 . . . . 0.0 110.94 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.52 111.66 0.91 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.855 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 89.8 p -156.13 168.99 25.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.935 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -160.57 27.39 0.31 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.531 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -110.71 -178.92 3.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.821 0.343 . . . . 0.0 111.108 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.906 HG22 HG21 ' A' ' 113' ' ' ILE . 45.4 t -130.29 110.0 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.127 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.712 ' CE2' HG21 ' A' ' 45' ' ' THR . 5.9 t80 -95.92 116.11 28.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.841 0.353 . . . . 0.0 110.514 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.918 HG21 HD11 ' A' ' 53' ' ' ILE . 21.9 t -120.92 108.96 23.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.637 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 51.06 -125.96 25.58 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.898 -0.668 . . . . 0.0 113.327 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.424 ' O ' ' HA ' ' A' ' 44' ' ' THR . 24.8 m120 -89.07 14.25 11.15 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.722 0.296 . . . . 0.0 111.672 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.658 ' HE1' HG22 ' A' ' 44' ' ' THR . 6.5 m-30 -130.37 146.94 52.02 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.8 tttt -137.67 114.93 10.98 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 121.197 -0.201 . . . . 0.0 110.651 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 1.037 HG12 HG22 ' A' ' 42' ' ' VAL . 0.6 OUTLIER -99.29 121.53 50.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 121.144 0.497 . . . . 0.0 111.145 -179.927 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.645 ' O ' HD12 ' A' ' 40' ' ' LEU . 14.1 p -136.74 161.1 36.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.805 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.506 ' N ' HG22 ' A' ' 18' ' ' VAL . 4.5 t-20 -59.84 141.24 55.74 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 179.176 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.44 ' HG2' ' CH2' ' A' ' 28' ' ' TRP . 25.3 mtp180 -56.61 -47.12 80.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.948 0.404 . . . . 0.0 110.842 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.22 -8.04 28.55 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.245 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.09 -2.42 12.78 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.621 ' HB3' ' NE1' ' A' ' 28' ' ' TRP . . . -88.62 129.01 35.59 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.102 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.595 ' O ' ' HD1' ' A' ' 28' ' ' TRP . 43.8 p -74.73 162.89 28.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.56 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 24.1 p80 -53.51 -29.49 36.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.888 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.0 t -69.95 -31.85 49.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.82 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.437 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 3.7 m-20 -68.22 -43.97 76.78 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.437 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.621 ' NE1' ' HB3' ' A' ' 23' ' ' ALA . 27.5 m95 -73.64 -37.23 65.4 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.015 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.31 -44.23 79.71 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.96 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -110.16 32.4 5.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.275 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.485 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 54.1 t -80.14 149.34 30.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.542 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.516 HG22 ' O ' ' A' ' 42' ' ' VAL . 15.9 m -107.92 -39.32 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.048 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.705 ' CZ3' HG23 ' A' ' 42' ' ' VAL . 0.7 OUTLIER -139.49 150.89 45.69 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.952 0.406 . . . . 0.0 111.7 -179.615 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.424 ' HG3' ' SG ' ' A' ' 31' ' ' CYS . 5.6 mp0 -147.0 118.47 7.92 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.792 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.453 ' HB2' ' CZ2' ' A' ' 33' ' ' TRP . 24.6 t70 -107.09 105.55 15.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.917 0.389 . . . . 0.0 110.891 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -64.46 -29.85 70.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.401 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.569 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 25.5 m120 -68.73 -27.59 66.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.88 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.566 ' HD2' ' HB1' ' A' ' 135' ' ' ALA . 9.4 ttp-105 -114.42 5.64 15.71 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 121.152 -0.219 . . . . 0.0 111.479 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.42 ' HA ' ' CD ' ' A' ' 20' ' ' ARG . 0.8 OUTLIER 46.55 38.98 6.14 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.994 0.426 . . . . 0.0 110.618 -179.862 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.821 HD11 HG23 ' A' ' 17' ' ' VAL . 26.5 tp -129.29 150.03 50.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.938 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.682 ' O ' HD23 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -144.88 155.57 43.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.321 179.489 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 1.037 HG22 HG12 ' A' ' 17' ' ' VAL . 24.9 t -115.94 130.05 71.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.29 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 12.2 p -120.69 157.35 29.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.532 179.262 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.658 HG22 ' HE1' ' A' ' 15' ' ' TYR . 17.8 p -97.49 130.67 44.56 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.22 0.533 . . . . 0.0 111.659 -179.047 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.712 HG21 ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -126.5 160.53 30.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.849 -179.296 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -118.19 58.02 0.83 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.796 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -135.05 -173.69 3.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.132 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -101.53 120.59 40.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.459 ' CA ' ' CE1' ' A' ' 11' ' ' TYR . . . -80.17 -170.36 41.2 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.52 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -155.48 -46.23 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.828 0.347 . . . . 0.0 110.859 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -64.3 141.95 58.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.892 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.789 ' O ' HG23 ' A' ' 120' ' ' VAL . 87.0 m -125.14 118.12 25.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.924 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 1.022 ' HB ' HD11 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -79.44 139.54 18.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.905 179.825 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -98.57 135.85 39.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.839 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.423 ' HB2' ' HB3' ' A' ' 146' ' ' ASP . 0.5 OUTLIER -92.45 42.93 1.11 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.457 0.646 . . . . 0.0 109.409 178.614 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 19.4 p -99.65 167.19 10.73 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.569 -178.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -120.15 24.89 10.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.2 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 16.1 p -64.17 139.52 58.77 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.048 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.544 HG22 ' O ' ' A' ' 76' ' ' PHE . 1.7 m -91.36 12.99 18.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.381 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 39.0 p -125.94 160.87 28.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.815 0.34 . . . . 0.0 110.883 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 176.13 152.81 9.9 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.442 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.864 HG23 ' C ' ' A' ' 72' ' ' TYR . 7.1 p -103.71 137.83 30.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.808 0.337 . . . . 0.0 111.032 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.69 ' CZ ' HG11 ' A' ' 132' ' ' VAL . 8.8 p90 -130.13 -170.9 2.41 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.357 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.438 ' CD2' ' HB2' ' A' ' 67' ' ' SER . 0.7 OUTLIER 73.88 -90.71 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.241 179.844 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 70' ' ' LYS . 0.1 OUTLIER 69.2 -65.02 0.31 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.722 0.296 . . . . 0.0 111.101 -179.933 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -82.06 -44.8 16.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.625 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.438 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -48.78 -70.49 0.09 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.169 -179.689 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.4 mmtt -78.4 -1.57 34.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.277 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.7 t 76.18 1.58 3.45 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.121 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 65' ' ' CYS . 0.0 OUTLIER -141.81 169.05 18.33 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.922 0.391 . . . . 0.0 110.617 179.738 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.807 ' HB2' HG21 ' A' ' 62' ' ' VAL . 0.4 OUTLIER -85.22 116.66 23.71 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.612 179.707 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.864 ' C ' HG23 ' A' ' 62' ' ' VAL . 1.3 m-85 -102.37 113.07 66.04 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.77 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 72' ' ' TYR . 4.6 Cg_exo -80.61 121.06 4.08 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.663 2.242 . . . . 0.0 111.217 179.455 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.69 HG21 ' CE2' ' A' ' 63' ' ' TYR . 44.4 t -134.21 147.48 30.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.073 0.463 . . . . 0.0 112.027 -178.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 74.2 m -100.58 128.62 46.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.458 178.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.743 ' HZ ' HD11 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -132.52 169.25 16.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.381 0.61 . . . . 0.0 112.05 -178.588 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.435 ' O ' ' HD2' ' A' ' 79' ' ' PRO . 28.6 tt0 -111.91 158.44 19.47 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.156 178.582 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -105.44 65.97 0.28 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.474 -0.869 . . . . 0.0 113.172 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.435 ' HD2' ' O ' ' A' ' 77' ' ' GLU . 41.2 Cg_endo -67.99 134.45 32.02 Favored 'Trans proline' 0 C--O 1.239 0.557 0 C-N-CA 122.29 1.993 . . . . 0.0 112.23 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -58.86 -87.77 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.202 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.606 HD22 ' HB2' ' A' ' 96' ' ' SER . 0.0 OUTLIER -94.32 119.84 33.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.031 0.444 . . . . 0.0 111.826 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.626 ' HB ' HG11 ' A' ' 98' ' ' VAL . 48.8 t -122.91 122.9 66.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.686 178.577 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.425 ' HG3' ' CE1' ' A' ' 94' ' ' TYR . 3.9 tt0 -72.08 107.61 4.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.976 0.417 . . . . 0.0 110.808 -179.123 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.781 HG13 ' CG ' ' A' ' 126' ' ' MET . 47.6 t -73.96 114.62 13.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.757 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -72.84 150.02 43.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.752 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.526 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 0.6 OUTLIER -67.71 100.9 0.96 Allowed 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.331 -0.548 . . . . 0.0 110.232 -179.388 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.522 ' O ' ' N ' ' A' ' 89' ' ' TYR . 3.7 m -144.78 169.58 17.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.591 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 45.65 -84.82 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.658 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.522 ' N ' ' O ' ' A' ' 87' ' ' SER . 0.6 OUTLIER -153.99 24.75 0.49 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.818 0.342 . . . . 0.0 110.378 179.652 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.526 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -117.43 116.47 37.08 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.623 -179.934 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.457 ' O ' ' N ' ' A' ' 93' ' ' ARG . 30.9 Cg_exo -61.51 148.52 92.78 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.706 2.271 . . . . 0.0 112.181 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.557 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -59.05 79.24 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.858 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.457 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.2 OUTLIER -123.97 179.96 4.64 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.172 0.51 . . . . 0.0 111.816 -179.498 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.455 ' HB3' HD11 ' A' ' 81' ' ' LEU . 12.5 m-85 -93.93 132.56 38.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.784 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.578 ' CD ' HG21 ' A' ' 125' ' ' THR . 2.2 tt0 -130.57 123.14 28.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.209 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.606 ' HB2' HD22 ' A' ' 81' ' ' LEU . 5.1 t -97.71 161.49 13.73 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.114 0.483 . . . . 0.0 112.02 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 55.72 56.32 6.26 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.585 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.626 HG11 ' HB ' ' A' ' 82' ' ' VAL . 11.1 p -123.66 139.64 49.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.815 0.341 . . . . 0.0 111.559 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.466 HD11 ' OD2' ' A' ' 136' ' ' ASP . 11.2 mp -101.97 140.25 36.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.169 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.815 HD23 ' O ' ' A' ' 132' ' ' VAL . 5.6 mt -133.18 142.29 48.54 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -179.246 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.57 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . . . -152.12 147.12 26.08 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.706 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 0.9 OUTLIER -100.42 118.24 36.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.058 0.456 . . . . 0.0 111.129 179.865 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -86.39 -6.02 81.59 Favored Glycine 0 CA--C 1.519 0.287 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.868 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 67.83 -69.73 0.14 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.775 0.322 . . . . 0.0 110.887 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.19 88.78 2.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.887 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -118.37 143.86 33.97 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.975 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -56.72 -62.86 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.507 2.138 . . . . 0.0 112.197 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 146.75 -28.03 1.61 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.445 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -102.72 140.56 36.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.829 0.347 . . . . 0.0 110.883 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -140.78 163.09 33.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.079 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 169.38 66.1 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.485 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -160.07 176.6 36.75 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.549 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.906 HG21 HG22 ' A' ' 10' ' ' VAL . 2.5 pp -97.61 146.39 7.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.738 0.304 . . . . 0.0 111.077 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.743 HD11 ' HZ ' ' A' ' 76' ' ' PHE . 47.0 tp -87.58 113.15 23.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.822 0.344 . . . . 0.0 110.843 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -119.36 138.11 53.28 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.298 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.945 ' SG ' HD11 ' A' ' 121' ' ' ILE . 28.0 p -111.5 177.01 4.79 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -56.61 -19.94 18.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.686 0.279 . . . . 0.0 111.218 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 22.1 m80 -90.77 -33.66 15.64 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 159.83 -150.65 21.07 Favored Glycine 0 C--N 1.334 0.445 0 C-N-CA 120.425 -0.893 . . . . 0.0 113.136 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.789 HG23 ' O ' ' A' ' 52' ' ' THR . 9.1 t -83.83 135.6 24.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.768 0.318 . . . . 0.0 111.63 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.945 HD11 ' SG ' ' A' ' 116' ' ' CYS . 3.0 mp -109.31 -47.97 7.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.028 179.439 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.85 ' HA2' HG23 ' A' ' 137' ' ' VAL . . . -168.45 -171.94 34.82 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.078 -1.058 . . . . 0.0 113.215 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.576 HD11 HD13 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -118.76 164.13 15.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.803 0.335 . . . . 0.0 110.826 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.476 ' O ' HG13 ' A' ' 124' ' ' VAL . 11.2 p -60.72 121.33 8.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.486 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.753 ' OG1' ' HB2' ' A' ' 135' ' ' ALA . 19.3 m -116.02 -98.49 0.45 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.4 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.781 ' CG ' HG13 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -87.06 161.85 17.92 Favored 'General case' 0 CA--C 1.527 0.059 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.644 179.664 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -146.64 93.61 0.16 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.467 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -74.98 -177.96 40.62 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.375 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -71.98 -19.36 61.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.702 0.287 . . . . 0.0 111.042 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -142.6 -7.34 0.65 Allowed Glycine 0 CA--C 1.523 0.545 0 C-N-CA 120.571 -0.823 . . . . 0.0 113.514 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.636 ' CG1' HD22 ' A' ' 100' ' ' LEU . 0.6 OUTLIER -115.86 157.08 16.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 117.242 0.521 . . . . 0.0 111.18 -179.842 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.815 ' O ' HD23 ' A' ' 100' ' ' LEU . 15.6 m -113.4 118.45 58.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.602 -179.36 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -95.77 119.3 6.19 Favored Glycine 0 C--N 1.329 0.178 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.162 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.539 ' HD2' HD22 ' A' ' 114' ' ' LEU . 18.5 m-85 -125.04 144.04 50.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.867 0.365 . . . . 0.0 111.557 -179.609 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.753 ' HB2' ' OG1' ' A' ' 125' ' ' THR . . . -93.11 113.64 25.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.11 179.135 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.466 ' OD2' HD11 ' A' ' 99' ' ' LEU . 2.7 t0 -67.99 133.76 49.59 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -178.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.85 HG23 ' HA2' ' A' ' 122' ' ' GLY . 48.9 t -97.17 2.39 10.29 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.505 178.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.44 ' HA ' HD23 ' A' ' 141' ' ' LEU . 6.4 mtm105 -72.73 -6.22 43.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.304 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.78 3.71 54.69 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.661 0.267 . . . . 0.0 111.278 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.836 ' O ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -163.78 57.25 0.17 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.228 0.537 . . . . 0.0 109.956 179.827 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 1.022 HD11 ' HB ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -72.67 -14.5 61.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.607 -179.048 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 142' ' ' TRP . . . . . 0.46 ' C ' HD12 ' A' ' 143' ' ' LEU . 16.7 p-90 -52.87 81.15 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.991 0.424 . . . . 0.0 111.219 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.717 HD12 ' C ' ' A' ' 141' ' ' LEU . 5.0 mp -151.1 -45.77 0.12 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.327 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.476 ' HB2' HG12 ' A' ' 12' ' ' VAL . 1.2 mm-40 -157.41 -170.19 3.15 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.645 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -59.4 144.99 45.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.063 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.423 ' HB3' ' HB2' ' A' ' 55' ' ' ARG . 0.1 OUTLIER -103.11 154.35 19.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.647 179.932 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.4 130.04 39.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.926 0.393 . . . . 0.0 111.32 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 6.8 mtt -141.13 -175.96 4.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.763 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -152.22 -46.37 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.052 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.815 -179.928 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.145 0 N-CA-C 112.56 -0.216 . . . . 0.0 112.56 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.01 -35.89 62.92 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.555 2.17 . . . . 0.0 112.379 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -165.27 -67.63 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.891 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.36 81.43 1.75 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.384 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 15.1 p80 -119.11 165.8 13.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.861 0.362 . . . . 0.0 110.895 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -132.25 81.7 1.97 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.823 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.9 t -119.37 146.74 45.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.948 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 143.08 -40.92 1.2 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.446 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.406 ' HB2' HG23 ' A' ' 18' ' ' VAL . . . -116.27 178.07 4.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.825 0.345 . . . . 0.0 111.051 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.5 t -114.49 107.1 22.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.019 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.73 ' CE2' HG21 ' A' ' 45' ' ' THR . 6.0 t80 -96.54 116.24 28.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.527 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.841 HG21 HD11 ' A' ' 53' ' ' ILE . 30.5 t -120.94 111.66 32.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.683 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.405 ' O ' ' CE1' ' A' ' 11' ' ' TYR . . . 50.88 -126.26 25.58 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.996 -0.621 . . . . 0.0 113.296 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.448 ' O ' ' HA ' ' A' ' 44' ' ' THR . 21.1 p30 -89.89 17.47 6.7 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.727 0.299 . . . . 0.0 111.561 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.668 ' HE1' HG22 ' A' ' 44' ' ' THR . 7.0 m-30 -130.29 145.51 51.78 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.05 114.8 11.25 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.578 0.227 . . . . 0.0 110.677 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 1.061 HG12 HG22 ' A' ' 42' ' ' VAL . 0.6 OUTLIER -101.22 121.36 51.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 121.123 0.487 . . . . 0.0 111.036 -179.855 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.555 ' O ' HD12 ' A' ' 40' ' ' LEU . 13.7 p -136.7 161.35 36.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.869 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.509 ' N ' HG22 ' A' ' 18' ' ' VAL . 2.5 t30 -58.99 141.16 54.63 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.77 -47.38 80.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.864 0.364 . . . . 0.0 111.267 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -67.7 -9.51 44.31 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.213 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.26 2.09 13.95 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.669 ' HB3' ' NE1' ' A' ' 28' ' ' TRP . . . -87.65 131.82 34.31 Favored 'General case' 0 C--O 1.23 0.07 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.975 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.509 ' O ' ' HD1' ' A' ' 28' ' ' TRP . 42.2 p -74.67 163.29 27.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.712 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 46.3 p-80 -53.74 -29.71 40.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.855 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.7 t -68.61 -33.2 58.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.804 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -68.0 -43.93 77.73 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.669 ' NE1' ' HB3' ' A' ' 23' ' ' ALA . 45.5 m95 -73.96 -29.95 62.26 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.993 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -60.89 -44.1 97.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.46 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -115.71 33.9 5.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.593 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.494 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 30.5 p -72.64 122.92 22.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.187 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.548 HG22 ' O ' ' A' ' 42' ' ' VAL . 11.6 m -86.19 -40.01 14.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.682 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.648 ' HH2' HD23 ' A' ' 40' ' ' LEU . 0.8 OUTLIER -139.87 151.18 45.45 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.202 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.441 ' HG2' ' HB2' ' A' ' 41' ' ' LEU . 5.3 mt-10 -154.79 116.3 4.09 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.188 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.428 ' HB2' ' CZ2' ' A' ' 33' ' ' TRP . 23.5 m-20 -107.26 110.27 22.26 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.804 0.335 . . . . 0.0 111.054 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -65.16 -29.91 70.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.427 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.525 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 2.8 m-20 -63.78 -27.83 69.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.128 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.409 ' HG2' ' HB3' ' A' ' 35' ' ' ASP . 0.9 OUTLIER -117.53 6.67 12.55 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 121.096 -0.242 . . . . 0.0 111.56 179.794 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 47.56 45.12 17.55 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.961 0.41 . . . . 0.0 110.673 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.852 HD11 HG23 ' A' ' 17' ' ' VAL . 23.0 tp -133.2 151.23 51.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.142 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.667 ' O ' HD23 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -148.36 155.7 41.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.374 179.569 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 1.061 HG22 HG12 ' A' ' 17' ' ' VAL . 39.0 t -117.95 132.48 67.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.325 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.9 t -123.86 157.01 35.17 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.215 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.668 HG22 ' HE1' ' A' ' 15' ' ' TYR . 18.6 p -97.76 128.89 44.73 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.269 0.557 . . . . 0.0 111.638 -179.119 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.73 HG21 ' CE2' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -121.39 167.15 13.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.831 -179.368 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.6 m -114.85 38.62 3.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.846 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.423 ' HB3' ' OH ' ' A' ' 11' ' ' TYR . . . -113.29 -168.77 1.38 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.105 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 29.5 m80 -101.57 144.76 29.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.855 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -106.42 129.55 9.79 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.529 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 92.2 m -113.69 -32.05 6.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.803 0.335 . . . . 0.0 111.043 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -70.09 134.12 47.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.939 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.868 ' O ' HG23 ' A' ' 120' ' ' VAL . 67.6 m -118.97 117.25 28.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.599 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.903 ' HB ' HD11 ' A' ' 141' ' ' LEU . 0.4 OUTLIER -76.36 139.46 18.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.04 0.448 . . . . 0.0 111.406 -179.591 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.823 ' HB1' ' SG ' ' A' ' 56' ' ' CYS . . . -96.59 101.53 13.16 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.397 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.4 ' CB ' ' HB2' ' A' ' 146' ' ' ASP . 11.0 tpt180 -80.18 59.19 3.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.089 0.471 . . . . 0.0 110.148 179.181 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.823 ' SG ' ' HB1' ' A' ' 54' ' ' ALA . 0.5 OUTLIER -120.73 158.97 26.33 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.159 -179.293 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -96.74 18.72 13.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.384 179.188 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 29.5 p -57.31 129.07 40.16 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.97 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.1 m -92.03 12.35 22.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.272 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 25.9 p -129.99 130.81 45.48 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.818 0.342 . . . . 0.0 110.947 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -153.96 -161.8 10.67 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.31 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.811 HG23 ' C ' ' A' ' 72' ' ' TYR . 7.9 p -140.05 135.52 37.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.096 0.474 . . . . 0.0 111.225 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.819 ' CD1' ' HB3' ' A' ' 66' ' ' ALA . 27.4 p90 -109.97 125.94 53.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.678 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.44 ' HA ' ' HA ' ' A' ' 71' ' ' HIS . 15.4 t80 -114.26 134.64 54.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.916 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 68' ' ' LYS . 0.8 OUTLIER 65.68 19.7 11.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.593 179.627 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.819 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . . . -92.0 -45.32 8.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.858 0.361 . . . . 0.0 110.937 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.0 t -115.2 -37.97 3.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.314 179.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 65' ' ' CYS . 2.2 mmtt -127.9 -173.5 2.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.078 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.26 29.37 1.93 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.935 0.398 . . . . 0.0 110.866 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.45 ' HE3' ' HB3' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -143.36 171.42 14.15 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.814 -179.429 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 64' ' ' PHE . 56.4 p-80 -83.91 136.48 34.08 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.109 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.811 ' C ' HG23 ' A' ' 62' ' ' VAL . 13.5 m-85 -129.84 114.9 17.84 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -178.248 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.542 ' N ' HG23 ' A' ' 62' ' ' VAL . 10.0 Cg_exo -69.98 120.65 7.37 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.259 1.973 . . . . 0.0 110.319 178.174 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.451 ' CG1' ' CE2' ' A' ' 76' ' ' PHE . 2.5 p -143.68 153.76 16.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.641 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.5 m -95.03 132.9 39.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.172 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.691 ' CZ ' HD11 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -135.02 163.27 30.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.324 0.583 . . . . 0.0 111.921 -179.008 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.47 ' O ' ' HA ' ' A' ' 99' ' ' LEU . 5.9 pt-20 -111.8 158.32 19.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.142 -0.936 . . . . 0.0 109.293 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -106.04 65.8 0.27 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.385 -0.912 . . . . 0.0 113.591 -179.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.525 ' HD2' ' HA ' ' A' ' 99' ' ' LEU . 37.5 Cg_endo -67.74 134.15 31.69 Favored 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 122.263 1.975 . . . . 0.0 111.949 179.405 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -58.27 -84.48 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.586 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.55 HD11 ' HB3' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -97.18 120.32 37.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.866 0.365 . . . . 0.0 111.855 -179.618 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.608 ' HB ' HG11 ' A' ' 98' ' ' VAL . 48.1 t -123.91 122.58 64.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.371 178.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -72.44 107.99 5.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.91 0.386 . . . . 0.0 110.521 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.5 HG13 ' HB2' ' A' ' 95' ' ' GLN . 17.2 m -76.11 123.46 32.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.666 -179.526 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -69.92 150.52 46.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.734 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.532 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 31.0 tt0 -67.7 102.43 1.2 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.939 0.399 . . . . 0.0 110.321 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.439 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.7 OUTLIER -143.94 165.95 26.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.331 -179.729 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 55.08 -82.42 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.564 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.439 ' N ' ' O ' ' A' ' 87' ' ' SER . 0.4 OUTLIER -154.92 22.84 0.44 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.703 0.287 . . . . 0.0 110.917 -179.878 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.532 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 2.3 t80 -122.88 133.18 24.33 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.918 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.432 ' O ' ' N ' ' A' ' 93' ' ' ARG . 89.1 Cg_endo -83.08 148.96 13.49 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.173 2.582 . . . . 0.0 112.417 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.2 OUTLIER -40.16 92.79 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.401 -179.908 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.447 ' O ' HG22 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -123.71 -179.19 4.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.133 0.492 . . . . 0.0 111.683 -179.342 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.55 ' HB3' HD11 ' A' ' 81' ' ' LEU . 23.0 m-85 -106.38 132.29 52.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.024 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.525 ' HA ' ' O ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -128.79 124.03 34.39 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.934 -179.888 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -96.74 156.58 16.28 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 121.058 0.456 . . . . 0.0 111.779 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 56.91 57.18 4.82 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.491 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.608 HG11 ' HB ' ' A' ' 82' ' ' VAL . 8.0 p -123.37 135.55 62.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.964 0.411 . . . . 0.0 111.367 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.787 HD11 ' HB2' ' A' ' 136' ' ' ASP . 2.7 mp -101.91 146.94 27.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.907 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.706 HD23 ' O ' ' A' ' 132' ' ' VAL . 6.5 mt -133.03 139.87 47.43 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.533 ' HB2' ' CD2' ' A' ' 76' ' ' PHE . . . -144.13 150.97 38.93 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.394 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.2 t -111.13 140.04 46.01 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.862 0.363 . . . . 0.0 111.231 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -131.89 -81.54 0.21 Allowed Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.468 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -123.91 157.43 34.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.844 0.354 . . . . 0.0 110.842 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.8 94.26 5.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.869 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -171.84 152.31 3.0 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.856 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.4 -59.81 0.95 Allowed 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.409 2.073 . . . . 0.0 112.284 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 117.49 -59.44 0.48 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.601 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.3 t70 61.18 170.29 0.1 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.783 0.325 . . . . 0.0 110.892 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 61.47 -172.23 0.15 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.011 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -156.31 133.34 3.63 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.441 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -138.44 -161.29 8.75 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.411 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 28.3 pt -126.07 146.11 32.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.773 0.321 . . . . 0.0 111.164 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.691 HD11 ' CZ ' ' A' ' 76' ' ' PHE . 6.7 tp -87.81 113.5 23.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.388 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.517 ' O ' HG12 ' A' ' 62' ' ' VAL . 0.0 OUTLIER -118.83 139.38 51.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.257 -179.858 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.576 ' HB3' HD11 ' A' ' 121' ' ' ILE . 21.8 p -105.66 166.87 10.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.194 179.079 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -55.93 -20.2 15.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.348 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 11.4 m80 -91.16 -22.21 20.78 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.79 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.612 ' CA ' ' HB2' ' A' ' 54' ' ' ALA . . . 163.56 -143.8 8.94 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.145 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 52' ' ' THR . 3.6 t -100.24 135.53 35.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.724 0.297 . . . . 0.0 111.107 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.576 HD11 ' HB3' ' A' ' 116' ' ' CYS . 1.3 mm -96.95 -67.15 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.835 0.35 . . . . 0.0 110.982 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.864 ' HA2' HG23 ' A' ' 137' ' ' VAL . . . -155.4 -154.01 6.76 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.831 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.811 ' CD1' ' HB3' ' A' ' 135' ' ' ALA . 0.0 OUTLIER -130.53 164.14 25.51 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.031 0.443 . . . . 0.0 111.069 179.958 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.576 ' O ' HG13 ' A' ' 124' ' ' VAL . 14.5 p -57.86 115.08 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.319 -179.225 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.737 ' OG1' ' HB2' ' A' ' 135' ' ' ALA . 1.6 m -101.49 -87.22 0.4 Allowed 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.692 ' N ' HG22 ' A' ' 125' ' ' THR . 0.0 OUTLIER -136.13 129.78 32.3 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-O 120.997 0.427 . . . . 0.0 111.583 179.57 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -109.14 149.13 17.08 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.654 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -104.47 -156.9 23.62 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.469 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -71.81 -19.44 61.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.725 0.298 . . . . 0.0 111.173 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -159.03 16.18 0.24 Allowed Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.983 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.628 ' CG1' HD22 ' A' ' 100' ' ' LEU . 0.9 OUTLIER -126.51 157.23 37.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.755 0.312 . . . . 0.0 110.857 179.861 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.706 ' O ' HD23 ' A' ' 100' ' ' LEU . 29.0 m -116.97 118.32 58.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.354 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.496 ' HA3' ' O ' ' A' ' 126' ' ' MET . . . -99.87 113.94 4.87 Favored Glycine 0 C--N 1.329 0.192 0 C-N-CA 120.499 -0.858 . . . . 0.0 111.997 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.467 ' CD2' ' HB2' ' A' ' 114' ' ' LEU . 53.4 m-85 -118.14 138.04 52.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.748 0.308 . . . . 0.0 111.357 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.811 ' HB3' ' CD1' ' A' ' 123' ' ' LEU . . . -88.41 115.4 25.88 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 179.049 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.787 ' HB2' HD11 ' A' ' 99' ' ' LEU . 2.7 t0 -67.38 141.93 56.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.25 0.548 . . . . 0.0 112.438 -178.148 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.864 HG23 ' HA2' ' A' ' 122' ' ' GLY . 56.5 t -89.9 9.87 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.413 178.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.492 ' HA ' HD23 ' A' ' 141' ' ' LEU . 9.3 mmm180 -70.63 -6.74 39.07 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.641 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -98.28 11.04 39.21 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.481 0.181 . . . . 0.0 111.439 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.853 ' O ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -177.19 47.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.018 0.437 . . . . 0.0 110.595 -179.811 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.903 HD11 ' HB ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -66.39 -14.6 62.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.15 -179.67 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 142' ' ' TRP . . . . . 0.459 ' C ' HD12 ' A' ' 143' ' ' LEU . 15.6 p-90 -54.52 81.61 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.068 0.461 . . . . 0.0 111.539 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.695 HD12 ' C ' ' A' ' 141' ' ' LEU . 5.0 mp -149.37 -43.89 0.14 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.954 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.425 ' HB2' ' CG1' ' A' ' 12' ' ' VAL . 7.6 mt-10 -152.29 -170.42 3.64 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.445 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -58.83 132.27 53.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.79 0.328 . . . . 0.0 110.888 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.4 ' HB2' ' CB ' ' A' ' 55' ' ' ARG . 1.5 p30 -94.63 154.11 17.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.003 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.27 147.86 44.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.086 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.22 118.58 21.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.86 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -116.52 31.06 6.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.889 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.901 -179.999 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 112.534 -0.227 . . . . 0.0 112.534 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.9 -33.22 16.49 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.583 2.189 . . . . 0.0 112.319 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -114.83 175.31 5.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.928 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.13 36.46 8.95 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.485 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.76 -62.27 1.76 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.82 0.343 . . . . 0.0 110.982 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 60.59 179.5 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.883 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.3 m -152.95 157.12 40.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.909 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -135.2 27.15 3.17 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.51 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -175.64 -179.65 1.27 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.799 0.333 . . . . 0.0 110.988 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.2 t -116.49 108.21 24.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.069 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.89 ' CE2' HG21 ' A' ' 45' ' ' THR . 6.1 t80 -99.57 116.41 31.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.692 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.891 HG21 HD11 ' A' ' 53' ' ' ILE . 24.8 t -120.77 108.95 23.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.804 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 50.8 -126.49 25.8 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.986 -0.626 . . . . 0.0 113.259 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.518 ' O ' ' HA ' ' A' ' 44' ' ' THR . 2.7 p-10 -88.58 13.06 12.95 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.657 ' HE1' HG22 ' A' ' 44' ' ' THR . 5.8 m-30 -130.49 127.93 40.17 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.6 tttt -120.56 114.88 22.38 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.994 -0.282 . . . . 0.0 110.792 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 1.067 HG12 HG22 ' A' ' 42' ' ' VAL . 0.6 OUTLIER -99.33 121.64 50.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-O 121.161 0.505 . . . . 0.0 110.916 179.894 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.546 ' O ' HD22 ' A' ' 41' ' ' LEU . 12.6 p -136.92 161.32 36.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.02 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.52 ' N ' HG22 ' A' ' 18' ' ' VAL . 56.7 m-80 -59.89 141.22 55.86 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.056 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.441 ' HB2' ' CH2' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -56.77 -43.98 81.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.796 0.332 . . . . 0.0 111.235 -179.493 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -67.82 -10.93 57.03 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.11 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -115.26 0.61 13.56 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.712 ' HB3' ' NE1' ' A' ' 28' ' ' TRP . . . -86.69 127.06 34.93 Favored 'General case' 0 C--O 1.23 0.072 0 C-N-CA 120.331 -0.548 . . . . 0.0 111.028 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.711 HG23 HG12 ' A' ' 26' ' ' VAL . 1.7 t -74.71 165.48 25.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.916 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -53.62 -29.86 40.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.878 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.711 HG12 HG23 ' A' ' 24' ' ' THR . 11.5 p -71.85 -31.67 41.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.716 0.293 . . . . 0.0 110.996 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.484 ' HB3' ' HB1' ' A' ' 23' ' ' ALA . 0.4 OUTLIER -68.11 -43.97 77.2 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.099 0.475 . . . . 0.0 109.751 179.332 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.712 ' NE1' ' HB3' ' A' ' 23' ' ' ALA . 53.2 m95 -74.05 -35.27 64.28 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.064 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.56 -40.92 80.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.75 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -116.94 34.63 5.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.782 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.476 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 29.2 p -77.15 125.62 29.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.043 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.574 HG22 ' O ' ' A' ' 42' ' ' VAL . 16.1 m -87.43 -38.04 11.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.705 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.641 ' HH2' HD23 ' A' ' 40' ' ' LEU . 2.9 t90 -139.56 153.52 47.44 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.776 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 5.2 tm-20 -162.69 120.54 2.06 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.789 0.328 . . . . 0.0 111.581 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.408 ' HB2' ' CZ2' ' A' ' 33' ' ' TRP . 0.7 OUTLIER -107.05 98.68 8.3 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.45 179.338 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -56.95 -29.55 63.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.935 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.614 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 6.3 t-20 -64.4 -41.04 96.86 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 120.584 0.23 . . . . 0.0 110.822 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -99.55 -4.23 31.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.532 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.411 ' CB ' ' HG2' ' A' ' 20' ' ' ARG . 1.0 OUTLIER 60.03 48.36 8.7 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.047 0.451 . . . . 0.0 110.706 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.641 HD23 ' HH2' ' A' ' 33' ' ' TRP . 21.2 tp -136.41 146.51 46.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.671 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.669 ' O ' HD23 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -147.24 155.79 42.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.987 0.422 . . . . 0.0 111.899 179.802 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 1.067 HG22 HG12 ' A' ' 17' ' ' VAL . 35.8 t -117.36 125.0 73.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.272 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.0 p -118.19 157.41 27.02 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.567 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.657 HG22 ' HE1' ' A' ' 15' ' ' TYR . 15.2 p -97.29 142.71 28.84 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.243 0.544 . . . . 0.0 111.638 -178.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.89 HG21 ' CE2' ' A' ' 11' ' ' TYR . 0.4 OUTLIER -137.52 172.49 12.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.89 -179.195 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -122.68 36.04 4.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.759 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.435 ' HB3' ' OH ' ' A' ' 11' ' ' TYR . . . -107.38 -167.89 1.32 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.183 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -102.83 148.03 26.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.985 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -57.09 -174.39 0.26 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.552 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -154.59 -45.97 0.09 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.9 0.381 . . . . 0.0 111.021 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -128.66 170.71 12.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.969 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.871 ' O ' HG23 ' A' ' 120' ' ' VAL . 29.6 m -125.13 123.39 39.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.533 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.954 ' HB ' HD11 ' A' ' 141' ' ' LEU . 0.5 OUTLIER -72.65 139.55 19.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.871 0.367 . . . . 0.0 111.175 -179.643 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.607 ' HB2' ' N ' ' A' ' 119' ' ' GLY . . . -88.08 122.93 32.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.383 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.58 ' H ' ' HB3' ' A' ' 147' ' ' ALA . 25.0 tpt180 -94.11 28.98 2.28 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.172 0.51 . . . . 0.0 109.962 178.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.484 ' SG ' ' HB1' ' A' ' 54' ' ' ALA . 23.0 p -99.82 167.3 10.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.996 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -117.69 28.81 8.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.26 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 34.0 m -58.84 131.16 50.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.853 0.359 . . . . 0.0 110.539 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.48 -1.07 44.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.326 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 16.3 p -127.91 123.99 36.32 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.998 0.428 . . . . 0.0 111.265 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.25 -169.14 12.01 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.753 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.739 HG23 ' C ' ' A' ' 72' ' ' TYR . 6.8 p -140.22 132.76 33.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 117.143 0.472 . . . . 0.0 111.327 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.806 ' CZ ' HG11 ' A' ' 132' ' ' VAL . 40.5 p90 -120.18 132.12 55.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.582 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.425 ' HA ' ' HA ' ' A' ' 71' ' ' HIS . 1.2 t80 -73.84 156.75 37.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.579 -179.313 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 1.3 m 66.01 60.57 0.66 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.204 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.558 ' HB2' ' HB2' ' A' ' 72' ' ' TYR . . . -92.22 -45.23 8.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.908 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 26.7 t 175.74 36.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.932 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.474 ' HG2' ' HD3' ' A' ' 70' ' ' LYS . 0.3 OUTLIER -176.29 31.91 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.595 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 45.86 31.24 1.01 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.09 0.471 . . . . 0.0 110.904 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.474 ' HD3' ' HG2' ' A' ' 68' ' ' LYS . 12.8 mtpt -134.87 171.55 14.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.768 -179.308 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 64' ' ' PHE . 5.1 p80 -83.19 139.04 33.38 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.739 ' C ' HG23 ' A' ' 62' ' ' VAL . 2.6 m-85 -126.03 114.58 24.14 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.57 -178.346 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -68.34 120.46 7.41 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 121.886 1.724 . . . . 0.0 109.964 178.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.514 HG21 ' HE1' ' A' ' 63' ' ' TYR . 43.8 t -140.41 141.83 32.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -178.104 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 87.9 p -93.02 133.15 36.45 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.608 ' CZ ' HD11 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -136.25 166.2 23.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.372 0.606 . . . . 0.0 112.166 -178.347 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.437 ' O ' ' HA ' ' A' ' 99' ' ' LEU . 0.1 OUTLIER -111.71 158.48 19.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.183 178.848 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -105.16 67.5 0.27 Allowed Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.378 -0.915 . . . . 0.0 113.464 -179.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.516 ' HD2' ' HA ' ' A' ' 99' ' ' LEU . 37.6 Cg_endo -67.63 134.28 32.33 Favored 'Trans proline' 0 C--O 1.237 0.47 0 C-N-CA 122.227 1.951 . . . . 0.0 111.952 179.435 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -54.84 -83.24 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.673 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.703 HD11 ' HB3' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -105.09 120.18 40.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.867 0.365 . . . . 0.0 111.959 -179.646 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.619 ' HB ' HG11 ' A' ' 98' ' ' VAL . 42.2 t -121.1 122.18 66.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.376 178.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -76.35 108.05 9.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.941 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 34.8 m -73.83 124.13 30.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.055 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -69.55 150.11 47.48 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.722 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.594 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 61.3 tt0 -68.02 102.16 1.25 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.999 0.428 . . . . 0.0 110.638 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.436 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.3 OUTLIER -144.07 160.11 41.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.364 -179.825 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 56.06 -81.51 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.679 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.436 ' N ' ' O ' ' A' ' 87' ' ' SER . 3.2 p90 -155.73 26.18 0.39 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.861 0.363 . . . . 0.0 110.822 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.594 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 1.0 OUTLIER -122.48 124.35 26.8 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.557 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.46 ' O ' ' N ' ' A' ' 93' ' ' ARG . 72.0 Cg_endo -76.46 148.65 30.06 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.881 2.387 . . . . 0.0 112.512 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -46.25 89.4 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.17 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.46 ' N ' ' O ' ' A' ' 91' ' ' PRO . 1.7 mmm180 -124.02 174.34 7.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.299 0.571 . . . . 0.0 112.156 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.703 ' HB3' HD11 ' A' ' 81' ' ' LEU . 5.4 m-85 -100.18 132.62 45.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.214 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.614 ' HA ' ' O ' ' A' ' 37' ' ' ASN . 12.2 mm-40 -118.85 116.58 26.8 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.245 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.532 ' HA ' HD22 ' A' ' 81' ' ' LEU . 44.3 t -83.15 146.07 28.85 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.048 0.452 . . . . 0.0 111.716 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.427 ' CE1' ' HB3' ' A' ' 136' ' ' ASP . 1.5 t-80 52.22 65.55 1.47 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.037 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.619 HG11 ' HB ' ' A' ' 82' ' ' VAL . 10.6 p -123.6 141.8 42.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.17 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.516 ' HA ' ' HD2' ' A' ' 79' ' ' PRO . 9.4 mp -102.13 142.49 33.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.009 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.719 HD23 ' O ' ' A' ' 132' ' ' VAL . 5.6 mt -133.09 142.08 48.54 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -179.279 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.485 ' HB1' ' CG1' ' A' ' 74' ' ' VAL . . . -152.17 146.08 25.19 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.806 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 1.1 t -99.93 129.28 45.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.913 0.387 . . . . 0.0 111.228 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -109.91 -115.68 3.73 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.436 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -148.11 30.07 0.87 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.896 0.379 . . . . 0.0 110.851 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.3 m -98.94 -163.6 1.05 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.873 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.466 ' CB ' ' CD ' ' A' ' 107' ' ' PRO . 1.6 mt-10 -159.97 -65.79 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.029 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.466 ' CD ' ' CB ' ' A' ' 106' ' ' GLU . 55.9 Cg_endo -70.09 -40.9 4.31 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.304 2.003 . . . . 0.0 112.302 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 93.68 137.93 8.73 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.62 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -113.53 -36.77 4.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.86 0.362 . . . . 0.0 110.958 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 61.29 172.72 0.11 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.141 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.629 ' H ' HG11 ' A' ' 124' ' ' VAL . . . 89.92 108.35 1.28 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.457 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 140.09 157.32 7.2 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.497 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 26.9 pt -109.32 145.68 15.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.793 0.33 . . . . 0.0 111.065 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.733 HD22 ' HD2' ' A' ' 134' ' ' PHE . 34.2 tp -87.77 117.02 26.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.444 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 8.1 mtt180 -118.49 145.86 44.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.148 0.499 . . . . 0.0 111.93 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.989 ' HB2' HD11 ' A' ' 121' ' ' ILE . 13.9 t -107.85 165.05 11.73 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.304 178.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.68 -17.46 5.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.777 0.322 . . . . 0.0 110.484 179.204 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 45.4 m80 -93.54 -36.25 12.51 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.581 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.607 ' N ' ' HB2' ' A' ' 54' ' ' ALA . . . 179.02 -136.91 3.0 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 120.191 -1.004 . . . . 0.0 113.936 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' ' 52' ' ' THR . 3.0 t -105.11 136.24 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -179.031 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.989 HD11 ' HB2' ' A' ' 116' ' ' CYS . 1.9 mp -95.47 -40.07 10.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.189 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.707 ' HA2' HG23 ' A' ' 137' ' ' VAL . . . 162.01 -156.78 28.44 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.889 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.539 ' N ' HD23 ' A' ' 123' ' ' LEU . 0.2 OUTLIER -116.79 164.11 15.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.791 0.329 . . . . 0.0 110.851 -179.714 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.629 HG11 ' H ' ' A' ' 111' ' ' GLY . 11.4 p -68.36 131.62 33.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.427 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.805 ' OG1' ' HB2' ' A' ' 135' ' ' ALA . 1.9 m -103.08 -87.49 0.42 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.231 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.677 ' N ' HG22 ' A' ' 125' ' ' THR . 0.0 OUTLIER -131.42 162.05 31.05 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-O 120.807 0.337 . . . . 0.0 111.415 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -133.48 150.92 19.98 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.669 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -104.13 -153.06 22.86 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.449 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.94 -19.55 61.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.651 0.262 . . . . 0.0 111.103 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -164.04 16.78 0.11 Allowed Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.597 -0.811 . . . . 0.0 113.081 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.634 ' CG1' HD22 ' A' ' 100' ' ' LEU . 0.9 OUTLIER -120.29 157.26 23.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.776 0.322 . . . . 0.0 110.692 179.806 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.806 HG11 ' CZ ' ' A' ' 63' ' ' TYR . 14.3 m -115.85 118.4 58.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.408 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.419 ' HA2' ' O ' ' A' ' 99' ' ' LEU . . . -100.2 123.19 7.84 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.966 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.733 ' HD2' HD22 ' A' ' 114' ' ' LEU . 10.0 m-85 -124.83 140.15 53.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.854 0.359 . . . . 0.0 111.413 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.805 ' HB2' ' OG1' ' A' ' 125' ' ' THR . . . -88.76 114.34 25.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.057 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.427 ' HB3' ' CE1' ' A' ' 97' ' ' HIS . 3.0 t0 -73.12 146.55 45.64 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -178.463 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.707 HG23 ' HA2' ' A' ' 122' ' ' GLY . 62.0 t -104.95 5.86 10.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.139 178.51 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.45 ' HA ' HD23 ' A' ' 141' ' ' LEU . 12.2 mtm-85 -72.17 -6.51 43.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.26 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -94.64 7.34 46.07 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 120.726 0.298 . . . . 0.0 111.277 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.812 ' O ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -169.6 59.79 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.289 0.566 . . . . 0.0 109.92 179.818 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.954 HD11 ' HB ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -74.06 -14.88 61.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.298 -179.092 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 142' ' ' TRP . . . . . 0.45 ' C ' HD12 ' A' ' 143' ' ' LEU . 15.5 p-90 -54.72 81.51 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.972 0.415 . . . . 0.0 111.388 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.68 HD12 ' C ' ' A' ' 141' ' ' LEU . 5.0 mp -150.17 -47.21 0.13 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.979 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.421 ' HB2' ' CG1' ' A' ' 12' ' ' VAL . 9.2 mm-40 -154.07 -170.01 3.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.527 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.95 139.8 56.27 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.832 0.349 . . . . 0.0 111.043 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.97 154.22 18.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.878 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.58 ' HB3' ' H ' ' A' ' 55' ' ' ARG . . . -79.04 149.02 32.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.114 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -179.2 -38.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.925 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -131.51 31.05 4.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.851 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.857 -179.981 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.24 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.07 146.52 58.51 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.625 2.216 . . . . 0.0 112.259 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -147.03 117.16 7.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.895 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -136.28 -143.43 4.66 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.5 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -108.45 -47.64 3.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.796 0.332 . . . . 0.0 110.8 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -113.77 149.87 34.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.932 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 91.1 p -169.55 -179.98 3.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.874 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 169.44 43.46 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.554 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -128.61 156.2 43.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.839 0.352 . . . . 0.0 111.107 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.62 117.62 50.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.242 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.807 ' CE2' HG21 ' A' ' 45' ' ' THR . 5.6 t80 -106.55 116.59 32.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.483 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.868 HG21 HD11 ' A' ' 53' ' ' ILE . 21.2 t -120.8 114.62 44.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.802 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 46.94 -123.87 8.01 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 121.157 -0.544 . . . . 0.0 113.335 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.445 ' O ' ' HA ' ' A' ' 44' ' ' THR . 68.6 m-20 -90.07 15.79 9.54 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.638 0.256 . . . . 0.0 111.602 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.647 ' HE1' HG22 ' A' ' 44' ' ' THR . 6.8 m-30 -130.41 148.62 52.24 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.399 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.01 114.71 9.93 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.56 0.219 . . . . 0.0 110.579 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 1.08 HG12 HG22 ' A' ' 42' ' ' VAL . 0.6 OUTLIER -100.38 122.0 51.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.054 0.454 . . . . 0.0 110.842 -179.969 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.727 ' O ' HD12 ' A' ' 40' ' ' LEU . 12.5 p -136.06 160.98 38.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.216 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.524 ' N ' HG22 ' A' ' 18' ' ' VAL . 10.4 m-20 -61.47 141.44 57.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.447 179.308 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.4 ttt-85 -56.63 -47.33 79.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.899 0.38 . . . . 0.0 110.736 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -68.75 -11.02 59.83 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.912 179.336 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.414 ' HB3' HG22 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -108.65 -12.1 15.0 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.686 -179.735 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.962 ' HB3' ' CZ2' ' A' ' 28' ' ' TRP . . . -70.02 150.71 46.36 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 120.763 0.316 . . . . 0.0 110.753 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 16.9 p -105.03 169.04 8.66 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.326 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.51 ' CD2' HG23 ' A' ' 26' ' ' VAL . 2.8 p80 -54.6 -29.63 52.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.044 0.449 . . . . 0.0 110.656 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.51 HG23 ' CD2' ' A' ' 25' ' ' HIS . 21.8 t -74.72 -31.32 26.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.385 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.42 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 4.0 m-20 -67.11 -44.14 80.69 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.962 ' CZ2' ' HB3' ' A' ' 23' ' ' ALA . 7.4 m-90 -74.47 -31.63 62.29 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.125 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -58.02 -42.31 85.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.483 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -115.81 33.93 5.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.494 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.462 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 29.2 t -80.05 129.38 34.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.26 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.507 HG13 HG23 ' A' ' 44' ' ' THR . 13.0 m -92.57 -40.73 12.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.622 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.601 ' CZ3' HG23 ' A' ' 42' ' ' VAL . 0.3 OUTLIER -139.72 153.49 47.23 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 121.047 0.451 . . . . 0.0 111.644 -179.361 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -154.41 120.25 5.23 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.472 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.424 ' HB2' ' CZ2' ' A' ' 33' ' ' TRP . 6.1 m-20 -100.42 116.7 32.99 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.414 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -65.83 -43.32 88.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.875 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.484 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 7.0 m120 -71.2 -10.96 60.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.011 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.454 ' NE ' ' HB1' ' A' ' 135' ' ' ALA . 3.5 tpm_? -117.1 -4.96 11.41 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 121.151 -0.22 . . . . 0.0 111.301 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 47.12 33.98 2.69 Favored 'General case' 0 N--CA 1.46 0.059 0 CA-C-O 121.122 0.486 . . . . 0.0 110.27 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.906 HD13 HD11 ' A' ' 123' ' ' LEU . 41.6 tp -126.8 153.37 45.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.747 -179.346 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.666 ' O ' HD23 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -146.79 155.69 42.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.871 0.367 . . . . 0.0 111.781 179.754 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 1.08 HG22 HG12 ' A' ' 17' ' ' VAL . 24.7 t -119.14 130.04 74.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.342 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.6 p -121.07 157.13 30.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.556 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.647 HG22 ' HE1' ' A' ' 15' ' ' TYR . 17.4 p -97.74 128.67 44.57 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.182 0.515 . . . . 0.0 111.471 -179.183 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.807 HG21 ' CE2' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -103.61 -34.19 8.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.889 -179.245 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.0 m 68.37 59.22 0.41 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.017 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.607 ' HB3' ' OH ' ' A' ' 11' ' ' TYR . . . -152.13 -167.86 2.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.201 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 46.8 p-80 -81.93 148.01 28.96 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.984 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -93.55 153.17 21.18 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.718 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.5 m -125.73 -62.72 1.17 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.869 0.366 . . . . 0.0 110.742 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -69.07 147.21 51.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.681 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.825 ' O ' HG23 ' A' ' 120' ' ' VAL . 62.8 m -123.56 117.53 25.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.94 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.889 ' HB ' HD11 ' A' ' 141' ' ' LEU . 0.4 OUTLIER -73.07 139.34 19.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.644 179.864 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.82 ' HB2' ' N ' ' A' ' 119' ' ' GLY . . . -95.96 124.84 40.14 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.926 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.608 ' H ' ' HB3' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -90.94 33.9 0.93 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.504 179.61 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 26.6 p -99.69 167.13 10.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.892 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -123.03 39.71 3.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.177 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 19.3 m -68.94 131.77 45.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.779 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.1 t -76.86 -7.15 54.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.811 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.7 p -117.84 123.93 47.11 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.988 0.423 . . . . 0.0 111.091 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -148.98 162.56 28.96 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.571 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.829 HG23 ' C ' ' A' ' 72' ' ' TYR . 13.2 p -99.86 134.42 39.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.193 0.521 . . . . 0.0 111.669 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -120.26 -170.7 2.02 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.059 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.453 ' CG ' ' HB2' ' A' ' 67' ' ' SER . 0.6 OUTLIER 68.43 -91.09 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.197 179.913 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 70.63 -63.34 0.41 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.658 0.266 . . . . 0.0 111.255 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.65 -38.63 12.97 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.774 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.453 ' HB2' ' CG ' ' A' ' 64' ' ' PHE . 3.6 m -46.58 -68.18 0.22 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.295 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.22 9.87 21.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.097 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 66.13 12.53 8.57 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.144 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.84 168.35 20.15 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.066 0.46 . . . . 0.0 110.937 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.769 ' HB2' HG21 ' A' ' 62' ' ' VAL . 12.5 p-80 -87.9 116.8 26.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.569 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.829 ' C ' HG23 ' A' ' 62' ' ' VAL . 1.8 m-85 -106.78 113.17 63.07 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.073 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.54 ' HA ' ' HA ' ' A' ' 62' ' ' VAL . 6.0 Cg_exo -80.27 139.11 12.97 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.846 2.364 . . . . 0.0 111.632 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.452 ' CG1' ' CE2' ' A' ' 76' ' ' PHE . 1.3 p -151.14 161.26 3.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.016 0.436 . . . . 0.0 111.892 -179.23 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.5 p -106.88 126.62 52.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.227 178.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.646 ' CZ ' HD11 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -128.48 166.18 19.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.654 0.74 . . . . 0.0 112.294 -179.111 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.69 ' C ' ' HD3' ' A' ' 79' ' ' PRO . 1.3 mp0 -111.91 159.36 18.45 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.552 -1.204 . . . . 0.0 108.918 178.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.461 ' HA2' ' HG ' ' A' ' 99' ' ' LEU . . . -108.57 64.19 0.26 Allowed Glycine 0 CA--C 1.522 0.495 0 C-N-CA 120.135 -1.031 . . . . 0.0 114.155 -179.159 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.69 ' HD3' ' C ' ' A' ' 77' ' ' GLU . 14.9 Cg_exo -66.96 138.27 47.44 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.12 1.88 . . . . 0.0 111.965 179.384 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -62.77 -90.7 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.752 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.615 HD22 ' HB2' ' A' ' 96' ' ' SER . 0.0 OUTLIER -87.79 120.0 28.68 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.343 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.599 ' HB ' HG11 ' A' ' 98' ' ' VAL . 89.1 t -124.8 122.93 64.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.534 178.402 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.407 ' OE2' ' CE1' ' A' ' 94' ' ' TYR . 1.2 tp10 -72.11 107.9 5.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.986 0.422 . . . . 0.0 110.686 -179.163 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.847 HG23 ' HB2' ' A' ' 126' ' ' MET . 2.9 p -83.06 114.39 23.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.739 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -74.35 150.37 40.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.471 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 5.8 pt-20 -67.72 100.78 0.95 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.274 0.559 . . . . 0.0 109.88 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.529 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.5 OUTLIER -145.16 172.92 12.42 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.62 -179.976 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 44.14 -85.17 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.614 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.529 ' N ' ' O ' ' A' ' 87' ' ' SER . 0.2 OUTLIER -150.15 23.21 0.84 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.818 0.342 . . . . 0.0 110.413 179.597 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.749 ' HD2' HG21 ' A' ' 84' ' ' VAL . 0.4 OUTLIER -116.34 145.68 35.66 Favored Pre-proline 0 C--O 1.232 0.17 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.999 -179.63 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.404 ' O ' ' N ' ' A' ' 93' ' ' ARG . 92.2 Cg_endo -85.44 148.74 10.13 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.307 2.671 . . . . 0.0 112.697 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.515 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -65.42 72.81 0.05 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 179.894 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.486 ' O ' HG12 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -123.92 -178.23 3.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.961 0.41 . . . . 0.0 111.621 -179.653 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.432 ' HB3' HD11 ' A' ' 81' ' ' LEU . 14.6 m-85 -94.99 132.17 40.15 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.586 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.484 ' HA ' ' O ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -131.15 125.56 33.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.667 0.27 . . . . 0.0 111.321 -179.681 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.615 ' HB2' HD22 ' A' ' 81' ' ' LEU . 1.4 t -102.09 154.21 19.2 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 120.917 0.389 . . . . 0.0 111.868 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 70.19 54.52 0.32 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.395 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.599 HG11 ' HB ' ' A' ' 82' ' ' VAL . 5.0 p -123.46 141.73 42.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.223 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.535 ' N ' HD12 ' A' ' 99' ' ' LEU . 5.6 mp -107.49 146.49 31.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.094 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.675 HD23 ' C ' ' A' ' 132' ' ' VAL . 6.1 mt -133.28 133.74 42.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.113 0.482 . . . . 0.0 112.189 -179.403 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.608 ' HB2' ' CD2' ' A' ' 76' ' ' PHE . . . -136.39 150.47 48.81 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.65 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.1 t -108.84 129.27 55.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.857 0.361 . . . . 0.0 110.98 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -89.96 -160.26 36.33 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.637 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -81.77 -66.18 0.92 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.78 0.324 . . . . 0.0 110.969 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 75.7 m -104.04 178.43 4.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.865 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -71.37 135.83 84.17 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.861 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -74.35 120.48 6.27 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.463 2.109 . . . . 0.0 112.379 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -91.19 -29.93 11.78 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.465 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -126.89 145.82 50.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.806 0.336 . . . . 0.0 110.885 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.67 172.26 0.73 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.051 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -114.51 -176.7 18.96 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.52 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -106.5 -96.06 2.44 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.443 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 34.5 pt -125.99 146.12 32.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.809 0.337 . . . . 0.0 111.218 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.646 HD11 ' CZ ' ' A' ' 76' ' ' PHE . 16.3 tp -87.82 119.46 28.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.24 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -118.13 149.32 41.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.067 0.46 . . . . 0.0 111.786 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.575 ' HB2' HD11 ' A' ' 121' ' ' ILE . 7.4 t -115.48 163.08 16.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.149 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -55.85 -20.07 14.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.814 0.34 . . . . 0.0 110.818 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.435 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . 26.7 m80 -90.64 -35.47 14.95 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.422 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.82 ' N ' ' HB2' ' A' ' 54' ' ' ALA . . . 177.45 -139.31 4.25 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.333 -0.937 . . . . 0.0 113.281 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' ' 52' ' ' THR . 3.4 t -100.91 135.39 37.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.687 0.279 . . . . 0.0 111.341 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.575 HD11 ' HB2' ' A' ' 116' ' ' CYS . 1.1 mm -95.78 -61.99 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.871 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.797 ' HA2' HG23 ' A' ' 137' ' ' VAL . . . -174.9 -163.57 28.26 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.302 -0.951 . . . . 0.0 113.387 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.906 HD11 HD13 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -116.89 141.75 47.82 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.864 0.364 . . . . 0.0 111.002 -179.792 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.407 ' HB ' ' CE1' ' A' ' 134' ' ' PHE . 10.6 p -57.94 148.81 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.94 -179.394 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.509 HG23 ' H ' ' A' ' 126' ' ' MET . 0.0 OUTLIER -128.87 -87.17 0.55 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.225 179.333 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.847 ' HB2' HG23 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -107.6 138.87 43.03 Favored 'General case' 0 N--CA 1.461 0.087 0 CA-C-O 120.997 0.427 . . . . 0.0 110.8 179.393 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -122.93 129.13 7.33 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.158 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -81.06 -160.19 23.98 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.497 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -71.84 -19.24 62.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.807 0.336 . . . . 0.0 110.815 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -158.07 18.23 0.33 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.708 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.57 ' CG1' HD22 ' A' ' 100' ' ' LEU . 0.9 OUTLIER -125.03 157.01 33.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-O 120.666 0.269 . . . . 0.0 110.783 -180.0 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.675 ' C ' HD23 ' A' ' 100' ' ' LEU . 11.3 m -118.55 118.79 59.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.801 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -91.67 124.51 7.65 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.615 -0.802 . . . . 0.0 111.487 179.114 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.434 ' CG ' ' HB2' ' A' ' 114' ' ' LEU . 19.2 m-85 -124.25 135.43 53.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.999 0.428 . . . . 0.0 111.912 -178.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.552 ' O ' ' HA3' ' A' ' 122' ' ' GLY . . . -88.84 112.19 22.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.836 178.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -67.55 136.76 55.03 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -178.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.797 HG23 ' HA2' ' A' ' 122' ' ' GLY . 67.6 t -89.5 7.57 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.382 178.674 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.432 ' HA ' HD23 ' A' ' 141' ' ' LEU . 30.6 mmm-85 -71.11 -6.66 40.93 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.588 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.43 10.99 38.25 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.62 0.248 . . . . 0.0 111.332 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.807 ' O ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -175.19 53.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.128 0.489 . . . . 0.0 110.6 -179.868 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.889 HD11 ' HB ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -70.61 -14.69 62.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.012 -179.52 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 142' ' ' TRP . . . . . 0.455 ' C ' HD12 ' A' ' 143' ' ' LEU . 15.6 p-90 -54.52 83.62 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.134 0.493 . . . . 0.0 111.358 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.701 HD12 ' C ' ' A' ' 141' ' ' LEU . 5.0 mp -151.52 -44.87 0.11 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.972 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.842 ' OE2' HG13 ' A' ' 12' ' ' VAL . 14.4 pt-20 -155.95 -163.19 1.43 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.662 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.03 145.62 55.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.889 0.376 . . . . 0.0 111.041 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -105.1 154.14 20.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.896 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.608 ' HB3' ' H ' ' A' ' 55' ' ' ARG . . . -80.01 119.98 23.57 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.876 0.369 . . . . 0.0 111.043 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 2.2 ptp -127.69 137.18 52.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.955 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.18 82.85 2.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.849 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.251 -0.881 . . . . 0.0 110.867 179.969 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.157 0 N-CA-C 112.467 -0.253 . . . . 0.0 112.467 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.86 158.68 56.02 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.516 2.144 . . . . 0.0 112.251 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -85.53 145.28 27.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.96 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -114.99 152.83 17.98 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.45 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -149.76 160.08 43.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.735 0.303 . . . . 0.0 110.949 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -150.86 154.52 37.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.91 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 24.7 p -120.1 178.14 4.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.847 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 96.76 -29.64 10.17 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.458 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.742 ' HB2' HG23 ' A' ' 18' ' ' VAL . . . -107.31 -169.8 1.6 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.759 0.314 . . . . 0.0 110.985 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.478 HG13 ' O ' ' A' ' 10' ' ' VAL . 8.4 p -124.61 119.13 55.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.981 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.683 ' CE1' HG21 ' A' ' 45' ' ' THR . 7.3 t80 -98.69 117.09 32.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.69 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.853 HG21 HD11 ' A' ' 53' ' ' ILE . 22.3 t -120.1 130.05 74.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.584 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.445 ' O ' ' CE1' ' A' ' 11' ' ' TYR . . . 46.01 -123.91 7.0 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 121.085 -0.579 . . . . 0.0 113.141 179.554 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.404 ' O ' ' HA ' ' A' ' 44' ' ' THR . 59.3 m-80 -99.27 19.82 14.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.784 0.326 . . . . 0.0 111.002 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.69 ' HB2' HD23 ' A' ' 143' ' ' LEU . 9.2 m-30 -130.22 152.14 49.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.085 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.403 ' HZ3' ' HB3' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -138.59 114.79 10.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.276 179.24 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 1.023 HG12 HG22 ' A' ' 42' ' ' VAL . 0.7 OUTLIER -102.59 122.05 54.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 121.229 0.538 . . . . 0.0 111.388 -179.588 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.742 HG23 ' HB2' ' A' ' 9' ' ' ALA . 7.4 p -136.4 161.03 37.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.626 179.692 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.523 ' N ' HG22 ' A' ' 18' ' ' VAL . 11.4 m-80 -63.53 140.02 58.83 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 179.392 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.1 -38.86 73.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.717 0.294 . . . . 0.0 110.977 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.72 -10.45 58.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.11 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.62 -6.89 13.89 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.724 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.798 ' HB3' ' CZ2' ' A' ' 28' ' ' TRP . . . -80.36 150.68 29.78 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.832 0.348 . . . . 0.0 110.925 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.413 ' O ' ' CE3' ' A' ' 28' ' ' TRP . 43.5 p -103.77 169.17 8.67 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.254 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.537 ' CE1' HG23 ' A' ' 26' ' ' VAL . 0.9 OUTLIER -54.49 -29.56 50.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.917 0.389 . . . . 0.0 110.645 179.87 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.537 HG23 ' CE1' ' A' ' 25' ' ' HIS . 21.5 t -74.28 -31.37 28.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.324 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.445 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 0.5 OUTLIER -67.19 -44.08 80.51 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 179.856 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.798 ' CZ2' ' HB3' ' A' ' 23' ' ' ALA . 7.5 m-90 -73.97 -30.15 62.36 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.884 179.172 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -58.1 -44.15 87.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.439 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -111.69 28.89 8.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.538 179.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 13.0 t -80.09 136.14 36.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.162 -179.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.504 HG22 ' O ' ' A' ' 42' ' ' VAL . 15.7 m -94.58 -41.61 12.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.753 179.277 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.612 ' CZ3' HG23 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -139.73 153.2 47.15 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.952 0.406 . . . . 0.0 111.503 -179.465 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -164.6 111.87 1.05 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.897 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 35.7 p-10 -107.26 126.54 52.55 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.017 0.437 . . . . 0.0 111.375 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -67.7 -34.56 77.13 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.295 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.436 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 11.7 p30 -59.75 -22.76 62.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.877 0.37 . . . . 0.0 110.601 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.446 ' NE ' ' HA ' ' A' ' 38' ' ' ARG . 3.2 tpm_? -117.39 -3.91 11.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.06 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 48.66 34.68 5.29 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.07 0.462 . . . . 0.0 110.059 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.776 HD13 HD11 ' A' ' 123' ' ' LEU . 41.5 tp -124.85 152.6 43.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.953 -179.181 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.765 HD12 ' NE1' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -143.78 155.92 44.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.472 179.692 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 1.023 HG22 HG12 ' A' ' 17' ' ' VAL . 24.4 t -121.41 130.33 74.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.152 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.0 p -121.93 157.26 31.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.29 179.098 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.645 HG22 ' HE1' ' A' ' 15' ' ' TYR . 17.8 p -97.36 125.11 41.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.166 0.508 . . . . 0.0 111.576 -179.105 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.683 HG21 ' CE1' ' A' ' 11' ' ' TYR . 0.7 OUTLIER -93.39 -31.55 14.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.904 -179.503 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.82 38.07 6.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.893 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -136.78 -175.39 4.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.078 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -71.77 125.85 28.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.895 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.38 173.53 11.24 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.498 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.2 m -142.9 -71.92 0.31 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.847 0.356 . . . . 0.0 110.903 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -67.52 146.67 53.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.007 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.926 ' O ' HG23 ' A' ' 120' ' ' VAL . 62.7 m -120.91 118.97 31.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.579 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.853 HD11 HG21 ' A' ' 12' ' ' VAL . 1.0 OUTLIER -76.56 139.55 18.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.996 -179.84 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.827 ' HB2' ' N ' ' A' ' 119' ' ' GLY . . . -100.81 118.42 36.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.802 179.487 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.554 ' H ' ' HB3' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -90.77 42.65 1.11 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.104 0.478 . . . . 0.0 110.519 179.701 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 15.6 p -99.7 167.16 10.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.835 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.64 39.32 3.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.43 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 28.9 m -72.85 128.06 34.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.759 0.314 . . . . 0.0 110.526 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.54 -13.03 62.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.961 179.601 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.5 p -108.38 159.26 16.8 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.952 0.406 . . . . 0.0 111.09 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -177.18 148.84 9.08 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.675 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.784 HG23 ' C ' ' A' ' 72' ' ' TYR . 7.4 p -105.08 136.47 38.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.997 0.427 . . . . 0.0 111.572 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.632 ' HE2' HG21 ' A' ' 74' ' ' VAL . 5.6 p90 -125.1 142.08 51.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.564 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -56.27 120.06 6.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.915 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.435 ' HB2' ' CD1' ' A' ' 72' ' ' TYR . 0.8 OUTLIER -69.72 140.16 53.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.068 -179.804 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.547 ' HB2' ' C ' ' A' ' 109' ' ' ASP . . . -85.14 -45.17 12.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.95 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.0 -30.64 62.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.535 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.9 tttp -115.15 152.89 31.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.67 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.2 m -96.02 36.25 1.33 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.951 0.405 . . . . 0.0 110.483 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.442 ' HD3' ' CE1' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -127.57 169.94 13.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.782 -179.472 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.689 ' HB3' HG21 ' A' ' 62' ' ' VAL . 5.5 m170 -84.24 127.05 33.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.75 179.377 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.784 ' C ' HG23 ' A' ' 62' ' ' VAL . 3.1 m-85 -110.28 114.01 55.91 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.659 -178.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 72' ' ' TYR . 4.4 Cg_exo -79.14 120.6 4.61 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.534 2.156 . . . . 0.0 110.712 178.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.632 HG21 ' HE2' ' A' ' 63' ' ' TYR . 54.9 t -134.63 141.9 42.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.038 0.446 . . . . 0.0 112.162 -178.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.1 p -95.22 126.45 40.55 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.517 ' HB3' ' HB2' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -130.45 167.65 18.26 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.548 0.69 . . . . 0.0 112.358 -178.279 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.621 ' C ' ' HD3' ' A' ' 79' ' ' PRO . 0.9 OUTLIER -111.79 159.14 18.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.799 178.741 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -110.52 65.97 0.24 Allowed Glycine 0 CA--C 1.522 0.501 0 C-N-CA 120.081 -1.057 . . . . 0.0 114.196 -179.005 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.621 ' HD3' ' C ' ' A' ' 77' ' ' GLU . 16.2 Cg_exo -66.92 141.66 59.49 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.113 1.875 . . . . 0.0 111.914 179.301 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -61.59 -94.55 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.777 -0.647 . . . . 0.0 113.089 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.556 HD22 ' HB3' ' A' ' 96' ' ' SER . 0.0 OUTLIER -86.22 119.92 27.02 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.119 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.625 ' HB ' HG11 ' A' ' 98' ' ' VAL . 67.6 t -124.36 122.96 65.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.218 177.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.01 107.68 4.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.042 0.449 . . . . 0.0 110.679 -178.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.81 HG13 ' HG2' ' A' ' 126' ' ' MET . 24.4 t -74.88 114.35 14.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.834 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.448 ' HA ' ' HG2' ' A' ' 92' ' ' LYS . 8.5 pt20 -77.02 150.18 35.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.574 179.013 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.592 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 23.0 tt0 -67.54 100.35 0.86 Allowed 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.945 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.523 ' O ' ' N ' ' A' ' 89' ' ' TYR . 43.0 t -145.12 159.8 42.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.674 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.401 ' HB3' ' H ' ' A' ' 89' ' ' TYR . 6.0 tt0 50.96 -82.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.664 178.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.523 ' N ' ' O ' ' A' ' 87' ' ' SER . 2.0 p90 -155.91 25.83 0.38 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.846 0.355 . . . . 0.0 110.594 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.592 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 0.3 OUTLIER -116.67 116.45 38.67 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.574 -179.934 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.461 ' O ' ' N ' ' A' ' 93' ' ' ARG . 37.9 Cg_exo -60.4 148.68 89.65 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.88 2.387 . . . . 0.0 112.729 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.2 OUTLIER -61.95 73.07 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.832 179.55 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.461 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -124.14 179.76 4.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.189 0.518 . . . . 0.0 112.027 -179.314 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.441 ' HB3' HD11 ' A' ' 81' ' ' LEU . 11.1 m-85 -99.28 132.26 44.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.642 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.436 ' HA ' ' O ' ' A' ' 37' ' ' ASN . 1.5 mm100 -131.57 130.6 42.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.713 0.292 . . . . 0.0 111.242 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.556 ' HB3' HD22 ' A' ' 81' ' ' LEU . 11.0 p -102.4 147.88 26.17 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.886 0.374 . . . . 0.0 111.736 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 73.74 56.3 0.1 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.876 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.625 HG11 ' HB ' ' A' ' 82' ' ' VAL . 10.0 p -123.57 143.18 37.59 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.036 179.258 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.446 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 10.7 mp -104.59 143.54 32.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.278 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.711 HD23 ' O ' ' A' ' 132' ' ' VAL . 6.5 mt -133.26 141.5 48.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.041 0.448 . . . . 0.0 112.158 -179.46 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.517 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . . . -150.99 144.86 25.17 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.971 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 1.2 t -100.28 125.32 46.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.914 0.387 . . . . 0.0 111.021 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -74.87 -45.98 19.08 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.527 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.6 t80 62.17 29.96 17.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.846 0.355 . . . . 0.0 110.917 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 43.9 m -138.94 -60.21 0.58 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.916 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -148.44 140.44 14.48 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.969 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -77.27 -175.51 2.7 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.611 2.207 . . . . 0.0 112.316 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.66 155.87 27.46 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.648 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.547 ' C ' ' HB2' ' A' ' 66' ' ' ALA . 0.5 OUTLIER -148.66 -49.76 0.16 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.777 0.322 . . . . 0.0 110.811 179.944 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 56.82 -168.3 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.222 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -90.36 104.55 3.15 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.561 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.798 ' O ' HG13 ' A' ' 124' ' ' VAL . . . -152.01 175.12 30.87 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.359 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.56 HD13 HG13 ' A' ' 120' ' ' VAL . 2.5 pp -126.04 146.19 32.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.881 0.372 . . . . 0.0 111.192 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.604 ' HG ' ' HB ' ' A' ' 121' ' ' ILE . 7.9 tp -87.61 115.57 25.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.083 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.99 148.3 42.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.222 0.534 . . . . 0.0 111.718 -179.389 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.519 ' HB2' HD11 ' A' ' 121' ' ' ILE . 8.2 t -109.4 164.79 12.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.08 179.438 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.81 -20.41 15.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.807 0.337 . . . . 0.0 110.618 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.506 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . 28.9 m80 -88.9 -36.84 15.72 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.291 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.827 ' N ' ' HB2' ' A' ' 54' ' ' ALA . . . 178.42 -135.3 2.6 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.398 -0.906 . . . . 0.0 113.063 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.926 HG23 ' O ' ' A' ' 52' ' ' THR . 3.9 t -104.38 135.67 41.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.793 0.33 . . . . 0.0 111.402 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.604 ' HB ' ' HG ' ' A' ' 114' ' ' LEU . 1.1 mm -97.86 -67.05 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.774 179.315 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.952 ' HA2' HG23 ' A' ' 137' ' ' VAL . . . -156.96 -168.34 19.42 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.023 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.776 HD11 HD13 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -116.75 164.45 14.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.637 0.256 . . . . 0.0 110.456 179.913 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.798 HG13 ' O ' ' A' ' 112' ' ' GLY . 31.3 m -71.99 137.78 22.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.933 0.397 . . . . 0.0 111.841 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.518 HG23 ' H ' ' A' ' 126' ' ' MET . 0.0 OUTLIER -130.01 -91.23 0.46 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.168 178.98 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.81 ' HG2' HG13 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -85.94 145.63 27.06 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.333 179.255 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -145.81 107.28 0.41 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.596 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -91.18 -167.2 40.99 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.439 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -92.92 17.2 11.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.661 0.267 . . . . 0.0 111.135 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 102' ' ' THR . . . -158.6 -31.09 0.02 OUTLIER Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.94 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.675 ' CG1' HD22 ' A' ' 100' ' ' LEU . 1.7 t -115.39 157.11 16.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.772 0.32 . . . . 0.0 111.108 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.711 ' O ' HD23 ' A' ' 100' ' ' LEU . 15.2 m -115.73 118.26 58.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.383 -179.442 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -96.06 122.02 7.16 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.055 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.585 ' HD2' HD22 ' A' ' 114' ' ' LEU . 15.6 m-85 -125.17 139.47 53.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.976 0.417 . . . . 0.0 111.608 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.441 ' N ' HG22 ' A' ' 125' ' ' THR . . . -88.87 115.08 26.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.364 179.274 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -68.98 140.07 55.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.984 0.421 . . . . 0.0 112.004 -179.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.952 HG23 ' HA2' ' A' ' 122' ' ' GLY . 81.2 t -90.46 9.02 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.511 178.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.559 ' HA ' HD23 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -70.1 -6.58 34.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.619 179.922 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -97.08 11.17 37.15 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.859 ' O ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -175.77 49.17 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.231 0.538 . . . . 0.0 110.61 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.738 HD11 ' HB ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -67.41 -14.75 63.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.997 -179.629 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 142' ' ' TRP . . . . . 0.422 ' CE3' ' CE2' ' A' ' 15' ' ' TYR . 16.7 p-90 -57.71 80.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.039 0.447 . . . . 0.0 111.495 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.69 HD23 ' HB2' ' A' ' 15' ' ' TYR . 4.9 mp -142.29 -47.28 0.34 Allowed 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.162 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.682 ' OE2' HG23 ' A' ' 52' ' ' THR . 17.4 pt-20 -154.71 -162.98 1.48 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.669 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.69 122.15 16.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.976 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.661 ' OD1' HD12 ' A' ' 141' ' ' LEU . 86.4 m-20 -85.33 154.21 22.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.935 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.554 ' HB3' ' H ' ' A' ' 55' ' ' ARG . . . -80.91 120.03 24.21 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.06 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -105.23 169.82 8.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.93 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.02 125.67 24.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.893 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.859 179.941 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.812 0.339 . . . . 0.0 110.996 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.459 HG22 HG21 ' A' ' 113' ' ' ILE . 53.7 t -121.02 109.23 24.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.126 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.934 ' CE2' HG21 ' A' ' 45' ' ' THR . 0.4 OUTLIER -93.88 115.83 28.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.423 179.864 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.956 HG21 HD11 ' A' ' 53' ' ' ILE . 19.2 t -121.29 108.89 23.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.786 0.327 . . . . 0.0 111.816 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 48.35 -124.59 11.63 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.94 -0.648 . . . . 0.0 113.242 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.45 ' O ' ' HA ' ' A' ' 44' ' ' THR . 33.0 p-10 -90.96 13.08 17.64 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.655 ' CB ' HD23 ' A' ' 143' ' ' LEU . 6.6 m-85 -130.34 127.8 40.17 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.461 ' HG3' ' CD1' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -116.4 114.89 24.89 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.561 0.219 . . . . 0.0 110.686 179.687 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 1.067 HG12 HG22 ' A' ' 42' ' ' VAL . 0.7 OUTLIER -100.63 122.08 52.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.119 0.485 . . . . 0.0 110.777 179.68 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.526 HG22 ' N ' ' A' ' 19' ' ' ASN . 10.6 p -136.07 161.03 38.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.152 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.526 ' N ' HG22 ' A' ' 18' ' ' VAL . 4.7 t-20 -59.97 141.51 55.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.558 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 11.8 ttt180 -56.59 -47.12 80.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.855 0.36 . . . . 0.0 110.832 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 41.7 t-80 -69.1 -8.79 48.55 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.15 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 13.9 tp -110.78 -10.87 14.43 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.873 ' HB3' ' CZ2' ' A' ' 28' ' ' TRP . . . -73.27 150.61 41.83 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 120.792 0.329 . . . . 0.0 110.814 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.7 p -103.65 169.32 8.59 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.442 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -54.64 -29.78 53.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.886 0.374 . . . . 0.0 110.543 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.5 t -73.93 -31.42 30.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.42 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.421 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 0.2 OUTLIER -67.29 -44.08 80.15 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.898 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.873 ' CZ2' ' HB3' ' A' ' 23' ' ' ALA . 7.1 m-90 -74.29 -31.33 62.46 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.226 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 9.5 mm-40 -58.22 -43.8 87.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.452 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -113.46 33.39 5.16 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.404 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.476 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 27.2 t -80.05 134.11 36.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.279 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 42' ' ' VAL . 15.3 m -97.28 -39.86 9.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.617 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.612 ' HH2' HD23 ' A' ' 40' ' ' LEU . 1.2 t90 -139.36 153.11 47.62 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.856 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 2.0 tm-20 -160.34 118.15 2.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.959 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -107.1 111.05 23.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.973 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.402 ' CE2' ' OD1' ' A' ' 37' ' ' ASN . 50.5 p90 -59.63 -47.23 86.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.242 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.425 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 2.1 m120 -60.02 -25.94 65.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.793 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.411 ' CZ ' ' HB3' ' A' ' 139' ' ' ASP . 20.7 ttm180 -100.07 -7.7 24.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.302 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 51.06 34.83 11.56 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 121.145 0.497 . . . . 0.0 110.258 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.872 HD11 HG23 ' A' ' 17' ' ' VAL . 13.5 tp -133.71 149.68 51.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.974 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.667 HD12 ' NE1' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -145.0 155.88 43.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.361 179.572 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 1.067 HG22 HG12 ' A' ' 17' ' ' VAL . 38.9 t -118.5 127.37 75.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.626 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.5 p -120.81 157.46 29.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.345 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.633 HG22 ' CE1' ' A' ' 15' ' ' TYR . 10.5 p -97.57 146.59 25.13 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.165 0.507 . . . . 0.0 111.66 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.934 HG21 ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -136.29 165.49 25.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.853 -179.25 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.1 t -93.29 -34.1 13.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.082 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.79 128.6 34.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.1 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -59.09 147.98 32.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.926 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -80.23 177.69 54.21 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.584 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -132.12 33.5 3.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.761 0.315 . . . . 0.0 110.905 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -138.45 144.49 40.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.911 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.85 ' O ' HG23 ' A' ' 120' ' ' VAL . 63.0 m -120.83 115.91 24.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.793 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.956 HD11 HG21 ' A' ' 12' ' ' VAL . 0.4 OUTLIER -73.86 139.54 19.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.018 -179.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.835 ' HB2' ' N ' ' A' ' 119' ' ' GLY . . . -93.38 133.53 36.54 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.402 ' HA ' ' HD2' ' A' ' 138' ' ' ARG . 0.0 OUTLIER -93.54 27.11 2.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.991 0.424 . . . . 0.0 110.402 179.275 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 30.8 p -100.01 167.13 10.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.029 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -127.72 32.42 4.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.89 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 25.2 m -56.61 132.63 52.3 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.791 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.5 t -74.15 -8.61 56.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.969 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.1 p -118.46 130.77 56.14 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.891 0.377 . . . . 0.0 111.073 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -153.33 -167.94 16.45 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.84 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.468 HG23 ' C ' ' A' ' 72' ' ' TYR . 7.5 p -133.75 126.24 50.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.007 0.432 . . . . 0.0 110.885 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.669 ' HE2' HG21 ' A' ' 74' ' ' VAL . 3.1 p90 -111.14 153.91 25.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.102 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 4.0 t80 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.647 179.747 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 . . . . . 0 N--CA 1.456 -0.128 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.468 ' C ' HG23 ' A' ' 62' ' ' VAL . 0.7 OUTLIER -126.47 114.03 23.15 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.661 -178.834 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 72' ' ' TYR . 4.4 Cg_exo -74.54 120.54 6.24 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.356 2.037 . . . . 0.0 110.255 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.697 ' CG1' ' HB1' ' A' ' 101' ' ' ALA . 97.1 t -144.3 147.42 19.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.048 0.452 . . . . 0.0 112.167 -178.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 53.6 p -92.02 137.19 32.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.295 178.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.741 ' HD2' ' HB2' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -146.48 168.43 21.22 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.22 0.534 . . . . 0.0 111.942 -178.882 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -113.0 158.39 20.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.05 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -106.03 68.17 0.24 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.917 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.551 ' HD2' ' HA ' ' A' ' 99' ' ' LEU . 38.0 Cg_endo -67.6 135.16 35.14 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.471 2.114 . . . . 0.0 112.227 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -59.27 -82.8 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.288 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.794 HD11 ' HB3' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -97.08 119.86 36.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.898 0.38 . . . . 0.0 111.749 -179.897 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.627 ' HB ' HG11 ' A' ' 98' ' ' VAL . 46.8 t -124.99 122.18 62.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.217 178.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.13 107.98 5.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.776 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.579 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 19.3 m -81.79 126.85 39.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.236 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.84 150.65 46.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.06 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.555 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 3.9 pt-20 -67.73 102.54 1.23 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.87 0.367 . . . . 0.0 110.431 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.428 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -143.89 164.1 31.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.425 -179.732 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.422 ' HG2' ' CE2' ' A' ' 89' ' ' TYR . 2.8 tt0 56.95 -81.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.543 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.428 ' N ' ' O ' ' A' ' 87' ' ' SER . 0.4 OUTLIER -155.64 22.93 0.4 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.926 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.555 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 9.7 t80 -123.79 136.8 27.78 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.883 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.446 ' O ' ' N ' ' A' ' 93' ' ' ARG . 86.4 Cg_endo -81.76 148.95 15.97 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.09 2.527 . . . . 0.0 112.451 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.579 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -49.2 89.52 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.804 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.572 ' O ' HG22 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -124.13 169.64 11.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.259 0.552 . . . . 0.0 112.209 -179.126 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.794 ' HB3' HD11 ' A' ' 81' ' ' LEU . 2.9 m-85 -90.86 132.46 35.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.928 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.561 ' O ' HD13 ' A' ' 81' ' ' LEU . 10.1 mm-40 -124.5 131.87 53.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.054 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 12.0 p -101.31 147.52 26.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.998 0.428 . . . . 0.0 111.835 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.492 ' CD2' ' HB3' ' A' ' 136' ' ' ASP . 4.2 t60 63.85 55.98 1.55 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.946 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.627 HG11 ' HB ' ' A' ' 82' ' ' VAL . 11.6 p -123.44 135.86 61.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.872 0.368 . . . . 0.0 111.364 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.771 HD11 ' HB2' ' A' ' 136' ' ' ASP . 1.8 mp -104.3 133.42 49.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.161 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.823 ' HA ' ' O ' ' A' ' 132' ' ' VAL . 7.4 mt -116.53 138.54 51.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.18 0.514 . . . . 0.0 112.311 -179.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.741 ' HB2' ' HD2' ' A' ' 76' ' ' PHE . . . -128.47 119.28 24.6 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.565 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 1.7 t -87.37 111.83 21.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.886 0.374 . . . . 0.0 110.648 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 0.239 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.541 -179.854 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 112.671 -0.172 . . . . 0.0 112.671 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.525 HD13 HG13 ' A' ' 120' ' ' VAL . 2.6 pp -126.0 146.18 32.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.922 0.391 . . . . 0.0 111.415 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.728 HD21 ' CZ ' ' A' ' 76' ' ' PHE . 56.2 tp -87.82 115.84 25.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.73 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 18.6 ptt-85 -118.74 143.95 46.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.076 0.465 . . . . 0.0 112.111 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.974 ' HB2' HD11 ' A' ' 121' ' ' ILE . 35.4 t -108.14 166.15 10.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.264 178.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -55.51 -18.13 6.67 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.657 0.265 . . . . 0.0 110.867 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 53.7 m80 -91.33 -36.86 13.6 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.47 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.835 ' N ' ' HB2' ' A' ' 54' ' ' ALA . . . 176.81 -140.82 5.14 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.201 -1.0 . . . . 0.0 113.57 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.85 HG23 ' O ' ' A' ' 52' ' ' THR . 3.6 t -100.72 135.87 34.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 122.536 0.335 . . . . 0.0 111.628 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.974 HD11 ' HB2' ' A' ' 116' ' ' CYS . 3.4 mp -98.94 -64.6 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.517 178.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.661 ' HA2' HG23 ' A' ' 137' ' ' VAL . . . -164.7 -167.02 24.61 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.196 -1.002 . . . . 0.0 113.239 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.685 HD21 HD13 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -117.0 164.15 15.15 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.92 0.39 . . . . 0.0 110.892 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.597 HG13 ' O ' ' A' ' 124' ' ' VAL . 10.3 p -60.35 109.23 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.936 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.81 ' OG1' ' HB2' ' A' ' 135' ' ' ALA . 2.0 m -91.34 -88.6 0.18 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.661 ' N ' HG22 ' A' ' 125' ' ' THR . 0.0 OUTLIER -128.56 162.1 28.04 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.941 0.4 . . . . 0.0 111.205 179.375 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -131.41 157.82 22.48 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.645 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -114.36 -153.89 10.86 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.411 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -71.96 -19.25 61.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.733 0.301 . . . . 0.0 110.998 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -168.71 28.4 0.15 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.547 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.565 ' HB ' HD22 ' A' ' 100' ' ' LEU . 1.4 t -130.03 157.05 42.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.716 0.294 . . . . 0.0 110.874 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.823 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 2.0 t -112.97 118.01 56.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.199 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' ' 126' ' ' MET . . . -99.12 123.7 7.99 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.61 -0.805 . . . . 0.0 111.871 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.515 ' CD2' HD22 ' A' ' 114' ' ' LEU . 52.6 m-85 -125.12 139.29 53.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.95 0.405 . . . . 0.0 111.727 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.81 ' HB2' ' OG1' ' A' ' 125' ' ' THR . . . -88.88 108.13 19.37 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.694 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.771 ' HB2' HD11 ' A' ' 99' ' ' LEU . 1.0 OUTLIER -67.55 143.36 56.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.472 0.653 . . . . 0.0 112.549 -178.095 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.661 HG23 ' HA2' ' A' ' 122' ' ' GLY . 19.3 t -102.24 7.17 9.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.149 178.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.403 ' HB3' ' CZ ' ' A' ' 138' ' ' ARG . 2.1 mmm180 -72.48 -6.29 42.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.435 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.462 ' HB2' ' CD2' ' A' ' 97' ' ' HIS . 4.4 t70 -97.72 -1.99 42.26 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.721 0.296 . . . . 0.0 111.363 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.831 ' O ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -156.1 64.71 0.57 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.464 0.65 . . . . 0.0 109.732 179.548 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.952 HD11 ' HB ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -77.64 -14.48 59.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.267 -0.879 . . . . 0.0 112.458 -178.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . 0.531 ' C ' HD12 ' A' ' 143' ' ' LEU . 14.4 p-90 -53.7 80.19 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.006 0.431 . . . . 0.0 111.216 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.681 HD12 ' C ' ' A' ' 141' ' ' LEU . 4.9 mp -153.36 -48.19 0.09 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.956 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.527 ' HG3' HG12 ' A' ' 12' ' ' VAL . 5.4 mt-10 -156.56 -171.14 3.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.462 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.85 144.24 45.01 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.913 0.387 . . . . 0.0 111.034 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -104.9 154.19 20.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.927 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.649 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . . . . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.186 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.882 ' HB2' HG23 ' A' ' 18' ' ' VAL . . . . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.745 0.307 . . . . 0.0 111.07 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.798 ' HB ' HG21 ' A' ' 113' ' ' ILE . 9.6 p -131.24 113.19 23.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.88 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.544 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 7.9 p90 -112.02 134.43 53.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.979 0.418 . . . . 0.0 111.157 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.581 ' HB ' HD22 ' A' ' 143' ' ' LEU . 93.1 t -119.19 128.25 75.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.439 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 49.54 -126.51 20.51 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 121.142 -0.551 . . . . 0.0 113.175 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.458 ' O ' ' HA ' ' A' ' 44' ' ' THR . 21.1 m-20 -89.56 14.72 10.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.624 0.249 . . . . 0.0 111.453 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.627 ' CE1' HG22 ' A' ' 44' ' ' THR . 7.2 m-85 -128.91 141.44 51.27 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.544 ' HA ' ' HA ' ' A' ' 11' ' ' TYR . 9.3 tttt -127.21 114.82 18.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.651 -0.25 . . . . 0.0 110.748 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 1.023 HG12 HG22 ' A' ' 42' ' ' VAL . 0.6 OUTLIER -102.36 121.74 53.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-O 121.202 0.525 . . . . 0.0 110.749 179.709 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.882 HG23 ' HB2' ' A' ' 9' ' ' ALA . 13.6 p -136.35 160.52 37.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.995 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.502 ' N ' HG22 ' A' ' 18' ' ' VAL . 7.0 t-20 -60.56 141.62 56.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.334 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.43 -47.35 79.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.811 0.339 . . . . 0.0 110.718 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.91 -9.04 53.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.909 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.419 ' HB3' HG22 ' A' ' 18' ' ' VAL . 13.9 tp -109.61 -11.48 14.76 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.652 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.945 ' HB3' ' CZ2' ' A' ' 28' ' ' TRP . . . -70.85 150.67 45.56 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 120.805 0.336 . . . . 0.0 110.826 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 58.6 p -104.67 169.2 8.59 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.329 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -54.72 -29.69 54.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.033 0.444 . . . . 0.0 110.576 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 23.9 t -74.66 -31.34 26.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.4 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.421 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 0.3 OUTLIER -67.16 -44.12 80.53 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.945 ' CZ2' ' HB3' ' A' ' 23' ' ' ALA . 7.2 m-90 -74.54 -30.78 61.89 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.217 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.4 mm100 -58.42 -44.14 88.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.509 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -114.21 34.78 4.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.519 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.47 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 36.9 t -80.1 134.56 36.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.404 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.472 HG22 ' O ' ' A' ' 42' ' ' VAL . 12.5 m -98.96 -39.38 7.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.522 179.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.682 ' CH2' HD23 ' A' ' 40' ' ' LEU . 1.9 t90 -139.39 152.91 47.49 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.989 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -160.86 120.39 2.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.975 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.407 ' HB2' ' CZ2' ' A' ' 33' ' ' TRP . 11.0 m-20 -107.04 111.99 24.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.007 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -61.27 -43.58 98.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.964 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.417 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 4.3 m-20 -65.73 -23.56 66.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.771 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.446 ' CZ ' ' HA ' ' A' ' 38' ' ' ARG . 3.4 tpm_? -105.55 -2.02 24.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.34 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 44.27 37.26 1.87 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.947 0.403 . . . . 0.0 110.818 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.846 HD11 HG23 ' A' ' 17' ' ' VAL . 7.0 tp -133.75 141.72 47.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.694 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.665 ' O ' HD23 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -139.2 155.84 47.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.913 0.387 . . . . 0.0 111.759 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 1.023 HG22 HG12 ' A' ' 17' ' ' VAL . 25.3 t -118.72 129.89 74.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.568 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.8 p -121.84 157.16 31.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.306 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.627 HG22 ' CE1' ' A' ' 15' ' ' TYR . 8.3 p -97.68 124.35 41.96 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.177 0.513 . . . . 0.0 111.628 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -113.65 162.99 15.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.78 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -108.69 37.45 2.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.885 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -126.73 169.42 13.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.044 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 10.4 m80 -83.74 141.12 31.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.861 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.431 ' HA2' ' CE2' ' A' ' 11' ' ' TYR . . . -91.04 152.0 21.44 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.558 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.43 -46.81 2.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.833 0.349 . . . . 0.0 110.909 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.579 ' OD2' HG23 ' A' ' 10' ' ' VAL . 2.8 m-20 -59.82 135.89 57.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.918 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.856 ' O ' HG23 ' A' ' 120' ' ' VAL . 33.2 m -117.27 116.0 26.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.824 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.974 ' HB ' HD11 ' A' ' 141' ' ' LEU . 0.2 OUTLIER -82.5 139.38 17.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.761 179.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -95.51 130.51 42.32 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.839 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.515 ' H ' ' HB3' ' A' ' 147' ' ' ALA . 2.7 ttt180 -93.31 42.5 1.1 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 178.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 8.2 p -99.86 167.31 10.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.955 -1.02 . . . . 0.0 111.501 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -117.66 25.54 10.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.073 178.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 14.8 p -66.51 145.38 55.7 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.061 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.0 m -103.04 13.18 34.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.216 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 56.0 p -132.91 125.32 29.63 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.855 0.359 . . . . 0.0 110.996 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -150.99 165.71 30.29 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.388 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.852 HG23 ' C ' ' A' ' 72' ' ' TYR . 10.6 p -104.51 134.83 44.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.933 0.397 . . . . 0.0 111.338 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.694 ' HE2' HG21 ' A' ' 74' ' ' VAL . 4.9 p90 -110.97 160.44 16.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.843 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 5.4 t80 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.026 -179.916 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.527 ' HB3' HG21 ' A' ' 62' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.118 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.852 ' C ' HG23 ' A' ' 62' ' ' VAL . 0.6 OUTLIER -111.41 114.39 52.98 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.435 -178.921 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 72' ' ' TYR . 3.4 Cg_exo -74.77 120.66 6.23 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.235 1.956 . . . . 0.0 110.422 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.694 HG21 ' HE2' ' A' ' 63' ' ' TYR . 90.6 t -142.56 144.99 23.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.107 0.479 . . . . 0.0 112.226 -178.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.66 135.78 33.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.39 178.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.802 ' CZ ' HD21 ' A' ' 114' ' ' LEU . 0.1 OUTLIER -141.46 169.66 17.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.226 0.536 . . . . 0.0 111.811 -178.879 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.403 ' O ' ' HD2' ' A' ' 79' ' ' PRO . 11.3 mm-40 -111.85 158.3 19.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.068 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -105.79 68.34 0.25 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.542 -0.837 . . . . 0.0 113.095 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.502 ' HD2' ' HA ' ' A' ' 99' ' ' LEU . 37.6 Cg_endo -67.52 135.44 36.25 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.391 2.06 . . . . 0.0 112.231 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -59.66 -90.82 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.195 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.722 HD11 ' HB3' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -88.32 119.56 28.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.853 0.359 . . . . 0.0 111.497 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.626 ' HB ' HG11 ' A' ' 98' ' ' VAL . 40.1 t -126.99 122.46 60.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.075 178.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -72.54 107.55 5.12 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.934 0.397 . . . . 0.0 110.55 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.579 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 18.3 m -75.24 123.88 31.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.732 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -69.4 150.38 47.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.027 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.547 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 0.6 OUTLIER -67.69 102.67 1.24 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.006 0.432 . . . . 0.0 110.458 -179.474 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.453 ' O ' ' N ' ' A' ' 89' ' ' TYR . 3.5 m -143.87 161.64 38.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.519 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 57.41 -79.14 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.534 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.453 ' N ' ' O ' ' A' ' 87' ' ' SER . 1.3 p90 -159.59 25.38 0.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.699 0.285 . . . . 0.0 110.942 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.547 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 3.6 t80 -124.73 126.09 25.4 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.831 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -69.68 148.77 66.32 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.113 2.542 . . . . 0.0 112.446 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.579 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 1.7 ttpp -53.14 92.26 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.853 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.443 ' O ' HG22 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -123.82 176.55 6.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.184 0.516 . . . . 0.0 112.085 -179.338 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.722 ' HB3' HD11 ' A' ' 81' ' ' LEU . 4.9 m-85 -98.28 132.32 43.86 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.163 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.495 ' O ' HD13 ' A' ' 81' ' ' LEU . 4.4 mt-30 -131.23 132.95 45.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.678 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.483 ' CB ' HD22 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -102.65 142.91 33.03 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.014 0.435 . . . . 0.0 112.06 -179.334 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.44 ' CE1' ' HB3' ' A' ' 139' ' ' ASP . 0.1 OUTLIER 75.76 55.53 0.06 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.064 179.1 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.626 HG11 ' HB ' ' A' ' 82' ' ' VAL . 12.4 p -123.4 139.45 50.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.962 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.502 ' HA ' ' HD2' ' A' ' 79' ' ' PRO . 4.4 mp -105.09 134.0 48.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.168 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.798 ' HA ' ' O ' ' A' ' 132' ' ' VAL . 6.8 mt -117.61 138.64 51.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.131 0.491 . . . . 0.0 112.192 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.722 ' O ' HG23 ' A' ' 132' ' ' VAL . . . -130.02 119.46 23.17 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.597 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 1.7 t -86.02 111.69 20.53 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.849 0.356 . . . . 0.0 110.727 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.255 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.45 -179.834 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.56 -0.216 . . . . 0.0 112.56 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.798 HG21 ' HB ' ' A' ' 10' ' ' VAL . 31.2 pt -125.99 146.22 32.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.711 0.291 . . . . 0.0 111.074 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.802 HD21 ' CZ ' ' A' ' 76' ' ' PHE . 41.6 tp -87.71 113.02 23.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.65 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.423 ' O ' HG12 ' A' ' 62' ' ' VAL . 25.9 mtm180 -119.56 146.88 45.1 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.474 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.9 ' SG ' HD11 ' A' ' 121' ' ' ILE . 27.2 p -118.99 177.42 4.87 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -56.77 -18.75 13.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.681 0.276 . . . . 0.0 111.251 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -93.3 -32.58 14.26 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 165.64 -133.58 3.01 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.176 -1.011 . . . . 0.0 113.643 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.856 HG23 ' O ' ' A' ' 52' ' ' THR . 20.0 t -107.78 135.67 45.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.774 0.321 . . . . 0.0 111.609 -179.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.9 HD11 ' SG ' ' A' ' 116' ' ' CYS . 2.5 mp -105.26 -52.83 7.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.155 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.679 ' HA2' HG23 ' A' ' 137' ' ' VAL . . . -161.06 -167.08 21.02 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 119.94 -1.124 . . . . 0.0 113.496 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.616 HD11 HD13 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -124.39 164.18 20.21 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.841 0.353 . . . . 0.0 111.021 -179.867 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.401 ' HA ' ' CD1' ' A' ' 134' ' ' PHE . 3.5 m -57.06 114.12 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.802 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.77 ' OG1' ' HB2' ' A' ' 135' ' ' ALA . 2.3 m -105.27 -88.95 0.43 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.01 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.625 ' N ' HG22 ' A' ' 125' ' ' THR . 1.5 tpt -132.28 162.1 31.84 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.247 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -133.23 161.43 24.17 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.513 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -119.26 -154.61 9.59 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.527 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -72.04 -19.08 61.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.691 0.282 . . . . 0.0 110.963 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -168.27 29.71 0.16 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.545 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.534 ' CG1' HD22 ' A' ' 100' ' ' LEU . 1.3 t -132.21 157.1 43.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.785 0.326 . . . . 0.0 111.001 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.798 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 1.8 t -113.72 117.98 56.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.903 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.41 ' HA3' ' O ' ' A' ' 126' ' ' MET . . . -102.07 122.33 7.51 Favored Glycine 0 CA--C 1.516 0.14 0 C-N-CA 120.525 -0.845 . . . . 0.0 111.84 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.489 ' CE2' ' CG1' ' A' ' 132' ' ' VAL . 48.9 m-85 -124.99 144.0 50.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.992 0.425 . . . . 0.0 111.742 -179.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.77 ' HB2' ' OG1' ' A' ' 125' ' ' THR . . . -88.9 114.22 25.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.739 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.435 ' HB2' HD11 ' A' ' 99' ' ' LEU . 7.9 t0 -67.53 137.6 55.88 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -178.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.679 HG23 ' HA2' ' A' ' 122' ' ' GLY . 69.2 t -99.42 3.67 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.943 178.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.497 ' HA ' HD23 ' A' ' 141' ' ' LEU . 0.5 OUTLIER -72.57 -6.27 42.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.43 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.44 ' HB3' ' CE1' ' A' ' 97' ' ' HIS . 1.4 p30 -95.32 3.35 54.54 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.708 0.29 . . . . 0.0 111.345 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.829 ' O ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -162.11 51.8 0.21 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.294 0.569 . . . . 0.0 110.119 179.669 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.974 HD11 ' HB ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -68.59 -14.63 63.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.149 -179.44 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . 0.459 ' C ' HD12 ' A' ' 143' ' ' LEU . 13.2 p-90 -53.86 81.92 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.17 0.51 . . . . 0.0 111.379 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.696 HD12 ' C ' ' A' ' 141' ' ' LEU . 5.0 mp -150.95 -44.84 0.12 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.834 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.534 ' HB2' ' CG1' ' A' ' 12' ' ' VAL . 1.1 tp10 -146.59 -159.23 0.99 Allowed 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.417 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -77.86 149.04 34.38 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.837 0.351 . . . . 0.0 110.988 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -84.84 154.2 22.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.936 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.515 ' HB3' ' H ' ' A' ' 55' ' ' ARG . . . . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.066 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.648 ' HB2' HG23 ' A' ' 18' ' ' VAL . . . . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.697 0.284 . . . . 0.0 110.937 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.683 ' HB ' HG21 ' A' ' 113' ' ' ILE . 9.0 p -127.59 107.32 16.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.032 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.6 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 6.0 p90 -104.43 129.42 52.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.951 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.896 HG21 HD11 ' A' ' 53' ' ' ILE . 31.2 t -119.28 133.21 66.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.773 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 49.84 -128.39 25.24 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 121.068 -0.586 . . . . 0.0 112.966 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.432 ' O ' ' HA ' ' A' ' 44' ' ' THR . 36.5 m120 -91.35 17.13 8.82 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.673 0.273 . . . . 0.0 111.176 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.683 ' HB2' HD23 ' A' ' 143' ' ' LEU . 9.7 m-85 -129.94 148.45 51.81 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.241 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.6 ' HA ' ' HA ' ' A' ' 11' ' ' TYR . 37.3 tttt -132.26 114.68 14.72 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.696 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.958 HG12 HG22 ' A' ' 42' ' ' VAL . 0.9 OUTLIER -101.94 121.42 52.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-O 121.209 0.528 . . . . 0.0 110.74 179.72 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.658 ' O ' HD12 ' A' ' 40' ' ' LEU . 13.0 p -136.94 161.42 35.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.428 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.51 ' N ' HG22 ' A' ' 18' ' ' VAL . 5.0 m-20 -60.55 141.79 56.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.152 178.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.439 ' HG3' ' N ' ' A' ' 21' ' ' HIS . 7.8 ptm180 -56.34 -46.99 79.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.803 0.335 . . . . 0.0 111.378 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.439 ' N ' ' HG3' ' A' ' 20' ' ' ARG . 4.0 t60 -69.66 -6.45 31.59 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.331 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -115.14 -1.39 13.01 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.68 ' HB3' ' NE1' ' A' ' 28' ' ' TRP . . . -87.29 126.75 35.03 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.238 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.545 ' O ' ' HD1' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -74.79 164.37 26.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.682 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -53.78 -29.71 41.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.332 -179.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.544 HG12 HG23 ' A' ' 24' ' ' THR . 13.8 p -71.86 -31.37 40.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.971 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.95 -44.06 77.64 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.035 0.445 . . . . 0.0 109.828 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.68 ' NE1' ' HB3' ' A' ' 23' ' ' ALA . 39.7 m95 -73.99 -33.44 63.84 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.623 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 13.2 tp60 -56.66 -44.0 80.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.644 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -111.56 30.01 7.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.423 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.437 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 10.8 t -77.3 131.88 38.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.092 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.506 HG22 ' O ' ' A' ' 42' ' ' VAL . 13.1 m -94.04 -39.76 10.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.979 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.608 ' HH2' HD23 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -139.7 153.41 47.23 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.976 0.417 . . . . 0.0 111.8 -179.216 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -158.52 120.52 3.58 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.576 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.425 ' HB2' ' CZ2' ' A' ' 33' ' ' TRP . 14.2 m-20 -106.99 116.92 32.77 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.484 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -66.39 -29.99 70.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.954 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.484 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 26.1 p30 -66.56 -25.89 66.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.057 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 18.0 mtm180 -117.44 -0.97 11.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.459 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 51.22 37.86 19.63 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.898 0.38 . . . . 0.0 110.572 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.861 HD11 HG23 ' A' ' 17' ' ' VAL . 18.4 tp -125.39 152.36 44.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.928 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.64 ' O ' HD23 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -143.93 156.07 44.3 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.944 0.402 . . . . 0.0 111.667 179.627 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.958 HG22 HG12 ' A' ' 17' ' ' VAL . 22.6 t -120.21 129.95 74.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.636 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.9 p -120.49 157.3 29.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.119 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.644 HG22 ' CE1' ' A' ' 15' ' ' TYR . 10.1 p -97.45 123.29 41.24 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.163 0.506 . . . . 0.0 111.596 -179.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -117.33 140.17 49.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.882 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.1 p -95.14 45.97 1.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.98 0.419 . . . . 0.0 110.907 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.94 177.17 5.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.022 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -87.94 121.6 30.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.928 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.435 ' HA2' ' CE2' ' A' ' 11' ' ' TYR . . . -64.44 175.75 11.42 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.441 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 m -154.1 -46.15 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.862 0.363 . . . . 0.0 110.94 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -73.34 143.78 46.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.058 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.923 ' O ' HG23 ' A' ' 120' ' ' VAL . 55.1 m -120.45 119.64 33.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.193 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.896 HD11 HG21 ' A' ' 12' ' ' VAL . 2.9 mm -72.5 139.36 19.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.089 0.471 . . . . 0.0 111.063 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.744 ' O ' ' HB3' ' A' ' 147' ' ' ALA . . . -75.36 -47.89 25.56 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.513 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.417 ' CB ' ' HB2' ' A' ' 146' ' ' ASP . 0.0 OUTLIER 67.93 13.54 9.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.825 -179.34 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.519 ' SG ' ' HB1' ' A' ' 54' ' ' ALA . 23.9 p -99.78 166.92 10.86 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.665 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -121.76 39.28 3.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.124 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 59.5 m -62.7 156.81 22.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.706 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.3 -19.87 20.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.964 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.3 p -116.34 123.91 48.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.946 0.403 . . . . 0.0 111.123 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -140.71 -164.02 9.74 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 121.028 -0.606 . . . . 0.0 111.89 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.654 HG23 ' C ' ' A' ' 72' ' ' TYR . 3.6 p -140.41 130.74 28.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 121.167 0.508 . . . . 0.0 111.815 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.479 ' CD1' ' O ' ' A' ' 63' ' ' TYR . 24.4 p90 -109.28 126.27 53.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.772 178.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.423 ' HB2' ' CD2' ' A' ' 71' ' ' HIS . 55.6 p90 . . . . . 0 C--N 1.328 -0.352 0 CA-C-O 120.993 0.425 . . . . 0.0 111.578 -179.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.423 ' CD2' ' HB2' ' A' ' 64' ' ' PHE . 13.0 m170 . . . . . 0 C--O 1.23 0.075 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.654 ' C ' HG23 ' A' ' 62' ' ' VAL . 3.9 m-85 -124.91 114.29 26.62 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.615 -178.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 72' ' ' TYR . 4.7 Cg_exo -74.21 120.78 6.45 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.354 2.036 . . . . 0.0 111.043 178.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.443 ' CG1' ' CE2' ' A' ' 76' ' ' PHE . 2.3 p -139.78 158.8 27.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.034 0.445 . . . . 0.0 111.923 -179.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.9 m -102.04 123.91 46.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.424 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.696 ' CZ ' HD11 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -125.11 161.78 26.05 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.41 0.624 . . . . 0.0 111.771 -179.259 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.442 ' O ' ' HD2' ' A' ' 79' ' ' PRO . 4.6 mt-10 -111.79 158.77 18.98 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.349 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -104.76 67.22 0.28 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.412 -0.899 . . . . 0.0 113.187 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.442 ' HD2' ' O ' ' A' ' 77' ' ' GLU . 41.7 Cg_endo -67.72 135.47 35.81 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.375 2.05 . . . . 0.0 112.07 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -60.84 -86.77 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.682 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.664 HD22 ' HB3' ' A' ' 96' ' ' SER . 0.0 OUTLIER -94.62 119.85 33.93 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -179.365 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.607 ' HB ' HG11 ' A' ' 98' ' ' VAL . 80.0 t -124.63 123.28 65.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.344 178.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.436 ' HG3' ' CZ ' ' A' ' 94' ' ' TYR . 0.1 OUTLIER -72.14 107.86 5.03 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.019 0.438 . . . . 0.0 111.037 -178.826 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.91 HG23 ' HG2' ' A' ' 126' ' ' MET . 2.2 p -73.31 114.41 12.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.486 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -76.27 150.23 37.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.56 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.693 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 28.0 tt0 -68.0 101.04 1.05 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.122 0.487 . . . . 0.0 110.505 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.43 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.5 OUTLIER -144.7 143.01 30.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.875 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 59.25 -80.21 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.423 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.43 ' N ' ' O ' ' A' ' 87' ' ' SER . 0.8 OUTLIER -152.11 22.18 0.66 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.658 0.266 . . . . 0.0 111.173 -179.945 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.693 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 0.8 OUTLIER -110.51 114.64 54.87 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.302 179.68 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -60.98 148.26 93.26 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.728 2.285 . . . . 0.0 112.888 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -67.77 71.51 0.14 Allowed 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.598 179.507 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.443 ' O ' HG12 ' A' ' 84' ' ' VAL . 1.4 ttm180 -123.61 -174.55 3.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.914 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.436 ' CZ ' ' HG3' ' A' ' 83' ' ' GLU . 13.6 m-85 -96.51 132.43 42.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.822 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.484 ' HA ' ' O ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -131.1 126.56 36.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.039 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.664 ' HB3' HD22 ' A' ' 81' ' ' LEU . 15.1 p -101.58 161.45 13.63 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.162 0.506 . . . . 0.0 111.926 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 61.63 57.57 2.23 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.565 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.607 HG11 ' HB ' ' A' ' 82' ' ' VAL . 4.8 p -123.55 143.45 36.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.758 0.313 . . . . 0.0 111.37 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.405 ' HA ' ' HD2' ' A' ' 79' ' ' PRO . 7.5 mp -107.29 143.31 35.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.804 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.73 HD23 ' O ' ' A' ' 132' ' ' VAL . 5.1 mt -133.01 139.42 47.22 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -179.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.556 ' HB2' ' CD2' ' A' ' 76' ' ' PHE . . . -143.71 146.64 33.33 Favored 'General case' 0 CA--C 1.522 -0.109 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.728 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 1.2 t -104.54 131.42 51.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.932 0.396 . . . . 0.0 111.192 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.272 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.424 -179.982 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.683 HG21 ' HB ' ' A' ' 10' ' ' VAL . 24.8 pt -126.08 146.49 31.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.822 0.344 . . . . 0.0 111.326 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.696 HD11 ' CZ ' ' A' ' 76' ' ' PHE . 11.5 tp -87.44 122.2 30.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.109 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.416 ' N ' HD12 ' A' ' 114' ' ' LEU . 27.5 mtp180 -118.26 138.74 52.15 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.254 0.549 . . . . 0.0 112.064 -178.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.446 ' HB2' ' CD1' ' A' ' 121' ' ' ILE . 15.1 t -106.03 166.51 10.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.614 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -55.77 -19.7 12.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.64 0.257 . . . . 0.0 111.031 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.424 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . 31.4 m80 -89.66 -35.92 15.54 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.514 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.501 ' C ' ' HB2' ' A' ' 54' ' ' ALA . . . 169.32 -142.41 7.31 Favored Glycine 0 C--O 1.227 -0.316 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.561 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.923 HG23 ' O ' ' A' ' 52' ' ' THR . 3.4 t -89.73 135.22 26.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.562 0.22 . . . . 0.0 110.704 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.446 ' CD1' ' HB2' ' A' ' 116' ' ' CYS . 6.3 mt -106.32 -52.75 7.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 121.051 -0.259 . . . . 0.0 111.05 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.702 ' HA2' HG23 ' A' ' 137' ' ' VAL . . . -161.74 -174.68 31.91 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.088 -1.053 . . . . 0.0 113.239 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.786 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 0.0 OUTLIER -121.16 164.06 17.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.833 0.349 . . . . 0.0 110.824 179.884 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.415 HG13 ' O ' ' A' ' 124' ' ' VAL . 13.7 p -55.47 127.14 13.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.767 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.665 ' OG1' ' HB2' ' A' ' 135' ' ' ALA . 3.2 m -120.56 -90.35 0.58 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.045 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.91 ' HG2' HG23 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -122.65 125.89 46.53 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.977 0.418 . . . . 0.0 111.301 179.618 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -110.26 128.48 8.86 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.606 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -83.95 -159.9 29.79 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.533 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -71.9 -19.38 61.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.75 0.31 . . . . 0.0 111.217 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -158.42 20.22 0.33 Allowed Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.678 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.672 ' CG1' HD22 ' A' ' 100' ' ' LEU . 1.3 t -129.17 157.07 42.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.755 0.312 . . . . 0.0 110.769 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.73 ' O ' HD23 ' A' ' 100' ' ' LEU . 18.8 m -115.19 118.35 58.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.212 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.452 ' HA3' ' O ' ' A' ' 126' ' ' MET . . . -100.64 109.54 3.7 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.074 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.456 ' CD2' ' HB2' ' A' ' 114' ' ' LEU . 61.1 m-85 -111.16 139.79 46.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.746 0.308 . . . . 0.0 110.912 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.786 ' HB3' ' CD2' ' A' ' 123' ' ' LEU . . . -88.57 120.56 30.07 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -67.36 137.1 55.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.197 0.522 . . . . 0.0 112.355 -178.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.702 HG23 ' HA2' ' A' ' 122' ' ' GLY . 95.1 t -90.53 7.85 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.474 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.613 ' HA ' HD23 ' A' ' 141' ' ' LEU . 8.8 mtm180 -70.49 -6.44 36.04 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.812 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.6 11.18 39.2 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.608 0.242 . . . . 0.0 111.581 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.834 ' O ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -173.14 48.67 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.256 0.551 . . . . 0.0 110.374 179.811 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.613 HD23 ' HA ' ' A' ' 138' ' ' ARG . 0.2 OUTLIER -67.67 -14.93 63.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.015 -179.551 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . 0.416 ' CE3' ' CE2' ' A' ' 15' ' ' TYR . 12.3 p-90 -56.65 82.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.069 0.461 . . . . 0.0 111.693 -179.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.683 HD23 ' HB2' ' A' ' 15' ' ' TYR . 5.1 mp -149.06 -47.29 0.14 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.805 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.455 ' HB2' HG12 ' A' ' 12' ' ' VAL . 0.5 OUTLIER -158.32 -168.89 2.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.418 179.895 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 14.7 p30 -58.83 138.94 57.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.851 0.358 . . . . 0.0 111.044 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.417 ' HB2' ' CB ' ' A' ' 55' ' ' ARG . 3.9 p-10 -105.01 154.11 20.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.999 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.744 ' HB3' ' O ' ' A' ' 54' ' ' ALA . . . . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.098 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.727 0.298 . . . . 0.0 111.052 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.607 HG22 HG21 ' A' ' 113' ' ' ILE . 39.2 t -112.94 103.01 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.001 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.912 ' CE2' HG21 ' A' ' 45' ' ' THR . 6.1 t80 -97.85 115.93 29.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.856 0.36 . . . . 0.0 110.631 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.877 HG21 HD11 ' A' ' 53' ' ' ILE . 32.8 t -121.21 108.96 23.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.517 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.405 ' O ' ' CE1' ' A' ' 11' ' ' TYR . . . 54.24 -128.75 41.99 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.897 -0.668 . . . . 0.0 113.309 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.432 ' O ' ' HA ' ' A' ' 44' ' ' THR . 22.6 m120 -88.75 13.26 12.83 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 111.706 0.262 . . . . 0.0 111.706 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.658 ' HE1' HG22 ' A' ' 44' ' ' THR . 5.7 m-30 -130.3 127.95 40.54 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -118.97 114.74 23.03 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 121.124 -0.23 . . . . 0.0 110.688 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.985 HG12 HG22 ' A' ' 42' ' ' VAL . 0.7 OUTLIER -101.07 121.66 52.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.231 0.538 . . . . 0.0 110.993 179.91 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.682 ' O ' HD12 ' A' ' 40' ' ' LEU . 14.1 p -136.7 161.36 36.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.047 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.506 ' N ' HG22 ' A' ' 18' ' ' VAL . 9.0 m120 -58.91 141.49 53.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.376 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.425 ' CD ' ' N ' ' A' ' 21' ' ' HIS . 0.0 OUTLIER -56.54 -47.09 80.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.874 0.369 . . . . 0.0 111.294 -179.339 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.425 ' N ' ' CD ' ' A' ' 20' ' ' ARG . 13.3 p80 -68.36 -9.83 50.81 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.162 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.3 2.32 13.97 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.703 ' HB3' ' NE1' ' A' ' 28' ' ' TRP . . . -87.34 130.27 34.69 Favored 'General case' 0 C--N 1.334 -0.081 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.189 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.51 ' O ' ' HD1' ' A' ' 28' ' ' TRP . 41.9 p -74.69 163.04 28.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.742 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 61.1 m-70 -53.74 -29.71 40.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.975 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.2 t -70.33 -31.91 48.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.83 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -68.09 -44.25 76.69 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.123 0.487 . . . . 0.0 109.707 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.703 ' NE1' ' HB3' ' A' ' 23' ' ' ALA . 40.6 m95 -74.13 -33.14 63.46 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.702 179.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -56.79 -44.12 81.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.726 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -114.46 30.99 6.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.372 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.498 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 13.8 t -72.61 126.63 30.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.128 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.562 ' CG2' HG12 ' A' ' 42' ' ' VAL . 18.4 m -88.9 -40.77 13.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.626 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.73 ' CE3' HG23 ' A' ' 42' ' ' VAL . 0.5 OUTLIER -139.75 153.21 47.12 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.916 0.388 . . . . 0.0 111.227 -179.94 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -157.61 119.37 3.69 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.974 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -107.13 117.73 34.84 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.133 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 19.4 p90 -68.2 -36.79 80.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.106 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.43 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 74.0 m-20 -70.13 -12.9 61.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.871 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.0 mpt_? -117.2 -6.35 11.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.178 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 50.77 36.04 13.47 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-O 121.074 0.464 . . . . 0.0 110.295 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.81 HD11 HG23 ' A' ' 17' ' ' VAL . 36.7 tp -132.85 153.19 51.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.931 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.707 ' O ' HD23 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -147.83 155.63 41.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.491 179.682 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.985 HG22 HG12 ' A' ' 17' ' ' VAL . 38.2 t -115.78 130.68 70.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.337 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.0 p -123.29 157.24 33.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.637 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.658 HG22 ' HE1' ' A' ' 15' ' ' TYR . 30.1 p -97.65 145.13 26.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.189 0.518 . . . . 0.0 111.793 -178.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.912 HG21 ' CE2' ' A' ' 11' ' ' TYR . 0.2 OUTLIER -140.02 171.28 14.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.841 -179.253 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.551 ' O ' HG23 ' A' ' 46' ' ' THR . 10.8 t -124.48 62.32 1.12 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.93 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.463 ' HB3' ' OH ' ' A' ' 11' ' ' TYR . . . -135.51 -173.54 3.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.978 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -90.83 142.88 27.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.866 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.58 159.45 30.46 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.556 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -142.23 -46.7 0.34 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.743 0.306 . . . . 0.0 110.956 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -103.23 142.5 34.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.025 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.925 ' O ' HG23 ' A' ' 120' ' ' VAL . 91.7 m -120.08 120.85 37.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.286 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.877 HD11 HG21 ' A' ' 12' ' ' VAL . 0.9 OUTLIER -75.09 139.61 18.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.909 0.385 . . . . 0.0 110.921 -179.811 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.81 ' HB2' ' N ' ' A' ' 119' ' ' GLY . . . -94.91 127.19 40.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.107 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.62 ' H ' ' HB3' ' A' ' 147' ' ' ALA . 0.1 OUTLIER -92.33 34.76 1.02 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.528 179.452 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 26.5 p -99.65 160.5 14.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.874 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.69 34.79 4.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.084 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 66.5 m -58.28 126.87 29.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.707 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.3 m -68.92 -17.7 64.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.881 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 75' ' ' SER . 1.4 t -129.74 151.01 50.79 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.023 0.439 . . . . 0.0 111.319 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.451 ' N ' ' CE1' ' A' ' 76' ' ' PHE . . . -154.92 -148.24 4.94 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.688 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.617 HG23 ' C ' ' A' ' 72' ' ' TYR . 7.1 p -140.08 123.57 17.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.015 0.436 . . . . 0.0 111.385 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.426 ' CZ ' ' HB3' ' A' ' 72' ' ' TYR . 8.5 p90 -94.87 172.06 8.39 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.892 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.849 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.581 ' HB2' HG21 ' A' ' 62' ' ' VAL . 9.2 p80 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.81 0.338 . . . . 0.0 110.272 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.617 ' C ' HG23 ' A' ' 62' ' ' VAL . 1.2 m-85 -121.98 114.45 30.93 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.06 -179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 62' ' ' VAL . 4.9 Cg_exo -76.49 120.82 5.74 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.5 2.134 . . . . 0.0 111.529 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.448 ' CG1' ' CE2' ' A' ' 76' ' ' PHE . 2.9 p -136.6 156.75 35.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.973 0.416 . . . . 0.0 111.773 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.468 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 59.0 p -97.41 123.34 41.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.71 178.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.617 ' CZ ' HD11 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -124.39 163.44 21.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.373 0.606 . . . . 0.0 111.78 -179.411 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.445 ' O ' ' HD2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -111.72 158.72 19.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.224 179.024 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -104.87 65.51 0.3 Allowed Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.364 -0.922 . . . . 0.0 113.716 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.451 ' HD2' ' HA ' ' A' ' 99' ' ' LEU . 41.6 Cg_endo -67.84 134.63 32.88 Favored 'Trans proline' 0 C--O 1.238 0.501 0 C-N-CA 122.254 1.97 . . . . 0.0 112.011 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -59.89 -86.82 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.981 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.608 HD22 ' HB3' ' A' ' 96' ' ' SER . 0.0 OUTLIER -96.25 119.76 35.32 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -179.227 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.619 ' HB ' HG11 ' A' ' 98' ' ' VAL . 87.1 t -122.99 122.85 66.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.341 178.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.28 109.61 6.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.067 0.46 . . . . 0.0 111.206 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.836 HG23 ' HG3' ' A' ' 126' ' ' MET . 1.2 p -72.79 114.54 12.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.452 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -75.06 149.53 39.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.326 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.573 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 2.4 tm-20 -68.51 101.3 1.23 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.044 0.45 . . . . 0.0 110.458 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.477 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.4 OUTLIER -144.79 155.11 43.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.047 179.816 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 51.41 -83.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.611 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.477 ' N ' ' O ' ' A' ' 87' ' ' SER . 0.6 OUTLIER -145.67 19.75 1.49 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.835 0.35 . . . . 0.0 110.905 179.771 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.573 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 1.4 m-85 -107.88 140.35 21.53 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.538 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.421 ' O ' ' N ' ' A' ' 93' ' ' ARG . 81.5 Cg_endo -86.35 148.5 8.95 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.095 2.53 . . . . 0.0 112.9 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -65.36 70.44 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.896 179.724 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.421 ' N ' ' O ' ' A' ' 91' ' ' PRO . 14.1 mtp180 -123.52 -175.03 3.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.995 0.426 . . . . 0.0 111.741 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.546 ' HB3' HD11 ' A' ' 81' ' ' LEU . 8.3 m-85 -98.47 132.7 43.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.205 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.657 HE22 HG23 ' A' ' 125' ' ' THR . 4.7 mt-30 -128.44 126.83 41.35 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.704 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.608 ' HB3' HD22 ' A' ' 81' ' ' LEU . 24.6 p -99.58 161.04 13.85 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.174 0.511 . . . . 0.0 112.332 -178.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 57.84 60.22 2.86 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.878 179.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.619 HG11 ' HB ' ' A' ' 82' ' ' VAL . 6.1 p -123.66 142.39 40.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 C-N-CA 120.894 -0.323 . . . . 0.0 111.093 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.569 HD13 ' CG ' ' A' ' 136' ' ' ASP . 10.7 mp -107.67 141.37 39.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.269 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.726 HD23 ' C ' ' A' ' 132' ' ' VAL . 6.3 mt -128.08 136.56 51.37 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.551 ' HB2' ' CB ' ' A' ' 76' ' ' PHE . . . -142.3 142.17 32.51 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.077 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 1.7 t -97.37 121.64 39.5 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.066 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.252 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.524 -179.855 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.874 ' O ' HG23 ' A' ' 124' ' ' VAL . . . . . . . . 0 N--CA 1.452 -0.269 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.607 HG21 HG22 ' A' ' 10' ' ' VAL . 17.6 pt -126.31 146.41 32.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.705 0.288 . . . . 0.0 111.302 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.738 HD22 ' HD2' ' A' ' 134' ' ' PHE . 20.6 tp -87.36 119.88 28.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.32 -0.4 . . . . 0.0 109.997 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 28.1 mtp85 -118.12 151.9 36.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.247 0.546 . . . . 0.0 111.648 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.486 ' HB2' HD11 ' A' ' 121' ' ' ILE . 4.2 t -119.03 160.92 21.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.175 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.421 ' CG ' ' CE1' ' A' ' 118' ' ' HIS . 3.0 pt-20 -56.29 -18.88 11.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.756 0.312 . . . . 0.0 110.925 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.428 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . 13.2 m80 -93.65 -33.66 13.58 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.656 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.81 ' N ' ' HB2' ' A' ' 54' ' ' ALA . . . 176.39 -138.67 4.18 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.408 -0.901 . . . . 0.0 113.102 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.925 HG23 ' O ' ' A' ' 52' ' ' THR . 4.9 t -102.57 135.56 39.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.765 0.317 . . . . 0.0 111.286 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.525 ' HB ' ' HG ' ' A' ' 114' ' ' LEU . 1.0 OUTLIER -99.03 -66.9 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.956 179.524 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.922 ' HA2' HG23 ' A' ' 137' ' ' VAL . . . -161.33 -164.4 16.15 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.698 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.585 HD21 HD22 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -116.94 164.24 14.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.701 0.286 . . . . 0.0 110.718 -179.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.874 HG23 ' O ' ' A' ' 112' ' ' GLY . 61.3 t -66.31 126.35 25.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.758 0.313 . . . . 0.0 111.188 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.732 ' OG1' ' HB2' ' A' ' 135' ' ' ALA . 2.9 m -109.45 -90.01 0.47 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.445 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.836 ' HG3' HG23 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -127.91 125.87 40.42 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 121.022 0.439 . . . . 0.0 111.742 179.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -107.87 128.33 9.11 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.66 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -81.69 -162.42 29.71 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.511 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -71.82 -19.72 61.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.71 0.291 . . . . 0.0 111.132 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -146.93 -7.27 0.28 Allowed Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.795 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.608 ' CG1' HD22 ' A' ' 100' ' ' LEU . 1.6 t -115.94 157.12 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 117.289 0.544 . . . . 0.0 110.927 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.726 ' C ' HD23 ' A' ' 100' ' ' LEU . 11.8 m -114.75 118.63 59.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.563 -179.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 126' ' ' MET . . . -97.68 118.7 6.17 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.47 -0.872 . . . . 0.0 112.041 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.738 ' HD2' HD22 ' A' ' 114' ' ' LEU . 11.5 m-85 -120.28 143.96 48.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.01 0.433 . . . . 0.0 111.637 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.732 ' HB2' ' OG1' ' A' ' 125' ' ' THR . . . -90.44 110.83 21.93 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.937 178.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.569 ' CG ' HD13 ' A' ' 99' ' ' LEU . 2.6 m-20 -67.97 143.61 55.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.095 0.474 . . . . 0.0 111.889 -178.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.922 HG23 ' HA2' ' A' ' 122' ' ' GLY . 92.8 t -90.05 9.86 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.624 179.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.661 ' HA ' HD23 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -70.23 -7.94 46.13 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.528 179.758 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -90.21 8.11 34.74 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.892 HD23 HG21 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -172.34 42.02 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.067 0.461 . . . . 0.0 110.899 179.886 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.719 HD11 ' HB ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -58.72 -14.99 9.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.229 -179.858 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . 0.437 ' CD1' ' HA ' ' A' ' 140' ' ' LEU . 16.1 p-90 -59.09 79.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.862 0.363 . . . . 0.0 111.327 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.676 HD22 ' HB ' ' A' ' 12' ' ' VAL . 4.7 mp -137.54 -45.98 0.55 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.469 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.462 ' HG2' ' CG1' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -165.58 -162.46 0.58 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.74 179.707 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -58.82 131.0 49.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.94 0.4 . . . . 0.0 111.189 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.483 ' HB2' ' HB2' ' A' ' 55' ' ' ARG . 3.7 p30 -105.0 154.25 20.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.639 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.62 ' HB3' ' H ' ' A' ' 55' ' ' ARG . . . . . . . . 0 C--N 1.331 -0.206 0 CA-C-O 120.843 0.354 . . . . 0.0 111.142 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.826 ' HB2' HG23 ' A' ' 18' ' ' VAL . . . . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.781 0.324 . . . . 0.0 111.232 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.632 HG13 HG22 ' A' ' 17' ' ' VAL . 8.3 p -126.82 106.26 15.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.939 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.512 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 2.5 p90 -103.13 127.46 50.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.916 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.69 HG21 HD11 ' A' ' 53' ' ' ILE . 39.2 t -119.06 133.21 66.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.67 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 50.89 -130.51 31.83 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.885 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.401 ' O ' ' HA ' ' A' ' 44' ' ' THR . 9.0 m-20 -91.35 18.62 6.89 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.741 0.305 . . . . 0.0 111.073 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.681 ' HB2' HD23 ' A' ' 143' ' ' LEU . 9.7 m-85 -129.87 144.2 51.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.119 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -127.7 114.72 17.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.587 179.386 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 1.008 HG12 HG22 ' A' ' 42' ' ' VAL . 0.7 OUTLIER -103.08 121.77 54.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-O 121.237 0.541 . . . . 0.0 111.024 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.826 HG23 ' HB2' ' A' ' 9' ' ' ALA . 7.3 p -136.47 160.55 37.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.076 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.507 ' N ' HG22 ' A' ' 18' ' ' VAL . 11.8 t-20 -59.71 141.51 55.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.463 179.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.43 -47.11 79.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.895 0.379 . . . . 0.0 110.908 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -68.86 -9.06 49.34 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.242 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.4 ' HB3' HG22 ' A' ' 18' ' ' VAL . 1.7 tp -109.58 -11.65 14.76 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.947 ' HB3' ' CZ2' ' A' ' 28' ' ' TRP . . . -70.39 150.48 46.22 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 120.81 0.338 . . . . 0.0 110.875 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.567 ' OG1' HG12 ' A' ' 26' ' ' VAL . 67.1 p -104.97 168.89 8.76 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.447 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -54.69 -29.79 53.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.972 0.415 . . . . 0.0 110.704 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.567 HG12 ' OG1' ' A' ' 24' ' ' THR . 8.2 p -76.47 -31.03 19.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.324 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.435 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 7.7 m-20 -66.27 -44.05 84.7 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.947 ' CZ2' ' HB3' ' A' ' 23' ' ' ALA . 6.7 m-90 -74.26 -30.12 61.99 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.872 179.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -57.3 -44.16 83.86 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.431 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -114.25 31.86 6.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.436 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.452 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 14.3 t -79.6 129.07 34.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.171 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.493 HG22 ' O ' ' A' ' 42' ' ' VAL . 12.7 m -91.47 -39.89 12.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.719 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.598 ' HH2' HD23 ' A' ' 40' ' ' LEU . 0.6 OUTLIER -139.43 152.4 47.03 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.01 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -159.83 117.41 2.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.977 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -107.03 118.33 36.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.232 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -65.96 -42.23 90.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.925 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.459 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 8.8 m-20 -66.63 -14.53 62.55 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.99 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.4 mtm180 -114.89 0.64 13.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.234 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.2 p30 42.54 38.99 1.41 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.996 0.427 . . . . 0.0 110.809 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.841 HD11 HG23 ' A' ' 17' ' ' VAL . 23.5 tp -137.12 152.15 49.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.091 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.683 HD11 ' CB ' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -147.79 155.72 41.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.153 179.455 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 1.008 HG22 HG12 ' A' ' 17' ' ' VAL . 29.3 t -119.78 129.97 74.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.94 0.4 . . . . 0.0 110.818 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.7 p -120.33 156.95 30.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.181 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.64 HG22 ' CE1' ' A' ' 15' ' ' TYR . 13.5 p -97.79 123.85 41.91 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.174 0.512 . . . . 0.0 111.542 -179.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -115.1 164.98 13.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.859 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.64 46.86 0.9 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.797 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -151.93 144.82 24.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.101 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 9.2 m170 -67.7 148.07 51.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.803 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.454 ' HA2' ' CE2' ' A' ' 11' ' ' TYR . . . -82.92 135.82 14.45 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.597 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 8.2 t -95.67 19.14 11.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.703 0.287 . . . . 0.0 111.037 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -135.27 145.9 48.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.751 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.903 ' O ' HG23 ' A' ' 120' ' ' VAL . 28.0 m -119.54 117.62 28.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.603 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.836 ' HB ' HD11 ' A' ' 141' ' ' LEU . 0.5 OUTLIER -77.05 139.52 18.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.748 -179.873 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.688 ' HB2' ' N ' ' A' ' 119' ' ' GLY . . . -93.21 132.21 37.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.225 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.652 ' H ' ' HB3' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -92.1 28.7 1.8 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.391 179.316 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 28.1 p -99.56 166.08 11.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.965 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.62 34.44 4.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.709 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 40.7 m -55.18 131.37 45.12 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.082 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.7 m -72.47 -11.46 60.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.619 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.1 p -120.26 153.51 36.25 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.765 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -171.29 -164.14 26.46 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.892 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.739 HG23 ' C ' ' A' ' 72' ' ' TYR . 10.2 p -139.66 128.08 26.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.962 0.411 . . . . 0.0 111.18 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.479 ' CE1' ' HB2' ' A' ' 72' ' ' TYR . 17.7 p90 -99.02 133.61 43.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.752 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.45 ' HB2' ' CD2' ' A' ' 71' ' ' HIS . 77.5 t80 . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.471 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.532 ' HD2' HG22 ' A' ' 62' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.133 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.739 ' C ' HG23 ' A' ' 62' ' ' VAL . 0.5 OUTLIER -122.1 114.28 30.84 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.754 -178.36 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.405 ' N ' HG23 ' A' ' 62' ' ' VAL . 13.9 Cg_exo -68.79 120.59 7.49 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 121.987 1.791 . . . . 0.0 110.284 178.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.459 ' CG1' ' CE2' ' A' ' 76' ' ' PHE . 2.2 p -142.51 153.43 17.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.973 0.416 . . . . 0.0 111.782 -178.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.5 m -97.05 125.52 41.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.886 178.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.731 ' CD2' ' HB2' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -130.74 161.23 32.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.442 0.639 . . . . 0.0 111.793 -179.506 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.681 ' C ' ' HD3' ' A' ' 79' ' ' PRO . 3.0 mm-40 -111.77 159.31 18.4 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.959 178.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -108.57 64.53 0.26 Allowed Glycine 0 CA--C 1.522 0.53 0 C-N-CA 120.251 -0.976 . . . . 0.0 114.004 -179.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.681 ' HD3' ' C ' ' A' ' 77' ' ' GLU . 14.0 Cg_exo -67.0 140.94 56.2 Favored 'Trans proline' 0 C--O 1.242 0.695 0 C-N-CA 122.326 2.017 . . . . 0.0 112.524 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 96' ' ' SER . . . -63.04 -60.16 8.02 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.276 -0.874 . . . . 0.0 112.514 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.484 HD11 ' HB3' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -120.06 122.29 40.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.997 0.427 . . . . 0.0 111.813 -179.877 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.539 ' HB ' HG11 ' A' ' 98' ' ' VAL . 17.8 t -128.66 122.7 57.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.406 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.64 107.83 5.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.635 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.557 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 32.7 m -77.46 122.34 31.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.026 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -69.69 150.28 47.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.172 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.522 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 3.3 tt0 -67.92 102.58 1.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.54 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 89' ' ' TYR . 2.8 p -143.74 160.81 40.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.581 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 56.39 -81.98 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.651 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.419 ' N ' ' O ' ' A' ' 87' ' ' SER . 0.3 OUTLIER -153.44 21.44 0.55 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.724 0.297 . . . . 0.0 111.161 -179.805 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.522 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 1.6 t80 -119.68 133.28 23.84 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.674 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.418 ' HD2' ' CD1' ' A' ' 90' ' ' TYR . 79.7 Cg_endo -77.3 148.58 27.05 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.856 2.371 . . . . 0.0 112.538 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.557 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.7 OUTLIER -55.36 89.24 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.631 179.819 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.91 -175.62 3.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.258 0.552 . . . . 0.0 112.119 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.484 ' HB3' HD11 ' A' ' 81' ' ' LEU . 15.8 m-85 -100.06 132.62 45.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.636 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.459 ' HA ' ' O ' ' A' ' 37' ' ' ASN . 0.8 OUTLIER -127.22 124.41 38.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.863 0.363 . . . . 0.0 111.24 -179.662 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 40.2 t -89.79 162.29 15.59 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.068 0.461 . . . . 0.0 111.905 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 44.39 56.93 4.66 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.741 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.619 ' O ' ' HD2' ' A' ' 79' ' ' PRO . 8.4 p -124.0 136.77 59.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.267 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.871 HD11 ' HB3' ' A' ' 136' ' ' ASP . 2.2 mp -101.92 149.19 24.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.332 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.775 HD23 ' C ' ' A' ' 132' ' ' VAL . 7.7 mt -127.69 132.51 49.64 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.343 -0.543 . . . . 0.0 112.213 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.731 ' HB2' ' CD2' ' A' ' 76' ' ' PHE . . . -128.14 132.28 48.93 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.535 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 1.8 t -93.34 115.31 27.88 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.945 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 0.215 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.589 -179.87 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.772 ' O ' HG23 ' A' ' 124' ' ' VAL . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.551 -0.219 . . . . 0.0 112.551 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.466 HG21 ' HB ' ' A' ' 10' ' ' VAL . 25.9 pt -126.12 146.35 32.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.881 0.372 . . . . 0.0 111.245 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.684 HD11 ' CZ ' ' A' ' 76' ' ' PHE . 23.3 tp -87.52 121.22 29.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.253 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 17.1 mtt85 -118.24 152.28 36.02 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.181 0.515 . . . . 0.0 111.999 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.591 ' HB2' HD11 ' A' ' 121' ' ' ILE . 5.6 t -118.75 164.24 15.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.086 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -58.54 -17.94 25.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.055 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 14.9 m80 -94.89 -30.87 13.95 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.54 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.688 ' N ' ' HB2' ' A' ' 54' ' ' ALA . . . 174.52 -135.93 3.32 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.516 -0.85 . . . . 0.0 112.811 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.903 HG23 ' O ' ' A' ' 52' ' ' THR . 5.4 t -105.48 134.99 45.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.653 0.263 . . . . 0.0 111.053 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.591 HD11 ' HB2' ' A' ' 116' ' ' CYS . 1.1 mm -93.62 -67.73 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.864 0.364 . . . . 0.0 110.983 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.901 ' HA2' HG23 ' A' ' 137' ' ' VAL . . . -159.08 -143.03 3.54 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.843 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.571 ' HG ' ' HB3' ' A' ' 135' ' ' ALA . 0.4 OUTLIER -136.31 164.15 28.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.852 0.358 . . . . 0.0 111.128 -179.84 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.772 HG23 ' O ' ' A' ' 112' ' ' GLY . 36.4 t -68.58 109.22 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.348 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.804 ' OG1' ' HB2' ' A' ' 135' ' ' ALA . 3.6 m -92.04 -90.83 0.17 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.4 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.635 ' N ' HG22 ' A' ' 125' ' ' THR . 97.5 mmm -138.67 125.94 21.58 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.049 0.452 . . . . 0.0 111.301 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -110.22 131.25 10.33 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.593 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -70.04 -146.5 0.29 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.248 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -86.59 -19.38 29.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.698 0.285 . . . . 0.0 111.089 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 102' ' ' THR . . . -140.42 -9.97 0.73 Allowed Glycine 0 CA--C 1.522 0.473 0 C-N-CA 120.551 -0.833 . . . . 0.0 113.459 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.639 ' HB ' HD22 ' A' ' 100' ' ' LEU . 0.9 OUTLIER -115.74 157.56 16.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-N 117.241 0.52 . . . . 0.0 111.123 -179.704 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.775 ' C ' HD23 ' A' ' 100' ' ' LEU . 20.2 t -114.61 118.33 58.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.109 -178.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.488 ' HA3' ' O ' ' A' ' 126' ' ' MET . . . -89.28 126.31 8.17 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.781 178.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.734 ' HE1' HG22 ' A' ' 124' ' ' VAL . 40.2 m-85 -125.18 133.54 52.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.871 0.367 . . . . 0.0 111.586 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.804 ' HB2' ' OG1' ' A' ' 125' ' ' THR . . . -88.85 105.28 17.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.771 178.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.871 ' HB3' HD11 ' A' ' 99' ' ' LEU . 1.3 p30 -67.69 146.62 53.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.23 0.538 . . . . 0.0 112.181 -178.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.901 HG23 ' HA2' ' A' ' 122' ' ' GLY . 60.7 t -89.53 9.92 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.304 178.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.54 ' HA ' HD23 ' A' ' 141' ' ' LEU . 3.5 mmm180 -71.36 -7.02 44.41 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.566 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -99.87 11.13 40.04 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.594 0.235 . . . . 0.0 111.421 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.858 ' O ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -174.98 40.53 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.016 0.436 . . . . 0.0 110.701 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.836 HD11 ' HB ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -57.75 -25.46 60.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.943 -0.572 . . . . 0.0 112.037 -179.557 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . 0.443 ' CD1' ' HA ' ' A' ' 140' ' ' LEU . 11.6 p-90 -47.22 88.12 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.039 0.447 . . . . 0.0 111.762 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.681 HD23 ' HB2' ' A' ' 15' ' ' TYR . 5.0 mp -153.02 -47.12 0.1 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.073 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.494 ' HB2' HG12 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -158.54 -169.92 2.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.755 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -59.05 133.02 55.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.953 0.406 . . . . 0.0 111.28 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -105.15 154.36 20.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.569 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.652 ' HB3' ' H ' ' A' ' 55' ' ' ARG . . . . . . . . 0 C--N 1.332 -0.193 0 CA-C-O 120.864 0.364 . . . . 0.0 111.059 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.549 ' HB2' HG23 ' A' ' 18' ' ' VAL . . . . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.829 0.347 . . . . 0.0 111.165 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.7 t -103.37 115.85 46.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.955 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.663 ' CE2' HG21 ' A' ' 45' ' ' THR . 5.7 t80 -104.18 115.91 31.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.808 0.337 . . . . 0.0 110.659 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.792 HG21 HD11 ' A' ' 53' ' ' ILE . 57.6 t -121.17 112.64 36.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.652 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 50.54 -126.22 24.01 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.98 -0.629 . . . . 0.0 113.379 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.466 ' O ' ' HA ' ' A' ' 44' ' ' THR . 4.5 m-20 -91.01 17.97 7.29 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.656 0.265 . . . . 0.0 111.589 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.641 ' CE1' HG22 ' A' ' 44' ' ' THR . 4.7 m-30 -130.49 127.74 39.8 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.04 114.74 22.46 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 121.024 -0.27 . . . . 0.0 110.888 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.926 HG12 HG22 ' A' ' 42' ' ' VAL . 0.7 OUTLIER -99.64 121.9 50.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-O 120.984 0.421 . . . . 0.0 110.453 179.585 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.666 ' O ' HD12 ' A' ' 40' ' ' LEU . 9.6 p -136.29 159.99 38.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.306 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.498 ' N ' HG22 ' A' ' 18' ' ' VAL . 32.5 m-80 -59.96 141.74 55.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.289 179.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 48.7 ttt-85 -56.17 -47.35 78.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.814 0.34 . . . . 0.0 110.774 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -69.2 -8.42 45.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.968 179.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.464 ' HB3' HG22 ' A' ' 18' ' ' VAL . 16.7 tp -110.59 -12.59 14.33 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.967 ' HB3' ' CZ2' ' A' ' 28' ' ' TRP . . . -66.97 150.73 48.82 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 120.896 0.379 . . . . 0.0 110.796 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.559 ' CG2' HG12 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -105.19 170.02 8.11 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.395 179.925 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 56.6 p-80 -54.76 -29.76 54.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.914 0.388 . . . . 0.0 110.954 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.559 HG12 ' CG2' ' A' ' 24' ' ' THR . 9.4 p -76.25 -31.21 20.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.559 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.25 -44.24 79.91 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.967 ' CZ2' ' HB3' ' A' ' 23' ' ' ALA . 5.0 m-90 -74.82 -30.45 61.4 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.33 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -58.62 -43.37 89.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.609 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -118.36 39.56 3.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.555 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.472 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 30.4 p -79.97 126.74 31.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.312 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.584 ' CG2' HG12 ' A' ' 42' ' ' VAL . 16.3 m -88.29 -39.16 12.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.543 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.637 ' CE3' HG23 ' A' ' 42' ' ' VAL . 0.5 OUTLIER -139.61 150.16 44.65 Favored 'General case' 0 CA--C 1.53 0.212 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.067 179.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -149.93 110.89 4.34 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.722 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.466 ' HB2' ' CZ2' ' A' ' 33' ' ' TRP . 27.4 t0 -107.23 112.88 25.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.88 0.371 . . . . 0.0 111.06 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -67.4 -34.82 78.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.076 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.448 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 0.3 OUTLIER -64.3 -20.24 65.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.845 179.718 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -115.11 0.96 13.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.316 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 46.58 35.12 2.75 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 121.221 0.534 . . . . 0.0 110.175 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.808 HD11 HG23 ' A' ' 17' ' ' VAL . 28.4 tp -131.84 153.46 50.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.911 -179.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.683 ' O ' HD23 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -146.43 155.73 42.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.177 179.648 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.926 HG22 HG12 ' A' ' 17' ' ' VAL . 33.9 t -119.11 127.97 75.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.288 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.9 p -122.3 157.17 32.32 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.787 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.641 HG22 ' CE1' ' A' ' 15' ' ' TYR . 25.1 p -97.57 145.09 26.59 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.216 0.531 . . . . 0.0 111.614 -179.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.663 HG21 ' CE2' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -137.4 171.76 14.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.907 -179.139 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.0 t -121.18 34.75 5.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.848 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -113.81 175.14 5.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.164 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.2 m80 -82.84 148.09 27.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.9 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.436 ' HA2' ' CE1' ' A' ' 11' ' ' TYR . . . -100.69 -174.18 29.48 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.563 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.9 t -165.06 -43.41 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.842 0.353 . . . . 0.0 110.879 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -74.15 137.17 43.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.973 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.92 ' O ' HG23 ' A' ' 120' ' ' VAL . 81.0 m -122.66 123.55 41.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.499 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.792 HD11 HG21 ' A' ' 12' ' ' VAL . 1.0 OUTLIER -74.09 139.51 19.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.804 0.335 . . . . 0.0 110.689 179.915 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.843 ' HB2' ' N ' ' A' ' 119' ' ' GLY . . . -95.21 128.2 41.87 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.008 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.585 ' H ' ' HB3' ' A' ' 147' ' ' ALA . 11.3 tpt180 -94.67 36.09 1.19 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.584 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 20.6 p -99.98 167.25 10.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.981 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -117.22 28.64 8.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.468 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 14.0 m -62.18 120.44 10.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.753 0.311 . . . . 0.0 110.704 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.4 t -69.35 -13.37 62.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.947 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -117.71 126.56 52.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.21 0.529 . . . . 0.0 111.464 -179.664 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 73' ' ' PRO . . . -135.83 -153.78 6.74 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.114 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.768 HG23 ' C ' ' A' ' 72' ' ' TYR . 11.2 p -140.08 131.31 31.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 117.26 0.53 . . . . 0.0 111.649 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -109.69 150.74 27.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.741 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.098 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.61 ' HB3' HG21 ' A' ' 62' ' ' VAL . 35.0 m80 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.894 0.378 . . . . 0.0 109.993 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.768 ' C ' HG23 ' A' ' 62' ' ' VAL . 0.6 OUTLIER -111.22 114.38 53.47 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.296 -179.096 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.506 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 6.3 Cg_exo -78.27 125.89 7.36 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.459 2.106 . . . . 0.0 111.834 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.462 ' CG1' ' CE2' ' A' ' 76' ' ' PHE . 2.3 p -136.77 153.03 29.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.945 0.403 . . . . 0.0 111.745 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.546 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 0.0 OUTLIER -95.35 133.52 39.18 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.493 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.609 ' CD2' ' HB2' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -135.28 166.5 22.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.507 0.67 . . . . 0.0 111.955 -178.886 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.696 ' C ' ' HD3' ' A' ' 79' ' ' PRO . 1.8 mp0 -111.71 159.54 18.14 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.121 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -108.42 62.23 0.3 Allowed Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.044 -1.074 . . . . 0.0 114.191 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.696 ' HD3' ' C ' ' A' ' 77' ' ' GLU . 15.1 Cg_exo -67.01 142.52 62.2 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.075 1.85 . . . . 0.0 111.948 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -64.83 -90.67 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.739 -0.664 . . . . 0.0 113.016 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.791 HD22 ' HB2' ' A' ' 96' ' ' SER . 0.0 OUTLIER -85.08 129.99 34.7 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.031 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.629 ' HB ' HG11 ' A' ' 98' ' ' VAL . 98.7 t -138.75 126.04 26.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.478 178.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -72.35 107.86 5.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.944 0.402 . . . . 0.0 111.598 -178.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.734 HG23 ' CG ' ' A' ' 126' ' ' MET . 4.1 p -73.11 114.27 12.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.959 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -73.01 149.39 43.3 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.546 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.575 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 1.0 OUTLIER -69.34 101.89 1.62 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.644 179.923 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.457 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -144.45 152.81 41.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.129 179.761 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 53.56 -82.85 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.558 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.457 ' N ' ' O ' ' A' ' 87' ' ' SER . 0.4 OUTLIER -146.38 18.65 1.36 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.693 0.283 . . . . 0.0 111.047 179.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.575 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 1.2 m-85 -106.9 136.54 19.43 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.315 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.495 ' HA ' ' HG2' ' A' ' 86' ' ' GLU . 95.2 Cg_endo -84.37 148.33 11.5 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.917 2.411 . . . . 0.0 112.954 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -65.05 77.58 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.518 179.547 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.55 ' O ' HG12 ' A' ' 84' ' ' VAL . 46.8 mtt180 -123.69 -174.75 3.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.126 0.489 . . . . 0.0 111.912 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.464 ' HB3' HD11 ' A' ' 81' ' ' LEU . 19.5 m-85 -99.14 132.26 44.58 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.841 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.606 ' OE1' HG11 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -131.22 126.74 36.33 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.098 -179.867 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.791 ' HB2' HD22 ' A' ' 81' ' ' LEU . 44.4 t -101.55 158.54 16.0 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.087 0.47 . . . . 0.0 111.803 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.42 ' CE1' ' HB2' ' A' ' 138' ' ' ARG . 0.0 OUTLIER 64.71 56.53 1.15 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.645 179.338 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.629 HG11 ' HB ' ' A' ' 82' ' ' VAL . 9.5 p -123.53 141.81 42.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.994 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.451 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 11.0 mp -104.95 147.96 27.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.315 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.721 HD23 ' C ' ' A' ' 132' ' ' VAL . 6.8 mt -133.08 131.5 40.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.069 0.461 . . . . 0.0 112.183 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.609 ' HB2' ' CD2' ' A' ' 76' ' ' PHE . . . -135.65 147.64 48.67 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.749 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.5 t -105.33 134.35 48.59 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.982 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 0.204 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.494 179.992 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.691 ' O ' HG13 ' A' ' 124' ' ' VAL . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.719 -0.152 . . . . 0.0 112.719 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 18.0 pt -126.11 146.72 31.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.829 0.347 . . . . 0.0 111.156 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.651 HD22 ' HD2' ' A' ' 134' ' ' PHE . 15.6 tp -87.14 115.49 24.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.126 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.643 ' HD3' HG22 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -118.05 150.94 38.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.059 0.457 . . . . 0.0 111.501 -179.416 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.523 ' HB2' HD11 ' A' ' 121' ' ' ILE . 5.7 t -114.57 162.34 16.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.279 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -56.22 -19.47 13.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.919 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.42 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . 18.9 m80 -92.26 -34.34 14.29 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.457 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.843 ' N ' ' HB2' ' A' ' 54' ' ' ALA . . . 178.03 -140.03 4.47 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.345 -0.931 . . . . 0.0 113.145 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.92 HG23 ' O ' ' A' ' 52' ' ' THR . 4.0 t -102.1 135.58 38.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.705 0.288 . . . . 0.0 111.287 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.554 ' HB ' ' HG ' ' A' ' 114' ' ' LEU . 1.1 mm -98.4 -67.15 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.896 0.379 . . . . 0.0 110.735 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.919 ' HA2' HG23 ' A' ' 137' ' ' VAL . . . -159.88 -166.43 18.75 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.667 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.464 HD11 HD13 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -116.93 164.08 15.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.789 0.328 . . . . 0.0 110.698 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.691 HG13 ' O ' ' A' ' 112' ' ' GLY . 7.7 m -65.6 128.94 29.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.453 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.748 ' OG1' ' HB2' ' A' ' 135' ' ' ALA . 2.5 m -111.09 -89.08 0.5 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.344 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.734 ' CG ' HG23 ' A' ' 84' ' ' VAL . 0.8 OUTLIER -130.44 125.77 35.3 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.934 0.397 . . . . 0.0 111.409 179.915 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -110.71 151.19 17.68 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.47 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -110.04 -153.23 14.1 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.578 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -93.98 17.28 12.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.595 0.236 . . . . 0.0 111.239 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -168.74 -28.25 0.02 OUTLIER Glycine 0 CA--C 1.52 0.357 0 C-N-CA 120.527 -0.844 . . . . 0.0 113.182 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.558 ' CG1' HD22 ' A' ' 100' ' ' LEU . 1.6 t -115.48 157.27 16.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.802 0.301 . . . . 0.0 111.038 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.721 ' C ' HD23 ' A' ' 100' ' ' LEU . 10.0 m -114.73 118.86 59.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.658 -179.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.472 ' HA3' ' O ' ' A' ' 126' ' ' MET . . . -95.59 117.93 5.78 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.39 -0.909 . . . . 0.0 112.177 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.651 ' HD2' HD22 ' A' ' 114' ' ' LEU . 13.5 m-85 -122.2 144.2 49.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.95 0.405 . . . . 0.0 111.512 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.748 ' HB2' ' OG1' ' A' ' 125' ' ' THR . . . -89.34 111.06 21.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.076 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -68.34 147.34 52.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.01 0.433 . . . . 0.0 111.836 -179.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.919 HG23 ' HA2' ' A' ' 122' ' ' GLY . 97.9 t -91.26 11.03 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.438 179.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.594 ' HA ' HD23 ' A' ' 141' ' ' LEU . 12.8 mmm180 -70.14 -6.93 37.61 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.748 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -98.26 11.11 38.98 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 111.706 0.261 . . . . 0.0 111.706 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.873 HD23 HG21 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -175.03 39.07 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.202 0.525 . . . . 0.0 110.471 179.81 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.662 HD11 ' HB ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -56.77 -20.86 24.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.32 -179.608 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . 0.432 ' CD1' ' HA ' ' A' ' 140' ' ' LEU . 12.7 p-90 -55.68 85.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.941 0.4 . . . . 0.0 111.45 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.575 HD23 ' CB ' ' A' ' 15' ' ' TYR . 4.2 mp -146.0 -48.16 0.21 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.309 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -151.12 -173.21 4.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.676 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -58.93 136.01 57.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.92 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -82.95 154.1 24.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.916 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.585 ' HB3' ' H ' ' A' ' 55' ' ' ARG . . . . . . . . 0 C--N 1.33 -0.239 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.069 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.601 ' HB2' HG23 ' A' ' 18' ' ' VAL . . . . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.772 0.32 . . . . 0.0 111.157 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.615 HG22 HG21 ' A' ' 113' ' ' ILE . 39.4 t -106.73 108.24 24.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.033 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.883 ' CE2' HG21 ' A' ' 45' ' ' THR . 6.5 t80 -98.11 116.53 30.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.688 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.895 HG21 HD11 ' A' ' 53' ' ' ILE . 41.7 t -120.58 108.83 23.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.587 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 51.59 -127.78 31.18 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.955 -0.64 . . . . 0.0 113.304 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.466 ' O ' ' HA ' ' A' ' 44' ' ' THR . 0.9 OUTLIER -88.88 14.27 10.78 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.572 0.225 . . . . 0.0 111.599 -179.637 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.647 ' HE1' HG22 ' A' ' 44' ' ' THR . 6.1 m-30 -130.34 128.01 40.6 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.49 114.68 23.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.66 0.267 . . . . 0.0 111.018 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.908 HG12 HG22 ' A' ' 42' ' ' VAL . 0.8 OUTLIER -99.13 122.49 50.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 121.032 0.444 . . . . 0.0 110.401 179.48 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.779 ' O ' HD12 ' A' ' 40' ' ' LEU . 12.6 p -135.42 161.49 39.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.256 -179.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.881 ' HB2' HD12 ' A' ' 22' ' ' LEU . 2.2 t30 -60.94 141.74 57.0 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 178.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.2 -47.03 79.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.824 0.345 . . . . 0.0 110.838 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -71.05 -6.93 42.79 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.151 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.881 HD12 ' HB2' ' A' ' 19' ' ' ASN . 52.4 mt -112.66 -3.68 14.24 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.825 ' HB3' ' CZ2' ' A' ' 28' ' ' TRP . . . -77.13 151.0 35.55 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.865 0.364 . . . . 0.0 110.829 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.445 ' O ' ' CE3' ' A' ' 28' ' ' TRP . 1.2 t -102.89 166.64 10.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.133 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 30.1 t60 -54.04 -29.57 44.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.042 0.448 . . . . 0.0 110.345 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.5 t -72.07 -31.18 39.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.019 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.482 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 0.4 OUTLIER -67.43 -44.14 79.47 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.941 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.825 ' CZ2' ' HB3' ' A' ' 23' ' ' ALA . 11.7 m-90 -73.9 -35.46 64.65 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.078 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.62 -38.62 72.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.045 0.45 . . . . 0.0 110.503 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -119.37 27.73 8.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.755 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 8.7 t -73.58 122.8 22.82 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.964 0.412 . . . . 0.0 110.863 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.549 HG22 ' O ' ' A' ' 42' ' ' VAL . 13.1 m -86.57 -39.77 13.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.515 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.604 ' HH2' HD23 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -139.71 153.12 47.14 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.172 -179.893 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -156.82 121.28 4.44 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.813 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.401 ' HB2' ' CZ2' ' A' ' 33' ' ' TRP . 17.6 m-20 -107.05 116.86 32.66 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.23 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -67.24 -36.88 82.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.963 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.53 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 3.8 m-20 -72.41 -14.15 61.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.863 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 mtt85 -115.54 -3.77 12.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.777 -0.192 . . . . 0.0 111.274 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 46.91 42.15 11.79 Favored 'General case' 0 CA--C 1.524 -0.046 0 CA-C-O 121.216 0.532 . . . . 0.0 110.038 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.85 HD11 HG23 ' A' ' 17' ' ' VAL . 29.3 tp -136.17 152.42 50.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.906 -178.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.662 HD12 ' NE1' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -147.33 150.79 35.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.042 0.449 . . . . 0.0 111.194 179.408 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.908 HG22 HG12 ' A' ' 17' ' ' VAL . 31.0 t -114.54 126.75 72.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.403 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.9 p -117.87 157.28 26.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.416 178.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.647 HG22 ' HE1' ' A' ' 15' ' ' TYR . 18.9 p -97.71 140.79 31.58 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.119 0.485 . . . . 0.0 111.701 -179.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.883 HG21 ' CE2' ' A' ' 11' ' ' TYR . 0.2 OUTLIER -135.29 168.94 18.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.875 -179.335 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.2 p -121.69 61.9 0.93 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.832 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.24 169.7 17.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.125 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 4.9 m170 -86.56 128.57 34.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.876 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -87.43 -179.48 48.13 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.489 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 73.3 m -144.09 -46.94 0.27 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.77 0.319 . . . . 0.0 110.892 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -64.25 138.88 58.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.939 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.873 ' O ' HG23 ' A' ' 120' ' ' VAL . 83.2 m -122.7 121.05 35.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.509 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.895 HD11 HG21 ' A' ' 12' ' ' VAL . 0.4 OUTLIER -74.24 139.36 19.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.928 0.394 . . . . 0.0 111.211 -179.677 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.83 ' HB2' ' N ' ' A' ' 119' ' ' GLY . . . -95.7 123.65 39.36 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.942 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.504 ' H ' ' HB3' ' A' ' 147' ' ' ALA . 0.3 OUTLIER -91.2 37.29 0.94 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.621 179.672 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 24.5 p -99.85 167.1 10.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.952 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -119.1 33.53 5.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.32 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 35.5 m -62.76 141.85 58.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.627 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -85.28 3.1 41.12 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.024 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.1 p -125.9 168.05 14.42 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.103 0.478 . . . . 0.0 111.117 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -179.44 -173.14 44.34 Favored Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.583 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.836 HG23 ' C ' ' A' ' 72' ' ' TYR . 9.2 p -140.22 125.83 20.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 117.044 0.422 . . . . 0.0 111.225 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.704 ' HE2' HG21 ' A' ' 74' ' ' VAL . 6.2 p90 -109.12 137.99 46.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.743 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.049 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.478 ' HB3' HG21 ' A' ' 62' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.131 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.836 ' C ' HG23 ' A' ' 62' ' ' VAL . 2.7 m-85 -108.59 113.86 59.52 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.512 -179.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 72' ' ' TYR . 2.7 Cg_exo -76.34 120.78 5.77 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.589 2.192 . . . . 0.0 111.024 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.704 HG21 ' HE2' ' A' ' 63' ' ' TYR . 54.5 t -134.83 141.78 42.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.977 0.418 . . . . 0.0 111.765 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 16.7 m -91.84 121.64 33.64 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.51 ' HB3' ' HB2' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -127.96 165.19 20.73 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.526 0.679 . . . . 0.0 111.947 -178.629 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.58 ' C ' ' HD3' ' A' ' 79' ' ' PRO . 10.7 mt-10 -111.72 158.83 18.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.899 178.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.484 ' HA2' ' HG ' ' A' ' 99' ' ' LEU . . . -112.16 68.6 0.23 Allowed Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.124 -1.036 . . . . 0.0 113.961 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.586 ' HD2' ' O ' ' A' ' 98' ' ' VAL . 15.7 Cg_exo -67.36 142.08 58.68 Favored 'Trans proline' 0 C--O 1.238 0.503 0 C-N-CA 122.22 1.946 . . . . 0.0 111.797 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -57.98 -91.73 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.538 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.585 HD22 ' CB ' ' A' ' 96' ' ' SER . 0.0 OUTLIER -94.37 119.82 33.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.91 0.386 . . . . 0.0 111.876 -179.587 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.643 ' HB ' HG11 ' A' ' 98' ' ' VAL . 61.7 t -122.76 122.62 66.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.923 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.401 ' HG3' ' CE1' ' A' ' 94' ' ' TYR . 1.8 tt0 -72.43 107.62 5.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.859 0.362 . . . . 0.0 110.741 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.709 HG13 ' HG2' ' A' ' 126' ' ' MET . 30.4 t -75.77 114.3 15.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.624 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.422 ' HA ' ' HD3' ' A' ' 92' ' ' LYS . 1.5 tt0 -71.86 150.02 44.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.032 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.472 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 0.8 OUTLIER -67.88 101.34 1.07 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.158 0.504 . . . . 0.0 110.159 -179.475 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.508 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.3 OUTLIER -144.65 175.7 9.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.839 -179.913 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 42.96 -86.23 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.787 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.508 ' N ' ' O ' ' A' ' 87' ' ' SER . 0.3 OUTLIER -150.56 23.5 0.8 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.825 0.345 . . . . 0.0 110.485 179.686 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.472 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -117.92 138.15 25.11 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.867 -179.704 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.427 ' O ' ' N ' ' A' ' 93' ' ' ARG . 93.7 Cg_endo -78.77 148.61 22.69 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.821 2.347 . . . . 0.0 112.247 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.578 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -60.9 79.9 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.866 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.427 ' N ' ' O ' ' A' ' 91' ' ' PRO . 1.5 ttp85 -123.65 177.41 5.7 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.692 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.457 ' HB3' HD11 ' A' ' 81' ' ' LEU . 10.6 m-85 -91.29 132.6 36.04 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.777 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.777 ' OE1' HG23 ' A' ' 125' ' ' THR . 0.1 OUTLIER -125.46 116.84 22.46 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.654 -179.571 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.585 ' CB ' HD22 ' A' ' 81' ' ' LEU . 3.0 t -91.53 154.4 19.12 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 120.92 0.391 . . . . 0.0 111.45 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 53.72 62.46 2.61 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.336 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.643 HG11 ' HB ' ' A' ' 82' ' ' VAL . 5.9 p -123.35 152.28 28.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.1 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.484 ' HG ' ' HA2' ' A' ' 78' ' ' GLY . 5.5 mp -116.43 140.27 49.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.205 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.8 HD23 ' O ' ' A' ' 132' ' ' VAL . 5.5 mt -133.23 142.06 48.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.268 0.556 . . . . 0.0 112.456 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.575 ' O ' HG12 ' A' ' 131' ' ' VAL . . . -151.97 161.06 43.23 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.412 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.1 t -118.92 129.45 55.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.947 0.403 . . . . 0.0 111.004 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.334 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.493 179.949 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.615 HG21 HG22 ' A' ' 10' ' ' VAL . 28.4 pt -126.15 144.21 37.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.782 0.325 . . . . 0.0 111.17 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.63 HD22 ' HD2' ' A' ' 134' ' ' PHE . 10.8 tp -87.9 113.99 24.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.208 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.63 ' HD3' HG22 ' A' ' 120' ' ' VAL . 3.1 mtm180 -114.1 143.24 45.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.098 0.475 . . . . 0.0 111.554 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.56 ' HB2' HD11 ' A' ' 121' ' ' ILE . 6.9 t -107.79 164.28 12.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.191 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -56.14 -20.35 17.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.788 0.328 . . . . 0.0 110.723 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.493 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . 26.7 m80 -89.59 -35.86 15.64 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.325 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.83 ' N ' ' HB2' ' A' ' 54' ' ' ALA . . . 177.46 -136.36 3.06 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.854 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.873 HG23 ' O ' ' A' ' 52' ' ' THR . 3.8 t -102.88 135.38 40.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.685 0.279 . . . . 0.0 110.926 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.56 HD11 ' HB2' ' A' ' 116' ' ' CYS . 1.0 OUTLIER -94.59 -69.9 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.698 0.285 . . . . 0.0 111.248 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.941 ' HA2' HG23 ' A' ' 137' ' ' VAL . . . -150.95 -160.09 9.2 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.381 -0.914 . . . . 0.0 113.236 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.634 ' CD1' HD13 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -121.38 164.48 17.01 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.737 0.303 . . . . 0.0 110.85 -179.789 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.481 HG13 ' O ' ' A' ' 124' ' ' VAL . 9.9 p -62.31 121.52 11.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.838 0.351 . . . . 0.0 111.796 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.777 HG23 ' OE1' ' A' ' 95' ' ' GLN . 3.0 m -112.17 -91.31 0.49 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.075 179.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.709 ' HG2' HG13 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -92.58 160.4 15.04 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 120.787 0.327 . . . . 0.0 110.743 179.517 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -150.03 88.66 0.14 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.442 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -77.32 -176.59 44.81 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.429 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.79 -19.32 62.02 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.667 0.27 . . . . 0.0 111.015 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -142.03 -6.3 0.8 Allowed Glycine 0 CA--C 1.522 0.482 0 C-N-CA 120.598 -0.81 . . . . 0.0 113.447 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.575 HG12 ' O ' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -115.82 157.17 16.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 117.322 0.561 . . . . 0.0 111.306 -179.764 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.8 ' O ' HD23 ' A' ' 100' ' ' LEU . 13.1 m -119.73 118.69 57.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.5 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -100.99 120.06 6.75 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.728 -0.749 . . . . 0.0 111.9 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.63 ' HD2' HD22 ' A' ' 114' ' ' LEU . 18.3 m-85 -125.13 136.72 53.9 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.914 0.387 . . . . 0.0 112.02 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.754 ' HB2' ' OG1' ' A' ' 125' ' ' THR . . . -88.86 114.22 25.25 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.198 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -67.79 141.16 56.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.975 0.417 . . . . 0.0 111.858 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.941 HG23 ' HA2' ' A' ' 122' ' ' GLY . 88.9 t -89.31 9.72 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.615 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.48 ' HA ' HD23 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -70.74 -6.68 39.21 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.599 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -95.93 11.05 35.27 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 120.685 0.279 . . . . 0.0 111.317 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.853 ' O ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -177.98 57.28 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.083 0.468 . . . . 0.0 110.484 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.871 HD11 ' HB ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -74.83 -14.83 60.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.883 -179.572 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . 0.465 ' C ' HD12 ' A' ' 143' ' ' LEU . 13.2 p-90 -55.99 82.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.896 0.379 . . . . 0.0 111.261 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.672 HD12 ' C ' ' A' ' 141' ' ' LEU . 5.1 mp -149.67 -45.67 0.13 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.466 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.433 ' HB2' ' CG1' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -154.35 -167.44 2.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.747 179.832 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -58.88 141.03 54.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.0 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.409 ' HB2' ' HB2' ' A' ' 55' ' ' ARG . 15.4 p30 -94.97 154.07 17.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.832 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.617 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . . . . . . . . 0 C--N 1.33 -0.268 0 CA-C-O 120.904 0.383 . . . . 0.0 111.156 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.801 0.334 . . . . 0.0 111.047 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.0 t -107.4 116.23 50.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.013 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.611 ' CZ ' HG21 ' A' ' 45' ' ' THR . 0.3 OUTLIER -98.02 115.52 28.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.604 179.889 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.988 HG21 HD11 ' A' ' 53' ' ' ILE . 17.3 t -121.47 108.8 23.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.525 179.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 48.21 -124.64 11.41 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.928 -0.653 . . . . 0.0 113.098 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.405 ' O ' ' HA ' ' A' ' 44' ' ' THR . 2.7 m120 -92.43 17.94 9.2 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.734 0.302 . . . . 0.0 111.403 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.662 ' HE1' HG22 ' A' ' 44' ' ' THR . 4.9 m-30 -130.31 144.4 51.36 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.411 ' HG3' ' CD1' ' A' ' 11' ' ' TYR . 18.6 ttpt -133.83 118.26 17.79 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.702 0.287 . . . . 0.0 110.994 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 1.098 HG12 HG22 ' A' ' 42' ' ' VAL . 0.6 OUTLIER -104.39 122.07 56.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.117 0.485 . . . . 0.0 110.434 179.572 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.737 ' O ' HD12 ' A' ' 40' ' ' LEU . 14.0 p -136.01 162.0 37.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.033 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.508 ' N ' HG22 ' A' ' 18' ' ' VAL . 1.0 OUTLIER -58.53 141.24 52.52 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.091 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.587 ' HG2' HD13 ' A' ' 41' ' ' LEU . 13.9 mtm105 -56.45 -47.82 78.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.916 0.389 . . . . 0.0 111.17 -179.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -69.52 -7.62 39.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.441 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.9 tp -115.33 5.73 14.72 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.8 ' HB2' HD21 ' A' ' 41' ' ' LEU . . . -89.27 131.89 35.16 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.353 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.563 ' O ' ' HD1' ' A' ' 28' ' ' TRP . 44.1 p -74.76 162.5 28.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.469 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.406 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 2.9 t-160 -53.66 -29.64 39.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.886 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.8 t -69.57 -31.94 50.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.915 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.437 ' O ' ' HB3' ' A' ' 31' ' ' CYS . 13.5 m-20 -67.72 -44.07 78.51 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.62 ' NE1' ' HB3' ' A' ' 23' ' ' ALA . 33.8 m95 -73.57 -29.88 62.69 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.594 179.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.406 ' HB2' ' O ' ' A' ' 25' ' ' HIS . 2.2 tp60 -58.8 -43.92 90.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.575 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -118.15 30.13 7.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.832 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.483 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 29.5 p -69.17 122.93 19.81 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.949 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.546 ' CG2' HG12 ' A' ' 42' ' ' VAL . 17.7 m -86.2 -39.74 13.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.434 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.755 ' HH2' HD23 ' A' ' 40' ' ' LEU . 1.0 OUTLIER -139.66 153.25 47.25 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.08 179.689 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -160.44 115.92 2.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.008 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -107.19 117.75 34.9 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.936 0.398 . . . . 0.0 111.136 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -62.26 -48.84 78.14 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.353 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -59.9 -19.09 49.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.134 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -108.38 -8.02 15.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.276 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.4 t70 49.49 43.22 23.63 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 121.088 0.47 . . . . 0.0 110.224 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.755 HD23 ' HH2' ' A' ' 33' ' ' TRP . 20.0 tp -137.1 154.15 50.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.126 -178.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.8 HD21 ' HB2' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -151.86 137.18 17.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.115 0.484 . . . . 0.0 111.131 179.555 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 1.098 HG22 HG12 ' A' ' 17' ' ' VAL . 34.3 t -100.96 130.58 50.11 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.406 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.4 p -123.19 157.45 32.99 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.261 -0.882 . . . . 0.0 109.435 178.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.662 HG22 ' HE1' ' A' ' 15' ' ' TYR . 19.4 p -97.21 134.48 40.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.235 0.54 . . . . 0.0 111.395 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.611 HG21 ' CZ ' ' A' ' 11' ' ' TYR . 0.5 OUTLIER -102.49 -29.56 11.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.026 -179.126 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.0 m 66.61 31.43 7.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.738 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -142.96 -167.78 2.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.017 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.85 144.94 43.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.827 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -72.65 -140.51 0.37 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.42 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.1 m -172.09 -44.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.693 0.282 . . . . 0.0 111.05 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -117.23 163.3 16.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.2 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.903 ' O ' HG23 ' A' ' 120' ' ' VAL . 73.9 m -125.28 122.5 37.09 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.664 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.988 HD11 HG21 ' A' ' 12' ' ' VAL . 0.4 OUTLIER -75.29 139.52 18.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.03 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.82 ' HB2' ' N ' ' A' ' 119' ' ' GLY . . . -94.57 128.45 41.2 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.061 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.443 ' HB3' ' HB3' ' A' ' 146' ' ' ASP . 0.0 OUTLIER -92.31 33.69 1.08 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.683 179.576 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 26.7 p -99.49 166.96 10.91 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.905 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -121.85 33.41 5.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.241 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 34.4 m -60.44 127.37 31.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.776 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.85 -9.32 58.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.994 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.9 p -117.84 124.0 47.28 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.008 0.432 . . . . 0.0 111.109 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.07 178.88 20.44 Favored Glycine 0 N--CA 1.452 -0.299 0 N-CA-C 111.632 -0.587 . . . . 0.0 111.632 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.844 HG21 ' HB2' ' A' ' 71' ' ' HIS . 8.3 p -119.28 124.83 73.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.205 0.526 . . . . 0.0 111.362 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -105.52 -173.94 2.42 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.433 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.134 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.844 ' HB2' HG21 ' A' ' 62' ' ' VAL . 7.8 p80 . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.639 0.257 . . . . 0.0 110.504 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.785 ' C ' HG23 ' A' ' 62' ' ' VAL . 4.5 m-85 -105.68 112.4 64.57 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.039 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.502 ' HA ' ' HA ' ' A' ' 62' ' ' VAL . 2.8 Cg_endo -84.03 120.88 2.69 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.044 2.496 . . . . 0.0 111.658 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.517 ' CG1' ' CE2' ' A' ' 76' ' ' PHE . 2.5 p -137.52 153.79 28.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.504 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.0 m -94.78 127.68 40.95 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.563 ' CD2' ' HB2' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -131.53 162.71 29.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.379 0.609 . . . . 0.0 111.919 -179.416 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' A' ' 99' ' ' LEU . 0.7 OUTLIER -111.83 158.86 18.9 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.142 178.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -104.82 65.48 0.3 Allowed Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.275 -0.964 . . . . 0.0 113.557 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.472 ' HD2' ' HA ' ' A' ' 99' ' ' LEU . 41.9 Cg_endo -68.34 135.23 33.41 Favored 'Trans proline' 0 C--O 1.239 0.535 0 C-N-CA 122.263 1.975 . . . . 0.0 112.198 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -59.3 -85.26 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.245 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.724 HD11 ' HB3' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -97.38 119.5 36.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.993 0.425 . . . . 0.0 111.594 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.626 ' HB ' HG11 ' A' ' 98' ' ' VAL . 44.1 t -123.25 122.42 65.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.823 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.59 107.51 5.13 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.992 0.425 . . . . 0.0 110.67 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.581 HG12 ' O ' ' A' ' 93' ' ' ARG . 2.7 p -74.53 119.29 21.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.557 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.427 ' HA ' ' HG2' ' A' ' 92' ' ' LYS . 24.3 mt-30 -69.65 149.41 48.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.06 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.544 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 14.3 tt0 -68.63 102.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.625 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.552 ' HB3' ' HE1' ' A' ' 126' ' ' MET . 0.1 OUTLIER -143.66 158.64 43.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.382 -179.827 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.451 ' HG2' ' CD2' ' A' ' 89' ' ' TYR . 5.7 tt0 53.54 -84.78 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.709 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.451 ' CD2' ' HG2' ' A' ' 88' ' ' GLU . 0.2 OUTLIER -145.43 19.36 1.53 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.663 0.268 . . . . 0.0 111.146 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.544 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 1.4 t80 -113.85 137.5 22.34 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.737 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.468 ' O ' ' N ' ' A' ' 93' ' ' ARG . 90.3 Cg_endo -85.79 148.59 9.66 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.065 2.51 . . . . 0.0 112.569 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -55.94 82.28 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.873 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.581 ' O ' HG12 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -123.84 174.29 7.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.168 0.509 . . . . 0.0 111.905 -179.477 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.724 ' HB3' HD11 ' A' ' 81' ' ' LEU . 3.8 m-85 -93.29 132.78 37.17 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.175 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.475 ' O ' HD13 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -125.36 126.28 44.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.818 179.896 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.498 ' HB2' HD22 ' A' ' 81' ' ' LEU . 12.1 t -96.28 154.68 17.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.091 0.472 . . . . 0.0 111.983 -179.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.474 ' CE1' ' HB3' ' A' ' 136' ' ' ASP . 1.6 t-80 57.82 57.52 4.14 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.922 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.626 HG11 ' HB ' ' A' ' 82' ' ' VAL . 11.1 p -123.72 141.07 45.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.528 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.744 HD11 ' OD2' ' A' ' 136' ' ' ASP . 6.2 mp -104.03 141.47 36.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.947 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.731 HD23 ' C ' ' A' ' 132' ' ' VAL . 7.3 mt -125.92 136.39 52.99 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.563 ' HB2' ' CD2' ' A' ' 76' ' ' PHE . . . -143.65 142.84 31.19 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.684 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 1.6 t -98.26 133.41 42.72 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.864 0.364 . . . . 0.0 111.217 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.277 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.507 -179.817 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.74 ' O ' HG13 ' A' ' 124' ' ' VAL . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.559 -0.216 . . . . 0.0 112.559 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 22.7 pt -126.25 146.39 32.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.806 0.336 . . . . 0.0 111.218 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.564 ' HG ' ' HB ' ' A' ' 121' ' ' ILE . 12.4 tp -87.43 117.05 25.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.175 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.15 153.11 34.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.111 0.481 . . . . 0.0 111.715 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.515 ' HB2' HD11 ' A' ' 121' ' ' ILE . 6.2 t -117.66 162.62 17.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.306 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -56.02 -20.86 18.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.926 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.434 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . 18.4 m80 -90.19 -34.77 15.7 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.422 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.82 ' N ' ' HB2' ' A' ' 54' ' ' ALA . . . 177.3 -139.13 4.2 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.026 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.903 HG23 ' O ' ' A' ' 52' ' ' THR . 4.0 t -102.0 135.5 38.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.759 0.314 . . . . 0.0 111.227 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.572 HG22 ' OD1' ' A' ' 136' ' ' ASP . 1.2 mm -94.49 -66.35 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.909 0.385 . . . . 0.0 110.631 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.913 ' HA2' HG23 ' A' ' 137' ' ' VAL . . . -164.05 -161.83 13.88 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.558 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.685 HD11 HD13 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -116.87 164.14 15.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.725 0.298 . . . . 0.0 110.631 179.93 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.74 HG13 ' O ' ' A' ' 112' ' ' GLY . 29.4 m -73.89 129.33 36.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.91 0.386 . . . . 0.0 111.653 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.674 HG22 ' N ' ' A' ' 126' ' ' MET . 3.6 m -110.16 -94.25 0.43 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.129 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.674 ' N ' HG22 ' A' ' 125' ' ' THR . 12.4 mmm -144.56 142.03 29.9 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.855 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -113.21 178.6 18.72 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.588 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -108.41 -139.38 8.81 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.499 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -72.5 -19.43 61.54 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.787 0.327 . . . . 0.0 111.095 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -165.64 19.17 0.1 Allowed Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.816 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.561 ' CG1' HD22 ' A' ' 100' ' ' LEU . 1.5 t -121.85 157.34 25.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.703 0.287 . . . . 0.0 110.576 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.731 ' C ' HD23 ' A' ' 100' ' ' LEU . 12.2 m -115.4 118.39 58.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.825 -179.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.572 ' HA3' ' O ' ' A' ' 126' ' ' MET . . . -96.9 116.17 5.42 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.323 -0.942 . . . . 0.0 111.686 178.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.517 ' HD2' HD22 ' A' ' 114' ' ' LEU . 12.9 m-85 -116.2 141.66 47.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.994 0.426 . . . . 0.0 111.726 -179.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.509 ' HB2' ' OG1' ' A' ' 125' ' ' THR . . . -88.89 109.36 20.16 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.066 178.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.744 ' OD2' HD11 ' A' ' 99' ' ' LEU . 0.6 OUTLIER -67.87 152.03 46.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.152 0.501 . . . . 0.0 111.984 -178.735 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.913 HG23 ' HA2' ' A' ' 122' ' ' GLY . 48.0 t -99.33 9.39 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.843 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.486 ' HA ' HD23 ' A' ' 141' ' ' LEU . 5.9 mtm180 -72.29 -6.9 46.41 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.401 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.401 ' HB2' ' ND1' ' A' ' 97' ' ' HIS . 1.1 t70 -94.93 10.77 34.24 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.719 0.295 . . . . 0.0 110.846 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.846 ' O ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -176.77 58.32 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.08 0.467 . . . . 0.0 110.303 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.902 HD11 ' HB ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -73.09 -14.86 61.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.914 -179.386 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . 0.423 ' C ' HD12 ' A' ' 143' ' ' LEU . 15.8 p-90 -56.88 83.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.934 0.397 . . . . 0.0 111.476 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.69 HD12 ' C ' ' A' ' 141' ' ' LEU . 4.8 mp -150.91 -47.0 0.12 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.614 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.436 ' HB2' HG12 ' A' ' 12' ' ' VAL . 0.4 OUTLIER -151.46 -166.81 2.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.065 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.48 149.09 50.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.369 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.443 ' HB3' ' HB3' ' A' ' 55' ' ' ARG . 9.6 m-20 -95.29 154.53 17.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.753 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.153 0 CA-C-O 120.897 0.379 . . . . 0.0 111.124 -179.787 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.104 0 CA-C-O 120.813 0.34 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.449 HG22 HG21 ' A' ' 113' ' ' ILE . 41.5 t -108.82 110.7 33.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.107 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.802 ' CE2' HG21 ' A' ' 45' ' ' THR . 5.2 t80 -99.73 116.32 31.55 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.791 0.329 . . . . 0.0 110.529 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.844 HG21 HD11 ' A' ' 53' ' ' ILE . 47.6 t -120.85 111.64 32.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.657 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.404 ' O ' ' CE1' ' A' ' 11' ' ' TYR . . . 53.0 -125.32 30.35 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.959 -0.639 . . . . 0.0 113.18 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.423 ' O ' ' HA ' ' A' ' 44' ' ' THR . 44.6 m-80 -91.93 18.73 7.44 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.701 0.286 . . . . 0.0 111.569 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.648 ' HE1' HG22 ' A' ' 44' ' ' THR . 6.2 m-30 -130.35 149.94 51.81 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.5 tttp -139.09 114.87 10.02 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.709 -0.223 . . . . 0.0 110.629 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 1.018 HG12 HG22 ' A' ' 42' ' ' VAL . 0.6 OUTLIER -100.3 121.64 51.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.041 0.448 . . . . 0.0 110.77 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.664 ' O ' HD12 ' A' ' 40' ' ' LEU . 7.3 p -136.43 160.26 37.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.037 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.513 ' N ' HG22 ' A' ' 18' ' ' VAL . 0.6 OUTLIER -62.26 141.51 58.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.227 179.054 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 8.4 ttp180 -56.27 -45.59 80.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.942 0.401 . . . . 0.0 110.85 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -66.85 -11.62 56.29 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.153 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.71 -13.41 14.79 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.961 ' HB3' ' CZ2' ' A' ' 28' ' ' TRP . . . -68.74 150.72 47.56 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 120.796 0.331 . . . . 0.0 110.834 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.403 ' O ' ' CE3' ' A' ' 28' ' ' TRP . 32.6 p -104.59 168.94 8.75 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.269 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 52.5 p-80 -54.76 -29.68 54.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.002 0.43 . . . . 0.0 110.564 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.4 t -74.66 -31.36 26.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.459 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.431 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 0.6 OUTLIER -67.18 -43.98 80.84 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.961 ' CZ2' ' HB3' ' A' ' 23' ' ' ALA . 7.2 m-90 -74.33 -30.37 62.01 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.145 179.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.15 -41.99 89.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.32 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -116.66 32.58 6.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.486 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.444 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 13.2 t -77.24 132.42 38.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.179 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.566 HG22 ' O ' ' A' ' 42' ' ' VAL . 16.8 m -96.06 -38.83 8.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.695 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.663 ' CE3' HG23 ' A' ' 42' ' ' VAL . 1.1 t90 -139.67 153.27 47.24 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.908 0.385 . . . . 0.0 111.548 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -155.69 120.51 4.74 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.79 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.439 ' HB2' ' CZ2' ' A' ' 33' ' ' TRP . 8.3 m-20 -107.09 99.2 8.77 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.038 0.447 . . . . 0.0 111.14 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -58.91 -28.92 66.66 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.8 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.69 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 0.9 OUTLIER -59.68 -38.74 82.35 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.755 -0.202 . . . . 0.0 111.301 -179.052 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.605 ' CZ ' HD22 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -117.31 0.75 12.31 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 60.24 54.83 3.84 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.85 0.357 . . . . 0.0 111.892 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.716 HD11 HG23 ' A' ' 17' ' ' VAL . 38.3 tp -137.11 133.65 35.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.449 179.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.67 ' O ' HD23 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -131.44 156.0 46.38 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.053 0.454 . . . . 0.0 112.068 -179.526 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 1.018 HG22 HG12 ' A' ' 17' ' ' VAL . 23.7 t -117.17 130.08 72.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.062 179.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.4 p -120.49 157.15 30.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.57 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.648 HG22 ' HE1' ' A' ' 15' ' ' TYR . 19.6 p -97.54 123.59 41.48 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.183 0.516 . . . . 0.0 111.493 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.802 HG21 ' CE2' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -98.28 -165.01 1.19 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.872 -179.429 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.0 t -138.86 42.35 2.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.856 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -136.03 -177.98 4.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.085 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -93.0 148.14 22.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.959 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -66.88 157.35 51.1 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.646 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -134.65 -49.17 0.76 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.872 0.368 . . . . 0.0 110.903 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -87.96 150.53 23.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.825 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.872 ' O ' HG23 ' A' ' 120' ' ' VAL . 39.9 m -122.99 116.98 24.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.763 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.9 ' HB ' HD11 ' A' ' 141' ' ' LEU . 0.4 OUTLIER -74.62 139.55 19.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.048 0.452 . . . . 0.0 110.968 -179.843 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.77 ' HB2' ' CA ' ' A' ' 119' ' ' GLY . . . -88.8 121.97 31.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.971 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.594 ' H ' ' HB3' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -88.44 29.01 1.02 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.11 0.481 . . . . 0.0 110.12 179.054 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 30.8 p -100.0 163.27 12.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.091 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.426 ' O ' ' O ' ' A' ' 58' ' ' CYS . 44.4 mt-30 -93.56 -70.19 0.71 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 178.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.426 ' O ' ' O ' ' A' ' 57' ' ' GLN . 96.3 m 54.47 159.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.74 178.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.11 -7.53 11.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.951 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.499 ' HA ' ' HA ' ' A' ' 75' ' ' SER . 10.0 p -132.41 123.97 27.75 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.973 0.416 . . . . 0.0 111.344 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -136.99 161.64 25.16 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.64 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.773 HG23 ' C ' ' A' ' 72' ' ' TYR . 7.3 p -102.52 132.91 47.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.951 0.405 . . . . 0.0 111.308 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.737 ' HE2' HG21 ' A' ' 74' ' ' VAL . 3.5 p90 -118.66 133.99 55.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.949 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 64.7 t80 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.902 -179.948 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 9.2 p80 . . . . . 0 N--CA 1.456 -0.137 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.773 ' C ' HG23 ' A' ' 62' ' ' VAL . 0.5 OUTLIER -116.31 113.94 40.92 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.835 -178.666 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 72' ' ' TYR . 5.5 Cg_exo -77.34 120.67 5.37 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.473 2.115 . . . . 0.0 110.319 178.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.737 HG21 ' HE2' ' A' ' 63' ' ' TYR . 43.2 t -137.47 151.09 26.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.164 0.507 . . . . 0.0 112.365 -178.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.499 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 20.7 m -98.71 133.92 42.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.522 178.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.723 ' CD2' ' HB2' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -145.75 174.14 11.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.444 0.64 . . . . 0.0 112.122 -179.188 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.607 ' C ' ' HD3' ' A' ' 79' ' ' PRO . 0.3 OUTLIER -111.86 158.84 18.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.703 179.425 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.445 ' HA2' ' HG ' ' A' ' 99' ' ' LEU . . . -112.77 66.76 0.25 Allowed Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.235 -0.983 . . . . 0.0 113.642 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.607 ' HD3' ' C ' ' A' ' 77' ' ' GLU . 14.0 Cg_exo -67.46 139.95 50.91 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.376 2.05 . . . . 0.0 112.212 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -57.42 -90.22 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.432 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.701 HD11 ' HB3' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -95.69 119.92 35.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.912 0.387 . . . . 0.0 111.733 -179.756 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.597 ' HB ' HG11 ' A' ' 98' ' ' VAL . 18.8 t -124.2 122.45 64.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.149 178.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -72.57 107.89 5.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.482 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.61 HG22 ' O ' ' A' ' 93' ' ' ARG . 4.8 m -72.77 123.73 28.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.855 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -69.29 150.28 47.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.669 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.584 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 22.8 tt0 -67.61 102.01 1.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.143 0.497 . . . . 0.0 110.373 -179.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 89' ' ' TYR . 4.1 m -144.3 164.08 31.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.188 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 55.93 -81.48 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.542 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.447 ' N ' ' O ' ' A' ' 87' ' ' SER . 0.7 OUTLIER -156.92 24.17 0.32 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.759 0.314 . . . . 0.0 110.877 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.584 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 1.6 t80 -122.69 131.62 24.35 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.695 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.473 ' O ' ' N ' ' A' ' 93' ' ' ARG . 87.0 Cg_endo -81.98 148.84 15.49 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.095 2.53 . . . . 0.0 112.524 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.4 OUTLIER -42.6 88.99 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.509 -179.931 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.61 ' O ' HG22 ' A' ' 84' ' ' VAL . 2.0 ttt180 -123.93 171.08 9.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.219 0.533 . . . . 0.0 112.074 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.701 ' HB3' HD11 ' A' ' 81' ' ' LEU . 3.9 m-85 -98.88 132.84 43.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.131 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.69 ' HA ' ' O ' ' A' ' 37' ' ' ASN . 2.0 tp60 -126.43 114.89 18.78 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.893 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.59 ' HA ' HD22 ' A' ' 81' ' ' LEU . 60.7 p -80.07 144.0 33.52 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.114 0.483 . . . . 0.0 111.875 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 21.7 m80 61.96 60.83 1.47 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.998 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.597 HG11 ' HB ' ' A' ' 82' ' ' VAL . 7.1 p -124.17 131.06 73.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.721 0.296 . . . . 0.0 111.266 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.766 HD11 ' HB3' ' A' ' 136' ' ' ASP . 2.2 mp -101.76 149.16 24.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.976 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.693 HD23 ' C ' ' A' ' 132' ' ' VAL . 9.0 mt -128.69 136.37 50.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.161 0.505 . . . . 0.0 111.96 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.723 ' HB2' ' CD2' ' A' ' 76' ' ' PHE . . . -125.69 124.3 40.8 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.352 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.3 t -96.78 112.01 23.94 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.799 0.333 . . . . 0.0 110.621 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.327 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.821 -179.744 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.386 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.449 HG21 HG22 ' A' ' 10' ' ' VAL . 27.3 pt -122.54 145.32 29.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.861 0.362 . . . . 0.0 111.139 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.596 HD21 ' CZ ' ' A' ' 76' ' ' PHE . 8.4 tp -87.82 121.18 29.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.319 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.441 ' N ' HD12 ' A' ' 114' ' ' LEU . 0.8 OUTLIER -118.36 149.5 41.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.207 0.527 . . . . 0.0 111.962 -179.271 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.654 ' HB2' HD11 ' A' ' 121' ' ' ILE . 6.2 t -111.68 163.67 13.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.982 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -58.51 -17.26 19.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.022 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 18.8 m80 -95.66 -30.68 13.63 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.653 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.77 ' CA ' ' HB2' ' A' ' 54' ' ' ALA . . . 176.82 -143.1 6.16 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.424 -0.893 . . . . 0.0 113.034 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.872 HG23 ' O ' ' A' ' 52' ' ' THR . 3.6 t -98.93 135.33 34.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.726 0.298 . . . . 0.0 111.024 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.654 HD11 ' HB2' ' A' ' 116' ' ' CYS . 1.7 mm -92.35 -66.14 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.839 0.352 . . . . 0.0 110.794 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.847 ' HA2' HG23 ' A' ' 137' ' ' VAL . . . -166.98 -156.26 9.6 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.622 -0.799 . . . . 0.0 113.045 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.668 HD11 HD13 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -116.94 164.16 15.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.804 0.335 . . . . 0.0 110.983 -179.824 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.486 ' HA ' ' CD1' ' A' ' 134' ' ' PHE . 11.6 p -66.51 129.53 31.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.625 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.74 ' OG1' ' HB2' ' A' ' 135' ' ' ALA . 7.3 m -110.07 -87.35 0.52 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.228 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.537 ' N ' HG22 ' A' ' 125' ' ' THR . 0.0 OUTLIER -104.75 144.37 31.83 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.852 0.358 . . . . 0.0 111.13 179.825 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -118.86 96.26 0.65 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.154 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -77.43 174.5 54.63 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.603 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -71.93 -19.36 61.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.713 0.292 . . . . 0.0 110.931 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -145.16 4.74 1.37 Allowed Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.631 -0.795 . . . . 0.0 113.062 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.537 ' CG1' HD22 ' A' ' 100' ' ' LEU . 1.4 t -128.66 157.05 41.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 117.023 0.412 . . . . 0.0 111.008 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.693 ' C ' HD23 ' A' ' 100' ' ' LEU . 3.4 t -114.89 117.83 56.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.989 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -96.19 118.44 5.98 Favored Glycine 0 CA--C 1.517 0.16 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.801 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.501 ' CZ ' ' HB2' ' A' ' 63' ' ' TYR . 21.4 m-85 -125.13 133.06 52.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.909 0.385 . . . . 0.0 111.787 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.74 ' HB2' ' OG1' ' A' ' 125' ' ' THR . . . -93.62 107.76 19.58 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.766 ' HB3' HD11 ' A' ' 99' ' ' LEU . 2.5 p30 -67.72 151.84 46.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.262 0.554 . . . . 0.0 112.42 -178.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.847 HG23 ' HA2' ' A' ' 122' ' ' GLY . 39.7 t -93.58 13.72 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.643 179.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.472 ' HA ' HD23 ' A' ' 141' ' ' LEU . 1.3 mtm105 -70.61 -6.99 40.86 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.772 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -96.69 11.13 36.54 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.555 0.217 . . . . 0.0 111.3 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.847 ' O ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER 179.8 58.6 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.027 0.441 . . . . 0.0 110.501 -179.876 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.9 HD11 ' HB ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -74.58 -14.78 60.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.07 -179.515 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . 0.414 ' CE3' ' CE2' ' A' ' 15' ' ' TYR . 16.3 p-90 -55.48 81.66 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.006 0.431 . . . . 0.0 111.267 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.704 HD12 ' C ' ' A' ' 141' ' ' LEU . 5.0 mp -147.14 -45.82 0.17 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.302 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -152.91 -173.41 4.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.815 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.84 130.46 47.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.07 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -83.75 154.21 23.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.863 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.594 ' HB3' ' H ' ' A' ' 55' ' ' ARG . . . . . . . . 0 C--N 1.331 -0.198 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.066 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.81 ' HB2' HG23 ' A' ' 18' ' ' VAL . . . . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.848 0.356 . . . . 0.0 111.039 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.896 ' HB ' HG21 ' A' ' 113' ' ' ILE . 10.7 p -125.38 111.45 27.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.728 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 9.8 p90 -113.71 136.06 53.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.978 0.418 . . . . 0.0 111.16 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.606 HG21 HD11 ' A' ' 53' ' ' ILE . 95.1 t -118.94 134.88 61.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.491 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 45.51 -124.24 6.62 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 115.933 -0.576 . . . . 0.0 113.206 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.469 ' O ' ' HA ' ' A' ' 44' ' ' THR . 3.7 m-20 -91.59 17.96 8.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.646 0.26 . . . . 0.0 111.228 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.652 ' HB2' HD23 ' A' ' 143' ' ' LEU . 6.9 m-30 -127.82 147.36 50.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.259 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 11' ' ' TYR . 1.0 OUTLIER -133.63 114.73 13.84 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.771 179.467 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.861 HG12 HG22 ' A' ' 42' ' ' VAL . 1.2 m -102.26 121.37 53.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 121.242 0.544 . . . . 0.0 110.834 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.81 HG23 ' HB2' ' A' ' 9' ' ' ALA . 12.0 p -137.17 161.44 35.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.32 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.502 ' N ' HG22 ' A' ' 18' ' ' VAL . 0.7 OUTLIER -59.6 141.64 54.53 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 178.713 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.426 ' O ' ' HZ2' ' A' ' 28' ' ' TRP . 5.1 mtp-105 -56.29 -47.54 78.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.905 0.383 . . . . 0.0 111.254 -179.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.406 ' CD2' ' CE1' ' A' ' 90' ' ' TYR . 5.3 m-70 -69.09 -8.4 44.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.344 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.7 tp -115.35 5.86 14.72 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.729 ' HB3' ' NE1' ' A' ' 28' ' ' TRP . . . -88.88 129.26 35.63 Favored 'General case' 0 C--N 1.334 -0.07 0 C-N-CA 120.291 -0.563 . . . . 0.0 111.444 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.512 ' O ' ' HD1' ' A' ' 28' ' ' TRP . 27.4 p -74.85 164.68 26.3 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.703 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -53.74 -29.81 41.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.221 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.421 ' HA ' ' HG2' ' A' ' 29' ' ' GLN . 21.7 t -68.76 -33.99 62.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.973 0.416 . . . . 0.0 110.97 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.445 ' O ' ' HB3' ' A' ' 31' ' ' CYS . 0.4 OUTLIER -68.45 -43.5 76.89 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.258 179.67 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.729 ' NE1' ' HB3' ' A' ' 23' ' ' ALA . 59.0 m95 -73.69 -45.84 49.96 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.91 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.421 ' HG2' ' HA ' ' A' ' 26' ' ' VAL . 3.2 pt20 -54.97 -37.39 66.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.896 0.379 . . . . 0.0 110.689 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.2 m-20 -115.36 34.42 4.9 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.782 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.5 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 20.4 p -80.17 127.38 32.26 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.027 0.441 . . . . 0.0 111.365 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.586 HG22 ' O ' ' A' ' 42' ' ' VAL . 16.0 m -88.26 -38.95 12.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.329 179.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.638 ' CZ3' HG23 ' A' ' 42' ' ' VAL . 0.4 OUTLIER -139.81 153.13 47.01 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.977 179.753 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.414 ' HG3' ' HB3' ' A' ' 41' ' ' LEU . 5.2 tt0 -166.11 107.06 0.71 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.019 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.425 ' OD1' ' CZ2' ' A' ' 33' ' ' TRP . 34.6 p-10 -107.36 125.15 50.83 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.089 0.471 . . . . 0.0 111.118 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -67.0 -34.5 77.89 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.567 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -59.79 -24.49 64.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.913 0.387 . . . . 0.0 110.562 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.513 ' HA ' ' NE ' ' A' ' 38' ' ' ARG . 4.6 tpm_? -113.14 -4.74 13.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.975 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.419 ' HA ' ' HD3' ' A' ' 20' ' ' ARG . 1.9 m-20 48.97 36.87 9.14 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-O 121.112 0.482 . . . . 0.0 109.982 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.804 HD12 ' O ' ' A' ' 18' ' ' VAL . 30.8 tp -130.79 154.58 47.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.247 -178.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.632 ' O ' HD23 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -146.58 156.02 42.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.59 179.795 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.861 HG22 HG12 ' A' ' 17' ' ' VAL . 19.8 t -120.27 129.82 75.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.234 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 24.1 p -121.15 157.34 30.38 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.208 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.631 HG22 ' CE1' ' A' ' 15' ' ' TYR . 16.6 p -97.49 119.86 36.81 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.164 0.506 . . . . 0.0 111.324 -179.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -111.7 -33.78 6.24 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.038 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.7 m 64.05 45.08 4.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.881 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.65 160.29 37.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.095 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -58.73 130.28 46.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.826 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.457 ' HA2' ' CE2' ' A' ' 11' ' ' TYR . . . -104.59 -32.48 4.18 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.624 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER 59.22 20.81 8.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.669 0.271 . . . . 0.0 111.018 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -130.04 137.25 50.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.873 0.368 . . . . 0.0 110.742 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.875 ' O ' HG23 ' A' ' 120' ' ' VAL . 73.5 m -121.99 120.37 34.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.421 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.765 ' HB ' HD11 ' A' ' 141' ' ' LEU . 0.9 OUTLIER -72.82 139.22 19.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.82 0.343 . . . . 0.0 110.652 -179.815 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.759 ' HB2' ' N ' ' A' ' 119' ' ' GLY . . . -91.06 121.65 33.04 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.225 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.508 ' H ' ' HB3' ' A' ' 147' ' ' ALA . 0.5 OUTLIER -94.44 38.66 1.1 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.382 179.395 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 12.5 p -99.86 167.06 10.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.069 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -114.69 30.26 7.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.07 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 63.6 m -59.4 163.51 3.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.881 0.372 . . . . 0.0 110.875 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.6 m -117.0 2.66 12.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.93 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 75' ' ' SER . 17.6 p -136.02 126.25 26.41 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 120.879 0.371 . . . . 0.0 111.159 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -134.69 -161.75 9.59 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.041 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.546 HG23 ' C ' ' A' ' 72' ' ' TYR . 7.2 p -140.37 137.78 36.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.992 0.425 . . . . 0.0 111.205 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.712 ' CE2' HG21 ' A' ' 74' ' ' VAL . 6.5 p90 -143.53 129.94 19.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.439 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 41.1 p90 . . . . . 0 C--N 1.328 -0.347 0 CA-C-O 120.804 0.335 . . . . 0.0 110.972 -179.813 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 26.5 p-80 . . . . . 0 C--O 1.232 0.133 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.546 ' C ' HG23 ' A' ' 62' ' ' VAL . 2.1 m-85 -123.85 114.11 28.32 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.619 -178.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 72' ' ' TYR . 7.9 Cg_exo -71.91 120.57 6.94 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.265 1.977 . . . . 0.0 110.423 178.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.712 HG21 ' CE2' ' A' ' 63' ' ' TYR . 56.0 t -132.69 142.02 43.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.08 0.467 . . . . 0.0 112.155 -178.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.443 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 75.6 p -93.88 121.0 34.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.331 178.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.436 ' CE1' HD21 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -125.34 164.78 19.64 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.439 0.638 . . . . 0.0 112.017 -178.657 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' A' ' 99' ' ' LEU . 12.0 mt-10 -111.8 159.02 18.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.162 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -104.56 65.03 0.32 Allowed Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.334 -0.936 . . . . 0.0 113.724 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.482 ' HD2' ' HA ' ' A' ' 99' ' ' LEU . 40.2 Cg_endo -67.97 136.09 37.08 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.419 2.079 . . . . 0.0 112.105 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -61.62 -87.43 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.255 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.686 HD11 ' HB3' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -90.76 119.65 31.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.813 0.34 . . . . 0.0 111.444 -179.878 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.638 ' HB ' HG11 ' A' ' 98' ' ' VAL . 23.4 t -129.04 122.2 55.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.34 178.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -74.42 108.1 6.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.839 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.565 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 35.0 m -72.65 124.59 29.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.234 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -69.24 149.84 48.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.327 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.649 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 2.0 pt-20 -68.36 102.83 1.48 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.793 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.411 ' O ' ' N ' ' A' ' 89' ' ' TYR . 1.4 m -143.57 155.19 44.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.395 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 59.48 -79.4 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.43 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.411 ' N ' ' O ' ' A' ' 87' ' ' SER . 1.0 OUTLIER -156.22 24.24 0.36 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.791 0.329 . . . . 0.0 111.028 -179.982 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.649 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -119.51 130.18 24.98 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.306 179.858 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.4 ' O ' ' N ' ' A' ' 93' ' ' ARG . 85.4 Cg_endo -83.92 148.42 12.16 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.862 2.375 . . . . 0.0 112.662 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.565 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -47.28 92.65 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.083 179.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.4 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.6 OUTLIER -123.88 166.31 15.87 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.116 0.484 . . . . 0.0 112.168 -179.304 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.686 ' HB3' HD11 ' A' ' 81' ' ' LEU . 4.3 m-85 -97.38 129.99 44.57 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.173 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.523 ' O ' HD13 ' A' ' 81' ' ' LEU . 22.7 mm-40 -131.45 137.92 48.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.701 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.539 ' HB2' HD22 ' A' ' 81' ' ' LEU . 23.2 t -103.66 142.81 33.68 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -179.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.454 ' HB2' ' O ' ' A' ' 96' ' ' SER . 96.3 m-70 75.93 56.04 0.05 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.353 179.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.638 HG11 ' HB ' ' A' ' 82' ' ' VAL . 12.1 p -123.57 143.85 35.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.737 0.304 . . . . 0.0 110.87 178.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.482 ' HA ' ' HD2' ' A' ' 79' ' ' PRO . 11.0 mp -102.71 140.54 36.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.039 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.712 HD23 ' O ' ' A' ' 132' ' ' VAL . 5.5 mt -130.96 140.33 50.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.188 0.518 . . . . 0.0 112.16 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.48 ' O ' HG12 ' A' ' 131' ' ' VAL . . . -152.07 159.37 43.7 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.526 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 130' ' ' GLY . 0.7 OUTLIER -112.19 127.13 55.86 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.02 0.438 . . . . 0.0 111.046 179.694 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.289 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.465 -179.758 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.697 ' O ' HG13 ' A' ' 124' ' ' VAL . . . . . . . . 0 N--CA 1.452 -0.297 0 N-CA-C 112.373 -0.291 . . . . 0.0 112.373 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.896 HG21 ' HB ' ' A' ' 10' ' ' VAL . 2.7 pp -126.25 146.4 32.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.931 0.396 . . . . 0.0 111.738 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.472 HD22 ' HD2' ' A' ' 134' ' ' PHE . 9.8 tp -87.5 123.47 32.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.146 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 2.7 mtm180 -115.5 145.5 42.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.155 0.502 . . . . 0.0 111.627 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.488 ' HB2' HD11 ' A' ' 121' ' ' ILE . 4.5 t -109.4 165.46 11.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.145 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -60.86 -16.28 39.69 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.805 0.336 . . . . 0.0 110.616 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.431 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . 19.3 m80 -95.39 -29.24 14.54 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.528 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.759 ' N ' ' HB2' ' A' ' 54' ' ' ALA . . . 171.27 -140.47 5.92 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.537 -0.839 . . . . 0.0 113.015 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' ' 52' ' ' THR . 2.7 t -99.24 135.23 35.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.637 0.256 . . . . 0.0 110.835 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.488 HD11 ' HB2' ' A' ' 116' ' ' CYS . 0.9 OUTLIER -99.96 -71.5 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.397 -179.95 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.921 ' HA2' HG23 ' A' ' 137' ' ' VAL . . . -153.65 -168.04 16.8 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.326 -0.94 . . . . 0.0 113.294 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.604 HD11 HD13 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -116.88 164.2 15.04 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.635 0.255 . . . . 0.0 110.884 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.697 HG13 ' O ' ' A' ' 112' ' ' GLY . 28.0 m -66.22 126.52 25.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.743 0.306 . . . . 0.0 111.189 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.743 ' OG1' ' HB2' ' A' ' 135' ' ' ALA . 3.7 m -108.38 -94.05 0.4 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.779 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.69 ' N ' HG22 ' A' ' 125' ' ' THR . 73.7 mmm -144.02 162.3 36.56 Favored 'General case' 0 C--O 1.228 -0.076 0 CA-C-O 121.085 0.469 . . . . 0.0 111.538 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 175.85 -159.2 26.64 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.232 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -130.39 -153.32 7.68 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.404 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -89.75 11.83 18.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.722 0.296 . . . . 0.0 110.92 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 102' ' ' THR . . . -134.17 -36.32 0.25 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.728 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -115.67 157.28 16.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-O 120.949 0.404 . . . . 0.0 111.421 -179.859 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.712 ' O ' HD23 ' A' ' 100' ' ' LEU . 4.5 m -122.42 118.83 56.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.423 -179.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.538 ' HA3' ' O ' ' A' ' 126' ' ' MET . . . -101.76 114.89 5.09 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.384 -0.912 . . . . 0.0 112.082 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.472 ' HD2' HD22 ' A' ' 114' ' ' LEU . 10.7 m-85 -114.76 140.52 48.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.871 0.367 . . . . 0.0 111.261 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.743 ' HB2' ' OG1' ' A' ' 125' ' ' THR . . . -88.85 115.35 26.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.41 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.413 ' OD1' HD13 ' A' ' 99' ' ' LEU . 1.0 OUTLIER -68.0 142.61 55.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.072 -178.862 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.921 HG23 ' HA2' ' A' ' 122' ' ' GLY . 93.6 t -91.37 9.68 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.38 178.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.537 ' HA ' HD23 ' A' ' 141' ' ' LEU . 4.4 mtm-85 -71.53 -6.76 43.0 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.406 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -95.04 10.99 33.62 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 120.579 0.228 . . . . 0.0 111.23 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.878 ' O ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -176.09 61.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.295 0.569 . . . . 0.0 110.332 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.765 HD11 ' HB ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -78.89 -14.66 59.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.024 -179.474 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 18.2 p-90 -59.78 76.46 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.006 0.432 . . . . 0.0 111.785 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.652 HD23 ' HB2' ' A' ' 15' ' ' TYR . 4.9 mp -140.77 -47.39 0.41 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.823 178.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.491 ' HB2' ' CG1' ' A' ' 12' ' ' VAL . 1.5 tp10 -150.05 -161.89 1.44 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.441 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -69.35 146.36 52.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.832 0.348 . . . . 0.0 110.851 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -93.17 154.12 18.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.906 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.508 ' HB3' ' H ' ' A' ' 55' ' ' ARG . . . . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.166 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.778 ' HB2' HG23 ' A' ' 18' ' ' VAL . . . . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.831 0.348 . . . . 0.0 111.108 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.852 HG22 HG21 ' A' ' 113' ' ' ILE . 25.6 t -108.68 111.89 37.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.059 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 1.5 p90 -117.34 124.09 48.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.898 0.38 . . . . 0.0 110.874 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.681 ' HB ' HD22 ' A' ' 143' ' ' LEU . 75.1 t -119.26 140.96 41.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.703 -179.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 45.37 -129.83 8.83 Favored Glycine 0 C--N 1.333 0.379 0 CA-C-N 115.94 -0.573 . . . . 0.0 113.306 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.457 ' O ' ' HA ' ' A' ' 44' ' ' THR . 28.6 p30 -89.49 18.84 4.94 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.693 0.282 . . . . 0.0 111.23 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.727 ' HB2' HD23 ' A' ' 143' ' ' LEU . 7.8 m-30 -127.61 147.69 50.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.287 -0.415 . . . . 0.0 109.954 179.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 11' ' ' TYR . 10.6 tttt -132.79 114.7 14.42 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.685 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.804 HG23 HD11 ' A' ' 40' ' ' LEU . 1.6 m -101.44 121.29 52.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-O 121.148 0.499 . . . . 0.0 110.765 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.778 HG23 ' HB2' ' A' ' 9' ' ' ALA . 12.0 p -137.02 161.41 35.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.31 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.501 ' N ' HG22 ' A' ' 18' ' ' VAL . 0.8 OUTLIER -61.74 141.51 57.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.044 178.823 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.55 -44.64 81.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.763 0.316 . . . . 0.0 111.211 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -69.41 -7.51 38.37 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.166 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.42 HD12 ' HB2' ' A' ' 19' ' ' ASN . 79.9 mt -115.1 -2.88 12.66 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.694 ' HB3' ' NE1' ' A' ' 28' ' ' TRP . . . -86.08 126.57 34.29 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.229 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.693 HG23 HG12 ' A' ' 26' ' ' VAL . 1.8 t -74.86 165.16 25.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.721 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -53.7 -29.98 41.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.845 -178.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.693 HG12 HG23 ' A' ' 24' ' ' THR . 11.4 p -72.65 -31.25 36.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.717 0.294 . . . . 0.0 110.967 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -67.66 -43.76 79.47 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.14 0.495 . . . . 0.0 109.697 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.694 ' NE1' ' HB3' ' A' ' 23' ' ' ALA . 48.9 m95 -73.85 -30.04 62.45 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.725 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -60.09 -44.23 94.96 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.556 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -110.2 27.75 9.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.336 179.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.465 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 7.0 t -73.13 123.64 24.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.043 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.56 ' CG2' HG12 ' A' ' 42' ' ' VAL . 13.3 m -86.32 -40.11 14.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.696 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.599 ' HH2' HD23 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -139.59 153.13 47.31 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.885 0.374 . . . . 0.0 111.181 179.825 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.408 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 1.0 OUTLIER -159.88 117.04 2.58 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.846 179.65 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.434 ' HB2' ' CZ2' ' A' ' 33' ' ' TRP . 0.7 OUTLIER -107.11 118.04 35.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.234 -179.759 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -62.93 -46.97 85.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.585 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -59.9 -18.86 47.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.242 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? -111.75 -6.05 14.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.191 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 48.55 38.93 12.08 Favored 'General case' 0 N--CA 1.461 0.079 0 CA-C-O 121.132 0.492 . . . . 0.0 110.401 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.804 HD11 HG23 ' A' ' 17' ' ' VAL . 27.1 tp -132.42 156.23 47.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.978 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.643 ' O ' HD23 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -150.2 156.12 41.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.478 179.746 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.91 HG21 HD23 ' A' ' 140' ' ' LEU . 21.3 t -120.01 133.04 68.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.98 0.419 . . . . 0.0 110.301 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.5 t -125.98 157.42 37.87 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.202 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.646 HG22 ' HE1' ' A' ' 15' ' ' TYR . 11.8 p -97.33 119.99 36.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.266 0.555 . . . . 0.0 111.529 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -108.14 160.72 15.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.887 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.0 t -105.99 42.48 1.25 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.875 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.33 169.94 16.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.139 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 10.1 p-80 -76.99 143.8 39.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.856 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -83.69 128.35 8.52 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.468 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -105.64 28.53 7.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.794 0.33 . . . . 0.0 110.87 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.516 ' O ' HG22 ' A' ' 12' ' ' VAL . 31.8 m-20 -153.02 133.57 13.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.82 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.905 ' O ' HG23 ' A' ' 120' ' ' VAL . 48.7 m -117.64 116.43 27.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.813 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.661 HG12 HG21 ' A' ' 12' ' ' VAL . 3.8 mm -72.9 139.72 19.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.839 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.849 ' HB2' ' N ' ' A' ' 119' ' ' GLY . . . -83.83 -53.57 5.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.785 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.405 ' CG ' ' HG ' ' A' ' 141' ' ' LEU . 29.0 ttt-85 63.75 35.54 11.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.997 0.427 . . . . 0.0 110.038 -178.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 6.0 p -99.71 146.65 26.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.991 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -88.03 54.22 3.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.051 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 77.1 m -85.98 164.8 17.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.828 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.65 -19.37 12.9 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.884 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 75' ' ' SER . 12.1 p -126.21 123.95 39.35 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.941 0.4 . . . . 0.0 111.336 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -138.3 166.02 25.33 Favored Glycine 0 N--CA 1.452 -0.265 0 N-CA-C 111.631 -0.588 . . . . 0.0 111.631 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.831 HG23 ' C ' ' A' ' 72' ' ' TYR . 14.9 p -102.57 130.82 51.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.967 0.413 . . . . 0.0 111.351 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.679 ' HE2' HG21 ' A' ' 74' ' ' VAL . 4.2 p90 -106.55 139.43 41.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.986 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 39.4 t80 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 179.992 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.587 ' HB3' HG21 ' A' ' 62' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.127 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.831 ' C ' HG23 ' A' ' 62' ' ' VAL . 0.5 OUTLIER -107.81 113.99 60.65 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.46 -179.121 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 72' ' ' TYR . 4.6 Cg_exo -77.03 120.81 5.55 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.389 2.059 . . . . 0.0 110.582 178.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.692 ' CG1' ' HB1' ' A' ' 101' ' ' ALA . 47.6 t -139.85 145.81 26.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.058 0.456 . . . . 0.0 112.186 -178.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.445 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 1.1 m -91.9 134.62 34.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.267 178.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.73 ' HD2' ' HB2' ' A' ' 101' ' ' ALA . 0.1 OUTLIER -143.5 169.2 18.15 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.479 0.657 . . . . 0.0 112.329 -178.966 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.537 ' C ' ' HD3' ' A' ' 79' ' ' PRO . 0.1 OUTLIER -111.92 159.29 18.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.747 179.384 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.465 ' HA2' ' HG ' ' A' ' 99' ' ' LEU . . . -111.61 72.31 0.21 Allowed Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.322 -0.942 . . . . 0.0 113.52 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.651 ' HD2' ' O ' ' A' ' 98' ' ' VAL . 15.9 Cg_exo -66.93 138.57 48.6 Favored 'Trans proline' 0 C--O 1.24 0.601 0 C-N-CA 122.401 2.067 . . . . 0.0 112.459 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -63.71 -59.98 7.97 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.621 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.448 HD13 ' O ' ' A' ' 95' ' ' GLN . 0.0 OUTLIER -120.15 119.96 34.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.993 0.425 . . . . 0.0 112.074 -179.786 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.63 ' HB ' HG11 ' A' ' 98' ' ' VAL . 37.4 t -125.15 127.62 72.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.823 178.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -72.17 107.86 5.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.922 0.392 . . . . 0.0 110.693 -179.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.959 HG23 ' CG ' ' A' ' 126' ' ' MET . 1.6 p -72.83 114.49 12.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.405 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -69.89 150.17 47.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.602 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.573 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -68.04 101.58 1.16 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.151 0.501 . . . . 0.0 110.318 -179.517 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.443 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.4 OUTLIER -144.39 163.37 33.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.002 179.999 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.42 ' HG2' ' CD2' ' A' ' 89' ' ' TYR . 15.6 tt0 53.39 -84.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.482 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.443 ' N ' ' O ' ' A' ' 87' ' ' SER . 0.1 OUTLIER -152.41 21.41 0.63 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.757 0.313 . . . . 0.0 110.917 179.921 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.573 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 1.9 t80 -116.61 125.9 28.0 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.707 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.437 ' O ' ' N ' ' A' ' 93' ' ' ARG . 59.8 Cg_endo -73.5 148.58 42.87 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.754 2.303 . . . . 0.0 112.665 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.3 OUTLIER -53.2 85.01 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.455 -179.676 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.437 ' N ' ' O ' ' A' ' 91' ' ' PRO . 5.3 mtp-105 -124.04 -174.39 2.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.084 0.469 . . . . 0.0 111.737 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.437 ' HB3' HD11 ' A' ' 81' ' ' LEU . 26.2 m-85 -100.34 132.49 45.69 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.745 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.448 ' O ' HD13 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -125.56 122.53 36.78 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.119 -179.722 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 28.1 t -92.03 158.25 16.33 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 121.104 0.478 . . . . 0.0 112.114 -179.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 51.4 60.6 3.75 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.774 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.651 ' O ' ' HD2' ' A' ' 79' ' ' PRO . 9.9 p -123.99 136.56 59.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.187 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.724 HD11 ' OD2' ' A' ' 136' ' ' ASP . 6.3 mp -102.0 149.0 24.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.301 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.765 ' HA ' ' O ' ' A' ' 132' ' ' VAL . 6.4 mt -133.25 134.13 43.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.074 0.464 . . . . 0.0 111.801 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.73 ' HB2' ' HD2' ' A' ' 76' ' ' PHE . . . -125.9 119.65 28.36 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.434 -179.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 1.5 t -86.15 111.7 20.61 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.907 0.384 . . . . 0.0 110.63 179.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.224 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.554 -179.711 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.544 -0.222 . . . . 0.0 112.544 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.852 HG21 HG22 ' A' ' 10' ' ' VAL . 31.3 pt -125.96 146.48 31.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.662 0.268 . . . . 0.0 111.156 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.6 HD21 ' CZ ' ' A' ' 76' ' ' PHE . 8.1 tp -87.24 115.87 24.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.855 0.36 . . . . 0.0 110.171 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.438 ' HE ' HD11 ' A' ' 113' ' ' ILE . 7.5 mtt180 -118.14 145.95 44.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.35 0.595 . . . . 0.0 111.842 -179.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.539 ' HB2' HD11 ' A' ' 121' ' ' ILE . 14.3 t -111.75 164.52 12.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.678 179.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -55.72 -18.71 8.82 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.72 0.295 . . . . 0.0 110.896 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.472 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . 50.8 m80 -91.34 -36.13 14.02 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.532 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.849 ' N ' ' HB2' ' A' ' 54' ' ' ALA . . . 174.91 -139.9 5.05 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.357 -0.925 . . . . 0.0 113.398 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.905 HG23 ' O ' ' A' ' 52' ' ' THR . 4.1 t -97.95 135.78 31.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.75 0.309 . . . . 0.0 111.63 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.539 HD11 ' HB2' ' A' ' 116' ' ' CYS . 0.9 OUTLIER -101.4 -66.91 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.928 179.195 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.846 ' HA2' HG23 ' A' ' 137' ' ' VAL . . . -151.51 -165.88 13.39 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.556 -0.83 . . . . 0.0 113.068 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.507 ' HG ' ' HB3' ' A' ' 135' ' ' ALA . 0.5 OUTLIER -120.11 164.19 16.55 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.785 0.326 . . . . 0.0 110.881 -179.92 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.556 HG13 ' O ' ' A' ' 124' ' ' VAL . 12.6 p -61.9 115.07 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.783 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.79 ' OG1' ' HB2' ' A' ' 135' ' ' ALA . 6.0 m -105.87 -93.21 0.37 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.984 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.959 ' CG ' HG23 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -105.1 158.78 16.34 Favored 'General case' 0 C--N 1.335 -0.043 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.851 179.329 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -135.77 106.96 0.59 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.448 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -79.23 -178.62 51.24 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.476 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -71.92 -19.3 61.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.703 0.287 . . . . 0.0 111.141 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -150.33 17.22 1.02 Allowed Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.754 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.56 ' CG1' HD22 ' A' ' 100' ' ' LEU . 1.0 OUTLIER -136.65 157.51 36.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.693 0.282 . . . . 0.0 110.831 179.888 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.765 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 2.5 t -112.59 117.94 56.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.008 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -96.89 119.01 6.21 Favored Glycine 0 CA--C 1.518 0.236 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.89 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.474 ' CZ ' ' HB2' ' A' ' 63' ' ' TYR . 27.7 m-85 -125.18 144.09 50.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.02 0.438 . . . . 0.0 112.039 -179.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.79 ' HB2' ' OG1' ' A' ' 125' ' ' THR . . . -93.78 111.05 22.68 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.724 ' OD2' HD11 ' A' ' 99' ' ' LEU . 0.8 OUTLIER -67.26 142.02 57.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.259 0.552 . . . . 0.0 112.174 -178.227 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.846 HG23 ' HA2' ' A' ' 122' ' ' GLY . 31.6 t -90.25 12.31 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.502 179.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.515 ' HA ' HD23 ' A' ' 141' ' ' LEU . 15.7 mmm-85 -71.52 -6.92 44.18 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.446 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -96.1 7.52 46.19 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.91 HD23 HG21 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -171.83 34.35 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 121.208 0.528 . . . . 0.0 110.36 179.716 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.625 HD11 ' CG2' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -57.6 -14.84 5.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.583 -179.506 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . 0.436 ' CD1' ' HA ' ' A' ' 140' ' ' LEU . 13.6 p-90 -61.45 77.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.903 0.382 . . . . 0.0 111.828 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.727 HD23 ' HB2' ' A' ' 15' ' ' TYR . 5.1 mp -136.32 -52.66 0.72 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.057 178.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.463 ' HB2' ' CG1' ' A' ' 12' ' ' VAL . 2.2 tp10 -144.41 -163.3 1.65 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.657 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -67.94 145.16 54.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.858 0.361 . . . . 0.0 110.822 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.405 ' CB ' ' HD3' ' A' ' 55' ' ' ARG . 1.4 p30 -105.03 154.16 20.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.981 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.062 179.942 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.665 ' HB2' HG23 ' A' ' 18' ' ' VAL . . . . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.838 0.352 . . . . 0.0 111.285 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.8 t -101.14 127.12 54.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.877 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.736 ' OH ' ' HB3' ' A' ' 47' ' ' ALA . 7.0 t80 -111.66 116.06 30.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.841 0.353 . . . . 0.0 110.624 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.815 HG21 HD11 ' A' ' 53' ' ' ILE . 48.3 t -120.77 111.25 31.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.667 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 50.41 -124.92 20.12 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 121.064 -0.588 . . . . 0.0 113.273 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.476 ' O ' ' HA ' ' A' ' 44' ' ' THR . 77.8 m-20 -91.45 17.18 8.91 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.573 0.225 . . . . 0.0 111.601 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.646 ' HE1' HG22 ' A' ' 44' ' ' THR . 5.2 m-30 -130.31 127.84 40.3 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 9.1 tttt -120.42 114.81 22.36 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 121.11 -0.236 . . . . 0.0 110.742 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 1.001 HG12 HG22 ' A' ' 42' ' ' VAL . 0.6 OUTLIER -98.97 121.52 49.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 121.02 0.438 . . . . 0.0 110.761 179.861 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.665 HG23 ' HB2' ' A' ' 9' ' ' ALA . 15.0 p -136.67 161.35 36.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.288 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.517 ' N ' HG22 ' A' ' 18' ' ' VAL . 25.4 t30 -61.05 141.48 57.36 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 179.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.418 ' HG2' ' CB ' ' A' ' 39' ' ' ASP . 1.8 ppt_? -56.46 -45.9 80.62 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.928 0.394 . . . . 0.0 111.311 -179.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -66.38 -10.29 41.97 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.157 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.4 mt -115.21 0.85 13.67 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.669 ' HB3' ' NE1' ' A' ' 28' ' ' TRP . . . -88.98 127.37 35.67 Favored 'General case' 0 N--CA 1.457 -0.084 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.212 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.544 ' O ' ' HD1' ' A' ' 28' ' ' TRP . 1.1 t -74.6 163.2 27.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.706 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -53.59 -29.77 39.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.746 0.308 . . . . 0.0 111.008 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.403 ' O ' ' HG2' ' A' ' 29' ' ' GLN . 22.3 t -69.79 -32.25 51.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.967 0.413 . . . . 0.0 110.767 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.447 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 0.5 OUTLIER -68.56 -43.62 76.21 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.417 179.587 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.669 ' NE1' ' HB3' ' A' ' 23' ' ' ALA . 46.6 m95 -73.27 -45.97 52.63 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.019 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.403 ' HG2' ' O ' ' A' ' 26' ' ' VAL . 14.4 pt20 -54.99 -44.07 74.16 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.768 0.318 . . . . 0.0 110.685 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -102.82 29.9 5.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.178 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.484 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 35.4 t -80.07 145.56 32.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.483 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.664 ' CG2' HG12 ' A' ' 42' ' ' VAL . 10.0 m -103.67 -41.96 7.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.335 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.578 ' HH2' HD23 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -139.69 152.86 47.03 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.018 179.696 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -157.22 117.81 3.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.136 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.412 ' HB3' ' CG ' ' A' ' 38' ' ' ARG . 26.6 t0 -107.13 105.02 14.81 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.789 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -63.27 -29.2 70.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.173 -179.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.531 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 10.7 m-20 -62.2 -30.16 70.88 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 120.403 0.144 . . . . 0.0 110.93 -179.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.582 ' NH2' HD22 ' A' ' 40' ' ' LEU . 14.5 ptm180 -113.71 -3.43 13.54 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.418 ' CB ' ' HG2' ' A' ' 20' ' ' ARG . 8.2 m-20 60.48 46.24 9.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.918 0.39 . . . . 0.0 110.906 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.588 HD11 HG23 ' A' ' 17' ' ' VAL . 26.6 tp -135.04 153.32 52.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.748 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.682 ' O ' HD23 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -152.04 155.88 38.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.064 0.459 . . . . 0.0 111.719 179.683 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 1.001 HG22 HG12 ' A' ' 17' ' ' VAL . 28.9 t -116.6 133.04 64.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.93 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.2 t -125.69 157.11 38.15 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.748 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.646 HG22 ' HE1' ' A' ' 15' ' ' TYR . 22.7 p -97.75 144.33 27.48 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.083 0.468 . . . . 0.0 111.538 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.685 HG21 ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -135.02 171.41 14.46 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.957 -179.167 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.0 m -115.68 55.34 0.79 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.884 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.736 ' HB3' ' OH ' ' A' ' 11' ' ' TYR . . . -133.5 -175.11 3.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.147 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -99.4 148.06 24.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.021 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -67.52 170.47 35.3 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.644 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.3 m -149.21 -60.58 0.22 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.81 0.338 . . . . 0.0 110.812 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -83.66 150.41 25.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.884 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.896 ' O ' HG23 ' A' ' 120' ' ' VAL . 86.6 m -122.38 119.29 30.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.959 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.927 ' HB ' HD11 ' A' ' 141' ' ' LEU . 0.4 OUTLIER -76.46 139.75 18.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.767 179.854 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.651 ' HA ' ' HB3' ' A' ' 147' ' ' ALA . . . -90.89 135.56 33.65 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.396 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -94.18 27.22 2.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.035 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.405 ' SG ' ' HB1' ' A' ' 54' ' ' ALA . 24.7 p -99.96 167.3 10.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.198 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -122.86 31.6 5.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.035 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 15.6 m -58.58 132.12 52.85 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.814 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.5 t -74.94 -8.17 55.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.115 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.2 p -107.98 127.21 53.56 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.89 0.376 . . . . 0.0 111.059 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -149.63 146.61 16.06 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.198 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.671 HG23 ' C ' ' A' ' 72' ' ' TYR . 9.6 p -103.86 125.39 58.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.933 0.396 . . . . 0.0 111.216 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.696 ' HE2' HG21 ' A' ' 74' ' ' VAL . 9.5 p90 -108.01 163.6 13.0 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.796 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.863 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 16.5 p80 . . . . . 0 N--CA 1.456 -0.134 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.671 ' C ' HG23 ' A' ' 62' ' ' VAL . 1.3 m-85 -126.04 114.25 24.14 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.631 -179.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 72' ' ' TYR . 7.0 Cg_exo -72.75 120.79 6.88 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.467 2.111 . . . . 0.0 110.497 178.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.696 HG21 ' HE2' ' A' ' 63' ' ' TYR . 84.6 t -137.64 142.02 37.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.257 0.551 . . . . 0.0 112.466 -178.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.19 135.0 39.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.495 -0.775 . . . . 0.0 108.961 178.222 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.593 ' HB3' ' HB2' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -141.97 172.76 12.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.381 0.61 . . . . 0.0 112.214 -178.362 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.464 ' O ' ' HA ' ' A' ' 99' ' ' LEU . 9.8 mt-10 -111.78 158.86 18.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.264 179.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -103.73 68.56 0.29 Allowed Glycine 0 CA--C 1.522 0.486 0 C-N-CA 120.366 -0.921 . . . . 0.0 113.735 -179.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.651 ' HD2' ' HA ' ' A' ' 99' ' ' LEU . 36.9 Cg_endo -67.77 139.2 47.2 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.464 2.109 . . . . 0.0 112.188 179.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -56.73 -91.77 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.693 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.496 HD22 ' HB3' ' A' ' 96' ' ' SER . 0.0 OUTLIER -98.62 122.73 42.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.921 0.391 . . . . 0.0 111.85 -179.772 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.668 ' HB ' HG11 ' A' ' 98' ' ' VAL . 96.0 t -119.25 126.19 75.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.149 179.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -72.33 107.85 5.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.674 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.822 HG22 ' HB2' ' A' ' 126' ' ' MET . 1.0 OUTLIER -74.55 114.83 14.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.099 -179.834 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -70.75 149.77 46.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.843 179.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.501 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 4.2 pt-20 -68.06 101.0 1.06 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.086 0.469 . . . . 0.0 109.892 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.05 145.18 31.36 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.972 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.582 ' O ' ' CD1' ' A' ' 89' ' ' TYR . 0.3 OUTLIER 43.33 93.72 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.31 -0.404 . . . . 0.0 112.072 178.702 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.582 ' CD1' ' O ' ' A' ' 88' ' ' GLU . 4.3 p90 37.91 28.87 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.501 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -131.38 125.11 20.62 Favored Pre-proline 0 C--N 1.329 -0.312 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.541 -179.64 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -86.68 148.84 8.57 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.335 2.69 . . . . 0.0 112.476 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 5.0 mttm -45.73 93.63 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.352 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.68 170.77 10.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.511 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -102.9 132.47 49.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.961 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.908 ' NE2' HG23 ' A' ' 125' ' ' THR . 0.0 OUTLIER -126.12 110.89 14.02 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.183 -179.823 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.496 ' HB3' HD22 ' A' ' 81' ' ' LEU . 97.5 p -82.84 153.93 24.92 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.981 0.419 . . . . 0.0 111.441 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 54.47 62.22 2.66 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.621 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.668 HG11 ' HB ' ' A' ' 82' ' ' VAL . 9.4 p -123.66 146.01 29.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.942 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.963 HD11 ' HB3' ' A' ' 136' ' ' ASP . 0.9 OUTLIER -105.28 146.64 29.06 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.133 179.72 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.71 HD23 ' C ' ' A' ' 132' ' ' VAL . 6.0 mt -133.02 143.27 49.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.27 0.557 . . . . 0.0 112.492 -179.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.593 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . . . -151.0 140.92 21.97 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.603 179.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 1.3 t -95.52 118.11 31.64 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.954 0.407 . . . . 0.0 111.017 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.266 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.424 -179.786 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.463 ' O ' HG12 ' A' ' 124' ' ' VAL . . . . . . . . 0 N--CA 1.451 -0.344 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.524 HD13 HG13 ' A' ' 120' ' ' VAL . 2.3 pp -126.0 146.74 31.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.798 0.332 . . . . 0.0 111.24 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.589 HD21 ' CE1' ' A' ' 76' ' ' PHE . 19.3 tp -87.18 120.4 28.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.713 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.06 145.03 45.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.394 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.814 ' HB2' HD12 ' A' ' 121' ' ' ILE . 5.1 t -108.4 164.56 12.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.111 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.49 -19.23 23.08 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.928 0.394 . . . . 0.0 110.482 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -92.68 -33.6 14.29 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.348 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.52 ' N ' ' HB2' ' A' ' 54' ' ' ALA . . . 176.78 -128.44 1.34 Allowed Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.894 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.896 HG23 ' O ' ' A' ' 52' ' ' THR . 3.3 t -113.0 135.66 51.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.596 0.236 . . . . 0.0 110.856 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.814 HD12 ' HB2' ' A' ' 116' ' ' CYS . 0.2 OUTLIER -100.06 -49.0 11.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.872 179.636 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.935 ' HA2' HG23 ' A' ' 137' ' ' VAL . . . -170.39 -165.61 28.01 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.319 -0.943 . . . . 0.0 113.252 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 0.3 OUTLIER -116.93 164.2 15.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.679 0.276 . . . . 0.0 110.626 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.463 HG12 ' O ' ' A' ' 112' ' ' GLY . 12.0 p -69.45 129.96 34.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.357 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.908 HG23 ' NE2' ' A' ' 95' ' ' GLN . 12.1 m -112.01 -95.37 0.44 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.682 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.822 ' HB2' HG22 ' A' ' 84' ' ' VAL . 95.0 mmm -144.07 140.19 29.35 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.717 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -115.25 154.47 16.94 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.52 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -86.89 -150.02 16.44 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.473 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -71.92 -19.45 61.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.759 0.314 . . . . 0.0 110.991 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -157.4 13.98 0.29 Allowed Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.784 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.653 ' CG1' HD22 ' A' ' 100' ' ' LEU . 1.2 t -121.39 157.05 25.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.725 0.298 . . . . 0.0 110.794 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.71 ' C ' HD23 ' A' ' 100' ' ' LEU . 7.6 m -115.66 118.41 58.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.406 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.547 ' HA3' ' O ' ' A' ' 126' ' ' MET . . . -101.19 115.28 5.24 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.378 -0.915 . . . . 0.0 112.085 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.634 ' O ' HD12 ' A' ' 99' ' ' LEU . 15.4 m-85 -117.55 139.83 50.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.778 0.323 . . . . 0.0 111.116 -179.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.69 ' HB2' ' OG1' ' A' ' 125' ' ' THR . . . -88.84 114.75 25.79 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.689 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.963 ' HB3' HD11 ' A' ' 99' ' ' LEU . 1.4 p30 -74.63 140.93 44.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.769 -179.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.935 HG23 ' HA2' ' A' ' 122' ' ' GLY . 48.8 t -89.51 10.09 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.48 178.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.42 ' HA ' HD23 ' A' ' 141' ' ' LEU . 10.8 mmm180 -70.82 -6.9 41.39 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.632 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -94.75 11.1 32.6 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.685 0.279 . . . . 0.0 111.206 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.826 ' O ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -178.17 62.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.245 0.545 . . . . 0.0 110.317 -179.918 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.927 HD11 ' HB ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -77.3 -14.75 59.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.026 -179.311 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 15.3 p-90 -56.23 78.65 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.004 0.43 . . . . 0.0 111.437 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.717 HD12 ' C ' ' A' ' 141' ' ' LEU . 5.0 mp -143.02 -46.66 0.31 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.147 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -151.48 -163.56 1.79 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.719 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -65.95 142.31 57.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.845 0.355 . . . . 0.0 111.039 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -86.57 154.13 21.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.914 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.651 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . . . . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.171 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.821 0.343 . . . . 0.0 111.108 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.906 HG22 HG21 ' A' ' 113' ' ' ILE . 45.4 t -130.29 110.0 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.127 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.712 ' CE2' HG21 ' A' ' 45' ' ' THR . 5.9 t80 -95.92 116.11 28.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.841 0.353 . . . . 0.0 110.514 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.918 HG21 HD11 ' A' ' 53' ' ' ILE . 21.9 t -120.92 108.96 23.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.637 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 51.06 -125.96 25.58 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.898 -0.668 . . . . 0.0 113.327 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.424 ' O ' ' HA ' ' A' ' 44' ' ' THR . 24.8 m120 -89.07 14.25 11.15 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.722 0.296 . . . . 0.0 111.672 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.658 ' HE1' HG22 ' A' ' 44' ' ' THR . 6.5 m-30 -130.37 146.94 52.02 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.8 tttt -137.67 114.93 10.98 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 121.197 -0.201 . . . . 0.0 110.651 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 1.037 HG12 HG22 ' A' ' 42' ' ' VAL . 0.6 OUTLIER -99.29 121.53 50.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 121.144 0.497 . . . . 0.0 111.145 -179.927 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.645 ' O ' HD12 ' A' ' 40' ' ' LEU . 14.1 p -136.74 161.1 36.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.805 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.506 ' N ' HG22 ' A' ' 18' ' ' VAL . 4.5 t-20 -59.84 141.24 55.74 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 179.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.44 ' HG2' ' CH2' ' A' ' 28' ' ' TRP . 25.3 mtp180 -56.61 -47.12 80.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.948 0.404 . . . . 0.0 110.842 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.22 -8.04 28.55 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.245 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.09 -2.42 12.78 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.621 ' HB3' ' NE1' ' A' ' 28' ' ' TRP . . . -88.62 129.01 35.59 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.102 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.595 ' O ' ' HD1' ' A' ' 28' ' ' TRP . 43.8 p -74.73 162.89 28.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.56 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 24.1 p80 -53.51 -29.49 36.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.888 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.0 t -69.95 -31.85 49.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.82 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.437 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 3.7 m-20 -68.22 -43.97 76.78 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.621 ' NE1' ' HB3' ' A' ' 23' ' ' ALA . 27.5 m95 -73.64 -37.23 65.4 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.015 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.31 -44.23 79.71 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.96 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -110.16 32.4 5.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.275 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.485 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 54.1 t -80.14 149.34 30.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.542 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.516 HG22 ' O ' ' A' ' 42' ' ' VAL . 15.9 m -107.92 -39.32 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.048 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.705 ' CZ3' HG23 ' A' ' 42' ' ' VAL . 0.7 OUTLIER -139.49 150.89 45.69 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.952 0.406 . . . . 0.0 111.7 -179.615 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.424 ' HG3' ' SG ' ' A' ' 31' ' ' CYS . 5.6 mp0 -147.0 118.47 7.92 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.792 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.453 ' HB2' ' CZ2' ' A' ' 33' ' ' TRP . 24.6 t70 -107.09 105.55 15.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.917 0.389 . . . . 0.0 110.891 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -64.46 -29.85 70.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.401 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.569 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 25.5 m120 -68.73 -27.59 66.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.88 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.566 ' HD2' ' HB1' ' A' ' 135' ' ' ALA . 9.4 ttp-105 -114.42 5.64 15.71 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 121.152 -0.219 . . . . 0.0 111.479 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.42 ' HA ' ' CD ' ' A' ' 20' ' ' ARG . 0.8 OUTLIER 46.55 38.98 6.14 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.994 0.426 . . . . 0.0 110.618 -179.862 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.821 HD11 HG23 ' A' ' 17' ' ' VAL . 26.5 tp -129.29 150.03 50.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.938 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.682 ' O ' HD23 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -144.88 155.57 43.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.321 179.489 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 1.037 HG22 HG12 ' A' ' 17' ' ' VAL . 24.9 t -115.94 130.05 71.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.29 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 12.2 p -120.69 157.35 29.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.532 179.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.658 HG22 ' HE1' ' A' ' 15' ' ' TYR . 17.8 p -97.49 130.67 44.56 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.22 0.533 . . . . 0.0 111.659 -179.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.712 HG21 ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -126.5 160.53 30.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.849 -179.296 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -118.19 58.02 0.83 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.796 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -135.05 -173.69 3.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.132 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -101.53 120.59 40.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.459 ' CA ' ' CE1' ' A' ' 11' ' ' TYR . . . -80.17 -170.36 41.2 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.52 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -155.48 -46.23 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.828 0.347 . . . . 0.0 110.859 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -64.3 141.95 58.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.892 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.789 ' O ' HG23 ' A' ' 120' ' ' VAL . 87.0 m -125.14 118.12 25.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.924 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 1.022 ' HB ' HD11 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -79.44 139.54 18.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.905 179.825 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -98.57 135.85 39.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.839 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.423 ' HB2' ' HB3' ' A' ' 146' ' ' ASP . 0.5 OUTLIER -92.45 42.93 1.11 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.457 0.646 . . . . 0.0 109.409 178.614 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 19.4 p -99.65 167.19 10.73 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.569 -178.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -120.15 24.89 10.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.2 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 16.1 p -64.17 139.52 58.77 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.048 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.544 HG22 ' O ' ' A' ' 76' ' ' PHE . 1.7 m -91.36 12.99 18.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.381 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 39.0 p -125.94 160.87 28.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.815 0.34 . . . . 0.0 110.883 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 176.13 152.81 9.9 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.442 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.864 HG23 ' C ' ' A' ' 72' ' ' TYR . 7.1 p -103.71 137.83 30.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.808 0.337 . . . . 0.0 111.032 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.69 ' CE2' HG21 ' A' ' 74' ' ' VAL . 8.8 p90 -130.13 -170.9 2.41 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.357 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.435 ' HB2' ' O ' ' A' ' 63' ' ' TYR . 0.7 OUTLIER . . . . . 0 N--CA 1.464 0.235 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.241 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.807 ' HB2' HG21 ' A' ' 62' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.731 0.3 . . . . 0.0 110.612 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.864 ' C ' HG23 ' A' ' 62' ' ' VAL . 1.3 m-85 -102.37 113.07 66.04 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.77 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 72' ' ' TYR . 4.6 Cg_exo -80.61 121.06 4.08 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.663 2.242 . . . . 0.0 111.217 179.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.69 HG21 ' CE2' ' A' ' 63' ' ' TYR . 44.4 t -134.21 147.48 30.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.073 0.463 . . . . 0.0 112.027 -178.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 74.2 m -100.58 128.62 46.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.458 178.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.743 ' HZ ' HD11 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -132.52 169.25 16.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.381 0.61 . . . . 0.0 112.05 -178.588 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.435 ' O ' ' HD2' ' A' ' 79' ' ' PRO . 28.6 tt0 -111.91 158.44 19.47 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.156 178.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -105.44 65.97 0.28 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.474 -0.869 . . . . 0.0 113.172 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.435 ' HD2' ' O ' ' A' ' 77' ' ' GLU . 41.2 Cg_endo -67.99 134.45 32.02 Favored 'Trans proline' 0 C--O 1.239 0.557 0 C-N-CA 122.29 1.993 . . . . 0.0 112.23 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -58.86 -87.77 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.202 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.606 HD22 ' HB2' ' A' ' 96' ' ' SER . 0.0 OUTLIER -94.32 119.84 33.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.031 0.444 . . . . 0.0 111.826 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.626 ' HB ' HG11 ' A' ' 98' ' ' VAL . 48.8 t -122.91 122.9 66.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.686 178.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.425 ' HG3' ' CE1' ' A' ' 94' ' ' TYR . 3.9 tt0 -72.08 107.61 4.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.976 0.417 . . . . 0.0 110.808 -179.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.781 HG13 ' CG ' ' A' ' 126' ' ' MET . 47.6 t -73.96 114.62 13.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.757 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -72.84 150.02 43.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.752 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.526 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 0.6 OUTLIER -67.71 100.9 0.96 Allowed 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.331 -0.548 . . . . 0.0 110.232 -179.388 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.522 ' O ' ' N ' ' A' ' 89' ' ' TYR . 3.7 m -144.78 169.58 17.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.591 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 45.65 -84.82 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.658 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.522 ' N ' ' O ' ' A' ' 87' ' ' SER . 0.6 OUTLIER -153.99 24.75 0.49 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.818 0.342 . . . . 0.0 110.378 179.652 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.526 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -117.43 116.47 37.08 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.623 -179.934 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.457 ' O ' ' N ' ' A' ' 93' ' ' ARG . 30.9 Cg_exo -61.51 148.52 92.78 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.706 2.271 . . . . 0.0 112.181 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.557 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -59.05 79.24 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.858 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.457 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.2 OUTLIER -123.97 179.96 4.64 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.172 0.51 . . . . 0.0 111.816 -179.498 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.455 ' HB3' HD11 ' A' ' 81' ' ' LEU . 12.5 m-85 -93.93 132.56 38.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.784 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.578 ' CD ' HG21 ' A' ' 125' ' ' THR . 2.2 tt0 -130.57 123.14 28.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.209 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.606 ' HB2' HD22 ' A' ' 81' ' ' LEU . 5.1 t -97.71 161.49 13.73 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.114 0.483 . . . . 0.0 112.02 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 55.72 56.32 6.26 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.585 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.626 HG11 ' HB ' ' A' ' 82' ' ' VAL . 11.1 p -123.66 139.64 49.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.815 0.341 . . . . 0.0 111.559 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.466 HD11 ' OD2' ' A' ' 136' ' ' ASP . 11.2 mp -101.97 140.25 36.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.169 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.815 HD23 ' O ' ' A' ' 132' ' ' VAL . 5.6 mt -133.18 142.29 48.54 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -179.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.57 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . . . -152.12 147.12 26.08 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.706 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 0.9 OUTLIER -100.42 118.24 36.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.058 0.456 . . . . 0.0 111.129 179.865 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.287 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.868 -179.928 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.29 0 N-CA-C 112.549 -0.22 . . . . 0.0 112.549 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.906 HG21 HG22 ' A' ' 10' ' ' VAL . 2.5 pp -97.61 146.39 7.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.738 0.304 . . . . 0.0 111.077 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.743 HD11 ' HZ ' ' A' ' 76' ' ' PHE . 47.0 tp -87.58 113.15 23.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.822 0.344 . . . . 0.0 110.843 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -119.36 138.11 53.28 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.298 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.945 ' SG ' HD11 ' A' ' 121' ' ' ILE . 28.0 p -111.5 177.01 4.79 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -56.61 -19.94 18.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.686 0.279 . . . . 0.0 111.218 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 22.1 m80 -90.77 -33.66 15.64 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 159.83 -150.65 21.07 Favored Glycine 0 C--N 1.334 0.445 0 C-N-CA 120.425 -0.893 . . . . 0.0 113.136 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.789 HG23 ' O ' ' A' ' 52' ' ' THR . 9.1 t -83.83 135.6 24.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.768 0.318 . . . . 0.0 111.63 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.945 HD11 ' SG ' ' A' ' 116' ' ' CYS . 3.0 mp -109.31 -47.97 7.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.028 179.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.85 ' HA2' HG23 ' A' ' 137' ' ' VAL . . . -168.45 -171.94 34.82 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.078 -1.058 . . . . 0.0 113.215 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.576 HD11 HD13 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -118.76 164.13 15.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.803 0.335 . . . . 0.0 110.826 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.476 HG13 ' O ' ' A' ' 124' ' ' VAL . 11.2 p -60.72 121.33 8.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.486 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.753 ' OG1' ' HB2' ' A' ' 135' ' ' ALA . 19.3 m -116.02 -98.49 0.45 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.4 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.781 ' CG ' HG13 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -87.06 161.85 17.92 Favored 'General case' 0 CA--C 1.527 0.059 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.644 179.664 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -146.64 93.61 0.16 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.467 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -74.98 -177.96 40.62 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.375 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -71.98 -19.36 61.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.702 0.287 . . . . 0.0 111.042 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -142.6 -7.34 0.65 Allowed Glycine 0 CA--C 1.523 0.545 0 C-N-CA 120.571 -0.823 . . . . 0.0 113.514 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.636 ' CG1' HD22 ' A' ' 100' ' ' LEU . 0.6 OUTLIER -115.86 157.08 16.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 117.242 0.521 . . . . 0.0 111.18 -179.842 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.815 ' O ' HD23 ' A' ' 100' ' ' LEU . 15.6 m -113.4 118.45 58.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.602 -179.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -95.77 119.3 6.19 Favored Glycine 0 C--N 1.329 0.178 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.162 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.539 ' HD2' HD22 ' A' ' 114' ' ' LEU . 18.5 m-85 -125.04 144.04 50.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.867 0.365 . . . . 0.0 111.557 -179.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.753 ' HB2' ' OG1' ' A' ' 125' ' ' THR . . . -93.11 113.64 25.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.11 179.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.466 ' OD2' HD11 ' A' ' 99' ' ' LEU . 2.7 t0 -67.99 133.76 49.59 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -178.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.85 HG23 ' HA2' ' A' ' 122' ' ' GLY . 48.9 t -97.17 2.39 10.29 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.505 178.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.44 ' HA ' HD23 ' A' ' 141' ' ' LEU . 6.4 mtm105 -72.73 -6.22 43.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.304 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.78 3.71 54.69 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.661 0.267 . . . . 0.0 111.278 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.836 ' O ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -163.78 57.25 0.17 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.228 0.537 . . . . 0.0 109.956 179.827 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 1.022 HD11 ' HB ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -72.67 -14.5 61.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.607 -179.048 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . 0.46 ' C ' HD12 ' A' ' 143' ' ' LEU . 16.7 p-90 -52.87 81.15 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.991 0.424 . . . . 0.0 111.219 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.717 HD12 ' C ' ' A' ' 141' ' ' LEU . 5.0 mp -151.1 -45.77 0.12 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.327 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.476 ' HB2' HG12 ' A' ' 12' ' ' VAL . 1.2 mm-40 -157.41 -170.19 3.15 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.645 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -59.4 144.99 45.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.063 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.423 ' HB3' ' HB2' ' A' ' 55' ' ' ARG . 0.1 OUTLIER -103.11 154.35 19.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.647 179.932 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.242 0 CA-C-O 120.926 0.393 . . . . 0.0 111.32 -179.677 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.406 ' HB2' HG23 ' A' ' 18' ' ' VAL . . . . . . . . 0 N--CA 1.458 -0.068 0 CA-C-O 120.825 0.345 . . . . 0.0 111.051 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.5 t -114.49 107.1 22.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.019 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.73 ' CE2' HG21 ' A' ' 45' ' ' THR . 6.0 t80 -96.54 116.24 28.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.527 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.841 HG21 HD11 ' A' ' 53' ' ' ILE . 30.5 t -120.94 111.66 32.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.683 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.405 ' O ' ' CE1' ' A' ' 11' ' ' TYR . . . 50.88 -126.26 25.58 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.996 -0.621 . . . . 0.0 113.296 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.448 ' O ' ' HA ' ' A' ' 44' ' ' THR . 21.1 p30 -89.89 17.47 6.7 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.727 0.299 . . . . 0.0 111.561 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.668 ' HE1' HG22 ' A' ' 44' ' ' THR . 7.0 m-30 -130.29 145.51 51.78 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.05 114.8 11.25 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.578 0.227 . . . . 0.0 110.677 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 1.061 HG12 HG22 ' A' ' 42' ' ' VAL . 0.6 OUTLIER -101.22 121.36 51.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 121.123 0.487 . . . . 0.0 111.036 -179.855 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.555 ' O ' HD12 ' A' ' 40' ' ' LEU . 13.7 p -136.7 161.35 36.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.869 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.509 ' N ' HG22 ' A' ' 18' ' ' VAL . 2.5 t30 -58.99 141.16 54.63 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.77 -47.38 80.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.864 0.364 . . . . 0.0 111.267 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -67.7 -9.51 44.31 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.213 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.26 2.09 13.95 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.669 ' HB3' ' NE1' ' A' ' 28' ' ' TRP . . . -87.65 131.82 34.31 Favored 'General case' 0 C--O 1.23 0.07 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.975 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.509 ' O ' ' HD1' ' A' ' 28' ' ' TRP . 42.2 p -74.67 163.29 27.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.712 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 46.3 p-80 -53.74 -29.71 40.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.855 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.7 t -68.61 -33.2 58.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.804 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -68.0 -43.93 77.73 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.669 ' NE1' ' HB3' ' A' ' 23' ' ' ALA . 45.5 m95 -73.96 -29.95 62.26 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.993 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -60.89 -44.1 97.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.46 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -115.71 33.9 5.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.593 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.494 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 30.5 p -72.64 122.92 22.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.187 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.548 HG22 ' O ' ' A' ' 42' ' ' VAL . 11.6 m -86.19 -40.01 14.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.682 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.648 ' HH2' HD23 ' A' ' 40' ' ' LEU . 0.8 OUTLIER -139.87 151.18 45.45 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.202 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.441 ' HG2' ' HB2' ' A' ' 41' ' ' LEU . 5.3 mt-10 -154.79 116.3 4.09 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.188 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.428 ' HB2' ' CZ2' ' A' ' 33' ' ' TRP . 23.5 m-20 -107.26 110.27 22.26 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.804 0.335 . . . . 0.0 111.054 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -65.16 -29.91 70.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.427 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.525 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 0.4 OUTLIER -63.78 -27.83 69.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.128 -179.727 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.409 ' HG2' ' HB3' ' A' ' 35' ' ' ASP . 0.9 OUTLIER -117.53 6.67 12.55 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 121.096 -0.242 . . . . 0.0 111.56 179.794 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 47.56 45.12 17.55 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.961 0.41 . . . . 0.0 110.673 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.852 HD11 HG23 ' A' ' 17' ' ' VAL . 23.0 tp -133.2 151.23 51.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.142 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.667 ' O ' HD23 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -148.36 155.7 41.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.374 179.569 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 1.061 HG22 HG12 ' A' ' 17' ' ' VAL . 39.0 t -117.95 132.48 67.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.325 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.9 t -123.86 157.01 35.17 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.215 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.668 HG22 ' HE1' ' A' ' 15' ' ' TYR . 18.6 p -97.76 128.89 44.73 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.269 0.557 . . . . 0.0 111.638 -179.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.73 HG21 ' CE2' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -121.39 167.15 13.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.831 -179.368 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.6 m -114.85 38.62 3.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.846 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.423 ' HB3' ' OH ' ' A' ' 11' ' ' TYR . . . -113.29 -168.77 1.38 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.105 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 29.5 m80 -101.57 144.76 29.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.855 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -106.42 129.55 9.79 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.529 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 92.2 m -113.69 -32.05 6.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.803 0.335 . . . . 0.0 111.043 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -70.09 134.12 47.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.939 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.868 ' O ' HG23 ' A' ' 120' ' ' VAL . 67.6 m -118.97 117.25 28.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.599 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.903 ' HB ' HD11 ' A' ' 141' ' ' LEU . 0.4 OUTLIER -76.36 139.46 18.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.04 0.448 . . . . 0.0 111.406 -179.591 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.823 ' HB1' ' SG ' ' A' ' 56' ' ' CYS . . . -96.59 101.53 13.16 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.397 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.4 ' CB ' ' HB2' ' A' ' 146' ' ' ASP . 11.0 tpt180 -80.18 59.19 3.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.089 0.471 . . . . 0.0 110.148 179.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.823 ' SG ' ' HB1' ' A' ' 54' ' ' ALA . 0.5 OUTLIER -120.73 158.97 26.33 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.159 -179.293 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -96.74 18.72 13.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.384 179.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 29.5 p -57.31 129.07 40.16 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.97 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.1 m -92.03 12.35 22.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.272 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 25.9 p -129.99 130.81 45.48 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.818 0.342 . . . . 0.0 110.947 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -153.96 -161.8 10.67 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.31 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.811 HG23 ' C ' ' A' ' 72' ' ' TYR . 7.9 p -140.05 135.52 37.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.096 0.474 . . . . 0.0 111.225 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.454 ' CE1' ' HB2' ' A' ' 72' ' ' TYR . 27.4 p90 -109.97 125.94 53.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.678 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.44 ' HA ' ' HA ' ' A' ' 71' ' ' HIS . 15.4 t80 . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.916 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 64' ' ' PHE . 56.4 p-80 . . . . . 0 C--O 1.231 0.131 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.811 ' C ' HG23 ' A' ' 62' ' ' VAL . 13.5 m-85 -129.84 114.9 17.84 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -178.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.542 ' N ' HG23 ' A' ' 62' ' ' VAL . 10.0 Cg_exo -69.98 120.65 7.37 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.259 1.973 . . . . 0.0 110.319 178.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.451 ' CG1' ' CE2' ' A' ' 76' ' ' PHE . 2.5 p -143.68 153.76 16.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.5 m -95.03 132.9 39.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.172 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.691 ' CZ ' HD11 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -135.02 163.27 30.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.324 0.583 . . . . 0.0 111.921 -179.008 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.47 ' O ' ' HA ' ' A' ' 99' ' ' LEU . 5.9 pt-20 -111.8 158.32 19.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.142 -0.936 . . . . 0.0 109.293 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -106.04 65.8 0.27 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.385 -0.912 . . . . 0.0 113.591 -179.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.525 ' HD2' ' HA ' ' A' ' 99' ' ' LEU . 37.5 Cg_endo -67.74 134.15 31.69 Favored 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 122.263 1.975 . . . . 0.0 111.949 179.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -58.27 -84.48 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.586 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.55 HD11 ' HB3' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -97.18 120.32 37.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.866 0.365 . . . . 0.0 111.855 -179.618 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.608 ' HB ' HG11 ' A' ' 98' ' ' VAL . 48.1 t -123.91 122.58 64.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.371 178.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -72.44 107.99 5.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.91 0.386 . . . . 0.0 110.521 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.5 HG13 ' HB2' ' A' ' 95' ' ' GLN . 17.2 m -76.11 123.46 32.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.666 -179.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -69.92 150.52 46.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.734 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.532 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 31.0 tt0 -67.7 102.43 1.2 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.939 0.399 . . . . 0.0 110.321 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.439 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.7 OUTLIER -143.94 165.95 26.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.331 -179.729 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 55.08 -82.42 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.564 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.439 ' N ' ' O ' ' A' ' 87' ' ' SER . 0.4 OUTLIER -154.92 22.84 0.44 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.703 0.287 . . . . 0.0 110.917 -179.878 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.532 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 2.3 t80 -122.88 133.18 24.33 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.918 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.432 ' O ' ' N ' ' A' ' 93' ' ' ARG . 89.1 Cg_endo -83.08 148.96 13.49 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.173 2.582 . . . . 0.0 112.417 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.2 OUTLIER -40.16 92.79 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.401 -179.908 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.447 ' O ' HG22 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -123.71 -179.19 4.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.133 0.492 . . . . 0.0 111.683 -179.342 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.55 ' HB3' HD11 ' A' ' 81' ' ' LEU . 23.0 m-85 -106.38 132.29 52.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.024 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.525 ' HA ' ' O ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -128.79 124.03 34.39 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.934 -179.888 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -96.74 156.58 16.28 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 121.058 0.456 . . . . 0.0 111.779 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 56.91 57.18 4.82 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.491 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.608 HG11 ' HB ' ' A' ' 82' ' ' VAL . 8.0 p -123.37 135.55 62.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.964 0.411 . . . . 0.0 111.367 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.787 HD11 ' HB2' ' A' ' 136' ' ' ASP . 2.7 mp -101.91 146.94 27.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.907 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.706 HD23 ' O ' ' A' ' 132' ' ' VAL . 6.5 mt -133.03 139.87 47.43 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.533 ' HB2' ' CD2' ' A' ' 76' ' ' PHE . . . -144.13 150.97 38.93 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.394 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.2 t -111.13 140.04 46.01 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.862 0.363 . . . . 0.0 111.231 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.19 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.468 179.995 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.405 0 N-CA-C 112.411 -0.276 . . . . 0.0 112.411 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 28.3 pt -126.07 146.11 32.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.773 0.321 . . . . 0.0 111.164 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.691 HD11 ' CZ ' ' A' ' 76' ' ' PHE . 6.7 tp -87.81 113.5 23.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.388 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.517 ' O ' HG12 ' A' ' 62' ' ' VAL . 0.0 OUTLIER -118.83 139.38 51.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.257 -179.858 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.576 ' HB3' HD11 ' A' ' 121' ' ' ILE . 21.8 p -105.66 166.87 10.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.194 179.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -55.93 -20.2 15.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.348 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 11.4 m80 -91.16 -22.21 20.78 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.79 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.612 ' CA ' ' HB2' ' A' ' 54' ' ' ALA . . . 163.56 -143.8 8.94 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.145 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 52' ' ' THR . 3.6 t -100.24 135.53 35.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.724 0.297 . . . . 0.0 111.107 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.576 HD11 ' HB3' ' A' ' 116' ' ' CYS . 1.3 mm -96.95 -67.15 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.835 0.35 . . . . 0.0 110.982 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.864 ' HA2' HG23 ' A' ' 137' ' ' VAL . . . -155.4 -154.01 6.76 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.831 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.811 ' CD1' ' HB3' ' A' ' 135' ' ' ALA . 0.0 OUTLIER -130.53 164.14 25.51 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.031 0.443 . . . . 0.0 111.069 179.958 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.576 HG13 ' O ' ' A' ' 124' ' ' VAL . 14.5 p -57.86 115.08 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.319 -179.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.737 ' OG1' ' HB2' ' A' ' 135' ' ' ALA . 1.6 m -101.49 -87.22 0.4 Allowed 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.692 ' N ' HG22 ' A' ' 125' ' ' THR . 0.0 OUTLIER -136.13 129.78 32.3 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-O 120.997 0.427 . . . . 0.0 111.583 179.57 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -109.14 149.13 17.08 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.654 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -104.47 -156.9 23.62 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.469 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -71.81 -19.44 61.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.725 0.298 . . . . 0.0 111.173 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -159.03 16.18 0.24 Allowed Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.983 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.628 ' CG1' HD22 ' A' ' 100' ' ' LEU . 0.9 OUTLIER -126.51 157.23 37.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.755 0.312 . . . . 0.0 110.857 179.861 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.706 ' O ' HD23 ' A' ' 100' ' ' LEU . 29.0 m -116.97 118.32 58.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.354 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.496 ' HA3' ' O ' ' A' ' 126' ' ' MET . . . -99.87 113.94 4.87 Favored Glycine 0 C--N 1.329 0.192 0 C-N-CA 120.499 -0.858 . . . . 0.0 111.997 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.467 ' CD2' ' HB2' ' A' ' 114' ' ' LEU . 53.4 m-85 -118.14 138.04 52.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.748 0.308 . . . . 0.0 111.357 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.811 ' HB3' ' CD1' ' A' ' 123' ' ' LEU . . . -88.41 115.4 25.88 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 179.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.787 ' HB2' HD11 ' A' ' 99' ' ' LEU . 2.7 t0 -67.38 141.93 56.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.25 0.548 . . . . 0.0 112.438 -178.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.864 HG23 ' HA2' ' A' ' 122' ' ' GLY . 56.5 t -89.9 9.87 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.413 178.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.492 ' HA ' HD23 ' A' ' 141' ' ' LEU . 9.3 mmm180 -70.63 -6.74 39.07 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.641 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -98.28 11.04 39.21 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.481 0.181 . . . . 0.0 111.439 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.853 ' O ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -177.19 47.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.018 0.437 . . . . 0.0 110.595 -179.811 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.903 HD11 ' HB ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -66.39 -14.6 62.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.15 -179.67 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . 0.459 ' C ' HD12 ' A' ' 143' ' ' LEU . 15.6 p-90 -54.52 81.61 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.068 0.461 . . . . 0.0 111.539 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.695 HD12 ' C ' ' A' ' 141' ' ' LEU . 5.0 mp -149.37 -43.89 0.14 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.954 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.425 ' HB2' ' CG1' ' A' ' 12' ' ' VAL . 7.6 mt-10 -152.29 -170.42 3.64 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.445 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -58.83 132.27 53.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.79 0.328 . . . . 0.0 110.888 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.4 ' HB2' ' CB ' ' A' ' 55' ' ' ARG . 1.5 p30 -94.63 154.11 17.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.003 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.086 179.973 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.799 0.333 . . . . 0.0 110.988 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.2 t -116.49 108.21 24.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.069 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.89 ' CE2' HG21 ' A' ' 45' ' ' THR . 6.1 t80 -99.57 116.41 31.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.692 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.891 HG21 HD11 ' A' ' 53' ' ' ILE . 24.8 t -120.77 108.95 23.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.804 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 50.8 -126.49 25.8 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.986 -0.626 . . . . 0.0 113.259 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.518 ' O ' ' HA ' ' A' ' 44' ' ' THR . 2.7 p-10 -88.58 13.06 12.95 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.657 ' HE1' HG22 ' A' ' 44' ' ' THR . 5.8 m-30 -130.49 127.93 40.17 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.6 tttt -120.56 114.88 22.38 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.994 -0.282 . . . . 0.0 110.792 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 1.067 HG12 HG22 ' A' ' 42' ' ' VAL . 0.6 OUTLIER -99.33 121.64 50.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-O 121.161 0.505 . . . . 0.0 110.916 179.894 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.546 ' O ' HD22 ' A' ' 41' ' ' LEU . 12.6 p -136.92 161.32 36.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.02 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.598 ' ND2' HD12 ' A' ' 123' ' ' LEU . 31.5 m120 -59.89 141.22 55.86 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.441 ' HB2' ' CH2' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -56.77 -43.98 81.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.796 0.332 . . . . 0.0 111.235 -179.493 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -67.82 -10.93 57.03 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.11 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -115.26 0.61 13.56 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.712 ' HB3' ' NE1' ' A' ' 28' ' ' TRP . . . -86.69 127.06 34.93 Favored 'General case' 0 C--O 1.23 0.072 0 C-N-CA 120.331 -0.548 . . . . 0.0 111.028 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.711 HG23 HG12 ' A' ' 26' ' ' VAL . 1.7 t -74.71 165.48 25.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.916 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -53.62 -29.86 40.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.878 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.711 HG12 HG23 ' A' ' 24' ' ' THR . 11.5 p -71.85 -31.67 41.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.716 0.293 . . . . 0.0 110.996 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.484 ' HB3' ' HB1' ' A' ' 23' ' ' ALA . 0.4 OUTLIER -68.11 -43.97 77.2 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.099 0.475 . . . . 0.0 109.751 179.332 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.712 ' NE1' ' HB3' ' A' ' 23' ' ' ALA . 53.2 m95 -74.05 -35.27 64.28 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.064 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.56 -40.92 80.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.75 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -116.94 34.63 5.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.782 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.476 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 29.2 p -77.15 125.62 29.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.043 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.574 HG22 ' O ' ' A' ' 42' ' ' VAL . 16.1 m -87.43 -38.04 11.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.705 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.641 ' HH2' HD23 ' A' ' 40' ' ' LEU . 2.9 t90 -139.56 153.52 47.44 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.776 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 5.2 tm-20 -162.69 120.54 2.06 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.789 0.328 . . . . 0.0 111.581 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.408 ' HB2' ' CZ2' ' A' ' 33' ' ' TRP . 0.7 OUTLIER -107.05 98.68 8.3 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.45 179.338 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -56.95 -29.55 63.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.935 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.614 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 6.3 t-20 -64.4 -41.04 96.86 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 120.584 0.23 . . . . 0.0 110.822 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -99.55 -4.23 31.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.532 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.411 ' CB ' ' HG2' ' A' ' 20' ' ' ARG . 1.0 OUTLIER 60.03 48.36 8.7 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.047 0.451 . . . . 0.0 110.706 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.641 HD23 ' HH2' ' A' ' 33' ' ' TRP . 21.2 tp -136.41 146.51 46.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.671 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.669 ' O ' HD23 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -147.24 155.79 42.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.987 0.422 . . . . 0.0 111.899 179.802 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 1.067 HG22 HG12 ' A' ' 17' ' ' VAL . 35.8 t -117.36 125.0 73.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.272 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.0 p -118.19 157.41 27.02 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.567 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.657 HG22 ' HE1' ' A' ' 15' ' ' TYR . 15.2 p -97.29 142.71 28.84 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.243 0.544 . . . . 0.0 111.638 -178.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.89 HG21 ' CE2' ' A' ' 11' ' ' TYR . 0.4 OUTLIER -137.52 172.49 12.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.89 -179.195 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -122.68 36.04 4.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.759 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.435 ' HB3' ' OH ' ' A' ' 11' ' ' TYR . . . -107.38 -167.89 1.32 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.183 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -102.83 148.03 26.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.985 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -57.09 -174.39 0.26 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.552 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -154.59 -45.97 0.09 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.9 0.381 . . . . 0.0 111.021 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -128.66 170.71 12.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.969 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.871 ' O ' HG23 ' A' ' 120' ' ' VAL . 29.6 m -125.13 123.39 39.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.533 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.954 ' HB ' HD11 ' A' ' 141' ' ' LEU . 0.5 OUTLIER -72.65 139.55 19.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.871 0.367 . . . . 0.0 111.175 -179.643 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.607 ' HB2' ' N ' ' A' ' 119' ' ' GLY . . . -88.08 122.93 32.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.383 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.58 ' H ' ' HB3' ' A' ' 147' ' ' ALA . 25.0 tpt180 -94.11 28.98 2.28 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.172 0.51 . . . . 0.0 109.962 178.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.484 ' SG ' ' HB1' ' A' ' 54' ' ' ALA . 23.0 p -99.82 167.3 10.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.996 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -117.69 28.81 8.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.26 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 34.0 m -58.84 131.16 50.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.853 0.359 . . . . 0.0 110.539 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.48 -1.07 44.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.326 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 16.3 p -127.91 123.99 36.32 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.998 0.428 . . . . 0.0 111.265 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.25 -169.14 12.01 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.753 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.739 HG23 ' C ' ' A' ' 72' ' ' TYR . 6.8 p -140.22 132.76 33.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 117.143 0.472 . . . . 0.0 111.327 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.806 ' CZ ' HG11 ' A' ' 132' ' ' VAL . 40.5 p90 -120.18 132.12 55.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.582 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.425 ' HA ' ' HA ' ' A' ' 71' ' ' HIS . 1.2 t80 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.579 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 64' ' ' PHE . 5.1 p80 . . . . . 0 N--CA 1.457 -0.098 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.739 ' C ' HG23 ' A' ' 62' ' ' VAL . 2.6 m-85 -126.03 114.58 24.14 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.57 -178.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -68.34 120.46 7.41 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 121.886 1.724 . . . . 0.0 109.964 178.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.514 HG21 ' HE1' ' A' ' 63' ' ' TYR . 43.8 t -140.41 141.83 32.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -178.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 87.9 p -93.02 133.15 36.45 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.608 ' CZ ' HD11 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -136.25 166.2 23.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.372 0.606 . . . . 0.0 112.166 -178.347 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.437 ' O ' ' HA ' ' A' ' 99' ' ' LEU . 0.1 OUTLIER -111.71 158.48 19.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.183 178.848 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -105.16 67.5 0.27 Allowed Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.378 -0.915 . . . . 0.0 113.464 -179.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.516 ' HD2' ' HA ' ' A' ' 99' ' ' LEU . 37.6 Cg_endo -67.63 134.28 32.33 Favored 'Trans proline' 0 C--O 1.237 0.47 0 C-N-CA 122.227 1.951 . . . . 0.0 111.952 179.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -54.84 -83.24 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.673 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.703 HD11 ' HB3' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -105.09 120.18 40.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.867 0.365 . . . . 0.0 111.959 -179.646 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.619 ' HB ' HG11 ' A' ' 98' ' ' VAL . 42.2 t -121.1 122.18 66.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.376 178.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -76.35 108.05 9.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.941 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 34.8 m -73.83 124.13 30.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.055 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -69.55 150.11 47.48 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.722 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.594 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 61.3 tt0 -68.02 102.16 1.25 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.999 0.428 . . . . 0.0 110.638 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.436 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.3 OUTLIER -144.07 160.11 41.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.364 -179.825 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 56.06 -81.51 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.679 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.436 ' N ' ' O ' ' A' ' 87' ' ' SER . 3.2 p90 -155.73 26.18 0.39 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.861 0.363 . . . . 0.0 110.822 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.594 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 1.0 OUTLIER -122.48 124.35 26.8 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.557 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.46 ' O ' ' N ' ' A' ' 93' ' ' ARG . 72.0 Cg_endo -76.46 148.65 30.06 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.881 2.387 . . . . 0.0 112.512 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -46.25 89.4 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.17 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.46 ' N ' ' O ' ' A' ' 91' ' ' PRO . 1.7 mmm180 -124.02 174.34 7.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.299 0.571 . . . . 0.0 112.156 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.703 ' HB3' HD11 ' A' ' 81' ' ' LEU . 5.4 m-85 -100.18 132.62 45.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.214 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.614 ' HA ' ' O ' ' A' ' 37' ' ' ASN . 12.2 mm-40 -118.85 116.58 26.8 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.245 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.532 ' HA ' HD22 ' A' ' 81' ' ' LEU . 44.3 t -83.15 146.07 28.85 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.048 0.452 . . . . 0.0 111.716 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.427 ' CE1' ' HB3' ' A' ' 136' ' ' ASP . 1.5 t-80 52.22 65.55 1.47 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.037 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.619 HG11 ' HB ' ' A' ' 82' ' ' VAL . 10.6 p -123.6 141.8 42.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.17 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.516 ' HA ' ' HD2' ' A' ' 79' ' ' PRO . 9.4 mp -102.13 142.49 33.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.009 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.719 HD23 ' O ' ' A' ' 132' ' ' VAL . 5.6 mt -133.09 142.08 48.54 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -179.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.485 ' HB1' ' CG1' ' A' ' 74' ' ' VAL . . . -152.17 146.08 25.19 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.806 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 1.1 t -99.93 129.28 45.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.913 0.387 . . . . 0.0 111.228 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.273 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.436 -179.855 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 26.9 pt -109.32 145.68 15.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.793 0.33 . . . . 0.0 111.065 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.733 HD22 ' HD2' ' A' ' 134' ' ' PHE . 34.2 tp -87.77 117.02 26.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.444 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 8.1 mtt180 -118.49 145.86 44.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.148 0.499 . . . . 0.0 111.93 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.989 ' HB2' HD11 ' A' ' 121' ' ' ILE . 13.9 t -107.85 165.05 11.73 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.304 178.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.68 -17.46 5.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.777 0.322 . . . . 0.0 110.484 179.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 45.4 m80 -93.54 -36.25 12.51 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.581 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.607 ' N ' ' HB2' ' A' ' 54' ' ' ALA . . . 179.02 -136.91 3.0 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 120.191 -1.004 . . . . 0.0 113.936 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' ' 52' ' ' THR . 3.0 t -105.11 136.24 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -179.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.989 HD11 ' HB2' ' A' ' 116' ' ' CYS . 1.9 mp -95.47 -40.07 10.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.707 ' HA2' HG23 ' A' ' 137' ' ' VAL . . . 162.01 -156.78 28.44 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.889 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.598 HD12 ' ND2' ' A' ' 19' ' ' ASN . 0.2 OUTLIER -116.79 164.11 15.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.791 0.329 . . . . 0.0 110.851 -179.714 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 11.4 p -68.36 131.62 33.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.427 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.805 ' OG1' ' HB2' ' A' ' 135' ' ' ALA . 1.9 m -103.08 -87.49 0.42 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.231 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.677 ' N ' HG22 ' A' ' 125' ' ' THR . 0.0 OUTLIER -131.42 162.05 31.05 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-O 120.807 0.337 . . . . 0.0 111.415 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -133.48 150.92 19.98 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.669 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -104.13 -153.06 22.86 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.449 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.94 -19.55 61.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.651 0.262 . . . . 0.0 111.103 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -164.04 16.78 0.11 Allowed Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.597 -0.811 . . . . 0.0 113.081 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.634 ' CG1' HD22 ' A' ' 100' ' ' LEU . 0.9 OUTLIER -120.29 157.26 23.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.776 0.322 . . . . 0.0 110.692 179.806 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.806 HG11 ' CZ ' ' A' ' 63' ' ' TYR . 14.3 m -115.85 118.4 58.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.408 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.419 ' HA2' ' O ' ' A' ' 99' ' ' LEU . . . -100.2 123.19 7.84 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.966 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.733 ' HD2' HD22 ' A' ' 114' ' ' LEU . 10.0 m-85 -124.83 140.15 53.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.854 0.359 . . . . 0.0 111.413 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.805 ' HB2' ' OG1' ' A' ' 125' ' ' THR . . . -88.76 114.34 25.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.057 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.427 ' HB3' ' CE1' ' A' ' 97' ' ' HIS . 3.0 t0 -73.12 146.55 45.64 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -178.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.707 HG23 ' HA2' ' A' ' 122' ' ' GLY . 62.0 t -104.95 5.86 10.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.139 178.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.45 ' HA ' HD23 ' A' ' 141' ' ' LEU . 12.2 mtm-85 -72.17 -6.51 43.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.26 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -94.64 7.34 46.07 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 120.726 0.298 . . . . 0.0 111.277 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.812 ' O ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -169.6 59.79 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.289 0.566 . . . . 0.0 109.92 179.818 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.954 HD11 ' HB ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -74.06 -14.88 61.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.298 -179.092 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . 0.45 ' C ' HD12 ' A' ' 143' ' ' LEU . 15.5 p-90 -54.72 81.51 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.972 0.415 . . . . 0.0 111.388 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.68 HD12 ' C ' ' A' ' 141' ' ' LEU . 5.0 mp -150.17 -47.21 0.13 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.979 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.421 ' HB2' ' CG1' ' A' ' 12' ' ' VAL . 9.2 mm-40 -154.07 -170.01 3.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.527 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.95 139.8 56.27 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.832 0.349 . . . . 0.0 111.043 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.97 154.22 18.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.878 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.58 ' HB3' ' H ' ' A' ' 55' ' ' ARG . . . . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.114 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.839 0.352 . . . . 0.0 111.107 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.62 117.62 50.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.242 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.807 ' CE2' HG21 ' A' ' 45' ' ' THR . 5.6 t80 -106.55 116.59 32.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.483 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.868 HG21 HD11 ' A' ' 53' ' ' ILE . 21.2 t -120.8 114.62 44.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.802 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 46.94 -123.87 8.01 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 121.157 -0.544 . . . . 0.0 113.335 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.445 ' O ' ' HA ' ' A' ' 44' ' ' THR . 68.6 m-20 -90.07 15.79 9.54 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.638 0.256 . . . . 0.0 111.602 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.647 ' HE1' HG22 ' A' ' 44' ' ' THR . 6.8 m-30 -130.41 148.62 52.24 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.01 114.71 9.93 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.56 0.219 . . . . 0.0 110.579 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 1.08 HG12 HG22 ' A' ' 42' ' ' VAL . 0.6 OUTLIER -100.38 122.0 51.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.054 0.454 . . . . 0.0 110.842 -179.969 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.727 ' O ' HD12 ' A' ' 40' ' ' LEU . 12.5 p -136.06 160.98 38.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.216 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.524 ' N ' HG22 ' A' ' 18' ' ' VAL . 10.4 m-20 -61.47 141.44 57.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.447 179.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.4 ttt-85 -56.63 -47.33 79.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.899 0.38 . . . . 0.0 110.736 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -68.75 -11.02 59.83 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.912 179.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.414 ' HB3' HG22 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -108.65 -12.1 15.0 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.686 -179.735 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.962 ' HB3' ' CZ2' ' A' ' 28' ' ' TRP . . . -70.02 150.71 46.36 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 120.763 0.316 . . . . 0.0 110.753 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 16.9 p -105.03 169.04 8.66 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.326 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.693 ' CE1' HG23 ' A' ' 26' ' ' VAL . 13.8 p-80 -54.6 -29.63 52.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.044 0.449 . . . . 0.0 110.656 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.693 HG23 ' CE1' ' A' ' 25' ' ' HIS . 21.8 t -74.72 -31.32 26.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.385 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.42 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 4.0 m-20 -67.11 -44.14 80.69 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.962 ' CZ2' ' HB3' ' A' ' 23' ' ' ALA . 7.4 m-90 -74.47 -31.63 62.29 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.125 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -58.02 -42.31 85.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.483 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -115.81 33.93 5.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.494 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.462 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 29.2 t -80.05 129.38 34.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.26 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.507 HG13 HG23 ' A' ' 44' ' ' THR . 13.0 m -92.57 -40.73 12.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.622 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.601 ' CZ3' HG23 ' A' ' 42' ' ' VAL . 0.3 OUTLIER -139.72 153.49 47.23 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 121.047 0.451 . . . . 0.0 111.644 -179.361 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -154.41 120.25 5.23 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.472 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.424 ' HB2' ' CZ2' ' A' ' 33' ' ' TRP . 6.1 m-20 -100.42 116.7 32.99 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.414 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -65.83 -43.32 88.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.875 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.484 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 7.0 m120 -71.2 -10.96 60.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.011 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.454 ' NE ' ' HB1' ' A' ' 135' ' ' ALA . 3.5 tpm_? -117.1 -4.96 11.41 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 121.151 -0.22 . . . . 0.0 111.301 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 47.12 33.98 2.69 Favored 'General case' 0 N--CA 1.46 0.059 0 CA-C-O 121.122 0.486 . . . . 0.0 110.27 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.906 HD13 HD11 ' A' ' 123' ' ' LEU . 41.6 tp -126.8 153.37 45.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.747 -179.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.666 ' O ' HD23 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -146.79 155.69 42.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.871 0.367 . . . . 0.0 111.781 179.754 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 1.08 HG22 HG12 ' A' ' 17' ' ' VAL . 24.7 t -119.14 130.04 74.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.342 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.6 p -121.07 157.13 30.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.556 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.647 HG22 ' HE1' ' A' ' 15' ' ' TYR . 17.4 p -97.74 128.67 44.57 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.182 0.515 . . . . 0.0 111.471 -179.183 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.807 HG21 ' CE2' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -103.61 -34.19 8.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.889 -179.245 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.0 m 68.37 59.22 0.41 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.017 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.607 ' HB3' ' OH ' ' A' ' 11' ' ' TYR . . . -152.13 -167.86 2.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.201 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 46.8 p-80 -81.93 148.01 28.96 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.984 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -93.55 153.17 21.18 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.718 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.5 m -125.73 -62.72 1.17 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.869 0.366 . . . . 0.0 110.742 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -69.07 147.21 51.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.681 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.825 ' O ' HG23 ' A' ' 120' ' ' VAL . 62.8 m -123.56 117.53 25.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.94 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.889 ' HB ' HD11 ' A' ' 141' ' ' LEU . 0.4 OUTLIER -73.07 139.34 19.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.644 179.864 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.82 ' HB2' ' N ' ' A' ' 119' ' ' GLY . . . -95.96 124.84 40.14 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.926 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.608 ' H ' ' HB3' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -90.94 33.9 0.93 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.504 179.61 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 26.6 p -99.69 167.13 10.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.892 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -123.03 39.71 3.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.177 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 19.3 m -68.94 131.77 45.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.779 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.1 t -76.86 -7.15 54.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.811 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.7 p -117.84 123.93 47.11 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.988 0.423 . . . . 0.0 111.091 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -148.98 162.56 28.96 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.571 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.829 HG23 ' C ' ' A' ' 72' ' ' TYR . 13.2 p -99.86 134.42 39.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.193 0.521 . . . . 0.0 111.669 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -120.26 -170.7 2.02 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.059 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.531 0.221 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.197 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.769 ' HB2' HG21 ' A' ' 62' ' ' VAL . 12.5 p-80 . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.612 0.244 . . . . 0.0 110.569 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.829 ' C ' HG23 ' A' ' 62' ' ' VAL . 1.8 m-85 -106.78 113.17 63.07 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.073 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.54 ' HA ' ' HA ' ' A' ' 62' ' ' VAL . 6.0 Cg_exo -80.27 139.11 12.97 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.846 2.364 . . . . 0.0 111.632 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.452 ' CG1' ' CE2' ' A' ' 76' ' ' PHE . 1.3 p -151.14 161.26 3.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.016 0.436 . . . . 0.0 111.892 -179.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.5 p -106.88 126.62 52.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.227 178.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.646 ' CZ ' HD11 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -128.48 166.18 19.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.654 0.74 . . . . 0.0 112.294 -179.111 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.69 ' C ' ' HD3' ' A' ' 79' ' ' PRO . 1.3 mp0 -111.91 159.36 18.45 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.552 -1.204 . . . . 0.0 108.918 178.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.461 ' HA2' ' HG ' ' A' ' 99' ' ' LEU . . . -108.57 64.19 0.26 Allowed Glycine 0 CA--C 1.522 0.495 0 C-N-CA 120.135 -1.031 . . . . 0.0 114.155 -179.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.69 ' HD3' ' C ' ' A' ' 77' ' ' GLU . 14.9 Cg_exo -66.96 138.27 47.44 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.12 1.88 . . . . 0.0 111.965 179.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -62.77 -90.7 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.752 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.615 HD22 ' HB2' ' A' ' 96' ' ' SER . 0.0 OUTLIER -87.79 120.0 28.68 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.343 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.599 ' HB ' HG11 ' A' ' 98' ' ' VAL . 89.1 t -124.8 122.93 64.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.534 178.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.407 ' OE2' ' CE1' ' A' ' 94' ' ' TYR . 1.2 tp10 -72.11 107.9 5.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.986 0.422 . . . . 0.0 110.686 -179.163 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.847 HG23 ' HB2' ' A' ' 126' ' ' MET . 2.9 p -83.06 114.39 23.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.739 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -74.35 150.37 40.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.471 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 5.8 pt-20 -67.72 100.78 0.95 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.274 0.559 . . . . 0.0 109.88 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.529 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.5 OUTLIER -145.16 172.92 12.42 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.62 -179.976 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 44.14 -85.17 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.614 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.529 ' N ' ' O ' ' A' ' 87' ' ' SER . 0.2 OUTLIER -150.15 23.21 0.84 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.818 0.342 . . . . 0.0 110.413 179.597 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.749 ' HD2' HG21 ' A' ' 84' ' ' VAL . 0.4 OUTLIER -116.34 145.68 35.66 Favored Pre-proline 0 C--O 1.232 0.17 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.999 -179.63 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.404 ' O ' ' N ' ' A' ' 93' ' ' ARG . 92.2 Cg_endo -85.44 148.74 10.13 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.307 2.671 . . . . 0.0 112.697 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.515 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -65.42 72.81 0.05 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 179.894 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.486 ' O ' HG12 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -123.92 -178.23 3.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.961 0.41 . . . . 0.0 111.621 -179.653 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.432 ' HB3' HD11 ' A' ' 81' ' ' LEU . 14.6 m-85 -94.99 132.17 40.15 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.586 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.484 ' HA ' ' O ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -131.15 125.56 33.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.667 0.27 . . . . 0.0 111.321 -179.681 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.615 ' HB2' HD22 ' A' ' 81' ' ' LEU . 1.4 t -102.09 154.21 19.2 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 120.917 0.389 . . . . 0.0 111.868 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 70.19 54.52 0.32 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.395 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.599 HG11 ' HB ' ' A' ' 82' ' ' VAL . 5.0 p -123.46 141.73 42.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.223 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.535 ' N ' HD12 ' A' ' 99' ' ' LEU . 5.6 mp -107.49 146.49 31.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.094 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.675 HD23 ' C ' ' A' ' 132' ' ' VAL . 6.1 mt -133.28 133.74 42.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.113 0.482 . . . . 0.0 112.189 -179.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.608 ' HB2' ' CD2' ' A' ' 76' ' ' PHE . . . -136.39 150.47 48.81 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.65 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.1 t -108.84 129.27 55.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.857 0.361 . . . . 0.0 110.98 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.637 -179.765 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.443 -0.263 . . . . 0.0 112.443 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 34.5 pt -125.99 146.12 32.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.809 0.337 . . . . 0.0 111.218 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.646 HD11 ' CZ ' ' A' ' 76' ' ' PHE . 16.3 tp -87.82 119.46 28.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.24 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -118.13 149.32 41.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.067 0.46 . . . . 0.0 111.786 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.575 ' HB2' HD11 ' A' ' 121' ' ' ILE . 7.4 t -115.48 163.08 16.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.149 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -55.85 -20.07 14.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.814 0.34 . . . . 0.0 110.818 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.435 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . 26.7 m80 -90.64 -35.47 14.95 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.422 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.82 ' N ' ' HB2' ' A' ' 54' ' ' ALA . . . 177.45 -139.31 4.25 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.333 -0.937 . . . . 0.0 113.281 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' ' 52' ' ' THR . 3.4 t -100.91 135.39 37.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.687 0.279 . . . . 0.0 111.341 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.575 HD11 ' HB2' ' A' ' 116' ' ' CYS . 1.1 mm -95.78 -61.99 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.871 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.797 ' HA2' HG23 ' A' ' 137' ' ' VAL . . . -174.9 -163.57 28.26 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.302 -0.951 . . . . 0.0 113.387 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.906 HD11 HD13 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -116.89 141.75 47.82 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.864 0.364 . . . . 0.0 111.002 -179.792 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.407 ' HB ' ' CE1' ' A' ' 134' ' ' PHE . 10.6 p -57.94 148.81 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.94 -179.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.509 HG23 ' H ' ' A' ' 126' ' ' MET . 0.0 OUTLIER -128.87 -87.17 0.55 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.225 179.333 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.847 ' HB2' HG23 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -107.6 138.87 43.03 Favored 'General case' 0 N--CA 1.461 0.087 0 CA-C-O 120.997 0.427 . . . . 0.0 110.8 179.393 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -122.93 129.13 7.33 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.158 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -81.06 -160.19 23.98 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.497 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -71.84 -19.24 62.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.807 0.336 . . . . 0.0 110.815 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -158.07 18.23 0.33 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.708 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.57 ' CG1' HD22 ' A' ' 100' ' ' LEU . 0.9 OUTLIER -125.03 157.01 33.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-O 120.666 0.269 . . . . 0.0 110.783 -180.0 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.675 ' C ' HD23 ' A' ' 100' ' ' LEU . 11.3 m -118.55 118.79 59.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.801 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -91.67 124.51 7.65 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.615 -0.802 . . . . 0.0 111.487 179.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.434 ' CG ' ' HB2' ' A' ' 114' ' ' LEU . 19.2 m-85 -124.25 135.43 53.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.999 0.428 . . . . 0.0 111.912 -178.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.552 ' O ' ' HA3' ' A' ' 122' ' ' GLY . . . -88.84 112.19 22.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.836 178.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -67.55 136.76 55.03 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -178.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.797 HG23 ' HA2' ' A' ' 122' ' ' GLY . 67.6 t -89.5 7.57 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.382 178.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.432 ' HA ' HD23 ' A' ' 141' ' ' LEU . 30.6 mmm-85 -71.11 -6.66 40.93 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.588 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.43 10.99 38.25 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.62 0.248 . . . . 0.0 111.332 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.807 ' O ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -175.19 53.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.128 0.489 . . . . 0.0 110.6 -179.868 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.889 HD11 ' HB ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -70.61 -14.69 62.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.012 -179.52 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . 0.455 ' C ' HD12 ' A' ' 143' ' ' LEU . 15.6 p-90 -54.52 83.62 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.134 0.493 . . . . 0.0 111.358 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.701 HD12 ' C ' ' A' ' 141' ' ' LEU . 5.0 mp -151.52 -44.87 0.11 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.972 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.842 ' OE2' HG13 ' A' ' 12' ' ' VAL . 14.4 pt-20 -155.95 -163.19 1.43 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.662 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.03 145.62 55.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.889 0.376 . . . . 0.0 111.041 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -105.1 154.14 20.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.896 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.608 ' HB3' ' H ' ' A' ' 55' ' ' ARG . . . . . . . . 0 C--N 1.331 -0.207 0 CA-C-O 120.876 0.369 . . . . 0.0 111.043 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.742 ' HB2' HG23 ' A' ' 18' ' ' VAL . . . . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.759 0.314 . . . . 0.0 110.985 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.478 HG13 ' O ' ' A' ' 10' ' ' VAL . 8.4 p -124.61 119.13 55.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.981 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.683 ' CE1' HG21 ' A' ' 45' ' ' THR . 7.3 t80 -98.69 117.09 32.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.69 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.853 HG21 HD11 ' A' ' 53' ' ' ILE . 22.3 t -120.1 130.05 74.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.584 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.445 ' O ' ' CE1' ' A' ' 11' ' ' TYR . . . 46.01 -123.91 7.0 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 121.085 -0.579 . . . . 0.0 113.141 179.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.404 ' O ' ' HA ' ' A' ' 44' ' ' THR . 59.3 m-80 -99.27 19.82 14.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.784 0.326 . . . . 0.0 111.002 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.69 ' HB2' HD23 ' A' ' 143' ' ' LEU . 9.2 m-30 -130.22 152.14 49.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.085 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.403 ' HZ3' ' HB3' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -138.59 114.79 10.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.276 179.24 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 1.023 HG12 HG22 ' A' ' 42' ' ' VAL . 0.7 OUTLIER -102.59 122.05 54.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 121.229 0.538 . . . . 0.0 111.388 -179.588 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.742 HG23 ' HB2' ' A' ' 9' ' ' ALA . 7.4 p -136.4 161.03 37.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.626 179.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.523 ' N ' HG22 ' A' ' 18' ' ' VAL . 3.7 m120 -63.53 140.02 58.83 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 179.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.1 -38.86 73.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.717 0.294 . . . . 0.0 110.977 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.72 -10.45 58.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.11 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.62 -6.89 13.89 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.724 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.798 ' HB3' ' CZ2' ' A' ' 28' ' ' TRP . . . -80.36 150.68 29.78 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.832 0.348 . . . . 0.0 110.925 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.413 ' O ' ' CE3' ' A' ' 28' ' ' TRP . 43.5 p -103.77 169.17 8.67 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.254 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.647 ' CD2' HG23 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -54.49 -29.56 50.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.917 0.389 . . . . 0.0 110.645 179.87 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.647 HG23 ' CD2' ' A' ' 25' ' ' HIS . 21.5 t -74.28 -31.37 28.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.324 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.445 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 0.5 OUTLIER -67.19 -44.08 80.51 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 179.856 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.798 ' CZ2' ' HB3' ' A' ' 23' ' ' ALA . 7.5 m-90 -73.97 -30.15 62.36 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.884 179.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -58.1 -44.15 87.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.439 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -111.69 28.89 8.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.538 179.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 13.0 t -80.09 136.14 36.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.162 -179.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.504 HG22 ' O ' ' A' ' 42' ' ' VAL . 15.7 m -94.58 -41.61 12.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.753 179.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.612 ' CZ3' HG23 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -139.73 153.2 47.15 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.952 0.406 . . . . 0.0 111.503 -179.465 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -164.6 111.87 1.05 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.897 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 35.7 p-10 -107.26 126.54 52.55 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.017 0.437 . . . . 0.0 111.375 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -67.7 -34.56 77.13 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.295 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.436 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 11.7 p30 -59.75 -22.76 62.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.877 0.37 . . . . 0.0 110.601 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.446 ' HA ' ' NE ' ' A' ' 38' ' ' ARG . 3.2 tpm_? -117.39 -3.91 11.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.06 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 48.66 34.68 5.29 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.07 0.462 . . . . 0.0 110.059 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.776 HD13 HD11 ' A' ' 123' ' ' LEU . 41.5 tp -124.85 152.6 43.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.953 -179.181 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.765 HD12 ' NE1' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -143.78 155.92 44.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.472 179.692 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 1.023 HG22 HG12 ' A' ' 17' ' ' VAL . 24.4 t -121.41 130.33 74.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.152 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.0 p -121.93 157.26 31.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.29 179.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.645 HG22 ' HE1' ' A' ' 15' ' ' TYR . 17.8 p -97.36 125.11 41.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.166 0.508 . . . . 0.0 111.576 -179.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.683 HG21 ' CE1' ' A' ' 11' ' ' TYR . 0.7 OUTLIER -93.39 -31.55 14.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.904 -179.503 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.82 38.07 6.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.893 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -136.78 -175.39 4.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.078 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -71.77 125.85 28.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.895 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.38 173.53 11.24 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.498 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.2 m -142.9 -71.92 0.31 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.847 0.356 . . . . 0.0 110.903 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -67.52 146.67 53.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.007 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.926 ' O ' HG23 ' A' ' 120' ' ' VAL . 62.7 m -120.91 118.97 31.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.579 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.853 HD11 HG21 ' A' ' 12' ' ' VAL . 1.0 OUTLIER -76.56 139.55 18.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.996 -179.84 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.827 ' HB2' ' N ' ' A' ' 119' ' ' GLY . . . -100.81 118.42 36.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.802 179.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.554 ' H ' ' HB3' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -90.77 42.65 1.11 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.104 0.478 . . . . 0.0 110.519 179.701 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 15.6 p -99.7 167.16 10.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.835 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.64 39.32 3.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.43 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 28.9 m -72.85 128.06 34.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.759 0.314 . . . . 0.0 110.526 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.54 -13.03 62.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.961 179.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.5 p -108.38 159.26 16.8 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.952 0.406 . . . . 0.0 111.09 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -177.18 148.84 9.08 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.675 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.784 HG23 ' C ' ' A' ' 72' ' ' TYR . 7.4 p -105.08 136.47 38.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.997 0.427 . . . . 0.0 111.572 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.632 ' HE2' HG21 ' A' ' 74' ' ' VAL . 5.6 p90 -125.1 142.08 51.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.564 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 8.9 t80 . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.915 -179.871 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.689 ' HB3' HG21 ' A' ' 62' ' ' VAL . 5.5 m170 . . . . . 0 N--CA 1.455 -0.18 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.784 ' C ' HG23 ' A' ' 62' ' ' VAL . 3.1 m-85 -110.28 114.01 55.91 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.659 -178.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 72' ' ' TYR . 4.4 Cg_exo -79.14 120.6 4.61 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.534 2.156 . . . . 0.0 110.712 178.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.632 HG21 ' HE2' ' A' ' 63' ' ' TYR . 54.9 t -134.63 141.9 42.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.038 0.446 . . . . 0.0 112.162 -178.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.1 p -95.22 126.45 40.55 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.517 ' HB3' ' HB2' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -130.45 167.65 18.26 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.548 0.69 . . . . 0.0 112.358 -178.279 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.621 ' C ' ' HD3' ' A' ' 79' ' ' PRO . 0.9 OUTLIER -111.79 159.14 18.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.799 178.741 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -110.52 65.97 0.24 Allowed Glycine 0 CA--C 1.522 0.501 0 C-N-CA 120.081 -1.057 . . . . 0.0 114.196 -179.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.621 ' HD3' ' C ' ' A' ' 77' ' ' GLU . 16.2 Cg_exo -66.92 141.66 59.49 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.113 1.875 . . . . 0.0 111.914 179.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -61.59 -94.55 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.777 -0.647 . . . . 0.0 113.089 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.556 HD22 ' HB3' ' A' ' 96' ' ' SER . 0.0 OUTLIER -86.22 119.92 27.02 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.119 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.625 ' HB ' HG11 ' A' ' 98' ' ' VAL . 67.6 t -124.36 122.96 65.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.218 177.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.01 107.68 4.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.042 0.449 . . . . 0.0 110.679 -178.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.81 HG13 ' HG2' ' A' ' 126' ' ' MET . 24.4 t -74.88 114.35 14.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.834 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.448 ' HA ' ' HG2' ' A' ' 92' ' ' LYS . 8.5 pt20 -77.02 150.18 35.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.574 179.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.592 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 23.0 tt0 -67.54 100.35 0.86 Allowed 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.945 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.523 ' O ' ' N ' ' A' ' 89' ' ' TYR . 43.0 t -145.12 159.8 42.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.674 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.401 ' HB3' ' H ' ' A' ' 89' ' ' TYR . 6.0 tt0 50.96 -82.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.664 178.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.523 ' N ' ' O ' ' A' ' 87' ' ' SER . 2.0 p90 -155.91 25.83 0.38 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.846 0.355 . . . . 0.0 110.594 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.592 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 0.3 OUTLIER -116.67 116.45 38.67 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.574 -179.934 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.461 ' O ' ' N ' ' A' ' 93' ' ' ARG . 37.9 Cg_exo -60.4 148.68 89.65 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.88 2.387 . . . . 0.0 112.729 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.2 OUTLIER -61.95 73.07 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.832 179.55 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.461 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -124.14 179.76 4.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.189 0.518 . . . . 0.0 112.027 -179.314 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.441 ' HB3' HD11 ' A' ' 81' ' ' LEU . 11.1 m-85 -99.28 132.26 44.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.642 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.436 ' HA ' ' O ' ' A' ' 37' ' ' ASN . 1.5 mm100 -131.57 130.6 42.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.713 0.292 . . . . 0.0 111.242 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.556 ' HB3' HD22 ' A' ' 81' ' ' LEU . 11.0 p -102.4 147.88 26.17 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.886 0.374 . . . . 0.0 111.736 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 73.74 56.3 0.1 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.876 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.625 HG11 ' HB ' ' A' ' 82' ' ' VAL . 10.0 p -123.57 143.18 37.59 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.036 179.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.446 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 10.7 mp -104.59 143.54 32.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.278 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.711 HD23 ' O ' ' A' ' 132' ' ' VAL . 6.5 mt -133.26 141.5 48.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.041 0.448 . . . . 0.0 112.158 -179.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.517 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . . . -150.99 144.86 25.17 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.971 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 1.2 t -100.28 125.32 46.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.914 0.387 . . . . 0.0 111.021 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.28 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.527 -179.749 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.798 ' O ' HG13 ' A' ' 124' ' ' VAL . . . . . . . . 0 N--CA 1.45 -0.376 0 N-CA-C 112.359 -0.297 . . . . 0.0 112.359 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.56 HD13 HG13 ' A' ' 120' ' ' VAL . 2.5 pp -126.04 146.19 32.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.881 0.372 . . . . 0.0 111.192 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.604 ' HG ' ' HB ' ' A' ' 121' ' ' ILE . 7.9 tp -87.61 115.57 25.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.083 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.99 148.3 42.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.222 0.534 . . . . 0.0 111.718 -179.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.519 ' HB2' HD11 ' A' ' 121' ' ' ILE . 8.2 t -109.4 164.79 12.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.08 179.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.81 -20.41 15.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.807 0.337 . . . . 0.0 110.618 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.506 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . 28.9 m80 -88.9 -36.84 15.72 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.291 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.827 ' N ' ' HB2' ' A' ' 54' ' ' ALA . . . 178.42 -135.3 2.6 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.398 -0.906 . . . . 0.0 113.063 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.926 HG23 ' O ' ' A' ' 52' ' ' THR . 3.9 t -104.38 135.67 41.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.793 0.33 . . . . 0.0 111.402 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.604 ' HB ' ' HG ' ' A' ' 114' ' ' LEU . 1.1 mm -97.86 -67.05 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.774 179.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.952 ' HA2' HG23 ' A' ' 137' ' ' VAL . . . -156.96 -168.34 19.42 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.023 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.776 HD11 HD13 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -116.75 164.45 14.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.637 0.256 . . . . 0.0 110.456 179.913 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.798 HG13 ' O ' ' A' ' 112' ' ' GLY . 31.3 m -71.99 137.78 22.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.933 0.397 . . . . 0.0 111.841 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.518 HG23 ' H ' ' A' ' 126' ' ' MET . 0.0 OUTLIER -130.01 -91.23 0.46 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.168 178.98 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.81 ' HG2' HG13 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -85.94 145.63 27.06 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.333 179.255 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -145.81 107.28 0.41 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.596 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -91.18 -167.2 40.99 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.439 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -92.92 17.2 11.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.661 0.267 . . . . 0.0 111.135 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 102' ' ' THR . . . -158.6 -31.09 0.02 OUTLIER Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.94 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.675 ' CG1' HD22 ' A' ' 100' ' ' LEU . 1.7 t -115.39 157.11 16.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.772 0.32 . . . . 0.0 111.108 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.711 ' O ' HD23 ' A' ' 100' ' ' LEU . 15.2 m -115.73 118.26 58.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.383 -179.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -96.06 122.02 7.16 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.055 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.585 ' HD2' HD22 ' A' ' 114' ' ' LEU . 15.6 m-85 -125.17 139.47 53.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.976 0.417 . . . . 0.0 111.608 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.441 ' N ' HG22 ' A' ' 125' ' ' THR . . . -88.87 115.08 26.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.364 179.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -68.98 140.07 55.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.984 0.421 . . . . 0.0 112.004 -179.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.952 HG23 ' HA2' ' A' ' 122' ' ' GLY . 81.2 t -90.46 9.02 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.511 178.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.559 ' HA ' HD23 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -70.1 -6.58 34.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.619 179.922 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -97.08 11.17 37.15 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.859 ' O ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -175.77 49.17 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.231 0.538 . . . . 0.0 110.61 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.738 HD11 ' HB ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -67.41 -14.75 63.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.997 -179.629 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . 0.422 ' CE3' ' CE2' ' A' ' 15' ' ' TYR . 16.7 p-90 -57.71 80.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.039 0.447 . . . . 0.0 111.495 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.69 HD23 ' HB2' ' A' ' 15' ' ' TYR . 4.9 mp -142.29 -47.28 0.34 Allowed 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.162 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.682 ' OE2' HG23 ' A' ' 52' ' ' THR . 17.4 pt-20 -154.71 -162.98 1.48 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.669 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.69 122.15 16.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.976 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.661 ' OD1' HD12 ' A' ' 141' ' ' LEU . 86.4 m-20 -85.33 154.21 22.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.935 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.554 ' HB3' ' H ' ' A' ' 55' ' ' ARG . . . . . . . . 0 C--N 1.331 -0.218 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.06 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 112.582 -0.207 . . . . 0.0 112.582 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.15 172.41 14.02 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.581 2.187 . . . . 0.0 112.358 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -161.62 -46.71 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.784 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -67.55 134.67 30.66 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.49 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -109.52 149.52 29.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.816 0.341 . . . . 0.0 110.95 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -163.75 143.95 8.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.876 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.3 t -103.3 -44.91 5.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.919 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.68 23.19 66.88 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.588 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -165.9 179.15 6.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.812 0.339 . . . . 0.0 110.996 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.459 HG22 HG21 ' A' ' 113' ' ' ILE . 53.7 t -121.02 109.23 24.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.126 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.934 ' CE2' HG21 ' A' ' 45' ' ' THR . 0.4 OUTLIER -93.88 115.83 28.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.423 179.864 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.956 HG21 HD11 ' A' ' 53' ' ' ILE . 19.2 t -121.29 108.89 23.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.786 0.327 . . . . 0.0 111.816 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 48.35 -124.59 11.63 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.94 -0.648 . . . . 0.0 113.242 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.45 ' O ' ' HA ' ' A' ' 44' ' ' THR . 33.0 p-10 -90.96 13.08 17.64 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.655 ' CB ' HD23 ' A' ' 143' ' ' LEU . 6.6 m-85 -130.34 127.8 40.17 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.461 ' HG3' ' CD1' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -116.4 114.89 24.89 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.561 0.219 . . . . 0.0 110.686 179.687 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 1.067 HG12 HG22 ' A' ' 42' ' ' VAL . 0.7 OUTLIER -100.63 122.08 52.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.119 0.485 . . . . 0.0 110.777 179.68 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.526 HG22 ' N ' ' A' ' 19' ' ' ASN . 10.6 p -136.07 161.03 38.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.152 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.526 ' N ' HG22 ' A' ' 18' ' ' VAL . 4.7 t-20 -59.97 141.51 55.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.558 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 11.8 ttt180 -56.59 -47.12 80.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.855 0.36 . . . . 0.0 110.832 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 41.7 t-80 -69.1 -8.79 48.55 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.15 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 13.9 tp -110.78 -10.87 14.43 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.873 ' HB3' ' CZ2' ' A' ' 28' ' ' TRP . . . -73.27 150.61 41.83 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 120.792 0.329 . . . . 0.0 110.814 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.7 p -103.65 169.32 8.59 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.442 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -54.64 -29.78 53.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.886 0.374 . . . . 0.0 110.543 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.5 t -73.93 -31.42 30.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.42 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.421 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 0.2 OUTLIER -67.29 -44.08 80.15 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.898 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.873 ' CZ2' ' HB3' ' A' ' 23' ' ' ALA . 7.1 m-90 -74.29 -31.33 62.46 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.226 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 9.5 mm-40 -58.22 -43.8 87.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.452 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -113.46 33.39 5.16 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.404 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.476 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 27.2 t -80.05 134.11 36.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.279 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 42' ' ' VAL . 15.3 m -97.28 -39.86 9.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.617 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.612 ' HH2' HD23 ' A' ' 40' ' ' LEU . 1.2 t90 -139.36 153.11 47.62 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.856 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 2.0 tm-20 -160.34 118.15 2.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.959 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -107.1 111.05 23.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.973 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.402 ' CE2' ' OD1' ' A' ' 37' ' ' ASN . 50.5 p90 -59.63 -47.23 86.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.242 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.425 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 2.1 m120 -60.02 -25.94 65.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.793 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.411 ' CZ ' ' HB3' ' A' ' 139' ' ' ASP . 20.7 ttm180 -100.07 -7.7 24.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.302 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 51.06 34.83 11.56 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 121.145 0.497 . . . . 0.0 110.258 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.872 HD11 HG23 ' A' ' 17' ' ' VAL . 13.5 tp -133.71 149.68 51.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.974 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.667 HD12 ' NE1' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -145.0 155.88 43.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.361 179.572 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 1.067 HG22 HG12 ' A' ' 17' ' ' VAL . 38.9 t -118.5 127.37 75.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.626 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.5 p -120.81 157.46 29.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.345 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.633 HG22 ' CE1' ' A' ' 15' ' ' TYR . 10.5 p -97.57 146.59 25.13 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.165 0.507 . . . . 0.0 111.66 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.934 HG21 ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -136.29 165.49 25.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.853 -179.25 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.1 t -93.29 -34.1 13.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.082 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.79 128.6 34.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.1 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -59.09 147.98 32.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.926 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -80.23 177.69 54.21 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.584 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -132.12 33.5 3.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.761 0.315 . . . . 0.0 110.905 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -138.45 144.49 40.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.911 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.85 ' O ' HG23 ' A' ' 120' ' ' VAL . 63.0 m -120.83 115.91 24.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.793 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.956 HD11 HG21 ' A' ' 12' ' ' VAL . 0.4 OUTLIER -73.86 139.54 19.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.018 -179.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.835 ' HB2' ' N ' ' A' ' 119' ' ' GLY . . . -93.38 133.53 36.54 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.402 ' HA ' ' HD2' ' A' ' 138' ' ' ARG . 0.0 OUTLIER -93.54 27.11 2.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.991 0.424 . . . . 0.0 110.402 179.275 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 30.8 p -100.01 167.13 10.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.029 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -127.72 32.42 4.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.89 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 25.2 m -56.61 132.63 52.3 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.791 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.5 t -74.15 -8.61 56.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.969 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.1 p -118.46 130.77 56.14 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.891 0.377 . . . . 0.0 111.073 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -153.33 -167.94 16.45 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.84 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.468 HG23 ' C ' ' A' ' 72' ' ' TYR . 7.5 p -133.75 126.24 50.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.007 0.432 . . . . 0.0 110.885 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.669 ' HE2' HG21 ' A' ' 74' ' ' VAL . 3.1 p90 -111.14 153.91 25.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.102 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -93.14 143.87 25.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.647 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 7.6 t -120.99 137.69 54.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.049 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.82 -45.07 53.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.016 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.7 -50.11 68.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.822 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.1 mmpt? -74.6 -27.52 60.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.882 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 59.57 21.06 9.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.954 0.407 . . . . 0.0 110.859 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.92 170.04 16.2 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.622 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -84.1 139.31 32.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.9 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.468 ' C ' HG23 ' A' ' 62' ' ' VAL . 0.7 OUTLIER -126.47 114.03 23.15 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.661 -178.834 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 72' ' ' TYR . 4.4 Cg_exo -74.54 120.54 6.24 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.356 2.037 . . . . 0.0 110.255 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.697 ' CG1' ' HB1' ' A' ' 101' ' ' ALA . 97.1 t -144.3 147.42 19.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.048 0.452 . . . . 0.0 112.167 -178.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 53.6 p -92.02 137.19 32.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.295 178.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.741 ' HD2' ' HB2' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -146.48 168.43 21.22 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.22 0.534 . . . . 0.0 111.942 -178.882 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -113.0 158.39 20.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.05 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -106.03 68.17 0.24 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.917 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.551 ' HD2' ' HA ' ' A' ' 99' ' ' LEU . 38.0 Cg_endo -67.6 135.16 35.14 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.471 2.114 . . . . 0.0 112.227 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -59.27 -82.8 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.288 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.794 HD11 ' HB3' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -97.08 119.86 36.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.898 0.38 . . . . 0.0 111.749 -179.897 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.627 ' HB ' HG11 ' A' ' 98' ' ' VAL . 46.8 t -124.99 122.18 62.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.217 178.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.13 107.98 5.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.776 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.579 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 19.3 m -81.79 126.85 39.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.236 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.84 150.65 46.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.06 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.555 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 3.9 pt-20 -67.73 102.54 1.23 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.87 0.367 . . . . 0.0 110.431 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.428 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -143.89 164.1 31.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.425 -179.732 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.422 ' HG2' ' CE2' ' A' ' 89' ' ' TYR . 2.8 tt0 56.95 -81.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.543 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.428 ' N ' ' O ' ' A' ' 87' ' ' SER . 0.4 OUTLIER -155.64 22.93 0.4 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.926 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.555 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 9.7 t80 -123.79 136.8 27.78 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.883 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.446 ' O ' ' N ' ' A' ' 93' ' ' ARG . 86.4 Cg_endo -81.76 148.95 15.97 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.09 2.527 . . . . 0.0 112.451 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.579 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -49.2 89.52 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.804 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.572 ' O ' HG22 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -124.13 169.64 11.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.259 0.552 . . . . 0.0 112.209 -179.126 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.794 ' HB3' HD11 ' A' ' 81' ' ' LEU . 2.9 m-85 -90.86 132.46 35.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.928 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.561 ' O ' HD13 ' A' ' 81' ' ' LEU . 10.1 mm-40 -124.5 131.87 53.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.054 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 12.0 p -101.31 147.52 26.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.998 0.428 . . . . 0.0 111.835 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.492 ' CD2' ' HB3' ' A' ' 136' ' ' ASP . 4.2 t60 63.85 55.98 1.55 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.946 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.627 HG11 ' HB ' ' A' ' 82' ' ' VAL . 11.6 p -123.44 135.86 61.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.872 0.368 . . . . 0.0 111.364 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.771 HD11 ' HB2' ' A' ' 136' ' ' ASP . 1.8 mp -104.3 133.42 49.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.161 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.823 ' HA ' ' O ' ' A' ' 132' ' ' VAL . 7.4 mt -116.53 138.54 51.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.18 0.514 . . . . 0.0 112.311 -179.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.741 ' HB2' ' HD2' ' A' ' 76' ' ' PHE . . . -128.47 119.28 24.6 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.565 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 1.7 t -87.37 111.83 21.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.886 0.374 . . . . 0.0 110.648 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -71.74 -165.24 7.13 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.541 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -123.89 29.89 6.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.889 0.376 . . . . 0.0 110.817 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.9 m -159.24 -177.24 6.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.799 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.506 ' HB2' ' HD3' ' A' ' 107' ' ' PRO . 2.0 mt-10 -83.17 -45.18 0.85 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.356 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.506 ' HD3' ' HB2' ' A' ' 106' ' ' GLU . 32.6 Cg_exo -59.4 174.42 1.08 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.326 2.017 . . . . 0.0 112.163 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.67 86.8 1.94 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.61 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -118.39 -63.69 1.38 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.797 0.332 . . . . 0.0 110.809 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -123.59 179.88 4.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.983 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -178.47 -103.94 0.18 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.57 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -143.53 -106.59 0.56 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.671 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.525 HD13 HG13 ' A' ' 120' ' ' VAL . 2.6 pp -126.0 146.18 32.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.922 0.391 . . . . 0.0 111.415 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.728 HD21 ' CZ ' ' A' ' 76' ' ' PHE . 56.2 tp -87.82 115.84 25.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.73 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 18.6 ptt-85 -118.74 143.95 46.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.076 0.465 . . . . 0.0 112.111 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.974 ' HB2' HD11 ' A' ' 121' ' ' ILE . 35.4 t -108.14 166.15 10.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.264 178.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -55.51 -18.13 6.67 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.657 0.265 . . . . 0.0 110.867 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 53.7 m80 -91.33 -36.86 13.6 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.47 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.835 ' N ' ' HB2' ' A' ' 54' ' ' ALA . . . 176.81 -140.82 5.14 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.201 -1.0 . . . . 0.0 113.57 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.85 HG23 ' O ' ' A' ' 52' ' ' THR . 3.6 t -100.72 135.87 34.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 122.536 0.335 . . . . 0.0 111.628 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.974 HD11 ' HB2' ' A' ' 116' ' ' CYS . 3.4 mp -98.94 -64.6 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.517 178.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.661 ' HA2' HG23 ' A' ' 137' ' ' VAL . . . -164.7 -167.02 24.61 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.196 -1.002 . . . . 0.0 113.239 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.685 HD21 HD13 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -117.0 164.15 15.15 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.92 0.39 . . . . 0.0 110.892 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.597 HG13 ' O ' ' A' ' 124' ' ' VAL . 10.3 p -60.35 109.23 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.936 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.81 ' OG1' ' HB2' ' A' ' 135' ' ' ALA . 2.0 m -91.34 -88.6 0.18 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.661 ' N ' HG22 ' A' ' 125' ' ' THR . 0.0 OUTLIER -128.56 162.1 28.04 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.941 0.4 . . . . 0.0 111.205 179.375 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -131.41 157.82 22.48 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.645 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -114.36 -153.89 10.86 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.411 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -71.96 -19.25 61.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.733 0.301 . . . . 0.0 110.998 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -168.71 28.4 0.15 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.547 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.565 ' HB ' HD22 ' A' ' 100' ' ' LEU . 1.4 t -130.03 157.05 42.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.716 0.294 . . . . 0.0 110.874 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.823 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 2.0 t -112.97 118.01 56.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.199 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' ' 126' ' ' MET . . . -99.12 123.7 7.99 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.61 -0.805 . . . . 0.0 111.871 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.515 ' CD2' HD22 ' A' ' 114' ' ' LEU . 52.6 m-85 -125.12 139.29 53.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.95 0.405 . . . . 0.0 111.727 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.81 ' HB2' ' OG1' ' A' ' 125' ' ' THR . . . -88.88 108.13 19.37 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.694 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.771 ' HB2' HD11 ' A' ' 99' ' ' LEU . 1.0 OUTLIER -67.55 143.36 56.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.472 0.653 . . . . 0.0 112.549 -178.095 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.661 HG23 ' HA2' ' A' ' 122' ' ' GLY . 19.3 t -102.24 7.17 9.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.149 178.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.403 ' HB3' ' CZ ' ' A' ' 138' ' ' ARG . 2.1 mmm180 -72.48 -6.29 42.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.435 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.462 ' HB2' ' CD2' ' A' ' 97' ' ' HIS . 4.4 t70 -97.72 -1.99 42.26 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.721 0.296 . . . . 0.0 111.363 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.831 ' O ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -156.1 64.71 0.57 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.464 0.65 . . . . 0.0 109.732 179.548 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.952 HD11 ' HB ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -77.64 -14.48 59.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.267 -0.879 . . . . 0.0 112.458 -178.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . 0.531 ' C ' HD12 ' A' ' 143' ' ' LEU . 14.4 p-90 -53.7 80.19 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.006 0.431 . . . . 0.0 111.216 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.681 HD12 ' C ' ' A' ' 141' ' ' LEU . 4.9 mp -153.36 -48.19 0.09 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.956 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.527 ' HG3' HG12 ' A' ' 12' ' ' VAL . 5.4 mt-10 -156.56 -171.14 3.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.462 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.85 144.24 45.01 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.913 0.387 . . . . 0.0 111.034 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -104.9 154.19 20.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.927 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.649 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . . . -89.13 136.65 32.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.186 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.31 177.57 4.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.948 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -106.37 -32.28 8.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.942 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.838 -179.995 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.213 0 N-CA-C 112.494 -0.243 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -51.97 169.16 0.29 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.582 2.188 . . . . 0.0 112.308 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -95.11 -43.78 7.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.918 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.57 -82.77 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.56 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 24.7 m-70 -100.12 -51.88 3.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.812 0.339 . . . . 0.0 110.944 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.07 111.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.805 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 63.87 131.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.887 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -157.26 37.78 0.55 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.562 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.882 ' HB2' HG23 ' A' ' 18' ' ' VAL . . . -103.66 -174.04 2.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.745 0.307 . . . . 0.0 111.07 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.798 ' HB ' HG21 ' A' ' 113' ' ' ILE . 9.6 p -131.24 113.19 23.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.88 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.544 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 7.9 p90 -112.02 134.43 53.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.979 0.418 . . . . 0.0 111.157 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.581 ' HB ' HD22 ' A' ' 143' ' ' LEU . 93.1 t -119.19 128.25 75.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.439 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 49.54 -126.51 20.51 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 121.142 -0.551 . . . . 0.0 113.175 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.458 ' O ' ' HA ' ' A' ' 44' ' ' THR . 21.1 m-20 -89.56 14.72 10.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.624 0.249 . . . . 0.0 111.453 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.627 ' CE1' HG22 ' A' ' 44' ' ' THR . 7.2 m-85 -128.91 141.44 51.27 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.544 ' HA ' ' HA ' ' A' ' 11' ' ' TYR . 9.3 tttt -127.21 114.82 18.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.651 -0.25 . . . . 0.0 110.748 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 1.023 HG12 HG22 ' A' ' 42' ' ' VAL . 0.6 OUTLIER -102.36 121.74 53.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-O 121.202 0.525 . . . . 0.0 110.749 179.709 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.882 HG23 ' HB2' ' A' ' 9' ' ' ALA . 13.6 p -136.35 160.52 37.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.995 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.502 ' N ' HG22 ' A' ' 18' ' ' VAL . 7.0 t-20 -60.56 141.62 56.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.334 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.43 -47.35 79.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.811 0.339 . . . . 0.0 110.718 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.91 -9.04 53.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.909 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.419 ' HB3' HG22 ' A' ' 18' ' ' VAL . 13.9 tp -109.61 -11.48 14.76 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.652 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.945 ' HB3' ' CZ2' ' A' ' 28' ' ' TRP . . . -70.85 150.67 45.56 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 120.805 0.336 . . . . 0.0 110.826 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 58.6 p -104.67 169.2 8.59 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.329 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -54.72 -29.69 54.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.033 0.444 . . . . 0.0 110.576 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 23.9 t -74.66 -31.34 26.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.4 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.421 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 0.3 OUTLIER -67.16 -44.12 80.53 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.945 ' CZ2' ' HB3' ' A' ' 23' ' ' ALA . 7.2 m-90 -74.54 -30.78 61.89 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.217 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.4 mm100 -58.42 -44.14 88.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.509 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -114.21 34.78 4.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.519 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.47 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 36.9 t -80.1 134.56 36.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.404 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.472 HG22 ' O ' ' A' ' 42' ' ' VAL . 12.5 m -98.96 -39.38 7.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.522 179.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.682 ' CH2' HD23 ' A' ' 40' ' ' LEU . 1.9 t90 -139.39 152.91 47.49 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.989 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -160.86 120.39 2.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.975 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.407 ' HB2' ' CZ2' ' A' ' 33' ' ' TRP . 11.0 m-20 -107.04 111.99 24.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.007 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -61.27 -43.58 98.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.964 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.417 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 4.3 m-20 -65.73 -23.56 66.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.771 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.446 ' CZ ' ' HA ' ' A' ' 38' ' ' ARG . 3.4 tpm_? -105.55 -2.02 24.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.34 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 44.27 37.26 1.87 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.947 0.403 . . . . 0.0 110.818 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.846 HD11 HG23 ' A' ' 17' ' ' VAL . 7.0 tp -133.75 141.72 47.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.694 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.665 ' O ' HD23 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -139.2 155.84 47.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.913 0.387 . . . . 0.0 111.759 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 1.023 HG22 HG12 ' A' ' 17' ' ' VAL . 25.3 t -118.72 129.89 74.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.568 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.8 p -121.84 157.16 31.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.306 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.627 HG22 ' CE1' ' A' ' 15' ' ' TYR . 8.3 p -97.68 124.35 41.96 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.177 0.513 . . . . 0.0 111.628 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -113.65 162.99 15.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.78 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -108.69 37.45 2.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.885 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -126.73 169.42 13.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.044 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 10.4 m80 -83.74 141.12 31.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.861 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.431 ' HA2' ' CE2' ' A' ' 11' ' ' TYR . . . -91.04 152.0 21.44 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.558 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.43 -46.81 2.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.833 0.349 . . . . 0.0 110.909 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.579 ' OD2' HG23 ' A' ' 10' ' ' VAL . 2.8 m-20 -59.82 135.89 57.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.918 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.856 ' O ' HG23 ' A' ' 120' ' ' VAL . 33.2 m -117.27 116.0 26.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.824 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.974 ' HB ' HD11 ' A' ' 141' ' ' LEU . 0.2 OUTLIER -82.5 139.38 17.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.761 179.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -95.51 130.51 42.32 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.839 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.515 ' H ' ' HB3' ' A' ' 147' ' ' ALA . 2.7 ttt180 -93.31 42.5 1.1 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 178.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 8.2 p -99.86 167.31 10.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.955 -1.02 . . . . 0.0 111.501 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -117.66 25.54 10.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.073 178.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 14.8 p -66.51 145.38 55.7 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.061 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.0 m -103.04 13.18 34.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.216 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 56.0 p -132.91 125.32 29.63 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.855 0.359 . . . . 0.0 110.996 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -150.99 165.71 30.29 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.388 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.852 HG23 ' C ' ' A' ' 72' ' ' TYR . 10.6 p -104.51 134.83 44.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.933 0.397 . . . . 0.0 111.338 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.694 ' HE2' HG21 ' A' ' 74' ' ' VAL . 4.9 p90 -110.97 160.44 16.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.843 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -85.11 129.36 34.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.026 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -103.91 141.77 35.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.862 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.634 ' HB2' ' O ' ' A' ' 110' ' ' ALA . . . -92.0 -45.05 8.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.087 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 58.7 m -70.71 -30.7 67.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.923 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.419 ' HG3' ' CE1' ' A' ' 72' ' ' TYR . 0.3 OUTLIER -94.22 -25.67 16.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.101 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.8 t 59.92 23.9 12.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.896 0.379 . . . . 0.0 110.748 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.4 mtpp -134.82 170.21 16.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.731 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.527 ' HB3' HG21 ' A' ' 62' ' ' VAL . 0.0 OUTLIER -84.26 125.21 32.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.925 179.528 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.852 ' C ' HG23 ' A' ' 62' ' ' VAL . 0.6 OUTLIER -111.41 114.39 52.98 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.435 -178.921 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 72' ' ' TYR . 3.4 Cg_exo -74.77 120.66 6.23 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.235 1.956 . . . . 0.0 110.422 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.694 HG21 ' HE2' ' A' ' 63' ' ' TYR . 90.6 t -142.56 144.99 23.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.107 0.479 . . . . 0.0 112.226 -178.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.66 135.78 33.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.39 178.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.802 ' CZ ' HD21 ' A' ' 114' ' ' LEU . 0.1 OUTLIER -141.46 169.66 17.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.226 0.536 . . . . 0.0 111.811 -178.879 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.403 ' O ' ' HD2' ' A' ' 79' ' ' PRO . 11.3 mm-40 -111.85 158.3 19.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.068 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -105.79 68.34 0.25 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.542 -0.837 . . . . 0.0 113.095 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.502 ' HD2' ' HA ' ' A' ' 99' ' ' LEU . 37.6 Cg_endo -67.52 135.44 36.25 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.391 2.06 . . . . 0.0 112.231 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -59.66 -90.82 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.195 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.722 HD11 ' HB3' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -88.32 119.56 28.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.853 0.359 . . . . 0.0 111.497 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.626 ' HB ' HG11 ' A' ' 98' ' ' VAL . 40.1 t -126.99 122.46 60.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.075 178.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -72.54 107.55 5.12 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.934 0.397 . . . . 0.0 110.55 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.579 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 18.3 m -75.24 123.88 31.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.732 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -69.4 150.38 47.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.027 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.547 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 0.6 OUTLIER -67.69 102.67 1.24 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.006 0.432 . . . . 0.0 110.458 -179.474 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.453 ' O ' ' N ' ' A' ' 89' ' ' TYR . 3.5 m -143.87 161.64 38.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.519 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 57.41 -79.14 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.534 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.453 ' N ' ' O ' ' A' ' 87' ' ' SER . 1.3 p90 -159.59 25.38 0.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.699 0.285 . . . . 0.0 110.942 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.547 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 3.6 t80 -124.73 126.09 25.4 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.831 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -69.68 148.77 66.32 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.113 2.542 . . . . 0.0 112.446 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.579 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 1.7 ttpp -53.14 92.26 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.853 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.443 ' O ' HG22 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -123.82 176.55 6.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.184 0.516 . . . . 0.0 112.085 -179.338 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.722 ' HB3' HD11 ' A' ' 81' ' ' LEU . 4.9 m-85 -98.28 132.32 43.86 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.163 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.495 ' O ' HD13 ' A' ' 81' ' ' LEU . 4.4 mt-30 -131.23 132.95 45.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.678 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.483 ' CB ' HD22 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -102.65 142.91 33.03 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.014 0.435 . . . . 0.0 112.06 -179.334 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.44 ' CE1' ' HB3' ' A' ' 139' ' ' ASP . 0.1 OUTLIER 75.76 55.53 0.06 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.064 179.1 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.626 HG11 ' HB ' ' A' ' 82' ' ' VAL . 12.4 p -123.4 139.45 50.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.962 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.502 ' HA ' ' HD2' ' A' ' 79' ' ' PRO . 4.4 mp -105.09 134.0 48.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.168 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.798 ' HA ' ' O ' ' A' ' 132' ' ' VAL . 6.8 mt -117.61 138.64 51.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.131 0.491 . . . . 0.0 112.192 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.722 ' O ' HG23 ' A' ' 132' ' ' VAL . . . -130.02 119.46 23.17 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.597 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 1.7 t -86.02 111.69 20.53 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.849 0.356 . . . . 0.0 110.727 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -85.16 -94.12 0.76 Allowed Glycine 0 C--N 1.331 0.255 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.45 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -156.32 -46.02 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.883 0.373 . . . . 0.0 110.841 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 16.3 t -171.63 80.79 0.07 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.89 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -120.21 89.52 43.38 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.925 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -51.7 -59.79 1.0 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.55 2.167 . . . . 0.0 112.27 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -96.61 -173.0 35.0 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.488 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -156.92 90.75 1.16 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.822 0.344 . . . . 0.0 110.842 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.634 ' O ' ' HB2' ' A' ' 66' ' ' ALA . . . -122.3 64.98 0.94 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.097 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -100.8 -102.61 2.55 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.554 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -178.58 -93.0 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.56 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.798 HG21 ' HB ' ' A' ' 10' ' ' VAL . 31.2 pt -125.99 146.22 32.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.711 0.291 . . . . 0.0 111.074 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.802 HD21 ' CZ ' ' A' ' 76' ' ' PHE . 41.6 tp -87.71 113.02 23.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.65 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.423 ' O ' HG12 ' A' ' 62' ' ' VAL . 25.9 mtm180 -119.56 146.88 45.1 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.474 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.9 ' SG ' HD11 ' A' ' 121' ' ' ILE . 27.2 p -118.99 177.42 4.87 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -56.77 -18.75 13.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.681 0.276 . . . . 0.0 111.251 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -93.3 -32.58 14.26 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 165.64 -133.58 3.01 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.176 -1.011 . . . . 0.0 113.643 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.856 HG23 ' O ' ' A' ' 52' ' ' THR . 20.0 t -107.78 135.67 45.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.774 0.321 . . . . 0.0 111.609 -179.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.9 HD11 ' SG ' ' A' ' 116' ' ' CYS . 2.5 mp -105.26 -52.83 7.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.155 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.679 ' HA2' HG23 ' A' ' 137' ' ' VAL . . . -161.06 -167.08 21.02 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 119.94 -1.124 . . . . 0.0 113.496 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.616 HD11 HD13 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -124.39 164.18 20.21 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.841 0.353 . . . . 0.0 111.021 -179.867 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.401 ' HA ' ' CD1' ' A' ' 134' ' ' PHE . 3.5 m -57.06 114.12 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.802 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.77 ' OG1' ' HB2' ' A' ' 135' ' ' ALA . 2.3 m -105.27 -88.95 0.43 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.01 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.625 ' N ' HG22 ' A' ' 125' ' ' THR . 1.5 tpt -132.28 162.1 31.84 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.247 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -133.23 161.43 24.17 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.513 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -119.26 -154.61 9.59 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.527 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -72.04 -19.08 61.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.691 0.282 . . . . 0.0 110.963 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -168.27 29.71 0.16 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.545 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.534 ' CG1' HD22 ' A' ' 100' ' ' LEU . 1.3 t -132.21 157.1 43.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.785 0.326 . . . . 0.0 111.001 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.798 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 1.8 t -113.72 117.98 56.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.903 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.41 ' HA3' ' O ' ' A' ' 126' ' ' MET . . . -102.07 122.33 7.51 Favored Glycine 0 CA--C 1.516 0.14 0 C-N-CA 120.525 -0.845 . . . . 0.0 111.84 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.489 ' CE2' ' CG1' ' A' ' 132' ' ' VAL . 48.9 m-85 -124.99 144.0 50.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.992 0.425 . . . . 0.0 111.742 -179.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.77 ' HB2' ' OG1' ' A' ' 125' ' ' THR . . . -88.9 114.22 25.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.739 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.435 ' HB2' HD11 ' A' ' 99' ' ' LEU . 7.9 t0 -67.53 137.6 55.88 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -178.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.679 HG23 ' HA2' ' A' ' 122' ' ' GLY . 69.2 t -99.42 3.67 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.943 178.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.497 ' HA ' HD23 ' A' ' 141' ' ' LEU . 0.5 OUTLIER -72.57 -6.27 42.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.43 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.44 ' HB3' ' CE1' ' A' ' 97' ' ' HIS . 1.4 p30 -95.32 3.35 54.54 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.708 0.29 . . . . 0.0 111.345 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.829 ' O ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -162.11 51.8 0.21 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.294 0.569 . . . . 0.0 110.119 179.669 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.974 HD11 ' HB ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -68.59 -14.63 63.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.149 -179.44 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . 0.459 ' C ' HD12 ' A' ' 143' ' ' LEU . 13.2 p-90 -53.86 81.92 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.17 0.51 . . . . 0.0 111.379 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.696 HD12 ' C ' ' A' ' 141' ' ' LEU . 5.0 mp -150.95 -44.84 0.12 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.834 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.534 ' HB2' ' CG1' ' A' ' 12' ' ' VAL . 1.1 tp10 -146.59 -159.23 0.99 Allowed 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.417 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -77.86 149.04 34.38 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.837 0.351 . . . . 0.0 110.988 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -84.84 154.2 22.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.936 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.515 ' HB3' ' H ' ' A' ' 55' ' ' ARG . . . -91.39 136.45 33.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.066 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.49 -175.81 0.2 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.895 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -112.9 147.03 37.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.913 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.182 -0.913 . . . . 0.0 110.909 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.207 0 N-CA-C 112.438 -0.265 . . . . 0.0 112.438 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.23 91.1 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.653 2.235 . . . . 0.0 112.408 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 60.82 174.82 0.1 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.948 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 72.55 -148.18 41.6 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.543 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -146.33 128.69 15.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.864 0.364 . . . . 0.0 110.871 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -74.82 70.57 1.93 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.741 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.3 m -114.55 113.22 24.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.927 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 166.76 -51.63 0.25 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.327 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.648 ' HB2' HG23 ' A' ' 18' ' ' VAL . . . -127.99 163.89 23.53 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.697 0.284 . . . . 0.0 110.937 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.683 ' HB ' HG21 ' A' ' 113' ' ' ILE . 9.0 p -127.59 107.32 16.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.032 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.6 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 6.0 p90 -104.43 129.42 52.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.951 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.896 HG21 HD11 ' A' ' 53' ' ' ILE . 31.2 t -119.28 133.21 66.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.773 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 49.84 -128.39 25.24 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 121.068 -0.586 . . . . 0.0 112.966 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.432 ' O ' ' HA ' ' A' ' 44' ' ' THR . 36.5 m120 -91.35 17.13 8.82 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.673 0.273 . . . . 0.0 111.176 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.683 ' HB2' HD23 ' A' ' 143' ' ' LEU . 9.7 m-85 -129.94 148.45 51.81 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.241 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.6 ' HA ' ' HA ' ' A' ' 11' ' ' TYR . 37.3 tttt -132.26 114.68 14.72 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.696 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.958 HG12 HG22 ' A' ' 42' ' ' VAL . 0.9 OUTLIER -101.94 121.42 52.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-O 121.209 0.528 . . . . 0.0 110.74 179.72 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.658 ' O ' HD12 ' A' ' 40' ' ' LEU . 13.0 p -136.94 161.42 35.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.428 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.51 ' N ' HG22 ' A' ' 18' ' ' VAL . 5.0 m-20 -60.55 141.79 56.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.152 178.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.439 ' HG3' ' N ' ' A' ' 21' ' ' HIS . 7.8 ptm180 -56.34 -46.99 79.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.803 0.335 . . . . 0.0 111.378 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.439 ' N ' ' HG3' ' A' ' 20' ' ' ARG . 4.0 t60 -69.66 -6.45 31.59 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.331 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -115.14 -1.39 13.01 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.68 ' HB3' ' NE1' ' A' ' 28' ' ' TRP . . . -87.29 126.75 35.03 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.238 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.545 ' O ' ' HD1' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -74.79 164.37 26.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.682 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -53.78 -29.71 41.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.332 -179.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.544 HG12 HG23 ' A' ' 24' ' ' THR . 13.8 p -71.86 -31.37 40.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.971 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.95 -44.06 77.64 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.035 0.445 . . . . 0.0 109.828 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.68 ' NE1' ' HB3' ' A' ' 23' ' ' ALA . 39.7 m95 -73.99 -33.44 63.84 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.623 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 13.2 tp60 -56.66 -44.0 80.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.644 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -111.56 30.01 7.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.423 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.437 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 10.8 t -77.3 131.88 38.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.092 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.506 HG22 ' O ' ' A' ' 42' ' ' VAL . 13.1 m -94.04 -39.76 10.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.979 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.608 ' HH2' HD23 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -139.7 153.41 47.23 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.976 0.417 . . . . 0.0 111.8 -179.216 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -158.52 120.52 3.58 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.576 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.425 ' HB2' ' CZ2' ' A' ' 33' ' ' TRP . 14.2 m-20 -106.99 116.92 32.77 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.484 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -66.39 -29.99 70.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.954 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.484 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 26.1 p30 -66.56 -25.89 66.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.057 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 18.0 mtm180 -117.44 -0.97 11.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.459 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 51.22 37.86 19.63 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.898 0.38 . . . . 0.0 110.572 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.861 HD11 HG23 ' A' ' 17' ' ' VAL . 18.4 tp -125.39 152.36 44.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.928 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.64 ' O ' HD23 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -143.93 156.07 44.3 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.944 0.402 . . . . 0.0 111.667 179.627 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.958 HG22 HG12 ' A' ' 17' ' ' VAL . 22.6 t -120.21 129.95 74.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.636 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.9 p -120.49 157.3 29.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.119 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.644 HG22 ' CE1' ' A' ' 15' ' ' TYR . 10.1 p -97.45 123.29 41.24 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.163 0.506 . . . . 0.0 111.596 -179.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -117.33 140.17 49.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.882 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.1 p -95.14 45.97 1.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.98 0.419 . . . . 0.0 110.907 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.94 177.17 5.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.022 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -87.94 121.6 30.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.928 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.435 ' HA2' ' CE2' ' A' ' 11' ' ' TYR . . . -64.44 175.75 11.42 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.441 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 m -154.1 -46.15 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.862 0.363 . . . . 0.0 110.94 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -73.34 143.78 46.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.058 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.923 ' O ' HG23 ' A' ' 120' ' ' VAL . 55.1 m -120.45 119.64 33.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.193 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.896 HD11 HG21 ' A' ' 12' ' ' VAL . 2.9 mm -72.5 139.36 19.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.089 0.471 . . . . 0.0 111.063 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.744 ' O ' ' HB3' ' A' ' 147' ' ' ALA . . . -75.36 -47.89 25.56 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.513 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.417 ' CB ' ' HB2' ' A' ' 146' ' ' ASP . 0.0 OUTLIER 67.93 13.54 9.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.825 -179.34 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.519 ' SG ' ' HB1' ' A' ' 54' ' ' ALA . 23.9 p -99.78 166.92 10.86 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.665 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -121.76 39.28 3.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.124 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 59.5 m -62.7 156.81 22.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.706 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.3 -19.87 20.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.964 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.3 p -116.34 123.91 48.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.946 0.403 . . . . 0.0 111.123 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -140.71 -164.02 9.74 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 121.028 -0.606 . . . . 0.0 111.89 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.654 HG23 ' C ' ' A' ' 72' ' ' TYR . 3.6 p -140.41 130.74 28.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 121.167 0.508 . . . . 0.0 111.815 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.664 ' CD1' ' HB3' ' A' ' 66' ' ' ALA . 24.4 p90 -109.28 126.27 53.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.772 178.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.423 ' HB2' ' CD2' ' A' ' 71' ' ' HIS . 55.6 p90 -115.55 149.77 37.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.993 0.425 . . . . 0.0 111.578 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 40.6 m 61.07 22.76 13.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.642 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.664 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . . . -92.07 -45.13 8.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.86 0.362 . . . . 0.0 110.971 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.41 -39.31 3.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.663 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.447 ' HB3' ' HD3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -125.08 -169.06 1.92 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.522 179.834 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.1 p -97.63 33.49 2.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.015 0.436 . . . . 0.0 110.458 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.447 ' HD3' ' HB3' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -144.2 170.93 15.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.668 -179.389 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.423 ' CD2' ' HB2' ' A' ' 64' ' ' PHE . 13.0 m170 -83.85 139.03 32.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.756 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.654 ' C ' HG23 ' A' ' 62' ' ' VAL . 3.9 m-85 -124.91 114.29 26.62 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.615 -178.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 72' ' ' TYR . 4.7 Cg_exo -74.21 120.78 6.45 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.354 2.036 . . . . 0.0 111.043 178.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.443 ' CG1' ' CE2' ' A' ' 76' ' ' PHE . 2.3 p -139.78 158.8 27.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.034 0.445 . . . . 0.0 111.923 -179.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.9 m -102.04 123.91 46.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.424 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.696 ' CZ ' HD11 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -125.11 161.78 26.05 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.41 0.624 . . . . 0.0 111.771 -179.259 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.442 ' O ' ' HD2' ' A' ' 79' ' ' PRO . 4.6 mt-10 -111.79 158.77 18.98 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.349 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -104.76 67.22 0.28 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.412 -0.899 . . . . 0.0 113.187 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.442 ' HD2' ' O ' ' A' ' 77' ' ' GLU . 41.7 Cg_endo -67.72 135.47 35.81 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.375 2.05 . . . . 0.0 112.07 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -60.84 -86.77 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.682 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.664 HD22 ' HB3' ' A' ' 96' ' ' SER . 0.0 OUTLIER -94.62 119.85 33.93 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -179.365 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.607 ' HB ' HG11 ' A' ' 98' ' ' VAL . 80.0 t -124.63 123.28 65.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.344 178.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.436 ' HG3' ' CZ ' ' A' ' 94' ' ' TYR . 0.1 OUTLIER -72.14 107.86 5.03 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.019 0.438 . . . . 0.0 111.037 -178.826 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.91 HG23 ' HG2' ' A' ' 126' ' ' MET . 2.2 p -73.31 114.41 12.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.486 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -76.27 150.23 37.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.56 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.693 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 28.0 tt0 -68.0 101.04 1.05 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.122 0.487 . . . . 0.0 110.505 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.43 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.5 OUTLIER -144.7 143.01 30.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.875 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 59.25 -80.21 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.423 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.43 ' N ' ' O ' ' A' ' 87' ' ' SER . 0.8 OUTLIER -152.11 22.18 0.66 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.658 0.266 . . . . 0.0 111.173 -179.945 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.693 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 0.8 OUTLIER -110.51 114.64 54.87 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.302 179.68 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -60.98 148.26 93.26 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.728 2.285 . . . . 0.0 112.888 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -67.77 71.51 0.14 Allowed 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.598 179.507 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.443 ' O ' HG12 ' A' ' 84' ' ' VAL . 1.4 ttm180 -123.61 -174.55 3.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.914 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.436 ' CZ ' ' HG3' ' A' ' 83' ' ' GLU . 13.6 m-85 -96.51 132.43 42.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.822 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.484 ' HA ' ' O ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -131.1 126.56 36.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.039 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.664 ' HB3' HD22 ' A' ' 81' ' ' LEU . 15.1 p -101.58 161.45 13.63 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.162 0.506 . . . . 0.0 111.926 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 61.63 57.57 2.23 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.565 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.607 HG11 ' HB ' ' A' ' 82' ' ' VAL . 4.8 p -123.55 143.45 36.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.758 0.313 . . . . 0.0 111.37 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.405 ' HA ' ' HD2' ' A' ' 79' ' ' PRO . 7.5 mp -107.29 143.31 35.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.804 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.73 HD23 ' O ' ' A' ' 132' ' ' VAL . 5.1 mt -133.01 139.42 47.22 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -179.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.556 ' HB2' ' CD2' ' A' ' 76' ' ' PHE . . . -143.71 146.64 33.33 Favored 'General case' 0 CA--C 1.522 -0.109 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.728 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 1.2 t -104.54 131.42 51.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.932 0.396 . . . . 0.0 111.192 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -134.13 63.45 0.61 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.424 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -58.21 95.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.867 0.365 . . . . 0.0 111.083 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 69.7 m -154.45 -46.48 0.09 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.9 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.31 154.72 36.41 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.888 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_exo -51.85 140.9 46.99 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.596 2.197 . . . . 0.0 112.196 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -134.22 167.08 23.91 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.662 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -170.65 -57.63 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.832 0.348 . . . . 0.0 110.886 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -131.51 148.91 52.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.984 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.438 ' H ' HG21 ' A' ' 124' ' ' VAL . . . -145.74 -153.55 5.91 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.535 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -112.1 -108.48 2.98 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.478 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.683 HG21 ' HB ' ' A' ' 10' ' ' VAL . 24.8 pt -126.08 146.49 31.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.822 0.344 . . . . 0.0 111.326 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.696 HD11 ' CZ ' ' A' ' 76' ' ' PHE . 11.5 tp -87.44 122.2 30.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.109 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.416 ' N ' HD12 ' A' ' 114' ' ' LEU . 27.5 mtp180 -118.26 138.74 52.15 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.254 0.549 . . . . 0.0 112.064 -178.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.446 ' HB2' ' CD1' ' A' ' 121' ' ' ILE . 15.1 t -106.03 166.51 10.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.614 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -55.77 -19.7 12.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.64 0.257 . . . . 0.0 111.031 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.424 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . 31.4 m80 -89.66 -35.92 15.54 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.514 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.501 ' C ' ' HB2' ' A' ' 54' ' ' ALA . . . 169.32 -142.41 7.31 Favored Glycine 0 C--O 1.227 -0.316 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.561 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.923 HG23 ' O ' ' A' ' 52' ' ' THR . 3.4 t -89.73 135.22 26.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.562 0.22 . . . . 0.0 110.704 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.446 ' CD1' ' HB2' ' A' ' 116' ' ' CYS . 6.3 mt -106.32 -52.75 7.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 121.051 -0.259 . . . . 0.0 111.05 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.702 ' HA2' HG23 ' A' ' 137' ' ' VAL . . . -161.74 -174.68 31.91 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.088 -1.053 . . . . 0.0 113.239 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.786 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 0.0 OUTLIER -121.16 164.06 17.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.833 0.349 . . . . 0.0 110.824 179.884 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.438 HG21 ' H ' ' A' ' 111' ' ' GLY . 13.7 p -55.47 127.14 13.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.767 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.665 ' OG1' ' HB2' ' A' ' 135' ' ' ALA . 3.2 m -120.56 -90.35 0.58 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.045 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.91 ' HG2' HG23 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -122.65 125.89 46.53 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.977 0.418 . . . . 0.0 111.301 179.618 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -110.26 128.48 8.86 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.606 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -83.95 -159.9 29.79 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.533 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -71.9 -19.38 61.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.75 0.31 . . . . 0.0 111.217 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -158.42 20.22 0.33 Allowed Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.678 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.672 ' CG1' HD22 ' A' ' 100' ' ' LEU . 1.3 t -129.17 157.07 42.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.755 0.312 . . . . 0.0 110.769 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.73 ' O ' HD23 ' A' ' 100' ' ' LEU . 18.8 m -115.19 118.35 58.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.212 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.452 ' HA3' ' O ' ' A' ' 126' ' ' MET . . . -100.64 109.54 3.7 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.074 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.456 ' CD2' ' HB2' ' A' ' 114' ' ' LEU . 61.1 m-85 -111.16 139.79 46.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.746 0.308 . . . . 0.0 110.912 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.786 ' HB3' ' CD2' ' A' ' 123' ' ' LEU . . . -88.57 120.56 30.07 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -67.36 137.1 55.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.197 0.522 . . . . 0.0 112.355 -178.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.702 HG23 ' HA2' ' A' ' 122' ' ' GLY . 95.1 t -90.53 7.85 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.474 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.613 ' HA ' HD23 ' A' ' 141' ' ' LEU . 8.8 mtm180 -70.49 -6.44 36.04 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.812 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.6 11.18 39.2 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.608 0.242 . . . . 0.0 111.581 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.834 ' O ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -173.14 48.67 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.256 0.551 . . . . 0.0 110.374 179.811 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.613 HD23 ' HA ' ' A' ' 138' ' ' ARG . 0.2 OUTLIER -67.67 -14.93 63.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.015 -179.551 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . 0.416 ' CE3' ' CE2' ' A' ' 15' ' ' TYR . 12.3 p-90 -56.65 82.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.069 0.461 . . . . 0.0 111.693 -179.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.683 HD23 ' HB2' ' A' ' 15' ' ' TYR . 5.1 mp -149.06 -47.29 0.14 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.805 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.455 ' HB2' HG12 ' A' ' 12' ' ' VAL . 0.5 OUTLIER -158.32 -168.89 2.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.418 179.895 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 14.7 p30 -58.83 138.94 57.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.851 0.358 . . . . 0.0 111.044 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.417 ' HB2' ' CB ' ' A' ' 55' ' ' ARG . 3.9 p-10 -105.01 154.11 20.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.999 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.744 ' HB3' ' O ' ' A' ' 54' ' ' ALA . . . -100.18 151.66 21.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.098 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 1.8 ttp -155.88 -57.75 0.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.948 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -61.58 171.08 1.63 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.863 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.895 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.181 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.56 -28.02 26.71 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.595 2.196 . . . . 0.0 112.269 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -127.12 -63.95 1.03 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.934 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 76.55 88.98 0.28 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.567 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 41.6 t60 -107.13 85.08 2.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.918 0.39 . . . . 0.0 110.874 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -63.28 -31.03 72.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.969 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.2 m -59.66 151.51 24.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.882 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -156.58 140.77 7.43 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.614 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -125.46 -172.72 2.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.727 0.298 . . . . 0.0 111.052 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.607 HG22 HG21 ' A' ' 113' ' ' ILE . 39.2 t -112.94 103.01 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.001 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.912 ' CE2' HG21 ' A' ' 45' ' ' THR . 6.1 t80 -97.85 115.93 29.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.856 0.36 . . . . 0.0 110.631 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.877 HG21 HD11 ' A' ' 53' ' ' ILE . 32.8 t -121.21 108.96 23.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.517 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.405 ' O ' ' CE1' ' A' ' 11' ' ' TYR . . . 54.24 -128.75 41.99 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.897 -0.668 . . . . 0.0 113.309 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.432 ' O ' ' HA ' ' A' ' 44' ' ' THR . 22.6 m120 -88.75 13.26 12.83 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 111.706 0.262 . . . . 0.0 111.706 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.658 ' HE1' HG22 ' A' ' 44' ' ' THR . 5.7 m-30 -130.3 127.95 40.54 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -118.97 114.74 23.03 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 121.124 -0.23 . . . . 0.0 110.688 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.985 HG12 HG22 ' A' ' 42' ' ' VAL . 0.7 OUTLIER -101.07 121.66 52.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.231 0.538 . . . . 0.0 110.993 179.91 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.682 ' O ' HD12 ' A' ' 40' ' ' LEU . 14.1 p -136.7 161.36 36.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.047 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.506 ' N ' HG22 ' A' ' 18' ' ' VAL . 9.0 m120 -58.91 141.49 53.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.376 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.425 ' CD ' ' N ' ' A' ' 21' ' ' HIS . 0.0 OUTLIER -56.54 -47.09 80.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.874 0.369 . . . . 0.0 111.294 -179.339 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.425 ' N ' ' CD ' ' A' ' 20' ' ' ARG . 13.3 p80 -68.36 -9.83 50.81 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.162 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.3 2.32 13.97 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.703 ' HB3' ' NE1' ' A' ' 28' ' ' TRP . . . -87.34 130.27 34.69 Favored 'General case' 0 C--N 1.334 -0.081 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.189 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.51 ' O ' ' HD1' ' A' ' 28' ' ' TRP . 41.9 p -74.69 163.04 28.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.742 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 61.1 m-70 -53.74 -29.71 40.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.975 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.2 t -70.33 -31.91 48.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.83 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -68.09 -44.25 76.69 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.123 0.487 . . . . 0.0 109.707 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.703 ' NE1' ' HB3' ' A' ' 23' ' ' ALA . 40.6 m95 -74.13 -33.14 63.46 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.702 179.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -56.79 -44.12 81.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.726 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -114.46 30.99 6.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.372 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.498 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 13.8 t -72.61 126.63 30.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.128 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.562 ' CG2' HG12 ' A' ' 42' ' ' VAL . 18.4 m -88.9 -40.77 13.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.626 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.73 ' CE3' HG23 ' A' ' 42' ' ' VAL . 0.5 OUTLIER -139.75 153.21 47.12 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.916 0.388 . . . . 0.0 111.227 -179.94 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -157.61 119.37 3.69 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.974 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -107.13 117.73 34.84 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.133 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 19.4 p90 -68.2 -36.79 80.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.106 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.43 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 74.0 m-20 -70.13 -12.9 61.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.871 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.0 mpt_? -117.2 -6.35 11.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.178 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 50.77 36.04 13.47 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-O 121.074 0.464 . . . . 0.0 110.295 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.81 HD11 HG23 ' A' ' 17' ' ' VAL . 36.7 tp -132.85 153.19 51.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.931 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.707 ' O ' HD23 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -147.83 155.63 41.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.491 179.682 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.985 HG22 HG12 ' A' ' 17' ' ' VAL . 38.2 t -115.78 130.68 70.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.337 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.0 p -123.29 157.24 33.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.637 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.658 HG22 ' HE1' ' A' ' 15' ' ' TYR . 30.1 p -97.65 145.13 26.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.189 0.518 . . . . 0.0 111.793 -178.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.912 HG21 ' CE2' ' A' ' 11' ' ' TYR . 0.2 OUTLIER -140.02 171.28 14.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.841 -179.253 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.551 ' O ' HG23 ' A' ' 46' ' ' THR . 10.8 t -124.48 62.32 1.12 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.93 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.463 ' HB3' ' OH ' ' A' ' 11' ' ' TYR . . . -135.51 -173.54 3.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.978 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -90.83 142.88 27.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.866 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.58 159.45 30.46 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.556 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -142.23 -46.7 0.34 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.743 0.306 . . . . 0.0 110.956 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -103.23 142.5 34.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.025 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.925 ' O ' HG23 ' A' ' 120' ' ' VAL . 91.7 m -120.08 120.85 37.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.286 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.877 HD11 HG21 ' A' ' 12' ' ' VAL . 0.9 OUTLIER -75.09 139.61 18.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.909 0.385 . . . . 0.0 110.921 -179.811 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.81 ' HB2' ' N ' ' A' ' 119' ' ' GLY . . . -94.91 127.19 40.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.107 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.62 ' H ' ' HB3' ' A' ' 147' ' ' ALA . 0.1 OUTLIER -92.33 34.76 1.02 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.528 179.452 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 26.5 p -99.65 160.5 14.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.874 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.69 34.79 4.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.084 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 66.5 m -58.28 126.87 29.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.707 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.3 m -68.92 -17.7 64.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.881 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 75' ' ' SER . 1.4 t -129.74 151.01 50.79 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.023 0.439 . . . . 0.0 111.319 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.451 ' N ' ' CE1' ' A' ' 76' ' ' PHE . . . -154.92 -148.24 4.94 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.688 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.617 HG23 ' C ' ' A' ' 72' ' ' TYR . 7.1 p -140.08 123.57 17.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.015 0.436 . . . . 0.0 111.385 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.426 ' CZ ' ' HB3' ' A' ' 72' ' ' TYR . 8.5 p90 -94.87 172.06 8.39 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.892 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.85 122.53 44.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.849 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -86.57 144.27 27.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.01 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.88 -43.63 9.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.165 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.6 t -80.95 -50.71 9.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.888 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.3 mmtm -65.28 -23.89 67.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.079 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 55.72 26.05 8.97 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.055 0.455 . . . . 0.0 110.803 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.2 mtpt -134.05 170.11 16.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.876 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.581 ' HB2' HG21 ' A' ' 62' ' ' VAL . 9.2 p80 -84.24 131.96 34.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.272 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.617 ' C ' HG23 ' A' ' 62' ' ' VAL . 1.2 m-85 -121.98 114.45 30.93 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.06 -179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 62' ' ' VAL . 4.9 Cg_exo -76.49 120.82 5.74 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.5 2.134 . . . . 0.0 111.529 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.448 ' CG1' ' CE2' ' A' ' 76' ' ' PHE . 2.9 p -136.6 156.75 35.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.973 0.416 . . . . 0.0 111.773 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.468 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 59.0 p -97.41 123.34 41.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.71 178.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.617 ' CZ ' HD11 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -124.39 163.44 21.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.373 0.606 . . . . 0.0 111.78 -179.411 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.445 ' O ' ' HD2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -111.72 158.72 19.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.224 179.024 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -104.87 65.51 0.3 Allowed Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.364 -0.922 . . . . 0.0 113.716 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.451 ' HD2' ' HA ' ' A' ' 99' ' ' LEU . 41.6 Cg_endo -67.84 134.63 32.88 Favored 'Trans proline' 0 C--O 1.238 0.501 0 C-N-CA 122.254 1.97 . . . . 0.0 112.011 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -59.89 -86.82 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.981 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.608 HD22 ' HB3' ' A' ' 96' ' ' SER . 0.0 OUTLIER -96.25 119.76 35.32 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -179.227 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.619 ' HB ' HG11 ' A' ' 98' ' ' VAL . 87.1 t -122.99 122.85 66.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.341 178.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.28 109.61 6.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.067 0.46 . . . . 0.0 111.206 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.836 HG23 ' HG3' ' A' ' 126' ' ' MET . 1.2 p -72.79 114.54 12.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.452 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -75.06 149.53 39.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.326 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.573 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 2.4 tm-20 -68.51 101.3 1.23 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.044 0.45 . . . . 0.0 110.458 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.477 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.4 OUTLIER -144.79 155.11 43.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.047 179.816 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 51.41 -83.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.611 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.477 ' N ' ' O ' ' A' ' 87' ' ' SER . 0.6 OUTLIER -145.67 19.75 1.49 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.835 0.35 . . . . 0.0 110.905 179.771 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.573 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 1.4 m-85 -107.88 140.35 21.53 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.538 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.421 ' O ' ' N ' ' A' ' 93' ' ' ARG . 81.5 Cg_endo -86.35 148.5 8.95 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.095 2.53 . . . . 0.0 112.9 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -65.36 70.44 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.896 179.724 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.421 ' N ' ' O ' ' A' ' 91' ' ' PRO . 14.1 mtp180 -123.52 -175.03 3.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.995 0.426 . . . . 0.0 111.741 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.546 ' HB3' HD11 ' A' ' 81' ' ' LEU . 8.3 m-85 -98.47 132.7 43.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.205 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.657 HE22 HG23 ' A' ' 125' ' ' THR . 4.7 mt-30 -128.44 126.83 41.35 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.704 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.608 ' HB3' HD22 ' A' ' 81' ' ' LEU . 24.6 p -99.58 161.04 13.85 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.174 0.511 . . . . 0.0 112.332 -178.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 57.84 60.22 2.86 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.878 179.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.619 HG11 ' HB ' ' A' ' 82' ' ' VAL . 6.1 p -123.66 142.39 40.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 C-N-CA 120.894 -0.323 . . . . 0.0 111.093 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.569 HD13 ' CG ' ' A' ' 136' ' ' ASP . 10.7 mp -107.67 141.37 39.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.269 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.726 HD23 ' C ' ' A' ' 132' ' ' VAL . 6.3 mt -128.08 136.56 51.37 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.551 ' HB2' ' CB ' ' A' ' 76' ' ' PHE . . . -142.3 142.17 32.51 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.077 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 1.7 t -97.37 121.64 39.5 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.066 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -139.84 -110.83 0.9 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.524 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -126.06 89.93 3.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.792 0.33 . . . . 0.0 110.843 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 37.7 m -101.1 62.69 0.98 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.91 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.498 ' N ' ' HD2' ' A' ' 107' ' ' PRO . 0.6 OUTLIER -73.77 -49.0 6.36 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.28 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 106' ' ' GLU . 72.1 Cg_endo -76.64 -172.43 1.4 Allowed 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.197 1.931 . . . . 0.0 112.345 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -133.0 39.44 1.74 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.478 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -120.91 178.63 4.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.842 0.353 . . . . 0.0 110.942 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -147.82 175.53 10.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.154 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 128.4 135.65 4.05 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.476 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.874 ' O ' HG23 ' A' ' 124' ' ' VAL . . . 126.56 175.25 14.07 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.468 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.607 HG21 HG22 ' A' ' 10' ' ' VAL . 17.6 pt -126.31 146.41 32.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.705 0.288 . . . . 0.0 111.302 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.738 HD22 ' HD2' ' A' ' 134' ' ' PHE . 20.6 tp -87.36 119.88 28.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.32 -0.4 . . . . 0.0 109.997 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 28.1 mtp85 -118.12 151.9 36.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.247 0.546 . . . . 0.0 111.648 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.486 ' HB2' HD11 ' A' ' 121' ' ' ILE . 4.2 t -119.03 160.92 21.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.175 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.421 ' CG ' ' CE1' ' A' ' 118' ' ' HIS . 3.0 pt-20 -56.29 -18.88 11.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.756 0.312 . . . . 0.0 110.925 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.428 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . 13.2 m80 -93.65 -33.66 13.58 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.656 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.81 ' N ' ' HB2' ' A' ' 54' ' ' ALA . . . 176.39 -138.67 4.18 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.408 -0.901 . . . . 0.0 113.102 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.925 HG23 ' O ' ' A' ' 52' ' ' THR . 4.9 t -102.57 135.56 39.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.765 0.317 . . . . 0.0 111.286 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.525 ' HB ' ' HG ' ' A' ' 114' ' ' LEU . 1.0 OUTLIER -99.03 -66.9 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.956 179.524 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.922 ' HA2' HG23 ' A' ' 137' ' ' VAL . . . -161.33 -164.4 16.15 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.698 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.585 HD21 HD22 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -116.94 164.24 14.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.701 0.286 . . . . 0.0 110.718 -179.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.874 HG23 ' O ' ' A' ' 112' ' ' GLY . 61.3 t -66.31 126.35 25.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.758 0.313 . . . . 0.0 111.188 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.732 ' OG1' ' HB2' ' A' ' 135' ' ' ALA . 2.9 m -109.45 -90.01 0.47 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.445 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.836 ' HG3' HG23 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -127.91 125.87 40.42 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 121.022 0.439 . . . . 0.0 111.742 179.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -107.87 128.33 9.11 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.66 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -81.69 -162.42 29.71 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.511 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -71.82 -19.72 61.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.71 0.291 . . . . 0.0 111.132 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -146.93 -7.27 0.28 Allowed Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.795 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.608 ' CG1' HD22 ' A' ' 100' ' ' LEU . 1.6 t -115.94 157.12 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 117.289 0.544 . . . . 0.0 110.927 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.726 ' C ' HD23 ' A' ' 100' ' ' LEU . 11.8 m -114.75 118.63 59.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.563 -179.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 126' ' ' MET . . . -97.68 118.7 6.17 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.47 -0.872 . . . . 0.0 112.041 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.738 ' HD2' HD22 ' A' ' 114' ' ' LEU . 11.5 m-85 -120.28 143.96 48.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.01 0.433 . . . . 0.0 111.637 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.732 ' HB2' ' OG1' ' A' ' 125' ' ' THR . . . -90.44 110.83 21.93 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.937 178.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.569 ' CG ' HD13 ' A' ' 99' ' ' LEU . 2.6 m-20 -67.97 143.61 55.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.095 0.474 . . . . 0.0 111.889 -178.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.922 HG23 ' HA2' ' A' ' 122' ' ' GLY . 92.8 t -90.05 9.86 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.624 179.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.661 ' HA ' HD23 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -70.23 -7.94 46.13 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.528 179.758 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -90.21 8.11 34.74 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.892 HD23 HG21 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -172.34 42.02 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.067 0.461 . . . . 0.0 110.899 179.886 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.719 HD11 ' HB ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -58.72 -14.99 9.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.229 -179.858 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . 0.437 ' CD1' ' HA ' ' A' ' 140' ' ' LEU . 16.1 p-90 -59.09 79.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.862 0.363 . . . . 0.0 111.327 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.676 HD22 ' HB ' ' A' ' 12' ' ' VAL . 4.7 mp -137.54 -45.98 0.55 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.469 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.462 ' HG2' ' CG1' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -165.58 -162.46 0.58 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.74 179.707 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -58.82 131.0 49.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.94 0.4 . . . . 0.0 111.189 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.483 ' HB2' ' HB2' ' A' ' 55' ' ' ARG . 3.7 p30 -105.0 154.25 20.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.639 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.62 ' HB3' ' H ' ' A' ' 55' ' ' ARG . . . -65.87 153.21 42.59 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.843 0.354 . . . . 0.0 111.142 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 58.97 71.5 0.58 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.853 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.03 177.45 4.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.919 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.918 179.967 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.228 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -69.51 127.93 15.51 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.553 2.169 . . . . 0.0 112.304 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -103.75 115.24 30.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.943 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.97 -48.48 85.87 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.443 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 63.43 140.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.766 0.317 . . . . 0.0 110.961 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 61.05 87.24 0.09 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.895 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.1 m 61.14 179.81 0.11 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.021 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -161.29 -76.02 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.349 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.826 ' HB2' HG23 ' A' ' 18' ' ' VAL . . . 60.39 -167.47 0.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.781 0.324 . . . . 0.0 111.232 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.632 HG13 HG22 ' A' ' 17' ' ' VAL . 8.3 p -126.82 106.26 15.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.939 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.512 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 2.5 p90 -103.13 127.46 50.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.916 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.69 HG21 HD11 ' A' ' 53' ' ' ILE . 39.2 t -119.06 133.21 66.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.67 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 50.89 -130.51 31.83 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.885 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.401 ' O ' ' HA ' ' A' ' 44' ' ' THR . 9.0 m-20 -91.35 18.62 6.89 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.741 0.305 . . . . 0.0 111.073 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.681 ' HB2' HD23 ' A' ' 143' ' ' LEU . 9.7 m-85 -129.87 144.2 51.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.119 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -127.7 114.72 17.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.587 179.386 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 1.008 HG12 HG22 ' A' ' 42' ' ' VAL . 0.7 OUTLIER -103.08 121.77 54.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-O 121.237 0.541 . . . . 0.0 111.024 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.826 HG23 ' HB2' ' A' ' 9' ' ' ALA . 7.3 p -136.47 160.55 37.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.076 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.507 ' N ' HG22 ' A' ' 18' ' ' VAL . 11.8 t-20 -59.71 141.51 55.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.463 179.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.43 -47.11 79.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.895 0.379 . . . . 0.0 110.908 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -68.86 -9.06 49.34 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.242 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.4 ' HB3' HG22 ' A' ' 18' ' ' VAL . 1.7 tp -109.58 -11.65 14.76 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.947 ' HB3' ' CZ2' ' A' ' 28' ' ' TRP . . . -70.39 150.48 46.22 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 120.81 0.338 . . . . 0.0 110.875 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.567 ' OG1' HG12 ' A' ' 26' ' ' VAL . 67.1 p -104.97 168.89 8.76 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.447 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -54.69 -29.79 53.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.972 0.415 . . . . 0.0 110.704 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.567 HG12 ' OG1' ' A' ' 24' ' ' THR . 8.2 p -76.47 -31.03 19.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.324 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.435 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 7.7 m-20 -66.27 -44.05 84.7 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.947 ' CZ2' ' HB3' ' A' ' 23' ' ' ALA . 6.7 m-90 -74.26 -30.12 61.99 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.872 179.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -57.3 -44.16 83.86 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.431 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -114.25 31.86 6.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.436 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.452 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 14.3 t -79.6 129.07 34.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.171 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.493 HG22 ' O ' ' A' ' 42' ' ' VAL . 12.7 m -91.47 -39.89 12.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.719 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.598 ' HH2' HD23 ' A' ' 40' ' ' LEU . 0.6 OUTLIER -139.43 152.4 47.03 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.01 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -159.83 117.41 2.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.977 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -107.03 118.33 36.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.232 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -65.96 -42.23 90.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.925 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.459 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 8.8 m-20 -66.63 -14.53 62.55 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.99 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.4 mtm180 -114.89 0.64 13.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.234 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.2 p30 42.54 38.99 1.41 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.996 0.427 . . . . 0.0 110.809 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.841 HD11 HG23 ' A' ' 17' ' ' VAL . 23.5 tp -137.12 152.15 49.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.091 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.683 HD11 ' CB ' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -147.79 155.72 41.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.153 179.455 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 1.008 HG22 HG12 ' A' ' 17' ' ' VAL . 29.3 t -119.78 129.97 74.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.94 0.4 . . . . 0.0 110.818 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.7 p -120.33 156.95 30.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.181 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.64 HG22 ' CE1' ' A' ' 15' ' ' TYR . 13.5 p -97.79 123.85 41.91 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.174 0.512 . . . . 0.0 111.542 -179.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -115.1 164.98 13.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.859 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.64 46.86 0.9 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.797 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -151.93 144.82 24.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.101 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 9.2 m170 -67.7 148.07 51.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.803 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.454 ' HA2' ' CE2' ' A' ' 11' ' ' TYR . . . -82.92 135.82 14.45 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.597 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 8.2 t -95.67 19.14 11.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.703 0.287 . . . . 0.0 111.037 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -135.27 145.9 48.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.751 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.903 ' O ' HG23 ' A' ' 120' ' ' VAL . 28.0 m -119.54 117.62 28.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.603 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.836 ' HB ' HD11 ' A' ' 141' ' ' LEU . 0.5 OUTLIER -77.05 139.52 18.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.748 -179.873 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.688 ' HB2' ' N ' ' A' ' 119' ' ' GLY . . . -93.21 132.21 37.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.225 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.652 ' H ' ' HB3' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -92.1 28.7 1.8 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.391 179.316 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 28.1 p -99.56 166.08 11.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.965 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.62 34.44 4.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.709 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 40.7 m -55.18 131.37 45.12 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.082 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.7 m -72.47 -11.46 60.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.619 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.1 p -120.26 153.51 36.25 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.765 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -171.29 -164.14 26.46 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.892 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.739 HG23 ' C ' ' A' ' 72' ' ' TYR . 10.2 p -139.66 128.08 26.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.962 0.411 . . . . 0.0 111.18 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.813 ' CD1' ' HB3' ' A' ' 66' ' ' ALA . 17.7 p90 -99.02 133.61 43.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.752 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.45 ' HB2' ' CD2' ' A' ' 71' ' ' HIS . 77.5 t80 -109.46 131.55 54.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.471 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 69' ' ' SER . 4.1 t 54.77 23.05 4.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.725 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.813 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . . . -71.59 -45.02 63.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.023 0.439 . . . . 0.0 110.461 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.5 m -160.2 20.49 0.15 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.196 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -148.7 6.72 0.73 Allowed 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.444 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 0.4 OUTLIER 52.35 21.93 1.88 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.769 0.319 . . . . 0.0 111.087 -179.649 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 69' ' ' SER . 0.5 OUTLIER -146.71 170.66 16.5 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.57 -179.504 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.532 ' HD2' HG22 ' A' ' 62' ' ' VAL . 0.2 OUTLIER -83.46 119.26 24.45 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.244 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.739 ' C ' HG23 ' A' ' 62' ' ' VAL . 0.5 OUTLIER -122.1 114.28 30.84 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.754 -178.36 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.405 ' N ' HG23 ' A' ' 62' ' ' VAL . 13.9 Cg_exo -68.79 120.59 7.49 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 121.987 1.791 . . . . 0.0 110.284 178.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.459 ' CG1' ' CE2' ' A' ' 76' ' ' PHE . 2.2 p -142.51 153.43 17.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.973 0.416 . . . . 0.0 111.782 -178.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.5 m -97.05 125.52 41.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.886 178.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.731 ' CD2' ' HB2' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -130.74 161.23 32.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.442 0.639 . . . . 0.0 111.793 -179.506 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.681 ' C ' ' HD3' ' A' ' 79' ' ' PRO . 3.0 mm-40 -111.77 159.31 18.4 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.959 178.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -108.57 64.53 0.26 Allowed Glycine 0 CA--C 1.522 0.53 0 C-N-CA 120.251 -0.976 . . . . 0.0 114.004 -179.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.681 ' HD3' ' C ' ' A' ' 77' ' ' GLU . 14.0 Cg_exo -67.0 140.94 56.2 Favored 'Trans proline' 0 C--O 1.242 0.695 0 C-N-CA 122.326 2.017 . . . . 0.0 112.524 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 96' ' ' SER . . . -63.04 -60.16 8.02 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.276 -0.874 . . . . 0.0 112.514 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.484 HD11 ' HB3' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -120.06 122.29 40.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.997 0.427 . . . . 0.0 111.813 -179.877 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.539 ' HB ' HG11 ' A' ' 98' ' ' VAL . 17.8 t -128.66 122.7 57.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.406 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.64 107.83 5.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.635 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.557 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 32.7 m -77.46 122.34 31.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.026 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -69.69 150.28 47.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.172 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.522 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 3.3 tt0 -67.92 102.58 1.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.54 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 89' ' ' TYR . 2.8 p -143.74 160.81 40.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.581 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 56.39 -81.98 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.651 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.419 ' N ' ' O ' ' A' ' 87' ' ' SER . 0.3 OUTLIER -153.44 21.44 0.55 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.724 0.297 . . . . 0.0 111.161 -179.805 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.522 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 1.6 t80 -119.68 133.28 23.84 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.674 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.418 ' HD2' ' CD1' ' A' ' 90' ' ' TYR . 79.7 Cg_endo -77.3 148.58 27.05 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.856 2.371 . . . . 0.0 112.538 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.557 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.7 OUTLIER -55.36 89.24 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.631 179.819 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.91 -175.62 3.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.258 0.552 . . . . 0.0 112.119 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.484 ' HB3' HD11 ' A' ' 81' ' ' LEU . 15.8 m-85 -100.06 132.62 45.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.636 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.459 ' HA ' ' O ' ' A' ' 37' ' ' ASN . 0.8 OUTLIER -127.22 124.41 38.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.863 0.363 . . . . 0.0 111.24 -179.662 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 40.2 t -89.79 162.29 15.59 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.068 0.461 . . . . 0.0 111.905 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 44.39 56.93 4.66 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.741 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.619 ' O ' ' HD2' ' A' ' 79' ' ' PRO . 8.4 p -124.0 136.77 59.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.267 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.871 HD11 ' HB3' ' A' ' 136' ' ' ASP . 2.2 mp -101.92 149.19 24.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.332 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.775 HD23 ' C ' ' A' ' 132' ' ' VAL . 7.7 mt -127.69 132.51 49.64 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.343 -0.543 . . . . 0.0 112.213 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.731 ' HB2' ' CD2' ' A' ' 76' ' ' PHE . . . -128.14 132.28 48.93 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.535 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 1.8 t -93.34 115.31 27.88 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.945 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -102.13 -110.46 3.38 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.589 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -128.6 -53.24 1.25 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.886 0.374 . . . . 0.0 110.915 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 24.8 m -168.0 178.59 5.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.952 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -128.52 112.43 19.35 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.854 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.13 -46.36 2.3 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.401 2.068 . . . . 0.0 112.238 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 158.38 -46.37 0.45 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.553 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -66.81 129.62 40.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.827 0.346 . . . . 0.0 110.866 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -144.09 116.15 8.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.205 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 176.16 109.69 0.25 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.489 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.772 ' O ' HG23 ' A' ' 124' ' ' VAL . . . 172.99 -171.62 44.56 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.551 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.466 HG21 ' HB ' ' A' ' 10' ' ' VAL . 25.9 pt -126.12 146.35 32.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.881 0.372 . . . . 0.0 111.245 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.684 HD11 ' CZ ' ' A' ' 76' ' ' PHE . 23.3 tp -87.52 121.22 29.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.253 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 17.1 mtt85 -118.24 152.28 36.02 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.181 0.515 . . . . 0.0 111.999 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.591 ' HB2' HD11 ' A' ' 121' ' ' ILE . 5.6 t -118.75 164.24 15.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.086 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -58.54 -17.94 25.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.055 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 14.9 m80 -94.89 -30.87 13.95 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.54 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.688 ' N ' ' HB2' ' A' ' 54' ' ' ALA . . . 174.52 -135.93 3.32 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.516 -0.85 . . . . 0.0 112.811 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.903 HG23 ' O ' ' A' ' 52' ' ' THR . 5.4 t -105.48 134.99 45.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.653 0.263 . . . . 0.0 111.053 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.591 HD11 ' HB2' ' A' ' 116' ' ' CYS . 1.1 mm -93.62 -67.73 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.864 0.364 . . . . 0.0 110.983 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.901 ' HA2' HG23 ' A' ' 137' ' ' VAL . . . -159.08 -143.03 3.54 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.843 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.571 ' HG ' ' HB3' ' A' ' 135' ' ' ALA . 0.4 OUTLIER -136.31 164.15 28.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.852 0.358 . . . . 0.0 111.128 -179.84 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.772 HG23 ' O ' ' A' ' 112' ' ' GLY . 36.4 t -68.58 109.22 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.348 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.804 ' OG1' ' HB2' ' A' ' 135' ' ' ALA . 3.6 m -92.04 -90.83 0.17 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.4 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.635 ' N ' HG22 ' A' ' 125' ' ' THR . 97.5 mmm -138.67 125.94 21.58 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.049 0.452 . . . . 0.0 111.301 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -110.22 131.25 10.33 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.593 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -70.04 -146.5 0.29 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.248 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -86.59 -19.38 29.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.698 0.285 . . . . 0.0 111.089 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 102' ' ' THR . . . -140.42 -9.97 0.73 Allowed Glycine 0 CA--C 1.522 0.473 0 C-N-CA 120.551 -0.833 . . . . 0.0 113.459 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.639 ' HB ' HD22 ' A' ' 100' ' ' LEU . 0.9 OUTLIER -115.74 157.56 16.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-N 117.241 0.52 . . . . 0.0 111.123 -179.704 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.775 ' C ' HD23 ' A' ' 100' ' ' LEU . 20.2 t -114.61 118.33 58.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.109 -178.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.488 ' HA3' ' O ' ' A' ' 126' ' ' MET . . . -89.28 126.31 8.17 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.781 178.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.734 ' HE1' HG22 ' A' ' 124' ' ' VAL . 40.2 m-85 -125.18 133.54 52.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.871 0.367 . . . . 0.0 111.586 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.804 ' HB2' ' OG1' ' A' ' 125' ' ' THR . . . -88.85 105.28 17.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.771 178.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.871 ' HB3' HD11 ' A' ' 99' ' ' LEU . 1.3 p30 -67.69 146.62 53.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.23 0.538 . . . . 0.0 112.181 -178.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.901 HG23 ' HA2' ' A' ' 122' ' ' GLY . 60.7 t -89.53 9.92 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.304 178.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.54 ' HA ' HD23 ' A' ' 141' ' ' LEU . 3.5 mmm180 -71.36 -7.02 44.41 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.566 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -99.87 11.13 40.04 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.594 0.235 . . . . 0.0 111.421 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.858 ' O ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -174.98 40.53 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.016 0.436 . . . . 0.0 110.701 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.836 HD11 ' HB ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -57.75 -25.46 60.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.943 -0.572 . . . . 0.0 112.037 -179.557 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . 0.443 ' CD1' ' HA ' ' A' ' 140' ' ' LEU . 11.6 p-90 -47.22 88.12 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.039 0.447 . . . . 0.0 111.762 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.681 HD23 ' HB2' ' A' ' 15' ' ' TYR . 5.0 mp -153.02 -47.12 0.1 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.073 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.494 ' HB2' HG12 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -158.54 -169.92 2.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.755 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -59.05 133.02 55.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.953 0.406 . . . . 0.0 111.28 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -105.15 154.36 20.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.569 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.652 ' HB3' ' H ' ' A' ' 55' ' ' ARG . . . -63.98 143.07 58.15 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.864 0.364 . . . . 0.0 111.059 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 1.5 mtm -89.33 145.82 25.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.957 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -143.58 -47.55 0.29 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.818 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.894 179.961 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.228 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 -28.37 25.32 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.572 2.181 . . . . 0.0 112.328 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -101.7 119.14 38.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.874 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -140.85 162.67 26.68 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.445 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -175.94 -40.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.798 0.332 . . . . 0.0 110.922 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -73.49 64.81 0.88 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.895 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.454 ' HB2' HD21 ' A' ' 22' ' ' LEU . 54.0 p -115.74 -37.37 3.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.921 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 97.24 83.98 1.72 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.484 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.549 ' HB2' HG23 ' A' ' 18' ' ' VAL . . . -151.84 159.47 43.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.829 0.347 . . . . 0.0 111.165 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.7 t -103.37 115.85 46.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.955 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.663 ' CE2' HG21 ' A' ' 45' ' ' THR . 5.7 t80 -104.18 115.91 31.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.808 0.337 . . . . 0.0 110.659 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.792 HG21 HD11 ' A' ' 53' ' ' ILE . 57.6 t -121.17 112.64 36.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.652 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 50.54 -126.22 24.01 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.98 -0.629 . . . . 0.0 113.379 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.466 ' O ' ' HA ' ' A' ' 44' ' ' THR . 4.5 m-20 -91.01 17.97 7.29 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.656 0.265 . . . . 0.0 111.589 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.641 ' CE1' HG22 ' A' ' 44' ' ' THR . 4.7 m-30 -130.49 127.74 39.8 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.04 114.74 22.46 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 121.024 -0.27 . . . . 0.0 110.888 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.926 HG12 HG22 ' A' ' 42' ' ' VAL . 0.7 OUTLIER -99.64 121.9 50.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-O 120.984 0.421 . . . . 0.0 110.453 179.585 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.666 ' O ' HD12 ' A' ' 40' ' ' LEU . 9.6 p -136.29 159.99 38.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.306 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.498 ' N ' HG22 ' A' ' 18' ' ' VAL . 32.5 m-80 -59.96 141.74 55.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.289 179.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 48.7 ttt-85 -56.17 -47.35 78.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.814 0.34 . . . . 0.0 110.774 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -69.2 -8.42 45.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.968 179.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.464 ' HB3' HG22 ' A' ' 18' ' ' VAL . 16.7 tp -110.59 -12.59 14.33 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.967 ' HB3' ' CZ2' ' A' ' 28' ' ' TRP . . . -66.97 150.73 48.82 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 120.896 0.379 . . . . 0.0 110.796 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.559 ' CG2' HG12 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -105.19 170.02 8.11 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.395 179.925 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 56.6 p-80 -54.76 -29.76 54.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.914 0.388 . . . . 0.0 110.954 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.559 HG12 ' CG2' ' A' ' 24' ' ' THR . 9.4 p -76.25 -31.21 20.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.559 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.25 -44.24 79.91 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.967 ' CZ2' ' HB3' ' A' ' 23' ' ' ALA . 5.0 m-90 -74.82 -30.45 61.4 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.33 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -58.62 -43.37 89.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.609 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -118.36 39.56 3.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.555 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.472 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 30.4 p -79.97 126.74 31.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.312 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.584 ' CG2' HG12 ' A' ' 42' ' ' VAL . 16.3 m -88.29 -39.16 12.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.543 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.637 ' CE3' HG23 ' A' ' 42' ' ' VAL . 0.5 OUTLIER -139.61 150.16 44.65 Favored 'General case' 0 CA--C 1.53 0.212 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.067 179.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -149.93 110.89 4.34 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.722 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.466 ' HB2' ' CZ2' ' A' ' 33' ' ' TRP . 27.4 t0 -107.23 112.88 25.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.88 0.371 . . . . 0.0 111.06 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -67.4 -34.82 78.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.076 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.448 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 0.3 OUTLIER -64.3 -20.24 65.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.845 179.718 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -115.11 0.96 13.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.316 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 46.58 35.12 2.75 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 121.221 0.534 . . . . 0.0 110.175 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.808 HD11 HG23 ' A' ' 17' ' ' VAL . 28.4 tp -131.84 153.46 50.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.911 -179.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.683 ' O ' HD23 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -146.43 155.73 42.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.177 179.648 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.926 HG22 HG12 ' A' ' 17' ' ' VAL . 33.9 t -119.11 127.97 75.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.288 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.9 p -122.3 157.17 32.32 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.787 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.641 HG22 ' CE1' ' A' ' 15' ' ' TYR . 25.1 p -97.57 145.09 26.59 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.216 0.531 . . . . 0.0 111.614 -179.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.663 HG21 ' CE2' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -137.4 171.76 14.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.907 -179.139 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.0 t -121.18 34.75 5.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.848 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -113.81 175.14 5.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.164 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.2 m80 -82.84 148.09 27.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.9 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.436 ' HA2' ' CE1' ' A' ' 11' ' ' TYR . . . -100.69 -174.18 29.48 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.563 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.9 t -165.06 -43.41 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.842 0.353 . . . . 0.0 110.879 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -74.15 137.17 43.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.973 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.92 ' O ' HG23 ' A' ' 120' ' ' VAL . 81.0 m -122.66 123.55 41.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.499 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.792 HD11 HG21 ' A' ' 12' ' ' VAL . 1.0 OUTLIER -74.09 139.51 19.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.804 0.335 . . . . 0.0 110.689 179.915 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.843 ' HB2' ' N ' ' A' ' 119' ' ' GLY . . . -95.21 128.2 41.87 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.008 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.585 ' H ' ' HB3' ' A' ' 147' ' ' ALA . 11.3 tpt180 -94.67 36.09 1.19 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.584 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 20.6 p -99.98 167.25 10.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.981 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -117.22 28.64 8.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.468 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 14.0 m -62.18 120.44 10.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.753 0.311 . . . . 0.0 110.704 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.4 t -69.35 -13.37 62.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.947 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -117.71 126.56 52.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.21 0.529 . . . . 0.0 111.464 -179.664 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 73' ' ' PRO . . . -135.83 -153.78 6.74 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.114 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.768 HG23 ' C ' ' A' ' 72' ' ' TYR . 11.2 p -140.08 131.31 31.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 117.26 0.53 . . . . 0.0 111.649 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -109.69 150.74 27.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.741 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -74.14 125.68 28.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.098 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -88.77 139.33 30.58 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.716 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.512 ' HB2' ' O ' ' A' ' 110' ' ' ALA . . . -92.06 -40.27 11.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.188 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -85.81 -28.83 24.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.166 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.3 mmtt -92.17 -24.56 19.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.295 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 55.94 29.21 13.84 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.995 0.426 . . . . 0.0 110.482 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.2 mtpp -134.37 170.54 15.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.845 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.61 ' HB3' HG21 ' A' ' 62' ' ' VAL . 35.0 m80 -83.91 117.09 23.11 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.993 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.768 ' C ' HG23 ' A' ' 62' ' ' VAL . 0.6 OUTLIER -111.22 114.38 53.47 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.296 -179.096 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.506 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 6.3 Cg_exo -78.27 125.89 7.36 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.459 2.106 . . . . 0.0 111.834 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.462 ' CG1' ' CE2' ' A' ' 76' ' ' PHE . 2.3 p -136.77 153.03 29.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.945 0.403 . . . . 0.0 111.745 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.546 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 0.0 OUTLIER -95.35 133.52 39.18 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.493 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.609 ' CD2' ' HB2' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -135.28 166.5 22.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.507 0.67 . . . . 0.0 111.955 -178.886 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.696 ' C ' ' HD3' ' A' ' 79' ' ' PRO . 1.8 mp0 -111.71 159.54 18.14 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.121 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -108.42 62.23 0.3 Allowed Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.044 -1.074 . . . . 0.0 114.191 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.696 ' HD3' ' C ' ' A' ' 77' ' ' GLU . 15.1 Cg_exo -67.01 142.52 62.2 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.075 1.85 . . . . 0.0 111.948 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -64.83 -90.67 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.739 -0.664 . . . . 0.0 113.016 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.791 HD22 ' HB2' ' A' ' 96' ' ' SER . 0.0 OUTLIER -85.08 129.99 34.7 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.031 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.629 ' HB ' HG11 ' A' ' 98' ' ' VAL . 98.7 t -138.75 126.04 26.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.478 178.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -72.35 107.86 5.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.944 0.402 . . . . 0.0 111.598 -178.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.734 HG23 ' CG ' ' A' ' 126' ' ' MET . 4.1 p -73.11 114.27 12.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.959 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -73.01 149.39 43.3 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.546 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.575 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 1.0 OUTLIER -69.34 101.89 1.62 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.644 179.923 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.457 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -144.45 152.81 41.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.129 179.761 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 53.56 -82.85 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.558 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.457 ' N ' ' O ' ' A' ' 87' ' ' SER . 0.4 OUTLIER -146.38 18.65 1.36 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.693 0.283 . . . . 0.0 111.047 179.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.575 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 1.2 m-85 -106.9 136.54 19.43 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.315 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.495 ' HA ' ' HG2' ' A' ' 86' ' ' GLU . 95.2 Cg_endo -84.37 148.33 11.5 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.917 2.411 . . . . 0.0 112.954 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -65.05 77.58 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.518 179.547 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.55 ' O ' HG12 ' A' ' 84' ' ' VAL . 46.8 mtt180 -123.69 -174.75 3.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.126 0.489 . . . . 0.0 111.912 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.464 ' HB3' HD11 ' A' ' 81' ' ' LEU . 19.5 m-85 -99.14 132.26 44.58 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.841 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.606 ' OE1' HG11 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -131.22 126.74 36.33 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.098 -179.867 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.791 ' HB2' HD22 ' A' ' 81' ' ' LEU . 44.4 t -101.55 158.54 16.0 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.087 0.47 . . . . 0.0 111.803 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.42 ' CE1' ' HB2' ' A' ' 138' ' ' ARG . 0.0 OUTLIER 64.71 56.53 1.15 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.645 179.338 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.629 HG11 ' HB ' ' A' ' 82' ' ' VAL . 9.5 p -123.53 141.81 42.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.994 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.451 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 11.0 mp -104.95 147.96 27.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.315 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.721 HD23 ' C ' ' A' ' 132' ' ' VAL . 6.8 mt -133.08 131.5 40.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.069 0.461 . . . . 0.0 112.183 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.609 ' HB2' ' CD2' ' A' ' 76' ' ' PHE . . . -135.65 147.64 48.67 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.749 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.5 t -105.33 134.35 48.59 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.982 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -103.57 -75.33 1.05 Allowed Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.494 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -146.54 -60.97 0.3 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.853 0.359 . . . . 0.0 110.905 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -177.38 73.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.888 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 60.77 84.23 0.2 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.913 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -68.67 -27.69 31.86 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.483 2.122 . . . . 0.0 112.311 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -179.25 -158.35 21.4 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.528 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -144.41 32.32 1.2 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.809 0.337 . . . . 0.0 110.914 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.512 ' O ' ' HB2' ' A' ' 66' ' ' ALA . . . -164.99 95.22 0.68 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.089 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -107.79 -169.23 21.67 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.498 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.691 ' O ' HG13 ' A' ' 124' ' ' VAL . . . -123.71 -107.72 1.81 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.719 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 18.0 pt -126.11 146.72 31.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.829 0.347 . . . . 0.0 111.156 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.651 HD22 ' HD2' ' A' ' 134' ' ' PHE . 15.6 tp -87.14 115.49 24.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.126 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.643 ' HD3' HG22 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -118.05 150.94 38.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.059 0.457 . . . . 0.0 111.501 -179.416 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.523 ' HB2' HD11 ' A' ' 121' ' ' ILE . 5.7 t -114.57 162.34 16.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.279 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -56.22 -19.47 13.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.919 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.42 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . 18.9 m80 -92.26 -34.34 14.29 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.457 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.843 ' N ' ' HB2' ' A' ' 54' ' ' ALA . . . 178.03 -140.03 4.47 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.345 -0.931 . . . . 0.0 113.145 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.92 HG23 ' O ' ' A' ' 52' ' ' THR . 4.0 t -102.1 135.58 38.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.705 0.288 . . . . 0.0 111.287 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.554 ' HB ' ' HG ' ' A' ' 114' ' ' LEU . 1.1 mm -98.4 -67.15 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.896 0.379 . . . . 0.0 110.735 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.919 ' HA2' HG23 ' A' ' 137' ' ' VAL . . . -159.88 -166.43 18.75 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.667 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.464 HD11 HD13 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -116.93 164.08 15.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.789 0.328 . . . . 0.0 110.698 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.691 HG13 ' O ' ' A' ' 112' ' ' GLY . 7.7 m -65.6 128.94 29.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.453 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.748 ' OG1' ' HB2' ' A' ' 135' ' ' ALA . 2.5 m -111.09 -89.08 0.5 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.344 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.734 ' CG ' HG23 ' A' ' 84' ' ' VAL . 0.8 OUTLIER -130.44 125.77 35.3 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.934 0.397 . . . . 0.0 111.409 179.915 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -110.71 151.19 17.68 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.47 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -110.04 -153.23 14.1 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.578 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -93.98 17.28 12.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.595 0.236 . . . . 0.0 111.239 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -168.74 -28.25 0.02 OUTLIER Glycine 0 CA--C 1.52 0.357 0 C-N-CA 120.527 -0.844 . . . . 0.0 113.182 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.558 ' CG1' HD22 ' A' ' 100' ' ' LEU . 1.6 t -115.48 157.27 16.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.802 0.301 . . . . 0.0 111.038 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.721 ' C ' HD23 ' A' ' 100' ' ' LEU . 10.0 m -114.73 118.86 59.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.658 -179.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.472 ' HA3' ' O ' ' A' ' 126' ' ' MET . . . -95.59 117.93 5.78 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.39 -0.909 . . . . 0.0 112.177 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.651 ' HD2' HD22 ' A' ' 114' ' ' LEU . 13.5 m-85 -122.2 144.2 49.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.95 0.405 . . . . 0.0 111.512 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.748 ' HB2' ' OG1' ' A' ' 125' ' ' THR . . . -89.34 111.06 21.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.076 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -68.34 147.34 52.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.01 0.433 . . . . 0.0 111.836 -179.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.919 HG23 ' HA2' ' A' ' 122' ' ' GLY . 97.9 t -91.26 11.03 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.438 179.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.594 ' HA ' HD23 ' A' ' 141' ' ' LEU . 12.8 mmm180 -70.14 -6.93 37.61 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.748 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -98.26 11.11 38.98 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 111.706 0.261 . . . . 0.0 111.706 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.873 HD23 HG21 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -175.03 39.07 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.202 0.525 . . . . 0.0 110.471 179.81 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.662 HD11 ' HB ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -56.77 -20.86 24.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.32 -179.608 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . 0.432 ' CD1' ' HA ' ' A' ' 140' ' ' LEU . 12.7 p-90 -55.68 85.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.941 0.4 . . . . 0.0 111.45 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.575 HD23 ' CB ' ' A' ' 15' ' ' TYR . 4.2 mp -146.0 -48.16 0.21 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.309 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -151.12 -173.21 4.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.676 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -58.93 136.01 57.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.92 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -82.95 154.1 24.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.916 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.585 ' HB3' ' H ' ' A' ' 55' ' ' ARG . . . -81.94 145.2 30.43 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.069 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 2.0 ttm 60.97 67.64 0.8 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.933 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -73.53 -63.82 1.12 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.836 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.855 179.981 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.169 0 N-CA-C 112.577 -0.209 . . . . 0.0 112.577 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.31 -176.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.626 2.217 . . . . 0.0 112.259 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -154.26 141.76 19.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.776 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 76.71 67.12 1.72 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.422 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -148.12 126.36 12.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.854 0.359 . . . . 0.0 110.863 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -133.16 40.89 3.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.855 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.7 m 62.11 170.87 0.13 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.946 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 158.61 -28.51 0.43 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.499 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.601 ' HB2' HG23 ' A' ' 18' ' ' VAL . . . -170.18 -174.28 1.7 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.772 0.32 . . . . 0.0 111.157 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.615 HG22 HG21 ' A' ' 113' ' ' ILE . 39.4 t -106.73 108.24 24.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.033 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.883 ' CE2' HG21 ' A' ' 45' ' ' THR . 6.5 t80 -98.11 116.53 30.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.688 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.895 HG21 HD11 ' A' ' 53' ' ' ILE . 41.7 t -120.58 108.83 23.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.587 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 51.59 -127.78 31.18 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.955 -0.64 . . . . 0.0 113.304 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.466 ' O ' ' HA ' ' A' ' 44' ' ' THR . 0.9 OUTLIER -88.88 14.27 10.78 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.572 0.225 . . . . 0.0 111.599 -179.637 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.647 ' HE1' HG22 ' A' ' 44' ' ' THR . 6.1 m-30 -130.34 128.01 40.6 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.49 114.68 23.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.66 0.267 . . . . 0.0 111.018 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.908 HG12 HG22 ' A' ' 42' ' ' VAL . 0.8 OUTLIER -99.13 122.49 50.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 121.032 0.444 . . . . 0.0 110.401 179.48 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.779 ' O ' HD12 ' A' ' 40' ' ' LEU . 12.6 p -135.42 161.49 39.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.256 -179.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.881 ' HB2' HD12 ' A' ' 22' ' ' LEU . 2.2 t30 -60.94 141.74 57.0 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 178.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.2 -47.03 79.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.824 0.345 . . . . 0.0 110.838 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -71.05 -6.93 42.79 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.151 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.881 HD12 ' HB2' ' A' ' 19' ' ' ASN . 52.4 mt -112.66 -3.68 14.24 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.825 ' HB3' ' CZ2' ' A' ' 28' ' ' TRP . . . -77.13 151.0 35.55 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.865 0.364 . . . . 0.0 110.829 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.445 ' O ' ' CE3' ' A' ' 28' ' ' TRP . 1.2 t -102.89 166.64 10.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.133 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 30.1 t60 -54.04 -29.57 44.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.042 0.448 . . . . 0.0 110.345 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.5 t -72.07 -31.18 39.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.019 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.482 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 0.4 OUTLIER -67.43 -44.14 79.47 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.941 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.825 ' CZ2' ' HB3' ' A' ' 23' ' ' ALA . 11.7 m-90 -73.9 -35.46 64.65 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.078 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.62 -38.62 72.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.045 0.45 . . . . 0.0 110.503 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -119.37 27.73 8.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.755 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 8.7 t -73.58 122.8 22.82 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.964 0.412 . . . . 0.0 110.863 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.549 HG22 ' O ' ' A' ' 42' ' ' VAL . 13.1 m -86.57 -39.77 13.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.515 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.604 ' HH2' HD23 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -139.71 153.12 47.14 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.172 -179.893 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -156.82 121.28 4.44 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.813 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.401 ' HB2' ' CZ2' ' A' ' 33' ' ' TRP . 17.6 m-20 -107.05 116.86 32.66 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.23 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -67.24 -36.88 82.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.963 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.53 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 3.8 m-20 -72.41 -14.15 61.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.863 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 mtt85 -115.54 -3.77 12.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.777 -0.192 . . . . 0.0 111.274 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 46.91 42.15 11.79 Favored 'General case' 0 CA--C 1.524 -0.046 0 CA-C-O 121.216 0.532 . . . . 0.0 110.038 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.85 HD11 HG23 ' A' ' 17' ' ' VAL . 29.3 tp -136.17 152.42 50.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.906 -178.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.662 HD12 ' NE1' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -147.33 150.79 35.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.042 0.449 . . . . 0.0 111.194 179.408 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.908 HG22 HG12 ' A' ' 17' ' ' VAL . 31.0 t -114.54 126.75 72.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.403 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.9 p -117.87 157.28 26.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.416 178.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.647 HG22 ' HE1' ' A' ' 15' ' ' TYR . 18.9 p -97.71 140.79 31.58 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.119 0.485 . . . . 0.0 111.701 -179.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.883 HG21 ' CE2' ' A' ' 11' ' ' TYR . 0.2 OUTLIER -135.29 168.94 18.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.875 -179.335 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.2 p -121.69 61.9 0.93 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.832 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.24 169.7 17.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.125 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 4.9 m170 -86.56 128.57 34.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.876 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -87.43 -179.48 48.13 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.489 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 73.3 m -144.09 -46.94 0.27 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.77 0.319 . . . . 0.0 110.892 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -64.25 138.88 58.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.939 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.873 ' O ' HG23 ' A' ' 120' ' ' VAL . 83.2 m -122.7 121.05 35.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.509 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.895 HD11 HG21 ' A' ' 12' ' ' VAL . 0.4 OUTLIER -74.24 139.36 19.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.928 0.394 . . . . 0.0 111.211 -179.677 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.83 ' HB2' ' N ' ' A' ' 119' ' ' GLY . . . -95.7 123.65 39.36 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.942 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.504 ' H ' ' HB3' ' A' ' 147' ' ' ALA . 0.3 OUTLIER -91.2 37.29 0.94 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.621 179.672 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 24.5 p -99.85 167.1 10.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.952 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -119.1 33.53 5.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.32 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 35.5 m -62.76 141.85 58.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.627 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -85.28 3.1 41.12 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.024 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.1 p -125.9 168.05 14.42 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.103 0.478 . . . . 0.0 111.117 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -179.44 -173.14 44.34 Favored Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.583 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.836 HG23 ' C ' ' A' ' 72' ' ' TYR . 9.2 p -140.22 125.83 20.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 117.044 0.422 . . . . 0.0 111.225 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.704 ' HE2' HG21 ' A' ' 74' ' ' VAL . 6.2 p90 -109.12 137.99 46.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.743 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.9 145.64 50.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.049 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 1.6 t -113.77 150.95 32.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.882 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.434 ' HB2' ' HB3' ' A' ' 110' ' ' ALA . . . -91.95 -45.14 8.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.237 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -70.76 -41.36 71.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.879 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.57 ' HG2' ' HD3' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -86.16 -28.57 23.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.979 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.0 p 58.75 37.15 25.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.181 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.57 ' HD3' ' HG2' ' A' ' 68' ' ' LYS . 1.3 ptmt -140.61 169.57 17.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.011 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.478 ' HB3' HG21 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -84.61 119.93 25.78 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.05 179.695 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.836 ' C ' HG23 ' A' ' 62' ' ' VAL . 2.7 m-85 -108.59 113.86 59.52 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.512 -179.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 72' ' ' TYR . 2.7 Cg_exo -76.34 120.78 5.77 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.589 2.192 . . . . 0.0 111.024 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.704 HG21 ' HE2' ' A' ' 63' ' ' TYR . 54.5 t -134.83 141.78 42.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.977 0.418 . . . . 0.0 111.765 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 16.7 m -91.84 121.64 33.64 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.51 ' HB3' ' HB2' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -127.96 165.19 20.73 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.526 0.679 . . . . 0.0 111.947 -178.629 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.58 ' C ' ' HD3' ' A' ' 79' ' ' PRO . 10.7 mt-10 -111.72 158.83 18.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.899 178.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.484 ' HA2' ' HG ' ' A' ' 99' ' ' LEU . . . -112.16 68.6 0.23 Allowed Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.124 -1.036 . . . . 0.0 113.961 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.586 ' HD2' ' O ' ' A' ' 98' ' ' VAL . 15.7 Cg_exo -67.36 142.08 58.68 Favored 'Trans proline' 0 C--O 1.238 0.503 0 C-N-CA 122.22 1.946 . . . . 0.0 111.797 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -57.98 -91.73 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.538 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.585 HD22 ' CB ' ' A' ' 96' ' ' SER . 0.0 OUTLIER -94.37 119.82 33.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.91 0.386 . . . . 0.0 111.876 -179.587 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.643 ' HB ' HG11 ' A' ' 98' ' ' VAL . 61.7 t -122.76 122.62 66.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.923 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.401 ' HG3' ' CE1' ' A' ' 94' ' ' TYR . 1.8 tt0 -72.43 107.62 5.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.859 0.362 . . . . 0.0 110.741 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.709 HG13 ' HG2' ' A' ' 126' ' ' MET . 30.4 t -75.77 114.3 15.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.624 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.422 ' HA ' ' HD3' ' A' ' 92' ' ' LYS . 1.5 tt0 -71.86 150.02 44.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.032 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.472 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 0.8 OUTLIER -67.88 101.34 1.07 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.158 0.504 . . . . 0.0 110.159 -179.475 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.508 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.3 OUTLIER -144.65 175.7 9.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.839 -179.913 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 42.96 -86.23 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.787 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.508 ' N ' ' O ' ' A' ' 87' ' ' SER . 0.3 OUTLIER -150.56 23.5 0.8 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.825 0.345 . . . . 0.0 110.485 179.686 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.472 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -117.92 138.15 25.11 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.867 -179.704 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.427 ' O ' ' N ' ' A' ' 93' ' ' ARG . 93.7 Cg_endo -78.77 148.61 22.69 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.821 2.347 . . . . 0.0 112.247 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.578 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -60.9 79.9 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.866 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.427 ' N ' ' O ' ' A' ' 91' ' ' PRO . 1.5 ttp85 -123.65 177.41 5.7 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.692 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.457 ' HB3' HD11 ' A' ' 81' ' ' LEU . 10.6 m-85 -91.29 132.6 36.04 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.777 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.777 ' OE1' HG23 ' A' ' 125' ' ' THR . 0.1 OUTLIER -125.46 116.84 22.46 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.654 -179.571 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.585 ' CB ' HD22 ' A' ' 81' ' ' LEU . 3.0 t -91.53 154.4 19.12 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 120.92 0.391 . . . . 0.0 111.45 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 53.72 62.46 2.61 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.336 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.643 HG11 ' HB ' ' A' ' 82' ' ' VAL . 5.9 p -123.35 152.28 28.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.1 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.484 ' HG ' ' HA2' ' A' ' 78' ' ' GLY . 5.5 mp -116.43 140.27 49.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.205 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.8 HD23 ' O ' ' A' ' 132' ' ' VAL . 5.5 mt -133.23 142.06 48.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.268 0.556 . . . . 0.0 112.456 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.575 ' O ' HG12 ' A' ' 131' ' ' VAL . . . -151.97 161.06 43.23 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.412 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.1 t -118.92 129.45 55.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.947 0.403 . . . . 0.0 111.004 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -70.64 -141.23 0.19 Allowed Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.493 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -155.5 -45.93 0.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.891 0.377 . . . . 0.0 110.937 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.42 107.12 9.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.788 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 61.92 114.21 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.916 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -68.94 -38.23 10.01 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.473 2.116 . . . . 0.0 112.27 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.11 161.02 24.52 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.504 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.69 -68.27 0.52 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.867 0.365 . . . . 0.0 110.914 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.434 ' HB3' ' HB2' ' A' ' 66' ' ' ALA . . . -101.94 -171.32 1.95 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.179 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -136.98 -45.71 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.494 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 84.67 -123.9 6.47 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.517 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.615 HG21 HG22 ' A' ' 10' ' ' VAL . 28.4 pt -126.15 144.21 37.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.782 0.325 . . . . 0.0 111.17 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.63 HD22 ' HD2' ' A' ' 134' ' ' PHE . 10.8 tp -87.9 113.99 24.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.208 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.63 ' HD3' HG22 ' A' ' 120' ' ' VAL . 3.1 mtm180 -114.1 143.24 45.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.098 0.475 . . . . 0.0 111.554 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.56 ' HB2' HD11 ' A' ' 121' ' ' ILE . 6.9 t -107.79 164.28 12.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.191 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -56.14 -20.35 17.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.788 0.328 . . . . 0.0 110.723 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.493 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . 26.7 m80 -89.59 -35.86 15.64 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.325 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.83 ' N ' ' HB2' ' A' ' 54' ' ' ALA . . . 177.46 -136.36 3.06 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.854 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.873 HG23 ' O ' ' A' ' 52' ' ' THR . 3.8 t -102.88 135.38 40.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.685 0.279 . . . . 0.0 110.926 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.56 HD11 ' HB2' ' A' ' 116' ' ' CYS . 1.0 OUTLIER -94.59 -69.9 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.698 0.285 . . . . 0.0 111.248 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.941 ' HA2' HG23 ' A' ' 137' ' ' VAL . . . -150.95 -160.09 9.2 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.381 -0.914 . . . . 0.0 113.236 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.634 ' CD1' HD13 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -121.38 164.48 17.01 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.737 0.303 . . . . 0.0 110.85 -179.789 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.481 HG13 ' O ' ' A' ' 124' ' ' VAL . 9.9 p -62.31 121.52 11.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.838 0.351 . . . . 0.0 111.796 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.777 HG23 ' OE1' ' A' ' 95' ' ' GLN . 3.0 m -112.17 -91.31 0.49 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.075 179.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.709 ' HG2' HG13 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -92.58 160.4 15.04 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 120.787 0.327 . . . . 0.0 110.743 179.517 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -150.03 88.66 0.14 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.442 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -77.32 -176.59 44.81 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.429 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.79 -19.32 62.02 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.667 0.27 . . . . 0.0 111.015 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -142.03 -6.3 0.8 Allowed Glycine 0 CA--C 1.522 0.482 0 C-N-CA 120.598 -0.81 . . . . 0.0 113.447 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.575 HG12 ' O ' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -115.82 157.17 16.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 117.322 0.561 . . . . 0.0 111.306 -179.764 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.8 ' O ' HD23 ' A' ' 100' ' ' LEU . 13.1 m -119.73 118.69 57.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.5 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -100.99 120.06 6.75 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.728 -0.749 . . . . 0.0 111.9 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.63 ' HD2' HD22 ' A' ' 114' ' ' LEU . 18.3 m-85 -125.13 136.72 53.9 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.914 0.387 . . . . 0.0 112.02 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.754 ' HB2' ' OG1' ' A' ' 125' ' ' THR . . . -88.86 114.22 25.25 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.198 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -67.79 141.16 56.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.975 0.417 . . . . 0.0 111.858 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.941 HG23 ' HA2' ' A' ' 122' ' ' GLY . 88.9 t -89.31 9.72 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.615 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.48 ' HA ' HD23 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -70.74 -6.68 39.21 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.599 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -95.93 11.05 35.27 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 120.685 0.279 . . . . 0.0 111.317 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.853 ' O ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -177.98 57.28 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.083 0.468 . . . . 0.0 110.484 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.871 HD11 ' HB ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -74.83 -14.83 60.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.883 -179.572 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . 0.465 ' C ' HD12 ' A' ' 143' ' ' LEU . 13.2 p-90 -55.99 82.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.896 0.379 . . . . 0.0 111.261 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.672 HD12 ' C ' ' A' ' 141' ' ' LEU . 5.1 mp -149.67 -45.67 0.13 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.466 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.433 ' HB2' ' CG1' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -154.35 -167.44 2.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.747 179.832 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -58.88 141.03 54.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.0 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.409 ' HB2' ' HB2' ' A' ' 55' ' ' ARG . 15.4 p30 -94.97 154.07 17.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.832 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.617 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . . . -98.39 126.18 43.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.904 0.383 . . . . 0.0 111.156 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 3.0 ptt? -132.39 -179.56 5.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.885 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -135.83 169.73 17.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.925 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 . . . . . 0 C--O 1.251 1.144 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.851 -179.954 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 112.539 -0.225 . . . . 0.0 112.539 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -52.99 -61.94 0.41 Allowed 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.535 2.156 . . . . 0.0 112.349 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 23.3 t80 68.4 -67.52 0.2 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.924 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -155.28 -44.17 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.573 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 10.6 p80 -108.38 144.62 35.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.803 0.335 . . . . 0.0 110.873 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 60.89 111.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.933 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.0 m -127.6 31.42 5.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.904 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.8 60.38 0.18 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.519 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -157.12 170.5 22.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.801 0.334 . . . . 0.0 111.047 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.0 t -107.4 116.23 50.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.013 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.611 ' CZ ' HG21 ' A' ' 45' ' ' THR . 0.3 OUTLIER -98.02 115.52 28.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.604 179.889 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.988 HG21 HD11 ' A' ' 53' ' ' ILE . 17.3 t -121.47 108.8 23.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.525 179.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 48.21 -124.64 11.41 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.928 -0.653 . . . . 0.0 113.098 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.405 ' O ' ' HA ' ' A' ' 44' ' ' THR . 2.7 m120 -92.43 17.94 9.2 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.734 0.302 . . . . 0.0 111.403 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.662 ' HE1' HG22 ' A' ' 44' ' ' THR . 4.9 m-30 -130.31 144.4 51.36 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.411 ' HG3' ' CD1' ' A' ' 11' ' ' TYR . 18.6 ttpt -133.83 118.26 17.79 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.702 0.287 . . . . 0.0 110.994 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 1.098 HG12 HG22 ' A' ' 42' ' ' VAL . 0.6 OUTLIER -104.39 122.07 56.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.117 0.485 . . . . 0.0 110.434 179.572 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.737 ' O ' HD12 ' A' ' 40' ' ' LEU . 14.0 p -136.01 162.0 37.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.033 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.508 ' N ' HG22 ' A' ' 18' ' ' VAL . 1.0 OUTLIER -58.53 141.24 52.52 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.091 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.587 ' HG2' HD13 ' A' ' 41' ' ' LEU . 13.9 mtm105 -56.45 -47.82 78.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.916 0.389 . . . . 0.0 111.17 -179.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -69.52 -7.62 39.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.441 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.9 tp -115.33 5.73 14.72 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.8 ' HB2' HD21 ' A' ' 41' ' ' LEU . . . -89.27 131.89 35.16 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.353 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.563 ' O ' ' HD1' ' A' ' 28' ' ' TRP . 44.1 p -74.76 162.5 28.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.469 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.406 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 2.9 t-160 -53.66 -29.64 39.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.886 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.8 t -69.57 -31.94 50.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.915 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.437 ' O ' ' HB3' ' A' ' 31' ' ' CYS . 13.5 m-20 -67.72 -44.07 78.51 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.62 ' NE1' ' HB3' ' A' ' 23' ' ' ALA . 33.8 m95 -73.57 -29.88 62.69 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.594 179.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.406 ' HB2' ' O ' ' A' ' 25' ' ' HIS . 2.2 tp60 -58.8 -43.92 90.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.575 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -118.15 30.13 7.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.832 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.483 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 29.5 p -69.17 122.93 19.81 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.949 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.546 ' CG2' HG12 ' A' ' 42' ' ' VAL . 17.7 m -86.2 -39.74 13.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.434 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.755 ' HH2' HD23 ' A' ' 40' ' ' LEU . 1.0 OUTLIER -139.66 153.25 47.25 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.08 179.689 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -160.44 115.92 2.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.008 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -107.19 117.75 34.9 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.936 0.398 . . . . 0.0 111.136 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -62.26 -48.84 78.14 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.353 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -59.9 -19.09 49.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.134 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -108.38 -8.02 15.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.276 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.4 t70 49.49 43.22 23.63 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 121.088 0.47 . . . . 0.0 110.224 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.755 HD23 ' HH2' ' A' ' 33' ' ' TRP . 20.0 tp -137.1 154.15 50.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.126 -178.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.8 HD21 ' HB2' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -151.86 137.18 17.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.115 0.484 . . . . 0.0 111.131 179.555 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 1.098 HG22 HG12 ' A' ' 17' ' ' VAL . 34.3 t -100.96 130.58 50.11 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.406 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.4 p -123.19 157.45 32.99 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.261 -0.882 . . . . 0.0 109.435 178.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.662 HG22 ' HE1' ' A' ' 15' ' ' TYR . 19.4 p -97.21 134.48 40.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.235 0.54 . . . . 0.0 111.395 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.611 HG21 ' CZ ' ' A' ' 11' ' ' TYR . 0.5 OUTLIER -102.49 -29.56 11.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.026 -179.126 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.0 m 66.61 31.43 7.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.738 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -142.96 -167.78 2.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.017 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.85 144.94 43.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.827 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -72.65 -140.51 0.37 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.42 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.1 m -172.09 -44.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.693 0.282 . . . . 0.0 111.05 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -117.23 163.3 16.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.2 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.903 ' O ' HG23 ' A' ' 120' ' ' VAL . 73.9 m -125.28 122.5 37.09 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.664 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.988 HD11 HG21 ' A' ' 12' ' ' VAL . 0.4 OUTLIER -75.29 139.52 18.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.03 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.82 ' HB2' ' N ' ' A' ' 119' ' ' GLY . . . -94.57 128.45 41.2 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.061 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.443 ' HB3' ' HB3' ' A' ' 146' ' ' ASP . 0.0 OUTLIER -92.31 33.69 1.08 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.683 179.576 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 26.7 p -99.49 166.96 10.91 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.905 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -121.85 33.41 5.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.241 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 34.4 m -60.44 127.37 31.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.776 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.85 -9.32 58.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.994 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.9 p -117.84 124.0 47.28 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.008 0.432 . . . . 0.0 111.109 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.07 178.88 20.44 Favored Glycine 0 N--CA 1.452 -0.299 0 N-CA-C 111.632 -0.587 . . . . 0.0 111.632 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.844 HG21 ' HB2' ' A' ' 71' ' ' HIS . 8.3 p -119.28 124.83 73.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.205 0.526 . . . . 0.0 111.362 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -105.52 -173.94 2.42 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.433 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.486 ' CG ' ' HB3' ' A' ' 67' ' ' SER . 0.6 OUTLIER 67.88 -90.03 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.134 179.739 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 69.37 -65.44 0.3 Allowed 'General case' 0 C--O 1.231 0.085 0 CA-C-O 120.785 0.326 . . . . 0.0 111.18 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -92.11 -39.55 11.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.695 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.486 ' HB3' ' CG ' ' A' ' 64' ' ' PHE . 20.9 t -46.37 -67.99 0.23 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.779 0.323 . . . . 0.0 111.37 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.437 ' HG3' ' HD3' ' A' ' 70' ' ' LYS . 2.6 tppt? -86.51 8.72 20.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.141 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 65.62 12.85 8.55 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.731 0.301 . . . . 0.0 111.079 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.437 ' HD3' ' HG3' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -142.68 168.98 18.44 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.911 0.386 . . . . 0.0 110.677 179.896 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.844 ' HB2' HG21 ' A' ' 62' ' ' VAL . 7.8 p80 -92.14 116.68 29.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.504 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.785 ' C ' HG23 ' A' ' 62' ' ' VAL . 4.5 m-85 -105.68 112.4 64.57 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.039 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.502 ' HA ' ' HA ' ' A' ' 62' ' ' VAL . 2.8 Cg_endo -84.03 120.88 2.69 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.044 2.496 . . . . 0.0 111.658 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.517 ' CG1' ' CE2' ' A' ' 76' ' ' PHE . 2.5 p -137.52 153.79 28.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.504 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.0 m -94.78 127.68 40.95 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.563 ' CD2' ' HB2' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -131.53 162.71 29.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.379 0.609 . . . . 0.0 111.919 -179.416 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' A' ' 99' ' ' LEU . 0.7 OUTLIER -111.83 158.86 18.9 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.142 178.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -104.82 65.48 0.3 Allowed Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.275 -0.964 . . . . 0.0 113.557 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.472 ' HD2' ' HA ' ' A' ' 99' ' ' LEU . 41.9 Cg_endo -68.34 135.23 33.41 Favored 'Trans proline' 0 C--O 1.239 0.535 0 C-N-CA 122.263 1.975 . . . . 0.0 112.198 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -59.3 -85.26 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.245 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.724 HD11 ' HB3' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -97.38 119.5 36.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.993 0.425 . . . . 0.0 111.594 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.626 ' HB ' HG11 ' A' ' 98' ' ' VAL . 44.1 t -123.25 122.42 65.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.823 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.59 107.51 5.13 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.992 0.425 . . . . 0.0 110.67 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.581 HG12 ' O ' ' A' ' 93' ' ' ARG . 2.7 p -74.53 119.29 21.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.557 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.427 ' HA ' ' HG2' ' A' ' 92' ' ' LYS . 24.3 mt-30 -69.65 149.41 48.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.06 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.544 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 14.3 tt0 -68.63 102.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.625 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.552 ' HB3' ' HE1' ' A' ' 126' ' ' MET . 0.1 OUTLIER -143.66 158.64 43.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.382 -179.827 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.451 ' HG2' ' CD2' ' A' ' 89' ' ' TYR . 5.7 tt0 53.54 -84.78 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.709 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.451 ' CD2' ' HG2' ' A' ' 88' ' ' GLU . 0.2 OUTLIER -145.43 19.36 1.53 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.663 0.268 . . . . 0.0 111.146 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.544 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 1.4 t80 -113.85 137.5 22.34 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.737 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.468 ' O ' ' N ' ' A' ' 93' ' ' ARG . 90.3 Cg_endo -85.79 148.59 9.66 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.065 2.51 . . . . 0.0 112.569 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -55.94 82.28 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.873 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.581 ' O ' HG12 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -123.84 174.29 7.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.168 0.509 . . . . 0.0 111.905 -179.477 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.724 ' HB3' HD11 ' A' ' 81' ' ' LEU . 3.8 m-85 -93.29 132.78 37.17 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.175 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.475 ' O ' HD13 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -125.36 126.28 44.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.818 179.896 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.498 ' HB2' HD22 ' A' ' 81' ' ' LEU . 12.1 t -96.28 154.68 17.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.091 0.472 . . . . 0.0 111.983 -179.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.474 ' CE1' ' HB3' ' A' ' 136' ' ' ASP . 1.6 t-80 57.82 57.52 4.14 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.922 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.626 HG11 ' HB ' ' A' ' 82' ' ' VAL . 11.1 p -123.72 141.07 45.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.528 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.744 HD11 ' OD2' ' A' ' 136' ' ' ASP . 6.2 mp -104.03 141.47 36.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.947 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.731 HD23 ' C ' ' A' ' 132' ' ' VAL . 7.3 mt -125.92 136.39 52.99 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.563 ' HB2' ' CD2' ' A' ' 76' ' ' PHE . . . -143.65 142.84 31.19 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.684 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 1.6 t -98.26 133.41 42.72 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.864 0.364 . . . . 0.0 111.217 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.3 -134.2 5.55 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.507 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -115.71 -41.32 3.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.801 0.334 . . . . 0.0 110.842 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.88 152.26 38.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.87 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -88.28 147.91 41.34 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.891 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.47 -169.35 0.47 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.513 2.142 . . . . 0.0 112.355 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -112.0 -65.97 0.5 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.499 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -96.51 -29.42 13.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.799 0.333 . . . . 0.0 110.886 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 62.8 157.06 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.105 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 153.93 49.92 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.448 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.74 ' O ' HG13 ' A' ' 124' ' ' VAL . . . -130.46 177.01 18.59 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.559 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 22.7 pt -126.25 146.39 32.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.806 0.336 . . . . 0.0 111.218 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.564 ' HG ' ' HB ' ' A' ' 121' ' ' ILE . 12.4 tp -87.43 117.05 25.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.175 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.15 153.11 34.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.111 0.481 . . . . 0.0 111.715 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.515 ' HB2' HD11 ' A' ' 121' ' ' ILE . 6.2 t -117.66 162.62 17.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.306 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -56.02 -20.86 18.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.926 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.434 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . 18.4 m80 -90.19 -34.77 15.7 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.422 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.82 ' N ' ' HB2' ' A' ' 54' ' ' ALA . . . 177.3 -139.13 4.2 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.026 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.903 HG23 ' O ' ' A' ' 52' ' ' THR . 4.0 t -102.0 135.5 38.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.759 0.314 . . . . 0.0 111.227 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.572 HG22 ' OD1' ' A' ' 136' ' ' ASP . 1.2 mm -94.49 -66.35 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.909 0.385 . . . . 0.0 110.631 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.913 ' HA2' HG23 ' A' ' 137' ' ' VAL . . . -164.05 -161.83 13.88 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.558 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.685 HD11 HD13 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -116.87 164.14 15.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.725 0.298 . . . . 0.0 110.631 179.93 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.74 HG13 ' O ' ' A' ' 112' ' ' GLY . 29.4 m -73.89 129.33 36.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.91 0.386 . . . . 0.0 111.653 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.674 HG22 ' N ' ' A' ' 126' ' ' MET . 3.6 m -110.16 -94.25 0.43 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.129 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.674 ' N ' HG22 ' A' ' 125' ' ' THR . 12.4 mmm -144.56 142.03 29.9 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.855 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -113.21 178.6 18.72 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.588 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -108.41 -139.38 8.81 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.499 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -72.5 -19.43 61.54 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.787 0.327 . . . . 0.0 111.095 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -165.64 19.17 0.1 Allowed Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.816 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.561 ' CG1' HD22 ' A' ' 100' ' ' LEU . 1.5 t -121.85 157.34 25.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.703 0.287 . . . . 0.0 110.576 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.731 ' C ' HD23 ' A' ' 100' ' ' LEU . 12.2 m -115.4 118.39 58.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.825 -179.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.572 ' HA3' ' O ' ' A' ' 126' ' ' MET . . . -96.9 116.17 5.42 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.323 -0.942 . . . . 0.0 111.686 178.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.517 ' HD2' HD22 ' A' ' 114' ' ' LEU . 12.9 m-85 -116.2 141.66 47.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.994 0.426 . . . . 0.0 111.726 -179.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.509 ' HB2' ' OG1' ' A' ' 125' ' ' THR . . . -88.89 109.36 20.16 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.066 178.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.744 ' OD2' HD11 ' A' ' 99' ' ' LEU . 0.6 OUTLIER -67.87 152.03 46.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.152 0.501 . . . . 0.0 111.984 -178.735 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.913 HG23 ' HA2' ' A' ' 122' ' ' GLY . 48.0 t -99.33 9.39 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.843 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.486 ' HA ' HD23 ' A' ' 141' ' ' LEU . 5.9 mtm180 -72.29 -6.9 46.41 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.401 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.401 ' HB2' ' ND1' ' A' ' 97' ' ' HIS . 1.1 t70 -94.93 10.77 34.24 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.719 0.295 . . . . 0.0 110.846 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.846 ' O ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -176.77 58.32 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.08 0.467 . . . . 0.0 110.303 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.902 HD11 ' HB ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -73.09 -14.86 61.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.914 -179.386 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . 0.423 ' C ' HD12 ' A' ' 143' ' ' LEU . 15.8 p-90 -56.88 83.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.934 0.397 . . . . 0.0 111.476 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.69 HD12 ' C ' ' A' ' 141' ' ' LEU . 4.8 mp -150.91 -47.0 0.12 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.614 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.436 ' HB2' HG12 ' A' ' 12' ' ' VAL . 0.4 OUTLIER -151.46 -166.81 2.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.065 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.48 149.09 50.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.369 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.443 ' HB3' ' HB3' ' A' ' 55' ' ' ARG . 9.6 m-20 -95.29 154.53 17.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.753 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.81 144.85 56.72 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.897 0.379 . . . . 0.0 111.124 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 1.7 ptm 174.54 -33.28 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.758 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 67.75 85.56 0.14 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.852 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.146 -0.93 . . . . 0.0 110.909 -179.991 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.161 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.05 105.22 1.49 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.591 2.194 . . . . 0.0 112.318 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -79.42 121.34 25.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.951 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -137.53 113.08 0.97 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.552 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.2 m170 -110.72 -54.37 2.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.826 0.346 . . . . 0.0 110.878 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -139.78 -47.45 0.45 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.863 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -155.51 163.93 39.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.938 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -160.13 179.27 35.78 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.479 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.37 -174.35 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.813 0.34 . . . . 0.0 111.099 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.449 HG22 HG21 ' A' ' 113' ' ' ILE . 41.5 t -108.82 110.7 33.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.107 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.802 ' CE2' HG21 ' A' ' 45' ' ' THR . 5.2 t80 -99.73 116.32 31.55 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.791 0.329 . . . . 0.0 110.529 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.844 HG21 HD11 ' A' ' 53' ' ' ILE . 47.6 t -120.85 111.64 32.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.657 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.404 ' O ' ' CE1' ' A' ' 11' ' ' TYR . . . 53.0 -125.32 30.35 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.959 -0.639 . . . . 0.0 113.18 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.423 ' O ' ' HA ' ' A' ' 44' ' ' THR . 44.6 m-80 -91.93 18.73 7.44 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.701 0.286 . . . . 0.0 111.569 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.648 ' HE1' HG22 ' A' ' 44' ' ' THR . 6.2 m-30 -130.35 149.94 51.81 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.5 tttp -139.09 114.87 10.02 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.709 -0.223 . . . . 0.0 110.629 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 1.018 HG12 HG22 ' A' ' 42' ' ' VAL . 0.6 OUTLIER -100.3 121.64 51.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.041 0.448 . . . . 0.0 110.77 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.664 ' O ' HD12 ' A' ' 40' ' ' LEU . 7.3 p -136.43 160.26 37.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.037 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.513 ' N ' HG22 ' A' ' 18' ' ' VAL . 0.6 OUTLIER -62.26 141.51 58.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.227 179.054 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 8.4 ttp180 -56.27 -45.59 80.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.942 0.401 . . . . 0.0 110.85 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -66.85 -11.62 56.29 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.153 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.71 -13.41 14.79 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.961 ' HB3' ' CZ2' ' A' ' 28' ' ' TRP . . . -68.74 150.72 47.56 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 120.796 0.331 . . . . 0.0 110.834 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.403 ' O ' ' CE3' ' A' ' 28' ' ' TRP . 32.6 p -104.59 168.94 8.75 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.269 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 52.5 p-80 -54.76 -29.68 54.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.002 0.43 . . . . 0.0 110.564 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.4 t -74.66 -31.36 26.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.459 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.431 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 0.6 OUTLIER -67.18 -43.98 80.84 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.961 ' CZ2' ' HB3' ' A' ' 23' ' ' ALA . 7.2 m-90 -74.33 -30.37 62.01 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.145 179.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.15 -41.99 89.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.32 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -116.66 32.58 6.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.486 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.444 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 13.2 t -77.24 132.42 38.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.179 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.566 HG22 ' O ' ' A' ' 42' ' ' VAL . 16.8 m -96.06 -38.83 8.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.695 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.663 ' CE3' HG23 ' A' ' 42' ' ' VAL . 1.1 t90 -139.67 153.27 47.24 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.908 0.385 . . . . 0.0 111.548 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -155.69 120.51 4.74 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.79 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.439 ' HB2' ' CZ2' ' A' ' 33' ' ' TRP . 8.3 m-20 -107.09 99.2 8.77 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.038 0.447 . . . . 0.0 111.14 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -58.91 -28.92 66.66 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.8 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.69 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 0.9 OUTLIER -59.68 -38.74 82.35 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.755 -0.202 . . . . 0.0 111.301 -179.052 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.605 ' CZ ' HD22 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -117.31 0.75 12.31 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 60.24 54.83 3.84 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.85 0.357 . . . . 0.0 111.892 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.716 HD11 HG23 ' A' ' 17' ' ' VAL . 38.3 tp -137.11 133.65 35.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.449 179.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.67 ' O ' HD23 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -131.44 156.0 46.38 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.053 0.454 . . . . 0.0 112.068 -179.526 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 1.018 HG22 HG12 ' A' ' 17' ' ' VAL . 23.7 t -117.17 130.08 72.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.062 179.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.4 p -120.49 157.15 30.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.57 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.648 HG22 ' HE1' ' A' ' 15' ' ' TYR . 19.6 p -97.54 123.59 41.48 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.183 0.516 . . . . 0.0 111.493 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.802 HG21 ' CE2' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -98.28 -165.01 1.19 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.872 -179.429 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.0 t -138.86 42.35 2.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.856 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -136.03 -177.98 4.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.085 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -93.0 148.14 22.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.959 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -66.88 157.35 51.1 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.646 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -134.65 -49.17 0.76 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.872 0.368 . . . . 0.0 110.903 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -87.96 150.53 23.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.825 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.872 ' O ' HG23 ' A' ' 120' ' ' VAL . 39.9 m -122.99 116.98 24.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.763 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.9 ' HB ' HD11 ' A' ' 141' ' ' LEU . 0.4 OUTLIER -74.62 139.55 19.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.048 0.452 . . . . 0.0 110.968 -179.843 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.77 ' HB2' ' CA ' ' A' ' 119' ' ' GLY . . . -88.8 121.97 31.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.971 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.594 ' H ' ' HB3' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -88.44 29.01 1.02 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.11 0.481 . . . . 0.0 110.12 179.054 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 30.8 p -100.0 163.27 12.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.091 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.426 ' O ' ' O ' ' A' ' 58' ' ' CYS . 44.4 mt-30 -93.56 -70.19 0.71 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 178.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.426 ' O ' ' O ' ' A' ' 57' ' ' GLN . 96.3 m 54.47 159.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.74 178.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.11 -7.53 11.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.951 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.499 ' HA ' ' HA ' ' A' ' 75' ' ' SER . 10.0 p -132.41 123.97 27.75 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.973 0.416 . . . . 0.0 111.344 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -136.99 161.64 25.16 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.64 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.773 HG23 ' C ' ' A' ' 72' ' ' TYR . 7.3 p -102.52 132.91 47.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.951 0.405 . . . . 0.0 111.308 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.737 ' HE2' HG21 ' A' ' 74' ' ' VAL . 3.5 p90 -118.66 133.99 55.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.949 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -68.4 132.69 47.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.902 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.403 ' CB ' ' HB2' ' A' ' 68' ' ' LYS . 0.8 OUTLIER -91.58 155.49 18.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.909 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -92.03 -36.29 13.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.058 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.2 t -90.69 -48.36 7.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.875 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.403 ' HB2' ' CB ' ' A' ' 65' ' ' CYS . 14.3 mmtt -63.38 -27.03 69.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.096 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.2 m 57.03 24.26 9.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.921 0.391 . . . . 0.0 110.738 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp -133.62 170.05 16.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.691 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -83.99 126.78 33.37 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.773 ' C ' HG23 ' A' ' 62' ' ' VAL . 0.5 OUTLIER -116.31 113.94 40.92 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.835 -178.666 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 72' ' ' TYR . 5.5 Cg_exo -77.34 120.67 5.37 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.473 2.115 . . . . 0.0 110.319 178.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.737 HG21 ' HE2' ' A' ' 63' ' ' TYR . 43.2 t -137.47 151.09 26.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.164 0.507 . . . . 0.0 112.365 -178.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.499 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 20.7 m -98.71 133.92 42.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.522 178.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.723 ' CD2' ' HB2' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -145.75 174.14 11.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.444 0.64 . . . . 0.0 112.122 -179.188 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.607 ' C ' ' HD3' ' A' ' 79' ' ' PRO . 0.3 OUTLIER -111.86 158.84 18.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.703 179.425 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.445 ' HA2' ' HG ' ' A' ' 99' ' ' LEU . . . -112.77 66.76 0.25 Allowed Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.235 -0.983 . . . . 0.0 113.642 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.607 ' HD3' ' C ' ' A' ' 77' ' ' GLU . 14.0 Cg_exo -67.46 139.95 50.91 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.376 2.05 . . . . 0.0 112.212 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -57.42 -90.22 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.432 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.701 HD11 ' HB3' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -95.69 119.92 35.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.912 0.387 . . . . 0.0 111.733 -179.756 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.597 ' HB ' HG11 ' A' ' 98' ' ' VAL . 18.8 t -124.2 122.45 64.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.149 178.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -72.57 107.89 5.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.482 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.61 HG22 ' O ' ' A' ' 93' ' ' ARG . 4.8 m -72.77 123.73 28.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.855 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -69.29 150.28 47.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.669 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.584 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 22.8 tt0 -67.61 102.01 1.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.143 0.497 . . . . 0.0 110.373 -179.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 89' ' ' TYR . 4.1 m -144.3 164.08 31.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.188 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 55.93 -81.48 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.542 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.447 ' N ' ' O ' ' A' ' 87' ' ' SER . 0.7 OUTLIER -156.92 24.17 0.32 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.759 0.314 . . . . 0.0 110.877 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.584 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 1.6 t80 -122.69 131.62 24.35 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.695 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.473 ' O ' ' N ' ' A' ' 93' ' ' ARG . 87.0 Cg_endo -81.98 148.84 15.49 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.095 2.53 . . . . 0.0 112.524 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.4 OUTLIER -42.6 88.99 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.509 -179.931 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.61 ' O ' HG22 ' A' ' 84' ' ' VAL . 2.0 ttt180 -123.93 171.08 9.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.219 0.533 . . . . 0.0 112.074 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.701 ' HB3' HD11 ' A' ' 81' ' ' LEU . 3.9 m-85 -98.88 132.84 43.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.131 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.69 ' HA ' ' O ' ' A' ' 37' ' ' ASN . 2.0 tp60 -126.43 114.89 18.78 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.893 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.59 ' HA ' HD22 ' A' ' 81' ' ' LEU . 60.7 p -80.07 144.0 33.52 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.114 0.483 . . . . 0.0 111.875 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 21.7 m80 61.96 60.83 1.47 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.998 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.597 HG11 ' HB ' ' A' ' 82' ' ' VAL . 7.1 p -124.17 131.06 73.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.721 0.296 . . . . 0.0 111.266 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.766 HD11 ' HB3' ' A' ' 136' ' ' ASP . 2.2 mp -101.76 149.16 24.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.976 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.693 HD23 ' C ' ' A' ' 132' ' ' VAL . 9.0 mt -128.69 136.37 50.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.161 0.505 . . . . 0.0 111.96 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.723 ' HB2' ' CD2' ' A' ' 76' ' ' PHE . . . -125.69 124.3 40.8 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.352 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.3 t -96.78 112.01 23.94 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.799 0.333 . . . . 0.0 110.621 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -48.78 150.09 3.85 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.821 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.43 -70.88 0.27 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.808 0.337 . . . . 0.0 110.855 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 52.6 m -141.48 143.57 33.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.848 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 60.06 79.48 0.29 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.867 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.81 163.22 39.86 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.572 2.181 . . . . 0.0 112.321 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -150.92 -177.61 24.95 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.396 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -67.49 163.44 21.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.881 0.372 . . . . 0.0 110.855 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -156.93 136.01 11.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.165 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -166.94 111.28 0.44 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.496 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 159.81 -140.1 6.58 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.484 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.449 HG21 HG22 ' A' ' 10' ' ' VAL . 27.3 pt -122.54 145.32 29.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.861 0.362 . . . . 0.0 111.139 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.596 HD21 ' CZ ' ' A' ' 76' ' ' PHE . 8.4 tp -87.82 121.18 29.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.319 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.441 ' N ' HD12 ' A' ' 114' ' ' LEU . 0.8 OUTLIER -118.36 149.5 41.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.207 0.527 . . . . 0.0 111.962 -179.271 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.654 ' HB2' HD11 ' A' ' 121' ' ' ILE . 6.2 t -111.68 163.67 13.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.982 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -58.51 -17.26 19.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.022 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 18.8 m80 -95.66 -30.68 13.63 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.653 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.77 ' CA ' ' HB2' ' A' ' 54' ' ' ALA . . . 176.82 -143.1 6.16 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.424 -0.893 . . . . 0.0 113.034 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.872 HG23 ' O ' ' A' ' 52' ' ' THR . 3.6 t -98.93 135.33 34.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.726 0.298 . . . . 0.0 111.024 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.654 HD11 ' HB2' ' A' ' 116' ' ' CYS . 1.7 mm -92.35 -66.14 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.839 0.352 . . . . 0.0 110.794 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.847 ' HA2' HG23 ' A' ' 137' ' ' VAL . . . -166.98 -156.26 9.6 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.622 -0.799 . . . . 0.0 113.045 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.668 HD11 HD13 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -116.94 164.16 15.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.804 0.335 . . . . 0.0 110.983 -179.824 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.486 ' HA ' ' CD1' ' A' ' 134' ' ' PHE . 11.6 p -66.51 129.53 31.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.625 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.74 ' OG1' ' HB2' ' A' ' 135' ' ' ALA . 7.3 m -110.07 -87.35 0.52 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.228 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.537 ' N ' HG22 ' A' ' 125' ' ' THR . 0.0 OUTLIER -104.75 144.37 31.83 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.852 0.358 . . . . 0.0 111.13 179.825 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -118.86 96.26 0.65 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.154 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -77.43 174.5 54.63 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.603 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -71.93 -19.36 61.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.713 0.292 . . . . 0.0 110.931 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -145.16 4.74 1.37 Allowed Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.631 -0.795 . . . . 0.0 113.062 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.537 ' CG1' HD22 ' A' ' 100' ' ' LEU . 1.4 t -128.66 157.05 41.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 117.023 0.412 . . . . 0.0 111.008 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.693 ' C ' HD23 ' A' ' 100' ' ' LEU . 3.4 t -114.89 117.83 56.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.989 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -96.19 118.44 5.98 Favored Glycine 0 CA--C 1.517 0.16 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.801 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.501 ' CZ ' ' HB2' ' A' ' 63' ' ' TYR . 21.4 m-85 -125.13 133.06 52.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.909 0.385 . . . . 0.0 111.787 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.74 ' HB2' ' OG1' ' A' ' 125' ' ' THR . . . -93.62 107.76 19.58 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.766 ' HB3' HD11 ' A' ' 99' ' ' LEU . 2.5 p30 -67.72 151.84 46.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.262 0.554 . . . . 0.0 112.42 -178.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.847 HG23 ' HA2' ' A' ' 122' ' ' GLY . 39.7 t -93.58 13.72 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.643 179.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.472 ' HA ' HD23 ' A' ' 141' ' ' LEU . 1.3 mtm105 -70.61 -6.99 40.86 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.772 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -96.69 11.13 36.54 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.555 0.217 . . . . 0.0 111.3 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.847 ' O ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER 179.8 58.6 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.027 0.441 . . . . 0.0 110.501 -179.876 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.9 HD11 ' HB ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -74.58 -14.78 60.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.07 -179.515 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . 0.414 ' CE3' ' CE2' ' A' ' 15' ' ' TYR . 16.3 p-90 -55.48 81.66 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.006 0.431 . . . . 0.0 111.267 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.704 HD12 ' C ' ' A' ' 141' ' ' LEU . 5.0 mp -147.14 -45.82 0.17 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.302 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -152.91 -173.41 4.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.815 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.84 130.46 47.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.07 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -83.75 154.21 23.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.863 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.594 ' HB3' ' H ' ' A' ' 55' ' ' ARG . . . -77.31 130.88 37.75 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.066 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 2.8 mtt -103.32 163.59 12.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.892 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.6 -61.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.86 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.173 -0.917 . . . . 0.0 110.918 -179.997 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.169 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.96 144.71 53.81 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.604 2.203 . . . . 0.0 112.359 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -164.62 145.82 8.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.96 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.76 -65.83 3.47 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.531 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -89.97 137.4 32.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.767 0.317 . . . . 0.0 110.939 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -119.17 119.14 33.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.878 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.1 p -79.39 123.78 27.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.963 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 152.45 -36.12 0.81 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.516 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.81 ' HB2' HG23 ' A' ' 18' ' ' VAL . . . -131.72 173.16 11.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.848 0.356 . . . . 0.0 111.039 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.896 ' HB ' HG21 ' A' ' 113' ' ' ILE . 10.7 p -125.38 111.45 27.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.728 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 9.8 p90 -113.71 136.06 53.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.978 0.418 . . . . 0.0 111.16 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.606 HG21 HD11 ' A' ' 53' ' ' ILE . 95.1 t -118.94 134.88 61.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.491 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 45.51 -124.24 6.62 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 115.933 -0.576 . . . . 0.0 113.206 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.469 ' O ' ' HA ' ' A' ' 44' ' ' THR . 3.7 m-20 -91.59 17.96 8.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.646 0.26 . . . . 0.0 111.228 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.652 ' HB2' HD23 ' A' ' 143' ' ' LEU . 6.9 m-30 -127.82 147.36 50.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.259 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 11' ' ' TYR . 1.0 OUTLIER -133.63 114.73 13.84 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.771 179.467 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.861 HG12 HG22 ' A' ' 42' ' ' VAL . 1.2 m -102.26 121.37 53.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 121.242 0.544 . . . . 0.0 110.834 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.81 HG23 ' HB2' ' A' ' 9' ' ' ALA . 12.0 p -137.17 161.44 35.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.32 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.502 ' N ' HG22 ' A' ' 18' ' ' VAL . 0.7 OUTLIER -59.6 141.64 54.53 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 178.713 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.426 ' O ' ' HZ2' ' A' ' 28' ' ' TRP . 5.1 mtp-105 -56.29 -47.54 78.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.905 0.383 . . . . 0.0 111.254 -179.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.406 ' CD2' ' CE1' ' A' ' 90' ' ' TYR . 5.3 m-70 -69.09 -8.4 44.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.344 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.7 tp -115.35 5.86 14.72 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.729 ' HB3' ' NE1' ' A' ' 28' ' ' TRP . . . -88.88 129.26 35.63 Favored 'General case' 0 C--N 1.334 -0.07 0 C-N-CA 120.291 -0.563 . . . . 0.0 111.444 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.512 ' O ' ' HD1' ' A' ' 28' ' ' TRP . 27.4 p -74.85 164.68 26.3 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.703 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -53.74 -29.81 41.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.221 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.421 ' HA ' ' HG2' ' A' ' 29' ' ' GLN . 21.7 t -68.76 -33.99 62.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.973 0.416 . . . . 0.0 110.97 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.445 ' O ' ' HB3' ' A' ' 31' ' ' CYS . 0.4 OUTLIER -68.45 -43.5 76.89 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.258 179.67 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.729 ' NE1' ' HB3' ' A' ' 23' ' ' ALA . 59.0 m95 -73.69 -45.84 49.96 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.91 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.421 ' HG2' ' HA ' ' A' ' 26' ' ' VAL . 3.2 pt20 -54.97 -37.39 66.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.896 0.379 . . . . 0.0 110.689 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.2 m-20 -115.36 34.42 4.9 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.782 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.5 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 20.4 p -80.17 127.38 32.26 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.027 0.441 . . . . 0.0 111.365 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.586 HG22 ' O ' ' A' ' 42' ' ' VAL . 16.0 m -88.26 -38.95 12.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.329 179.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.638 ' CZ3' HG23 ' A' ' 42' ' ' VAL . 0.4 OUTLIER -139.81 153.13 47.01 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.977 179.753 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.414 ' HG3' ' HB3' ' A' ' 41' ' ' LEU . 5.2 tt0 -166.11 107.06 0.71 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.019 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.425 ' OD1' ' CZ2' ' A' ' 33' ' ' TRP . 34.6 p-10 -107.36 125.15 50.83 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.089 0.471 . . . . 0.0 111.118 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -67.0 -34.5 77.89 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.567 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -59.79 -24.49 64.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.913 0.387 . . . . 0.0 110.562 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.513 ' HA ' ' NE ' ' A' ' 38' ' ' ARG . 4.6 tpm_? -113.14 -4.74 13.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.975 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.419 ' HA ' ' HD3' ' A' ' 20' ' ' ARG . 1.9 m-20 48.97 36.87 9.14 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-O 121.112 0.482 . . . . 0.0 109.982 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.804 HD12 ' O ' ' A' ' 18' ' ' VAL . 30.8 tp -130.79 154.58 47.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.247 -178.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.632 ' O ' HD23 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -146.58 156.02 42.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.59 179.795 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.861 HG22 HG12 ' A' ' 17' ' ' VAL . 19.8 t -120.27 129.82 75.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.234 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 24.1 p -121.15 157.34 30.38 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.208 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.631 HG22 ' CE1' ' A' ' 15' ' ' TYR . 16.6 p -97.49 119.86 36.81 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.164 0.506 . . . . 0.0 111.324 -179.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -111.7 -33.78 6.24 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.038 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.7 m 64.05 45.08 4.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.881 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.65 160.29 37.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.095 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -58.73 130.28 46.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.826 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.457 ' HA2' ' CE2' ' A' ' 11' ' ' TYR . . . -104.59 -32.48 4.18 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.624 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER 59.22 20.81 8.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.669 0.271 . . . . 0.0 111.018 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -130.04 137.25 50.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.873 0.368 . . . . 0.0 110.742 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.875 ' O ' HG23 ' A' ' 120' ' ' VAL . 73.5 m -121.99 120.37 34.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.421 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.765 ' HB ' HD11 ' A' ' 141' ' ' LEU . 0.9 OUTLIER -72.82 139.22 19.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.82 0.343 . . . . 0.0 110.652 -179.815 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.759 ' HB2' ' N ' ' A' ' 119' ' ' GLY . . . -91.06 121.65 33.04 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.225 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.508 ' H ' ' HB3' ' A' ' 147' ' ' ALA . 0.5 OUTLIER -94.44 38.66 1.1 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.382 179.395 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 12.5 p -99.86 167.06 10.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.069 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -114.69 30.26 7.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.07 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 63.6 m -59.4 163.51 3.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.881 0.372 . . . . 0.0 110.875 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.6 m -117.0 2.66 12.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.93 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 75' ' ' SER . 17.6 p -136.02 126.25 26.41 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 120.879 0.371 . . . . 0.0 111.159 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -134.69 -161.75 9.59 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.041 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.546 HG23 ' C ' ' A' ' 72' ' ' TYR . 7.2 p -140.37 137.78 36.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.992 0.425 . . . . 0.0 111.205 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.712 ' CE2' HG21 ' A' ' 74' ' ' VAL . 6.5 p90 -143.53 129.94 19.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.439 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -59.87 134.06 56.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.804 0.335 . . . . 0.0 110.972 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -70.2 159.19 34.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.092 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.76 -45.05 54.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.206 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.4 m -85.72 -42.92 13.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.714 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.5 mmtt -81.28 129.27 34.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.657 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.19 50.06 1.94 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.012 0.434 . . . . 0.0 110.69 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.43 170.03 17.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.652 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 26.5 p-80 -83.71 139.51 32.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.059 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.546 ' C ' HG23 ' A' ' 62' ' ' VAL . 2.1 m-85 -123.85 114.11 28.32 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.619 -178.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 72' ' ' TYR . 7.9 Cg_exo -71.91 120.57 6.94 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.265 1.977 . . . . 0.0 110.423 178.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.712 HG21 ' CE2' ' A' ' 63' ' ' TYR . 56.0 t -132.69 142.02 43.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.08 0.467 . . . . 0.0 112.155 -178.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.443 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 75.6 p -93.88 121.0 34.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.331 178.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.436 ' CE1' HD21 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -125.34 164.78 19.64 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.439 0.638 . . . . 0.0 112.017 -178.657 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' A' ' 99' ' ' LEU . 12.0 mt-10 -111.8 159.02 18.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.162 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -104.56 65.03 0.32 Allowed Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.334 -0.936 . . . . 0.0 113.724 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.482 ' HD2' ' HA ' ' A' ' 99' ' ' LEU . 40.2 Cg_endo -67.97 136.09 37.08 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.419 2.079 . . . . 0.0 112.105 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -61.62 -87.43 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.255 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.686 HD11 ' HB3' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -90.76 119.65 31.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.813 0.34 . . . . 0.0 111.444 -179.878 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.638 ' HB ' HG11 ' A' ' 98' ' ' VAL . 23.4 t -129.04 122.2 55.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.34 178.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -74.42 108.1 6.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.839 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.565 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 35.0 m -72.65 124.59 29.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.234 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -69.24 149.84 48.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.327 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.649 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 2.0 pt-20 -68.36 102.83 1.48 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.793 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.411 ' O ' ' N ' ' A' ' 89' ' ' TYR . 1.4 m -143.57 155.19 44.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.395 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 59.48 -79.4 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.43 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.411 ' N ' ' O ' ' A' ' 87' ' ' SER . 1.0 OUTLIER -156.22 24.24 0.36 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.791 0.329 . . . . 0.0 111.028 -179.982 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.649 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -119.51 130.18 24.98 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.306 179.858 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.4 ' O ' ' N ' ' A' ' 93' ' ' ARG . 85.4 Cg_endo -83.92 148.42 12.16 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.862 2.375 . . . . 0.0 112.662 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.565 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -47.28 92.65 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.083 179.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.4 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.6 OUTLIER -123.88 166.31 15.87 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.116 0.484 . . . . 0.0 112.168 -179.304 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.686 ' HB3' HD11 ' A' ' 81' ' ' LEU . 4.3 m-85 -97.38 129.99 44.57 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.173 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.523 ' O ' HD13 ' A' ' 81' ' ' LEU . 22.7 mm-40 -131.45 137.92 48.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.701 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.539 ' HB2' HD22 ' A' ' 81' ' ' LEU . 23.2 t -103.66 142.81 33.68 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -179.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.454 ' HB2' ' O ' ' A' ' 96' ' ' SER . 96.3 m-70 75.93 56.04 0.05 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.353 179.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.638 HG11 ' HB ' ' A' ' 82' ' ' VAL . 12.1 p -123.57 143.85 35.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.737 0.304 . . . . 0.0 110.87 178.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.482 ' HA ' ' HD2' ' A' ' 79' ' ' PRO . 11.0 mp -102.71 140.54 36.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.039 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.712 HD23 ' O ' ' A' ' 132' ' ' VAL . 5.5 mt -130.96 140.33 50.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.188 0.518 . . . . 0.0 112.16 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.48 ' O ' HG12 ' A' ' 131' ' ' VAL . . . -152.07 159.37 43.7 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.526 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 130' ' ' GLY . 0.7 OUTLIER -112.19 127.13 55.86 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.02 0.438 . . . . 0.0 111.046 179.694 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -125.19 -121.58 2.55 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.465 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -154.47 77.75 1.06 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.861 0.363 . . . . 0.0 110.684 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 34.7 p -134.75 -162.99 1.31 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.844 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.452 ' CB ' ' CD ' ' A' ' 107' ' ' PRO . 0.1 OUTLIER -161.96 -65.02 0.02 OUTLIER Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.931 179.911 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.452 ' CD ' ' CB ' ' A' ' 106' ' ' GLU . 28.2 Cg_endo -62.43 -45.08 15.72 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.432 2.088 . . . . 0.0 112.138 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 70.41 -66.21 0.76 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.509 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 61.14 178.83 0.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.801 0.334 . . . . 0.0 110.842 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -101.4 -175.09 2.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.097 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 67.87 135.32 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.562 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.697 ' O ' HG13 ' A' ' 124' ' ' VAL . . . 129.23 140.47 4.88 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.373 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.896 HG21 ' HB ' ' A' ' 10' ' ' VAL . 2.7 pp -126.25 146.4 32.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.931 0.396 . . . . 0.0 111.738 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.472 HD22 ' HD2' ' A' ' 134' ' ' PHE . 9.8 tp -87.5 123.47 32.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.146 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 2.7 mtm180 -115.5 145.5 42.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.155 0.502 . . . . 0.0 111.627 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.488 ' HB2' HD11 ' A' ' 121' ' ' ILE . 4.5 t -109.4 165.46 11.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.145 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -60.86 -16.28 39.69 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.805 0.336 . . . . 0.0 110.616 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.431 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . 19.3 m80 -95.39 -29.24 14.54 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.528 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.759 ' N ' ' HB2' ' A' ' 54' ' ' ALA . . . 171.27 -140.47 5.92 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.537 -0.839 . . . . 0.0 113.015 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' ' 52' ' ' THR . 2.7 t -99.24 135.23 35.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.637 0.256 . . . . 0.0 110.835 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.488 HD11 ' HB2' ' A' ' 116' ' ' CYS . 0.9 OUTLIER -99.96 -71.5 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.397 -179.95 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.921 ' HA2' HG23 ' A' ' 137' ' ' VAL . . . -153.65 -168.04 16.8 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.326 -0.94 . . . . 0.0 113.294 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.604 HD11 HD13 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -116.88 164.2 15.04 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.635 0.255 . . . . 0.0 110.884 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.697 HG13 ' O ' ' A' ' 112' ' ' GLY . 28.0 m -66.22 126.52 25.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.743 0.306 . . . . 0.0 111.189 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.743 ' OG1' ' HB2' ' A' ' 135' ' ' ALA . 3.7 m -108.38 -94.05 0.4 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.779 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.69 ' N ' HG22 ' A' ' 125' ' ' THR . 73.7 mmm -144.02 162.3 36.56 Favored 'General case' 0 C--O 1.228 -0.076 0 CA-C-O 121.085 0.469 . . . . 0.0 111.538 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 175.85 -159.2 26.64 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.232 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -130.39 -153.32 7.68 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.404 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -89.75 11.83 18.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.722 0.296 . . . . 0.0 110.92 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 102' ' ' THR . . . -134.17 -36.32 0.25 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.728 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -115.67 157.28 16.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-O 120.949 0.404 . . . . 0.0 111.421 -179.859 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.712 ' O ' HD23 ' A' ' 100' ' ' LEU . 4.5 m -122.42 118.83 56.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.423 -179.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.538 ' HA3' ' O ' ' A' ' 126' ' ' MET . . . -101.76 114.89 5.09 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.384 -0.912 . . . . 0.0 112.082 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.472 ' HD2' HD22 ' A' ' 114' ' ' LEU . 10.7 m-85 -114.76 140.52 48.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.871 0.367 . . . . 0.0 111.261 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.743 ' HB2' ' OG1' ' A' ' 125' ' ' THR . . . -88.85 115.35 26.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.41 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.413 ' OD1' HD13 ' A' ' 99' ' ' LEU . 1.0 OUTLIER -68.0 142.61 55.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.072 -178.862 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.921 HG23 ' HA2' ' A' ' 122' ' ' GLY . 93.6 t -91.37 9.68 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.38 178.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.537 ' HA ' HD23 ' A' ' 141' ' ' LEU . 4.4 mtm-85 -71.53 -6.76 43.0 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.406 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -95.04 10.99 33.62 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 120.579 0.228 . . . . 0.0 111.23 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.878 ' O ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -176.09 61.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.295 0.569 . . . . 0.0 110.332 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.765 HD11 ' HB ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -78.89 -14.66 59.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.024 -179.474 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 18.2 p-90 -59.78 76.46 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.006 0.432 . . . . 0.0 111.785 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.652 HD23 ' HB2' ' A' ' 15' ' ' TYR . 4.9 mp -140.77 -47.39 0.41 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.823 178.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.491 ' HB2' ' CG1' ' A' ' 12' ' ' VAL . 1.5 tp10 -150.05 -161.89 1.44 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.441 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -69.35 146.36 52.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.832 0.348 . . . . 0.0 110.851 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -93.17 154.12 18.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.906 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.508 ' HB3' ' H ' ' A' ' 55' ' ' ARG . . . -91.74 132.43 36.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.166 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 19.7 ttt -164.48 -55.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.996 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -109.09 164.02 12.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.877 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.956 179.992 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.87 173.88 10.42 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.63 2.22 . . . . 0.0 112.309 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 99.8 m-85 60.38 -177.81 0.1 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.93 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 165.4 80.9 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.545 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -112.64 -36.61 5.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.735 0.302 . . . . 0.0 110.892 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -160.17 106.61 1.57 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.898 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.2 m -140.84 79.55 1.7 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.91 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 178.73 37.45 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.546 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.778 ' HB2' HG23 ' A' ' 18' ' ' VAL . . . -124.99 140.31 53.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.831 0.348 . . . . 0.0 111.108 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.852 HG22 HG21 ' A' ' 113' ' ' ILE . 25.6 t -108.68 111.89 37.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.059 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 1.5 p90 -117.34 124.09 48.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.898 0.38 . . . . 0.0 110.874 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.681 ' HB ' HD22 ' A' ' 143' ' ' LEU . 75.1 t -119.26 140.96 41.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.703 -179.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 45.37 -129.83 8.83 Favored Glycine 0 C--N 1.333 0.379 0 CA-C-N 115.94 -0.573 . . . . 0.0 113.306 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.457 ' O ' ' HA ' ' A' ' 44' ' ' THR . 28.6 p30 -89.49 18.84 4.94 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.693 0.282 . . . . 0.0 111.23 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.727 ' HB2' HD23 ' A' ' 143' ' ' LEU . 7.8 m-30 -127.61 147.69 50.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.287 -0.415 . . . . 0.0 109.954 179.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 11' ' ' TYR . 10.6 tttt -132.79 114.7 14.42 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.685 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.804 HG23 HD11 ' A' ' 40' ' ' LEU . 1.6 m -101.44 121.29 52.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-O 121.148 0.499 . . . . 0.0 110.765 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.778 HG23 ' HB2' ' A' ' 9' ' ' ALA . 12.0 p -137.02 161.41 35.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.31 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.501 ' N ' HG22 ' A' ' 18' ' ' VAL . 0.8 OUTLIER -61.74 141.51 57.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.044 178.823 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.55 -44.64 81.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.763 0.316 . . . . 0.0 111.211 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -69.41 -7.51 38.37 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.166 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.42 HD12 ' HB2' ' A' ' 19' ' ' ASN . 79.9 mt -115.1 -2.88 12.66 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.694 ' HB3' ' NE1' ' A' ' 28' ' ' TRP . . . -86.08 126.57 34.29 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.229 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.693 HG23 HG12 ' A' ' 26' ' ' VAL . 1.8 t -74.86 165.16 25.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.721 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -53.7 -29.98 41.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.845 -178.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.693 HG12 HG23 ' A' ' 24' ' ' THR . 11.4 p -72.65 -31.25 36.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.717 0.294 . . . . 0.0 110.967 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -67.66 -43.76 79.47 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.14 0.495 . . . . 0.0 109.697 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.694 ' NE1' ' HB3' ' A' ' 23' ' ' ALA . 48.9 m95 -73.85 -30.04 62.45 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.725 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -60.09 -44.23 94.96 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.556 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -110.2 27.75 9.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.336 179.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.465 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 7.0 t -73.13 123.64 24.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.043 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.56 ' CG2' HG12 ' A' ' 42' ' ' VAL . 13.3 m -86.32 -40.11 14.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.696 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.599 ' HH2' HD23 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -139.59 153.13 47.31 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.885 0.374 . . . . 0.0 111.181 179.825 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.408 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 1.0 OUTLIER -159.88 117.04 2.58 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.846 179.65 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.434 ' HB2' ' CZ2' ' A' ' 33' ' ' TRP . 0.7 OUTLIER -107.11 118.04 35.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.234 -179.759 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -62.93 -46.97 85.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.585 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -59.9 -18.86 47.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.242 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? -111.75 -6.05 14.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.191 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 48.55 38.93 12.08 Favored 'General case' 0 N--CA 1.461 0.079 0 CA-C-O 121.132 0.492 . . . . 0.0 110.401 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.804 HD11 HG23 ' A' ' 17' ' ' VAL . 27.1 tp -132.42 156.23 47.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.978 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.643 ' O ' HD23 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -150.2 156.12 41.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.478 179.746 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.91 HG21 HD23 ' A' ' 140' ' ' LEU . 21.3 t -120.01 133.04 68.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.98 0.419 . . . . 0.0 110.301 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.5 t -125.98 157.42 37.87 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.202 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.646 HG22 ' HE1' ' A' ' 15' ' ' TYR . 11.8 p -97.33 119.99 36.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.266 0.555 . . . . 0.0 111.529 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -108.14 160.72 15.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.887 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.0 t -105.99 42.48 1.25 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.875 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.33 169.94 16.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.139 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 10.1 p-80 -76.99 143.8 39.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.856 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -83.69 128.35 8.52 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.468 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -105.64 28.53 7.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.794 0.33 . . . . 0.0 110.87 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.516 ' O ' HG22 ' A' ' 12' ' ' VAL . 31.8 m-20 -153.02 133.57 13.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.82 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.905 ' O ' HG23 ' A' ' 120' ' ' VAL . 48.7 m -117.64 116.43 27.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.813 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.661 HG12 HG21 ' A' ' 12' ' ' VAL . 3.8 mm -72.9 139.72 19.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.839 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.849 ' HB2' ' N ' ' A' ' 119' ' ' GLY . . . -83.83 -53.57 5.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.785 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.405 ' CG ' ' HG ' ' A' ' 141' ' ' LEU . 29.0 ttt-85 63.75 35.54 11.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.997 0.427 . . . . 0.0 110.038 -178.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 6.0 p -99.71 146.65 26.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.991 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -88.03 54.22 3.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.051 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 77.1 m -85.98 164.8 17.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.828 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.65 -19.37 12.9 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.884 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 75' ' ' SER . 12.1 p -126.21 123.95 39.35 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.941 0.4 . . . . 0.0 111.336 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -138.3 166.02 25.33 Favored Glycine 0 N--CA 1.452 -0.265 0 N-CA-C 111.631 -0.588 . . . . 0.0 111.631 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.831 HG23 ' C ' ' A' ' 72' ' ' TYR . 14.9 p -102.57 130.82 51.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.967 0.413 . . . . 0.0 111.351 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.679 ' HE2' HG21 ' A' ' 74' ' ' VAL . 4.2 p90 -106.55 139.43 41.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.986 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -67.45 123.55 20.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 13.5 m -86.63 135.99 33.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.851 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -84.5 -34.39 23.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.011 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.3 m -93.55 -53.57 4.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.757 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.02 -25.59 65.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.985 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.1 m 58.97 22.67 10.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.872 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.4 mtpt -133.09 169.81 16.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.697 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.587 ' HB3' HG21 ' A' ' 62' ' ' VAL . 0.3 OUTLIER -84.34 119.74 25.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.107 179.637 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.831 ' C ' HG23 ' A' ' 62' ' ' VAL . 0.5 OUTLIER -107.81 113.99 60.65 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.46 -179.121 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 72' ' ' TYR . 4.6 Cg_exo -77.03 120.81 5.55 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.389 2.059 . . . . 0.0 110.582 178.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.692 ' CG1' ' HB1' ' A' ' 101' ' ' ALA . 47.6 t -139.85 145.81 26.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.058 0.456 . . . . 0.0 112.186 -178.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.445 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 1.1 m -91.9 134.62 34.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.267 178.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.73 ' HD2' ' HB2' ' A' ' 101' ' ' ALA . 0.1 OUTLIER -143.5 169.2 18.15 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.479 0.657 . . . . 0.0 112.329 -178.966 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.537 ' C ' ' HD3' ' A' ' 79' ' ' PRO . 0.1 OUTLIER -111.92 159.29 18.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.747 179.384 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.465 ' HA2' ' HG ' ' A' ' 99' ' ' LEU . . . -111.61 72.31 0.21 Allowed Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.322 -0.942 . . . . 0.0 113.52 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.651 ' HD2' ' O ' ' A' ' 98' ' ' VAL . 15.9 Cg_exo -66.93 138.57 48.6 Favored 'Trans proline' 0 C--O 1.24 0.601 0 C-N-CA 122.401 2.067 . . . . 0.0 112.459 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -63.71 -59.98 7.97 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.621 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.448 HD13 ' O ' ' A' ' 95' ' ' GLN . 0.0 OUTLIER -120.15 119.96 34.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.993 0.425 . . . . 0.0 112.074 -179.786 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.63 ' HB ' HG11 ' A' ' 98' ' ' VAL . 37.4 t -125.15 127.62 72.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.823 178.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -72.17 107.86 5.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.922 0.392 . . . . 0.0 110.693 -179.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.959 HG23 ' CG ' ' A' ' 126' ' ' MET . 1.6 p -72.83 114.49 12.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.405 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -69.89 150.17 47.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.602 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.573 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -68.04 101.58 1.16 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.151 0.501 . . . . 0.0 110.318 -179.517 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.443 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.4 OUTLIER -144.39 163.37 33.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.002 179.999 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.42 ' HG2' ' CD2' ' A' ' 89' ' ' TYR . 15.6 tt0 53.39 -84.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.482 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.443 ' N ' ' O ' ' A' ' 87' ' ' SER . 0.1 OUTLIER -152.41 21.41 0.63 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.757 0.313 . . . . 0.0 110.917 179.921 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.573 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 1.9 t80 -116.61 125.9 28.0 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.707 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.437 ' O ' ' N ' ' A' ' 93' ' ' ARG . 59.8 Cg_endo -73.5 148.58 42.87 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.754 2.303 . . . . 0.0 112.665 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.3 OUTLIER -53.2 85.01 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.455 -179.676 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.437 ' N ' ' O ' ' A' ' 91' ' ' PRO . 5.3 mtp-105 -124.04 -174.39 2.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.084 0.469 . . . . 0.0 111.737 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.437 ' HB3' HD11 ' A' ' 81' ' ' LEU . 26.2 m-85 -100.34 132.49 45.69 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.745 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.448 ' O ' HD13 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -125.56 122.53 36.78 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.119 -179.722 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 28.1 t -92.03 158.25 16.33 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 121.104 0.478 . . . . 0.0 112.114 -179.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 51.4 60.6 3.75 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.774 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.651 ' O ' ' HD2' ' A' ' 79' ' ' PRO . 9.9 p -123.99 136.56 59.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.187 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.724 HD11 ' OD2' ' A' ' 136' ' ' ASP . 6.3 mp -102.0 149.0 24.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.301 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.765 ' HA ' ' O ' ' A' ' 132' ' ' VAL . 6.4 mt -133.25 134.13 43.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.074 0.464 . . . . 0.0 111.801 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.73 ' HB2' ' HD2' ' A' ' 76' ' ' PHE . . . -125.9 119.65 28.36 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.434 -179.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 1.5 t -86.15 111.7 20.61 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.907 0.384 . . . . 0.0 110.63 179.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -78.78 -132.21 0.75 Allowed Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.554 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -152.89 136.39 15.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.814 0.34 . . . . 0.0 110.723 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.4 m 61.45 -177.04 0.12 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.797 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -58.87 109.66 2.04 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.975 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.1 -167.82 0.26 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.452 2.101 . . . . 0.0 112.325 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -170.74 39.09 0.18 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.504 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -99.86 153.63 19.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.81 0.338 . . . . 0.0 110.995 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -168.63 39.92 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.136 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.664 ' HA2' HG11 ' A' ' 124' ' ' VAL . . . 151.71 165.78 13.36 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.473 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 115.45 -177.11 17.03 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.544 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.852 HG21 HG22 ' A' ' 10' ' ' VAL . 31.3 pt -125.96 146.48 31.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.662 0.268 . . . . 0.0 111.156 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.6 HD21 ' CZ ' ' A' ' 76' ' ' PHE . 8.1 tp -87.24 115.87 24.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.855 0.36 . . . . 0.0 110.171 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.438 ' HE ' HD11 ' A' ' 113' ' ' ILE . 7.5 mtt180 -118.14 145.95 44.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.35 0.595 . . . . 0.0 111.842 -179.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.539 ' HB2' HD11 ' A' ' 121' ' ' ILE . 14.3 t -111.75 164.52 12.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.678 179.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -55.72 -18.71 8.82 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.72 0.295 . . . . 0.0 110.896 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.472 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . 50.8 m80 -91.34 -36.13 14.02 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.532 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.849 ' N ' ' HB2' ' A' ' 54' ' ' ALA . . . 174.91 -139.9 5.05 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.357 -0.925 . . . . 0.0 113.398 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.905 HG23 ' O ' ' A' ' 52' ' ' THR . 4.1 t -97.95 135.78 31.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.75 0.309 . . . . 0.0 111.63 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.539 HD11 ' HB2' ' A' ' 116' ' ' CYS . 0.9 OUTLIER -101.4 -66.91 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.928 179.195 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.846 ' HA2' HG23 ' A' ' 137' ' ' VAL . . . -151.51 -165.88 13.39 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.556 -0.83 . . . . 0.0 113.068 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.507 ' HG ' ' HB3' ' A' ' 135' ' ' ALA . 0.5 OUTLIER -120.11 164.19 16.55 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.785 0.326 . . . . 0.0 110.881 -179.92 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.664 HG11 ' HA2' ' A' ' 111' ' ' GLY . 12.6 p -61.9 115.07 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.783 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.79 ' OG1' ' HB2' ' A' ' 135' ' ' ALA . 6.0 m -105.87 -93.21 0.37 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.984 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.959 ' CG ' HG23 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -105.1 158.78 16.34 Favored 'General case' 0 C--N 1.335 -0.043 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.851 179.329 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -135.77 106.96 0.59 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.448 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -79.23 -178.62 51.24 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.476 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -71.92 -19.3 61.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.703 0.287 . . . . 0.0 111.141 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -150.33 17.22 1.02 Allowed Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.754 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.56 ' CG1' HD22 ' A' ' 100' ' ' LEU . 1.0 OUTLIER -136.65 157.51 36.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.693 0.282 . . . . 0.0 110.831 179.888 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.765 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 2.5 t -112.59 117.94 56.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.008 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -96.89 119.01 6.21 Favored Glycine 0 CA--C 1.518 0.236 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.89 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.474 ' CZ ' ' HB2' ' A' ' 63' ' ' TYR . 27.7 m-85 -125.18 144.09 50.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.02 0.438 . . . . 0.0 112.039 -179.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.79 ' HB2' ' OG1' ' A' ' 125' ' ' THR . . . -93.78 111.05 22.68 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.724 ' OD2' HD11 ' A' ' 99' ' ' LEU . 0.8 OUTLIER -67.26 142.02 57.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.259 0.552 . . . . 0.0 112.174 -178.227 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.846 HG23 ' HA2' ' A' ' 122' ' ' GLY . 31.6 t -90.25 12.31 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.502 179.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.515 ' HA ' HD23 ' A' ' 141' ' ' LEU . 15.7 mmm-85 -71.52 -6.92 44.18 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.446 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -96.1 7.52 46.19 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.91 HD23 HG21 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -171.83 34.35 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 121.208 0.528 . . . . 0.0 110.36 179.716 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.625 HD11 ' CG2' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -57.6 -14.84 5.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.583 -179.506 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . 0.436 ' CD1' ' HA ' ' A' ' 140' ' ' LEU . 13.6 p-90 -61.45 77.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.903 0.382 . . . . 0.0 111.828 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.727 HD23 ' HB2' ' A' ' 15' ' ' TYR . 5.1 mp -136.32 -52.66 0.72 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.057 178.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.463 ' HB2' ' CG1' ' A' ' 12' ' ' VAL . 2.2 tp10 -144.41 -163.3 1.65 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.657 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -67.94 145.16 54.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.858 0.361 . . . . 0.0 110.822 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.405 ' CB ' ' HD3' ' A' ' 55' ' ' ARG . 1.4 p30 -105.03 154.16 20.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.981 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -78.87 121.08 24.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.062 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 10.9 ttp -120.77 36.08 4.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.043 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.44 133.71 44.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.91 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.91 -179.992 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 112.577 -0.209 . . . . 0.0 112.577 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.3 147.79 27.45 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.553 2.169 . . . . 0.0 112.322 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -111.54 95.98 5.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.884 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 116.59 36.99 1.02 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.467 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.28 -31.59 72.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.838 0.352 . . . . 0.0 110.911 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -126.13 177.97 6.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.907 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.6 m -153.22 -46.34 0.1 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.92 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 140.08 -25.07 2.67 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.615 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.665 ' HB2' HG23 ' A' ' 18' ' ' VAL . . . -84.75 152.26 23.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.838 0.352 . . . . 0.0 111.285 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.8 t -101.14 127.12 54.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.877 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.736 ' OH ' ' HB3' ' A' ' 47' ' ' ALA . 7.0 t80 -111.66 116.06 30.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.841 0.353 . . . . 0.0 110.624 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.815 HG21 HD11 ' A' ' 53' ' ' ILE . 48.3 t -120.77 111.25 31.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.667 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 50.41 -124.92 20.12 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 121.064 -0.588 . . . . 0.0 113.273 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.476 ' O ' ' HA ' ' A' ' 44' ' ' THR . 77.8 m-20 -91.45 17.18 8.91 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.573 0.225 . . . . 0.0 111.601 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.646 ' HE1' HG22 ' A' ' 44' ' ' THR . 5.2 m-30 -130.31 127.84 40.3 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 9.1 tttt -120.42 114.81 22.36 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 121.11 -0.236 . . . . 0.0 110.742 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 1.001 HG12 HG22 ' A' ' 42' ' ' VAL . 0.6 OUTLIER -98.97 121.52 49.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 121.02 0.438 . . . . 0.0 110.761 179.861 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.665 HG23 ' HB2' ' A' ' 9' ' ' ALA . 15.0 p -136.67 161.35 36.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.288 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.517 ' N ' HG22 ' A' ' 18' ' ' VAL . 25.4 t30 -61.05 141.48 57.36 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 179.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.418 ' HG2' ' CB ' ' A' ' 39' ' ' ASP . 1.8 ppt_? -56.46 -45.9 80.62 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.928 0.394 . . . . 0.0 111.311 -179.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -66.38 -10.29 41.97 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.157 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.4 mt -115.21 0.85 13.67 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.669 ' HB3' ' NE1' ' A' ' 28' ' ' TRP . . . -88.98 127.37 35.67 Favored 'General case' 0 N--CA 1.457 -0.084 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.212 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.544 ' O ' ' HD1' ' A' ' 28' ' ' TRP . 1.1 t -74.6 163.2 27.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.706 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -53.59 -29.77 39.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.746 0.308 . . . . 0.0 111.008 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.403 ' O ' ' HG2' ' A' ' 29' ' ' GLN . 22.3 t -69.79 -32.25 51.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.967 0.413 . . . . 0.0 110.767 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.447 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 0.5 OUTLIER -68.56 -43.62 76.21 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.417 179.587 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.669 ' NE1' ' HB3' ' A' ' 23' ' ' ALA . 46.6 m95 -73.27 -45.97 52.63 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.019 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.403 ' HG2' ' O ' ' A' ' 26' ' ' VAL . 14.4 pt20 -54.99 -44.07 74.16 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.768 0.318 . . . . 0.0 110.685 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -102.82 29.9 5.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.178 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.484 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 35.4 t -80.07 145.56 32.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.483 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.664 ' CG2' HG12 ' A' ' 42' ' ' VAL . 10.0 m -103.67 -41.96 7.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.335 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.578 ' HH2' HD23 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -139.69 152.86 47.03 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.018 179.696 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -157.22 117.81 3.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.136 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.412 ' HB3' ' CG ' ' A' ' 38' ' ' ARG . 26.6 t0 -107.13 105.02 14.81 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.789 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -63.27 -29.2 70.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.173 -179.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.531 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 10.7 m-20 -62.2 -30.16 70.88 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 120.403 0.144 . . . . 0.0 110.93 -179.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.582 ' NH2' HD22 ' A' ' 40' ' ' LEU . 14.5 ptm180 -113.71 -3.43 13.54 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.418 ' CB ' ' HG2' ' A' ' 20' ' ' ARG . 8.2 m-20 60.48 46.24 9.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.918 0.39 . . . . 0.0 110.906 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.588 HD11 HG23 ' A' ' 17' ' ' VAL . 26.6 tp -135.04 153.32 52.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.748 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.682 ' O ' HD23 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -152.04 155.88 38.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.064 0.459 . . . . 0.0 111.719 179.683 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 1.001 HG22 HG12 ' A' ' 17' ' ' VAL . 28.9 t -116.6 133.04 64.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.93 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.2 t -125.69 157.11 38.15 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.748 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.646 HG22 ' HE1' ' A' ' 15' ' ' TYR . 22.7 p -97.75 144.33 27.48 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.083 0.468 . . . . 0.0 111.538 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.685 HG21 ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -135.02 171.41 14.46 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.957 -179.167 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.0 m -115.68 55.34 0.79 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.884 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.736 ' HB3' ' OH ' ' A' ' 11' ' ' TYR . . . -133.5 -175.11 3.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.147 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -99.4 148.06 24.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.021 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -67.52 170.47 35.3 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.644 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.3 m -149.21 -60.58 0.22 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.81 0.338 . . . . 0.0 110.812 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -83.66 150.41 25.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.884 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.896 ' O ' HG23 ' A' ' 120' ' ' VAL . 86.6 m -122.38 119.29 30.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.959 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.927 ' HB ' HD11 ' A' ' 141' ' ' LEU . 0.4 OUTLIER -76.46 139.75 18.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.767 179.854 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.651 ' HA ' ' HB3' ' A' ' 147' ' ' ALA . . . -90.89 135.56 33.65 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.396 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -94.18 27.22 2.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.035 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.405 ' SG ' ' HB1' ' A' ' 54' ' ' ALA . 24.7 p -99.96 167.3 10.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.198 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -122.86 31.6 5.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.035 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 15.6 m -58.58 132.12 52.85 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.814 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.5 t -74.94 -8.17 55.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.115 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.2 p -107.98 127.21 53.56 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.89 0.376 . . . . 0.0 111.059 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -149.63 146.61 16.06 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.198 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.671 HG23 ' C ' ' A' ' 72' ' ' TYR . 9.6 p -103.86 125.39 58.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.933 0.396 . . . . 0.0 111.216 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.696 ' HE2' HG21 ' A' ' 74' ' ' VAL . 9.5 p90 -108.01 163.6 13.0 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.796 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -90.28 128.31 36.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.863 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -84.54 151.54 24.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.92 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.98 -42.27 10.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.984 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.8 p -89.7 -49.07 6.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.782 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.7 mmtm -59.84 -25.82 65.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.035 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 8.3 t 55.66 24.0 6.71 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.806 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.4 mtpt -135.23 170.03 16.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.73 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -84.4 135.15 34.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.103 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.671 ' C ' HG23 ' A' ' 62' ' ' VAL . 1.3 m-85 -126.04 114.25 24.14 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.631 -179.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 72' ' ' TYR . 7.0 Cg_exo -72.75 120.79 6.88 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.467 2.111 . . . . 0.0 110.497 178.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.696 HG21 ' HE2' ' A' ' 63' ' ' TYR . 84.6 t -137.64 142.02 37.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.257 0.551 . . . . 0.0 112.466 -178.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.19 135.0 39.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.495 -0.775 . . . . 0.0 108.961 178.222 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.593 ' HB3' ' HB2' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -141.97 172.76 12.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.381 0.61 . . . . 0.0 112.214 -178.362 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.464 ' O ' ' HA ' ' A' ' 99' ' ' LEU . 9.8 mt-10 -111.78 158.86 18.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.264 179.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -103.73 68.56 0.29 Allowed Glycine 0 CA--C 1.522 0.486 0 C-N-CA 120.366 -0.921 . . . . 0.0 113.735 -179.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.651 ' HD2' ' HA ' ' A' ' 99' ' ' LEU . 36.9 Cg_endo -67.77 139.2 47.2 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.464 2.109 . . . . 0.0 112.188 179.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -56.73 -91.77 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.693 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.496 HD22 ' HB3' ' A' ' 96' ' ' SER . 0.0 OUTLIER -98.62 122.73 42.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.921 0.391 . . . . 0.0 111.85 -179.772 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.668 ' HB ' HG11 ' A' ' 98' ' ' VAL . 96.0 t -119.25 126.19 75.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.149 179.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -72.33 107.85 5.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.674 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.822 HG22 ' HB2' ' A' ' 126' ' ' MET . 1.0 OUTLIER -74.55 114.83 14.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.099 -179.834 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -70.75 149.77 46.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.843 179.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.501 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 4.2 pt-20 -68.06 101.0 1.06 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.086 0.469 . . . . 0.0 109.892 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.05 145.18 31.36 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.972 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.582 ' O ' ' CD1' ' A' ' 89' ' ' TYR . 0.3 OUTLIER 43.33 93.72 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.31 -0.404 . . . . 0.0 112.072 178.702 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.582 ' CD1' ' O ' ' A' ' 88' ' ' GLU . 4.3 p90 37.91 28.87 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.501 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -131.38 125.11 20.62 Favored Pre-proline 0 C--N 1.329 -0.312 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.541 -179.64 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -86.68 148.84 8.57 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.335 2.69 . . . . 0.0 112.476 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 5.0 mttm -45.73 93.63 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.352 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.68 170.77 10.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.511 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -102.9 132.47 49.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.961 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.908 ' NE2' HG23 ' A' ' 125' ' ' THR . 0.0 OUTLIER -126.12 110.89 14.02 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.183 -179.823 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.496 ' HB3' HD22 ' A' ' 81' ' ' LEU . 97.5 p -82.84 153.93 24.92 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.981 0.419 . . . . 0.0 111.441 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 54.47 62.22 2.66 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.621 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.668 HG11 ' HB ' ' A' ' 82' ' ' VAL . 9.4 p -123.66 146.01 29.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.942 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.963 HD11 ' HB3' ' A' ' 136' ' ' ASP . 0.9 OUTLIER -105.28 146.64 29.06 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.133 179.72 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.71 HD23 ' C ' ' A' ' 132' ' ' VAL . 6.0 mt -133.02 143.27 49.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.27 0.557 . . . . 0.0 112.492 -179.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.593 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . . . -151.0 140.92 21.97 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.603 179.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 1.3 t -95.52 118.11 31.64 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.954 0.407 . . . . 0.0 111.017 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -71.66 -112.14 0.05 OUTLIER Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.424 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -166.61 74.69 0.17 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.911 0.386 . . . . 0.0 110.768 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.8 m 63.22 85.18 0.13 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.865 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -132.67 141.69 42.09 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.937 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.88 -62.9 0.23 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.382 2.055 . . . . 0.0 112.273 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -139.96 -55.31 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.495 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.409 ' O ' ' HB3' ' A' ' 110' ' ' ALA . 16.2 m-20 61.81 -174.76 0.13 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.815 0.34 . . . . 0.0 110.845 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.741 ' HB1' ' CG2' ' A' ' 124' ' ' VAL . . . 67.85 113.27 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.098 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -173.68 34.67 0.12 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.442 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.463 ' O ' HG12 ' A' ' 124' ' ' VAL . . . -165.63 -140.96 3.0 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.514 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.524 HD13 HG13 ' A' ' 120' ' ' VAL . 2.3 pp -126.0 146.74 31.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.798 0.332 . . . . 0.0 111.24 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.589 HD21 ' CE1' ' A' ' 76' ' ' PHE . 19.3 tp -87.18 120.4 28.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.713 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.06 145.03 45.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.394 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.814 ' HB2' HD12 ' A' ' 121' ' ' ILE . 5.1 t -108.4 164.56 12.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.111 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.49 -19.23 23.08 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.928 0.394 . . . . 0.0 110.482 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -92.68 -33.6 14.29 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.348 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.52 ' N ' ' HB2' ' A' ' 54' ' ' ALA . . . 176.78 -128.44 1.34 Allowed Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.894 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.896 HG23 ' O ' ' A' ' 52' ' ' THR . 3.3 t -113.0 135.66 51.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.596 0.236 . . . . 0.0 110.856 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.814 HD12 ' HB2' ' A' ' 116' ' ' CYS . 0.2 OUTLIER -100.06 -49.0 11.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.872 179.636 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.935 ' HA2' HG23 ' A' ' 137' ' ' VAL . . . -170.39 -165.61 28.01 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.319 -0.943 . . . . 0.0 113.252 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 0.3 OUTLIER -116.93 164.2 15.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.679 0.276 . . . . 0.0 110.626 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.741 ' CG2' ' HB1' ' A' ' 110' ' ' ALA . 12.0 p -69.45 129.96 34.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.357 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.908 HG23 ' NE2' ' A' ' 95' ' ' GLN . 12.1 m -112.01 -95.37 0.44 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.682 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.822 ' HB2' HG22 ' A' ' 84' ' ' VAL . 95.0 mmm -144.07 140.19 29.35 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.717 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -115.25 154.47 16.94 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.52 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -86.89 -150.02 16.44 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.473 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -71.92 -19.45 61.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.759 0.314 . . . . 0.0 110.991 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -157.4 13.98 0.29 Allowed Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.784 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.653 ' CG1' HD22 ' A' ' 100' ' ' LEU . 1.2 t -121.39 157.05 25.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.725 0.298 . . . . 0.0 110.794 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.71 ' C ' HD23 ' A' ' 100' ' ' LEU . 7.6 m -115.66 118.41 58.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.406 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.547 ' HA3' ' O ' ' A' ' 126' ' ' MET . . . -101.19 115.28 5.24 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.378 -0.915 . . . . 0.0 112.085 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.634 ' O ' HD12 ' A' ' 99' ' ' LEU . 15.4 m-85 -117.55 139.83 50.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.778 0.323 . . . . 0.0 111.116 -179.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.69 ' HB2' ' OG1' ' A' ' 125' ' ' THR . . . -88.84 114.75 25.79 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.689 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.963 ' HB3' HD11 ' A' ' 99' ' ' LEU . 1.4 p30 -74.63 140.93 44.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.769 -179.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.935 HG23 ' HA2' ' A' ' 122' ' ' GLY . 48.8 t -89.51 10.09 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.48 178.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.42 ' HA ' HD23 ' A' ' 141' ' ' LEU . 10.8 mmm180 -70.82 -6.9 41.39 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.632 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -94.75 11.1 32.6 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.685 0.279 . . . . 0.0 111.206 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.826 ' O ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -178.17 62.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.245 0.545 . . . . 0.0 110.317 -179.918 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.927 HD11 ' HB ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -77.3 -14.75 59.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.026 -179.311 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 15.3 p-90 -56.23 78.65 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.004 0.43 . . . . 0.0 111.437 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.717 HD12 ' C ' ' A' ' 141' ' ' LEU . 5.0 mp -143.02 -46.66 0.31 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.147 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -151.48 -163.56 1.79 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.719 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -65.95 142.31 57.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.845 0.355 . . . . 0.0 111.039 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -86.57 154.13 21.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.914 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.651 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . . . -95.91 120.0 35.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.171 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 4.9 mtt -75.55 -177.54 3.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.902 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.68 176.06 12.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.868 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.907 179.953 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.144 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -52.16 164.15 1.31 Allowed 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.584 2.189 . . . . 0.0 112.332 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -87.86 119.48 28.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.832 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 154.83 -133.18 3.72 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.464 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 15.3 t60 -107.66 173.68 6.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.799 0.333 . . . . 0.0 110.94 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.52 111.66 0.91 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.855 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 89.8 p -156.13 168.99 25.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.935 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -160.57 27.39 0.31 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.531 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -110.71 -178.92 3.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.821 0.343 . . . . 0.0 111.108 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.906 HG22 HG21 ' A' ' 113' ' ' ILE . 45.4 t -130.29 110.0 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.127 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.712 ' CE2' HG21 ' A' ' 45' ' ' THR . 5.9 t80 -95.92 116.11 28.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.841 0.353 . . . . 0.0 110.514 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.918 HG21 HD11 ' A' ' 53' ' ' ILE . 21.9 t -120.92 108.96 23.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.637 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 51.06 -125.96 25.58 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.898 -0.668 . . . . 0.0 113.327 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.424 ' O ' ' HA ' ' A' ' 44' ' ' THR . 24.8 m120 -89.07 14.25 11.15 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.722 0.296 . . . . 0.0 111.672 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.658 ' HE1' HG22 ' A' ' 44' ' ' THR . 6.5 m-30 -130.37 146.94 52.02 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.8 tttt -137.67 114.93 10.98 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 121.197 -0.201 . . . . 0.0 110.651 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 1.037 HG12 HG22 ' A' ' 42' ' ' VAL . 0.6 OUTLIER -99.29 121.53 50.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 121.144 0.497 . . . . 0.0 111.145 -179.927 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.645 ' O ' HD12 ' A' ' 40' ' ' LEU . 14.1 p -136.74 161.1 36.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.805 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.506 ' N ' HG22 ' A' ' 18' ' ' VAL . 4.5 t-20 -59.84 141.24 55.74 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 179.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.44 ' HG2' ' CH2' ' A' ' 28' ' ' TRP . 25.3 mtp180 -56.61 -47.12 80.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.948 0.404 . . . . 0.0 110.842 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.22 -8.04 28.55 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.245 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.09 -2.42 12.78 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.621 ' HB3' ' NE1' ' A' ' 28' ' ' TRP . . . -88.62 129.01 35.59 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.102 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.595 ' O ' ' HD1' ' A' ' 28' ' ' TRP . 43.8 p -74.73 162.89 28.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.56 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 24.1 p80 -53.51 -29.49 36.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.888 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.0 t -69.95 -31.85 49.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.82 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.437 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 3.7 m-20 -68.22 -43.97 76.78 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.621 ' NE1' ' HB3' ' A' ' 23' ' ' ALA . 27.5 m95 -73.64 -37.23 65.4 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.015 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.31 -44.23 79.71 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.96 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -110.16 32.4 5.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.275 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.485 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 54.1 t -80.14 149.34 30.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.542 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.516 HG22 ' O ' ' A' ' 42' ' ' VAL . 15.9 m -107.92 -39.32 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.048 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.705 ' CZ3' HG23 ' A' ' 42' ' ' VAL . 0.7 OUTLIER -139.49 150.89 45.69 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.952 0.406 . . . . 0.0 111.7 -179.615 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.424 ' HG3' ' SG ' ' A' ' 31' ' ' CYS . 5.6 mp0 -147.0 118.47 7.92 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.792 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.453 ' HB2' ' CZ2' ' A' ' 33' ' ' TRP . 24.6 t70 -107.09 105.55 15.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.917 0.389 . . . . 0.0 110.891 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -64.46 -29.85 70.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.401 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.569 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 25.5 m120 -68.73 -27.59 66.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.88 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.566 ' HD2' ' HB1' ' A' ' 135' ' ' ALA . 9.4 ttp-105 -114.42 5.64 15.71 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 121.152 -0.219 . . . . 0.0 111.479 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.42 ' HA ' ' CD ' ' A' ' 20' ' ' ARG . 0.8 OUTLIER 46.55 38.98 6.14 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.994 0.426 . . . . 0.0 110.618 -179.862 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.821 HD11 HG23 ' A' ' 17' ' ' VAL . 26.5 tp -129.29 150.03 50.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.938 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.682 ' O ' HD23 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -144.88 155.57 43.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.321 179.489 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 1.037 HG22 HG12 ' A' ' 17' ' ' VAL . 24.9 t -115.94 130.05 71.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.29 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 12.2 p -120.69 157.35 29.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.532 179.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.658 HG22 ' HE1' ' A' ' 15' ' ' TYR . 17.8 p -97.49 130.67 44.56 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.22 0.533 . . . . 0.0 111.659 -179.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.712 HG21 ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -126.5 160.53 30.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.849 -179.296 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -118.19 58.02 0.83 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.796 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -135.05 -173.69 3.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.132 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -101.53 120.59 40.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.459 ' CA ' ' CE1' ' A' ' 11' ' ' TYR . . . -80.17 -170.36 41.2 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.52 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -155.48 -46.23 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.828 0.347 . . . . 0.0 110.859 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -64.3 141.95 58.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.892 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.789 ' O ' HG23 ' A' ' 120' ' ' VAL . 87.0 m -125.14 118.12 25.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.924 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 1.022 ' HB ' HD11 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -79.44 139.54 18.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.905 179.825 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -98.57 135.85 39.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.839 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.423 ' HB2' ' HB3' ' A' ' 146' ' ' ASP . 0.5 OUTLIER -92.45 42.93 1.11 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.457 0.646 . . . . 0.0 109.409 178.614 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 19.4 p -99.65 167.19 10.73 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.569 -178.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -120.15 24.89 10.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.2 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 16.1 p -64.17 139.52 58.77 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.048 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.544 HG22 ' O ' ' A' ' 76' ' ' PHE . 1.7 m -91.36 12.99 18.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.381 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 39.0 p -125.94 160.87 28.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.815 0.34 . . . . 0.0 110.883 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 176.13 152.81 9.9 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.442 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.864 HG23 ' C ' ' A' ' 72' ' ' TYR . 7.1 p -103.71 137.83 30.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.808 0.337 . . . . 0.0 111.032 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.69 ' CE2' HG21 ' A' ' 74' ' ' VAL . 8.8 p90 -130.13 -170.9 2.41 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.357 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.438 ' CD2' ' HB2' ' A' ' 67' ' ' SER . 0.7 OUTLIER 73.88 -90.71 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.241 179.844 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 70' ' ' LYS . 0.1 OUTLIER 69.2 -65.02 0.31 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.722 0.296 . . . . 0.0 111.101 -179.933 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -82.06 -44.8 16.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.625 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.438 ' HB2' ' CD2' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -48.78 -70.49 0.09 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.169 -179.689 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.4 mmtt -78.4 -1.57 34.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.277 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.7 t 76.18 1.58 3.45 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.121 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 65' ' ' CYS . 0.0 OUTLIER -141.81 169.05 18.33 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.922 0.391 . . . . 0.0 110.617 179.738 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.807 ' HB2' HG21 ' A' ' 62' ' ' VAL . 0.2 OUTLIER -85.22 116.66 23.71 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.612 179.707 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.864 ' C ' HG23 ' A' ' 62' ' ' VAL . 1.3 m-85 -102.37 113.07 66.04 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.77 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 72' ' ' TYR . 4.6 Cg_exo -80.61 121.06 4.08 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.663 2.242 . . . . 0.0 111.217 179.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.69 HG21 ' CE2' ' A' ' 63' ' ' TYR . 44.4 t -134.21 147.48 30.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.073 0.463 . . . . 0.0 112.027 -178.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 74.2 m -100.58 128.62 46.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.458 178.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.743 ' HZ ' HD11 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -132.52 169.25 16.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.381 0.61 . . . . 0.0 112.05 -178.588 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.435 ' O ' ' HD2' ' A' ' 79' ' ' PRO . 28.6 tt0 -111.91 158.44 19.47 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.156 178.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -105.44 65.97 0.28 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.474 -0.869 . . . . 0.0 113.172 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.435 ' HD2' ' O ' ' A' ' 77' ' ' GLU . 41.2 Cg_endo -67.99 134.45 32.02 Favored 'Trans proline' 0 C--O 1.239 0.557 0 C-N-CA 122.29 1.993 . . . . 0.0 112.23 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -58.86 -87.77 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.202 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.606 HD22 ' HB2' ' A' ' 96' ' ' SER . 0.0 OUTLIER -94.32 119.84 33.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.031 0.444 . . . . 0.0 111.826 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.626 ' HB ' HG11 ' A' ' 98' ' ' VAL . 48.8 t -122.91 122.9 66.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.686 178.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.425 ' HG3' ' CE1' ' A' ' 94' ' ' TYR . 3.9 tt0 -72.08 107.61 4.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.976 0.417 . . . . 0.0 110.808 -179.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.781 HG13 ' CG ' ' A' ' 126' ' ' MET . 47.6 t -73.96 114.62 13.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.757 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -72.84 150.02 43.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.752 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.526 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 0.6 OUTLIER -67.71 100.9 0.96 Allowed 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.331 -0.548 . . . . 0.0 110.232 -179.388 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.522 ' O ' ' N ' ' A' ' 89' ' ' TYR . 3.7 m -144.78 169.58 17.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.591 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 45.65 -84.82 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.658 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.522 ' N ' ' O ' ' A' ' 87' ' ' SER . 0.6 OUTLIER -153.99 24.75 0.49 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.818 0.342 . . . . 0.0 110.378 179.652 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.526 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -117.43 116.47 37.08 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.623 -179.934 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.457 ' O ' ' N ' ' A' ' 93' ' ' ARG . 30.9 Cg_exo -61.51 148.52 92.78 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.706 2.271 . . . . 0.0 112.181 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.557 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -59.05 79.24 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.858 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.457 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.2 OUTLIER -123.97 179.96 4.64 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.172 0.51 . . . . 0.0 111.816 -179.498 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.455 ' HB3' HD11 ' A' ' 81' ' ' LEU . 12.5 m-85 -93.93 132.56 38.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.784 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.578 ' CD ' HG21 ' A' ' 125' ' ' THR . 2.2 tt0 -130.57 123.14 28.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.209 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.606 ' HB2' HD22 ' A' ' 81' ' ' LEU . 5.1 t -97.71 161.49 13.73 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.114 0.483 . . . . 0.0 112.02 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 55.72 56.32 6.26 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.585 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.626 HG11 ' HB ' ' A' ' 82' ' ' VAL . 11.1 p -123.66 139.64 49.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.815 0.341 . . . . 0.0 111.559 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.466 HD11 ' OD2' ' A' ' 136' ' ' ASP . 11.2 mp -101.97 140.25 36.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.169 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.815 HD23 ' O ' ' A' ' 132' ' ' VAL . 5.6 mt -133.18 142.29 48.54 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -179.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.57 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . . . -152.12 147.12 26.08 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.706 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 0.9 OUTLIER -100.42 118.24 36.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.058 0.456 . . . . 0.0 111.129 179.865 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -86.39 -6.02 81.59 Favored Glycine 0 CA--C 1.519 0.287 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.868 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 67.83 -69.73 0.14 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.775 0.322 . . . . 0.0 110.887 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.19 88.78 2.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.887 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -118.37 143.86 33.97 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.975 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -56.72 -62.86 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.507 2.138 . . . . 0.0 112.197 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 146.75 -28.03 1.61 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.445 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -102.72 140.56 36.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.829 0.347 . . . . 0.0 110.883 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -140.78 163.09 33.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.079 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 169.38 66.1 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.485 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -160.07 176.6 36.75 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.549 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.906 HG21 HG22 ' A' ' 10' ' ' VAL . 2.5 pp -97.61 146.39 7.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.738 0.304 . . . . 0.0 111.077 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.743 HD11 ' HZ ' ' A' ' 76' ' ' PHE . 47.0 tp -87.58 113.15 23.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.822 0.344 . . . . 0.0 110.843 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -119.36 138.11 53.28 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.298 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.945 ' SG ' HD11 ' A' ' 121' ' ' ILE . 28.0 p -111.5 177.01 4.79 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -56.61 -19.94 18.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.686 0.279 . . . . 0.0 111.218 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 22.1 m80 -90.77 -33.66 15.64 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 159.83 -150.65 21.07 Favored Glycine 0 C--N 1.334 0.445 0 C-N-CA 120.425 -0.893 . . . . 0.0 113.136 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.789 HG23 ' O ' ' A' ' 52' ' ' THR . 9.1 t -83.83 135.6 24.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.768 0.318 . . . . 0.0 111.63 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.945 HD11 ' SG ' ' A' ' 116' ' ' CYS . 3.0 mp -109.31 -47.97 7.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.028 179.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.85 ' HA2' HG23 ' A' ' 137' ' ' VAL . . . -168.45 -171.94 34.82 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.078 -1.058 . . . . 0.0 113.215 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.576 HD11 HD13 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -118.76 164.13 15.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.803 0.335 . . . . 0.0 110.826 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.476 HG13 ' O ' ' A' ' 124' ' ' VAL . 11.2 p -60.72 121.33 8.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.486 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.753 ' OG1' ' HB2' ' A' ' 135' ' ' ALA . 19.3 m -116.02 -98.49 0.45 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.4 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.781 ' CG ' HG13 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -87.06 161.85 17.92 Favored 'General case' 0 CA--C 1.527 0.059 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.644 179.664 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -146.64 93.61 0.16 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.467 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -74.98 -177.96 40.62 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.375 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -71.98 -19.36 61.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.702 0.287 . . . . 0.0 111.042 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -142.6 -7.34 0.65 Allowed Glycine 0 CA--C 1.523 0.545 0 C-N-CA 120.571 -0.823 . . . . 0.0 113.514 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.636 ' CG1' HD22 ' A' ' 100' ' ' LEU . 0.6 OUTLIER -115.86 157.08 16.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 117.242 0.521 . . . . 0.0 111.18 -179.842 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.815 ' O ' HD23 ' A' ' 100' ' ' LEU . 15.6 m -113.4 118.45 58.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.602 -179.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -95.77 119.3 6.19 Favored Glycine 0 C--N 1.329 0.178 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.162 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.539 ' HD2' HD22 ' A' ' 114' ' ' LEU . 18.5 m-85 -125.04 144.04 50.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.867 0.365 . . . . 0.0 111.557 -179.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.753 ' HB2' ' OG1' ' A' ' 125' ' ' THR . . . -93.11 113.64 25.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.11 179.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.466 ' OD2' HD11 ' A' ' 99' ' ' LEU . 2.7 t0 -67.99 133.76 49.59 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -178.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.85 HG23 ' HA2' ' A' ' 122' ' ' GLY . 48.9 t -97.17 2.39 10.29 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.505 178.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.44 ' HA ' HD23 ' A' ' 141' ' ' LEU . 6.4 mtm105 -72.73 -6.22 43.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.304 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.78 3.71 54.69 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.661 0.267 . . . . 0.0 111.278 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.836 ' O ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -163.78 57.25 0.17 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.228 0.537 . . . . 0.0 109.956 179.827 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 1.022 HD11 ' HB ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -72.67 -14.5 61.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.607 -179.048 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . 0.46 ' C ' HD12 ' A' ' 143' ' ' LEU . 16.7 p-90 -52.87 81.15 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.991 0.424 . . . . 0.0 111.219 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.717 HD12 ' C ' ' A' ' 141' ' ' LEU . 5.0 mp -151.1 -45.77 0.12 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.327 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.476 ' HB2' HG12 ' A' ' 12' ' ' VAL . 1.2 mm-40 -157.41 -170.19 3.15 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.645 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -59.4 144.99 45.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.063 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.423 ' HB3' ' HB2' ' A' ' 55' ' ' ARG . 0.1 OUTLIER -103.11 154.35 19.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.647 179.932 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.4 130.04 39.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.926 0.393 . . . . 0.0 111.32 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 6.8 mtt -141.13 -175.96 4.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.763 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -152.22 -46.37 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.052 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.815 -179.928 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.145 0 N-CA-C 112.56 -0.216 . . . . 0.0 112.56 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.01 -35.89 62.92 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.555 2.17 . . . . 0.0 112.379 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -165.27 -67.63 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.891 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.36 81.43 1.75 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.384 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 15.1 p80 -119.11 165.8 13.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.861 0.362 . . . . 0.0 110.895 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -132.25 81.7 1.97 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.823 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.9 t -119.37 146.74 45.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.948 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 143.08 -40.92 1.2 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.446 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.406 ' HB2' HG23 ' A' ' 18' ' ' VAL . . . -116.27 178.07 4.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.825 0.345 . . . . 0.0 111.051 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.5 t -114.49 107.1 22.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.019 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.73 ' CE2' HG21 ' A' ' 45' ' ' THR . 6.0 t80 -96.54 116.24 28.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.527 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.841 HG21 HD11 ' A' ' 53' ' ' ILE . 30.5 t -120.94 111.66 32.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.683 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.405 ' O ' ' CE1' ' A' ' 11' ' ' TYR . . . 50.88 -126.26 25.58 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.996 -0.621 . . . . 0.0 113.296 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.448 ' O ' ' HA ' ' A' ' 44' ' ' THR . 21.1 p30 -89.89 17.47 6.7 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.727 0.299 . . . . 0.0 111.561 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.668 ' HE1' HG22 ' A' ' 44' ' ' THR . 7.0 m-30 -130.29 145.51 51.78 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.05 114.8 11.25 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.578 0.227 . . . . 0.0 110.677 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 1.061 HG12 HG22 ' A' ' 42' ' ' VAL . 0.6 OUTLIER -101.22 121.36 51.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 121.123 0.487 . . . . 0.0 111.036 -179.855 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.555 ' O ' HD12 ' A' ' 40' ' ' LEU . 13.7 p -136.7 161.35 36.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.869 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.509 ' N ' HG22 ' A' ' 18' ' ' VAL . 2.5 t30 -58.99 141.16 54.63 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.77 -47.38 80.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.864 0.364 . . . . 0.0 111.267 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -67.7 -9.51 44.31 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.213 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.26 2.09 13.95 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.669 ' HB3' ' NE1' ' A' ' 28' ' ' TRP . . . -87.65 131.82 34.31 Favored 'General case' 0 C--O 1.23 0.07 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.975 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.509 ' O ' ' HD1' ' A' ' 28' ' ' TRP . 42.2 p -74.67 163.29 27.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.712 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 46.3 p-80 -53.74 -29.71 40.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.855 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.7 t -68.61 -33.2 58.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.804 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -68.0 -43.93 77.73 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.669 ' NE1' ' HB3' ' A' ' 23' ' ' ALA . 45.5 m95 -73.96 -29.95 62.26 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.993 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -60.89 -44.1 97.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.46 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -115.71 33.9 5.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.593 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.494 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 30.5 p -72.64 122.92 22.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.187 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.548 HG22 ' O ' ' A' ' 42' ' ' VAL . 11.6 m -86.19 -40.01 14.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.682 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.648 ' HH2' HD23 ' A' ' 40' ' ' LEU . 0.8 OUTLIER -139.87 151.18 45.45 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.202 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.441 ' HG2' ' HB2' ' A' ' 41' ' ' LEU . 5.3 mt-10 -154.79 116.3 4.09 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.188 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.428 ' HB2' ' CZ2' ' A' ' 33' ' ' TRP . 23.5 m-20 -107.26 110.27 22.26 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.804 0.335 . . . . 0.0 111.054 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -65.16 -29.91 70.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.427 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.525 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 0.4 OUTLIER -63.78 -27.83 69.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.128 -179.727 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.409 ' HG2' ' HB3' ' A' ' 35' ' ' ASP . 0.9 OUTLIER -117.53 6.67 12.55 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 121.096 -0.242 . . . . 0.0 111.56 179.794 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 47.56 45.12 17.55 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.961 0.41 . . . . 0.0 110.673 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.852 HD11 HG23 ' A' ' 17' ' ' VAL . 23.0 tp -133.2 151.23 51.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.142 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.667 ' O ' HD23 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -148.36 155.7 41.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.374 179.569 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 1.061 HG22 HG12 ' A' ' 17' ' ' VAL . 39.0 t -117.95 132.48 67.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.325 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.9 t -123.86 157.01 35.17 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.215 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.668 HG22 ' HE1' ' A' ' 15' ' ' TYR . 18.6 p -97.76 128.89 44.73 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.269 0.557 . . . . 0.0 111.638 -179.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.73 HG21 ' CE2' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -121.39 167.15 13.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.831 -179.368 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.6 m -114.85 38.62 3.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.846 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.423 ' HB3' ' OH ' ' A' ' 11' ' ' TYR . . . -113.29 -168.77 1.38 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.105 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 29.5 m80 -101.57 144.76 29.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.855 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -106.42 129.55 9.79 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.529 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 92.2 m -113.69 -32.05 6.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.803 0.335 . . . . 0.0 111.043 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -70.09 134.12 47.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.939 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.868 ' O ' HG23 ' A' ' 120' ' ' VAL . 67.6 m -118.97 117.25 28.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.599 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.903 ' HB ' HD11 ' A' ' 141' ' ' LEU . 0.4 OUTLIER -76.36 139.46 18.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.04 0.448 . . . . 0.0 111.406 -179.591 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.823 ' HB1' ' SG ' ' A' ' 56' ' ' CYS . . . -96.59 101.53 13.16 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.397 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.4 ' CB ' ' HB2' ' A' ' 146' ' ' ASP . 11.0 tpt180 -80.18 59.19 3.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.089 0.471 . . . . 0.0 110.148 179.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.823 ' SG ' ' HB1' ' A' ' 54' ' ' ALA . 0.5 OUTLIER -120.73 158.97 26.33 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.159 -179.293 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -96.74 18.72 13.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.384 179.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 29.5 p -57.31 129.07 40.16 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.97 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.1 m -92.03 12.35 22.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.272 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 25.9 p -129.99 130.81 45.48 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.818 0.342 . . . . 0.0 110.947 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -153.96 -161.8 10.67 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.31 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.811 HG23 ' C ' ' A' ' 72' ' ' TYR . 7.9 p -140.05 135.52 37.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.096 0.474 . . . . 0.0 111.225 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.819 ' CD1' ' HB3' ' A' ' 66' ' ' ALA . 27.4 p90 -109.97 125.94 53.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.678 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.44 ' HA ' ' HA ' ' A' ' 71' ' ' HIS . 15.4 t80 -114.26 134.64 54.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.916 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 68' ' ' LYS . 0.8 OUTLIER 65.68 19.7 11.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.593 179.627 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.819 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . . . -92.0 -45.32 8.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.858 0.361 . . . . 0.0 110.937 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.0 t -115.2 -37.97 3.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.314 179.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 65' ' ' CYS . 2.2 mmtt -127.9 -173.5 2.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.078 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.26 29.37 1.93 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.935 0.398 . . . . 0.0 110.866 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.45 ' HE3' ' HB3' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -143.36 171.42 14.15 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.814 -179.429 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 64' ' ' PHE . 56.4 p-80 -83.91 136.48 34.08 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.811 ' C ' HG23 ' A' ' 62' ' ' VAL . 13.5 m-85 -129.84 114.9 17.84 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -178.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.542 ' N ' HG23 ' A' ' 62' ' ' VAL . 10.0 Cg_exo -69.98 120.65 7.37 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.259 1.973 . . . . 0.0 110.319 178.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.451 ' CG1' ' CE2' ' A' ' 76' ' ' PHE . 2.5 p -143.68 153.76 16.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.5 m -95.03 132.9 39.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.172 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.691 ' CZ ' HD11 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -135.02 163.27 30.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.324 0.583 . . . . 0.0 111.921 -179.008 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.47 ' O ' ' HA ' ' A' ' 99' ' ' LEU . 5.9 pt-20 -111.8 158.32 19.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.142 -0.936 . . . . 0.0 109.293 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -106.04 65.8 0.27 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.385 -0.912 . . . . 0.0 113.591 -179.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.525 ' HD2' ' HA ' ' A' ' 99' ' ' LEU . 37.5 Cg_endo -67.74 134.15 31.69 Favored 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 122.263 1.975 . . . . 0.0 111.949 179.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -58.27 -84.48 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.586 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.55 HD11 ' HB3' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -97.18 120.32 37.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.866 0.365 . . . . 0.0 111.855 -179.618 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.608 ' HB ' HG11 ' A' ' 98' ' ' VAL . 48.1 t -123.91 122.58 64.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.371 178.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -72.44 107.99 5.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.91 0.386 . . . . 0.0 110.521 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.5 HG13 ' HB2' ' A' ' 95' ' ' GLN . 17.2 m -76.11 123.46 32.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.666 -179.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -69.92 150.52 46.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.734 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.532 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 31.0 tt0 -67.7 102.43 1.2 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.939 0.399 . . . . 0.0 110.321 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.439 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.7 OUTLIER -143.94 165.95 26.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.331 -179.729 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 55.08 -82.42 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.564 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.439 ' N ' ' O ' ' A' ' 87' ' ' SER . 0.4 OUTLIER -154.92 22.84 0.44 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.703 0.287 . . . . 0.0 110.917 -179.878 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.532 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 2.3 t80 -122.88 133.18 24.33 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.918 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.432 ' O ' ' N ' ' A' ' 93' ' ' ARG . 89.1 Cg_endo -83.08 148.96 13.49 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.173 2.582 . . . . 0.0 112.417 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.2 OUTLIER -40.16 92.79 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.401 -179.908 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.447 ' O ' HG22 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -123.71 -179.19 4.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.133 0.492 . . . . 0.0 111.683 -179.342 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.55 ' HB3' HD11 ' A' ' 81' ' ' LEU . 23.0 m-85 -106.38 132.29 52.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.024 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.525 ' HA ' ' O ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -128.79 124.03 34.39 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.934 -179.888 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -96.74 156.58 16.28 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 121.058 0.456 . . . . 0.0 111.779 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 56.91 57.18 4.82 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.491 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.608 HG11 ' HB ' ' A' ' 82' ' ' VAL . 8.0 p -123.37 135.55 62.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.964 0.411 . . . . 0.0 111.367 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.787 HD11 ' HB2' ' A' ' 136' ' ' ASP . 2.7 mp -101.91 146.94 27.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.907 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.706 HD23 ' O ' ' A' ' 132' ' ' VAL . 6.5 mt -133.03 139.87 47.43 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.533 ' HB2' ' CD2' ' A' ' 76' ' ' PHE . . . -144.13 150.97 38.93 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.394 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.2 t -111.13 140.04 46.01 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.862 0.363 . . . . 0.0 111.231 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -131.89 -81.54 0.21 Allowed Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.468 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -123.91 157.43 34.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.844 0.354 . . . . 0.0 110.842 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.8 94.26 5.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.869 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -171.84 152.31 3.0 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.856 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.4 -59.81 0.95 Allowed 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.409 2.073 . . . . 0.0 112.284 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 117.49 -59.44 0.48 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.601 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.3 t70 61.18 170.29 0.1 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.783 0.325 . . . . 0.0 110.892 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 61.47 -172.23 0.15 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.011 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -156.31 133.34 3.63 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.441 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -138.44 -161.29 8.75 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.411 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 28.3 pt -126.07 146.11 32.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.773 0.321 . . . . 0.0 111.164 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.691 HD11 ' CZ ' ' A' ' 76' ' ' PHE . 6.7 tp -87.81 113.5 23.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.388 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.517 ' O ' HG12 ' A' ' 62' ' ' VAL . 0.0 OUTLIER -118.83 139.38 51.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.257 -179.858 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.576 ' HB3' HD11 ' A' ' 121' ' ' ILE . 21.8 p -105.66 166.87 10.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.194 179.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -55.93 -20.2 15.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.348 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 11.4 m80 -91.16 -22.21 20.78 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.79 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.612 ' CA ' ' HB2' ' A' ' 54' ' ' ALA . . . 163.56 -143.8 8.94 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.145 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 52' ' ' THR . 3.6 t -100.24 135.53 35.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.724 0.297 . . . . 0.0 111.107 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.576 HD11 ' HB3' ' A' ' 116' ' ' CYS . 1.3 mm -96.95 -67.15 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.835 0.35 . . . . 0.0 110.982 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.864 ' HA2' HG23 ' A' ' 137' ' ' VAL . . . -155.4 -154.01 6.76 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.831 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.811 ' CD1' ' HB3' ' A' ' 135' ' ' ALA . 0.0 OUTLIER -130.53 164.14 25.51 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.031 0.443 . . . . 0.0 111.069 179.958 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.576 HG13 ' O ' ' A' ' 124' ' ' VAL . 14.5 p -57.86 115.08 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.319 -179.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.737 ' OG1' ' HB2' ' A' ' 135' ' ' ALA . 1.6 m -101.49 -87.22 0.4 Allowed 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.692 ' N ' HG22 ' A' ' 125' ' ' THR . 0.0 OUTLIER -136.13 129.78 32.3 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-O 120.997 0.427 . . . . 0.0 111.583 179.57 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -109.14 149.13 17.08 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.654 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -104.47 -156.9 23.62 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.469 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -71.81 -19.44 61.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.725 0.298 . . . . 0.0 111.173 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -159.03 16.18 0.24 Allowed Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.983 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.628 ' CG1' HD22 ' A' ' 100' ' ' LEU . 0.9 OUTLIER -126.51 157.23 37.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.755 0.312 . . . . 0.0 110.857 179.861 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.706 ' O ' HD23 ' A' ' 100' ' ' LEU . 29.0 m -116.97 118.32 58.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.354 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.496 ' HA3' ' O ' ' A' ' 126' ' ' MET . . . -99.87 113.94 4.87 Favored Glycine 0 C--N 1.329 0.192 0 C-N-CA 120.499 -0.858 . . . . 0.0 111.997 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.467 ' CD2' ' HB2' ' A' ' 114' ' ' LEU . 53.4 m-85 -118.14 138.04 52.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.748 0.308 . . . . 0.0 111.357 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.811 ' HB3' ' CD1' ' A' ' 123' ' ' LEU . . . -88.41 115.4 25.88 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 179.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.787 ' HB2' HD11 ' A' ' 99' ' ' LEU . 2.7 t0 -67.38 141.93 56.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.25 0.548 . . . . 0.0 112.438 -178.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.864 HG23 ' HA2' ' A' ' 122' ' ' GLY . 56.5 t -89.9 9.87 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.413 178.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.492 ' HA ' HD23 ' A' ' 141' ' ' LEU . 9.3 mmm180 -70.63 -6.74 39.07 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.641 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -98.28 11.04 39.21 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.481 0.181 . . . . 0.0 111.439 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.853 ' O ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -177.19 47.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.018 0.437 . . . . 0.0 110.595 -179.811 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.903 HD11 ' HB ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -66.39 -14.6 62.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.15 -179.67 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . 0.459 ' C ' HD12 ' A' ' 143' ' ' LEU . 15.6 p-90 -54.52 81.61 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.068 0.461 . . . . 0.0 111.539 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.695 HD12 ' C ' ' A' ' 141' ' ' LEU . 5.0 mp -149.37 -43.89 0.14 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.954 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.425 ' HB2' ' CG1' ' A' ' 12' ' ' VAL . 7.6 mt-10 -152.29 -170.42 3.64 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.445 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -58.83 132.27 53.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.79 0.328 . . . . 0.0 110.888 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.4 ' HB2' ' CB ' ' A' ' 55' ' ' ARG . 1.5 p30 -94.63 154.11 17.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.003 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.27 147.86 44.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.086 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.22 118.58 21.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.86 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -116.52 31.06 6.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.889 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.901 -179.999 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 112.534 -0.227 . . . . 0.0 112.534 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.9 -33.22 16.49 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.583 2.189 . . . . 0.0 112.319 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -114.83 175.31 5.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.928 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.13 36.46 8.95 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.485 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.76 -62.27 1.76 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.82 0.343 . . . . 0.0 110.982 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 60.59 179.5 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.883 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.3 m -152.95 157.12 40.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.909 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -135.2 27.15 3.17 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.51 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -175.64 -179.65 1.27 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.799 0.333 . . . . 0.0 110.988 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.2 t -116.49 108.21 24.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.069 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.89 ' CE2' HG21 ' A' ' 45' ' ' THR . 6.1 t80 -99.57 116.41 31.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.692 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.891 HG21 HD11 ' A' ' 53' ' ' ILE . 24.8 t -120.77 108.95 23.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.804 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 50.8 -126.49 25.8 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.986 -0.626 . . . . 0.0 113.259 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.518 ' O ' ' HA ' ' A' ' 44' ' ' THR . 2.7 p-10 -88.58 13.06 12.95 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.657 ' HE1' HG22 ' A' ' 44' ' ' THR . 5.8 m-30 -130.49 127.93 40.17 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.6 tttt -120.56 114.88 22.38 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.994 -0.282 . . . . 0.0 110.792 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 1.067 HG12 HG22 ' A' ' 42' ' ' VAL . 0.6 OUTLIER -99.33 121.64 50.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-O 121.161 0.505 . . . . 0.0 110.916 179.894 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.546 ' O ' HD22 ' A' ' 41' ' ' LEU . 12.6 p -136.92 161.32 36.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.02 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.598 ' ND2' HD12 ' A' ' 123' ' ' LEU . 31.5 m120 -59.89 141.22 55.86 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.441 ' HB2' ' CH2' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -56.77 -43.98 81.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.796 0.332 . . . . 0.0 111.235 -179.493 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -67.82 -10.93 57.03 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.11 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -115.26 0.61 13.56 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.712 ' HB3' ' NE1' ' A' ' 28' ' ' TRP . . . -86.69 127.06 34.93 Favored 'General case' 0 C--O 1.23 0.072 0 C-N-CA 120.331 -0.548 . . . . 0.0 111.028 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.711 HG23 HG12 ' A' ' 26' ' ' VAL . 1.7 t -74.71 165.48 25.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.916 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -53.62 -29.86 40.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.878 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.711 HG12 HG23 ' A' ' 24' ' ' THR . 11.5 p -71.85 -31.67 41.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.716 0.293 . . . . 0.0 110.996 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.484 ' HB3' ' HB1' ' A' ' 23' ' ' ALA . 0.4 OUTLIER -68.11 -43.97 77.2 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.099 0.475 . . . . 0.0 109.751 179.332 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.712 ' NE1' ' HB3' ' A' ' 23' ' ' ALA . 53.2 m95 -74.05 -35.27 64.28 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.064 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.56 -40.92 80.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.75 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -116.94 34.63 5.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.782 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.476 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 29.2 p -77.15 125.62 29.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.043 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.574 HG22 ' O ' ' A' ' 42' ' ' VAL . 16.1 m -87.43 -38.04 11.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.705 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.641 ' HH2' HD23 ' A' ' 40' ' ' LEU . 2.9 t90 -139.56 153.52 47.44 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.776 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 5.2 tm-20 -162.69 120.54 2.06 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.789 0.328 . . . . 0.0 111.581 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.408 ' HB2' ' CZ2' ' A' ' 33' ' ' TRP . 0.7 OUTLIER -107.05 98.68 8.3 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.45 179.338 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -56.95 -29.55 63.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.935 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.614 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 6.3 t-20 -64.4 -41.04 96.86 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 120.584 0.23 . . . . 0.0 110.822 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -99.55 -4.23 31.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.532 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.411 ' CB ' ' HG2' ' A' ' 20' ' ' ARG . 1.0 OUTLIER 60.03 48.36 8.7 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.047 0.451 . . . . 0.0 110.706 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.641 HD23 ' HH2' ' A' ' 33' ' ' TRP . 21.2 tp -136.41 146.51 46.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.671 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.669 ' O ' HD23 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -147.24 155.79 42.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.987 0.422 . . . . 0.0 111.899 179.802 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 1.067 HG22 HG12 ' A' ' 17' ' ' VAL . 35.8 t -117.36 125.0 73.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.272 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.0 p -118.19 157.41 27.02 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.567 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.657 HG22 ' HE1' ' A' ' 15' ' ' TYR . 15.2 p -97.29 142.71 28.84 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.243 0.544 . . . . 0.0 111.638 -178.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.89 HG21 ' CE2' ' A' ' 11' ' ' TYR . 0.4 OUTLIER -137.52 172.49 12.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.89 -179.195 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -122.68 36.04 4.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.759 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.435 ' HB3' ' OH ' ' A' ' 11' ' ' TYR . . . -107.38 -167.89 1.32 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.183 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -102.83 148.03 26.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.985 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -57.09 -174.39 0.26 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.552 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -154.59 -45.97 0.09 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.9 0.381 . . . . 0.0 111.021 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -128.66 170.71 12.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.969 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.871 ' O ' HG23 ' A' ' 120' ' ' VAL . 29.6 m -125.13 123.39 39.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.533 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.954 ' HB ' HD11 ' A' ' 141' ' ' LEU . 0.5 OUTLIER -72.65 139.55 19.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.871 0.367 . . . . 0.0 111.175 -179.643 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.607 ' HB2' ' N ' ' A' ' 119' ' ' GLY . . . -88.08 122.93 32.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.383 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.58 ' H ' ' HB3' ' A' ' 147' ' ' ALA . 25.0 tpt180 -94.11 28.98 2.28 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.172 0.51 . . . . 0.0 109.962 178.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.484 ' SG ' ' HB1' ' A' ' 54' ' ' ALA . 23.0 p -99.82 167.3 10.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.996 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -117.69 28.81 8.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.26 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 34.0 m -58.84 131.16 50.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.853 0.359 . . . . 0.0 110.539 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.48 -1.07 44.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.326 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 16.3 p -127.91 123.99 36.32 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.998 0.428 . . . . 0.0 111.265 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.25 -169.14 12.01 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.753 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.739 HG23 ' C ' ' A' ' 72' ' ' TYR . 6.8 p -140.22 132.76 33.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 117.143 0.472 . . . . 0.0 111.327 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.806 ' CZ ' HG11 ' A' ' 132' ' ' VAL . 40.5 p90 -120.18 132.12 55.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.582 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.425 ' HA ' ' HA ' ' A' ' 71' ' ' HIS . 1.2 t80 -73.84 156.75 37.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.579 -179.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 1.3 m 66.01 60.57 0.66 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.204 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.558 ' HB2' ' HB2' ' A' ' 72' ' ' TYR . . . -92.22 -45.23 8.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.908 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 26.7 t 175.74 36.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.932 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.474 ' HG2' ' HD3' ' A' ' 70' ' ' LYS . 0.3 OUTLIER -176.29 31.91 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.595 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 45.86 31.24 1.01 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.09 0.471 . . . . 0.0 110.904 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.474 ' HD3' ' HG2' ' A' ' 68' ' ' LYS . 12.8 mtpt -134.87 171.55 14.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.768 -179.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 64' ' ' PHE . 5.1 p80 -83.19 139.04 33.38 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.739 ' C ' HG23 ' A' ' 62' ' ' VAL . 2.6 m-85 -126.03 114.58 24.14 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.57 -178.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -68.34 120.46 7.41 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 121.886 1.724 . . . . 0.0 109.964 178.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.514 HG21 ' HE1' ' A' ' 63' ' ' TYR . 43.8 t -140.41 141.83 32.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -178.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 87.9 p -93.02 133.15 36.45 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.608 ' CZ ' HD11 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -136.25 166.2 23.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.372 0.606 . . . . 0.0 112.166 -178.347 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.437 ' O ' ' HA ' ' A' ' 99' ' ' LEU . 0.1 OUTLIER -111.71 158.48 19.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.183 178.848 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -105.16 67.5 0.27 Allowed Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.378 -0.915 . . . . 0.0 113.464 -179.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.516 ' HD2' ' HA ' ' A' ' 99' ' ' LEU . 37.6 Cg_endo -67.63 134.28 32.33 Favored 'Trans proline' 0 C--O 1.237 0.47 0 C-N-CA 122.227 1.951 . . . . 0.0 111.952 179.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -54.84 -83.24 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.673 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.703 HD11 ' HB3' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -105.09 120.18 40.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.867 0.365 . . . . 0.0 111.959 -179.646 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.619 ' HB ' HG11 ' A' ' 98' ' ' VAL . 42.2 t -121.1 122.18 66.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.376 178.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -76.35 108.05 9.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.941 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 34.8 m -73.83 124.13 30.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.055 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -69.55 150.11 47.48 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.722 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.594 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 61.3 tt0 -68.02 102.16 1.25 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.999 0.428 . . . . 0.0 110.638 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.436 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.3 OUTLIER -144.07 160.11 41.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.364 -179.825 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 56.06 -81.51 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.679 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.436 ' N ' ' O ' ' A' ' 87' ' ' SER . 3.2 p90 -155.73 26.18 0.39 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.861 0.363 . . . . 0.0 110.822 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.594 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 1.0 OUTLIER -122.48 124.35 26.8 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.557 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.46 ' O ' ' N ' ' A' ' 93' ' ' ARG . 72.0 Cg_endo -76.46 148.65 30.06 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.881 2.387 . . . . 0.0 112.512 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -46.25 89.4 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.17 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.46 ' N ' ' O ' ' A' ' 91' ' ' PRO . 1.7 mmm180 -124.02 174.34 7.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.299 0.571 . . . . 0.0 112.156 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.703 ' HB3' HD11 ' A' ' 81' ' ' LEU . 5.4 m-85 -100.18 132.62 45.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.214 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.614 ' HA ' ' O ' ' A' ' 37' ' ' ASN . 12.2 mm-40 -118.85 116.58 26.8 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.245 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.532 ' HA ' HD22 ' A' ' 81' ' ' LEU . 44.3 t -83.15 146.07 28.85 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.048 0.452 . . . . 0.0 111.716 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.427 ' CE1' ' HB3' ' A' ' 136' ' ' ASP . 1.5 t-80 52.22 65.55 1.47 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.037 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.619 HG11 ' HB ' ' A' ' 82' ' ' VAL . 10.6 p -123.6 141.8 42.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.17 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.516 ' HA ' ' HD2' ' A' ' 79' ' ' PRO . 9.4 mp -102.13 142.49 33.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.009 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.719 HD23 ' O ' ' A' ' 132' ' ' VAL . 5.6 mt -133.09 142.08 48.54 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -179.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.485 ' HB1' ' CG1' ' A' ' 74' ' ' VAL . . . -152.17 146.08 25.19 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.806 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 1.1 t -99.93 129.28 45.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.913 0.387 . . . . 0.0 111.228 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -109.91 -115.68 3.73 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.436 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -148.11 30.07 0.87 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.896 0.379 . . . . 0.0 110.851 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.3 m -98.94 -163.6 1.05 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.873 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.466 ' CB ' ' CD ' ' A' ' 107' ' ' PRO . 1.6 mt-10 -159.97 -65.79 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.029 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.466 ' CD ' ' CB ' ' A' ' 106' ' ' GLU . 55.9 Cg_endo -70.09 -40.9 4.31 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.304 2.003 . . . . 0.0 112.302 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 93.68 137.93 8.73 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.62 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -113.53 -36.77 4.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.86 0.362 . . . . 0.0 110.958 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 61.29 172.72 0.11 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.141 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.629 ' H ' HG11 ' A' ' 124' ' ' VAL . . . 89.92 108.35 1.28 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.457 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 140.09 157.32 7.2 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.497 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 26.9 pt -109.32 145.68 15.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.793 0.33 . . . . 0.0 111.065 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.733 HD22 ' HD2' ' A' ' 134' ' ' PHE . 34.2 tp -87.77 117.02 26.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.444 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 8.1 mtt180 -118.49 145.86 44.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.148 0.499 . . . . 0.0 111.93 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.989 ' HB2' HD11 ' A' ' 121' ' ' ILE . 13.9 t -107.85 165.05 11.73 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.304 178.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.68 -17.46 5.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.777 0.322 . . . . 0.0 110.484 179.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 45.4 m80 -93.54 -36.25 12.51 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.581 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.607 ' N ' ' HB2' ' A' ' 54' ' ' ALA . . . 179.02 -136.91 3.0 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 120.191 -1.004 . . . . 0.0 113.936 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' ' 52' ' ' THR . 3.0 t -105.11 136.24 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -179.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.989 HD11 ' HB2' ' A' ' 116' ' ' CYS . 1.9 mp -95.47 -40.07 10.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.707 ' HA2' HG23 ' A' ' 137' ' ' VAL . . . 162.01 -156.78 28.44 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.889 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.598 HD12 ' ND2' ' A' ' 19' ' ' ASN . 0.2 OUTLIER -116.79 164.11 15.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.791 0.329 . . . . 0.0 110.851 -179.714 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.629 HG11 ' H ' ' A' ' 111' ' ' GLY . 11.4 p -68.36 131.62 33.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.427 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.805 ' OG1' ' HB2' ' A' ' 135' ' ' ALA . 1.9 m -103.08 -87.49 0.42 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.231 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.677 ' N ' HG22 ' A' ' 125' ' ' THR . 0.0 OUTLIER -131.42 162.05 31.05 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-O 120.807 0.337 . . . . 0.0 111.415 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -133.48 150.92 19.98 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.669 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -104.13 -153.06 22.86 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.449 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.94 -19.55 61.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.651 0.262 . . . . 0.0 111.103 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -164.04 16.78 0.11 Allowed Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.597 -0.811 . . . . 0.0 113.081 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.634 ' CG1' HD22 ' A' ' 100' ' ' LEU . 0.9 OUTLIER -120.29 157.26 23.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.776 0.322 . . . . 0.0 110.692 179.806 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.806 HG11 ' CZ ' ' A' ' 63' ' ' TYR . 14.3 m -115.85 118.4 58.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.408 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.419 ' HA2' ' O ' ' A' ' 99' ' ' LEU . . . -100.2 123.19 7.84 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.966 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.733 ' HD2' HD22 ' A' ' 114' ' ' LEU . 10.0 m-85 -124.83 140.15 53.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.854 0.359 . . . . 0.0 111.413 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.805 ' HB2' ' OG1' ' A' ' 125' ' ' THR . . . -88.76 114.34 25.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.057 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.427 ' HB3' ' CE1' ' A' ' 97' ' ' HIS . 3.0 t0 -73.12 146.55 45.64 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -178.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.707 HG23 ' HA2' ' A' ' 122' ' ' GLY . 62.0 t -104.95 5.86 10.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.139 178.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.45 ' HA ' HD23 ' A' ' 141' ' ' LEU . 12.2 mtm-85 -72.17 -6.51 43.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.26 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -94.64 7.34 46.07 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 120.726 0.298 . . . . 0.0 111.277 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.812 ' O ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -169.6 59.79 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.289 0.566 . . . . 0.0 109.92 179.818 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.954 HD11 ' HB ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -74.06 -14.88 61.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.298 -179.092 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . 0.45 ' C ' HD12 ' A' ' 143' ' ' LEU . 15.5 p-90 -54.72 81.51 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.972 0.415 . . . . 0.0 111.388 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.68 HD12 ' C ' ' A' ' 141' ' ' LEU . 5.0 mp -150.17 -47.21 0.13 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.979 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.421 ' HB2' ' CG1' ' A' ' 12' ' ' VAL . 9.2 mm-40 -154.07 -170.01 3.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.527 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.95 139.8 56.27 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.832 0.349 . . . . 0.0 111.043 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.97 154.22 18.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.878 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.58 ' HB3' ' H ' ' A' ' 55' ' ' ARG . . . -79.04 149.02 32.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.114 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -179.2 -38.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.925 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -131.51 31.05 4.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.851 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.857 -179.981 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.24 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.07 146.52 58.51 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.625 2.216 . . . . 0.0 112.259 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -147.03 117.16 7.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.895 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -136.28 -143.43 4.66 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.5 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -108.45 -47.64 3.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.796 0.332 . . . . 0.0 110.8 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -113.77 149.87 34.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.932 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 91.1 p -169.55 -179.98 3.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.874 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 169.44 43.46 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.554 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -128.61 156.2 43.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.839 0.352 . . . . 0.0 111.107 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.62 117.62 50.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.242 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.807 ' CE2' HG21 ' A' ' 45' ' ' THR . 5.6 t80 -106.55 116.59 32.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.483 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.868 HG21 HD11 ' A' ' 53' ' ' ILE . 21.2 t -120.8 114.62 44.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.802 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 46.94 -123.87 8.01 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 121.157 -0.544 . . . . 0.0 113.335 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.445 ' O ' ' HA ' ' A' ' 44' ' ' THR . 68.6 m-20 -90.07 15.79 9.54 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.638 0.256 . . . . 0.0 111.602 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.647 ' HE1' HG22 ' A' ' 44' ' ' THR . 6.8 m-30 -130.41 148.62 52.24 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.01 114.71 9.93 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.56 0.219 . . . . 0.0 110.579 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 1.08 HG12 HG22 ' A' ' 42' ' ' VAL . 0.6 OUTLIER -100.38 122.0 51.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.054 0.454 . . . . 0.0 110.842 -179.969 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.727 ' O ' HD12 ' A' ' 40' ' ' LEU . 12.5 p -136.06 160.98 38.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.216 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.524 ' N ' HG22 ' A' ' 18' ' ' VAL . 10.4 m-20 -61.47 141.44 57.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.447 179.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.4 ttt-85 -56.63 -47.33 79.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.899 0.38 . . . . 0.0 110.736 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -68.75 -11.02 59.83 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.912 179.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.414 ' HB3' HG22 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -108.65 -12.1 15.0 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.686 -179.735 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.962 ' HB3' ' CZ2' ' A' ' 28' ' ' TRP . . . -70.02 150.71 46.36 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 120.763 0.316 . . . . 0.0 110.753 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 16.9 p -105.03 169.04 8.66 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.326 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.693 ' CE1' HG23 ' A' ' 26' ' ' VAL . 13.8 p-80 -54.6 -29.63 52.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.044 0.449 . . . . 0.0 110.656 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.693 HG23 ' CE1' ' A' ' 25' ' ' HIS . 21.8 t -74.72 -31.32 26.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.385 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.42 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 4.0 m-20 -67.11 -44.14 80.69 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.962 ' CZ2' ' HB3' ' A' ' 23' ' ' ALA . 7.4 m-90 -74.47 -31.63 62.29 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.125 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -58.02 -42.31 85.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.483 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -115.81 33.93 5.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.494 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.462 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 29.2 t -80.05 129.38 34.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.26 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.507 HG13 HG23 ' A' ' 44' ' ' THR . 13.0 m -92.57 -40.73 12.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.622 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.601 ' CZ3' HG23 ' A' ' 42' ' ' VAL . 0.3 OUTLIER -139.72 153.49 47.23 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 121.047 0.451 . . . . 0.0 111.644 -179.361 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -154.41 120.25 5.23 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.472 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.424 ' HB2' ' CZ2' ' A' ' 33' ' ' TRP . 6.1 m-20 -100.42 116.7 32.99 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.414 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -65.83 -43.32 88.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.875 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.484 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 7.0 m120 -71.2 -10.96 60.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.011 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.454 ' NE ' ' HB1' ' A' ' 135' ' ' ALA . 3.5 tpm_? -117.1 -4.96 11.41 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 121.151 -0.22 . . . . 0.0 111.301 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 47.12 33.98 2.69 Favored 'General case' 0 N--CA 1.46 0.059 0 CA-C-O 121.122 0.486 . . . . 0.0 110.27 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.906 HD13 HD11 ' A' ' 123' ' ' LEU . 41.6 tp -126.8 153.37 45.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.747 -179.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.666 ' O ' HD23 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -146.79 155.69 42.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.871 0.367 . . . . 0.0 111.781 179.754 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 1.08 HG22 HG12 ' A' ' 17' ' ' VAL . 24.7 t -119.14 130.04 74.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.342 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.6 p -121.07 157.13 30.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.556 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.647 HG22 ' HE1' ' A' ' 15' ' ' TYR . 17.4 p -97.74 128.67 44.57 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.182 0.515 . . . . 0.0 111.471 -179.183 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.807 HG21 ' CE2' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -103.61 -34.19 8.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.889 -179.245 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.0 m 68.37 59.22 0.41 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.017 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.607 ' HB3' ' OH ' ' A' ' 11' ' ' TYR . . . -152.13 -167.86 2.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.201 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 46.8 p-80 -81.93 148.01 28.96 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.984 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -93.55 153.17 21.18 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.718 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.5 m -125.73 -62.72 1.17 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.869 0.366 . . . . 0.0 110.742 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -69.07 147.21 51.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.681 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.825 ' O ' HG23 ' A' ' 120' ' ' VAL . 62.8 m -123.56 117.53 25.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.94 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.889 ' HB ' HD11 ' A' ' 141' ' ' LEU . 0.4 OUTLIER -73.07 139.34 19.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.644 179.864 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.82 ' HB2' ' N ' ' A' ' 119' ' ' GLY . . . -95.96 124.84 40.14 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.926 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.608 ' H ' ' HB3' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -90.94 33.9 0.93 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.504 179.61 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 26.6 p -99.69 167.13 10.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.892 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -123.03 39.71 3.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.177 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 19.3 m -68.94 131.77 45.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.779 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.1 t -76.86 -7.15 54.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.811 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.7 p -117.84 123.93 47.11 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.988 0.423 . . . . 0.0 111.091 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -148.98 162.56 28.96 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.571 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.829 HG23 ' C ' ' A' ' 72' ' ' TYR . 13.2 p -99.86 134.42 39.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.193 0.521 . . . . 0.0 111.669 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -120.26 -170.7 2.02 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.059 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.453 ' CG ' ' HB2' ' A' ' 67' ' ' SER . 0.6 OUTLIER 68.43 -91.09 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.197 179.913 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 70.63 -63.34 0.41 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.658 0.266 . . . . 0.0 111.255 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.65 -38.63 12.97 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.774 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.453 ' HB2' ' CG ' ' A' ' 64' ' ' PHE . 3.6 m -46.58 -68.18 0.22 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.295 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.22 9.87 21.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.097 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 66.13 12.53 8.57 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.144 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.84 168.35 20.15 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.066 0.46 . . . . 0.0 110.937 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.769 ' HB2' HG21 ' A' ' 62' ' ' VAL . 12.5 p-80 -87.9 116.8 26.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.569 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.829 ' C ' HG23 ' A' ' 62' ' ' VAL . 1.8 m-85 -106.78 113.17 63.07 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.073 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.54 ' HA ' ' HA ' ' A' ' 62' ' ' VAL . 6.0 Cg_exo -80.27 139.11 12.97 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.846 2.364 . . . . 0.0 111.632 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.452 ' CG1' ' CE2' ' A' ' 76' ' ' PHE . 1.3 p -151.14 161.26 3.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.016 0.436 . . . . 0.0 111.892 -179.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.5 p -106.88 126.62 52.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.227 178.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.646 ' CZ ' HD11 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -128.48 166.18 19.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.654 0.74 . . . . 0.0 112.294 -179.111 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.69 ' C ' ' HD3' ' A' ' 79' ' ' PRO . 1.3 mp0 -111.91 159.36 18.45 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.552 -1.204 . . . . 0.0 108.918 178.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.461 ' HA2' ' HG ' ' A' ' 99' ' ' LEU . . . -108.57 64.19 0.26 Allowed Glycine 0 CA--C 1.522 0.495 0 C-N-CA 120.135 -1.031 . . . . 0.0 114.155 -179.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.69 ' HD3' ' C ' ' A' ' 77' ' ' GLU . 14.9 Cg_exo -66.96 138.27 47.44 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.12 1.88 . . . . 0.0 111.965 179.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -62.77 -90.7 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.752 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.615 HD22 ' HB2' ' A' ' 96' ' ' SER . 0.0 OUTLIER -87.79 120.0 28.68 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.343 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.599 ' HB ' HG11 ' A' ' 98' ' ' VAL . 89.1 t -124.8 122.93 64.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.534 178.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.407 ' OE2' ' CE1' ' A' ' 94' ' ' TYR . 1.2 tp10 -72.11 107.9 5.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.986 0.422 . . . . 0.0 110.686 -179.163 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.847 HG23 ' HB2' ' A' ' 126' ' ' MET . 2.9 p -83.06 114.39 23.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.739 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -74.35 150.37 40.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.471 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 5.8 pt-20 -67.72 100.78 0.95 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.274 0.559 . . . . 0.0 109.88 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.529 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.5 OUTLIER -145.16 172.92 12.42 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.62 -179.976 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 44.14 -85.17 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.614 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.529 ' N ' ' O ' ' A' ' 87' ' ' SER . 0.2 OUTLIER -150.15 23.21 0.84 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.818 0.342 . . . . 0.0 110.413 179.597 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.749 ' HD2' HG21 ' A' ' 84' ' ' VAL . 0.4 OUTLIER -116.34 145.68 35.66 Favored Pre-proline 0 C--O 1.232 0.17 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.999 -179.63 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.404 ' O ' ' N ' ' A' ' 93' ' ' ARG . 92.2 Cg_endo -85.44 148.74 10.13 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.307 2.671 . . . . 0.0 112.697 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.515 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -65.42 72.81 0.05 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 179.894 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.486 ' O ' HG12 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -123.92 -178.23 3.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.961 0.41 . . . . 0.0 111.621 -179.653 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.432 ' HB3' HD11 ' A' ' 81' ' ' LEU . 14.6 m-85 -94.99 132.17 40.15 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.586 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.484 ' HA ' ' O ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -131.15 125.56 33.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.667 0.27 . . . . 0.0 111.321 -179.681 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.615 ' HB2' HD22 ' A' ' 81' ' ' LEU . 1.4 t -102.09 154.21 19.2 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 120.917 0.389 . . . . 0.0 111.868 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 70.19 54.52 0.32 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.395 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.599 HG11 ' HB ' ' A' ' 82' ' ' VAL . 5.0 p -123.46 141.73 42.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.223 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.535 ' N ' HD12 ' A' ' 99' ' ' LEU . 5.6 mp -107.49 146.49 31.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.094 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.675 HD23 ' C ' ' A' ' 132' ' ' VAL . 6.1 mt -133.28 133.74 42.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.113 0.482 . . . . 0.0 112.189 -179.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.608 ' HB2' ' CD2' ' A' ' 76' ' ' PHE . . . -136.39 150.47 48.81 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.65 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.1 t -108.84 129.27 55.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.857 0.361 . . . . 0.0 110.98 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -89.96 -160.26 36.33 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.637 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -81.77 -66.18 0.92 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.78 0.324 . . . . 0.0 110.969 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 75.7 m -104.04 178.43 4.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.865 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -71.37 135.83 84.17 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.861 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -74.35 120.48 6.27 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.463 2.109 . . . . 0.0 112.379 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -91.19 -29.93 11.78 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.465 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -126.89 145.82 50.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.806 0.336 . . . . 0.0 110.885 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.67 172.26 0.73 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.051 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -114.51 -176.7 18.96 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.52 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -106.5 -96.06 2.44 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.443 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 34.5 pt -125.99 146.12 32.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.809 0.337 . . . . 0.0 111.218 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.646 HD11 ' CZ ' ' A' ' 76' ' ' PHE . 16.3 tp -87.82 119.46 28.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.24 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -118.13 149.32 41.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.067 0.46 . . . . 0.0 111.786 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.575 ' HB2' HD11 ' A' ' 121' ' ' ILE . 7.4 t -115.48 163.08 16.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.149 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -55.85 -20.07 14.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.814 0.34 . . . . 0.0 110.818 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.435 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . 26.7 m80 -90.64 -35.47 14.95 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.422 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.82 ' N ' ' HB2' ' A' ' 54' ' ' ALA . . . 177.45 -139.31 4.25 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.333 -0.937 . . . . 0.0 113.281 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' ' 52' ' ' THR . 3.4 t -100.91 135.39 37.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.687 0.279 . . . . 0.0 111.341 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.575 HD11 ' HB2' ' A' ' 116' ' ' CYS . 1.1 mm -95.78 -61.99 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.871 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.797 ' HA2' HG23 ' A' ' 137' ' ' VAL . . . -174.9 -163.57 28.26 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.302 -0.951 . . . . 0.0 113.387 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.906 HD11 HD13 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -116.89 141.75 47.82 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.864 0.364 . . . . 0.0 111.002 -179.792 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.407 ' HB ' ' CE1' ' A' ' 134' ' ' PHE . 10.6 p -57.94 148.81 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.94 -179.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.509 HG23 ' H ' ' A' ' 126' ' ' MET . 0.0 OUTLIER -128.87 -87.17 0.55 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.225 179.333 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.847 ' HB2' HG23 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -107.6 138.87 43.03 Favored 'General case' 0 N--CA 1.461 0.087 0 CA-C-O 120.997 0.427 . . . . 0.0 110.8 179.393 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -122.93 129.13 7.33 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.158 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -81.06 -160.19 23.98 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.497 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -71.84 -19.24 62.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.807 0.336 . . . . 0.0 110.815 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -158.07 18.23 0.33 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.708 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.57 ' CG1' HD22 ' A' ' 100' ' ' LEU . 0.9 OUTLIER -125.03 157.01 33.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-O 120.666 0.269 . . . . 0.0 110.783 -180.0 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.675 ' C ' HD23 ' A' ' 100' ' ' LEU . 11.3 m -118.55 118.79 59.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.801 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -91.67 124.51 7.65 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.615 -0.802 . . . . 0.0 111.487 179.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.434 ' CG ' ' HB2' ' A' ' 114' ' ' LEU . 19.2 m-85 -124.25 135.43 53.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.999 0.428 . . . . 0.0 111.912 -178.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.552 ' O ' ' HA3' ' A' ' 122' ' ' GLY . . . -88.84 112.19 22.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.836 178.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -67.55 136.76 55.03 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -178.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.797 HG23 ' HA2' ' A' ' 122' ' ' GLY . 67.6 t -89.5 7.57 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.382 178.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.432 ' HA ' HD23 ' A' ' 141' ' ' LEU . 30.6 mmm-85 -71.11 -6.66 40.93 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.588 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.43 10.99 38.25 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.62 0.248 . . . . 0.0 111.332 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.807 ' O ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -175.19 53.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.128 0.489 . . . . 0.0 110.6 -179.868 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.889 HD11 ' HB ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -70.61 -14.69 62.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.012 -179.52 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . 0.455 ' C ' HD12 ' A' ' 143' ' ' LEU . 15.6 p-90 -54.52 83.62 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.134 0.493 . . . . 0.0 111.358 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.701 HD12 ' C ' ' A' ' 141' ' ' LEU . 5.0 mp -151.52 -44.87 0.11 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.972 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.842 ' OE2' HG13 ' A' ' 12' ' ' VAL . 14.4 pt-20 -155.95 -163.19 1.43 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.662 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.03 145.62 55.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.889 0.376 . . . . 0.0 111.041 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -105.1 154.14 20.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.896 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.608 ' HB3' ' H ' ' A' ' 55' ' ' ARG . . . -80.01 119.98 23.57 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.876 0.369 . . . . 0.0 111.043 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 2.2 ptp -127.69 137.18 52.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.955 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.18 82.85 2.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.849 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.251 -0.881 . . . . 0.0 110.867 179.969 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.157 0 N-CA-C 112.467 -0.253 . . . . 0.0 112.467 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.86 158.68 56.02 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.516 2.144 . . . . 0.0 112.251 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -85.53 145.28 27.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.96 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -114.99 152.83 17.98 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.45 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -149.76 160.08 43.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.735 0.303 . . . . 0.0 110.949 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -150.86 154.52 37.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.91 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 24.7 p -120.1 178.14 4.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.847 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 96.76 -29.64 10.17 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.458 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.742 ' HB2' HG23 ' A' ' 18' ' ' VAL . . . -107.31 -169.8 1.6 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.759 0.314 . . . . 0.0 110.985 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.478 HG13 ' O ' ' A' ' 10' ' ' VAL . 8.4 p -124.61 119.13 55.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.981 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.683 ' CE1' HG21 ' A' ' 45' ' ' THR . 7.3 t80 -98.69 117.09 32.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.69 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.853 HG21 HD11 ' A' ' 53' ' ' ILE . 22.3 t -120.1 130.05 74.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.584 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.445 ' O ' ' CE1' ' A' ' 11' ' ' TYR . . . 46.01 -123.91 7.0 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 121.085 -0.579 . . . . 0.0 113.141 179.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.404 ' O ' ' HA ' ' A' ' 44' ' ' THR . 59.3 m-80 -99.27 19.82 14.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.784 0.326 . . . . 0.0 111.002 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.69 ' HB2' HD23 ' A' ' 143' ' ' LEU . 9.2 m-30 -130.22 152.14 49.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.085 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.403 ' HZ3' ' HB3' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -138.59 114.79 10.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.276 179.24 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 1.023 HG12 HG22 ' A' ' 42' ' ' VAL . 0.7 OUTLIER -102.59 122.05 54.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 121.229 0.538 . . . . 0.0 111.388 -179.588 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.742 HG23 ' HB2' ' A' ' 9' ' ' ALA . 7.4 p -136.4 161.03 37.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.626 179.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.523 ' N ' HG22 ' A' ' 18' ' ' VAL . 3.7 m120 -63.53 140.02 58.83 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 179.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.1 -38.86 73.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.717 0.294 . . . . 0.0 110.977 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.72 -10.45 58.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.11 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.62 -6.89 13.89 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.724 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.798 ' HB3' ' CZ2' ' A' ' 28' ' ' TRP . . . -80.36 150.68 29.78 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.832 0.348 . . . . 0.0 110.925 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.413 ' O ' ' CE3' ' A' ' 28' ' ' TRP . 43.5 p -103.77 169.17 8.67 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.254 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.647 ' CD2' HG23 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -54.49 -29.56 50.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.917 0.389 . . . . 0.0 110.645 179.87 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.647 HG23 ' CD2' ' A' ' 25' ' ' HIS . 21.5 t -74.28 -31.37 28.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.324 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.445 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 0.5 OUTLIER -67.19 -44.08 80.51 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 179.856 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.798 ' CZ2' ' HB3' ' A' ' 23' ' ' ALA . 7.5 m-90 -73.97 -30.15 62.36 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.884 179.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -58.1 -44.15 87.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.439 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -111.69 28.89 8.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.538 179.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 13.0 t -80.09 136.14 36.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.162 -179.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.504 HG22 ' O ' ' A' ' 42' ' ' VAL . 15.7 m -94.58 -41.61 12.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.753 179.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.612 ' CZ3' HG23 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -139.73 153.2 47.15 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.952 0.406 . . . . 0.0 111.503 -179.465 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -164.6 111.87 1.05 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.897 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 35.7 p-10 -107.26 126.54 52.55 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.017 0.437 . . . . 0.0 111.375 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -67.7 -34.56 77.13 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.295 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.436 ' O ' ' HA ' ' A' ' 95' ' ' GLN . 11.7 p30 -59.75 -22.76 62.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.877 0.37 . . . . 0.0 110.601 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.446 ' HA ' ' NE ' ' A' ' 38' ' ' ARG . 3.2 tpm_? -117.39 -3.91 11.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.06 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 48.66 34.68 5.29 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.07 0.462 . . . . 0.0 110.059 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.776 HD13 HD11 ' A' ' 123' ' ' LEU . 41.5 tp -124.85 152.6 43.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.953 -179.181 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.765 HD12 ' NE1' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -143.78 155.92 44.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.472 179.692 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 1.023 HG22 HG12 ' A' ' 17' ' ' VAL . 24.4 t -121.41 130.33 74.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.152 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.0 p -121.93 157.26 31.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.29 179.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.645 HG22 ' HE1' ' A' ' 15' ' ' TYR . 17.8 p -97.36 125.11 41.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.166 0.508 . . . . 0.0 111.576 -179.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.683 HG21 ' CE1' ' A' ' 11' ' ' TYR . 0.7 OUTLIER -93.39 -31.55 14.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.904 -179.503 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.82 38.07 6.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.893 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -136.78 -175.39 4.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.078 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -71.77 125.85 28.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.895 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.38 173.53 11.24 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.498 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.2 m -142.9 -71.92 0.31 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.847 0.356 . . . . 0.0 110.903 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -67.52 146.67 53.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.007 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.926 ' O ' HG23 ' A' ' 120' ' ' VAL . 62.7 m -120.91 118.97 31.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.579 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.853 HD11 HG21 ' A' ' 12' ' ' VAL . 1.0 OUTLIER -76.56 139.55 18.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.996 -179.84 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.827 ' HB2' ' N ' ' A' ' 119' ' ' GLY . . . -100.81 118.42 36.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.802 179.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.554 ' H ' ' HB3' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -90.77 42.65 1.11 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.104 0.478 . . . . 0.0 110.519 179.701 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 15.6 p -99.7 167.16 10.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.835 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.64 39.32 3.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.43 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 28.9 m -72.85 128.06 34.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.759 0.314 . . . . 0.0 110.526 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.54 -13.03 62.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.961 179.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.5 p -108.38 159.26 16.8 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.952 0.406 . . . . 0.0 111.09 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -177.18 148.84 9.08 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.675 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.784 HG23 ' C ' ' A' ' 72' ' ' TYR . 7.4 p -105.08 136.47 38.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.997 0.427 . . . . 0.0 111.572 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.632 ' HE2' HG21 ' A' ' 74' ' ' VAL . 5.6 p90 -125.1 142.08 51.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.564 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -56.27 120.06 6.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.915 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.435 ' HB2' ' CD1' ' A' ' 72' ' ' TYR . 0.8 OUTLIER -69.72 140.16 53.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.068 -179.804 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.547 ' HB2' ' C ' ' A' ' 109' ' ' ASP . . . -85.14 -45.17 12.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.95 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.0 -30.64 62.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.535 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.9 tttp -115.15 152.89 31.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.67 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.2 m -96.02 36.25 1.33 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.951 0.405 . . . . 0.0 110.483 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.442 ' HD3' ' CE1' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -127.57 169.94 13.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.782 -179.472 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.689 ' HB3' HG21 ' A' ' 62' ' ' VAL . 5.5 m170 -84.24 127.05 33.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.75 179.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.784 ' C ' HG23 ' A' ' 62' ' ' VAL . 3.1 m-85 -110.28 114.01 55.91 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.659 -178.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 72' ' ' TYR . 4.4 Cg_exo -79.14 120.6 4.61 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.534 2.156 . . . . 0.0 110.712 178.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.632 HG21 ' HE2' ' A' ' 63' ' ' TYR . 54.9 t -134.63 141.9 42.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.038 0.446 . . . . 0.0 112.162 -178.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.1 p -95.22 126.45 40.55 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.517 ' HB3' ' HB2' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -130.45 167.65 18.26 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.548 0.69 . . . . 0.0 112.358 -178.279 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.621 ' C ' ' HD3' ' A' ' 79' ' ' PRO . 0.9 OUTLIER -111.79 159.14 18.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.799 178.741 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -110.52 65.97 0.24 Allowed Glycine 0 CA--C 1.522 0.501 0 C-N-CA 120.081 -1.057 . . . . 0.0 114.196 -179.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.621 ' HD3' ' C ' ' A' ' 77' ' ' GLU . 16.2 Cg_exo -66.92 141.66 59.49 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.113 1.875 . . . . 0.0 111.914 179.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -61.59 -94.55 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.777 -0.647 . . . . 0.0 113.089 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.556 HD22 ' HB3' ' A' ' 96' ' ' SER . 0.0 OUTLIER -86.22 119.92 27.02 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.119 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.625 ' HB ' HG11 ' A' ' 98' ' ' VAL . 67.6 t -124.36 122.96 65.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.218 177.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.01 107.68 4.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.042 0.449 . . . . 0.0 110.679 -178.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.81 HG13 ' HG2' ' A' ' 126' ' ' MET . 24.4 t -74.88 114.35 14.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.834 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.448 ' HA ' ' HG2' ' A' ' 92' ' ' LYS . 8.5 pt20 -77.02 150.18 35.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.574 179.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.592 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 23.0 tt0 -67.54 100.35 0.86 Allowed 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.945 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.523 ' O ' ' N ' ' A' ' 89' ' ' TYR . 43.0 t -145.12 159.8 42.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.674 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.401 ' HB3' ' H ' ' A' ' 89' ' ' TYR . 6.0 tt0 50.96 -82.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.664 178.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.523 ' N ' ' O ' ' A' ' 87' ' ' SER . 2.0 p90 -155.91 25.83 0.38 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.846 0.355 . . . . 0.0 110.594 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.592 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 0.3 OUTLIER -116.67 116.45 38.67 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.574 -179.934 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.461 ' O ' ' N ' ' A' ' 93' ' ' ARG . 37.9 Cg_exo -60.4 148.68 89.65 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.88 2.387 . . . . 0.0 112.729 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.2 OUTLIER -61.95 73.07 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.832 179.55 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.461 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -124.14 179.76 4.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.189 0.518 . . . . 0.0 112.027 -179.314 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.441 ' HB3' HD11 ' A' ' 81' ' ' LEU . 11.1 m-85 -99.28 132.26 44.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.642 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.436 ' HA ' ' O ' ' A' ' 37' ' ' ASN . 1.5 mm100 -131.57 130.6 42.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.713 0.292 . . . . 0.0 111.242 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.556 ' HB3' HD22 ' A' ' 81' ' ' LEU . 11.0 p -102.4 147.88 26.17 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.886 0.374 . . . . 0.0 111.736 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 73.74 56.3 0.1 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.876 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.625 HG11 ' HB ' ' A' ' 82' ' ' VAL . 10.0 p -123.57 143.18 37.59 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.036 179.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.446 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 10.7 mp -104.59 143.54 32.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.278 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.711 HD23 ' O ' ' A' ' 132' ' ' VAL . 6.5 mt -133.26 141.5 48.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.041 0.448 . . . . 0.0 112.158 -179.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.517 ' HB2' ' HB3' ' A' ' 76' ' ' PHE . . . -150.99 144.86 25.17 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.971 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 1.2 t -100.28 125.32 46.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.914 0.387 . . . . 0.0 111.021 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -74.87 -45.98 19.08 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.527 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.6 t80 62.17 29.96 17.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.846 0.355 . . . . 0.0 110.917 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 43.9 m -138.94 -60.21 0.58 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.916 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -148.44 140.44 14.48 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.969 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -77.27 -175.51 2.7 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.611 2.207 . . . . 0.0 112.316 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.66 155.87 27.46 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.648 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.547 ' C ' ' HB2' ' A' ' 66' ' ' ALA . 0.5 OUTLIER -148.66 -49.76 0.16 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.777 0.322 . . . . 0.0 110.811 179.944 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 56.82 -168.3 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.222 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -90.36 104.55 3.15 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.561 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.798 ' O ' HG13 ' A' ' 124' ' ' VAL . . . -152.01 175.12 30.87 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.359 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.56 HD13 HG13 ' A' ' 120' ' ' VAL . 2.5 pp -126.04 146.19 32.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.881 0.372 . . . . 0.0 111.192 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.604 ' HG ' ' HB ' ' A' ' 121' ' ' ILE . 7.9 tp -87.61 115.57 25.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.083 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.99 148.3 42.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.222 0.534 . . . . 0.0 111.718 -179.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.519 ' HB2' HD11 ' A' ' 121' ' ' ILE . 8.2 t -109.4 164.79 12.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.08 179.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.81 -20.41 15.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.807 0.337 . . . . 0.0 110.618 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.506 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . 28.9 m80 -88.9 -36.84 15.72 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.291 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.827 ' N ' ' HB2' ' A' ' 54' ' ' ALA . . . 178.42 -135.3 2.6 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.398 -0.906 . . . . 0.0 113.063 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.926 HG23 ' O ' ' A' ' 52' ' ' THR . 3.9 t -104.38 135.67 41.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.793 0.33 . . . . 0.0 111.402 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.604 ' HB ' ' HG ' ' A' ' 114' ' ' LEU . 1.1 mm -97.86 -67.05 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.774 179.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.952 ' HA2' HG23 ' A' ' 137' ' ' VAL . . . -156.96 -168.34 19.42 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.023 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.776 HD11 HD13 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -116.75 164.45 14.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.637 0.256 . . . . 0.0 110.456 179.913 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.798 HG13 ' O ' ' A' ' 112' ' ' GLY . 31.3 m -71.99 137.78 22.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.933 0.397 . . . . 0.0 111.841 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.518 HG23 ' H ' ' A' ' 126' ' ' MET . 0.0 OUTLIER -130.01 -91.23 0.46 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.168 178.98 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.81 ' HG2' HG13 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -85.94 145.63 27.06 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.333 179.255 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -145.81 107.28 0.41 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.596 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -91.18 -167.2 40.99 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.439 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -92.92 17.2 11.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.661 0.267 . . . . 0.0 111.135 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 102' ' ' THR . . . -158.6 -31.09 0.02 OUTLIER Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.94 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.675 ' CG1' HD22 ' A' ' 100' ' ' LEU . 1.7 t -115.39 157.11 16.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.772 0.32 . . . . 0.0 111.108 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.711 ' O ' HD23 ' A' ' 100' ' ' LEU . 15.2 m -115.73 118.26 58.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.383 -179.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -96.06 122.02 7.16 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.055 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.585 ' HD2' HD22 ' A' ' 114' ' ' LEU . 15.6 m-85 -125.17 139.47 53.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.976 0.417 . . . . 0.0 111.608 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.441 ' N ' HG22 ' A' ' 125' ' ' THR . . . -88.87 115.08 26.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.364 179.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -68.98 140.07 55.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.984 0.421 . . . . 0.0 112.004 -179.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.952 HG23 ' HA2' ' A' ' 122' ' ' GLY . 81.2 t -90.46 9.02 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.511 178.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.559 ' HA ' HD23 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -70.1 -6.58 34.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.619 179.922 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -97.08 11.17 37.15 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.859 ' O ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -175.77 49.17 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.231 0.538 . . . . 0.0 110.61 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.738 HD11 ' HB ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -67.41 -14.75 63.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.997 -179.629 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . 0.422 ' CE3' ' CE2' ' A' ' 15' ' ' TYR . 16.7 p-90 -57.71 80.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.039 0.447 . . . . 0.0 111.495 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.69 HD23 ' HB2' ' A' ' 15' ' ' TYR . 4.9 mp -142.29 -47.28 0.34 Allowed 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.162 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.682 ' OE2' HG23 ' A' ' 52' ' ' THR . 17.4 pt-20 -154.71 -162.98 1.48 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.669 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.69 122.15 16.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.976 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.661 ' OD1' HD12 ' A' ' 141' ' ' LEU . 86.4 m-20 -85.33 154.21 22.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.935 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.554 ' HB3' ' H ' ' A' ' 55' ' ' ARG . . . -80.91 120.03 24.21 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.06 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -105.23 169.82 8.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.93 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.02 125.67 24.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.893 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.859 179.941 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_